0000742112-22-000085.txt : 20221107 0000742112-22-000085.hdr.sgml : 20221107 20221107163438 ACCESSION NUMBER: 0000742112-22-000085 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 125 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221107 DATE AS OF CHANGE: 20221107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 221366014 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 MAIL ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 10-Q 1 ivc-20220930.htm 10-Q ivc-20220930
000074211212/312022Q3FALSEP5YP5YP5D00007421122022-01-012022-09-300000742112us-gaap:CommonStockMember2022-11-04xbrli:shares0000742112us-gaap:CommonClassBMember2022-11-0400007421122022-07-012022-09-30iso4217:USD00007421122021-07-012021-09-3000007421122021-01-012021-09-30iso4217:USDxbrli:shares00007421122022-09-3000007421122021-12-310000742112us-gaap:CommonStockMember2021-12-310000742112us-gaap:CommonStockMember2022-09-300000742112us-gaap:CommonClassBMember2022-09-300000742112us-gaap:CommonClassBMember2021-12-3100007421122020-12-3100007421122021-09-300000742112us-gaap:CommonStockMember2022-06-300000742112us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-06-300000742112us-gaap:AdditionalPaidInCapitalMember2022-06-300000742112us-gaap:RetainedEarningsMember2022-06-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000742112us-gaap:TreasuryStockMember2022-06-3000007421122022-06-300000742112us-gaap:CommonStockMember2022-07-012022-09-300000742112us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300000742112us-gaap:TreasuryStockMember2022-07-012022-09-300000742112us-gaap:RetainedEarningsMember2022-07-012022-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300000742112us-gaap:CommonStockMember2022-09-300000742112us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-09-300000742112us-gaap:AdditionalPaidInCapitalMember2022-09-300000742112us-gaap:RetainedEarningsMember2022-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300000742112us-gaap:TreasuryStockMember2022-09-300000742112us-gaap:CommonStockMember2021-06-300000742112us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-06-300000742112us-gaap:AdditionalPaidInCapitalMember2021-06-300000742112us-gaap:RetainedEarningsMember2021-06-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300000742112us-gaap:TreasuryStockMember2021-06-3000007421122021-06-300000742112us-gaap:CommonStockMember2021-07-012021-09-300000742112us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300000742112us-gaap:TreasuryStockMember2021-07-012021-09-300000742112us-gaap:RetainedEarningsMember2021-07-012021-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300000742112us-gaap:CommonStockMember2021-09-300000742112us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-09-300000742112us-gaap:AdditionalPaidInCapitalMember2021-09-300000742112us-gaap:RetainedEarningsMember2021-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300000742112us-gaap:TreasuryStockMember2021-09-300000742112us-gaap:CommonStockMember2021-12-310000742112us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-12-310000742112us-gaap:AdditionalPaidInCapitalMember2021-12-310000742112us-gaap:RetainedEarningsMember2021-12-310000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000742112us-gaap:TreasuryStockMember2021-12-310000742112us-gaap:CommonStockMember2022-01-012022-09-300000742112us-gaap:AdditionalPaidInCapitalMember2022-01-012022-09-300000742112us-gaap:TreasuryStockMember2022-01-012022-09-300000742112us-gaap:RetainedEarningsMember2022-01-012022-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300000742112us-gaap:CommonStockMember2020-12-310000742112us-gaap:CommonStockMemberus-gaap:CommonClassBMember2020-12-310000742112us-gaap:AdditionalPaidInCapitalMember2020-12-310000742112us-gaap:RetainedEarningsMember2020-12-310000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000742112us-gaap:TreasuryStockMember2020-12-310000742112us-gaap:CommonStockMember2021-01-012021-09-300000742112us-gaap:AdditionalPaidInCapitalMember2021-01-012021-09-300000742112us-gaap:TreasuryStockMember2021-01-012021-09-300000742112us-gaap:RetainedEarningsMember2021-01-012021-09-300000742112us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-300000742112us-gaap:RiskLevelLowMember2022-01-012022-09-30xbrli:pure0000742112us-gaap:RiskLevelMediumMember2022-01-012022-09-300000742112us-gaap:RiskLevelHighMember2022-01-012022-09-30ivc:payment00007421122021-01-012021-12-310000742112ivc:AllOtherMember2022-09-300000742112ivc:AllOtherMember2022-01-012022-09-300000742112ivc:AllOtherMember2021-12-310000742112ivc:AllOtherMember2021-01-012021-12-310000742112us-gaap:MachineryAndEquipmentMember2022-09-300000742112us-gaap:MachineryAndEquipmentMember2021-12-310000742112ivc:CapitalizedSoftwareMember2022-09-300000742112ivc:CapitalizedSoftwareMember2021-12-310000742112us-gaap:LandBuildingsAndImprovementsMember2022-09-300000742112us-gaap:LandBuildingsAndImprovementsMember2021-12-310000742112us-gaap:FurnitureAndFixturesMember2022-09-300000742112us-gaap:FurnitureAndFixturesMember2021-12-310000742112us-gaap:LeaseholdImprovementsMember2022-09-300000742112us-gaap:LeaseholdImprovementsMember2021-12-310000742112us-gaap:CustomerListsMember2022-09-300000742112us-gaap:CustomerListsMember2021-12-310000742112us-gaap:TrademarksMember2022-09-300000742112us-gaap:TrademarksMember2021-12-310000742112us-gaap:DevelopedTechnologyRightsMember2022-09-300000742112us-gaap:DevelopedTechnologyRightsMember2021-12-310000742112us-gaap:PatentsMember2022-09-300000742112us-gaap:PatentsMember2021-12-310000742112us-gaap:LicensingAgreementsMember2022-09-300000742112us-gaap:LicensingAgreementsMember2021-12-310000742112us-gaap:OtherIntangibleAssetsMember2022-09-300000742112us-gaap:OtherIntangibleAssetsMember2021-12-310000742112srt:MinimumMember2022-01-012022-09-300000742112srt:MaximumMember2022-01-012022-09-300000742112srt:WeightedAverageMember2022-01-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt450February20221Member2022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt450February20221Member2021-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt500November2024AMember2022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt500November2024AMember2021-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024BMember2022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024BMember2021-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt425March2026CMember2022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt425March2026CMember2021-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember2022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember2021-12-310000742112us-gaap:SecuredDebtMemberivc:SecuredTermLoansDueJuly2026Member2022-09-300000742112ivc:SecuredTermLoanIssuanceJuly26th2022Memberivc:SecuredTermLoansDueJuly2026Member2021-12-310000742112ivc:OtherNotesandCapitalLeaseObligationsMember2022-09-300000742112ivc:OtherNotesandCapitalLeaseObligationsMember2021-12-310000742112us-gaap:LetterOfCreditMember2022-09-300000742112us-gaap:LetterOfCreditMember2021-12-310000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember2022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember2021-12-310000742112currency:EURus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember2021-12-310000742112currency:GBPus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember2021-12-310000742112us-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMemberus-gaap:LetterOfCreditMember2022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember2022-01-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembersrt:MinimumMember2022-01-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembersrt:MaximumMember2022-01-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMembersrt:MinimumMember2022-01-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMembersrt:MaximumMember2022-01-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMembersrt:MinimumMember2022-01-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMembersrt:MaximumMember2022-01-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementNorthAmericaCreditAgreementMember2022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember2022-09-300000742112us-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMemberus-gaap:LetterOfCreditMember2022-09-300000742112ivc:SwingLineLoansMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember2022-09-300000742112ivc:AmountAvailableToInvacareLimitedAndInvacarePoirierSASMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember2022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember2022-01-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembersrt:MinimumMember2022-01-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembersrt:MaximumMember2022-01-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMembersrt:MinimumMember2022-01-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMembersrt:MaximumMember2022-01-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMembersrt:MinimumMember2022-01-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMembersrt:MaximumMember2022-01-012022-09-300000742112ivc:SecuredRevolvingCreditAndSecurityAgreementABLCreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2022-07-260000742112ivc:SecuredRevolvingCreditAndSecurityAgreementABLCreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2022-07-012022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember2022-07-260000742112ivc:SecuredRevolvingCreditAndSecurityAgreementABLCreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-07-012022-09-300000742112ivc:SecuredRevolvingCreditAndSecurityAgreementABLCreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:PrimeRateMember2022-07-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorSubordinatedDebenturesAt500February2021Member2022-01-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt450February20221Member2017-06-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt450February20221Member2017-04-012017-06-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt450February20221Member2017-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00February2021Member2020-04-012020-06-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt450February20221Member2020-04-012020-06-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2020-04-012020-06-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2020-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt450February2022Member2021-03-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2021-01-012021-03-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt450February20221Member2022-07-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt450February20221Member2022-01-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt450February20221Member2021-07-012021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt450February20221Member2021-01-012021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesat5.00February2021Member2019-10-012019-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt500November2024BMember2022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt500November2024BMember2019-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt500November2024BMember2022-01-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt500November2024AMember2022-01-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt500November2024BMember2021-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt500November2024BMember2022-07-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt500November2024BMember2021-07-012021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt500November2024BMember2021-01-012021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2022-01-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024BMember2022-01-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2022-07-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2021-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2021-07-012021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2021-01-012021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt425March2026CMember2021-03-110000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt425March2026Member2022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt425March2026Member2022-01-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt425March2026Member2021-03-110000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt425March2026Member2021-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt425March2026Member2022-07-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt425March2026Member2021-07-012021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt425March2026Member2021-01-012021-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorNotesAt425March2026Memberivc:Round1FundingInitialClosingMember2022-07-012022-09-300000742112us-gaap:SecuredDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026Member2022-07-012022-09-3000007421122021-01-012021-06-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026Member2022-09-300000742112us-gaap:SecuredDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheINotesMember2022-07-260000742112us-gaap:SecuredDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheIINotesMember2022-07-260000742112us-gaap:ConvertibleSubordinatedDebtMemberus-gaap:SubsequentEventMemberivc:ConvertibleSeniorNotesAt425March2026Memberivc:AdditionalAmountAfterClosingRound2Member2022-10-012022-12-310000742112us-gaap:SecuredDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026Member2022-07-260000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026Member2022-07-012022-09-30utr:D0000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember2022-07-260000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember2022-07-012022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheINotesMember2022-07-260000742112us-gaap:SecuredDebtMemberivc:SecuredTermLoansDueJuly2026Member2022-07-260000742112us-gaap:SecuredDebtMemberivc:InitialAmountAtClosingMemberivc:SecuredTermLoansDueJuly2026Member2022-07-260000742112ivc:SecuredTermLoansDueJuly2026Member2022-07-260000742112us-gaap:SecuredDebtMemberivc:AdditionalAmountAfterClosingRound2Memberivc:SecuredTermLoansDueJuly2026Member2022-07-260000742112us-gaap:SecuredDebtMemberivc:AdditionalAmountAfterClosingRound3Memberivc:SecuredTermLoansDueJuly2026Member2022-07-260000742112us-gaap:SecuredDebtMemberivc:AdditionalAmountAfterClosingRound4Memberivc:SecuredTermLoansDueJuly2026Member2022-07-260000742112us-gaap:SecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberivc:FirstYearOfLoanPeriodMemberivc:SecuredTermLoansDueJuly2026Member2022-07-012022-09-300000742112us-gaap:SecuredDebtMemberus-gaap:BaseRateMemberivc:FirstYearOfLoanPeriodMemberivc:SecuredTermLoansDueJuly2026Member2022-07-012022-09-300000742112ivc:Year2AndOnMemberus-gaap:SecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberivc:SecuredTermLoansDueJuly2026Member2022-07-012022-09-300000742112ivc:Year2AndOnMemberus-gaap:SecuredDebtMemberus-gaap:BaseRateMemberivc:SecuredTermLoansDueJuly2026Member2022-07-012022-09-300000742112us-gaap:SecuredDebtMemberivc:SecuredTermLoansDueJuly2026Member2022-07-012022-09-300000742112us-gaap:SecuredDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026Memberivc:FirstYearOfLoanPeriodMember2022-07-012022-09-300000742112ivc:Year2AndOnMemberus-gaap:SecuredDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026Member2022-07-012022-09-300000742112ivc:Year2AndOnMemberus-gaap:SecuredDebtMemberus-gaap:SubsequentEventMemberivc:ConvertibleSeniorSecuredNotesAt568July2026Member2022-10-012022-12-310000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2022-09-300000742112us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-12-310000742112us-gaap:SecuredDebtMemberivc:AdditionalAmountAfterClosingRound3Memberus-gaap:SubsequentEventMemberivc:SecuredTermLoansDueJuly2026Member2022-10-030000742112us-gaap:SecuredDebtMemberivc:AdditionalAmountAfterClosingRound4Memberus-gaap:SubsequentEventMemberivc:SecuredTermLoansDueJuly2026Member2022-10-030000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheINotesMemberivc:AdditionalAmountAfterClosingRound3Memberus-gaap:SubsequentEventMember2022-10-030000742112us-gaap:SecuredDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheINotesMemberus-gaap:SubsequentEventMember2022-10-030000742112us-gaap:ConvertibleSubordinatedDebtMemberivc:AdditionalAmountAfterClosingRound3Memberivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheIINotesMemberus-gaap:SubsequentEventMember2022-10-030000742112us-gaap:SecuredDebtMemberivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheIINotesMemberus-gaap:SubsequentEventMember2022-10-030000742112us-gaap:ConvertibleSubordinatedDebtMemberus-gaap:SubsequentEventMemberivc:ConvertibleSeniorNotesAt425March2026Member2022-10-012022-12-3100007421122015-04-2300007421122015-07-012015-09-3000007421122015-04-222015-04-230000742112us-gaap:ProductMemberivc:EuropeEMEAMember2022-07-012022-09-300000742112ivc:EuropeEMEAMemberivc:ServicesMember2022-07-012022-09-300000742112ivc:EuropeEMEAMember2022-07-012022-09-300000742112us-gaap:ProductMemberivc:NorthAmericaNAMember2022-07-012022-09-300000742112ivc:NorthAmericaNAMemberivc:ServicesMember2022-07-012022-09-300000742112ivc:NorthAmericaNAMember2022-07-012022-09-300000742112ivc:AllOtherMemberus-gaap:ProductMember2022-07-012022-09-300000742112ivc:AllOtherMemberivc:ServicesMember2022-07-012022-09-300000742112ivc:AllOtherMember2022-07-012022-09-300000742112us-gaap:ProductMember2022-07-012022-09-300000742112ivc:ServicesMember2022-07-012022-09-300000742112us-gaap:ProductMemberivc:EuropeEMEAMember2022-01-012022-09-300000742112ivc:EuropeEMEAMemberivc:ServicesMember2022-01-012022-09-300000742112ivc:EuropeEMEAMember2022-01-012022-09-300000742112us-gaap:ProductMemberivc:NorthAmericaNAMember2022-01-012022-09-300000742112ivc:NorthAmericaNAMemberivc:ServicesMember2022-01-012022-09-300000742112ivc:NorthAmericaNAMember2022-01-012022-09-300000742112ivc:AllOtherMemberus-gaap:ProductMember2022-01-012022-09-300000742112ivc:AllOtherMemberivc:ServicesMember2022-01-012022-09-300000742112us-gaap:ProductMember2022-01-012022-09-300000742112ivc:ServicesMember2022-01-012022-09-300000742112us-gaap:ProductMemberivc:EuropeEMEAMember2021-07-012021-09-300000742112ivc:EuropeEMEAMemberivc:ServicesMember2021-07-012021-09-300000742112ivc:EuropeEMEAMember2021-07-012021-09-300000742112us-gaap:ProductMemberivc:NorthAmericaNAMember2021-07-012021-09-300000742112ivc:NorthAmericaNAMemberivc:ServicesMember2021-07-012021-09-300000742112ivc:NorthAmericaNAMember2021-07-012021-09-300000742112ivc:AllOtherMemberus-gaap:ProductMember2021-07-012021-09-300000742112ivc:AllOtherMemberivc:ServicesMember2021-07-012021-09-300000742112ivc:AllOtherMember2021-07-012021-09-300000742112us-gaap:ProductMember2021-07-012021-09-300000742112ivc:ServicesMember2021-07-012021-09-300000742112us-gaap:ProductMemberivc:EuropeEMEAMember2021-01-012021-09-300000742112ivc:EuropeEMEAMemberivc:ServicesMember2021-01-012021-09-300000742112ivc:EuropeEMEAMember2021-01-012021-09-300000742112us-gaap:ProductMemberivc:NorthAmericaNAMember2021-01-012021-09-300000742112ivc:NorthAmericaNAMemberivc:ServicesMember2021-01-012021-09-300000742112ivc:NorthAmericaNAMember2021-01-012021-09-300000742112ivc:AllOtherMemberus-gaap:ProductMember2021-01-012021-09-300000742112ivc:AllOtherMemberivc:ServicesMember2021-01-012021-09-300000742112ivc:AllOtherMember2021-01-012021-09-300000742112us-gaap:ProductMember2021-01-012021-09-300000742112ivc:ServicesMember2021-01-012021-09-300000742112ivc:GeneralTermsandConditionsMember2022-01-012022-09-300000742112ivc:LargeNationalCustomersMember2022-01-012022-09-300000742112ivc:GovernmentTendersMember2022-01-012022-09-300000742112ivc:OtherCustomersMember2022-01-012022-09-300000742112us-gaap:CommonClassBMember2022-01-012022-09-30ivc:votes0000742112us-gaap:CommonStockMember2022-01-012022-09-300000742112us-gaap:EmployeeStockOptionMember2022-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberivc:RestrictedStockandRestrictedStockUnitsRSUsMember2022-01-012022-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberivc:RestrictedStockandRestrictedStockUnitsRSUsMember2021-01-012021-09-300000742112us-gaap:PerformanceSharesMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-09-300000742112us-gaap:PerformanceSharesMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-09-300000742112ivc:RestrictedStockandRestrictedStockUnitsRSUsMember2022-09-300000742112us-gaap:PerformanceSharesMember2022-09-300000742112us-gaap:EmployeeStockOptionMember2022-01-012022-09-300000742112ivc:RangeOfExercisePriceRangeMinMember2022-01-012022-09-300000742112ivc:RangeOfExercisePriceMaxMember2022-01-012022-09-300000742112ivc:A2013PlanMember2022-09-300000742112ivc:RangeOfExercisePriceRangeMinMembersrt:MinimumMember2022-01-012022-09-300000742112ivc:RangeOfExercisePriceRangeMinMembersrt:MaximumMember2022-01-012022-09-300000742112us-gaap:EmployeeStockOptionMemberivc:RangeOfExercisePriceRangeMinMember2022-09-300000742112us-gaap:EmployeeStockOptionMemberivc:RangeOfExercisePriceRangeMinMember2022-01-012022-09-300000742112ivc:RestrictedStockandRestrictedStockUnitsRSUsMember2021-12-310000742112ivc:RestrictedStockandRestrictedStockUnitsRSUsMember2022-01-012022-09-300000742112us-gaap:PerformanceSharesMember2021-12-310000742112us-gaap:PerformanceSharesMember2022-01-012022-09-300000742112srt:WeightedAverageMemberus-gaap:PerformanceSharesMember2022-01-012022-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2022-06-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-06-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2022-07-012022-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2022-07-012022-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-012022-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-07-012022-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2022-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2022-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000742112ivc:AccumulatedLongTermNotesAdjustmentMember2021-12-310000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-12-310000742112us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2022-01-012022-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-01-012022-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2021-06-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2021-06-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-06-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-06-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2021-07-012021-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2021-07-012021-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-07-012021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-07-012021-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2021-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2021-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-09-300000742112us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310000742112ivc:AccumulatedLongTermNotesAdjustmentMember2020-12-310000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-12-310000742112us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-09-300000742112ivc:AccumulatedLongTermNotesAdjustmentMember2021-01-012021-09-300000742112us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-012021-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-012022-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-07-012021-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-09-300000742112us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeForwardMember2022-07-012022-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeForwardMember2021-07-012021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeForwardMember2022-01-012022-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeForwardMember2021-01-012021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300000742112us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-300000742112ivc:NorthAmericaNAMemberus-gaap:EmployeeSeveranceMember2021-01-012021-09-300000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2021-01-012021-09-300000742112ivc:EuropeEMEAMemberus-gaap:ContractTerminationMember2021-01-012021-09-300000742112ivc:NorthAmericaNAMemberus-gaap:EmployeeSeveranceMember2021-12-310000742112us-gaap:OtherRestructuringMemberivc:NorthAmericaNAMember2021-12-310000742112ivc:NorthAmericaNAMember2021-12-310000742112us-gaap:EmployeeSeveranceMember2021-12-310000742112us-gaap:OtherRestructuringMember2021-12-310000742112ivc:NorthAmericaNAMemberus-gaap:EmployeeSeveranceMember2022-01-012022-03-310000742112us-gaap:OtherRestructuringMemberivc:NorthAmericaNAMember2022-01-012022-03-310000742112ivc:NorthAmericaNAMember2022-01-012022-03-310000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2022-01-012022-03-310000742112ivc:EuropeEMEAMemberus-gaap:OtherRestructuringMember2022-01-012022-03-310000742112ivc:EuropeEMEAMember2022-01-012022-03-310000742112ivc:AllOtherMemberus-gaap:EmployeeSeveranceMember2022-01-012022-03-310000742112ivc:AllOtherMemberus-gaap:OtherRestructuringMember2022-01-012022-03-310000742112ivc:AllOtherMember2022-01-012022-03-310000742112us-gaap:EmployeeSeveranceMember2022-01-012022-03-310000742112us-gaap:OtherRestructuringMember2022-01-012022-03-3100007421122022-01-012022-03-310000742112ivc:NorthAmericaNAMemberus-gaap:EmployeeSeveranceMember2022-03-310000742112us-gaap:OtherRestructuringMemberivc:NorthAmericaNAMember2022-03-310000742112ivc:NorthAmericaNAMember2022-03-310000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2022-03-310000742112ivc:EuropeEMEAMemberus-gaap:OtherRestructuringMember2022-03-310000742112ivc:EuropeEMEAMember2022-03-310000742112us-gaap:EmployeeSeveranceMember2022-03-310000742112us-gaap:OtherRestructuringMember2022-03-3100007421122022-03-310000742112ivc:NorthAmericaNAMemberus-gaap:EmployeeSeveranceMember2022-04-012022-06-300000742112us-gaap:OtherRestructuringMemberivc:NorthAmericaNAMember2022-04-012022-06-300000742112ivc:NorthAmericaNAMember2022-04-012022-06-300000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2022-04-012022-06-300000742112ivc:EuropeEMEAMemberus-gaap:OtherRestructuringMember2022-04-012022-06-300000742112ivc:EuropeEMEAMember2022-04-012022-06-300000742112us-gaap:EmployeeSeveranceMember2022-04-012022-06-300000742112us-gaap:OtherRestructuringMember2022-04-012022-06-3000007421122022-04-012022-06-300000742112ivc:NorthAmericaNAMemberus-gaap:EmployeeSeveranceMember2022-06-300000742112us-gaap:OtherRestructuringMemberivc:NorthAmericaNAMember2022-06-300000742112ivc:NorthAmericaNAMember2022-06-300000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2022-06-300000742112ivc:EuropeEMEAMemberus-gaap:OtherRestructuringMember2022-06-300000742112ivc:EuropeEMEAMember2022-06-300000742112us-gaap:EmployeeSeveranceMember2022-06-300000742112us-gaap:OtherRestructuringMember2022-06-300000742112ivc:NorthAmericaNAMemberus-gaap:EmployeeSeveranceMember2022-07-012022-09-300000742112us-gaap:OtherRestructuringMemberivc:NorthAmericaNAMember2022-07-012022-09-300000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2022-07-012022-09-300000742112ivc:EuropeEMEAMemberus-gaap:OtherRestructuringMember2022-07-012022-09-300000742112ivc:AllOtherMemberus-gaap:EmployeeSeveranceMember2022-07-012022-09-300000742112ivc:AllOtherMemberus-gaap:OtherRestructuringMember2022-07-012022-09-300000742112us-gaap:EmployeeSeveranceMember2022-07-012022-09-300000742112us-gaap:OtherRestructuringMember2022-07-012022-09-300000742112ivc:NorthAmericaNAMemberus-gaap:EmployeeSeveranceMember2022-09-300000742112us-gaap:OtherRestructuringMemberivc:NorthAmericaNAMember2022-09-300000742112ivc:NorthAmericaNAMember2022-09-300000742112ivc:EuropeEMEAMemberus-gaap:EmployeeSeveranceMember2022-09-300000742112ivc:EuropeEMEAMemberus-gaap:OtherRestructuringMember2022-09-300000742112ivc:EuropeEMEAMember2022-09-300000742112ivc:AllOtherMemberus-gaap:EmployeeSeveranceMember2022-09-300000742112ivc:AllOtherMemberus-gaap:OtherRestructuringMember2022-09-300000742112us-gaap:EmployeeSeveranceMember2022-09-300000742112us-gaap:OtherRestructuringMember2022-09-300000742112us-gaap:EmployeeStockOptionMember2022-07-012022-09-300000742112us-gaap:EmployeeStockOptionMember2022-01-012022-09-300000742112us-gaap:EmployeeStockOptionMember2021-07-012021-09-300000742112us-gaap:EmployeeStockOptionMember2021-01-012021-09-300000742112us-gaap:EmployeeStockOptionMember2022-09-300000742112us-gaap:EmployeeStockOptionMember2021-09-300000742112us-gaap:ForeignExchangeForwardMember2022-01-012022-09-300000742112us-gaap:ForeignExchangeForwardMember2021-01-012021-09-300000742112us-gaap:ForeignExchangeForwardMember2022-07-012022-09-300000742112us-gaap:ForeignExchangeForwardMember2021-07-012021-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDEURMember2022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDEURMember2022-01-012022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDEURMember2021-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDEURMember2022-01-012022-03-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDCADMember2022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDCADMember2022-01-012022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDCADMember2021-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDCADMember2022-01-012022-03-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardEURGBPMember2022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardEURGBPMember2022-01-012022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardEURGBPMember2021-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardEURGBPMember2022-01-012022-03-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardEURNOKMember2022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardEURNOKMember2022-01-012022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardEURNOKMember2021-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardEURNOKMember2022-01-012022-03-310000742112ivc:ForeignExchangeForwardNOKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300000742112ivc:ForeignExchangeForwardNOKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300000742112ivc:ForeignExchangeForwardNOKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000742112ivc:ForeignExchangeForwardNOKSEKMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-03-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDMXPMember2022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDMXPMember2022-01-012022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDMXPMember2021-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberivc:ForeignExchangeForwardUSDMXPMember2022-01-012022-03-310000742112us-gaap:DesignatedAsHedgingInstrumentMember2022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-03-310000742112ivc:ForeignExchangeForwardAUDUSDMemberus-gaap:NondesignatedMember2022-09-300000742112ivc:ForeignExchangeForwardAUDUSDMemberus-gaap:NondesignatedMember2022-01-012022-09-300000742112ivc:ForeignExchangeForwardAUDUSDMemberus-gaap:NondesignatedMember2021-12-310000742112ivc:ForeignExchangeForwardAUDUSDMemberus-gaap:NondesignatedMember2022-01-012022-03-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardCADUSDMember2022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardCADUSDMember2022-01-012022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardCADUSDMember2021-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardCADUSDMember2022-01-012022-03-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURUSDMember2022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURUSDMember2022-01-012022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURUSDMember2021-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURUSDMember2022-01-012022-03-310000742112ivc:ForeignExchangeForwardDKKUSDMemberus-gaap:NondesignatedMember2022-09-300000742112ivc:ForeignExchangeForwardDKKUSDMemberus-gaap:NondesignatedMember2022-01-012022-09-300000742112ivc:ForeignExchangeForwardDKKUSDMemberus-gaap:NondesignatedMember2021-12-310000742112ivc:ForeignExchangeForwardDKKUSDMemberus-gaap:NondesignatedMember2022-01-012022-03-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPUSDMember2022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPUSDMember2022-01-012022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPUSDMember2021-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardGBPUSDMember2022-01-012022-03-310000742112ivc:ForeignExchangeForwardNOKUSDMemberus-gaap:NondesignatedMember2022-09-300000742112ivc:ForeignExchangeForwardNOKUSDMemberus-gaap:NondesignatedMember2022-01-012022-09-300000742112ivc:ForeignExchangeForwardNOKUSDMemberus-gaap:NondesignatedMember2021-12-310000742112ivc:ForeignExchangeForwardNOKUSDMemberus-gaap:NondesignatedMember2022-01-012022-03-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardSEKUSDMember2022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardSEKUSDMember2022-01-012022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardSEKUSDMember2021-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardSEKUSDMember2022-01-012022-03-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURGBPMember2022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURGBPMember2022-01-012022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURGBPMember2021-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURGBPMember2022-01-012022-03-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURNOKMember2022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURNOKMember2022-01-012022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURNOKMember2021-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURNOKMember2022-01-012022-03-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardAUDNZDMember2022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardAUDNZDMember2022-01-012022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardAUDNZDMember2021-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardAUDNZDMember2022-01-012022-03-310000742112ivc:ForeignExchangeForwardUSDTHBMemberus-gaap:NondesignatedMember2022-09-300000742112ivc:ForeignExchangeForwardUSDTHBMemberus-gaap:NondesignatedMember2022-01-012022-09-300000742112ivc:ForeignExchangeForwardUSDTHBMemberus-gaap:NondesignatedMember2021-12-310000742112ivc:ForeignExchangeForwardUSDTHBMemberus-gaap:NondesignatedMember2022-01-012022-03-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURSEKMember2022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURSEKMember2022-01-012022-09-300000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURSEKMember2021-12-310000742112us-gaap:NondesignatedMemberivc:ForeignExchangeForwardEURSEKMember2022-01-012022-03-310000742112us-gaap:NondesignatedMember2022-09-300000742112us-gaap:NondesignatedMember2022-01-012022-09-300000742112us-gaap:NondesignatedMember2021-12-310000742112us-gaap:NondesignatedMember2022-01-012022-03-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMember2022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2022-09-300000742112us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMember2021-12-310000742112us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2021-12-310000742112us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMember2022-09-300000742112us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2022-09-300000742112us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMember2021-12-310000742112us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2021-12-310000742112us-gaap:OtherCurrentAssetsMember2022-09-300000742112us-gaap:AccruedLiabilitiesMember2022-09-300000742112us-gaap:OtherCurrentAssetsMember2021-12-310000742112us-gaap:AccruedLiabilitiesMember2021-12-310000742112us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2022-07-012022-09-300000742112us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2022-01-012022-09-300000742112us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2021-07-012021-09-300000742112us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2021-01-012021-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeForwardMember2022-07-012022-09-300000742112us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:ForeignExchangeForwardMember2022-01-012022-09-300000742112us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2021-07-012021-09-300000742112us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2021-01-012021-09-300000742112us-gaap:CashFlowHedgingMemberus-gaap:SalesMember2022-07-012022-09-300000742112us-gaap:CashFlowHedgingMemberus-gaap:SalesMember2022-01-012022-09-300000742112us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2022-07-012022-09-300000742112us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2022-01-012022-09-300000742112us-gaap:CashFlowHedgingMember2022-07-012022-09-300000742112us-gaap:CashFlowHedgingMember2022-01-012022-09-300000742112us-gaap:CashFlowHedgingMemberus-gaap:SalesMember2021-07-012021-09-300000742112us-gaap:CashFlowHedgingMemberus-gaap:SalesMember2021-01-012021-09-300000742112us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2021-07-012021-09-300000742112us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2021-01-012021-09-300000742112us-gaap:CashFlowHedgingMember2021-07-012021-09-300000742112us-gaap:CashFlowHedgingMember2021-01-012021-09-300000742112us-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300000742112us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueMeasurementsRecurringMember2022-09-300000742112us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueMeasurementsRecurringMember2022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300000742112ivc:ConvertibleDebtDerivativeMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300000742112us-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000742112us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000742112us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-09-300000742112us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000742112us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMember2022-09-300000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMember2022-09-300000742112us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMember2021-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMember2021-12-310000742112us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2022-09-300000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2022-09-300000742112us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:ForeignExchangeForwardMember2021-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2021-12-310000742112us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300000742112ivc:ConvertibleSeniorNotesAt450February2022Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorNotesAt450February2022Member2022-09-300000742112ivc:ConvertibleSeniorNotesAt450February2022Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorNotesAt450February2022Member2021-12-310000742112ivc:ConvertibleSeniorNotesAt500November2024BMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorNotesAt500November2024BMember2022-09-300000742112ivc:ConvertibleSeniorNotesAt500November2024BMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorNotesAt500November2024BMember2021-12-310000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2022-09-300000742112ivc:SeriesIIConvertibleSeniorNotesAt500November2024Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:SeriesIIConvertibleSeniorNotesAt500November2024Member2021-12-310000742112ivc:ConvertibleSeniorNotesAt425March2026Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorNotesAt425March2026Member2022-09-300000742112ivc:ConvertibleSeniorNotesAt425March2026Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorNotesAt425March2026Member2021-12-310000742112ivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember2022-09-300000742112ivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember2021-12-310000742112us-gaap:CarryingReportedAmountFairValueDisclosureMemberivc:SecuredTermLoansDueJuly2026Member2022-09-300000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:SecuredTermLoansDueJuly2026Member2022-09-300000742112us-gaap:CarryingReportedAmountFairValueDisclosureMemberivc:SecuredTermLoansDueJuly2026Member2021-12-310000742112us-gaap:EstimateOfFairValueFairValueDisclosureMemberivc:SecuredTermLoansDueJuly2026Member2021-12-310000742112ivc:OtherNotesandCapitalLeaseObligationsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300000742112ivc:OtherNotesandCapitalLeaseObligationsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-09-300000742112ivc:OtherNotesandCapitalLeaseObligationsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000742112ivc:OtherNotesandCapitalLeaseObligationsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-09-300000742112us-gaap:ConvertibleSubordinatedDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000742112us-gaap:ConvertibleSubordinatedDebtMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000742112ivc:EuropeEMEAMemberus-gaap:IntersegmentEliminationMember2022-07-012022-09-300000742112ivc:EuropeEMEAMemberus-gaap:IntersegmentEliminationMember2021-07-012021-09-300000742112ivc:EuropeEMEAMemberus-gaap:IntersegmentEliminationMember2022-01-012022-09-300000742112ivc:EuropeEMEAMemberus-gaap:IntersegmentEliminationMember2021-01-012021-09-300000742112ivc:NorthAmericaNAMemberus-gaap:IntersegmentEliminationMember2022-07-012022-09-300000742112ivc:NorthAmericaNAMemberus-gaap:IntersegmentEliminationMember2021-07-012021-09-300000742112ivc:NorthAmericaNAMemberus-gaap:IntersegmentEliminationMember2022-01-012022-09-300000742112ivc:NorthAmericaNAMemberus-gaap:IntersegmentEliminationMember2021-01-012021-09-300000742112us-gaap:IntersegmentEliminationMember2022-07-012022-09-300000742112us-gaap:IntersegmentEliminationMember2021-07-012021-09-300000742112us-gaap:IntersegmentEliminationMember2022-01-012022-09-300000742112us-gaap:IntersegmentEliminationMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:LifestyleProductsDomain2022-07-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:LifestyleProductsDomain2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:LifestyleProductsDomain2022-01-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:LifestyleProductsDomain2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:MobilityandSeatingDomain2022-07-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:MobilityandSeatingDomain2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:MobilityandSeatingDomain2022-01-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:MobilityandSeatingDomain2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:RespiratoryTherapyDomain2022-07-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:RespiratoryTherapyDomain2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:RespiratoryTherapyDomain2022-01-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:RespiratoryTherapyDomain2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:OtherDomain2022-07-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:OtherDomain2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:OtherDomain2022-01-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMemberivc:OtherDomain2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMember2022-07-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMember2022-01-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:EuropeEMEAMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMemberivc:LifestyleProductsDomain2022-07-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMemberivc:LifestyleProductsDomain2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMemberivc:LifestyleProductsDomain2022-01-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMemberivc:LifestyleProductsDomain2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:MobilityandSeatingDomainivc:NorthAmericaNAMember2022-07-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:MobilityandSeatingDomainivc:NorthAmericaNAMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:MobilityandSeatingDomainivc:NorthAmericaNAMember2022-01-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:MobilityandSeatingDomainivc:NorthAmericaNAMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomainivc:NorthAmericaNAMember2022-07-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomainivc:NorthAmericaNAMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomainivc:NorthAmericaNAMember2022-01-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomainivc:NorthAmericaNAMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:OtherDomainivc:NorthAmericaNAMember2022-07-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:OtherDomainivc:NorthAmericaNAMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:OtherDomainivc:NorthAmericaNAMember2022-01-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:OtherDomainivc:NorthAmericaNAMember2021-01-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMember2022-07-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMember2021-07-012021-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMember2022-01-012022-09-300000742112us-gaap:OperatingSegmentsMemberivc:NorthAmericaNAMember2021-01-012021-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:MobilityandSeatingDomain2022-07-012022-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:MobilityandSeatingDomain2021-07-012021-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:MobilityandSeatingDomain2022-01-012022-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:MobilityandSeatingDomain2021-01-012021-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomain2022-07-012022-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomain2021-07-012021-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomain2022-01-012022-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:LifestyleProductsDomain2021-01-012021-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2022-07-012022-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2021-07-012021-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2022-01-012022-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:RespiratoryTherapyDomain2021-01-012021-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2022-07-012022-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2021-07-012021-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2022-01-012022-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMemberivc:OtherDomain2021-01-012021-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300000742112ivc:AllOtherMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
[☒] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2022
OR
[☐] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from            to           
Commission File Number 001-15103
INVACARE CORPORATION
(Exact name of registrant as specified in its charter)
ivc-20220930_g1.jpg 
Ohio95-2680965
(State or other jurisdiction of
incorporation or organization)		(IRS Employer Identification No.)
One Invacare Way,Elyria,Ohio44035
(Address of principal executive offices)(Zip Code)
(440) 329-6000
(Registrant's telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each classTrading SymbolName of exchange on which registered
Common Shares, without par valueIVCNew York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 (the “Exchange Act”) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “small reporting company” in Rule 12b-2 of the Exchange Act. (Check One):    Large accelerated filer ☐    Accelerated filer ☒  Non-accelerated filer  ☐ Smaller reporting company ☒ Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐  No  ☒
As of November 4, 2022, the registrant had 37,754,335 Common Shares and 3,667 Class B Common Shares outstanding.


ivc-20220930_g1.jpg

Table of Contents
 
 ItemPage
PART I: FINANCIAL INFORMATION
2
1
3
4
PART II: OTHER INFORMATION
1
1A
2
3
4
5
6

About Invacare Corporation

Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, age related, bariatric) conditions. The company's products are important parts of care for people with a wide range of challenges, from those who are active and heading to work or school each day and may need additional mobility to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, dealers and government health services in North America, Europe and Asia Pacific. For more information about the company and its products, visit the company's website at www.invacare.com. The contents of the company's website are not part of this Quarterly Report on Form 10-Q and are not incorporated by reference herein.



MD&AOverview

Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations.

The discussion and analysis presented below is concerned with material changes in financial condition and results of operations between the periods specified in the condensed consolidated balance sheets at September 30, 2022 and December 31, 2021, and in the condensed consolidated statement of comprehensive income (loss) for the three and nine months ended September 30, 2022 and September 30, 2021. All comparisons


presented are with respect to the same period last year, unless otherwise stated. This discussion and analysis should be read in conjunction with the condensed consolidated financial statements and accompanying notes that appear elsewhere in this Quarterly Report on Form 10-Q and the MD&A included in the company's Annual Report on Form 10-K for the year ended December 31, 2021. For some matters, SEC filings from prior periods may be useful sources of information.

OVERVIEW
OVERVIEW
Invacare is a multi-national company with integrated capabilities to design, manufacture and distribute durable medical devices. The company makes products that help people move, rest and perform essential hygiene, and with those products the company supports people with congenital, acquired and degenerative conditions. The company's products and solutions are important parts of care for people with a range of challenges, from those who are active and involved in work or school each day and may need additional mobility support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company operates in facilities in North America, Europe and Asia Pacific, which are the result of dozens of acquisitions made over the company's forty-two-year history. Some of these acquisitions have been combined into integrated operating units, while others have remained relatively independent.
Supply Chain Impacts
Supply chain disruptions continue to negatively impact the company’s business in 2022, impacting both input costs and availability of components, resulting in lower revenue and compressed gross margins. The company expects these issues will continue into 2023. While the company has implemented actions to mitigate the negative impact of higher input costs, including pricing actions, it is expected that there could continue to be a difference between the timing of when the benefits of mitigation actions are realized and when the cost inflation is incurred.
The company continues to experience elevated open orders across all product categories and regions. During the third quarter of 2022, the company continued to experience slower demand for respiratory products which we believe is influenced by reduction in pandemic-related demand. The company has, and continues to, experience availability issues
with components which has limited and may continue to limit the ability to increase output and meet demand across product categories. In addition, the company has continued to experience cost increases from higher input costs and supply chain disruptions. These disruptions and availability issues, from supply chain challenges and supplier delivery holds resulting from delayed payments, have resulted in intermittent production stoppages and difficulty in fulfilling orders to meet demand. This has contributed to the year-over-year decline in revenue experienced in the third quarter of 2022.
The extent to which the company’s operations will continue to be impacted by the supply chain disruptions will depend on component and product availability. Supply chain disruptions and inflation continue to negatively impact the global economy and have affected and may continue to affect the business including availability and cost of components and freight, which may continue to have a negative impact on the company and results of operations, if mitigation actions are not effective.
Strategy
The company remains committed to taking necessary and decisive action to increase shareholder value. With the change to senior management and the Board of Directors in August 2022 and after careful evaluation of strategic options, the company concluded that the lifestyle and mobility & seating businesses are core to restoring growth and profitability. As a result, the company has decided to discontinue the production of respiratory products. This will allow us to further streamline our operations and improve profitability by focusing resources on lifestyle and mobility & seating products, which continue to experience strong demand. The company will fulfill existing customer orders with inventory on hand and continue to operate its respiratory parts and service business, as well as meet all warranty and regulatory obligations.
1
MD&AOverview
The company's anticipated business optimization actions balance product portfolio changes across all regions and cost improvements in supply chain and administrative functions. Key elements of the global business optimization plans are:
•Focus on lifestyle and mobility & seating product lines based on their potential to achieve a leading market position and to support profitability goals;
•Simplify the organization to leverage a reduced cost structure while allocating resources to the business units or product categories which deliver improved financial returns;
•Product rationalization and discontinuance with consideration of cost increases incurred by the company and those anticipated to continue. Adjust the product portfolio to consistently grow profitability amid cost increases by adding new products, reducing costs and continuing to improve customer experiences; and
•Take actions globally to reduce working capital and improve free cash flow.
As it navigates the uncertain business environment, the company continues to allocate more resources to the business units experiencing increased demand and expects to continue taking actions to mitigate the potential negative financial and operational impacts on other parts of the business that have declined.
The company intends to continue to make significant investments in its business improvement initiatives with a focus on improving profitability and free cash flow generation. As a result, the company may take actions which may reduce sales in certain areas, refocus resources away from less profitable activities, and look at its global infrastructure for opportunities to further optimize the business. As part of the company’s efforts to streamline its operations and focus its resources on core product lines that provide the greatest value and financial returns, the company continuously evaluates opportunities and activities, including potential divestitures, which it considers from time to time, particularly if they involve businesses or assets outside of the company’s primary areas of focus.
Outlook
The company participates in durable healthcare markets and serves a persistent need for its products. By continuing to drive for improved operating efficiency, the company seeks to grow revenue and profit, and improve its cash flow performance into the future.
Cost pressures on the business due to supply chain disruptions and inflationary economic conditions are anticipated to continue into 2023. The company continues to
see higher input costs related to freight and materials, increasing the challenges to schedule deliveries of key components, including electronic components. While the company has implemented actions to mitigate these cost increases, additional restructuring actions may be implemented to drive profit and improve cash flows. These actions are expected to include organization and supply chain changes, and a narrowing of the product portfolio for those items which no longer meet customer or business needs. These actions are anticipated to continue into 2023, and as a result, the company anticipates incurring additional costs related to its restructuring actions.
The company has begun to realize the benefit of improved access to key materials and components as a result of the increased financial flexibility funded from the financing transactions completed in 3Q22. On a consolidated basis, the company expects to see sequential constant currency revenue growth in 4Q22. Profitability is also anticipated to improve sequentially driven by revenue growth, higher gross profit attributable to the increased effectiveness of pricing actions, operational efficiencies, and restructuring benefits partially offset by continued higher input costs, and unfavorable foreign exchange. Through the first two months of its fiscal 4Q22, Europe has achieved sequential revenue growth and is on pace to deliver sequential constant currency net sales improvement and profitability for the quarter. The company anticipates that it will incur additional restructuring charges in 4Q22 as it focuses on improving the profitability for the long-term. In addition, a portion of the additional liquidity from the Secured Term Loan in October 2022 is anticipated to be used to fund working capital in 4Q22 to fulfill open orders and increase revenues.
The company's earnings performance in the future is expected to benefit from: (1) margin expansion if pricing actions are effective, favorable product mix results from product rationalization efforts and improved efficiencies in our operations offset our higher material and freight costs; and (2) restructuring actions. SG&A expense is anticipated to continue to be impacted by classification of IT costs as operating expenses as a result of a temporary pause in the ERP roll-out.
The company continues to focus on executing its transformation plan to drive revenue growth and deliver significant improvement in financial performance to enhance long-term shareholder value.
Favorable Long-Term Demand
Ultimately, demand for the company's products and services is based on the need to provide care for people with certain conditions. The company's medical devices provide solutions for end-users and caregivers. Therefore, the demand for the company's medical equipment is largely driven by population growth and the incidence of certain conditions
2
MD&AOverview
where treatment may be supplemented by the company's devices. The company also provides solutions to help equipment providers and residential care operators deliver cost-effective and high-quality care. The company believes that its commercial team, customer relationships, products and solutions, supply chain infrastructure, and strong research and development pipeline will create favorable business potential.
July and October 2022 Financings
On July 26, 2022, the company entered into a senior secured term loan agreement (the "Secured Term Loan") with certain funds managed by Highbridge Capital Management LLC (the "Highbridge Loan Agreement") providing for an aggregate of up to $104.5 million. The company completed an initial drawdown of $66.5 million under the Highbridge Loan Agreement on July 26, 2022. The company completed the first and second additional fundings on October 3, 2022 for a total of $18.5 million under the Highbridge Loan Agreement. The Secured Term Loan matures on July 26, 2026 (subject to a springing maturity date of 91 days prior to the scheduled maturity date of the 5.00% Convertible Senior Notes due 2024 and the 5.00% Series II Convertible Senior Notes due 2024 if the aggregate principal amount of such notes exceeds $20.0 million) and accrues interest at an initial annual rate of SOFR plus 7.00% or a base rate plus 6.00% and after the second anniversary of the closing date at an annual rate of SOFR plus 8.75% or a base rate plus 7.75%. The company may draw the remaining $19.5 million under the Highbridge Loan Agreement subject to certain conditions.
Concurrently with the entry into the Secured Term Loan Agreement, on July 26, 2022, the company entered into agreements providing for the settlement of $5.0 million aggregate principal amount of the company’s outstanding 5% Series II Convertible Senior Notes due 2024 and private exchange up to $55.3 million aggregate principal amount of its outstanding 4.25% Convertible Senior Notes due 2026 (the "2026 Notes"). The company completed the settlement of $5.0 million aggregate principal amount of the 2024 Notes and exchange of $41.5 million aggregate principal amount of the 2026 Notes on July 26, 2022. This exchange was funded by $31.1 million aggregate principal amount of newly issued 5.68% Convertible Senior Secured Notes due 2026, 2.7 million Common Shares of the company, cash payment of $4.5 million, and cash equal to accrued and unpaid interest on the outstanding convertible notes exchanged in the transaction. As result of finalizing the debt transactions in 3Q22, the company recognized a net gain on debt extinguishment of $6.4 million related to the partial retirement of 2024 and 2026 convertible notes; and net gain on convertible debt derivatives of $1.0 million related to new Secured 2026 convertible notes. On October 3, 2022, the company exchanged the remaining $13.8 million aggregate principal amount of 2026 Notes for $10.4 million aggregate principal amount of Secured 2026
Notes in two incremental tranches. The Secured 2026 Notes pay interest at a 5.68% annual rate and mature on July 1, 2026.
In addition, on July 26, 2022, the company amended its existing asset based lending credit facility to extend its maturity to January 16, 2026 and reduce the maximum notional amount from $90 million to $35 million. Proceeds from the Secured Term Loan were used to repay in full outstanding borrowings under the asset based lending credit facility.
Proceeds from the secured term loan are also anticipated to be used to fund working capital, restructuring actions and general corporate purposes. The company recognizes that the near-term external factors of inflation and supply chain challenges, as well as costs associated with restructuring actions, may require balance sheet action, including additional financing to support working capital requirements (refer to "Liquidity and Capital Resources"). The company will continue to take actions to optimize its business as required to operate in the present landscape.
Refer to Part I, Item 1-Long-Term Liabilities Long-Term Debt October 2022 Financing in the notes to the condensed consolidated financial statements for more information about the October 2022 financing transactions.
3
MD&ANet Sales
RESULTS OF OPERATIONS - NET SALES

The company operates in two primary business segments: North America and Europe with each selling the company's primary product categories, which include: lifestyle, mobility and seating and respiratory therapy products. Sales in Asia Pacific are reported in All Other and include products similar to those sold in North America and Europe.
($ in thousands USD)3Q22*3Q21% Change
Fav/(Unfav)		Foreign Exchange % ImpactConstant Currency % Change
Fav/(Unfav)
Europe97,487 127,026 (23.3)(11.8)(11.5)
North America65,314 88,054 (25.8)(0.2)(25.6)
All Other (Asia Pacific)7,607 9,120 (16.6)(8.8)(7.8)
Consolidated170,408 224,200 (24.0)(7.1)(16.9)

($ in thousands USD)YTD 3Q22**YTD 3Q21% Change
Fav/(Unfav)		Foreign Exchange % ImpactConstant Currency % Change
Fav/(Unfav)
Europe328,334 361,097 (9.1)(9.5)0.4 
North America209,351 260,275 (19.6)(0.2)(19.4)
All Other (Asia Pacific)22,728 24,894 (8.7)(7.7)(1.0)
Consolidated560,413 646,266 (13.3)(5.7)(7.6)
* Date format is quarter and year in each instance.
** YTD means the first nine months of the year in each instance.

The table above provides net sales change as reported and as adjusted to exclude the impact of foreign exchange translation (constant currency net sales). “Constant currency net sales" is a non-Generally Accepted Accounting Principles ("GAAP") financial measure, which is defined as net sales excluding the impact of foreign currency translation. The current year's functional currency net sales are translated using the prior year's foreign exchange rates. These amounts are then compared to the prior year's sales to calculate the constant currency net sales change.
Global supply chain challenges and availability limits due to past-due payables to suppliers continued to delay receipt of components and limit conversion of orders to sales, which continued to impact each of the regions in 3Q22 in different ways.
The company continues to experience strong demand for its lifestyle and mobility & seating products. Open orders related to lifestyle and mobility & seating products was $80.5 million at the end of 3Q22 as compared to $60.5 million at the end of 2021. Open orders remain elevated due to global component shortages, primarily related to electronic components and other key input materials.

Europe - Constant currency net sales decreased $14,628,000, or 11.5% in 3Q22 compared to 3Q21. Net sales in the quarter were impacted by supply chain challenges. Constant currency net sales increased 0.4% YTD 3Q22 compared to YTD 3Q21 led by mobility and seating products.
North America - Constant currency net sales for 3Q22 decreased $22,560,000 or 25.6% compared to 3Q21 with decreases in all categories but primarily attributable to lower respiratory sales as pandemic-related demand slowed. Supply chain disruptions continued to burden order fulfillment in all product categories. Constant currency net sales decreased 19.4% YTD 3Q22 compared to YTD 3Q21 primarily due to lower respiratory sales which had higher sales in prior periods benefiting from pandemic-related demand.
All Other - Constant currency net sales, which relates entirely to the Asia Pacific region, decreased $713,000 or 7.8% for 3Q22 compared to 3Q21 driven by respiratory products. Constant currency net sales decreased 1.0% YTD 3Q22 compared to YTD 3Q21 driven by respiratory products which more than offset increased sales in mobility and seating and lifestyle products.



4
MD&AGross Profit

GROSS PROFIT
ivc-20220930_g2.jpg
Gross profit decreased $28,931,000 and gross profit as a percentage of net sales for 3Q22 decreased 850 basis points to 18.4%. Inventory and purchasing obligation charges related to the decision to exit the respiratory product line burdened gross profit dollars $8,651,000 or 510 basis points in 3Q22. Excluding these charges, gross profit decreased 340 basis points primarily attributable to lower net sales impacting the efficiency of the operations, intermittent production stoppages and unfavorable foreign currency translation. These were partially offset by increased pricing across product portfolios, which continue to lag higher costs as lower-priced orders are fulfilled.

ivc-20220930_g3.jpg
Gross profit decreased $48,676,000 and gross profit as a percentage of net sales for YTD 3Q22 decreased 450 basis points to 22.7%. Inventory and purchasing obligation charges related to the decision to exit the respiratory product line burdened gross profit dollars $8,651,000 or 150 basis points in YTD 3Q22. Excluding these charges, gross profit decreased primarily attributable to lower sales impacting gross profit
dollars and unfavorable foreign currency translation. Increased pricing across product portfolios continue to lag higher costs as lower-priced orders are fulfilled.

Gross profit drivers by segment:
Europe - Gross profit dollars for 3Q22 decreased $13,761,000 compared to 3Q21. Gross profit as a percentage of net sales decreased 4.9% compared to 3Q21. Gross profit dollars were burdened primarily by lower sales, increased input costs and unfavorable foreign exchange. Inventory write downs related to the decision to exit the respiratory product line burdened gross profit dollars $916,000 or 90 basis points in 3Q22.
Gross profit dollars decreased $21,272,000 and gross profit as a percentage of net sales decreased 3.2% for YTD 3Q22 compared to YTD 3Q21. The year-to-date gross profit was impacted by similar items as 3Q22.
North America - Gross profit dollars decreased $15,424,000 and gross profit as a percentage of net sales decreased 12.0% for 3Q22 compared to 3Q21 driven primarily by lower net sales. The decrease in gross profit as a percentage of net sales was driven by lower sales in relation to fixed costs. Inventory and purchasing obligation charges related to the decision to exit the respiratory product line burdened gross profit dollars $7,679,000 and gross margin 1,080 basis points in 3Q22.
Gross profit dollars decreased $27,964,000 and gross profit as a percentage of net sales decreased 5.2% for YTD 3Q22 compared to YTD 3Q21. The decrease in gross profit dollars and gross profit as a percentage of net sales driven primarily by lower net sales in relation to fixed costs.
All Other - Asia Pacific gross profit dollars decreased $562,000 and gross profit as a percentage of net sales decreased 1.0% for 3Q22 compared to 3Q21 driven primarily by lower volume and higher material costs.
Asia Pacific gross profit dollars decreased $467,000 and gross profit as a percentage of net sales increased 1.1% for YTD 3Q22 compared to YTD 3Q21 driven primarily by pricing actions mitigating higher material costs.
All Other also includes the impact of intercompany profit eliminations for the consolidated company.
5
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
($ in thousands USD)3Q22*3Q21Reported ChangeForeign Exchange ImpactConstant Currency Change
SG&A expenses - $55,365 56,135 (770)(3,282)2,512 
SG&A expenses - % change(1.4)(5.9)4.5 
% to net sales32.5 25.0 
($ in thousands USD)YTD 3Q22**YTD 3Q21Reported ChangeForeign Exchange ImpactConstant Currency Change
SG&A expenses - $174,552 178,721 (4,169)(7,749)3,580 
SG&A expenses - % change(2.3)(4.3)2.0 
% to net sales31.1 27.7 
* Date format is quarter and year in each instance.
** YTD means the first nine months of the year in each instance.
The table above provides selling, general and administrative (SG&A) expenses change as reported and as adjusted to exclude the impact of foreign exchange translation (constant currency SG&A). “Constant currency SG&A" is a non-GAAP financial measure, which is defined as SG&A expenses excluding the impact of foreign currency translation. The current year's functional currency SG&A expenses are translated using the prior year's foreign exchange rates. These amounts are then compared to the prior year's SG&A expenses to calculate the constant currency SG&A expenses change. Management believes this financial measure provides meaningful information for evaluating the core operating performance of the company.

Constant currency SG&A increased $2,512,000 or 4.5% for 3Q22 compared to the same period last year. 3Q22 includes IT expenses being classified as operating costs as a result of the temporary pause in the ERP roll-out, similar to 1H22. In addition, the company incurred higher expense related to foreign currency transactions offset by lower employment costs.

Constant currency SG&A increased $3,580,000 or 2.0% for YTD 3Q22 compared to the same period last year primarily due to increased IT costs partially offset by lower employment costs. 3Q22 YTD benefited from reduced stock compensation expense attributable to forfeitures, and to lowered performance projection and a lower trading price on the company's Common Shares in 2022 on outstanding equity awards to which variable accounting applies. In addition, the company incurred higher expense related to foreign currency transactions and lower employment costs.




SG&A expense drivers by segment:

Europe - SG&A expenses for 3Q22 decreased $1,620,000 or 6.2% compared to 3Q21 with foreign currency translation decreasing SG&A expenses by $2,950,000, or 11.3%. Constant currency SG&A expenses increased $1,330,000, or 5.1% primarily driven by foreign currency transactions losses and outside services.
SG&A expenses for YTD 3Q22 decreased $7,021,000 or 8.5% compared to YTD 3Q21 with foreign currency translation decreasing SG&A expenses by $6,915,000, or 8.4%. Constant currency SG&A expenses decreased $106,000, or 0.1% primarily driven by foreign currency transactions losses and outside services.
North America - SG&A expenses for 3Q22 decreased $1,940,000, or 8.2%, compared to 3Q21. Constant currency SG&A expenses decreased $1,871,000, or 7.9% primarily attributable to employment costs.
SG&A expenses for YTD 3Q22 decreased $665,000, or 1.0%, compared to YTD 3Q21. Constant currency SG&A expenses decreased $496,000, or 0.7% primarily attributable to employment costs.
All Other - SG&A expenses for 3Q22 increased $2,790,000 compared to 3Q21 with foreign currency translation decreasing SG&A expenses by $263,000. Constant currency SG&A expenses increased by $3,053,000. All Other includes SG&A related to the Asia Pacific businesses and non-allocated corporate costs. Constant currency SG&A expenses related to Asia Pacific businesses for 3Q22 decreased 23.3% or $798,000, compared to 3Q21 driven primarily by favorable foreign currency transactions. Unallocated corporate costs increased primarily due to IT costs.
6
SG&A expenses for YTD 3Q22 increased $3,517,000 compared to YTD 3Q21 with foreign currency translation decreasing SG&A expenses by $665,000. Constant currency SG&A expenses increased by $4,182,000. Constant currency SG&A expenses related to Asia Pacific businesses for YTD 3Q22 decreased 9.3% or $835,000, compared to YTD 3Q21 driven primarily by favorable foreign currency transactions. Unallocated corporate costs increased primarily due to IT costs partially offset by lower stock compensation expense, as noted above.
7
MD&AOperating Income (Loss)
OPERATING INCOME (LOSS)
($ in thousands USD)3Q223Q21$ ChangeYTD 3Q22YTD 3Q21$
Change
Europe(2,588)9,554 (12,142)4,126 18,378 (14,252)
North America(15,007)(1,523)(13,484)(29,607)(2,308)(27,299)
All Other(6,391)(3,856)(2,535)(21,981)(19,025)(2,956)
Charges related to restructuring(8,440)(377)(8,063)(16,383)(2,476)(13,907)
Impairment of an intangible asset(1,012)— (1,012)(1,012)— (1,012)
Impairment of goodwill— (28,564)28,564 — (28,564)28,564 
Consolidated Operating Income (Loss)(33,438)(24,766)(8,672)(64,857)(33,995)(30,862)
For the quarter and year-to-date, consolidated operating loss increased compared to last year due to lower net sales impacted lower gross profit, higher input costs not fully mitigated by pricing actions and unfavorable foreign currency.
Operating income (loss) by segment:
Europe - The decline in operating profit for 3Q22 was primarily due to lower gross profit dollars impacted by lower net sales, higher input costs, respiratory product line exit charges and unfavorable foreign exchange.
Operating income for YTD 3Q22 decreased $14,252,000 compared to YTD 3Q21 attributable to lower gross profit dollars impacted by lower sales, higher input costs, respiratory product line exit charges and unfavorable foreign exchange.
North America - Operating loss for 3Q22 increased by $13,484,000 primarily due to lower gross profit dollars on lower sales and respiratory product line exit charges of $7,679,000.
Operating loss for YTD 3Q22 was $29,607,000 compared to YTD 3Q21 operating loss of $2,308,000 due to lower gross profit impacted by lower net sales and respiratory product line exit charges.
All Other - Operating loss for All Other includes the operating results of the Asia Pacific businesses, as well as unallocated SG&A expenses and intercompany eliminations. Operating loss increased $2,535,000 primarily driven by increased IT expenses classified as operating expenses partially offset by lower employment costs.
Operating loss for YTD 3Q22 increased $2,956,000 compared to YTD 3Q21 primarily driven by increased IT expenses classified as operating expenses, partially offset by lower employment costs.







Charges Related to Restructuring Activities
Restructuring charges were $8,440,000 for 3Q22 compared to $377,000 for 3Q21 which includes severance and other restructuring costs. Restructuring charges were incurred in the Europe segment of $5,034,000, North America segment of $2,332,000, and All Other of $1,074,000.
Restructuring charges were $16,383,000 for YTD 3Q22 compared to $2,476,000 for YTD 3Q21 which includes severance and other restructuring costs. Restructuring charges were incurred in the Europe segment of $9,766,000, North America segment of $5,534,000, and All Other of $1,083,000.



8
MD&AOther Items
OTHER ITEMS

Impairment of an intangible asset
($ in thousands USD)3Q223Q21$ Change
Impairment of an intangible asset1,012 — 1,012 
($ in thousands USD)YTD 3Q22YTD 3Q21$ Change
Impairment of an intangible asset1,012 — 1,012 
During the third quarter of 2022, the company recognized an intangible impairment charge in the North America segment of $1,012,000 related to a trademark with an indefinite life which the company determined it would no longer use.
Impairment of goodwill
($ in thousands USD)3Q223Q21$ Change
Impairment of goodwill — 28,564 (28,564)
($ in thousands USD)YTD 3Q22YTD 3Q21$ Change
Impairment of goodwill — 28,564 (28,564)
During the third quarter of 2021, the company's reporting units of North America / HME and Institutional Products Group were merged into one reporting unit of North America, consistent with the operating segment. Developments in the third quarter of 2021 and the completion of the reporting units merger were tied most closely to the actions of the company to implement components of a new ERP system which both changed the level of discrete financial information readily available and the go-forward manner in which the company assesses performance and allocates resources to the North America operating segment.

The reporting unit change within the North America operating segment in the third quarter of 2021 was a triggering event and required the company to perform an interim goodwill impairment test. Based on the interim goodwill impairment test, the company concluded the carrying value of the North America reporting unit was above its fair value. That conclusion resulted in the recording of impairment of goodwill in the third quarter of 2021 of $28,564,000.
As a result of the goodwill impairment, the company recorded a reversal of deferred taxes related to the tax deductible goodwill previously deducted by the company, resulting in the company recognizing a tax benefit of $661,000 for the three months ended September 30, 2021.
Net gain on convertible debt derivatives
($ in thousands USD)3Q223Q21$ Change
Net gain on convertible debt derivatives(950)— (950)
($ in thousands USD)YTD 3Q22YTD 3Q21$ Change
Net gain on convertible debt derivatives(950)— (950)
The company recognized a net gain of $950,000 for the three and nine months ended September 30, 2022 related to the fair value of convertible debt derivatives related to the Secured 2026 Notes. Refer to "Long-Term Debt" in the notes to the condensed consolidated financial statements.
Net gain on debt extinguishment
($ in thousands USD)3Q223Q21$ Change
Net gain on debt extinguishment(6,398)(10,131)3,733 
($ in thousands USD)YTD 3Q22YTD 3Q21$ Change
Net gain on debt extinguishment(6,398)(9,422)3,024 
During the third quarter of 2022, the company entered into various transactions which included the amendment and restatement of asset-based lending facility, partial retirement of Series II 2024 Notes and partial exchange and retirement of 2026 Notes for new Secured 2026 Notes, a term loan and issuance of Common Shares as consideration for the transactions. The result of the transactions was a net gain on debt extinguishment including debt and finance fees of $6,398,000.
During the third quarter of 2021, the company applied for forgiveness of its CARES Act loan along with its accrued interest. The company received notification of approval of its debt forgiveness including accrued interest, in full, and the company recorded a gain on extinguishment of debt of $10,131,000.
During the first quarter of 2021, the company repurchased and retired, at par plus accrued interest, $78,850,000 of its 2022 Notes. The result of the transaction was a loss on debt extinguishment including debt and finance fees of $709,000.
Interest
9
MD&AOther Items
($ in thousands USD)3Q223Q21$ Change% Change
Interest expense7,354 6,284 1,070 17.0 
Interest income(10)— (10)(100.0)
($ in thousands USD)YTD 3Q22YTD 3Q21$ Change% Change
Interest expense19,836 18,099 1,737 9.6 
Interest income(11)(1)(10)1,000.0 
The increase in interest expense for 3Q22 and YTD 3Q22 compared to the same periods of prior year was primarily related to higher interest bearing debt for the full periods of 2022 compared to 2021.
Income Taxes
The company had an effective tax rate of 2.8% and 4.1% on losses before tax for the three and nine months ended September 30, 2022, respectively, compared to a statutory benefit of 21.0% on the pre-tax loss for each period. The company had an effective tax rate of 8.8% and 11.3% on losses before tax for the three and nine months ended September 30, 2021, respectively, compared to a statutory benefit of 21.0% on the pre-tax loss for each period. The company's effective tax rate for the three and nine months ended September 30, 2022 and September 30, 2021 were unfavorable as compared to the U.S. federal statutory rate, principally due to the negative impact of the company not being able to record tax benefits related to the significant losses in countries which had tax valuation allowances. The effective tax rate was increased for the three and nine months ended September 30, 2022 and September 30, 2021 by certain taxes outside the United States, excluding countries with tax valuation allowances, that were at an effective rate higher than the U.S. statutory rate.

10
MD&ALiquidity and Capital Resources
LIQUIDITY AND CAPITAL RESOURCES

The company continues to maintain an adequate liquidity position through its cash balances, bank lines of credit and Secured Term Loan credit facility (refer to Long-Term Debt in the notes to condensed consolidated financial statements included in this report) as described below.

As described below, the company recently completed a series of strategic capital markets transactions that altered its long-term debt and credit facility borrowing structure. Key balances on the company's balance sheet and related metrics prior to the October 2022 Financings are presented below:
($ in thousands USD)September 30, 2022December 31, 2021$ Change% Change
Cash and cash equivalents$45,439 $83,745 $(38,306)(45.7)
Working capital (1)
72,142 138,134 (65,992)(47.8)
Total debt (2)
410,104 382,586 27,518 7.2 
Long-term debt (2)
404,923 376,462 28,461 7.6 
Total shareholders' equity81,045 218,489 (137,444)(62.9)
ABL & Prior Credit Agreement borrowing availability (3)
17,336 41,845 (24,509)(58.6)
(1)    Current assets less current liabilities.
(2)    Total debt and Long-term debt include finance leases but exclude debt issuance costs and discount recognized as a deduction from the carrying amount of debt liability and operating leases.
(3)    Reflects the combined availability of the company's North American and prior European asset-based revolving credit facilities before borrowings. At September 30, 2022, the company had $16,900,000 of borrowings outstanding on its North America Credit Facility. Outstanding borrowings are based on credit availability calculated on a month lag related to the prior European credit facility.
The company's cash and cash equivalents balances were $45,439,000 and $83,745,000 at September 30, 2022 and December 31, 2021, respectively. The decrease in cash in the first nine months of 2022 is primarily attributable to use from operating activities and cash used for continued investment in business improvement initiatives. Cash used by operating activities was partially offset by credit facilities borrowings and additional debt from financing transactions in July 2022.

Refer to "Long-Term Debt" in the notes to the condensed consolidated financial statements included in this report for a summary of the material terms of the company's long-term indebtedness.

Debt repayments, acquisitions, divestitures, the timing of vendor payments, the timing of customer rebate payments, the granting of extended payment terms to significant national accounts and other activity can have a significant impact on the company's cash flow and borrowings outstanding such that the cash reported at the end of a given period may be materially different than cash levels during a given period. While the company has cash balances in various jurisdictions around the world, there are no material restrictions regarding the use of such cash for dividends within the company, loans or other purposes.

The company's total debt outstanding, inclusive of the company's convertible senior notes due 2022 (as of December 31, 2021), 2024 and 2026, secured convertible senior notes
due 2026, Secured Term Loan due 2026 and finance leases, increased by $27,518,000 to $410,104,000 at September 30, 2022 from $382,586,000 as of December 31, 2021. The increase is primarily driven by July 2022 financing transactions which included a new term loan for $66,500,000 offset by retirement of $5,000,000 of 2024 convertible senior notes, exchange of $41,475,000 2026 convertible senior notes for $31,106,000 secured 2026 convertible senior notes and reduced asset-based lending facility balance by $18,602,000. The increase in outstanding debt was also attributable to accretion on convertible senior notes due 2024, amortization of debt issuance costs and credit facility borrowings and payments, $2,000,000 debt borrowed against cash surrender value of insurance policies, offset by the repayment of $2,650,000 principal amount of 2022 Notes at maturity on June 1, 2022 and finance lease payments.
October 2022 Financings
In October 2022, the company completed the first and second additional fundings under debt agreements entered into in July 2022. Refer to "Long-Term Debt" / "October 2022 Financings" in the notes to the condensed consolidated financial statements included in this report for more information about the October 2022 financing transactions.


11
MD&ALiquidity and Capital Resources
Outlook
The company may incur additional financing in the future, which could include substantial additional debt (including secured debt) or equity or equity-linked financing. Although the terms of the agreements governing existing debt restrict the company's ability to incur additional debt (including secured debt), such restrictions are subject to several exceptions and qualifications and such restrictions and qualifications may be waived or amended, and debt (including secured debt) incurred in compliance with such restrictions and qualifications (as they may be waived or amended) may be substantial.

The company may from time to time seek to repay or purchase, exchange or otherwise retire its convertible notes or other debt obligations, in open market transactions, privately negotiated transactions, tender offers, exchange offers, pursuant to the term of debt or otherwise. The company may also incur additional debt (including secured debt) or equity or equity-linked financing to fund such transactions, refinance or restructure existing debt and/or exchange existing debt for newly issued debt obligations or equity or equity-like securities. The number of Common Shares or securities convertible into Common Shares that may be issued in connection with such transactions may be material. Such transactions, if any, will depend on prevailing market conditions, trading prices of debt from time to time, the company's liquidity requirements and cash position, contractual restrictions and other factors. The amount involved in any such transactions, individually or in the aggregate, may be material. From time to time the company engages in discussions with holders of its existing debt and other potential financing sources regarding such transactions and the company expects to continue to engage in such discussions. The company cannot provide any assurance as to if or when it will consummate any such transactions or the terms of any such transactions.

After consideration of various actions implemented during 2022, including various restructuring actions that have reduced aspects of our cost structure and price increases with our customers to substantially offset cost increases experienced in 2021 and 2022, the company believes that its cash balances and available borrowing capacity under its ABL Credit Agreement should be sufficient to meet working capital needs, capital requirements, debt service obligations and other commitments for at least the next twelve months. If the company's operating results decrease as the result of pressures on the business due to, for example, prolonged, or worsening of, negative impacts of the pandemic, the impact of the pandemic on the company's supply chain, or political or geopolitical crises such the Russian war with Ukraine, and actions taken in response on global and regional economies and economic activity, continued supply chain challenges, limited supply availability resulting from past-due payables, inflationary economic conditions, increases in interest rates on floating-rate debt, currency fluctuations or regulatory issues,
or the company's failure to execute its business plans or if the company's business improvement actions take longer than expected to materialize or development of one or more of the other risks discussed in "Item 1A. Risk Factors" of the company’s Annual Report on Form 10-K and this Quarterly Report on Form 10-Q, or if the conditions for subsequent draw under the Highbridge Loan Agreement is not satisfied, the company may require additional financing, or may be unable to comply with its obligations under the credit facilities or its other obligations, and its lenders or creditors could demand repayment of any amounts outstanding. If additional financing is required, there can be no assurance that it will be available on terms satisfactory to the company, if at all. The company also may evaluate and implement further changes to its strategic goals and business plans, which may involve additional restructuring of its operations. If and to the extent undertaken, any such restructuring may be substantial and involve significant effort and expense, and the company can make no assurances that such efforts, if undertaken, would be successful and result in improvements to the company’s business performance and financial condition. Refer to "Item 1A. Risk Factors" in the company’s Annual Report on Form 10-K and this Quarterly Report on Form 10-Q for a further discussion of risks applicable to the company's liquidity, capital resources and financial condition.

The company also has an agreement with De Lage Landen, Inc. (“DLL”), a third-party financing company, to provide lease financing to the company's U.S. customers. Either party could terminate this agreement with 180 days' notice or 90 days' notice by DLL upon the occurrence of certain events. Should this agreement be terminated, the company's borrowing needs under its credit facilities could increase.

While most of the company's debt has fixed interest, should interest rates increase, the company expects that it would be able to absorb modest rate increases without material impact on its liquidity or capital resources. An increase of 1% to variable rate debt outstanding at September 30, 2022 would increase interest expense $834,000 annually. The weighted average interest rate on borrowings, excluding finance leases, was 5.8% for the three months and 5.0% for the nine months ended September 30, 2022, respectively, and 4.5% for the year ended December 31, 2021. This weighted average interest rate will increase in the fourth quarter of the year as a result of the first and second additional fundings completed in October 2022. Refer to "Long-Term Debt" and "Leases and Commitments" in the notes to the condensed consolidated financial statements for more details regarding the company's credit facilities and lease liabilities, respectively.
12
MD&AAccounting Estimates and Pronouncements
ACCOUNTING ESTIMATES AND PRONOUNCEMENTS

CRITICAL ACCOUNTING ESTIMATES

The condensed consolidated financial statements included in the report include accounts of the company and all majority-owned subsidiaries. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions in certain circumstances that affect amounts reported in the accompanying condensed consolidated financial statements and related footnotes. In preparing the financial statements, management has made its best estimates and judgments of certain amounts included in the financial statements, giving due consideration to materiality. However, application of these accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties and, thus, actual results could differ from these estimates. Refer to the Critical Accounting Estimates section within MD&A of company's Annual Report on Form 10-K for the period ending December 31, 2021.

Except as set forth below, there have been no significant changes to critical accounting policies and estimates included in the company's Annual Report.

Valuation of Goodwill, Intangible Assets and Other Long-Lived Assets

Goodwill recorded represents the excess of the aggregate fair value of the consideration transferred for a business combination over the fair value of the assets acquired, net of liabilities assumed. Goodwill is subject to an annual impairment test and is tested more frequently if indicators of impairment are identified. An impairment would be recorded if an assessment determined that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. A quantitative assessment for impairment requires management to use significant judgment and estimates, including estimates of future revenue, net available cash flows, as well as a discount rate, and a terminal growth rate. Management's estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable. If actual results are materially lower than originally estimated, it could result in a material impact to consolidated financial statements in future periods.

Under the quantitative goodwill impairment test, if a reporting unit’s carrying value exceeds its fair value, an impairment charge will be recorded based on that difference. To determine reporting unit fair value, management used the income approach. Under the income approach, projected future cash flows are discounted to reflect their relative risk. The cash flows used were consistent with those used in management's internal planning, and reflect actual business
trends experienced as well as management's long-term business strategy for the reporting unit.
The company concluded based on the results of the interim quantitative goodwill impairment assessment performed as of September 30, 2022 that goodwill was not impaired. The company assessed the results if the discount rate used were 100 basis points higher for the third quarter quantitative assessment and determined that there still would not be impairment of goodwill for the Europe reporting unit.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
For the company’s disclosure regarding recently issued accounting pronouncements, refer to Accounting Policies - Recent Accounting Pronouncements in the notes to the condensed consolidated financial statements contained in this Quarterly Report on Form 10-Q.

CAPITAL EXPENDITURES
The company estimates that capital investments for 2022 to be approximately $5,000,000 compared to actual capital expenditures of $17,698,000 in 2021 which were elevated due to ERP system implementation activities. The company believes that its balances of cash and cash equivalents and available borrowing capacity under its existing credit facilities should be sufficient to meet its operating cash requirements and fund capital expenditures (refer to "Liquidity and Capital Resources"). The ABL Credit Agreement limits the company's annual capital expenditures to $25,000,000.
DIVIDEND POLICY
On May 21, 2020, the Board of Directors suspended the quarterly dividend on the company's Common Shares. The Board of Directors suspended the company's regular dividend on the Class B Common Shares starting in the third quarter of 2018. Less than 4,000 Class B Common Shares remain outstanding and suspending the regular Class B dividend allows the company to save on the administrative costs and compliance expenses associated with that dividend. Holders of Class B Common Shares are entitled to convert their shares into Common Shares at any time on a share-for-share basis and would be eligible for any Common Share dividends declared following any such conversion.
13
MD&ACash Flows
CASH FLOWS
ivc-20220930_g4.jpg
The increase in cash used by operating activities for the three and nine months ended September 30, 2022 was driven primarily by funding of an operating loss and accounts payable offset by accounts receivable collections and lower inventory levels.
ivc-20220930_g5.jpg
The year over year changes in cash flows related to investing activities was driven primarily by lower capital expenditures related to the ERP implementation.
ivc-20220930_g6.jpg
Cash flows provided by financing activities in the first nine months of 2022 included credit facility borrowings and repayments, repayment of $2,650,000 principal amount of 2022 Notes, additional debt borrowings of $66,500,000 under the 2026 Term Loan, net of $2,000,000 of original issuance discount, offset by ABL credit facility net payments and payment of $8,046,000 in financing costs related to the financing transactions executed in the third quarter of 2022. The first nine months of 2021 included the issuance of $125,000,000 principal amount of 2026 Notes, payment of $5,175,000 in financing costs, purchase of capped calls related to the 2026 Notes for $18,787,000, repurchase of $78,850,000 principal amount of 2022 Notes and repayment of $1,250,000 principal amount of the company's previously outstanding convertible notes due 2021 (the "2021 Notes"). Borrowings on credit facilities are under the asset-based-lending senior secured revolving credit facilities.
14
MD&ACash Flows
Free cash flow is a non-GAAP financial measure and is reconciled to the corresponding GAAP measure as follows:
 ($ in thousands USD)3Q223Q21YTD 3Q22YTD 3Q21
Net cash used by operating activities$(19,932)$(775)$(46,874)$(36,825)
Plus: Sales of property and equipment— — 5 23 
Less: Purchases of property and equipment(538)(5,350)(3,302)(14,397)
Free Cash Flow (usage)$(20,470)$(6,125)$(50,171)$(51,199)
 
Free cash flow (usage) for the first nine months 2022 and 2021 was primarily impacted by the same items that affected cash flows used by operating activities. Free cash flow is a non-GAAP financial measure that is comprised of net cash provided (used) by operating activities less purchases of property and equipment plus proceeds from sales of property and equipment. Management believes that this financial measure provides meaningful information for evaluating the overall financial performance of the company and its ability to repay debt or make future investments (including acquisitions, etc.).
Generally, the first half of the year is cash consumptive and impacted by significant disbursements related to annual customer rebate payments which normally occur in the first quarter of the year and earned employee bonuses historically paid in the first half of the year. In addition, investment in inventory is typically heavy in the first half of the year, particularly in 2022 and 2021 with efforts to mitigate the company's supply chain disruptions and position the company to fulfill shipments in the second half of the year and can be impacted by footprint rationalization projects. Semi-annual interest payments on debt from the July and October 2022 financing transactions start in January 2023.
In addition, a portion of the additional liquidity in October 2022 from the Secured Term Loan is anticipated to be used to fund working capital in 4Q22 to increase revenues and fulfill open orders.
15
MD&ACash Flows
The company's approximate cash conversion days at September 30, 2022, December 31, 2021 and September 30, 2021 were as follows:
ivc-20220930_g7.jpg
Days in receivables are equal to current quarter net current receivables divided by trailing four quarters of net sales multiplied by 365 days. Days in inventory and accounts payable are equal to current quarter net inventory and accounts payable, respectively, divided by trailing four quarters of cost of sales multiplied by 365 days. Total cash conversion days are equal to days in receivables plus days in inventory less days in accounts payable.

The improvement in days in receivables is impacted by customer mix and region. Decline in days in accounts receivable is due to increased levels of payments in the first nine months of 2022.

The company provides a summary of days of cash conversion for the components of working capital so investors may see the rate at which cash is disbursed, collected and how quickly inventory is converted and sold.
16
MD&AForward-Looking Statements
FORWARD-LOOKING STATEMENTS

This Form 10-Q contains forward-looking statements within the meaning of the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are those that describe future outcomes or expectations that are usually identified by words such as “will,” 'may," “should,” “could,” “plan,” “intend,” “expect,” “continue,” "forecast," “believe” and “anticipate,” as well as similar comments, denote forward-looking statements that are subject to inherent uncertainties that are difficult to predict. These include, for example, statements related to the company’s ability to address on-going supply chain challenges and component shortages; sales and free cash flow trends; the impact of contingency plans and cost containment actions; the company’s intention to discontinue the production of respiratory products and focus on lifestyle and mobility & seating products; the company’s liquidity and working capital expectations; the company’s future financial results including expectations as to consolidated and segment revenue, net sales and profitability in 4Q22; the company’s future business plans and similar statements. Actual results and events may differ significantly from those expressed or anticipated as a result of various risks and uncertainties, including the availability and cost to the company of needed products, components or raw materials from the company’s suppliers, including delivery delays and production interruptions from pandemic-related supply chain challenges and supplier delivery holds resulting from past due payables; the duration and scope of the COVID-19 pandemic, the pace of resumption of access to healthcare, including clinics and elective care, and loosening of public health restrictions, or any reimposed restrictions on access to healthcare or tightening of public health restrictions, which could impact the demand for the company’s products; global shortages in, or increasing costs for, transportation and logistics services and capacity; actions that governments, businesses and individuals take in response to the pandemic, including mandatory business closures and restrictions on onsite commercial interactions; the impact of the pandemic or political or geopolitical crises, such as the Russian war with Ukraine, and actions taken in response, on global and regional economies and economic activity; the pace of recovery when the COVID-19 pandemic subsides; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth, including negative conditions attributable to inflationary economic conditions and rising interest rates; the effects of steps the company has taken or will take to reduce operating costs; the ability of the company to sustain profitable sales growth, achieve anticipated improvements in segment operating performance, convert high inventory levels to cash or reduce its costs; the ability of the company to successfully improve output and convert order backlog into sales; the ability of the company to successfully focus on lifestyle and mobility & seating products; lack of market acceptance of the company's new product innovations; potential adverse effects of revised product pricing and/or product surcharges on revenues or the demand for the company's products; any failure to satisfy the
continued listing standards of the NYSE and delisting of the company’s common shares from the NYSE; circumstances or developments that may make the company unable to implement or realize the anticipated benefits, or that may increase the costs, of its current and planned business initiatives, in particular the key elements of its growth plans, such as its new product introductions, commercialization plans, additional investments in demonstration equipment, product distribution strategy in Europe, supply chain actions and global information technology outsourcing and ERP implementation activities; possible adverse effects on the company's liquidity, including (i) the company's ability to address future debt maturities or other obligations, including additional debt that may be incurred in the future or (ii) the company's ability to access the remaining portion of the financing under the July and October 2022 financing transactions (as discussed in the notes to the condensed consolidated financial statements) in the event of a failure to satisfy one or more of the applicable closing conditions; increases in interest rates or the costs of borrowing; potential limitations on the company’s business activities from obligations in the company’s debt agreements; adverse changes in government and third-party payor reimbursement levels and practices; decreased availability or increased costs of materials which could increase the company’s cost of producing or acquiring the company’s products, including the adverse impacts of tariffs and increases in commodity costs or freight costs; consolidation of health care providers; increasing pricing pressures in the markets for the company's products; risks of failures in, or disruptions to, legacy IT systems; risks of cybersecurity attack, data breach or data loss and/or delays in or inability to recover or restore data and IT systems; adverse effects of the company's consent decree of injunction with the U.S. Food and Drug Administration (FDA), including but not limited to, compliance costs, inability to rebuild negatively impacted customer relationships, unabsorbed capacity utilization, including fixed costs and overhead; any circumstances or developments that might adversely impact the third-party expert auditor's required audits of the company's quality systems at the facilities impacted by the consent decree, including any possible failure to comply with the consent decree or FDA regulations or the inability to adequately address the matters identified in the FDA Letters; regulatory proceedings or the company's failure to comply with regulatory requirements or receive regulatory clearance or approval for the company's products or operations in the United States or abroad; adverse effects of regulatory or governmental inspections of the company's facilities at any time and governmental enforcement actions; product liability or warranty claims; product recalls, including more extensive warranty or recall experience than expected; possible adverse effects of being leveraged, including interest rate or event of default risks; exchange rate fluctuations, particularly in light of the relative importance of the company's foreign operations to its overall financial performance; legal actions, including adverse judgments or settlements of litigation or claims in excess of available insurance limits; tax rate fluctuations; additional tax expense or additional tax exposures, which could affect the company's
17
MD&AForward-Looking Statements
future profitability and cash flow; uncollectible accounts receivable; risks inherent in managing and operating businesses in many different foreign jurisdictions; heightened vulnerability to a hostile takeover attempt or other shareholder activism; provisions of Ohio law or in the company's debt agreements, charter documents or other agreements that may prevent or delay a change in control, as well as the risks described elsewhere in this Quarterly Report on Form 10-Q, the company’s Annual Report on Form 10-K and from time to time in the company's reports as filed with the Securities and Exchange Commission. The company may not be able to predict and may have little or no control over many factors or events that may influence its future results and, except to the extent required by law, the company does not undertake and specifically declines any obligation to review or update any forward-looking statements or to publicly announce the results of any revisions to any of such statements to reflect future events or developments or otherwise.


18
Financial Statements
Part I.    FINANCIAL INFORMATION
Item 1.    Financial Statements.

INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited)
 (In thousands, except per share data)Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Net sales$170,408 $224,200 $560,413 $646,266 
Cost of products sold139,029 163,890 433,323 470,500 
Gross Profit31,379 60,310 127,090 175,766 
Selling, general and administrative expenses55,365 56,135 174,552 178,721 
Charges related to restructuring activities8,440 377 16,383 2,476 
Impairment of an intangible asset1,012 — 1,012 — 
Impairment of goodwill— 28,564 — 28,564 
Operating Loss(33,438)(24,766)(64,857)(33,995)
Net gain on convertible debt derivatives(950)— (950)— 
Net gain on debt extinguishment(6,398)(10,131)(6,398)(9,422)
Interest expense7,354 6,284 19,836 18,099 
Interest income(10)— (11)(1)
Loss Before Income Taxes(33,434)(20,919)(77,334)(42,671)
Income tax provision920 1,840 3,160 4,830 
Net Loss$(34,354)$(22,759)$(80,494)$(47,501)
Net Loss per Share—Basic$(0.92)$(0.65)$(2.23)$(1.36)
Weighted Average Shares Outstanding—Basic37,537 35,013 36,073 34,826 
Loss per Share—Assuming Dilution$(0.92)$(0.65)$(2.23)$(1.36)
Weighted Average Shares Outstanding—Assuming Dilution37,680 35,488 36,241 35,371 
Net Loss$(34,354)$(22,759)$(80,494)$(47,501)
Other comprehensive income (loss):
Foreign currency translation adjustments(34,051)(19,202)(66,938)(6,487)
Defined Benefit Plans:
Amortization of prior service costs and unrecognized losses45 (27)4,608 (422)
Deferred tax adjustment resulting from defined benefit plan activity(9)20 (94)(43)
Valuation reserve associated with defined benefit plan activity9 (20)94 43 
Current period gain (loss) on cash flow hedges(1,394)1,423 298 649 
Deferred tax benefit (provision) related to gain on cash flow hedges178 (170)(62)(73)
Other Comprehensive Loss(35,222)(17,976)(62,094)(6,333)
Comprehensive Loss$(69,576)$(40,735)$(142,588)$(53,834)
See notes to condensed consolidated financial statements.
19
Financial Statements
INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(unaudited)
September 30,
2022		December 31,
2021
Assets(In thousands)
Current Assets
Cash and cash equivalents$45,439 $83,745 
Trade receivables, net80,105 117,115 
Installment receivables, net255 218 
Inventories, net120,687 144,274 
Other current assets48,338 40,036 
Total Current Assets294,824 385,388 
Other Assets5,330 5,362 
Intangibles, net23,390 26,356 
Property and Equipment, net53,244 60,921 
Finance Lease Assets, net56,083 63,029 
Operating Lease Assets, net9,980 12,600 
Goodwill314,755 355,875 
Total Assets$757,606 $909,531 
Liabilities and Shareholders’ Equity
Current Liabilities
Accounts payable$95,973 $130,036 
Accrued expenses116,330 102,971 
Current taxes payable2,136 3,914 
Current portion of long-term debt2,150 3,107 
Current portion of finance lease obligations3,031 3,009 
Current portion of operating lease obligations3,062 4,217 
Total Current Liabilities222,682 247,254 
Long-Term Debt333,129 305,022 
Finance Lease Long-Term Obligations57,511 63,736 
Operating Leases Long-Term Obligations 6,865 8,234 
Other Long-Term Obligations56,374 66,796 
Shareholders’ Equity
Preferred Shares (Authorized 300 shares; none outstanding)
— — 
Common Shares (Authorized 150,000 shares; 42,328 and 39,416 issued and outstanding at September 30, 2022 and December 31, 2021, respectively)—no par
10,807 9,977 
Class B Common Shares (Authorized 12,000 shares; 4 and 4 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively)—no par
2 2 
Additional paid-in-capital281,130 276,665 
Retained earnings (accumulated deficit)(57,849)22,645 
Accumulated other comprehensive income (loss)(45,106)16,988 
Treasury Shares (4,535 and 4,397 shares at September 30, 2022 and December 31, 2021, respectively)
(107,939)(107,788)
Total Shareholders’ Equity81,045 218,489 
Total Liabilities and Shareholders’ Equity$757,606 $909,531 
See notes to condensed consolidated financial statements.
20
Financial Statements
INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows (unaudited)
 
For the Nine Months Ended September 30,
20222021
Operating Activities(In thousands)
Net loss$(80,494)$(47,501)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization11,796 12,511 
Amortization of operating lease right of use assets3,749 4,757 
Provision for losses on trade and installment receivables715 327 
Provision (benefit) for deferred income taxes33 (148)
Provision (benefit) for other deferred liabilities(738)165 
Provision for equity compensation1,839 5,369 
Loss (gain) on disposals of property and equipment216 (232)
Net gain on debt extinguishment(6,398)(9,422)
Impairment of an intangible asset1,012 — 
Impairment of goodwill— 28,564 
Inventory write-downs and product line exit obligations8,651 — 
Amortization of convertible debt discount, term loan original issuance discount and accretion of convertible debt2,864 2,637 
Amortization of debt fees1,676 1,622 
Net gain on convertible debt derivatives(950)— 
Changes in operating assets and liabilities:
Trade receivables29,087 (8,030)
Installment sales contracts, net296 222 
Inventories, net5,969 (37,199)
Other current assets(7,784)8,215 
Accounts payable(26,160)24,769 
Accrued expenses11,714 (24,182)
Other long-term liabilities(3,967)731 
Net Cash Used by Operating Activities(46,874)(36,825)
Investing Activities
Purchases of property and equipment(3,302)(14,397)
Proceeds from sale of property and equipment5 23 
Change in other long-term assets(77)(93)
Other(539)— 
Net Cash Used by Investing Activities(3,913)(14,467)
Financing Activities
Proceeds from revolving lines of credit and long-term borrowings84,693 154,830 
Repurchases of convertible debt, payments on revolving lines of credit and finance leases(59,152)(109,139)
Payment of financing costs(8,046)(5,369)
Purchases of capped calls— (18,787)
Purchases of treasury shares(151)(1,752)
Net Cash Provided by Financing Activities17,344 19,783 
Effect of exchange rate changes on cash(4,863)(133)
Decrease in cash and cash equivalents(38,306)(31,642)
Cash and cash equivalents at beginning of year83,745 105,298 
Cash and cash equivalents at end of period$45,439 $73,656 
See notes to condensed consolidated financial statements.
21
Financial Statements
INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Shareholders' Equity (unaudited)
(In thousands)Common
Shares		Class B
Shares		Additional
Paid-in-
Capital		Retained
Earnings (Accumulated Deficit)		Accumulated Other
Comprehensive
Income (Loss)		Treasury
Shares		Total
June 30, 2022 Balance$10,132 $2 $278,788 $(23,495)$(9,884)$(107,939)$147,604 
Performance awards— — (495)— — — (495)
Restricted share awards— — 56 — — — 56 
Net loss— — — (34,354)— — (34,354)
Foreign currency translation adjustments— — — — (34,051)— (34,051)
Unrealized loss on cash flow hedges— — — — (1,216)— (1,216)
Defined benefit plans: Amortization of prior service costs and unrecognized losses and credits— — — — 45 — 45 
Total comprehensive loss— — — — — — (69,576)
Issuance of common shares675 — 2,781 — — — 3,456 
September 30, 2022 Balance$10,807 $2 $281,130 $(57,849)$(45,106)$(107,939)$81,045 
June 30, 2021 Balance$9,977 $2 $278,152 $43,466 $57,079 $(107,786)$280,890 
Performance awards— — (1,250)— — — (1,250)
Restricted share awards— — 809 — — — 809 
Net loss— — — (22,759)— — (22,759)
Foreign currency translation adjustments— — — — (19,202)— (19,202)
Unrealized gain on cash flow hedges— — — — 1,253 — 1,253 
Defined benefit plans: Amortization of prior service costs and unrecognized losses and credits— — — — (27)— (27)
Total comprehensive loss— — — — — — (40,735)
September 30, 2021 Balance$9,977 $2 $277,711 $20,707 $39,103 $(107,786)$239,714 
See notes to condensed consolidated financial statements.
22
Financial Statements
INVACARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Shareholders' Equity (unaudited)
(In thousands)Common
Shares		Class B
Shares		Additional
Paid-in-
Capital		Retained
Earnings (Accumulated Deficit)		Accumulated Other
Comprehensive
Income (Loss)		Treasury SharesTotal
January 1, 2022 Balance$9,977 $2 $276,665 $22,645 $16,988 $(107,788)$218,489 
Performance awards— — (814)— — — (814)
Restricted share awards155 — 2,498 — — (151)2,502 
Net loss— — — (80,494)— — (80,494)
Foreign currency translation adjustments— — — — (66,938)— (66,938)
Unrealized gain on cash flow hedges— — — — 236 — 236 
Defined benefit plans: Amortization of prior service costs and unrecognized losses and credits— — — — 4,608 — 4,608 
Total comprehensive loss— — — — — — (142,588)
Issuance of common shares675 — 2,781 — — — 3,456 
September 30, 2022 Balance$10,807 $2 $281,130 $(57,849)$(45,106)$(107,939)$81,045 
January 1, 2021 Balance$9,816 $2 $326,088 $58,538 $45,436 $(106,034)$333,846 
Performance awards52 — 747 — — (668)131 
Restricted share awards109 — 4,461 — — (1,084)3,486 
Net loss— — — (47,501)— — (47,501)
Foreign currency translation adjustments— — — — (6,487)— (6,487)
Unrealized gain on cash flow hedges— — — — 576 — 576 
Defined benefit plans: Amortization of prior service costs and unrecognized losses and credits— — — — (422)— (422)
Total comprehensive loss— — — — — — (53,834)
Adoption of ASU 2020-06— — (34,798)9,670 — — (25,128)
Purchase of capped calls— — (18,787)— — — (18,787)
September 30, 2021 Balance$9,977 $2 $277,711 $20,707 $39,103 $(107,786)$239,714 
See notes to condensed consolidated financial statements.
23
Notes to Financial StatementsAccounting Policies

Accounting Policies
Principles of Consolidation: The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2022 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2022 and 2021, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year.

Use of Estimates: The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.

Recent Accounting Pronouncements (Already Adopted): 
In March 2020, the FASB issued ASU 2020-04 "Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting," which is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burden related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates if certain criteria are met. The guidance may be adopted in any period prior to the guidance expiration on December 31, 2022.
The company adopted ASU 2020-04 effective January 1, 2022 and the adoption did not have a material impact on the company's financial statements. Interest arrangements previously referring to LIBOR prior to adoption, now refer to a secured overnight finance rate (SOFR).

24
Notes to Financial StatementsCurrent Assets
Current Assets

Receivables

Receivables consist of the following (in thousands):
September 30, 2022December 31, 2021
Accounts receivable, gross$99,780 $142,806 
Customer rebate reserve(8,722)(12,267)
Cash discount reserves(7,174)(9,179)
Allowance for doubtful accounts(3,214)(3,642)
Other, principally returns and allowances reserves(565)(603)
Accounts receivable, net$80,105 $117,115 

Reserves for customer rebates and cash discounts are recorded as a reduction in revenue and netted against gross accounts receivable. Customer rebates in excess of a given customer's accounts receivable balance are classified in Accrued Expenses. Customer rebates and cash discounts are estimated based on the most likely amount principle as well as historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such, the company estimates the expected returns based on an analysis of historical experience and adjusts revenue accordingly.

During the third quarter of 2021, the company entered into an agreement with a bank to sell certain trade receivables with governmental entity customers in the Nordic region without recourse. Under ASC 860, the sale of the receivables qualify as a true sale and not a secured borrowing. No gain or loss was recorded on the sale of the receivables. Bank charges, which are recorded as interest expense attributable to the program, were immaterial for the nine months ended September 30, 2022.

Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities predominantly located throughout the United States, Australia, Canada, New Zealand and Europe. A significant portion of products sold to providers, both foreign and domestic, are ultimately funded through government reimbursement programs such as Medicare and Medicaid in the U.S. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability.

The company's approach is to separate its receivables into good-standing and collection receivables. Good-standing
receivables are assigned to risk pools of high, medium and low. The risk pools are driven by the specifics associated with the geography of origination. Expected loss percentages are calculated and assigned to each risk pool, driven primarily by historical experience. The historical loss percentages are calculated for each risk pool and then judgmentally revised to consider current risk factors as well as consideration of the impact of forecasted events, as applicable. The expected loss percentages are then applied to receivables balances each period to determine the allowance for doubtful accounts.

In North America, excluding Canada, good-standing receivables are assigned to the low risk pool and assigned an expected loss percentage of 1.0% as these receivables are deemed to share the same risk profile and collections efforts are the same. Installment receivables in North America are characterized as collection receivables and thus reserves are based on specific analysis of each customer. In Canada, good-standing receivables are deemed low risk and assigned a loss percentage of 0.1%.

In Europe, expected losses are determined by each location in each region. Most locations have a majority of their receivables assigned to the low risk pool, which has an average expected loss percentage of 0.3%. About half of the locations have a portion of their receivables assigned as medium risk with an average expected loss percentage of 0.7%. Only a few locations have any receivables characterized as high risk and the average credit loss percentage for those locations is 2.8%. Collection risk is generally low as payment terms in certain key markets, such as Germany, are immediate and in many locations the ultimate customer is the government.

In the Asia Pacific region, receivables are characterized as low risk, which have an average expected loss percentage of 1.0%. Historical losses are low in this region where the use of credit insurance is often customary.


25
Notes to Financial StatementsCurrent Assets
The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended
September 30, 2022
Balance as of beginning of period$3,642 
Current period provision715 
Recoveries (direct write-offs), net(1,143)
Balance as of end of period$3,214 

The company did not make any material changes to the assignment of receivables to the different risk pools or to the expected loss reserves in the quarter. The company is monitoring the impacts of the COVID-19 pandemic and the possibility for an impact on collections, but to date this has not materially impacted 2022.

For collections receivables, the estimated allowance for uncollectible amounts is based primarily on management’s evaluation of the financial condition of each customer. In addition, as a result of the company's financing arrangement with DLL, a third-party financing company which the company has worked with since 2000, management monitors the collection status of these contracts in accordance with the company’s limited recourse obligations and provides amounts necessary for estimated losses in the allowance for doubtful accounts and establishes reserves for specific customers as needed.

The company writes off uncollectible trade accounts receivable after such receivables are moved to collection status and legal remedies are exhausted. Refer to Concentration of Credit Risk in the notes to the condensed consolidated financial statements for a description of the financing arrangement. Long-term installment receivables are included in “Other Assets” on the condensed consolidated balance sheets.

The company has recorded a contingent liability in the amount of $393,000 related to the contingent aspect of the company's guarantee associated with its arrangement with DLL. The contingent liability is recorded applying the same expected loss model used for the trade and installment receivables recorded on the company's books. Specifically, historical loss history is used to determine the expected loss percentage, which is then adjusted judgmentally to consider other factors, as needed.

The company’s U.S. customers electing to finance their purchases can do so using DLL. Repurchased DLL receivables recorded on the books of the company represent a single portfolio segment of receivables to the independent provider channel and long-term care customers. The portfolio segment
of these receivables are distinguished by geography and credit quality. These receivables were repurchased from DLL because the customers were in default. Default with DLL is defined as a customer being delinquent by three payments.

The estimated allowance for uncollectible amounts and evaluation for both classes of installment receivables is based on the company’s quarterly review of the financial condition of each individual customer with the allowance for doubtful accounts adjusted accordingly. Installments are individually and not collectively reviewed. The company assesses the bad debt reserve levels based upon the status of the customer’s adherence to a legally negotiated payment schedule and the company’s ability to enforce judgments, liens, etc.

For purposes of granting or extending credit, the company utilizes a scoring model to generate a composite score that considers each customer’s consumer credit score and/or D&B credit rating, payment history, security collateral and time in business. Additional analysis is performed for most customers desiring credit greater than $250,000, which generally includes a detailed review of the customer’s financial statements as well as consideration of other factors such as exposure to changing reimbursement laws.

Interest income is recognized on installment receivables based on the terms of the installment agreements. Installment accounts are monitored and if a customer defaults on payments and is moved to collection, interest income is no longer recognized. Subsequent payments received once an account is put on non-accrual status are generally first applied to the principal balance and then to the interest. Accruing of interest on collection accounts would only be restarted if the account became current again.

All installment accounts are accounted for using the same methodology regardless of the duration of the installment agreements. When an account is placed in collection status, the company goes through a legal process for pursuing collection of outstanding amounts, the length of which typically approximates eighteen months. Any write-offs are made after the legal process has been completed.
26
Notes to Financial StatementsCurrent Assets
Installment receivables consist of the following (in thousands):
 September 30, 2022December 31, 2021
 CurrentLong-TermTotalCurrentLong-TermTotal
Installment receivables$255 $274 $529 $218 $734 $952 
Allowance for doubtful accounts— — — — — — 
Installment receivables, net$255 $274 $529 $218 $734 $952 
No sales of installment receivables were recorded by the company in 2022.

The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):
 Nine Months Ended September 30, 2022Year Ended December 31, 2021
Balance as of beginning of period$— $487 
Current period provision (benefit)— (75)
Direct write-offs charged against the allowance— (412)
Balance as of end of period$— $— 
 
Installment receivables by class as of September 30, 2022 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
Asia Pacific
Non-Impaired installment receivables with no related allowance recorded529 529 — — 
Total
Non-Impaired installment receivables with no related allowance recorded529 529 — — 
Impaired installment receivables with a related allowance recorded— — — — 
Total installment receivables$529 $529 $— $— 
27
Notes to Financial StatementsCurrent Assets
Installment receivables by class as of December 31, 2021 consist of the following (in thousands):
 Total
Installment
Receivables		Unpaid
Principal
Balance		Related
Allowance for
Doubtful
Accounts		Interest
Income
Recognized
Asia Pacific
Non-impaired installment receivables with no related allowance recorded952 952 — — 
Total installment receivables$952 $952 $— $— 

The aging of the company’s installment receivables was as follows (in thousands):
September 30, 2022December 31, 2021
TotalAsia PacificTotalAsia Pacific
Current$529 $529 $952 $952 
0-30 days past due— — — — 
31-60 days past due— — — — 
61-90 days past due— — — — 
90+ days past due— — — — 
$529 $529 $952 $952 

28
Notes to Financial StatementsCurrent Assets
Inventories, Net

Inventories consist of the following (in thousands):
September 30, 2022December 31, 2021
Raw materials$60,082 $69,371 
Finished goods49,270 62,124 
Work in process11,335 12,779 
Inventories, net$120,687 $144,274 

Other Current Assets


Other current assets consist of the following (in thousands):
September 30, 2022December 31, 2021
Tax receivables principally value added taxes$29,152 $21,943 
Prepaid insurance3,045 4,462 
Prepaid inventory and freight2,938 2,394 
Derivatives (foreign currency forward exchange contracts)2,626 386 
Recoverable income taxes2,440 2,301 
Service contracts682 304 
Receivable due from information technology provider612 612 
Deferred financing fees323 379 
Prepaid and other current assets6,520 7,255 
Other Current Assets$48,338 $40,036 



29
Notes to Financial StatementsLong-Term Assets
Long-Term Assets

Other Long-Term Assets


Other long-term assets consist of the following (in thousands):
September 30, 2022December 31, 2021
Cash surrender value of life insurance policies$2,551 $2,481 
Deferred income taxes1,615 1,540 
Deferred financing fees726 409 
Installment receivables274 734 
Investments85 86 
Other79 112 
Other Long-Term Assets$5,330 $5,362 
Property and Equipment
Property and equipment consist of the following (in thousands):
September 30, 2022December 31, 2021
Machinery and equipment$267,218 $278,347 
Capitalized software30,904 30,448 
Land, buildings and improvements24,432 27,299 
Furniture and fixtures7,970 8,943 
Leasehold improvements4,730 6,782 
Property and Equipment, gross335,254 351,819 
Accumulated depreciation(282,010)(290,898)
Property and Equipment, net$53,244 $60,921 

Machinery and equipment includes demonstration units placed in provider locations which are depreciated to their estimated recoverable values over their estimated useful lives.

In the fourth quarter of 2019, the company initiated the first stage of an Enterprise Resource Planning ("ERP") software implementation. Related to the ERP project, the company capitalized certain costs in accordance with ASC 350 as shown in capitalized software above. The net book value of capitalized software was $26,833,000 and $28,715,000 at September 30, 2022 and December 31, 2021, respectively. Depreciation expense related to capitalized software started in 2021 and was $832,000 and $2,342,000 for the three and nine months ended September 30, 2022, respectively, compared to $419,000 and $1,084,000 for the three and nine months ended September 30, 2021, respectively.




Unpaid purchases of property and equipment at September 30, 2022 and December 31, 2021 were $0 and $1,090,000, respectively and are excluded from purchases of property and equipment on the condensed consolidated statements of cash flows for the periods ending and are included in subsequent periods when paid.








30
Notes to Financial StatementsLong-Term Assets
Goodwill
The change in goodwill from December 31, 2021 to September 30, 2022 was due to foreign currency translation.
In accordance with Intangibles—Goodwill and Other, ASC 350, goodwill is tested annually for impairment or whenever events or changes in circumstances indicate the carrying value of a reporting unit could be above its fair value. A reporting unit is defined as an operating segment or one level below. The company has determined that its reporting units are North America, Europe and Asia Pacific.
During the three months ended September 30, 2022, a continued decline in the share price of the company's Common Shares sustained the company's market capitalization below the carrying value of shareholders' equity. Further, inputs used in estimating the weighted average cost of capital ("WACC") had moved unfavorably to increase the WACC used in a discounted cash flows model. The combination of these and other developments were identified as a triggering event and the company proceeded with a quantitative goodwill impairment assessment of its Europe reporting unit (the only reporting unit with goodwill).
A quantitative goodwill impairment assessment was performed as of September 30, 2022, utilizing a discounted cash flows methodology. Key assumptions used in the discounted cash flow analysis included, but were not limited to, a WACC of approximately 14.51%, terminal growth rates and financial projections of performance and cash flows. Components of the WACC include quoted rates for 20-year debt of potential acquirer companies with similar credit risk and the cost of equity based on the 20-year treasury rate for the risk free rate, a market risk premium, an industry average beta and a small cap stock adjustment. The assumptions are based on a market participant's point of view and thus these inputs are deemed Level III inputs in regard to the fair value hierarchy. The WACC used in the 2021 annual assessment was 11.19%. The WACC used has a significant impact in the outcome of the discounted cash flow methodology utilized in the company's impairment assessment as a higher WACC would decrease fair value estimates.
The company also utilized an Enterprise Value ("EV") to Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA") method to compute the fair value of reporting units which considers potential acquirers and their EV to EBITDA multiples adjusted by an estimated premium. The EV method is used to corroborate fair values but more weight is placed on the discounted cash flow method results.
The company concluded based on the results of the interim quantitative goodwill impairment assessment
performed as of September 30, 2022 that goodwill was not impaired.
The valuation of goodwill can differ materially if financial projections or market inputs used to determine the WACC change significantly. For instance, higher interest rates or greater stock price volatility would increase the WACC and thus increase the chance of impairment. Assumptions used in the quantitative assessment require significant judgements and estimates which are inherently uncertain. If actual results are materially lower than estimates, it could result in a material impact on the consolidated financial statements in future periods. In addition, business changes impacting the company's assessment of reporting units could also have a material impact on impairment assessment results. For instance, higher interest rates or greater stock price volatility would increase the WACC and thus increase the chance of impairment. In consideration of this potential, the company assessed the results if the discount rate used were 100 basis points higher for the third quarter quantitative assessment and determined that there still would not be impairment of goodwill for the Europe reporting unit.
The company completed an interim test of the North America reporting unit in the third quarter of 2021 which resulted in impairment of $28,564,000.

Refer to Goodwill in the company's Annual Report on Form 10-K for the period ending December 31, 2021 for further disclosure regarding the company's annual impairment assessment methodology.
31
Notes to Financial StatementsLong-Term Assets
Intangibles

The company's intangibles consist of the following (in thousands):
 
 September 30, 2022December 31, 2021
 Historical
Cost		Accumulated
Amortization		Historical
Cost		Accumulated
Amortization
Customer lists$47,041 $47,041 $52,447 $52,447 
Trademarks20,447 — 24,137 — 
Developed technology6,973 6,648 7,652 7,149 
Patents5,471 5,471 5,543 5,543 
License agreements3,967 1,356 2,905 1,196 
Other1,148 1,141 1,147 1,140 
Intangibles$85,047 $61,657 $93,831 $67,475 

All of the company’s intangible assets have been assigned definite lives and continue to be amortized over their useful lives, except for trademarks shown above, which have indefinite lives.

The changes in intangible balances reflected on the balance sheet from December 31, 2021 to September 30, 2022 were primarily the result of foreign currency translation on historical cost and accumulated amortization as well as new license agreements.
The company evaluates the carrying value of definite-lived assets annually in the fourth quarter and whenever events or circumstances indicate possible impairment.
Definite-lived assets are determined to be impaired if the future undiscounted cash flows expected to be generated by the asset are less than the carrying value. Actual impairment amounts for definite-lived assets are then calculated using a discounted cash flow calculation.
Any impairment for indefinite-lived intangible assets is calculated as the difference between the future discounted cash flows expected to be generated by the asset and the carrying value of the asset.
Amortization expense related to intangible assets was $358,000 in the first nine months of 2022 and is expected to be $510,000 in 2022, $612,000 in 2023, $547,000 in 2024, $439,000 in 2025, $437,000 in 2026 and $311,000 in 2027. Amortized intangible assets are being amortized on a straight-line basis over remaining lives of 2 to 7 years with a weighted average remaining life of approximately 5.8 years.

During the third quarter of 2022, the company recognized an intangible impairment charge in the North America segment of $1,012,000 related to a trademark with an indefinite life the company determined it would no longer use.
32
Notes to Financial StatementsCurrent Liabilities
Current Liabilities

Accrued Expenses

Accrued expenses consist of accruals for the following (in thousands):
September 30, 2022December 31, 2021
Taxes other than income taxes, primarily value added taxes$32,221 $23,217 
Salaries and wages17,177 24,012 
Professional11,759 8,697 
Warranty8,576 11,198 
Freight5,918 5,460 
Interest5,197 3,297 
Derivative liabilities (foreign currency forward exchange contracts)4,890 1,938 
Rebates4,782 6,569 
IT service contracts4,000 4,013 
Insurance3,837 625 
Severance3,450 400 
Product line exit obligations3,264 — 
Product liability, current portion2,620 2,362 
Deferred revenue1,903 4,156 
Supplemental executive retirement program liability391 391 
Other items, principally trade accruals6,345 6,636 
Accrued Expenses$116,330 $102,971 
Generally, the company's products are covered by warranties against defects in material and workmanship for various periods depending on the product from the date of sales to the customer. Certain components carry a lifetime warranty. A provision for estimated warranty cost is recorded at the time of sale based upon actual experience. In addition, the company has sold extended warranties that, while immaterial, require the company to defer the revenue associated with those warranties until earned. The company has established procedures to appropriately defer such revenue. The company continuously assesses the adequacy of its product warranty accrual and makes adjustments as needed. Historical analysis is primarily used to determine the company's warranty reserves. Claims history is reviewed and provisions are adjusted as needed. However, the company does consider other events, such as a product field action and recalls, which could require additional warranty reserve provision.







Accrued rebates relate to several volume incentive programs the company offers its customers. The company accounts for these rebates as a reduction of revenue when the products are sold. Rebates are netted against gross accounts receivables. If rebates are in excess of such receivables, they are then classified as accrued expenses. The reduction in accrued rebates from December 31, 2021 to September 30, 2022 primarily relates to payments principally made in the first quarter each year, earned from the previous year.
















33
Notes to Financial StatementsCurrent Liabilities




The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):
Balance as of January 1, 2022$11,198 
Warranties provided during the period1,842 
Settlements made during the period(4,596)
Changes in liability for pre-existing warranties during the period, including expirations132 
Balance as of September 30, 2022$8,576 

Warranty reserves are subject to adjustment in future periods as new developments change the company's estimate of the total cost. Lower balance at September 30, 2022 is primarily attributable to favorable claim development and lower sales.










































34
Notes to Financial StatementsLong-Term Liabilities
Long-Term Liabilities

Long-Term Debt

Debt consists of the following (in thousands):
September 30, 2022December 31, 2021
Convertible senior notes at 4.50%, due in June 2022— 2,642 
Convertible senior notes Series I at 5.00%, due in November 202472,341 72,140 
Convertible senior notes Series II at 5.00%, due in November 202475,764 78,251 
Convertible senior notes at 4.25%, due in March 202680,898 119,036 
Secured convertible senior notes at 5.68%, due in July 202627,463 — 
Term loan, due in July 202659,724 — 
Other obligations19,089 36,060 
335,279 308,129 
Less current maturities of long-term debt(2,150)(3,107)
Long-Term Debt$333,129 $305,022 
On September 30, 2015, the company entered into an Amended and Restated Revolving Credit and Security Agreement, which was subsequently amended (the “Prior Credit Agreement”) and which was to mature on January 16, 2024. The Prior Credit Agreement was entered into by and among the company, certain of the company’s direct and indirect U.S. and Canadian subsidiaries and certain of the company’s European subsidiaries, certain other of the company’s direct and indirect U.S., Canadian and European subsidiaries, and PNC Bank, National Association (“PNC”), JPMorgan Chase Bank, N.A., J.P. Morgan Europe Limited, KeyBank National Association, and Citizens Bank, National Association. PNC was the administrative agent (the “Prior Credit Agreement Administrative Agent”) and J.P. Morgan Europe Limited is the European agent (the “European Agent”) under the Prior Credit Agreement. As discussed further below, the Prior Credit Agreement was amended and restated ("the ABL Credit Agreement") on July 26, 2022.

The company had outstanding letters of credit of $3,576,000 and $3,450,000 as of September 30, 2022 and December 31, 2021, respectively. Outstanding letters of credit and other reserves impacting borrowing capacity were $4,902,000 and $2,585,000 as of September 30, 2022 and December 31, 2021, respectively.

The company had outstanding borrowings of $16,900,000 under its ABL Credit Agreement as of September 30, 2022. The company had outstanding borrowings of $22,150,000 under its North America Credit Facility under the Prior Credit Agreement as of December 31, 2021. The company had outstanding borrowings of $7,366,000 (€6,500,000) under its
French Credit Facility and $5,986,000 (£4,500,000) under its UK Credit Facility under its Prior Credit Agreement as of December 31, 2021, together referred to as the European Credit Facility. No borrowings were outstanding under the European Credit Facility as of September 30, 2022 as it was terminated July 26, 2022.

North America Borrowers Credit Facility

For the company's North America Borrowers, the Prior Credit Agreement provided for an asset-based-lending senior secured revolving credit facility which was secured by substantially all the company’s U.S. and Canadian assets, other than real estate. The Prior Credit Agreement provided the company and the other Borrowers with a credit facility in an aggregate principal amount of $60,000,000, subject to availability based on a borrowing base formula, under a senior secured revolving credit, letter of credit and swing line loan facility (the “North America Credit Facility”). Up to $20,000,000 of the North America Credit Facility was available for issuance of letters of credit. The aggregate principal amount of the North America Credit Facility could have been increased by up to $25,000,000 to the extent requested by the company and agreed to by any lender or new financial institution approved by the Prior Credit Agreement Administrative Agent.

The aggregate borrowing availability under the North America Credit Facility was determined based on a borrowing base formula. The aggregate usage under the North America Credit Facility could not exceed an amount equal to the sum of (a) 85% of eligible U.S. accounts receivable plus (b) the lesser
35
Notes to Financial StatementsLong-Term Liabilities
of (i) 70% of eligible U.S. inventory and eligible foreign in-transit inventory and (ii) 85% of the net orderly liquidation value of eligible U.S. inventory and eligible foreign in-transit inventory (not to exceed $4,000,000), plus (c) the lesser of (i) 80% of the net orderly liquidation value of U.S. eligible machinery and equipment and (ii) $0 as of September 30, 2022 (subject to reduction as provided in the Prior Credit Agreement), plus (d) 85% of eligible Canadian accounts receivable, plus (e) the lesser of (i) 70% of eligible Canadian inventory and (ii) 85% of the net orderly liquidation value of eligible Canadian inventory, less (f) swing loans outstanding under the North America Credit Facility, less (g) letters of credit issued and undrawn under the North America Credit Facility, less (h) a $3,000,000 minimum availability reserve, less (i) other reserves required by the Prior Credit Agreement Administrative Agent, and in each case subject to the definitions and limitations in the Prior Credit Agreement.

Interest accrued on outstanding indebtedness under the Prior Credit Agreement at the SOFR rate, plus a margin ranging from 2.25% to 2.75%, or at the alternate base rate, plus a margin ranging from 1.25% to 1.75%, as selected by the company. Borrowings under the North America Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization.

The Prior Credit Agreement contained customary representations, warranties and covenants. Exceptions to the operating covenants in the Prior Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale and leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Prior Credit Agreement, as amended. The Prior Credit Agreement also contained a covenant requiring the company to maintain minimum availability under the North America Credit Facility of not less than (i) 12.5% of the maximum amount that may be drawn under the North America Credit Facility for five (5) consecutive business days, or (ii) 11.25% of the maximum amount that may be drawn under the North America Credit Facility on any business day. The company also is subject to dominion triggers under the North America Credit Facility requiring the company to maintain borrowing capacity of not less than $7,500,000 on any business day or any five consecutive days in order to avoid triggering full control by an agent for the lenders of the company's cash receipts for application to the company’s obligations under the agreement.

The Prior Credit Agreement contained customary default provisions, with certain grace periods and exceptions, which provide for events of default that include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical
reimbursement program, and an interruption of any material manufacturing facilities for more than 10 consecutive days. The proceeds of the North America Credit Facility were used to finance the working capital and other business needs of the company. There was $16,900,000 of outstanding borrowings under the North America Credit Facility on September 30, 2022.

European Credit Facility

The Prior Credit Agreement also provided for a revolving credit, letter of credit and swing line loan facility which gives the company and the European Borrowers the ability to borrow up to an aggregate principal amount of $30,000,000, with a $5,000,000 sublimit for letters of credit and a $2,000,000 sublimit for swing line loans (the “European Credit Facility”). Up to $15,000,000 of the European Credit Facility was available to each of Invacare Limited (the “UK Borrower”) and Invacare Poirier SAS (the “French Borrower” and, together with the UK Borrower, the “European Borrowers”). The European Credit Facility was terminated on July 26, 2022.

The aggregate borrowing availability for each European Borrower under the European Credit Facility is determined based on a borrowing base formula. The aggregate borrowings of each of the European Borrowers under the European Credit Facility may not exceed an amount equal to (a) 85% of the European Borrower’s eligible accounts receivable, less (b) the European Borrower’s borrowings and swing line loans outstanding under the European Credit Facility, less (c) the European Borrower’s letters of credit issued and undrawn under the European Credit Facility, less (d) a $3,000,000 minimum availability reserve, less (e) other reserves required by the European Agent, and in each case subject to the definitions and limitations in the Prior Credit Agreement.

Interest was accrued on outstanding indebtedness under the European Credit Facility at the SOFR rate, plus a margin ranging from 2.50% to 3.00%, or for swing line loans, at the overnight SOFR rate, plus a margin ranging from 2.50% to 3.00%, as selected by the company. The margin was adjusted quarterly based on utilization. Borrowings under the European Credit Facility were subject to commitment fees of 0.25% or 0.375% per year, depending on utilization.

The European Credit Facility was secured by substantially all the personal property assets of the UK Borrower and its in-country subsidiaries, and all the receivables of the French Borrower and its in-country subsidiaries. The UK and French facilities (which comprised the European Credit Facility) were cross collateralized, and the US personal property assets previously pledged under the North America Credit Facility also served as collateral for the European Credit Facility.
36
Notes to Financial StatementsLong-Term Liabilities

The European Credit Facility was subject to customary representations, warranties and covenants generally consistent with those applicable to the North America Credit Facility. Exceptions to the operating covenants in the Prior Credit Agreement provided the company with flexibility to, among other things, enter into or undertake certain sale/leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Prior Credit Agreement. The Prior Credit Agreement also contained a covenant requiring the European Borrowers to maintain undrawn availability under the European Credit Facility of not less than (i) 12.5% of the maximum amount that may be drawn under the European Credit Facility for five (5) consecutive business days, or (ii) 11.25% of the maximum amount that may be drawn under the European Credit Facility on any business day. The European Borrowers also were subject to cash dominion triggers under the European Credit Facility requiring the European Borrower to maintain borrowing capacity of not less than $3,750,000 on any business day or $3,750,000 for five consecutive business days in order to avoid triggering full control by an agent for the lenders of the European Borrower’s cash receipts for application to its obligations under the European Credit Facility.

The European Credit Facility was subject to customary default provisions, with certain grace periods and exceptions, consistent with those applicable to the North America Credit Facility, which provide that events of default include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, cross-default, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption in the operations of any material manufacturing facility for more than 10 consecutive days. The proceeds of the European Credit Facility were used to finance the working capital and other business needs of the company. The company had outstanding borrowings of $7,366,000 (€6,500,000) under its French Credit Facility and $5,986,000 (£4,500,000) under its UK Credit Facility as of December 31, 2021.

In January 2021, the Prior Credit Agreement was amended to provide for, among other things, the addition of the company's Netherlands subsidiary as a guarantor under the European Credit Facility, amendments to the restrictive covenants in the Prior Credit Agreement to (1) increase the maximum amount of permitted miscellaneous indebtedness to $30,000,000 from $10,000,000 and (2) permit up to $9,000,000 of financing based on certain European public and government receivables, and terms that, upon the occurrence of certain events related to a transition from the use of LIBOR, permit the agent for the lenders to amend the Prior Credit
Agreement to replace the LIBOR rate and/or the Euro rate with a benchmark replacement rate.

In March 2021, the Prior Credit Agreement was further amended to permit the issuance of the 2026 Notes and the capped call transactions entered into by the company in connection with the issuance of the 2026 Notes, as further discussed in the sections below.

On December 29, 2021, the Prior Credit Agreement was further amended with the primary provisions to replace the references to the LIBOR rate or Euro rate to a term secured overnight finance rate ("SOFR").
ABL Credit Agreement
On July 26, 2022, the company entered into a Second Amended and Restated Revolving Credit and Security Agreement (the “ABL Credit Agreement”), amending and restating the company’s existing Revolving Credit and Security Agreement, as amended (the “Prior Credit Agreement”). The ABL Credit Agreement was entered into by and among the company, certain of the company’s direct and indirect domestic and Canadian subsidiaries (together with the company, the “Borrowers”), certain other of the company’s direct and indirect domestic and Canadian subsidiaries (the “Guarantors”), and PNC Bank, National Association (“PNC”) and JPMorgan Chase Bank, N.A. (the “ABL Lenders”). PNC is the administrative agent (the “Administrative Agent”) under the ABL Credit Agreement.
The ABL Credit Agreement retained the existing asset-based lending senior secured revolving credit facility provided for the company and the domestic and Canadian Borrowers under the Prior Credit Agreement but extended the maturity date to January 16, 2026, reduced the maximum aggregate principal amount the company and the domestic and Canadian Borrowers may borrow to $35,000,000, limits the borrowing base thereunder to eligible domestic and Canadian accounts receivable and includes a minimum availability reserve of $3,000,000. Borrowings under the ABL Credit Agreement also are subject to a springing maturity date of 191 days prior to the maturity dates of certain convertible notes due 2024 and 2026, and 100 days prior to the maturity date of the Secured Term Loan under the Highbridge Loan Agreement, if such notes or such term loan remain outstanding as of such respective dates. The ABL Credit Agreement also permits the loans made under the Highbridge Loan Agreement and terminated the European Credit Facility under the Prior Credit Agreement. In connection with the ABL Credit Agreement and the Highbridge Loan Agreement, the European Credit Facility under the Prior Credit Agreement was repaid in full and the liens securing the European Credit Facility under the Prior Credit Agreement were terminated and released.
The aggregate borrowing availability under the ABL Credit Agreement is determined based on a borrowing base formula. As of September 30, 2022, the company had gross
37
Notes to Financial StatementsLong-Term Liabilities
borrowing base of $33,133,000 and net borrowing availability of $17,336,000 under the ABL Credit Agreement, considering the minimum availability reserve, then-outstanding letters of credit, other reserves and the $4,375,000 dominion trigger amount.
Interest accrues on outstanding indebtedness under the ABL Credit Agreement at an adjusted Term SOFR rate, plus a margin of 3.25%, or for swing line loans and prime rate revolving loans, at the overnight Prime rate, plus a margin of 2.25%.
The ABL Credit Agreement contains customary terms and covenants and negative covenants, such as limitations on indebtedness, liens, fundamental changes, asset sales, investments and other matters customarily restricted in such agreements. Most of these restrictions are subject to certain minimum thresholds and exceptions. The ABL Credit Agreement also contains customary events of default, after which the revolving loan may be due and payable immediately, including, without limitation, payment defaults, material inaccuracy of representations and warranties, covenant defaults, bankruptcy and insolvency proceedings, cross-defaults to certain other agreements, judgments against the company and its subsidiaries, change in control and lien priority.
Proceeds from the Secured Term Loan under the Highbridge Loan Agreement were used to repay in full outstanding borrowings under the Prior Credit Agreement. Refer to the Term Loan due 2026 section below.
In connection with entering into the company's Prior Credit Agreement and the ABL Credit Agreement, the company incurred fees which were capitalized and are being amortized as interest expense. As of September 30, 2022, debt fees yet to be amortized totaled $1,043,000.
The company was in compliance with the ABL Credit Agreement covenants at September 30, 2022.

Convertible senior notes due 2022

In the second quarter of 2017, the company issued $120,000,000 aggregate principal amount of 4.50% Convertible Senior Notes due 2022 (the “2022 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2022 Notes bore interest at a rate of 4.50% per year payable semi-annually in arrears on June 1 and December 1 of each year, beginning December 1, 2017. The 2022 Notes matured on June 1, 2022. At maturity, $2,650,000 principal amount of the 2022 Notes were outstanding, which the company repaid in cash.

In connection with the offering of the 2022 Notes, the company entered into privately negotiated convertible note hedge transactions with one financial institution (the “option counterparty”). The company evaluated the note hedges under
the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the note hedges should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and were adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $24,780,000. All note hedge options relating to the 2022 Notes expired on June 1, 2022.

The company entered into separate, privately negotiated warrant transactions with the option counterparty at a higher strike price relating to the same number of the company’s Common Shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding Common Shares and the company’s earnings per share to the extent that the price of the company’s Common Shares exceeds the strike price of those warrants. The initial strike price of the warrants is $21.4375 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the warrants meet the definition of a derivative, are indexed to the company's own shares and should be classified in shareholders' equity. The amount paid for the warrants and capitalized in shareholders' equity was $14,100,000.

Warrants relating to the 2022 Notes outstanding on September 30, 2022 were 6,918,006. If exercised, one common share is issued upon exercise of each warrant, but may be adjusted under certain circumstances if the relevant share price exceeds the warrant strike price for the relevant measurement period at the time of exercise. Common Shares are reserved for issuance upon exercise of the remaining warrants relating to the 2022 Notes at two Common Shares per warrant. The warrants began to expire on September 1, 2022 and then partially expire on each trading day over the 220 trading day period following September 1, 2022.

The net proceeds from the offering of the 2022 Notes were approximately $115,289,000, after deducting fees and offering expenses of $4,711,000, which were paid in 2017. These debt issuance costs were capitalized and were amortized as interest expense through June 2022. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. A portion of the net proceeds from the offering were used to pay the cost of the convertible note hedge transactions (after such cost is partially offset by the proceeds to the company from the warrant transactions), which net cost was $10,680,000.

During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of the company's previously outstanding convertible notes due 2021 (the "2021 Notes") and certain holders of its
38
Notes to Financial StatementsLong-Term Liabilities
2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 Notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new Series II 2024 Notes and $5,593,000 in cash.

During the first quarter of 2021, the company repurchased $78,850,000 in principal amount of 2022 Notes, resulting in a loss on debt extinguishment of $709,000.

The liability components of the 2022 Notes consist of the following (in thousands):
September 30, 2022December 31, 2021
Principal amount of liability component$— $2,650 
Debt fees— (8)
Net carrying amount of liability component$— $2,642 

The effective interest rate on the liability component was 10.9% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption of ASU 2020-06 includes coupon interest and amortization of debt fees. Interest expense of $0 and $50,000 was accrued for the three and nine months ended September 30, 2022 compared to $30,000 and $829,000 for the three and nine months ended September 30, 2021, based on the stated coupon rate of 4.5%.

Convertible senior notes Series I due 2024

During the fourth quarter of 2019, the company entered into separate privately negotiated agreements with certain holders of its 2021 Notes to exchange $72,909,000 in aggregate principal amount of 2021 Notes for aggregate consideration of $72,909,000 in aggregate principal amount of new 5.00% Convertible Senior Notes due 2024 (the “Series I 2024 Notes”) of the company and $6,928,000 in cash.

The notes bear interest at a rate of 5.00% per year payable semi-annually in arrears on May 15 and November 15 of each year, beginning May 15, 2020. The notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series I 2024 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series I 2024 Notes may be settled in cash, the company’s Common Shares or a combination of cash and the company’s Common Shares, at the company’s election.

Prior to the maturity of the Series I 2024 Notes, the company may, at its election, redeem for cash all or part of the Series I 2024 Notes if the last reported sale price of the company’s Common Shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the Series I 2024 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series I 2024 Notes, which means the company is not required to redeem or retire the Series I 2024 Notes periodically.

Holders of the Series I 2024 Notes may convert their Series I 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending December 31, 2019 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the Series I 2024 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series I 2024 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the Series I 2024 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series I 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the Series I 2024 Notes will have the right to require the company to repurchase all or some of their Series I 2024 Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 Common Shares per $1,000 principal amount of Series I 2024 Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series I 2024 Notes, holders may convert their Series I 2024 Notes, at the option of the holder, regardless of the foregoing circumstances.

39
Notes to Financial StatementsLong-Term Liabilities
Debt issuance costs of $1,394,000 were capitalized and are being amortized as interest expense through November 15, 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

The liability components of the Series I 2024 Notes consist of the following (in thousands):
September 30, 2022December 31, 2021
Principal amount of liability component$72,909 $72,909 
Debt fees(568)(769)
Net carrying amount of liability component$72,341 $72,140 

The effective interest rate on the liability component was 8.8% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption of ASU 2020-06 includes coupon interest and amortization of debt fees. Interest expense of $911,000 and $2,734,000 was accrued for the three and nine months ended September 30, 2022 compared to $911,000 and $2,733,000 for the three and nine months ended September 30, 2021 based on the stated coupon rate of 5.0%. The effective interest rate of the Series I 2024 Notes as of September 30, 2022 was 5.4%. The Series I 2024 Notes were not convertible as of September 30, 2022 nor was the applicable conversion threshold met.

Convertible senior notes Series II due 2024

During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 Notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new 5.00% Series II Convertible Senior Notes due 2024 (the “Series II 2024 Notes”) of the company and $5,593,000 in cash.

The Series II 2024 Notes bear interest at a rate of 5.00% per year, payable semi-annually in arrears on May 15 and November 15 of each year, beginning November 15, 2020. The Series II 2024 Notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series II 2024 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series II 2024 Notes may be settled in cash, the company’s Common Shares or a combination of cash and the company’s Common Shares, at the company’s election.

Prior to the maturity of the Series II 2024 Notes, the company may, at its election, redeem for cash all or part of the Series II 2024 Notes, if the last reported sale price of the company’s Common Shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the accreted principal amount of the Series II 2024 Notes to be redeemed, plus any accrued and unpaid interest, if any, on the original principal amount of the Series II 2024 Notes redeemed to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series II 2024 Notes, which means the company is not required to redeem or retire the Series II 2024 Notes periodically.

Holders of the Series II 2024 Notes may convert their Series II 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the Series II 2024 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series II 2024 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the Series II 2024 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series II 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the Series II 2024 Notes will have the right to require the company to repurchase all or some of their Series II 2024 Notes at 100% of the accreted principal amount, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 Common Shares per $1,000 principal amount of Series II 2024 Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series II 2024 Notes, holders may convert their Series II 2024 Notes,
40
Notes to Financial StatementsLong-Term Liabilities
at the option of the holder, regardless of the foregoing circumstances.

The principal amount of the Series II 2024 Notes also will accrete at a rate of approximately 4.7% per year commencing June 4, 2020, compounding on a semi-annual basis. The accreted portion of the principal is payable in cash upon maturity but does not bear interest and is not convertible into the company’s Common Shares. The total amount accreted as of September 30, 2022 was $7,558,000, of which $383,000 and $2,211,000 was for the three and nine months ended September 30, 2022, respectively, compared to $890,000 and $2,637,000 for the three and nine months ended September 30, 2021, respectively. Remaining accretion until maturity (at current principal) was $9,064,000 at September 30, 2022.

Debt issuance costs of $1,505,000 were capitalized and are being amortized as interest expense through November 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

In the third quarter of 2022, $5,000,000 aggregate principal amount of Series II 2024 Notes were retired as part of the Secured 2026 Notes and Secured Term Loan transactions discussed below.

The liability components of the Series II 2024 Notes consist of the following (in thousands):
September 30, 2022December 31, 2021
Principal amount of liability component - including accretion$76,433 $79,222 
Debt fees(669)(971)
Net carrying amount of liability component$75,764 $78,251 

The effective interest rate on the liability component was 9.0% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption of ASU 2020-06 includes coupon interest, accretion and amortization of debt fees. Interest expense for accretion of $886,000 and $2,714,000 was recognized for the three and nine months ended September 30, 2022 compared to $890,000 and $2,637,000 for the three and nine months ended September 30, 2021. Interest expense of $879,000 and $2,726,000 were recognized for the three and nine months ended September 30, 2022 compared to $923,000 and $2,770,000 for the three and nine months ended September 30, 2021, based on the stated coupon rate of 5.0%. The effective interest rate of the Series II 2024 Notes as of September 30, 2022 including coupon interest, amortization of debt fees and accretion to maturity was 10.4%. The Series II 2024 Notes
were not convertible as of September 30, 2022 nor was the applicable conversion threshold met.

Convertible senior notes due 2026

In the first quarter of 2021, the company issued $125,000,000 aggregate principal amount of 4.25% Convertible Senior Notes due 2026 (the “2026 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act.

The notes bear interest at a rate of 4.25% per year payable semi-annually in arrears on March 15 and September 15 of each year, beginning September 15, 2021. The notes will mature on March 15, 2026, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to September 15, 2025, the 2026 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The 2026 Notes may be settled in cash, the company’s Common Shares or a combination of cash and the company’s Common Shares, at the company’s election.

The company may not redeem the 2026 Notes prior to March 20, 2024. The company may, at its election, redeem for cash all or part of the 2026 Notes, on or after March 20, 2024, if the last reported sale price of the company’s Common Shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the 2026 Notes, which means the company is not required to redeem or retire the 2026 Notes periodically.

Holders of the 2026 Notes may convert their 2026 Notes at their option at any time prior to the close of business on the business day immediately preceding September 15, 2025 in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2021 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the 2026 Notes on each applicable trading day; (2) during the five business day period
41
Notes to Financial StatementsLong-Term Liabilities
after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2026 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2026 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls any or all of the 2026 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date. Holders of the 2026 Notes will have the right to require the company to repurchase all or some of their 2026 Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 94.6096 Common Shares per $1,000 principal amount of 2026 notes (equivalent to an initial conversion price of approximately $10.57 per common share). On or after September 15, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2026 Notes, holders may convert their 2026 Notes, at the option of the holder, regardless of the foregoing circumstances.

Debt issuance costs of $5,697,000 were capitalized and are being amortized as interest expense through March 2026. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

The liability components of the 2026 Notes consist of the following (in thousands):
September 30, 2022December 31, 2021
Principal amount of liability component$83,525 $125,000 
Debt fees(2,627)(5,964)
Net carrying amount of liability component$80,898 $119,036 

Interest expense of $1,015,000 and $3,671,000 was accrued for the three and nine months ended September 30, 2022 compared to $1,328,000 and $2,892,000 for the three and nine months ended September 30, 2021 based on the stated coupon rate of 4.25%. The effective interest rate of the 2026 Notes as of September 30, 2022 was 5.4%. The 2026 Notes were not convertible as of September 30, 2022 nor was the applicable conversion threshold met.

In the third quarter of 2022, $41,475,000 aggregate principal amount of 2026 Notes were exchanged and retired as part of the Secured 2026 Notes and Secured Term Loan transactions discussed below.

As part of the transactions for the closing of the Term Loan, exchange of 2026 Notes for Secured 2026 Notes and retirement of $5,000,000 of Series II 2024 Notes in the third quarter of 2022, 2,700,000 Common Shares were issued. These transactions resulted in a net gain on extinguishment of debt of $6,398,000.

In March 2021, in connection with the pricing of the 2026 Notes, the company entered into capped call transactions (the “Capped Call Transactions”) with certain option counterparties. The company used $18,787,000 of the net proceeds of the private offering of the 2026 Notes to pay the cost of the Capped Call Transactions with the offset recorded to additional paid-in-capital.

The Capped Call Transactions are expected generally to reduce the potential dilution upon conversion of the 2026 Notes and/or offset any cash payments the company is required to make in excess of the principal amount of converted notes, as the case may be, in the event that the market price per share of the company’s Common Shares, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which is initially $10.57, corresponding to the initial conversion price of the 2026 Notes, subject to anti-dilution adjustments. If, however, the market price per company common share, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions, which is initially $16.58 (subject to adjustments), there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the Capped Call Transactions. The Capped Call Transactions expire March 15, 2026, subject to earlier exercise. There were 125,000 capped call options related to the 2026 Notes outstanding on September 30, 2022.

The company will not be required to make any cash payments to the option counterparties upon the exercise of the options that are a part of the Capped Call Transactions, but the company will be entitled to receive from the option counterparties a number of company Common Shares, an amount of cash or a combination thereof generally based on the amount by which the market price per company common share, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions during the relevant valuation period under the Capped Call Transactions. However, if the market price per Company common share, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions during such valuation period, the number of company Common Shares and/or the amount of cash the company expects to receive upon exercise of the Capped Call Transactions will be capped based on the amount
42
Notes to Financial StatementsLong-Term Liabilities
by which the cap price exceeds the strike price of the Capped Call Transactions.

For any conversions of the 2026 Notes prior to September 15, 2025, a corresponding portion of the relevant Capped Call Transactions may be terminated at the company’s option. Upon any such termination, the company expects to receive from the option counterparties a number of company Common Shares, or, if the company so elects, subject to certain conditions, an amount of cash, in each case, with a value equal to the fair value of such portion of the relevant Capped Call Transactions being terminated, as calculated in accordance with the terms of the relevant Capped Call Transaction.

The Capped Call Transactions are separate transactions, in each case, entered into by the company with the option counterparties, and are not part of the terms of the 2026 Notes and will not affect any holder’s rights under the 2026 Notes. Holders of the 2026 Notes will not have any rights with respect to the Capped Call Transactions.
Secured convertible senior notes due 2026

In the third quarter of 2022, the company issued and aggregate $31,106,000 (split equally between two separate tranches ("Tranche I Notes" and "Tranche II Notes" or "Indentures") in aggregate principal amount of 5.68% Secured Convertible Senior Notes due 2026 (the “Secured 2026 Notes”) in a private offering. This was in exchange for $41,475,000 aggregate principal amount of 2026 Notes which were retired. In October 2022, additional principal amount of Secured 2026 Notes were issued aggregating to $20,739,000 and $20,736,000 in aggregate principal amount of Tranche I Notes and Tranche II Notes, respectively, in exchange for $13,825,000 of 2026 Notes. Refer to October 2022 Financings below.
The Secured 2026 Notes are initially guaranteed by certain subsidiaries of the company in the United States, United Kingdom, Canada, France, the Netherlands and Luxembourg pursuant to separate guarantees (each, a “Guarantee”), and are secured on a pari passu basis by the same collateral that secures the Highbridge Loan Agreement (discussed below). In addition, the company's subsidiaries that provide guarantees of the Highbridge Loan Agreement in connection with the post-closing draws provided Guarantees of the Secured 2026 Notes.
Interest on the Secured 2026 Notes will be payable semi-annually in cash in arrears on January 1 and July 1 of each year, beginning on January 1, 2023, at a rate of 5.68% per year. The Secured 2026 Notes will mature on July 1, 2026, unless earlier converted, redeemed or repurchased in accordance with their terms. Holders of the Secured 2026 Notes have the right, at their option, at any time prior to the close of business on the second scheduled trading day immediately preceding July 1, 2026 (the maturity date), to
convert any Secured 2026 Notes or portion thereof that is $1,000 or an integral multiple thereof, subject to certain conditions, into cash, Common Shares or a combination of cash and Common Shares at the company’s election (subject to, and in accordance with, the settlement provisions set forth the Indentures). The initial conversion rate for the (i) Tranche I Notes is 333.3333 Common Shares (subject to adjustment as provided for in the Tranche I Indenture) per $1,000 principal amount of the Tranche I Notes, which is equal to an initial conversion price of $3.00 per share, and (ii) Tranche II Notes is 222.222 Common Shares (subject to adjustment as provided for in the Tranche II Indenture) per $1,000 principal amount of the Tranche II Notes, which is equal to an initial conversion price of $4.50 per share. In addition, following certain corporate events as described in the Indentures that occur prior to the maturity date of the Secured 2026 Notes or if the company delivers a notice of redemption, the company will pay a make-whole premium by increasing the conversion rate for a holder who elects to convert its Secured 2026 Notes in connection with such a corporate event or notice of redemption, as the case may be, in certain circumstances, subject to adjustment as provided for and in accordance with the Indentures. These features are bifurcated driving convertible derivative liability.
The company may not elect to redeem the Secured 2026 Notes prior to January 26, 2023. The company may redeem for cash all or any portion of the Secured 2026 Notes, at its option, on or after January 26, 2023 if the last reported sale price of the Common Shares exceeds 150% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the Secured 2026 Notes to be redeemed, plus any accrued and unpaid interest on such Secured 2026 Notes to, but excluding, the redemption date (subject to certain conditions set forth the Indentures). No sinking fund is provided for the Secured 2026 Notes.
If the company undergoes a Fundamental Change (as defined in the Indentures), prior to the maturity date of the Secured 2026 Notes, holders of the Secured 2026 Notes will, subject to specified conditions, have the right, at their option, to require the company to repurchase for cash all or a portion of their Secured 2026 Notes at a repurchase price equal to 100% of the principal amount of the Secured 2026 Notes to be repurchased, plus any accrued and unpaid interest to, but not including, the Fundamental Change repurchase date.
The Indentures provide for customary events of default. In the case of an event of default with respect to the Secured 2026 Notes arising from specified events of bankruptcy or insolvency, all outstanding Secured 2026 Notes will become due and payable immediately without further action or notice. If any other event of default with respect to the Secured 2026
43
Notes to Financial StatementsLong-Term Liabilities
Notes under the Indentures occur or is continuing, the Trustee or holders of at least 25% in aggregate principal amount of the then outstanding Secured 2026 Notes may declare the principal amount of the Secured 2026 Notes to be immediately due and payable.
In certain circumstances if, at any time during the six-month period beginning on, and including, the date that is six months after the date of original issuance for any sub-tranche of the Secured 2026 Notes, the company fails to timely file certain documents or reports required under the Securities Exchange Act of 1934, as amended, or the Secured 2026 Notes are not otherwise freely tradable under Rule 144 by holders of the Secured 2026 Notes other than the company’s affiliates or holders that were affiliates at any time during the three months preceding, additional interest will accrue at a rate of up to 0.50% on the Secured 2026 Notes during the period in which its failure to file has occurred and is continuing or such Secured 2026 Notes are not otherwise freely tradable under Rule 144 by holders other than the company’s affiliates or holders that were affiliates at any time during the three months preceding until such failure is cured.
In addition, if, and for so long as, the restrictive legend on any sub-tranche of the Secured 2026 Notes has not been removed, any sub-tranche of the Secured 2026 Notes are assigned a restricted CUSIP number or any sub-tranche of the Secured 2026 Notes are not otherwise freely tradable under Rule 144 by holders other than the company’s affiliates or holders that were affiliates at any time during the three months preceding (without restrictions pursuant to U.S. securities laws or the terms of the Indentures or the Secured 2026 Notes) as of the 380th day after the date of original issuance of such sub-tranche of the Secured 2026 Notes, the company will pay additional interest at a rate of 0.50% on the Secured 2026 Notes during the period in which the Secured 2026 Notes remain so restricted.
The company may not issue Common Shares upon conversions of the Secured 2026 Notes, net of the 2,700,000 Common Shares issued in the Exchange, in excess of 19.99% of the company’s Common Shares outstanding on July 25, 2022; until the requisite approval under the applicable New York Stock Exchange rules by the company’s shareholders is obtained. The company intends to seek this approval at its 2023 Annual Meeting of Shareholders.

Debt issuance costs of $2,389,000 were capitalized and are being amortized as interest expense through July 2026. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.






The liability components of the Secured 2026 Notes consist of the following (in thousands):
September 30, 2022
Principal amount of liability component$31,106 
Unamortized discount(1,365)
Debt fees(2,278)
Net carrying amount of liability component$27,463 

Interest expense of $324,000 was accrued for the three and nine months ended September 30, 2022 based on the stated coupon rate of 5.68%. The effective interest rate of the 2026 Notes as of September 30, 2022 was 8.7%. The 2026 Notes were not convertible as of September 30, 2022 nor was the applicable conversion threshold met.
Secured Term Loan due 2026
On July 26, 2022, the company entered into a Credit Agreement (the “Highbridge Loan Agreement” or "Secured Term Loan") with a certain fund managed by Highbridge Capital Management, LLC (“Highbridge”), as the lender (together with the other lenders from time to time party thereto, the “Lenders”), Cantor Fitzgerald Securities as administrative agent and GLAS Trust Corporation Limited, as collateral agent.
Pursuant to the Highbridge Loan Agreement, the company may borrow up to an aggregate of $104,500,000 principal amount of Secured Term Loan, including $66,500,000 with $2,000,000 original issuance discount in initial secured term loans drawn at closing, $8,500,000 in additional Secured Term Loans principal to be made in a single draw subject to satisfaction of certain conditions, another $10,000,000 in additional Secured Term Loan principal to be made in a single draw subject to satisfaction of certain further conditions and $19,500,000 in additional Secured Term Loan to be made in a single draw subject to satisfaction of certain further conditions. The company expects to use the proceeds of the Secured Term loan for working capital and general corporate purposes and to pay fees and expenses in connection with the transactions described herein.
The Secured Term Loan is scheduled to mature on July 26, 2026 and accrues interest at an initial annual rate of SOFR plus 7.00% or a base rate plus 6.00% and after the second anniversary of closing at an annual rate of SOFR plus 8.75% or a base rate plus 7.75%. The Secured Term Loan is also subject to a springing maturity date of 91 days prior to the maturity date of certain convertible notes due November 2024 if more than $20,000,000 of such notes remain outstanding as of such date. The obligations under the Highbridge Loan Agreement are secured, initially, by substantially all assets of the company and certain subsidiaries of the company (subject
44
Notes to Financial StatementsLong-Term Liabilities
to certain exceptions), subject to intercreditor agreements in connection with the ABL Credit Agreement and the 5.68% Indentures, and are guaranteed by certain subsidiaries of the company in the United States, United Kingdom, Canada, France, the Netherlands and Luxembourg at the closing. Additional collateral owned by subsidiaries of the company in various jurisdictions will be added to the security for the Secured Term Loan and additional subsidiaries of the company in various jurisdictions will guarantee the obligations in connection with the post-closing draws.
The company will have the right to prepay the Secured Term Loan at any time, subject to a prepayment premium, which in case of a prepayment before the second anniversary of the closing date is equal to the greater of (i) 1.00% of the aggregate principal amount of the Secured Term Loan so prepaid and (ii) the excess, if any of (A) the present value as of the date of repayment of all interest that would have accrued on the Secured Term Loan being prepaid from such date through the second anniversary of the closing plus the present value as of such date of the principal amount of the Secured Term Loan being prepaid assuming a prepayment date of the second anniversary of the closing over (B) the principal amount of such Secured Term Loan being prepaid and, after the second anniversary of the closing is equal to 1.00% of the aggregate principal amount of the Secured Term Loan so prepaid, as well as, in each case, an additional redemption fee equal to 3.00% of the aggregate principal amount of the Secured Term Loan so prepaid.
The Highbridge Loan Agreement contains customary terms and covenants, including without limitation a financial covenant to maintain a minimum liquidity of $20,000,000 and negative covenants, such as limitations on indebtedness, liens, fundamental changes, asset sales, investments and other matters customarily restricted in such agreements. Most of these restrictions are subject to certain minimum thresholds and exceptions. The Highbridge Loan Agreement also contains customary events of default, after which the Secured Term Loan may be due and payable immediately, including, without limitation, payment defaults, material inaccuracy of representations and warranties, covenant defaults, bankruptcy and insolvency proceedings, cross-defaults to certain other agreements, judgments against the company and its subsidiaries, change in control and lien priority.
Debt issuance costs of $5,107,000 were capitalized and are being amortized as interest expense through July 2026. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.






The liability components of the Secured Term Loan consist of the following (in thousands):
September 30, 2022
Principal amount of liability component$66,500 
Unamortized original issuance discount(1,907)
Debt fees(4,869)
Net carrying amount of liability component$59,724 

Interest expense of $1,217,000 was accrued for the three and nine months ended September 30, 2022 based on the stated coupon rate of 5.68%. The effective interest rate of the 2026 Notes as of September 30, 2022 was 12.7%.

The weighted average interest rate on all borrowings, excluding finance leases, was 5.0% for the nine months ended September 30, 2022 and 4.5% for the year ended December 31, 2021.
Other

In the second quarter of 2022, the company borrowed $2,000,000 against the cash surrender value of its life insurance policies which the company intends to repay in the next twelve months.

October 2022 Financings
Highbridge Loan Agreement and Indentures
On October 3, 2022, the company consummated additional draws of an aggregate of $18,500,000 under the Highbridge Loan Agreement. Additional borrowing under the Term Loan of $19,500,000 remains available, subject to the satisfaction of certain conditions.
Further, the company issued $5,186,000 in aggregate principal amount of additional 5.68% Tranche I Notes and $5,183,000 in aggregate principal amount of additional 5.68% Tranche II Notes of the Secured 2026 Notes in exchange for $13,825,000 of 2026 Notes which were retired. Following these transactions, $69,700,000 aggregate principal amount of 2026 Notes remain outstanding.
45
Notes to Financial StatementsLong-Term Liabilities
Other Long-Term Obligations

Other long-term obligations consist of the following (in thousands):
September 30, 2022December 31, 2021
Deferred income taxes$19,385 $21,664 
Product liability12,010 11,342 
Deferred compensation5,090 6,174 
Deferred gain on sale leaseback4,920 5,174 
Supplemental executive retirement plan liability4,697 5,106 
Death benefit obligation plan3,499 4,568 
Uncertain tax obligation including interest2,980 3,171 
Pension 2,783 7,814 
Secured Convertible 2026 debt conversion liability473 — 
Other537 1,783 
Other Long-Term Obligations$56,374 $66,796 

The Secured Convertible 2026 debt conversion liability amounts included in the above table represent the fair values of the conversion liabilities.

On April 23, 2015, the company entered into a real estate sale leaseback transaction which resulted in the company recording an initial deferred gain of $7,414,000, the majority of which is included in Other Long-Term Obligations and will be recognized over the 20-year life of the leases. The gains realized were $82,000 and $245,000 for the three and nine months ended September 30, 2022 respectively, compared to $80,000 and $237,000 for the three and nine months ended September 30, 2021 respectively.














46
Notes to Financial StatementsLong-Term Liabilities
Leases and Commitments

The company reviews new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, the company has recognized those amounts as part of the right-of-use assets and lease liabilities. The company combines lease and certain non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, the company uses an incremental borrowing rate (IBR) based on information available at commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. The company calculates its IBR based on the secured rates of the company's recent debt issuances, the credit rating of the company, changes in currencies, lease repayment timing as well as other publicly available data.

The company leases a portion of its facilities, transportation equipment, data processing equipment and certain other equipment. These leases have terms from 1 to 20 years and provide for renewal options. Generally, the company is required to pay taxes and normal expenses associated with operating the facilities and equipment. As of September 30, 2022, the company is committed under non-cancelable leases, which have initial or remaining terms in excess of one year and expire on various dates through 2040.

On April 23, 2015, the company sold and leased back, under four separate lease agreements, four properties located in Ohio and one property in Florida for net proceeds of $23,000,000, which were used to reduce debt under the U.S. and Canadian Credit Facility. The initial total annual rent for the properties was $2,275,000 and can increase annually over the 20-year term of the leases based on the applicable geographical consumer price index (CPI). Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases.

In connection with the transaction, the requirements for sale lease-back accounting were met. Accordingly, the company recorded the sale of the properties, removed the related property and equipment from the company's balance sheet, recognized an initial deferred gain of $7,414,000 and an immediate loss of $257,000 related to one property and recorded new lease liabilities. Specifically, the company
recorded four finance leases totaling $32,339,000 and one operating lease related to leased land, which was not a material component of the transaction. The gains on the sales of the properties were required to be deferred and recognized over the life of the leases as the property sold is being leased back. The deferred gain is classified under Other Long-Term Obligations on the condensed consolidated balance sheets.
Lease expenses for the three and nine months ended September 30, 2022 and September 30, 2021, respectively, were as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2022202120222021
Operating leases$1,391 $1,811 $4,421 $5,592 
Variable and short-term leases616 764 1,961 2,825 
Total operating leases$2,007 $2,575 $6,382 $8,417 
Finance lease interest cost$1,062 $1,146 $3,224 $3,487 
Finance lease depreciation1,055 1,265 3,210 3,807 
Total finance leases$2,117 $2,411 $6,434 $7,294 






















47
Notes to Financial StatementsLong-Term Liabilities
Future minimum operating and finance lease commitments, as of September 30, 2022, are as follows (in thousands):
Finance 
Leases		Operating Leases
2022$1,637 $1,100 
20236,501 3,192 
20246,443 2,452 
20256,353 1,973 
20266,248 1,209 
Thereafter65,253 1,615 
Total future minimum lease payments92,435 11,541 
Amounts representing interest(31,893)(1,614)
Present value of minimum lease payments60,542 9,927 
Less: current maturities of lease obligations(3,031)(3,062)
Long-term lease obligations$57,511 $6,865 
Supplemental cash flow amounts for the three and nine months ended September 30, 2022 and September 30, 2021 were as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
Cash Activity: Cash paid in measurement of amounts for lease liabilities2022202120222021
Operating leases$1,967 $2,584 $6,266 $8,501 
Finance leases1,810 2,100 5,478 6,311 
Total$3,777 $4,684 $11,744 $14,812 
Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligations2022202120222021
Operating leases$1,264 $989 $2,429 $5,418 
Finance leases54 189 969 6,345 
Total$1,318 $1,178 $3,398 $11,763 











Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2022 and December 31, 2021, respectively:
September 30, 2022December 31, 2021
Weighted-average remaining lease term - finance leases14.9 years15.8 years
Weighted-average remaining lease term - operating leases4.8 years5.0 years
Weighted-average discount rate - finance leases6.37%6.43%
Weighted-average discount rate - operating leases8.07%7.10%


48
Notes to Financial StatementsRevenue
Revenue

The company has two revenue streams: products and services. Services include repair, refurbishment, preventive maintenance and rental of products. Services for the North America segment include maintenance and repair of products. Services for the Europe segment include repair, refurbishment and preventive maintenance services. Services in All Other, are in the Asia Pacific region, and include rental and repair of products.

The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2022 and September 30, 2021 (in thousands):
Three Months Ended September 30, 2022
ProductServiceTotal
Europe$94,723 $2,764 $97,487 
North America65,068 246 65,314 
All Other6,380 1,227 7,607 
Total$166,171 $4,237 $170,408 
% Split98%2%100%
Nine Months Ended September 30, 2022
ProductServiceTotal
Europe$319,467 $8,867 $328,334 
North America208,776 575 209,351 
All Other19,067 3,661 22,728 
Total$547,310 $13,103 $560,413 
% Split98%2%100%
Three Months Ended September 30, 2021
ProductServiceTotal
Europe$123,671 $3,355 $127,026 
North America87,936 118 88,054 
All Other7,788 1,332 9,120 
Total$219,395 $4,805 $224,200 
% Split98%2%100%
Nine Months Ended September 30, 2021
ProductServiceTotal
Europe$351,680 $9,417 $361,097 
North America259,623 652 260,275 
All Other21,010 3,884 24,894 
Total$632,313 $13,953 $646,266 
% Split98%2%100%
The company's revenues are principally related to the sale of products, approximately 98%, with the remaining 2% related to services including repair, refurbishment, preventive maintenance and rental of products. While the company has a significant amount of contract types, the sales split by contract type is estimated as follows: general terms and conditions (30%), large national customers (23%), governments, principally pursuant to tender contracts (22%) and other customers including buying groups and independent customers (25%).

All product revenues and substantially all service revenues are recognized at a point in time. The remaining service revenue, recognized over time, are reflected in the Europe segment and include multiple performance obligations. For such contracts, the company allocates revenue to each performance obligation based on its relative standalone selling price. The company generally determines the standalone selling price based on the expected cost-plus margin methodology.    

Revenue is recognized when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the company’s products and services. The amount of consideration received and revenue recognized by the company can vary as a result of variable consideration terms included in the contracts related to customer rebates, cash discounts and return policies. Revenue is measured as the amount of consideration probable of not having a significant reversal of cumulative revenue recognized when related uncertainties are resolved. Customer rebates and cash discounts are estimated based on the most likely amount principle and these estimates are based on historical experience and anticipated performance. In addition, customers have the right to return products within the company’s normal terms policy, and as such the company estimates the expected returns based on an analysis of historical experience. The company adjusts its estimate of revenue at the earlier of when the most likely amount of consideration it expects to receive changes or when the consideration becomes fixed. The company generally does not expect that there will be significant changes to its estimates of variable consideration (refer to “Receivables” and "Accrued
49
Notes to Financial StatementsRevenue
Expenses" in the notes to the condensed consolidated financial statements include elsewhere in this report for more detail).

Depending on the terms of the contract, the company may defer the recognition of a portion of the revenue at the end of a reporting period to align with transfer of control of the company’s products to the customer. In addition, to the extent performance obligations are satisfied over time, the company defers revenue recognition until the performance obligations are satisfied. As of September 30, 2022 and December 31, 2021, the company had deferred revenue of $1,903,000 and $4,156,000, respectively, related to outstanding performance obligations with substantially all expected to be recognized as revenue within a year.
50
Notes to Financial StatementsEquity Compensation
Equity Compensation

The company’s Common Shares have a $0.25 stated value. The Common Shares and the Class B Common Shares generally have identical rights, terms and conditions and vote together as a single class on most issues, except that the Class B Common Shares have ten votes per share and, in general, can only be transferred to family members or for estate planning purposes. Holders of Class B Common Shares are entitled to convert their shares into Common Shares at any time on a share-for-share basis. When Class B Common Shares are transferred out of a familial relationship, they automatically convert to Common Shares.

As of September 30, 2022, 3,667 Class B Common Shares remained outstanding. Prior conversions of Class B Common Shares have virtually eliminated the company’s dual class voting structure. As of September 30, 2022, the holders of the Common Shares represented approximately 99.9% of the company’s total outstanding voting power.

Equity Compensation Plan

On May 17, 2018, the shareholders of the company approved the Invacare Corporation 2018 Equity Compensation Plan (the “2018 Plan”), which was adopted on March 27, 2018 by the company's Board of Directors (the “Board”). The company’s Board adopted the 2018 Plan in order to authorize additional Common Shares for grant as equity compensation, and to reflect changes to Section 162(m) of the Internal Revenue Code (the “Code”) resulting from the U.S. Tax Cuts and Jobs Act of 2017.
Following shareholder approval of the 2018 Plan, all of the Common Shares then-remaining available for issuance under the Invacare Corporation 2013 Equity Compensation Plan (the “2013 Plan”) and all of the Common Shares that were forfeited or remained unpurchased or undistributed upon termination or expiration of awards under the 2013 Plan and under the Invacare Corporation 2003 Performance Plan (the “2003 Plan”), become available for issuance under the 2018 Plan. Awards granted previously under the 2013 Plan and 2003 Plan will remain in effect under their original terms.
The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of stock options or stock appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a stock option or a SAR will count against the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003
Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share.
The Compensation and Management Development Committee of the Board (the “Compensation Committee”), in its discretion, may grant an award under the 2018 Plan to any director or employee of the company or an affiliate. As of September 30, 2022, 5,507,144 Common Shares were available for future issuance under the 2018 Plan in connection with the following types of awards with respect to the company's Common Shares: incentive stock options, nonqualified stock options, SARs, restricted stock, restricted stock units, unrestricted stock and performance shares. The Compensation Committee also may grant performance units that are payable in cash. The Compensation Committee has the authority to determine which participants will receive awards, the amount of the awards and the other terms and conditions of the awards.
The 2018 Plan provides that shares granted come from the company's authorized but unissued Common Shares or treasury shares. In addition, the company's stock-based compensation plans allow employee participants to exchange shares for minimum withholding taxes, which results in the company acquiring treasury shares.
51
Notes to Financial StatementsEquity Compensation
The amounts of equity-based compensation expense recognized as part of SG&A expenses in All Other in business segment reporting were as follows (in thousands):
For the Nine Months Ended September 30,
20222021
Restricted stock and restricted stock units$2,653 $4,570 
Performance shares and performance share units(814)799 
Total stock-based compensation expense$1,839 $5,369 

As of September 30, 2022, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan, which is related to non-vested awards, was as follows (in thousands):
September 30, 2022
Restricted stock and restricted stock units$2,826 
Performance shares and performance share units168 
Total unrecognized stock-based compensation expense$2,994 
Total unrecognized compensation cost will be adjusted for future changes in actual and estimated forfeitures and for updated vesting assumptions for the performance share awards (refer to "Performance Shares and Performance Share Units" below). No tax benefits for stock compensation were realized during the three and nine months ended September 30, 2022 and 2021, respectively, due to a valuation allowance against deferred tax assets. In accordance with ASC 718, any tax benefits resulting from tax deductions in excess of the compensation expense recognized is classified as a component of financing cash flows.

Stock Options

Generally, non-qualified stock option awards have a term of ten years and were granted with an exercise price per share equal to the fair market value of the company’s Common Shares on the date of grant.

The following table summarizes information about stock option activity for the nine months ended September 30, 2022:
Weighted Average
Exercise Price
Options outstanding at January 1, 2022750,159 $12.69 
Expired(107,987)13.48
Options outstanding at September 30, 2022642,172 $12.55 
Options exercise price range at September 30, 2022$12.15 to$14.49 
Options exercisable at September 30, 2022642,172 
Shares available for grant under the 2018 Plan at September 30, 2022*5,507,144 
________
 *    Shares available for grant under the 2018 Plan as of September 30, 2022 are reduced by awards and increased by forfeitures or expirations. At September 30, 2022, an aggregate of 910,624 Common Shares underlie awards which were forfeited or expired unexercised under the 2003 and 2013 Plans and thus are available for future issuance under the 2018 Plan upon transfer.

The following table summarizes information about stock options outstanding at September 30, 2022:
 Options OutstandingOptions Exercisable
Exercise PricesNumber
Outstanding at
September 30, 2022		Weighted Average
Remaining
Contractual Life (Years)		Weighted Average
Exercise Price		Number Exercisable at
September 30, 2022		Weighted Average
Exercise Price
$12.15 – $14.49
642,172 0.8$12.55 642,172 $12.55 

52
Notes to Financial StatementsEquity Compensation

The 2018 Plan provides for a one-year minimum vesting period for stock options and, generally, options must be exercised within ten years from the date granted. No stock options were issued in 2022 or 2021.

Restricted Stock and Restricted Stock Units

The following table summarizes information about restricted stock and restricted stock units (primarily for non-U.S. recipients):
Weighted Average Fair Value
Stock / Units unvested at January 1, 20221,160,847 $8.17 
Granted1,321,249 1.37 
Vested(553,071)8.43 
Forfeited(741,679)4.30 
Stock / Units unvested at
September 30, 2022		1,187,346 $2.90 

The restricted awards generally vest ratably over the three years after the award date. Unearned restricted awards compensation, determined as the market value of the shares at the date of grant, is being amortized on a straight-line basis over the vesting period as adjusted for forfeiture estimates.

Performance Shares and Performance Share Units

The following table summarizes information about performance shares and performance share units (primarily for non-U.S. recipients):
 Weighted Average Fair Value
Shares / Units unvested at January 1, 2022972,288 $7.76 
Granted460,187 1.48 
Forfeited(942,201)5.79 
Shares / Units unvested at
September 30, 2022		490,274 $5.67 

During the nine months ended September 30, 2022, performance shares and performance share units (for non-U.S. recipients) were granted. Performance awards have a three year performance period with payouts based on achievement of certain performance goals. The awards are classified as equity awards as they will be settled in Common Shares upon vesting. The number of shares earned will be determined at the end of the three year performance period based on achievement of performance criteria for January 1, 2020 through December 31, 2022, January 1, 2021 through
December 31, 2023 and January 1, 2022 through December 31, 2024, respectively established by the Compensation Committee at the time of grant. Recipients will be entitled to receive a number of Common Shares equal to the number of performance shares that vest based upon the levels of achievement which may range between 0% and 150% of the target number of shares with the target being 100% of the initial grant.

The fair value of the performance awards is based on the stock price on the date of grant discounted for the estimated value of dividends foregone as the awards are not eligible for dividends except to the extent vested. The grant fair value is further updated each reporting period while variable accounting applies. The company assesses the probability that the performance targets will be met with expense recognized whenever it is probable that at least the minimum performance criteria will be achieved. Depending upon the company's assessment of the probability of achievement of the goals, the company may not recognize any expense associated with performance awards in a given period, may reverse prior expense recorded or record additional expense to recognize the cumulative estimated achievement level of proportionate term of the award. Performance award compensation expense is generally expected to be recognized over three years. The company continues to recognize expense (benefit) related to the awards granted in 2020, 2021 and 2022 based on estimates that the performance goals for those awards will be or will not be met.



53
Notes to Financial StatementsAccumulated Other Comprehensive Income
Accumulated Other Comprehensive Income (Loss) by Component

Changes in accumulated other comprehensive income (loss) ("OCI") (in thousands):
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2022$(13,347)$1,548 $462 $1,453 $(9,884)
OCI before reclassifications(31,883)(2,168)155 59 (33,837)
Amount reclassified from accumulated OCI— — (110)(1,275)(1,385)
Net current-period OCI(31,883)(2,168)45 (1,216)(35,222)
September 30, 2022$(45,230)$(620)$507 $237 $(45,106)
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2021$18,961 $2,127 $(4,101)$1 $16,988 
OCI before reclassifications(64,191)(2,747)4,772 2,197 (59,969)
Amount reclassified from accumulated OCI— — (164)(1,961)(2,125)
Net current-period OCI(64,191)(2,747)4,608 236 (62,094)
September 30, 2022$(45,230)$(620)$507 $237 $(45,106)
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
June 30, 2021$60,381 $2,146 $(4,069)$(1,379)$57,079 
OCI before reclassifications(19,155)(47)(209)944 (18,467)
Amount reclassified from accumulated OCI— — 182 309 491 
Net current-period OCI(19,155)(47)(27)1,253 (17,976)
September 30, 2021$41,226 $2,099 $(4,096)$(126)$39,103 
Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
December 31, 2020$50,329 $(517)$(3,674)$(702)$45,436 
OCI before reclassifications(9,103)2,616 (440)(643)(7,570)
Amount reclassified from accumulated OCI— — 18 1,219 1,237 
Net current-period OCI(9,103)2,616 (422)576 (6,333)
September 30, 2021$41,226 $2,099 $(4,096)$(126)$39,103 











54
Notes to Financial StatementsAccumulated Other Comprehensive Income
Reclassifications out of accumulated OCI were as follows (in thousands):
Amount reclassified from OCIAmount reclassified from OCIAffected line item in the Statement of Comprehensive (Income) Loss
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2022202120222021
Defined Benefit Plans 
Service and interest costs$(110)$182 $(164)$18 Selling, general and administrative expenses
Tax— — — — Income taxes
Total after tax$(110)$182 $(164)$18 
Derivatives
Foreign currency forward contracts hedging sales$(68)$476 $(125)$657 Net sales
Foreign currency forward contracts hedging purchases(1,263)(92)(1,997)746 Cost of products sold
Total loss (income) before tax(1,331)384 (2,122)1,403 
Tax56 (75)161 (184)Income taxes
Total after tax$(1,275)$309 $(1,961)$1,219 
55
Notes to Financial StatementsCharges Related to Restructuring Activities
Charges Related to Restructuring Activities

The company's restructuring charges were originally necessitated primarily by continued declines in Medicare and Medicaid reimbursement by the U.S. government, as well as similar healthcare reimbursement pressures abroad, which negatively affected the company's customers (e.g. home health care providers) and continued pricing pressures faced by the company due to the outsourcing by competitors to lower cost locations. Restructuring decisions were also the result of reduced profitability in each of the segments. Restructuring actions have continued into 2022.

For the nine months ended September 30, 2022, severance and other charges totaled $16,383,000 which were related to North America of $5,534,000, Europe of $9,766,000 and All Other of $1,083,000. Payments for the nine months ended September 30, 2022 were $10,789,000 and the cash payments were funded with the company's cash on hand. The 2022 charges are expected to be paid out within 12 months.

For the nine months ended September 30, 2021, charges totaled $2,476,000 which were related to North America of $975,000 and Europe of $1,501,000. In North America costs were incurred related to severance. The European charges were for severance costs $895,000 and contract terminations $606,000, primarily related to the closure of a German manufacturing facility. Payments for the nine months ended September 30, 2021 were $7,367,000 and the cash payments were funded with company's cash on hand.
There have been no material changes in accrued balances related to the charges, either as a result of revisions to the plans or changes in estimates. In addition, the savings anticipated as a result of the company's restructuring plans have been or are expected to be achieved, primarily resulting in reduced salary and benefit costs principally impacting selling, general and administrative expenses, and to a lesser extent, costs of products sold. To date, the company's liquidity has been sufficient to absorb these charges and payments.

56
Notes to Financial StatementsCharges Related to Restructuring Activities
A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2022 is as follows (in thousands):
SeveranceOtherTotal
December 31, 2021 Balances
North America$482 $— $482 
Total482 — 482 
Charges
North America 1,124 538 1,662 
Europe2,119 — 2,119 
All Other9 — 9 
Total 3,252 538 3,790 
Payments
North America (422)(538)(960)
Europe (367)— (367)
All Other(9)— (9)
Total (798)(538)(1,336)
March 31, 2022 Balances
North America1,184 — 1,184 
Europe1,752 — 1,752 
Total$2,936 $— $2,936 
Charges
North America$542 998 $1,540 
Europe1,288 1,325 2,613 
Total1,830 2,323 4,153 
Payments
North America(768)(442)(1,210)
Europe(1,254)(624)(1,878)
Total(2,022)(1,066)(3,088)
June 30, 2022 Balances
North America958 556 1,514 
Europe1,786 701 2,487 
Total$2,744 $1,257 $4,001 
Charges
North America116 2,216 2,332 
Europe1,033 4,001 5,034 
All Other1,074 — 1,074 
Total2,223 6,217 8,440 
Payments
North America(438)(1,807)(2,245)
Europe(1,067)(3,041)(4,108)
All Other(12)— (12)
Total(1,517)(4,848)(6,365)
September 30, 2022 Balances
North America636 965 1,601 
Europe1,752 1,661 3,413 
All Other1,062 — 1,062 
Total$3,450 $2,626 $6,076 
57
Notes to Financial StatementsIncome Taxes
Income Taxes

The company had an effective tax rate of 2.8% and 4.1% on losses before tax for the three and nine months ended September 30, 2022, respectively, compared to a statutory benefit of 21.0% on the pre-tax loss for each period. The company had an effective tax rate of 8.8% and 11.3% on losses before tax for the three and nine months ended September 30, 2021, respectively, compared to a statutory benefit of 21.0% on the pre-tax loss for each period. The company's effective tax rate for the three and nine months ended September 30, 2022 and September 30, 2021 were unfavorable as compared to the U.S. federal statutory rate, principally due to the negative impact of the company not being able to record tax benefits related to the significant losses in countries which had tax valuation allowances. The effective tax rate was increased for the three and nine months ended September 30, 2022 and September 30, 2021 by certain taxes outside the United States, excluding countries with tax valuation allowances, that were at an effective rate higher than the U.S. statutory rate.

58
Notes to Financial StatementsNet Income (Loss) Per Common Share
Net Loss Per Common Share

The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.
(In thousands except per share data)For the Three Months Ended September 30,For the Nine Months Ended September 30,
2022202120222021
Basic
Weighted average common shares outstanding37,537 35,013 36,073 34,826 
Net loss$(34,354)$(22,759)$(80,494)$(47,501)
Net loss per common share$(0.92)$(0.65)$(2.23)$(1.36)
Diluted
Weighted average common shares outstanding37,537 35,013 36,073 34,826 
Share options and awards143 475 168 545 
Weighted average common shares assuming dilution37,680 35,488 36,241 35,371 
Net loss$(34,354)$(22,759)$(80,494)$(47,501)
Net loss per common share *$(0.92)$(0.65)$(2.23)$(1.36)
________
* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.
For the three and nine months ended September 30, 2022, shares associated with equity compensation awards of 1,659,909 and 1,120,192, respectively, and for the three and nine months ended September 30, 2021, shares associated with equity compensation awards of 1,432,833 and 1,163,526, respectively, were excluded from the weighted average common shares assuming dilution as incremental shares were antidilutive.

At September 30, 2022, the majority of the antidilutive incremental shares were awards granted at an exercise price above $12.14, which was higher than the average fair market value price of $1.05 and $1.50 for the three and nine months ended September 30, 2022. At September 30, 2021, the majority of the antidilutive incremental shares were awards granted at an exercise price above $14.49, which was higher than the average fair market value price of $7.30 and $8.30 for the three and nine months ended September 30, 2021.

For the three and nine months ended September 30, 2022 and September 30, 2021, respectively, no shares were included in the common shares assuming dilution related to the company's issued warrants as the average market price of the company shares for these periods did not exceed the strike price of the warrants.

Further, upon adoption of ASU 2020-06, effective in 2021 for the company, use of the if-converted earnings per share method is required. However, no shares were included in the weighted average common shares assuming dilution for the three and nine months ended September 30, 2022 and September 30, 2021 related to the company's convertible senior notes as conversion prices were above the company's average stock price for the periods and other requirements for the notes to be convertible to shares were not met.

59
Notes to Financial StatementsConcentration of Credit Risk
Concentration of Credit Risk

The company manufactures and distributes durable medical equipment to the home health care, retail and extended care markets. The company performs credit evaluations of its customers’ financial condition. The company utilizes De Lage Landen, Inc. (“DLL”), a third-party financing company, to provide lease financing to Invacare's U.S. customers. The DLL agreement provides for direct leasing between DLL and the Invacare customer. The company retains a recourse obligation of $2,071,000 at September 30, 2022 to DLL for events of default under the contracts, which total $8,588,000 at September 30, 2022. Guarantees, ASC 460, requires the company to record a guarantee liability as it relates to the limited recourse obligation. As such, the company has recorded an immaterial liability for this guarantee obligation within other long-term obligations. The company's recourse is reevaluated by DLL biannually, considers activity between the biannual dates and excludes any receivables purchased by the company from DLL. The company monitors the collections status of these contracts and has provided amounts for estimated losses in its allowances for doubtful accounts in accordance with Receivables, ASC 310-10-05-4. Credit losses are provided for in the financial statements.






























Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities located throughout the United States, Australia, Canada, New Zealand and Europe or also direct from governmental entities in certain countries. A significant portion of products sold to dealers, both foreign and domestic, is ultimately funded through government reimbursement programs such as Medicare and Medicaid. Changes in these programs can have a significant shift in reimbursement to customers from managed care entities. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability. In addition, reimbursement guidelines in the home health care industry have a substantial impact on the nature and type of equipment an end user can obtain as well as the timing of reimbursement and, thus, affect the product mix, pricing and payment patterns of the company’s customers.

60
Notes to Financial StatementsDerivatives
Derivatives

ASC 815 requires companies to recognize all derivative instruments in the condensed consolidated balance sheets as either assets or liabilities at fair value. The accounting for changes in fair value of a derivative is dependent upon whether or not the derivative has been designated and qualifies for hedge accounting treatment and the type of hedging relationship. For derivatives designated and qualifying as hedging instruments, the company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

Cash Flow Hedging Strategy

The company uses derivative instruments in an attempt to manage its exposure to transactional foreign currency exchange risk. Foreign forward exchange contracts are used to manage the price risk associated with forecasted sales denominated in foreign currencies and the price risk associated with forecasted purchases of inventory over the next twelve months.

The company recognizes its derivative instruments as assets or liabilities in the condensed consolidated balance sheets measured at fair value. All of the company’s derivative instruments are designated and qualify as cash flow hedges. Accordingly, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The remaining gain or loss on the derivative instrument in excess of the cumulative change in the fair value of the hedged item, if any, is recognized in current earnings during the period of change.



















To protect against increases/decreases in forecasted foreign currency cash flows resulting from inventory purchases/sales over the next year, the company utilizes foreign currency forward contracts to hedge portions of its forecasted purchases/sales denominated in foreign currencies. The gains and losses are included in cost of products sold and selling, general and administrative expenses on the condensed consolidated statements of comprehensive income (loss). If it is later determined that a hedged forecasted transaction is unlikely to occur, any prospective gains or losses on the forward contracts would be recognized in earnings. The company does not expect any material amount of hedge ineffectiveness related to forward contract cash flow hedges during the next twelve months.

The company has historically not recognized any material amount of ineffectiveness related to forward contract cash flow hedges because the company generally limits its hedges to between 50% and 90% of total forecasted transactions for a given entity’s exposure to currency rate changes and the transactions hedged are recurring in nature. Furthermore, most of the hedged transactions are related to intercompany sales and purchases for which settlement occurs on a specific day each month. Forward contracts with a total notional amount in USD of $67,853,000 and $90,800,000 matured during the nine months ended September 30, 2022 and September 30, 2021, respectively, compared to $29,189,000 and $32,685,000 during the three month ended September 30, 2022 and September 30, 2021, respectively.






61
Notes to Financial StatementsDerivatives
Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):
 September 30, 2022December 31, 2021
 Notional
Amount		Unrealized
Net Gain
(Loss)		Notional
Amount		Unrealized
Net Gain
(Loss)
USD / EUR3,492 441 — — 
USD / CAD4,523 (343)— — 
EUR / GBP5,961 179 — — 
EUR / NOK689 (5)— — 
NOK / SEK1,089 (43)— — 
USD / MXN1,089 70 23 1 
$16,843 $299 $23 $1 

Derivatives Not Qualifying or Designated for Hedge Accounting Treatment

The company utilizes foreign currency forward contracts that are not designated as hedges in accordance with ASC 815. These contracts are entered into to eliminate the risk associated with the settlement of short-term intercompany trading receivables and payables between Invacare Corporation and its foreign subsidiaries. The currency forward contracts are entered into at the same time as the intercompany
receivables or payables are created so that upon settlement, the gain/loss on the settlement is offset by the gain/loss on the foreign currency forward contract. No material net gain or loss was realized by the company in 2022 or 2021 related to these contracts and the associated short-term intercompany trading receivables and payables.

Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2022 and 2021, respectively, and outstanding were as follows (in thousands USD):
 September 30, 2022December 31, 2021
 Notional
Amount		Gain
(Loss)		Notional
Amount		Gain
(Loss)
USD / AUD$1,194 $104 $3,792 $(57)
USD / CAD19,765 (272)14,556 (24)
USD / EUR73,507 (1,852)70,454 (1,104)
USD / DKK5,099 (137)10,850 (257)
USD / GBP— — 4,028 32 
USD / NOK4,790 (467)2,352 (81)
USD / SEK1,880 (72)2,344 (131)
EUR / GBP1,200 36 — — 
EUR / NOK1,099 (8)— — 
AUD / NZD17,082 (163)7,366 (17)
USD / THB4,310 278 4,500 86 
EUR / SEK2,353 (10)— — 
$132,279 $(2,563)$120,242 $(1,553)







62
Notes to Financial StatementsDerivatives


The fair values of the company’s derivative instruments were as follows (in thousands):
 September 30, 2022December 31, 2021
 AssetsLiabilitiesAssetsLiabilities
Derivatives designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts$690 $391 $1 $— 
Derivatives not designated as hedging instruments under ASC 815
Foreign currency forward exchange contracts1,936 4,499 385 1,938 
Total derivatives$2,626 $4,890 $386 $1,938 

The fair values of the company’s foreign currency forward exchange contract assets and liabilities are included in Other Current Assets and Accrued Expenses, respectively in the condensed consolidated balance sheets.

The effect of derivative instruments on Accumulated Other Comprehensive Income (Loss) (OCI) and the condensed consolidated Statements of comprehensive income (loss) was as follows (in thousands):
Derivatives (foreign currency forward exchange contracts) in ASC 815 cash flow hedge
relationships		Amount of Gain
(Loss) Recognized in Accumulated OCI on Derivatives
(Effective Portion)		Amount of Gain (Loss)
Reclassified from
Accumulated OCI into
Income (Effective
Portion)		Amount of Gain (Loss)
Recognized in Income on
Derivatives (Ineffective Portion and Amount Excluded from
Effectiveness Testing)
Three months ended September 30, 2022
Foreign currency forward exchange contracts$59 $1,275 $1,002 
Nine months ended September 30, 2022
Foreign currency forward exchange contracts$2,197 $1,961 $1,117 
Three months ended September 30, 2021
Foreign currency forward exchange contracts$944 $(309)$51 
Nine months ended September 30, 2021
Foreign currency forward exchange contracts$(643)$(1,219)$(37)
Derivatives (foreign currency forward exchange contracts) not designated as hedging
instruments under ASC 815		  Amount of Gain (Loss)
Recognized in Income on Derivatives
Three months ended September 30, 2022
Foreign currency forward exchange contracts$2,072 
Nine months ended September 30, 2022
Foreign currency forward exchange contracts$(2,563)
Three months ended September 30, 2021
Foreign currency forward exchange contracts$(592)
Nine months ended September 30, 2021
Foreign currency forward exchange contracts$(1,315)
The gains or losses recognized as the result of the settlement of cash flow hedge foreign currency forward contracts are recognized in net sales for hedges of inventory sales and in cost of products sold for hedges of inventory purchases. For the three and nine months ended September 30, 2022, net sales were increased by $68,000 and $125,000, while cost of products sold was decreased by $1,263,000 and $1,997,000 for net pre-tax realized gains of $1,331,000 and
$2,122,000, respectively. For the three and nine months ended September 30, 2021, net sales were decreased by $476,000 and $657,000 while cost of products sold was decreased by $92,000 and increased by $746,000 for net realized pre-tax losses of $384,000 and $1,403,000, respectively.

A gain of $2,072,000 and $2,563,000 was recognized in selling, general and administrative (SG&A) expenses for the
63
Notes to Financial StatementsDerivatives
three and nine months ended September 30, 2022 compared to a loss of $592,000 and a loss of $1,315,000 for the three and nine months ended September 30, 2021 related to forward contracts not designated as hedging instruments. The forward contracts were entered into to offset gains/losses that were also recorded in SG&A expenses on intercompany trade receivables or payables. The gains/losses on the non-designated hedging instruments were substantially offset by gains/losses on intercompany trade payables.

The company's derivative agreements provide the counterparties with a right of set off in the event of a default. The right of set off would enable the counterparty to offset any net payment due by the counterparty to the company under the applicable agreement by any amount due by the company to the counterparty under any other agreement. For example, the terms of the agreement would permit a counterparty to a derivative contract that is also a lender under the company's
Prior Credit Agreement and ABL Credit Agreement to reduce any derivative settlement amounts owed to the company under the derivative contract by any amounts owed to the counterparty by the company under the Prior Credit Agreement and ABL Credit Agreement. In addition, the agreements contain cross-default provisions that could trigger a default by the company under the agreement in the event of a default by the company under another agreement with the same counterparty.

During the third quarter of 2022, the company entered into privately negotiated Secured Convertible 2026 Notes of $31,106,000 in aggregate principal amount. Convertible debt conversion liabilities of $1,423,000 were recorded based on initial fair values and these fair values are updated quarterly with the offset to the income statement. Refer to "Long-Term Debt" in the notes to the condensed consolidated financial statements for more detail.
The fair values of the outstanding convertible note derivatives as of September 30, 2022 and their effect on the Statement of Comprehensive Income (Loss) were as follows (in thousands):
 Gain
 Fair ValueThree and Nine Months Ended
September 30, 2022September 30, 2022
Secured Convertible 2026 Notes conversion long-term liability$473 $950 
The secured convertible 2026 notes conversion liability amounts are included in Other Long-Term Obligations in the company's condensed consolidated balance sheets.

64
Notes to Financial StatementsFair Values
Fair Values

Pursuant to ASC 820, the inputs used to derive the fair value of assets and liabilities are analyzed and assigned a level I, II or III priority, with level I being the highest and level III being the lowest in the hierarchy. Level I inputs are quoted prices in active markets for identical assets or liabilities.


Level II inputs are quoted prices for similar assets or liabilities in active markets: quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets. Level III inputs are based on valuations derived from valuation techniques in which one or more significant inputs are unobservable.
The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):
 Basis for Fair Value Measurements at Reporting Date
Quoted Prices in Active
Markets for Identical
Assets / (Liabilities)		Significant Other
Observable
Inputs		Significant Other
Unobservable
Inputs
Level ILevel IILevel III
September 30, 2022
Forward exchange contracts—net—$(2,264)—
Secured convertible 2026 debt conversion liability—(473)—
December 31, 2021
Forward exchange contracts—net—$(1,552)—

The carrying values and fair values of the company’s financial instruments are as follows (in thousands):
 September 30, 2022December 31, 2021
 Carrying ValueFair ValueCarrying ValueFair Value
Cash and cash equivalents$45,439 $45,439 $83,745 $83,745 
Forward contracts in Other current assets2,626 2,626 386 386 
Forward contracts in Accrued expenses(4,890)(4,890)(1,938)(1,938)
Total debt (including current maturities of long-term debt) *(335,279)(272,485)(308,129)(259,472)
2022 Notes— — (2,642)(2,632)
Series I 2024 Notes(72,341)(62,887)(72,140)(64,897)
Series II 2024 Notes(75,764)(63,963)(78,251)(74,165)
2026 Notes(80,898)(36,832)(119,036)(81,718)
2026 Secured Notes(27,463)(25,369)— — 
2026 Term Loan(59,724)(64,345)— — 
Other(19,089)(19,089)(36,060)(36,060)
Secured convertible 2026 debt conversion liability in Other Long-Term Obligations(473)(473)— — 
________
* The company's total debt is shown net of discount and fees associated with the convertible senior notes and term loan due in 2022, 2024 and 2026 on the company's condensed consolidated balance sheets. Accordingly, the fair values due in 2022, 2024 and 2026 are included in the long-term debt presented in this table are also shown net of fees. Total debt amounts exclude operating and finance lease obligations.
65
Notes to Financial StatementsFair Values
The company, in estimating its fair value disclosures for financial instruments, used the following methods and assumptions:

Cash, cash equivalents: The carrying value reported in the balance sheet for cash, cash equivalents equals its fair value. The fair values are deemed to be categorized as Level 1.

Forward Contracts: The company operates internationally, and as a result, is exposed to foreign currency fluctuations. Specifically, the exposure includes intercompany loans and third-party sales or payments. In an attempt to reduce this exposure, foreign currency forward contracts are utilized and accounted for as hedging instruments. The forward contracts are used to hedge the following currencies: AUD, CAD, DKK, EUR, GBP, MXN, NOK, NZD, SEK, THB, and USD. The company does not use derivative financial instruments for speculative purposes. Fair values for the company’s foreign exchange forward contracts are based on quoted market prices for contracts with similar maturities. The fair values are deemed to be categorized as Level 2. The company's forward contracts are included in Other Current Assets or Accrued Expenses in the condensed consolidated balance sheets.

Total debt: Fair value for the company’s convertible debt other than the 2026 Secured Notes and Term Loan is based on quoted market-based estimates as of the end of the period, while the revolving credit facility fair value is based on an estimate of the market for similar borrowing arrangements. The fair values are deemed to be categorized as Level 2 in the fair value hierarchy. The 2026 Secured Notes and Term Loan fair values are based on valuation models in which significant inputs are observable in active markets. The fair values are deemed to be categorized as Level 2. Other total debt is primarily attributable to credit facilities borrowings where the carrying value reported in the balance approximates its fair value.

Convertible debt derivative: The fair value for the convertible debt conversion liability is based on valuation models in which significant inputs are observable in active markets. The fair values are deemed to be categorized as Level 2.
66
Notes to Financial StatementsBusiness Segments
Business Segments
The company operates in two primary business segments: North America and Europe with each selling the company's primary product categories, which include: lifestyle, mobility and seating and respiratory therapy products. Sales in Asia Pacific are reported in All Other and include products similar to those sold in North America and Europe. The accounting policies of each segment are the same as those described in the summary of significant accounting policies for the company's condensed consolidated financial statements. Intersegment sales and transfers are based on the costs to manufacture plus a reasonable profit element.

Segment performance is measured and resources are allocated based on a number of factors, with the primary income or loss measure being segment operating income (loss). Segment operating income (loss) represents net sales less cost of products sold less selling general and administrative expenses. Segment operating income (loss)
excludes unallocated corporate general and administrative expenses not allocated to the segments and intersegment sales and profit eliminations, which are included in All Other. In addition, segment operating income (loss) further excludes charges related to restructuring activities, asset impairment and gain on sale of business (as applicable).

This performance measure, segment operating income (loss), is used by the Chief Operating Decision Maker (CODM) for purposes of making decisions about allocating resources to a segment and assessing its performance. In addition, this metric is reviewed by the company's Board of Directors regarding segment performance and is a key metric in the performance management assessment of the company's employees.




67
Notes to Financial StatementsBusiness Segments
The information by segment is as follows (in thousands):
 For the Three Months Ended September 30,For the Nine Months Ended September 30,
2022202120222021
Revenues from external customers
Europe$97,487 $127,026 $328,334 $361,097 
North America65,314 88,054 209,351 260,275 
All Other (Asia Pacific)7,607 9,120 22,728 24,894 
Consolidated$170,408 $224,200 $560,413 $646,266 
Intersegment revenues
Europe$2,763 $6,221 $11,327 $17,758 
North America5,738 15,044 24,274 45,903 
Consolidated$8,501 $21,265 $35,601 $63,661 
Restructuring charges before income taxes
Europe$5,034 $255 $9,766 $1,501 
North America2,332 122 5,534 975 
All Other1,074 — 1,083 — 
Consolidated$8,440 $377 $16,383 $2,476 
Operating income (loss)
Europe$(2,588)$9,554 $4,126 $18,378 
North America(15,007)(1,523)(29,607)(2,308)
All Other(6,391)(3,856)(21,981)(19,025)
Charges related to restructuring activities(8,440)(377)(16,383)(2,476)
Impairment of an intangible asset(1,012)— (1,012)— 
Impairment of goodwill— (28,564)— (28,564)
Consolidated operating loss(33,438)(24,766)(64,857)(33,995)
Net gain on convertible debt derivatives950 — 950 — 
Net gain on debt extinguishment6,398 10,131 6,398 9,422 
Net interest expense(7,344)(6,284)(19,825)(18,098)
Loss before income taxes$(33,434)$(20,919)$(77,334)$(42,671)
68
Notes to Financial StatementsBusiness Segments
Net sales by product, are as follows (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2022202120222021
Europe
Lifestyle$46,881 $61,683 $162,942 $181,628 
Mobility and Seating43,778 56,535 139,010 152,660 
Respiratory Therapy2,262 4,225 11,847 13,613 
Other(1)4,566 4,583 14,535 13,196 
$97,487 $127,026 $328,334 $361,097 
North America
Lifestyle$34,379 $38,666 $102,516 $114,951 
Mobility and Seating23,453 28,414 74,876 82,243 
Respiratory Therapy7,236 20,856 31,384 62,429 
Other(1)246 118 575 652 
$65,314 $88,054 $209,351 $260,275 
All Other (Asia Pacific)
Mobility and Seating$3,311 $3,171 $8,989 $9,239 
Lifestyle2,556 3,230 8,239 8,736 
Respiratory Therapy407 1,215 1,538 2,547 
Other(1)1,333 1,504 3,962 4,372 
$7,607 $9,120 $22,728 $24,894 
Total Consolidated$170,408 $224,200 $560,413 $646,266 
   ________________________
(1)Includes various services, including repair services, equipment rentals and external contracting.

69
Notes to Financial StatementsContingencies
Contingencies
General

In the ordinary course of its business, the company is a defendant in a number of lawsuits, primarily product liability actions in which various plaintiffs seek damages for injuries allegedly caused by defective products. All the product liability lawsuits that the company faces in the United States have been referred to the company's captive insurance company and/or excess insurance carriers while all non-U.S. lawsuits have been referred to the company's commercial insurance carriers. All such lawsuits are generally contested vigorously. The coverage territory of the company's insurance is worldwide with the exception of those countries with respect to which, at the time the product is sold for use or at the time a claim is made, the U.S. government has suspended or prohibited diplomatic or trade relations. The amount recorded for identified contingent liabilities is based on estimates. Amounts recorded are reviewed periodically and adjusted to reflect additional technical and legal information that becomes available. Actual costs to be incurred in future periods may vary from the estimates, given the inherent uncertainties in evaluating certain exposures.

As a medical device manufacturer, the company is subject to extensive government regulation, including numerous laws directed at preventing fraud and abuse and laws regulating reimbursement under various government programs. The marketing, invoicing, documenting, developing, testing, manufacturing, labeling, promoting, distributing and other practices of health care suppliers and medical device manufacturers are all subject to government scrutiny. Most of the company's facilities are subject to inspection at any time by the FDA or similar medical device regulatory agencies in other jurisdictions. Violations of law or regulations can result in administrative, civil and criminal penalties and sanctions, which could have a material adverse effect on the company's business.

Medical Device Regulatory Matters

The FDA in the United States and comparable medical device regulatory authorities in other jurisdictions regulate virtually all aspects of the marketing, invoicing, documenting, development, testing, manufacturing, labeling, promotion, distribution and other practices regarding medical devices. The company and its products are subject to the laws and regulations of the FDA and other regulatory bodies in the various jurisdictions where the company's products are manufactured or sold. The company's failure to comply with the regulatory requirements of the FDA and other applicable medical device regulatory requirements can subject the company to administrative or judicially imposed sanctions or
enforcement actions. These sanctions include injunctions, consent decrees, warning letters, civil penalties, criminal penalties, product seizure or detention, product recalls and total or partial suspension of production.
In December 2012, the company became subject to a consent decree of injunction filed by the FDA with respect to the company's Corporate facility and its Taylor Street manufacturing facility in Elyria, Ohio. The consent decree initially limited the company's (i) manufacture and distribution of power and manual wheelchairs, wheelchair components and wheelchair sub-assemblies at or from its Taylor Street manufacturing facility ("Taylor Street products") , except in verified cases of medical necessity, (ii) design activities related to wheelchairs and power beds that take place at the impacted Elyria facilities and (iii) replacement, service and repair of products already in use from the Taylor Street manufacturing facility. Under the terms of the consent decree, in order to resume full operations, the company had to successfully complete independent, third-party expert certification audits at the impacted Elyria facilities, comprising three distinct certification reports separately submitted to, and subject to acceptance by, the FDA; submit its own report to the FDA; and successfully complete a reinspection by the FDA of the company's Corporate and Taylor Street facilities.
On July 24, 2017, following its June 2017 reinspection of the Corporate and Taylor Street facilities, the FDA notified the company that it was in substantial compliance with the FDA Act, FDA regulations and the terms of the consent decree and, that the company was permitted to resume full operations at those facilities including the resumption of unrestricted sales of products made in those facilities.
The consent decree will continue in effect for at least five years from July 24, 2017, during which time the company's Corporate and Taylor Street facilities must complete two semi-annual audits in the first year and then four annual audits in the next four years performed by an independent company-retained audit firm. The expert audit firm will determine whether the facilities remain in continuous compliance with the Federal Food, Drug and Cosmetic Act ("FDA Act"), FDA regulations and the terms of the consent decree and issue post audit reports contemporaneously to the FDA, and the FDA has the authority to inspect these facilities and any other FDA registered facility, at any time.
The FDA has continued to actively inspect the company's facilities, other than through the processes established under the consent decree. The company expects that the FDA will, from time to time, inspect substantially all the company's domestic and foreign FDA-registered facilities.
70
Notes to Financial StatementsContingencies
In 2021, FDA conducted an inspection of the company’s Corporate and Taylor Street facilities from May 25 through June 24, 2021. At the close of the inspection, six FDA Form 483 observations were issued, and the company timely responded to FDA, has diligently taken actions to address FDA’s inspectional observations, and has provided FDA monthly updates on the corrective actions taken to address these observations. On November 18, 2021, the company received a warning letter from the FDA concerning certain of the inspectional observations in the June 2021 FDA Form 483 related to the complaint handling process, the corrective and preventive action (“CAPA”) process, and medical device reporting (“MDR”) associated with oxygen concentrators (the “Warning Letter”). On November 16, 2021, the company received a consent decree non-compliance letter from the FDA concerning the same complaint and CAPA handling matters as in the Warning Letter observations but associated with the Taylor Street products (this letter, together with the Warning Letter, the “FDA Letters”). The company timely responded to the FDA Letters, has diligently taken actions to address FDA’s concerns, and has provided FDA with periodic updates on the corrective actions taken to address the matters in the FDA Letters. The company remains committed to resolving the FDA’s concerns; however, it is not possible to predict the outcome or timing of a resolution at this time. There can be no assurance that the FDA will be satisfied with the company’s responses to the FDA Letters, nor any assurance as to the timeframe that may be required for the company to adequately address the FDA’s concerns or whether the matters in the FDA Letters will result in an extension in the duration of the consent decree. As of the date of filing of the company’s Quarterly Report on Form 10-Q, there has been no impact on the Company’s ability to produce and market its products as a result of the FDA Letters.

Under the consent decree, the FDA has the authority to order the company to take a wide variety of actions if the FDA finds that the company is not in compliance with the consent decree, FDA Act or FDA regulations, including requiring the company to cease all operations relating to Taylor Street products. The FDA also can order the company to undertake a partial cessation of operations or a recall, issue a safety alert, public health advisory, or press release, or to take any other corrective action the FDA deems necessary with respect to Taylor Street products.

The FDA also has authority under the consent decree to assess liquidated damages of $15,000 per violation per day for any violations of the consent decree, FDA regulations or the FDA Act. The FDA also may assess liquidated damages for shipments of adulterated or misbranded devices in the amount of twice the sale price of any such adulterated or misbranded device. The liquidated damages, if assessed, are limited to a total of $7,000,000 for each calendar year. The authority to
assess liquidated damages is in addition to any other remedies otherwise available to the FDA, including civil money penalties.
The results of regulatory claims, proceedings, investigations, or litigation are difficult to predict. An unfavorable resolution or outcome of the FDA Letters, any other FDA warning letters or inspectional observations, or other FDA enforcement related to company facilities, could materially and adversely affect the company's business, financial condition, and results of operations.
The limitations previously imposed by the FDA consent decree negatively affected net sales in the North America segment and, to a certain extent, the Asia Pacific region beginning in 2012. The limitations led to delays in new product introductions. Further, uncertainty regarding how long the limitations would be in effect limited the company's ability to renegotiate and bid on certain customer contracts and otherwise led to a decline in customer orders.
Although the company has been permitted to resume full operations at the Corporate and Taylor Street facilities, the negative effect of the consent decree on customer orders and net sales in the North America segment and Asia Pacific region has been considerable, and it is uncertain as to whether, or how quickly, the company will be able to rebuild net sales to more typical historical levels, irrespective of market conditions. Accordingly, when compared to the company's historic results, the previous limitations in the consent decree had, and likely may continue to have, a material adverse effect on the company's business, financial condition and results of operations.
Warranty Matters
The company's warranty reserves are subject to adjustment in future periods based on historical analysis of warranty claims and as new developments occur that may change the company's estimates related to specific product recalls. Refer to Current Liabilities in the notes to the condensed consolidated financial statements for the total provision amounts and a reconciliation of the changes in the warranty accrual.
Any of the above contingencies could have an adverse impact on the company's financial condition or results of operations.
For additional information regarding the consent decree, other regulatory matters, and risks and trends that may impact the company’s financial condition or results of operations, please see the following sections of the company's Annual Report on Form 10-K for the year ended December 31, 2021: Item 1. Business - Government Regulation and Item 1A. Risk Factors; Item 3. Legal Proceedings; and Item 7. Management's
71
Notes to Financial StatementsContingencies
Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources.
72
Notes to Financial StatementsMarket Risk and Controls
Item 3. Quantitative and Qualitative Disclosures About Market Risk.

The company is at times exposed to market risk through various financial instruments, including fixed rate and floating rate debt instruments. An increase of 1% to variable rate debt outstanding at September 30, 2022 would increase interest expense $834,000 annually. Additionally, the company operates internationally and, as a result, is exposed to foreign currency fluctuations. Specifically, the exposure results from intercompany loans, intercompany sales or payments and third-party sales or payments. In an attempt to reduce this exposure, foreign currency forward contracts are utilized to hedge intercompany purchases and sales as well as third-party purchases and sales. The company does not believe that any potential loss related to these financial instruments would have a material adverse effect on the company's financial condition or results of operations.

The company is party to the ABL Credit Agreement which became effective on July 26, 2022. Accordingly, while the company is exposed to increases in interest rates, its exposure to the volatility of the current market environment is currently limited until the ABL Credit Agreement expires. The ABL Credit Agreement and Highbridge Loan Agreement contain customary default provisions, with certain grace periods and exceptions, which provide that events of default that include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption of any material manufacturing facilities for more than ten consecutive days. Should the company fail to comply with these requirements, the company would potentially have to attempt to obtain alternative financing and thus likely be required to pay much higher interest rates.



















Item 4.    Controls and Procedures.

(a) Evaluation of Disclosure Controls and Procedures
As of September 30, 2022, an evaluation was performed, under the supervision and with the participation of the company’s management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based on that evaluation, the company’s management, including the Chief Executive Officer and Chief Financial Officer, concluded that the company’s disclosure controls and procedures were effective as of September 30, 2022, in ensuring that information required to be disclosed by the company in the reports it files and submits under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms and (2) accumulated and communicated to the company’s management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate to allow for timely decisions regarding required disclosure.
(b) Changes in Internal Control Over Financial Reporting
There have been no changes in the company’s internal control over financial reporting that occurred during the company’s last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the company’s internal control over financial reporting.





73
Part IIOther Information
Part II. OTHER INFORMATION


Item 1.    Legal Proceedings.
In the ordinary course of its business, the company is a defendant in a number of lawsuits, primarily product liability actions in which various plaintiffs seek damages for injuries allegedly caused by defective products. All the product liability lawsuits that the company faces in the United States have been referred to the company's captive insurance company and/or excess insurance carriers while all non-U.S. lawsuits have been referred to the company's commercial insurance carriers. All such lawsuits are generally contested vigorously. The coverage territory of the company's insurance is worldwide with the exception of those countries with respect to which, at the time the product is sold for use or at the time a claim is made, the U.S. government has suspended or prohibited diplomatic or trade relations. Management does not believe that the outcome of any of these actions will have a material adverse effect upon the company's business or financial condition.
In December 2012, the company became subject to a consent decree of injunction filed by the FDA in the U.S. District Court for the Northern District of Ohio with respect to the company's Corporate facility and its Taylor Street manufacturing facility in Elyria, Ohio. On July 24, 2017, following its reinspection of the Corporate and Taylor Street facilities, FDA notified the company that it was in substantial compliance with the FDA Act, FDA regulations and the terms of the consent decree and that the company was permitted to resume full operations at those facilities, including the resumption of unrestricted sales of products made in those facilities.

The consent decree will continue in effect for at least five years from July 24, 2017, during which time the company's Corporate and Taylor Street facilities must complete to two semi-annual audits in the first year and then four annual audits in the next four years performed by a company-retained expert firm. The expert audit firm will determine whether the facilities remain in continuous compliance with the FDA Act, regulations and the terms of the consent decree.

The FDA has the authority to inspect the Corporate and Taylor Street facilities, and any other FDA registered facility, at any time. The FDA also has the authority to order the company to take a wide variety of actions if the FDA finds that the company is not in compliance with the consent decree, FDA Act or FDA regulations, including requiring the company to cease all operations relating to Taylor Street products. The FDA also can order the company to undertake a partial cessation of operations or a recall, issue a safety alert, public health advisory, or press release, or to take any other
corrective action the FDA deems necessary with respect to Taylor Street products.

The FDA also has authority under the consent decree to assess liquidated damages of $15,000 per violation per day for any violations of the consent decree, FDA Act or FDA regulations. The FDA also may assess liquidated damages for shipments of adulterated or misbranded devices in the amount of twice the sale price of any such adulterated or misbranded device. The liquidated damages, if assessed, are limited to a total of $7,000,000 for each calendar year. The authority to assess liquidated damages is in addition to any other remedies otherwise available to the FDA, including civil money penalties.

In November 2021, the company received a Warning Letter from the FDA concerning certain of the June 2021 FDA Form 483 inspectional observations related to the complaint handling, CAPA and MDR processes, associated with oxygen concentrators. The company also received a consent decree non-compliance letter from the FDA concerning the same complaint and CAPA handling matters as in the Warning Letter but associated with the Taylor Street products. The company timely responded to the FDA Letters, has diligently taken actions to address FDA’s concerns, and has provided FDA with periodic updates on the corrective actions taken to address the matters in the FDA Letters. The company remains committed to resolving the FDA’s concerns; however, it is not possible to predict the outcome or timing of a resolution at this time. There can be no assurance that the FDA will be satisfied with the company’s responses to the FDA Letters, nor any assurance as to the timeframe that may be required for the company to adequately address the FDA’s concerns or whether the matters in the FDA Letters will result in an extension in the duration of the consent decree.

For additional information regarding the consent decree, please see the "Contingencies" note to the financial statements contained in Part I of this Quarterly Report on Form 10-Q, the risk factors referred to in Part I, Item 1A of this Quarterly Report on Form 10-Q, and the following sections of the company's Annual Report on Form 10-K for the period ending December 31, 2021 Item 1. Business - Government Regulation; Item 1A. Risk Factors; and Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Outlook and - Liquidity and Capital Resources.
74
Part IIOther Information
Item 1A. Risk Factors
Except as set forth below, there have been no material changes to the risk factors disclosed in Part 1, Item 1A, of the company’s Annual Report on Form 10-K for the year ended December 31, 2021.
Restrictive covenants under the company’s new credit agreements and the indentures related to the company’s secured convertible notes may limit the manner in which the company operates.
The Highbridge Loan Agreement, the ABL Credit Agreement and the Indentures related to the company’s secured convertible notes due 2026 contain, and any future indebtedness the company incurs may contain, various negative covenants that restrict, among other things, the company’s indebtedness, liens, fundamental changes, asset sales, investments and other matters. In addition, the Highbridge Loan Agreement has a minimum liquidity requirement. The company’s obligations under the Highbridge Loan Agreement, the ABL Credit Agreement and the Indentures, collectively, are secured by substantially all of the company’s assets. As a result, the company is limited in the manner in which it conducts its business and the company may be unable to engage in favorable business activities.
Servicing the company’s debt requires a significant amount of cash, and the company may not have sufficient cash flow from its business to pay its substantial debt.
The company’s ability to make scheduled payments of the principal of, to pay interest on or to refinance its indebtedness depends on its future performance, which is subject to economic, financial, competitive and other factors beyond its control, including uncertainties related to the company’s supply chain. Pandemic-related supply chain challenges, as well as supplier delivery holds resulting from past due payables, have had, and may continue to have, the effect of interrupting production and negatively impacting the company’s ability to fulfill orders and generate sales and cash flow. The company’s business may not generate cash flow from operations in the future sufficient to service its debt and make necessary capital expenditures. If the company is unable to generate such cash flow, it may be required to adopt one or more alternatives, such as selling assets, restructuring debt or obtaining additional equity capital on terms that may be onerous or highly dilutive. The company’s ability to refinance its indebtedness will depend on the capital markets and its financial condition at such time. The company may not be able to engage in any of these activities or engage in these activities on desirable terms, which could result in a default on the company’s debt obligations.
Despite the company’s current debt levels, subject to certain conditions and limitations, it may still incur substantially more debt or take other actions which would intensify the risks discussed above.
Despite the company’s current consolidated debt levels, subject to certain conditions and limitations in the Highbridge Loan Agreement, the ABL Credit Agreement and the Indentures related to the company’s secured convertible notes, the company may be able to incur substantial additional debt in the future, some of which may be secured debt. If new debt is added to the company’s current debt levels, the related risks that the company faces could intensify.
If the company cannot regain compliance with the NYSE’s continued listing standards, the NYSE may delist the company’s common shares, which could negatively affect the company, the price of its common shares and shareholders’ ability to sell the company’s common shares and may lead to potential events of default on existing debt instruments.

On September 23, 2022, the company was notified by the NYSE that the company was not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the company’s common shares was less than $1.00 per share over a consecutive 30 trading-day period. The company intends to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard. The company can regain compliance at any time within the six-month period following receipt of the NYSE notice if on the last trading day of any calendar month during the six-month period the company has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. The company intends to consider available alternatives, including but not limited to, a reverse stock split, subject to shareholder approval no later than at the company’s next annual meeting of shareholders, if necessary to cure the stock price non-compliance. Under the NYSE’s rules, if the company determines that it will cure the stock price deficiency by taking an action that will require shareholder approval at its next annual meeting of shareholders, the price condition will be deemed cured if the price promptly exceeds $1.00 per share, and the price remains above that level for at least the following 30 trading days.

If the company fails to regain compliance with Section 802.01C of the NYSE Listed Company Manual by the end of the cure period, the common shares will be subject to the NYSE’s suspension and delisting procedures. In addition, if the company’s average global market capitalization over a consecutive 30 trading-day period drops below $15.0 million, the NYSE will initiate delisting proceedings without a cure period in which the company can regain compliance. While the company intends to regain compliance with the NYSE listing standards, there is no assurance that the company’s efforts will be successful, nor is there any assurance that the company will remain in compliance with Section 802.01C of the NYSE Listed Company Manual or other NYSE continued listing standards in the future.
75
Part IIOther Information
A suspension and delisting of the company’s common shares could, among other things, further reduce the liquidity and market price of the company’s common shares; reduce the number of investors willing to hold or acquire the company’s common shares; negatively impact the company’s ability to raise capital through equity financing; and limit the company’s ability to issue additional securities or obtain additional financing in the future. A delisting of the common shares could constitute a “fundamental change” under the terms of the company’s outstanding convertible notes, requiring the company to make an offer to repurchase all of the notes at 100% of their principal amount plus accrued and unpaid interest. There is no assurance the company would have sufficient funds available to it to repurchase the notes if required to do so. Failure to repurchase the notes if required could cause an event of default under the convertible notes, which in turn also could cause a cross-default under the company’s credit facilities and term loans, which would permit the holders of the indebtedness to accelerate the maturity thereof and proceed against their collateral and could have a material adverse effect on the company’s business and financial condition as well as its ability to continue as a going concern.

76
Part IIOther Information
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

The following table presents information with respect to repurchases of Common Shares made by the company during the three months ended September 30, 2022.
PeriodTotal Number
of Shares
Purchased (1)		Avg. Price Paid
Per Share $		Total Number
of Shares Purchased 
as Part of Publicly
Announced Plans 
or Programs		Maximum Number
of Shares That May 
Yet Be Purchased Under the Plans or 
Programs (2)
7/1/2022-7/31/2022—$— —2,453,978
8/1/2022-8/31/2022—— —2,453,978
9/1/2022-9/30/20221920.78 —2,453,978
Total
192$0.78 —2,453,978
________ 
(1)All 192 were repurchased between July 1, 2022 and September 30, 2022 or were surrendered to the company by employees for minimum tax withholding purposes in conjunction with the vesting of restricted shares awarded to the employees or exercise of non-qualified options under the company's equity compensation plans.

(2)In 2001, the Board of Directors authorized the company to purchase up to 2,000,000 Common Shares, excluding any shares acquired from employees or directors as a result of the exercise of options or vesting of restricted shares pursuant to the company’s performance plans. The Board of Directors reaffirmed its authorization of this repurchase program on November 5, 2010, and on August 17, 2011 authorized an additional 2,046,500 shares for repurchase under the plan. To date, the company has purchased 1,592,522 shares under this program, with authorization remaining to purchase 2,453,978 shares. The company purchased no shares pursuant to this Board authorized program during the quarter ended September 30, 2022.

Under the terms of the company's Prior Credit Agreement and ABL Credit Agreement, repurchases of shares by the company generally are not permitted except in certain limited circumstances in connection with the vesting or exercise of employee equity compensation awards.


Item 3.    Defaults Upon Senior Securities.

None.

Item 4.    Mine Safety Disclosures.

Not applicable.

Item 5.    Other Information.

After careful evaluation of strategic options and its core revenue streams, the company has decided to discontinue its respiratory line of products. The company will fulfill existing customer orders as possible with inventory on hand. The company expects to discontinue production of respiratory products in the fourth quarter of 2022. The company will continue to produce and supply respiratory parts and service needs of customers and will remain obligated under respiratory-related warranty and regulatory requirements.

In connection with the discontinuation of the respiratory product line, the company incurred charges of $8.7 million of in the third quarter of 2022 related to a write-down of inventory and purchase obligations. As the company ceases production during the fourth quarter of 2022, there may be
additional restructuring charges for one-time termination benefits and other asset write-downs related to inventory or fixed assets. The company is unable at this time to estimate the amount or range of amounts of any such additional restructuring charges. The company expects to include such information in an amendment to Form 8-K and/or the company's Annual Report on Form 10-K for the year ended December 31, 2022.
77
Part IIOther Information
Item 6.    Exhibits
Exhibit      
No. 		 
Indenture, dated as of July 26, 2022, by and between Invacare Corporation, the guarantors party thereto, Computershare Trust Company, N.A., as trustee, and GLAS Corporation Limited, as notes collateral agent (incorporated by reference to Exhibit 4.1 to the Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on July 26, 2022).
Form of 5.68% Convertible Senior Secured Notes due 2026, Tranche I (incorporated by reference to Exhibit 4.2 to the Form 8-K filed with the SEC on July 26, 2022).
Form of Guarantee (incorporated by reference to Exhibit 4.3 to the Form 8-K filed with the SEC on July 26, 2022).
Indenture, dated as of July 26, 2022, by and between Invacare Corporation, the guarantors party thereto, Computershare Trust Company, N.A., as trustee, and GLAS Corporation Limited, as notes collateral agent (incorporated by reference to Exhibit 4.4 to the Form 8-K filed with the SEC on July 26, 2022).
Form of 5.68% Convertible Senior Secured Notes due 2026, Tranche II (incorporated by reference to Exhibit 4.5 to the Form 8-K filed with the SEC on July 26, 2022).
Form of Guarantee (incorporated by reference to Exhibit 4.6 to the Form 8-K filed with the SEC on July 26, 2022).
Resale Registration Rights Agreement, dated as of July 26, 2022, by and among Invacare Corporation and the noteholders parties thereto (incorporated by reference to Exhibit 4.7 to the Form 8-K filed with the SEC on July 26, 2022).
Credit Agreement, dated as of July 26, 2022, among Invacare Corporation, the lenders party thereto, Cantor Fitzgerald Securities, as administrative agent, and GLAS Trust Corporation Limited, as collateral agent (incorporated by reference to Exhibit 10.1 to the Form 8-K filed with the SEC on July 26, 2022).
Second Amended and Restated Credit Agreement, dated as of July 26, 2022, by and among Invacare Corporation, the borrowers, guarantors and lenders party thereto, and PNC Bank, National Association, as administrative agent (incorporated by reference to Exhibit 10.2 to the Form 8-K filed with the SEC on July 26, 2022).
Cooperation Agreement, dated as of August 22, 2022, by and among Invacare Corporation, Azurite Management LLC and the other parties named therein (incorporated by reference to Exhibit 10.1 to the Form 8-K filed with the SEC on August 22, 2022).
Amendment to Termination Agreement - Ledda (filed herewith).
Chief Executive Officer Rule 13a-14(a)/15d-14(a) Certification (filed herewith).
Chief Financial Officer Rule 13a-14(a)/15d-14(a) Certification (filed herewith).
Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
101.INS*XBRL instance document
101.SCH*XBRL taxonomy extension schema
101.CAL*XBRL taxonomy extension calculation linkbase
101.DEF*XBRL taxonomy extension definition linkbase
101.LAB*XBRL taxonomy extension label linkbase
101.PRE*XBRL taxonomy extension presentation linkbase
104Cover page of the Quarterly Report on Form 10-Q formatted in Inline XBRL.
 
* Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

78
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
  INVACARE CORPORATION
Date:November 7, 2022By: /s/ Kathleen P. Leneghan
Name:  Kathleen P. Leneghan
   Title:  Senior Vice President and Chief Financial Officer
   (As Principal Financial and Accounting Officer and on behalf of the registrant)

79
 EX-10.4 2 q32022ivcex104.htm EX-10.4 Document

CONFIDENTIAL, WITHOUT PREJUDICE & NOT TO BE USED IN COURT


AMENDMENT TO TERMINATION AGREEMENT

between

Invacare International GmbH, Benkenstrasse 260, 4108 Witterswil, Switzerland
(the "Company")
and

Ralf Ledda, Helsinkistrasse 7, 4142 Münchenstein, Switzerland

(the "Employee")

(each individually a "Party" and collectively the "Parties")

Preamble

The Parties entered into a Termination Agreement dated Feb 27/ March 1, 2022 (the "Termination Agreement") to amicably settle all aspects of the Employee’s employment and the termination thereof effective September 30, 2022.

Employee informed Company of his desire to start a new employment contract as the CEO of Auxillium, which is a Competitor within the scope of the Non-Competition provisions in Annex paragraph 2 of the Termination Agreement.

The Company is willing to enter into this this amendment (the “Amendment”) to modify the Termination Agreement to enable Employee to work for Auxillium, in accordance with the terms of this Amendment.

Terms that are defined in the Termination Agreement are used in this Amendment with the same meaning, unless otherwise defined herein.

The Parties agree as follows:


1.Non-Competition Waiver


The Company hereby agrees to waive the restrictions of clause 2 of the Annex to the Termination Agreement solely with respect to Employee becoming employed by Auxillium beginning on October 1, 2022. In consideration of the Company’s waiver, the Parties agree to delete clause 8.2 of the Termination Agreement to cancel the Employee’s right to be paid any compensation during the Restricted Period.

2.Non-Recruitment and Non-Sollicitation
1.The Parties agree that the employee stays obliged to respect and honor the Non-Recruitment and Non-Solicitation obligations in clauses 3 and 4 of the Annex to the Termination Agreement during the Restricted Period.

3.Final provisions
1.All other terms and conditions described in the original Termination Agreement remains unchanged.

2.This Agreement shall in all respects be governed by and construed in accordance with the substantive Swiss law.

4.Signatures


Place, Date:    Witterswil, 15 July 2022            


Invacare International GmbH

/s/Cintia Ferreira                    
[Name]    Cintia Ferreira            
[Function]    VP HR EMEA            




Place, Date:    Minchenstein, 15 July2022            



/s/Ralf Ledda            
Ralf Ledda
2

 EX-31.1 3 q32022ivcex311.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATIONS
I, Geoffrey P. Purtill, certify that:
1.    I have reviewed this quarterly report on Form 10-Q of Invacare Corporation;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 /s/ GEOFFREY P. PURTILL
Date:November 7, 2022
Geoffrey P. Purtill
President and Chief Executive Officer
(Principal Executive Officer)


 EX-31.2 4 q32022ivcex312.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATIONS
I, Kathleen P. Leneghan, certify that:
1.    I have reviewed this quarterly report on Form 10-Q of Invacare Corporation;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 /s/ KATHLEEN P. LENEGHAN
Date:November 7, 2022
Kathleen P. Leneghan
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)


 EX-32.1 5 q32022ivcex321.htm EX-32.1 Document

Exhibit 32.1
Certification
Pursuant to Section 18 U.S.C. Section 1350,
as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of Invacare Corporation (the “company”) on Form 10-Q for the period ending September 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Geoffrey P. Purtill, President and Chief Executive Officer of the company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company.
 /s/ GEOFFREY P. PURTILL
Date:November 7, 2022Geoffrey P. Purtill
President and Chief Executive Officer
(Principal Executive Officer)
A signed original of this written statement required by Section 906 has been provided to Invacare Corporation and will be retained by Invacare Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

 EX-32.2 6 q32022ivcex322.htm EX-32.2 Document

Exhibit 32.2
Certification
Pursuant to Section 18 U.S.C. Section 1350,
as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of Invacare Corporation (the “company”) on Form 10-Q for the period ending September 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kathleen P. Leneghan, Senior Vice President and Chief Financial Officer of the company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company.
 /s/ KATHLEEN P. LENEGHAN
Date:November 7, 2022Kathleen P. Leneghan
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
A signed original of this written statement required by Section 906 has been provided to Invacare Corporation and will be retained by Invacare Corporation and furnished to the Securities and Exchange Commission or its staff upon request.


 EX-101.SCH 7 ivc-20220930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - DEI Document link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Condensed Consolidated Statement of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Condensed Consolidated Statement Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Condensed Consolidated Statement of Shareholders' Equity Statement link:presentationLink link:calculationLink link:definitionLink 0000007 - Disclosure - Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Divested Businesses (Notes) link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Receivables link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Other Current Assets link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Other Long-Term Assets link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Property And Equipment link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Intangibles link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Other Long-Term Obligations link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Leases and Commitments (Notes) link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Revenue Revenue link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Equity Compensation link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Charges Related To Restructuring Activities link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Net Earnings (Loss) Per Common Share link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Concentration Of Credit Risk link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Derivatives link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Fair Values link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Business Segments link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Divested Businesses (Tables) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Receivables (Tables) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Other Long-Term Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Property And Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Intangibles (Tables) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Other Long-Term Obligations (Tables) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Leases and Commitments (Tables) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - Equity Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Tables) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - Charges Related To Restructuring Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - Net Earnings (Loss) Per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - Derivatives (Tables) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - Fair Values (Tables) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - Business Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - Divested Businesses (Details) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - Receivables (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - Receivables (Schedule of Accounts Receivable) (Details) link:presentationLink link:calculationLink link:definitionLink 0000055 - Disclosure - Receivables Schedule for Allowance for Credit Losses (Details) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - Receivables (Installment Recevables) (Details) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - Receivables (Rollforward of Allowance for Doubtful Accounts) (Details) link:presentationLink link:calculationLink link:definitionLink 0000058 - Disclosure - Receivables (Installment Receivables by Class) (Details) link:presentationLink link:calculationLink link:definitionLink 0000059 - Disclosure - Receivables (Aging of Installment Receivables) (Details) link:presentationLink link:calculationLink link:definitionLink 0000060 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 0000061 - Disclosure - Other Current Assets Components of Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000062 - Disclosure - Other Long-Term Assets Components of Other Long-Term Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000063 - Disclosure - Other Long-Term Assets Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000064 - Disclosure - Property And Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 0000065 - Disclosure - Goodwill Goodwill Details (Details) link:presentationLink link:calculationLink link:definitionLink 0000066 - Disclosure - Intangibles (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000067 - Disclosure - Intangibles (Intangible Table) (Details) link:presentationLink link:calculationLink link:definitionLink 0000068 - Disclosure - Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 0000069 - Disclosure - Accrued Expenses Components of Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 0000070 - Disclosure - Accrued Expenses Warranty Schedule (Details) link:presentationLink link:calculationLink link:definitionLink 0000071 - Disclosure - Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000072 - Disclosure - Long-Term Debt Components of Convertible Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000073 - Disclosure - Long-Term Debt Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000074 - Disclosure - Long-Term Debt Sale Leaseback Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 0000075 - Disclosure - Other Long-Term Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 0000076 - Disclosure - Leases and Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 0000077 - Disclosure - Leases and Commitments Lease Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 0000078 - Disclosure - Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 0000079 - Disclosure - Leases and Commitments Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000080 - Disclosure - Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details) link:presentationLink link:calculationLink link:definitionLink 0000081 - Disclosure - Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 0000082 - Disclosure - Equity Compensation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000083 - Disclosure - Equity Compensation Share-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000084 - Disclosure - Equity Compensation Unrecognized Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000085 - Disclosure - Equity Compensation (Options Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 0000086 - Disclosure - Equity Compensation (Stock Options Outstanding by Exercise Price) (Details) link:presentationLink link:calculationLink link:definitionLink 0000087 - Disclosure - Equity Compensation Restricted Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000088 - Disclosure - Equity Compensation Performance Share Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000089 - Disclosure - Equity Compensation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 0000090 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details) link:presentationLink link:calculationLink link:definitionLink 0000091 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details) link:presentationLink link:calculationLink link:definitionLink 0000092 - Disclosure - Charges Related To Restructuring Activities (Details) link:presentationLink link:calculationLink link:definitionLink 0000093 - Disclosure - Charges Related To Restructuring Activities Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000094 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0000095 - Disclosure - Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000096 - Disclosure - Net Earnings (Loss) Per Common Share Textuals (Details) link:presentationLink link:calculationLink link:definitionLink 0000097 - Disclosure - Concentration Of Credit Risk (Details) link:presentationLink link:calculationLink link:definitionLink 0000098 - Disclosure - Derivatives Notional Amounts - Designated as Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 0000099 - Disclosure - Derivatives Notional Amounts - Not Designated as Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 0000100 - Disclosure - Derivatives Balance Sheet Location (Details) link:presentationLink link:calculationLink link:definitionLink 0000101 - Disclosure - Derivatives Gain (Loss) in Statement of Finacial Position (Details) link:presentationLink link:calculationLink link:definitionLink 0000102 - Disclosure - Derivatives Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000103 - Disclosure - Derivatives Fair Value of Convertible Debt Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 0000104 - Disclosure - Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) link:presentationLink link:calculationLink link:definitionLink 0000105 - Disclosure - Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 0000106 - Disclosure - Business Segments (Information by Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 0000107 - Disclosure - Contingencies Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 ivc-20220930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 ivc-20220930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 ivc-20220930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT EUR / SEK Foreign Exchange Forward EUR / SEK [Member] Foreign Exchange Forward EUR / SEK [Member] Installment receivables, net, long-term Installment receivables Financing Receivable, after Allowance for Credit Loss, Noncurrent Other, principally returns and allowances reserves Returns and Allowances Reserve Returns and Allowances Reserve Letter of Credit Letter of Credit [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Leasehold improvements Leasehold Improvements [Member] Debt Instrument, Common Shares Exchanged Debt Instrument, Common Shares Exchanged Debt Instrument, Common Shares Exchanged Risks and Uncertainties [Abstract] Risks and Uncertainties [Abstract] Preferred Stock, Shares Outstanding Preferred Stock, Shares Outstanding Financing Receivables Not Past 90 Days Due Financing Receivables Not Accruing Interest Past 90 Days Due Financing Receivables Not Accruing Interest Past 90 Days Due Receivable Type [Axis] Receivable Type [Axis] Goodwill Goodwill Disclosure [Text Block] Other Other Intangible Assets [Member] Derivative liabilities Derivative Liability Dividends, Common Stock, Cash Dividends, Common Stock, Cash Security Exchange Name Security Exchange Name Debt Instrument, Convertible, Conversion Price Debt Instrument, Convertible, Conversion Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Large National Customers Large National Customers [Member] Large National Customers [Member] Schedule of Installment Receivables by Class Impaired Financing Receivables [Table Text Block] Canceled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Operating Lease, Weighted Average Remaining Lease Term Operating Lease, Weighted Average Remaining Lease Term Allowance for doubtful accounts, current Financing Receivable, Allowance for Credit Loss, Current Installment receivables, net Installment receivables, net Financing Receivable, after Allowance for Credit Loss, Current Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Debt Instrument, Fee Amount Debt fees Debt Instrument, Fee Amount, Net Balance Shown as a Liability Debt Instrument, Fee Amount, Net Balance Shown as a Liability Contract Termination Contract Termination [Member] Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Options available for grant at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Cash, Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect EUR / GBP Foreign Exchange Forward EUR / GBP [Member] Foreign Exchange Forward EUR / GBP [Member] Class of Financing Receivable, Type [Axis] Class of Financing Receivable [Axis] Installment Receivables, Current Financing Receivable, before Allowance for Credit Loss, Current Other [Domain] Other [Domain] Other Net award activity (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease) Net Gain (Loss), as a percent of Net Sales Net Gain (Loss), as a percent of Net Sales Net Gain (Loss), as a percent of Net Sales Deferred Tax Reversal, related to Goodwill Impairment Deferred Tax Reversal, related to Goodwill Impairment Deferred Tax Reversal, related to Goodwill Impairment Interest Income, Other Interest Income, Other Right-of-Use Asset Obtained in Exchange for Total Lease Liability Right-of-Use Asset Obtained in Exchange for Total Lease Liability Right-of-Use Asset Obtained in Exchange for Total Lease Liability Exercise price range, lower limit (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit Fair value stock price Average Fair Value Stock Price Average Fair Value Stock Price Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Risk Level, High Risk Level, High [Member] Amortization expense Amortization of Intangible Assets Schedule of Restructuring and Related Costs Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Antidilutive securities excluded from computation of earnings per share, amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Operating Lease, Weighted Average Discount Rate, Percent Operating Lease, Weighted Average Discount Rate, Percent Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments Industry Sector [Axis] Industry Sector [Axis] Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Cash Flow Hedging [Member] Cash Flow Hedging [Member] Legal Entity Type of Counterparty [Domain] Legal Entity Type of Counterparty [Domain] Valuation Allowance [Line Items] Valuation Allowance [Line Items] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Equity Award [Domain] Award Type [Domain] Local Phone Number Local Phone Number Options exercisable at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Impaired installment receivables with a related allowance recorded Impaired Financing Receivable, with Related Allowance, Recorded Investment 90+ days past due Installment Receivable, Greater than 90 Days Past Due Installment Receivable, Greater than 90 Days Past Due Percentage of eligible domestic inventory and in-transit inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Domestic, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Domestic, Percent Class of Financing Receivable, Type Class of Financing Receivable [Domain] Preferred Shares (Authorized 300 shares; none outstanding) Preferred Stock, Value, Issued Legal Entity of Counterparty, Type [Axis] Legal Entity of Counterparty, Type [Axis] Debt Instrument, Convertible, Threshold Consecutive Trading Days Debt Instrument, Convertible, Threshold Consecutive Trading Days Currency [Axis] Currency [Axis] Derivative assets (liabilities), at fair value, net Derivative Assets (Liabilities), at Fair Value, Net Retained Earnings [Member] Retained Earnings [Member] Debt Instrument, Fair Value Disclosure Debt Instrument, Fair Value Disclosure Net loss (gain) on debt extinguishment, as a Percent of Net Sales [Line Items] Net loss (gain) on debt extinguishment, as a Percent of Net Sales Net loss (gain) on debt extinguishment, as a Percent of Net Sales Liability Components of Convertible 2024 Note Liability Components of Convertible 2024 Note [Table Text Block] Liability Components of Convertible 2024 Note Other Liabilities Disclosure [Abstract] Other Liabilities Disclosure [Abstract] Financing Receivable, Recorded Investment, Past Due [Line Items] Financing Receivable, Past Due [Line Items] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Percentage of eligible Canadian accounts receivable Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Foreign, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Foreign, Percent Trade receivables Increase (Decrease) in Accounts Receivable Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Convertible Senior Notes at 4.50% February 2022 Convertible Senior Notes at 4.50% February 2022 [Member] Convertible Senior Notes at 4.50% February 2022 Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Additional amount after closing (round 3) [Domain] Additional amount after closing (round 3) [Member] Additional amount after closing (round 3) Consecutive business days for minimum undrawn balance Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn Balance Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn Balance Disposal Group, Including Discontinued Operation, Property, Plant and Equipment Disposal Group, Including Discontinued Operation, Property, Plant and Equipment Tax Period [Domain] Tax Period [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Net Loss per Share—Basic Net earnings (loss) per common share Earnings Per Share, Basic Other Long-Term Assets Other Assets Disclosure [Text Block] Operating Lease, Expense Operating Lease, Expense Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Loss per Share—Assuming Dilution Earnings Per Share, Diluted [Abstract] Disposal Group, Including Discontinued Operation, Accounts Payable Disposal Group, Including Discontinued Operation, Accounts Payable Pension Liability, Defined Benefit Pension Plan, Noncurrent Total installment receivables Financing Receivable, Interest Income, Accrual Method Financing Receivable, Interest Income, Accrual Method Machinery and equipment Machinery and Equipment [Member] Percentage of domestic accounts receivable Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Domestic, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Domestic, Percent Provision (benefit) for other deferred liabilities Other Noncash Income (Expense) Derivative assets Derivative Asset, Fair Value, Gross Asset USD / CAD Foreign Exchange Forward USD / CAD [Member] Foreign Exchange Forward USD / CAD [Member] Class of Financing Receivable, Type of Borrower [Axis] Type of Borrower [Axis] Minimum required undrawn balance (as a percent) Line of Credit, Covenant Compliance, Required Undrawn Balance, Minimum, Percent Line of Credit, Covenant Compliance, Required Undrawn Balance, Minimum, Percent Industry of Counterparty, Type [Axis] Industry of Counterparty, Type [Axis] Impaired Financing Receivable, Related Allowance Impaired Financing Receivable, Related Allowance Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Long-term Debt and Capital Lease Obligations, Current Long-term Debt and Lease Obligation, Current Restructuring Reserve, Accrual Adjustment Restructuring Reserve, Accrual Adjustment Plan Name [Axis] Plan Name [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Goodwill, Impairment Loss Goodwill, Impairment Loss Goodwill, Impairment Loss Schedule of Aging of Installment Receivables Financing Receivable, Past Due [Table Text Block] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Entity Small Business Entity Small Business Base Rate Base Rate [Member] Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France) Schedule of Installment Receivables Allowance for Doubtful Accounts Financing Receivable, Allowance for Credit Loss [Table Text Block] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Deferred financing fees Prepaid Debt Fees Prepaid Debt Fees Accounts Receivable, Net Accounts Receivable, after Allowance for Credit Loss Adjustments for Change in Accounting Principle [Axis] Change in Accounting Principle, Type [Axis] Scenario [Axis] Scenario [Axis] Additional paid-in-capital Additional Paid in Capital Debt Instrument, Net Proceeds Debt Instrument, Net Proceeds Debt Instrument, Net Proceeds Average period of adjudication Notes, Loans, Financing Receivable, Average Period of Adjudication Notes, Loans, Financing Receivable, Average Period of Adjudication Liabilities and Shareholders’ Equity Liabilities and Equity [Abstract] Product liability Product Liability, Noncurrent Product Liability, Noncurrent Accounts payable Increase (Decrease) in Accounts Payable Hedging Relationship [Domain] Hedging Relationship [Domain] Total Cash Paid in Measurement of Amounts for Lease Liabilities Total Cash Paid in Measurement of Amounts for Lease Liabilities Total Cash Paid in Measurement of Amounts for Lease Liabilities Adoption of Credit Loss Standard Adoption of Credit Loss Standard Adoption of Credit Loss Standard Derivative liabilities (foreign currency forward exchange contracts) Derivative Liability, Current Entity Interactive Data Current Entity Interactive Data Current Future amortization expense, 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Four Stock Issued During Period, Value, Stock Options Exercised Stock Issued During Period, Value, Stock Options Exercised Recoverable income taxes Income Taxes Receivable, Current Amortization of operating lease right of use assets Operating Lease, Right-of-Use, Amortization Operating Lease, Right-of-Use, Amortization Uncertain tax obligation including interest Liability for Uncertainty in Income Taxes, Noncurrent Lifestyle Products [Domain] Lifestyle Products [Domain] Lifestyle Products Balance Sheet Location [Domain] Balance Sheet Location [Domain] Revenue Recognition, Multiple-deliverable Arrangements [Table] Revenue Recognition, Multiple-deliverable Arrangements [Table] Current period provision (benefit) Allowance for Loan and Lease Losses, Adjustments, Other Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Derivatives (foreign currency forward exchange contracts) Derivative Asset, Current Entity Address, State or Province Entity Address, State or Province Lessee, Finance Leases Lessee, Finance Leases [Text Block] Beginning Balance Ending Balance Restructuring Reserve Restructuring Reserve Rebates Accrued Marketing Costs, Current Current Liabilities Liabilities, Current [Abstract] Net gain on convertible debt derivatives Net gain on convertible debt derivatives Loss (gain) on Convertible Debt Derivatives Gain (loss) on Convertible Debt Derivatives Accrued Rent, Current Accrued Rent, Current Receivable [Domain] Receivable [Domain] Debt Instrument Exchange Amount Debt Instrument Exchange Amount Debt Instrument Exchange Amount IT service contracts IT Service Contract IT Service Contract Restatement [Axis] Revision of Prior Period [Axis] Debt Instrument, Debt Default, Amount Debt Instrument, Debt Default, Amount Antidilutive share granted, average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Inventories Inventory Disclosure [Text Block] Accounting Policies [Abstract] Accounting Policies [Abstract] Derivative Instrument [Axis] Derivative Instrument [Axis] USD / GBP Foreign Exchange Forward GBP / USD [Member] Foreign Exchange Forward GBP / USD [Member] Document Transition Report Document Transition Report Net loss from Continuing Operations Net loss from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Finance Lease, Weighted Average Discount Rate, Percent Finance Lease, Weighted Average Discount Rate, Percent Convertible Senior Notes at 4.50% February 2022 [Domain] Convertible Senior Notes at 4.50% February 2022 1 [Member] Convertible Senior Notes at 4.50% February 2022 1 Disposal Group, Including Discontinued Operation, Liabilities Disposal Group, Including Discontinued Operation, Liabilities Period for recognition of unrecognized compensation costs Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Debt Instrument, Convertible, Beneficial Conversion Feature Debt Instrument, Convertible, Beneficial Conversion Feature Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Total installment receivables Financing Receivable, Unpaid Principal Balance Financing Receivable, Unpaid Principal Balance Net orderly liquidation value of domestic eligible machinery and equipment Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Property, Plant and Equipment, Liquidation Value, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Property, Plant and Equipment, Liquidation Value, Percent USD / CHF Foreign Exchange Forward USD / CHF [Member] Foreign Exchange Forward USD / CHF Lessee, Operating Leases Lessee, Operating Leases [Text Block] Proceeds from sale of business Proceeds from Divestiture of Businesses, Net of Cash Divested Fair Value, by Balance Sheet Grouping Fair Value, by Balance Sheet Grouping [Table Text Block] Finance Lease, Right-of-Use Asset, Amortization Finance Lease, Right-of-Use Asset, Amortization Revolving Credit and Security Agreement (North America Credit Agreement) Revolving Credit and Security Agreement (North America Credit Agreement) [Member] Revolving Credit and Security Agreement (North America Credit Agreement) Other investments Other Investments Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Schedule of Other Assets, Noncurrent Schedule of Other Assets, Noncurrent [Table Text Block] Deferred tax benefit (provision) related to gain on cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance Stock options and awards Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Goodwill [Line Items] Goodwill [Line Items] Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax Class of Stock [Axis] Class of Stock [Axis] Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] United Kingdom, Pounds United Kingdom, Pounds Allowance for Doubtful Accounts [Roll Forward] Financing Receivable, Allowance for Credit Loss [Roll Forward] Land, buildings and improvements Land, Buildings and Improvements [Member] Customer rebate reserve Customer Rebate Reserve Customer Rebate Reserve Liability Components of Convertible 2022 Note Liability Components of Convertible 2022 Note [Table Text Block] Liability Components of Convertible 2022 Note [Table Text Block] [Table Text Block] Performance achievement level, upper range Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Upper Range, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Upper Range, Percentage Work in process Inventory, Work in Process, Net of Reserves Derivative Instruments and Hedging Activities [Abstract] Derivative Instruments and Hedging Activities [Abstract] Derivative Instruments and Hedging Activities [Abstract] First year of loan period First year of loan period [Member] First year of loan period Finance Lease, Liability, Payments, Due after Year Five Finance Lease, Liability, to be Paid, after Year Five Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] Selling, General and Administrative Expenses Selling, General and Administrative Expenses [Member] Accrued expenses Accrued expenses Accrued Liabilities, Current Dividends Declared per Common Share Common Stock, Dividends, Per Share, Declared Restricted Stock and Restricted Stock Units (RSUs) Restricted Stock and Restricted Stock Units (RSUs) [Member] Restricted Stock and Restricted Stock Units (RSUs) [Member] Foreign Exchange Forward Contracts, by Exchange [Domain] Foreign Exchange Forward Contracts, by Exchange [Domain] Foreign Exchange Forward Contracts, by Exchange [Domain] Convertible Debt Derivative Convertible Debt Derivative Convertible Debt Derivative Finished goods Inventory, Finished Goods, Net of Reserves Receivables Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Stock Options Share-based Payment Arrangement, Option [Member] Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Equity [Abstract] Equity [Abstract] Document Quarterly Report Document Quarterly Report Europe (EMEA) Europe (EMEA) [Member] Europe (EMEA) Convertible Subordinated Debt Convertible Subordinated Debt [Member] Variable Rate [Axis] Variable Rate [Axis] Finance Lease, Weighted Average Remaining Lease Term Finance Lease, Weighted Average Remaining Lease Term Business Segments Segment Reporting Disclosure [Text Block] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Long-term debt Long-term debt Long-term Debt and Lease Obligation, Including Current Maturities Document Fiscal Year Focus Document Fiscal Year Focus Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Variable Rate [Domain] Variable Rate [Domain] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Performance achievement level, target range Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Percentage Level of Performance Award Achievement, Target Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Series II Convertible Senior Notes at 5.00% November 2024 Series II Convertible Senior Notes at 5.00% November 2024 [Member] Series II Convertible Senior Notes at 5.00% November 2024 Collateral [Domain] Collateral Held [Domain] USD / SEK Foreign Exchange Forward SEK/USD [Member] Foreign Exchange Forward SEK/USD Entity Information [Line Items] Entity Information [Line Items] Installment receivables, net Financing Receivable, after Allowance for Credit Loss Installment sales contracts, net Increase (Decrease) in Finance Receivables Industry Sector [Domain] Industry Sector [Domain] Other Payments for (Proceeds from) Other Investing Activities Prepaid insurance Prepaid Insurance Other Long-Term Obligations Other Liabilities Disclosure [Text Block] Maximum Maximum [Member] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-based Payment Arrangement [Abstract] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Raw materials Inventory, Raw Materials, Net of Reserves Supplemental executive retirement program liability Deferred Compensation Cash-based Arrangements, Liability, Current Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Award Type [Axis] Award Type [Axis] Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Debt Instrument, Percent limit on issuing common shares upon Conversion of the New 2026 Notes Debt Instrument, Percent limit on issuing common shares upon Conversion of the New 2026 Notes Debt Instrument, Percent limit on issuing common shares upon Conversion of the New 2026 Notes Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Adjustments for Change in Accounting Principle [Domain] Change in Accounting Principle, Type [Domain] Total Shareholders’ Equity Total Shareholders’ Equity Total Shareholders’ Equity Total Shareholders’ Equity Stockholders' Equity Attributable to Parent Percent of the Applicable Conversion Price Percent of the Applicable Conversion Price Percent of the Applicable Conversion Price Billing Status, Type [Axis] Billing Status, Type [Axis] City Area Code City Area Code Schedule of Financing Receivable, Allowance for Credit Losses [Table] Financing Receivable, Allowance for Credit Loss [Table] Schedule of Cash Flow, Supplemental Disclosures [Table] Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Designated as Hedging Instrument [Member] Designated as Hedging Instrument [Member] Accretion Expense, net of extinguishment fees Accretion Expense, net of extinguishment fees Accretion Expense, net of extinguishment fees Non-Impaired installment receivables with no related allowance recorded Financing Receivable, with No Related Allowance, Interest Income, Accrual Method Financing Receivable, with No Related Allowance, Interest Income, Accrual Method Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] $12.15 – $14.49 Range of Exercise Price Range Min [Member] Range of Exercise Price Range Min Other Intangibles Intangible Assets Disclosure [Text Block] Convertible Senior Notes at 5.00% November 2024 [Domain] Convertible Senior Notes at 5.00% November 2024 a [Member] Convertible Senior Notes at 5.00% November 2024 a Accounts receivable, gross Accounts Receivable, before Allowance for Credit Loss Purchases of treasury shares Payments for Repurchase of Common Stock Payments for Repurchase of Common Stock Gain on sale of business, as a Percent of Net Sales Gain on sale of business, as a Percent of Net Sales Gain on sale of business, as a Percent of Net Sales Shareholders’ Equity Stockholders' Equity Attributable to Parent [Abstract] Operating Leases Long-Term Obligations Operating Lease, Liability, Noncurrent Finance Lease, Liability, Payments, Due Finance Lease, Liability, Payment, Due Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] Debt Instrument, Face Amount Debt Instrument, Face Amount Operating Segments [Member] Operating Segments [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Restatement [Domain] Revision of Prior Period [Domain] Severance Other Employee-related Liabilities, Current Notional amount of derivatives, matured during period Notional Amount of Derivatives, Matured During Period Notional Amount of Derivatives, Matured During Period Industry of Counterparty [Domain] Industry of Counterparty [Domain] North America (NA) North America (NA) [Member] North America (NA) Convertible due 2021 - Bond Hedge, Fair Value at Issuance Convertible due 2021 - Bond Hedge, Fair Value at Issuance Convertible due 2021 - Bond Hedge, Fair Value at Issuance Entity Registrant Name Entity Registrant Name Finance Lease, Liability, Payments, Due Year Three Finance Lease, Liability, to be Paid, Year Three Finance Lease, Liability, Payments, Due Year Four Finance Lease, Liability, to be Paid, Year Four Interest Income Recognized Impaired Financing Receivable, Interest Income, Accrual Method [Abstract] Warranties provided during the period Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Schedule for Allowance for Credit Losses Allowance for Credit Losses [Table Text Block] Allowance for Credit Losses Convertible Debt Derivative Convertible Debt Derivative [Member] Convertible Debt Derivative Canceled - Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Income tax provision Income tax provision Income Tax Expense (Benefit) Liability Components of Convertible Series II 2024 Note Liability Components of Convertible Series II 2024 Note [Table Text Block] Liability Components of Convertible Series II 2024 Note Trade receivables, net Accounts Receivable, after Allowance for Credit Loss, Current Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Entity Tax Identification Number Entity Tax Identification Number Document Fiscal Period Focus Document Fiscal Period Focus Total Current Assets Assets, Current Assets, Current Schedule of Share-based Compensation, Stock Options Outstanding Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Sale Leaseback Transaction, Annual Payments Sale Leaseback Transaction, Annual Payments Sale Leaseback Transaction, Annual Payments Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK) Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Contract Type [Axis] Contract Type [Axis] Contract Type [Axis] Current portion of long-term debt Long-term Debt, Current Maturities Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Deferred gain on sale leaseback, Net Deferred gain on sale leaseback, Net Deferred gain on sale leaseback, Net Service contracts Prepaid Service Contracts Prepaid Service Contracts Adjustments for Error Correction [Domain] Error Correction, Type [Domain] Equity Component [Domain] Equity Component [Domain] Sale and Leaseback Transaction, Gain (Loss), Net Sale and Leaseback Transaction, Gain (Loss), Net Financing Receivable, Allowance for Credit Losses [Line Items] Financing Receivable, Allowance for Credit Loss [Line Items] Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables 2022 Lessee, Operating Lease, Liability, to be Paid, Year One Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Disposal Groups, Including Discontinued Operations, Name [Domain] Disposal Group Name [Domain] Liability Components of Secured 2026 Notes Liability Components of Secured 2026 Notes [Table Text Block] Liability Components of Secured 2026 Notes Sale Leaseback Transaction, Lease Terms Sale Leaseback Transaction, Lease Terms Amortization of Debt Discount (Premium) Amortization of Debt Discount (Premium) Deferred financing fees Debt Issuance Costs, Noncurrent, Net Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan Share-based Payment Arrangement, Cost by Plan [Table Text Block] Counterparty Name [Domain] Counterparty Name [Domain] 2025 Lessee, Operating Lease, Liability, to be Paid, Year Four Weighted Average Weighted Average [Member] Current portion of finance lease obligations Finance Lease, Liability, Current Finance Lease, Liability, Current Loss Before Income Taxes Earnings (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Financing Lease Liability, non-current Financing Lease Liability, non-current Financing Lease Liability, non-current Geographic Distribution [Domain] Geographic Distribution [Domain] Type of Adoption [Domain] Accounting Standards Update [Domain] Issuance of warrants Proceeds from Issuance of Warrants Proceeds from Issuance of Warrants Gain (Loss) Gain (Loss) Gain (Loss) Derivative, Gain (Loss) on Derivative, Net Type of Restructuring [Domain] Type of Restructuring [Domain] Segment Reporting [Abstract] Segment Reporting [Abstract] Finite-Lived intangible assets, useful life Finite-Lived Intangible Asset, Useful Life Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Finance Lease, Interest Expense Finance Lease, Interest Expense Use of Estimates Use of Estimates, Policy [Policy Text Block] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Debt Discount Amortization, per Basic and Diluted Share Debt Discount Amortization, per Basic and Diluted Share Debt Discount Amortization, per Basic and Diluted Share Performance achievement level, lower range Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Lower Range, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Lower Range, Percentage Title of 12(b) Security Title of 12(b) Security Assets and Liabilities of Divested Business [Table Text Block] Assets and Liabilities of Divested Business [Table Text Block] Assets and Liabilities of Divested Business Common Stock, Shares Authorized Common Stock, Shares Authorized Schedule of Accounts Receivable [Abstract] Schedule of Accounts Receivable [Abstract] Schedule of Accounts Receivable [Abstract] Unpaid Purchases of Property and Equipment Unpaid Purchases of Property and Equipment Unpaid Purchases of Property and Equipment Document Type Document Type Product and Service [Domain] Product and Service [Domain] Accrued Expenses Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Selling, general and administrative expenses, as a Percent of Net Sales Selling, general and administrative expenses, as a Percent of Net Sales Selling, general and administrative expenses, as a Percent of Net Sales Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Line of Credit Facility, Covenant Feature, Dominion Trigger Line of Credit Facility, Covenant Feature, Dominion Trigger Line of Credit Facility, Covenant Feature, Dominion Trigger Other Prepaid Expense and Other Assets, Noncurrent Non-Impaired installment receivables with no related allowance recorded Financing Receivable, with No Related Allowance, Recorded Investment Financing Receivable, with No Related Allowance, Recorded Investment USD / EUR Foreign Exchange Forward USD / EUR [Member] Foreign Exchange Forward USD / EUR [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Senior secured revolving credit facility, due in October 2015 Revolving Credit Facility Revolving Credit Facility [Member] Measurement Frequency [Axis] Measurement Frequency [Axis] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Share-based Payment Arrangement, Option, Exercise Price Range [Table] Revolving Credit and Security Agreement (Europe Credit Agreement) Revolving Credit and Security Agreement (Europe Credit Agreement) [Member] Revolving Credit and Security Agreement (Europe Credit Agreement) [Member] [Domain] Total installment receivables Financing Receivable, Recorded Investment Financing Receivable, Recorded Investment Lease, Cost [Table] Lease, Cost [Table Text Block] Geographical [Axis] Geographical [Axis] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Debt Instrument, Fee Amount Debt Instrument, Fee Amount Schedule of Impaired Financing Receivable [Table] Schedule of Impaired Financing Receivable [Table] Vesting [Domain] Vesting [Domain] Product Product [Member] Liquidated Damages amount per violation per day Liquidated Damages amount per violation per day Liquidated Damages amount per violation per day Hedging Relationship [Axis] Hedging Relationship [Axis] Weighted average interest rate (as a percent) Long-term Debt, Weighted Average Interest Rate, at Point in Time Divested Businesses Mergers, Acquisitions and Dispositions Disclosures [Text Block] Amortization of prior service costs and unrecognized losses Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Cost of products sold Cost of Products Sold Cost of Revenue Net Cash Provided by Financing Activities Net Cash Provided by (Used in) Financing Activities USD / MXN Foreign Exchange Forward USD / MXP [Member] Foreign Exchange Forward USD / MXP [Member] Treasury Shares (4,535 and 4,397 shares at September 30, 2022 and December 31, 2021, respectively) Treasury Stock, Value Treasury Stock, Value Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Finance Lease, Liability, Fiscal Year Maturity Finance Lease, Liability, Fiscal Year Maturity [Table Text Block] Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Charges related to restructuring activities Charges Charges Restructuring Charges Concentration Risk Type [Axis] Concentration Risk Type [Axis] Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Debt Instrument Repurchase Amount, Cash Paid Debt Instrument Repurchase Amount, Cash Paid Debt Instrument Repurchase Amount, Cash Paid Salaries and wages Accrued Salaries, Current Future amortization expense, 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Three Derivative [Table] Derivative [Table] Installment Receivable, Not Past Due Installment Receivable, Not Past Due Installment Receivable, Not Past Due Document Period End Date Document Period End Date Lease Contractual Term [Axis] Lease Contractual Term [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Sale Leaseback Transaction, Immediate Loss Recognized Sale Leaseback Transaction, Immediate Loss Recognized Sale Leaseback Transaction, Immediate Loss Recognized Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Related Allowance for Doubtful Accounts Impaired Financing Receivable, Related Allowance [Abstract] Impaired Financing Receivable, Related Allowance [Abstract] Award Date [Domain] Award Date [Domain] Debt Instrument, Interest Rate on Liability Component, Effective Percentage Debt Instrument, Interest Rate on Liability Component, Effective Percentage Debt Instrument, Interest Rate on Liability Component, Effective Percentage Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Interest expense, as a Percent of Net Sales Interest expense, as a Percent of Net Sales Interest expense, as a Percent of Net Sales Income Statement Location [Domain] Income Statement Location [Domain] Debt instrument, Springing Maturity Date Debt instrument, Springing Maturity Date, days prior to maturity date Debt instrument, Springing Maturity, days prior to maturity date Other Notes and Capital Lease Obligations Other Notes and Capital Lease Obligations [Member] Other Notes and Capital Lease Obligations [Member] Property and Equipment, net Property and equipment, net Property, Plant and Equipment, Net Repurchases of convertible debt, payments on revolving lines of credit and finance leases Repayments of Long-term Debt Earnings Per Share [Abstract] Earnings Per Share [Abstract] Property and equipment, gross Property, Plant and Equipment, Gross Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Net Sales Net Sales Revenues Amount reclassified from accumulated OCI Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Trademarks Trademarks [Member] Capped Call Options, Outstanding Capped Call Options, Outstanding Capped Call Options, Outstanding Options outstanding at beginning of period - Weighted Average Exercise Price (in dollars per share) Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share) Options Outstanding - Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Borrowing against Cash Surrender Value of Life Insurance Borrowing against Cash Surrender Value of Life Insurance Borrowing against Cash Surrender Value of Life Insurance Purchases of capped calls Purchases of capped calls Purchase of Capped Calls Purchase of Capped Calls Change in other long-term assets Payments for (Proceeds from) Long-term Investments Liquidated Damages - Yearly Limit Liquidated Damages - Yearly Limit Liquidated Damages - Yearly Limit Disposal Group, Including Discontinued Operation, Inter-Company Revenue Disposal Group, Including Discontinued Operation, Inter-Company Revenue Disposal Group, Including Discontinued Operation, Inter-Company Revenue Patents Patents [Member] Class of Financing Receivable, Type of Borrower [Domain] Class of Financing Receivable, Type of Borrower [Domain] Entity Current Reporting Status Entity Current Reporting Status Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent Notional Amount Notional Amount, Derivative Notional Amount, Derivative Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Effective income tax rate, continuing operations Effective Income Tax Rate Reconciliation, Percent Net Revenue Net Revenue Net Revenue Convertible Preferred Stock, Shares Issued upon Conversion Convertible Preferred Stock, Shares Issued upon Conversion Remaining Accretion Remaining Accretion Remaining Accretion Amortization of debt fees Amortization of Debt Issuance Costs Other Customers Other Customers [Member] Other Customers [Member] Counterparty Name [Axis] Counterparty Name [Axis] Loss (gain) on disposals of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Convertible Senior Secured Notes at 5.68% July 2026 - July 26, 2022 Issuance [Domain] Convertible Senior Secured Notes at 5.68% July 2026 - July 26, 2022 Issuance [Member] Convertible Senior Secured Notes at 5.68% July 2026 - July 26, 2022 Issuance Current taxes payable Taxes Payable, Current Award Date [Axis] Award Date [Axis] Leases [Abstract] Leases [Abstract] Debt Instrurment Repurchase Amount, Net Reduction of debt Debt Instrurment Repurchase Amount, Net Reduction of debt Debt Instrurment Repurchase Amount, Net Reduction of debt Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Non-Impaired installment receivables with no related allowance recorded Financing Receivable, with No Related Allowance, Unpaid Principal Balance Financing Receivable, with No Related Allowance, Unpaid Principal Balance Entity Address, Postal Zip Code Entity Address, Postal Zip Code Secured Term Loan - issuance July 26th, 2022 [Domain] Secured Term Loan - issuance July 26th, 2022 [Member] Secured Term Loan - issuance July 26th, 2022 Convertible Senior Notes, Holders Aggregate Principal Minimum requirement percentage, in the event of default Convertible Senior Notes, Holders Aggregate Principal Minimum requirement percentage, in the event of default Convertible Senior Notes, Holders Aggregate Principal Minimum requirement percentage, in the event of default Weighted Average Shares Outstanding—Assuming Dilution Average common shares assuming dilution Weighted Average Number of Shares Outstanding, Diluted Initial amount at closing [Domain] Initial amount at closing [Member] Initial amount at closing IVC Canada IVC Canada [Member] IVC Canada Income Taxes Income Tax Disclosure [Text Block] Debt Instrument, Net Carrying Amount Debt Instrument, Net Carrying Amount Debt Instrument, Net Carrying Amount Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Schedule of Share-based Compensation, Stock Options, Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Product liability, current portion Product Liability, Current Product Liability, Current Not Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument [Member] Credit Facility [Axis] Credit Facility [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Entity Address, Address Line One Entity Address, Address Line One Less allowance for depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Principles of Consolidation Consolidation, Policy [Policy Text Block] Entity Shell Company Entity Shell Company Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Total Current Liabilities Liabilities, Current Liabilities, Current Intersegment revenues Intersegment Eliminations [Member] Foreign currency forward contracts Forward exchange contracts—net Foreign Exchange Forward [Member] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Adoption of ASU 2020-06, Convertible Debt Discounts Removed Adoption of ASU 2020-06, Convertible Debt Discounts Removed Adoption of ASU 2020-06, Convertible Debt Discounts Removed Current Fiscal Year End Date Current Fiscal Year End Date Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Total Installment Receivables Financing Receivable, before Allowance for Credit Loss Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Secured Term Loans due July 2026 [Domain] Secured Term Loans due July 2026 [Member] Secured Term Loans due July 2026 Statement [Table] Statement [Table] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Convertible Debt, Conversion Rate of Commmon Shares, Principal Convertible Debt, Conversion Rate of Commmon Shares, Principal Convertible Debt, Conversion Rate of Commmon Shares, Principal Financing Leases, Future Minimum Payments, Interest Included in Payments Financing Leases, Future Minimum Payments, Interest Included in Payments Financing Leases, Future Minimum Payments, Interest Included in Payments Gross Profit, as a Percent of Net Sales Gross Profit, as a Percent of Net Sales Gross Profit, as a Percent of Net Sales Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location Derivatives Not Designated as Hedging Instruments [Table Text Block] Schedule of Amounts Recognized in Other Comprehensive Income (Loss) Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Range [Axis] Statistical Measurement [Axis] Number of missed payments before delinquent Notes, Loans, and Financing Receivables, Number of Missed Payments before Delinquent Notes, Loans, and Financing Receivables, Number of Missed Payments before Delinquent Subsequent Event Subsequent Event [Member] Impaired Financing Receivable, with Related Allowance, Interest Income, Accrual Method Impaired Financing Receivable, with Related Allowance, Interest Income, Accrual Method Finance Lease Long-Term Obligations Finance Lease, Liability, Noncurrent Goodwill Goodwill Convertible Senior Secured Notes at 5.68% July 2026 - Tranche I Notes [Domain] Convertible Senior Secured Notes at 5.68% July 2026 - Tranche I Notes [Member] Convertible Senior Secured Notes at 5.68% July 2026 - Tranche I Notes Total Unearned Interest Deferred Revenue Deferred Revenue Debt Instrument, Warrants Issued and Outstanding Debt Instrument, Warrants Issued and Outstanding Debt Instrument, Warrants Issued and Outstanding Adjustments to reconcile net loss to net cash used by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Scenario, Unspecified [Domain] Scenario [Domain] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Schedule of Derivatives Instruments Statements of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Valuation reserve associated with defined benefit plan activity Other Comprehensive Income (Loss), Deferred Tax Valuation Reserve Other Comprehensive Income (Loss), Deferred Tax Valuation Reserve Operating Lease, Cost Operating Lease, Cost Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Geographic Distribution [Axis] Geographic Distribution [Axis] Accumulated Defined Benefit Plans Adjustment [Member] Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Provision (benefit) for deferred income taxes Deferred Income Tax Expense (Benefit) Hedging Designation [Domain] Hedging Designation [Domain] Convertible Senior Notes at 5.00% February 2021 Convertible Senior Notes at 5.00% February 2021 [Member] Convertible Senior Notes at 5.00% February 2021 [Member] Schedule for Allowance for Credit Losses [Abstract] Schedule for Allowance for Credit Losses [Abstract] Schedule for Allowance for Credit Losses [Abstract] U.S. statutory income tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Convertible Senior Notes, Percentage of Principal Required for Repurchase Convertible Senior Notes, Percentage of Principal Required for Repurchase Convertible Senior Notes, Percentage of Principal Required for Repurchase Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Debt Instrument, Additional Prepayment Premium, Percentage of aggregate principal amount Debt Instrument, Additional Prepayment Premium, Percentage of aggregate principal amount Debt Instrument, Additional Prepayment Premium, Percentage of aggregate principal amount Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Net Loss Net loss Net Loss Net Income (Loss) Attributable to Parent Convertible Debt Discount Amortization and Accretion Convertible Debt Discount Amortization and Accretion Convertible Debt Discount Amortization and Accretion Operating Lease, Right-of-Use Asset Operating Lease, Right-of-Use Asset Events of Default Under Contract by Third Party Concentration Risk, Recourse for Customer Lease Obligation Under Default Concentration Risk, Recourse for Customer Lease Obligation Under Default Schedule of Notional Amounts of Outstanding Derivative Positions Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Respiratory Therapy [Domain] Respiratory Therapy [Domain] Respiratory Therapy Income Statement Location [Axis] Income Statement Location [Axis] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Range [Domain] Statistical Measurement [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 Plan Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 and 2013 Plans Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 and 2013 Plans Payments to debt holders Payments to Debt Holders Payments to Debt Holders Convertible Senior Notes at 4.25% March 2026 [Domain] Convertible Senior Notes at 4.25% March 2026 c [Member] Convertible Senior Notes at 4.25% March 2026 c USD / THB Foreign Exchange Forward USD / THB [Member] Foreign Exchange Forward USD / THB Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment General Terms and Conditions General Terms and Conditions [Member] General Terms and Conditions [Member] Impairment of Intangible Assets (Excluding Goodwill) Impairment of Intangible Assets (Excluding Goodwill) Impairment of Intangible Assets (Excluding Goodwill) Restructuring Cost and Reserve [Axis] Restructuring Type [Axis] Convertible Senior Notes, Additional Accrued interest in the Event of restrictive legends not being removed as of the 380th day after date of original issuance Convertible Senior Notes, Additional Accrued interest in the Event of restrictive legends not being removed as of the 380th day after date of original issuance Convertible Senior Notes, Additional Accrued interest in the Event of restrictive legends not being removed as of the 380th day after date of original issuance Tax receivables principally value added taxes Value Added Tax Receivable, Current Other Assets Other Long-Term Assets Other Assets, Noncurrent Segments [Axis] Segments [Axis] Line Of Credit Facility Gross Borrowing Base Line Of Credit Facility Gross Borrowing Base Line Of Credit Facility Gross Borrowing Base Entity File Number Entity File Number Gain (Loss) on Repurchase of Debt Instrument Gain (Loss) on Repurchase of Debt Instrument Total Installment Receivables Impaired Financing Receivable, Recorded Investment [Abstract] Line of Credit Facility, Covenant Feature, Prior Limit Line of Credit Facility, Covenant Feature, Prior Limit Line of Credit Facility, Covenant Feature, Prior Limit Financing Receivable, Impaired [Line Items] Financing Receivable, Impaired [Line Items] EUR / NOK Foreign Exchange Forward EUR / NOK [Member] Foreign Exchange Forward EUR / NOK [Member] Payment of financing costs Payments of Financing Costs Other Current Assets Other Current Assets [Member] Common Stock, Holders Percentage of Total Outstanding Common Stock, Holders Percentage of Total Outstanding Common Stock, Holders Percentage of Total Outstanding Long-term debt net of current maturities Long-term Debt and Lease Obligation Unamortized Financing Costs Unamortized Financing Costs Unamortized Financing Costs Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation, Performance Shares Award Unvested Activity Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block] Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] Operating Leases, Future Minimum Payments, Interest Included in Payments Operating Leases, Future Minimum Payments, Interest Included in Payments Operating Leases, Future Minimum Payments, Interest Included in Payments 2013 Plan [Member] 2013 Plan [Member] 2013 Plan [Member] Disposal Group Name [Axis] Disposal Group Name [Axis] Exercise Price Range [Axis] Exercise Price Range [Axis] Credit Facility [Domain] Credit Facility [Domain] Assets Assets [Abstract] Subsegments [Axis] Subsegments [Axis] Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Computer Software Depreciation Expense Computer Software Depreciation Expense Computer Software Depreciation Expense Derivatives Derivative Instruments and Hedging Activities Disclosure [Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period All Other All Other [Member] All Other Exchange of Convertible Notes Exchange of Convertible Notes Exchange of Convertible Notes Accumulated Long-Term Notes Adjustment [Member] Accumulated Long-Term Notes Adjustment [Member] Accumulated Long-Term Notes Adjustment [Member] Options outstanding at beginning of period (in shares) Options outstanding at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Receivable due from information technology provider Receivable Due From Information Technology Provider Receivable Due From Information Technology Provider Debt Instrument [Axis] Debt Instrument [Axis] Disposal Group, Including Discontinued Operation, Accrued Liabilities Disposal Group, Including Discontinued Operation, Accrued Liabilities Valuation Allowance [Table] Valuation Allowance [Table] USD / AUD Foreign Exchange Forward AUD / USD [Member] Foreign Exchange Forward AUD / USD [Member] Convertible Debt Conversion Feature Gain (Loss) Convertible Debt Conversion Feature Gain (Loss) Convertible Debt Conversion Feature Gain (Loss) Convertible Debt Conversion Feature Gain (Loss) Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current Revenue Recognition, Multiple-deliverable Arrangements Revenue Recognition, Multiple-deliverable Arrangements [Table Text Block] Percentage of net orderly liquidation value of eligible Canadian inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Liquidation Value, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Liquidation Value, Percent Revenue Recognition, Deferred Revenue [Policy Text Block] Revenue Recognition, Deferred Revenue [Policy Text Block] Impairment of goodwill, as a Percent of net Sales Impairment of goodwill, as a Percent of net Sales Impairment of goodwill, as a Percent of net Sales Contract Type [Domain] Contract Type [Domain] [Domain] for Contract Type [Axis] Secured Debt Secured Debt [Member] Range of Exercise Price Max [Member] Range of Exercise Price Max [Member] Range of Exercise Price Max Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability EUR / CHF Foreign Exchange Forward EUR / CHF [Member] Foreign Exchange Forward EUR / CHF [Member] Debt Instrument, Increase, Accrued Interest Debt Instrument, Increase, Accrued Interest Receivables, Expected Loss Percentage, North America excluding Canada Receivables, Expected Loss Percentage, North America excluding Canada Receivables, Expected Loss Percentage, North America excluding Canada Contingencies Contingencies Disclosure [Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] Prime Rate Prime Rate [Member] Risk Factor [Domain] Risk Factor [Domain] [Domain] for Risk Factor Line of Credit Facility, Remaining Borrowing Capacity Line of Credit Facility, Remaining Borrowing Capacity Gain on sale of business Gain (Loss) on Disposition of Business Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] 2024 Lessee, Operating Lease, Liability, to be Paid, Year Three Disposal Group, Including Discontinued Operation, Divestiture Accrual Balance Disposal Group, Including Discontinued Operation, Divestiture Accrual Balance Disposal Group, Including Discontinued Operation, Divestiture Accrual Balance Liability Components of Secured Term Loan Liability Components of Secured Term Loan [Table Text Block] Liability Components of Secured Term Loan Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Unrealized Gain (Loss) Unrealized Gain (Loss) on Derivatives USD / GBP Foreign Exchange Forward USD / GBP [Member] Foreign Exchange Forward USD / GBP [Member] Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Lifetime to date - Accretion Expense Lifetime to date - Accretion Expense Lifetime to date - Accretion Expense Accretion Rate Accretion Rate Accretion Rate Liability Components of Convertible 2021 Note Liability Components of Convertible 2021 Note [Table Text Block] [Table Text Block] for Liability Components of Convertible 2021 Note Convertible Senior Secured Notes at 5.68% July 2026 - Tranche II Notes [Domain] Convertible Senior Secured Notes at 5.68% July 2026 - Tranche II Notes [Member] Convertible Senior Secured Notes at 5.68% July 2026 - Tranche II Notes Swing Line Loans Swing Line Loans [Member] Swing Line Loans [Domain] Provision for Doubtful Accounts Provision for losses on trade and installment receivables Accounts Receivable, Credit Loss Expense (Reversal) Maximum value of net orderly liquidation value domestic inventory and in-transit inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Amount Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Amount Finance Lease, Right-of-Use Asset Finance Lease, Right-of-Use Asset, after Accumulated Amortization Financing Receivable Portfolio Segment [Axis] Financing Receivable Portfolio Segment [Axis] Insurance Accrued Insurance, Current Death benefit obligation plan Life Insurance Liability, Noncurrent Life Insurance Liability, Noncurrent Total Liabilities and Shareholders’ Equity Liabilities and Equity Liabilities and Equity Other items, principally trade accruals Other Accrued Liabilities, Current Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 2026 Lessee, Operating Lease, Liability, to be Paid, Year Five Percent of the Product of the Last Reported Sale Price, Common Shares Percent of the Product of the Last Reported Sale Price, Common Shares Percent of the Product of the Last Reported Sale Price, Common Shares Sale Leaseback Transaction, Net Proceeds, Investing Activities Sale Leaseback Transaction, Net Proceeds, Investing Activities Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Allowance for Loan and Lease Losses, Adjustments, Other Allowance for Losses, Adjustments, Other Allowance for Losses, Adjustments, Other Derivative [Line Items] Derivative [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Options Exercisable - Weighted Average Exercise Price (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Interest Expense, Sale of Receivables Interest Expense, Sale of Receivables Interest Expense, Sale of Receivables Schedule of Other Current Assets Schedule of Other Current Assets [Table Text Block] Debt Instrument, Prepayment Premium, Percentage of aggregate principal amount Debt Instrument, Prepayment Premium, Percentage of aggregate principal amount Debt Instrument, Prepayment Premium, Percentage of aggregate principal amount Adjustments to reconcile net loss to net cash used by operating activities: Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Total Assets Disposal Group, Including Discontinued Operation, Assets Net Earnings (Loss) Per Common Share Earnings Per Share [Text Block] Receivables, Expected Loss Percentage, Europe Receivables, Expected Loss Percentage, Europe Receivables, Expected Loss Percentage, Europe Foreign Exchange Forward Contracts, by Exchange [Axis] Foreign Exchange Forward Contracts, by Exchange [Axis] Foreign Exchange Forward Contracts, by Exchange [Axis] General Lease Term General Lease Term General Lease Term Minimum Minimum [Member] Last Reported Sales Price Period, Common Stock Last Reported Sales Price Period, Common Stock Last Reported Sales Price Period, Common Stock Adjustments for Error Corrections [Axis] Error Correction, Type [Axis] Revenue [Abstract] Revenue [Abstract] Revenue [Abstract] Gross Profit Gross Profit 2023 Lessee, Operating Lease, Liability, to be Paid, Year Two Effect of exchange rate changes on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Income (Loss) from Continuing Operations before Income Taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Selling, general and administrative expenses Amortization of prior service costs and unrecognized gains Selling, General and Administrative Expense Indefinite-lived Intangible Assets by Major Class [Axis] Indefinite-lived Intangible Assets [Axis] Preferred Stock, Shares Authorized Preferred Stock, Shares Authorized Operating Gain (Loss), as a Percent of Net Sales Operating Gain (Loss), as a Percent of Net Sales Operating Gain (Loss), as a Percent of Net Sales Reversal of Accrued Withholding Taxes on Earnings Reversal of Accrued Withholding Taxes on Earnings Reversal of Accrued Withholding Taxes on Earnings Cap Price of Capped Call Transaction Cap Price of Capped Call Transaction Cap Price of Capped Call Transaction Stock Issued During Period, Value, New Issues Stock Issued During Period, Value, New Issues Deferred income taxes Deferred Income Taxes and Other Tax Liabilities, Noncurrent USD / NOK Foreign Exchange Forward NOK / USD [Member] Foreign Exchange Forward NOK / USD [Member] Accumulated Translation Adjustment [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Debt Disclosure Debt Disclosure [Text Block] Other Restructuring Other Restructuring [Member] Options Exercisable - Number Exercisable At end of period (in shares) Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Line of Credit Line of Credit [Member] Shareholders' Equity Transactions Share-based Payment Arrangement [Text Block] Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Payment of dividends Payments of Ordinary Dividends, Common Stock Payments of Ordinary Dividends, Common Stock Professional Accrued Professional Fees, Current Letters of Credit Outstanding, Amount Letters of Credit Outstanding, Amount Revenue from External Customers by Products and Services [Table Text Block] Revenue from External Customers by Products and Services [Table Text Block] 61-90 days past due Installment Sales, 61 to 90 Days Past Due Installment Sales, 61 to 90 Days Past Due Convertible Debt Conversion Feature, Fair Value at Issuance Convertible Debt Conversion Feature, Fair Value at Issuance Convertible Debt Conversion Feature, Fair Value at Issuance Performance Shares Performance Shares [Member] Accumulated other comprehensive income (loss) Beginning Balance Ending Balance Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Emerging Growth Company Entity Emerging Growth Company GBP / THB Foreign Exchange Forward GBP / THB [Member] Foreign Exchange Forward GBP / THB Sale Leaseback Transactions [Abstract] Sale Leaseback Transactions [Abstract] Sale Leaseback Transactions [Abstract] Inventory Write-down Inventory Write-down Receivables [Abstract] Receivables [Abstract] New Accounting Pronouncements, Not yet Adopted New Accounting Pronouncements, Not yet Adopted [Policy Text Block] New Accounting Pronouncements, Not yet Adopted Cover [Abstract] Cover [Abstract] USD / SEK Foreign Exchange Forward USD / SEK [Member] Foreign Exchange Forward USD / SEK [Member] Debt Instrument, Springing Maturity, days prior to maturity of secured term loans due 2026 Debt Instrument, Springing Maturity, days prior to maturity of secured term loans due 2026 Debt Instrument, Springing Maturity, days prior to maturity of secured term loans due 2026 OCI before reclassifications Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Treasury Stock, Shares Treasury Stock, Shares Class of Warrant or Right, Outstanding Class of Warrant or Right, Outstanding Deferred tax adjustment resulting from defined benefit plan activity Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax Financing Receivable, Allowance for Credit Losses, Write-downs Allowance for Credit Losses, Write-downs Allowance for Credit Losses, Write-downs Financial Instrument [Axis] Financial Instrument [Axis] Options Outstanding - Weighted Average Remaining Contractual Life Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Convertible Senior Notes at 5.00% November 2024 Convertible Senior Notes at 5.00% November 2024 b [Member] Convertible Senior Subordinated Debentures at 4.125% February 2027 Contingent Liability, Guarantee Contingent Liability, Guarantee Contingent Liability, Guarantee Carrying Value Reported Value Measurement [Member] Payments Payments for Restructuring Finance Lease, Liability, Payments, Due Year Five Finance Lease, Liability, to be Paid, Year Five Common Shares [Member] Common Stock [Member] Common Stock [Member] Minimum availability reserve Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Availability Reserve, Minimum Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Availability Reserve, Minimum Disposal Group, Including Discontinued Operation, Inventory Disposal Group, Including Discontinued Operation, Inventory Operating Loss Operating Loss Operating Income (Loss) Amount of Gain (Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Receivables, Expected Loss Percentage, Canada Receivables, Expected Loss Percentage, Canada Receivables, Expected Loss Percentage, Canada Current portion of operating lease obligations Operating Lease, Liability, Current Operating Lease, Liability, Current Non-Impaired Financing Receivable, Related Allowance Non-Impaired Financing Receivable, Related Allowance Non-Impaired Financing Receivable, Related Allowance Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Future amortization expense, 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Two Hedging Designation [Axis] Hedging Designation [Axis] Provision for equity compensation Share-based Payment Arrangement, Noncash Expense Charges Related To Restructuring Activities Restructuring and Related Activities Disclosure [Text Block] Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value 12.6 Years 12.6 Years [Member] 12.6 Years Impaired installment receivables with a related allowance recorded Impaired Financing Receivable, with Related Allowance, Unpaid Principal Balance Common Stock, Number of Votes Common Stock, Number of Votes Common Stock, Number of Votes Interest income, as a Percent of Net Sales Interest income, as a Percent of Net Sales Interest income, as a Percent of Net Sales Treasury Stock [Member] Treasury Stock [Member] Deferred compensation Deferred Compensation Liability, Classified, Noncurrent Schedule of Product Warranty Liability Schedule of Product Warranty Liability [Table Text Block] Accrued expenses Increase (Decrease) in Accrued Liabilities Unpaid Principal Balance Impaired Financing Receivable, Unpaid Principal Balance [Abstract] Interruption of material manufacturing facilities, period Line of Credit, Covenant Compliance, Interruption of Manufacturing Facilities Period Line of Credit, Covenant Compliance, Interruption of Manufacturing Facilities Period Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Debt Instrument, Non-Cash Interest Expense Recognized in the Period Debt Instrument, Non-Cash Interest Expense Recognized in the Period Debt Instrument, Non-Cash Interest Expense Recognized in the Period Allowance for Credit Losses Allowance for Credit Losses Allowance for Credit Losses AUD / NZD Foreign Exchange Forward AUD / NZD [Member] Foreign Exchange Forward AUD / NZD [Member] Share-based Compensation Arrangement by Share-based Payment Award, Description Share-based Compensation Arrangement by Share-based Payment Award, Description Settlements made during the period Standard and Extended Product Warranty Accrual, Decrease for Payments Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Percentage of net orderly liquidation value of domestic inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Percent Cash discount reserves Cash Discount Reserves Cash Discount Reserves Future amortization expense, 2022 Finite-Lived Intangible Asset, Expected Amortization, Year One Receivables, Expected Loss Percentage, AsiaPac Receivables, Expected Loss Percentage, AsiaPac Receivables, Expected Loss Percentage, AsiaPac Consolidation Items [Axis] Consolidation Items [Axis] Sale Leaseback Transaction, Lease Term Sale Leaseback Transaction, Lease Term Sale Leaseback Transaction, Lease Term Common Stock, Shares, Issued Common Stock, Shares, Issued Interest Revenue (Expense), Net Interest Revenue (Expense), Net Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] Amount of Gain (Loss) Recognized  in Accumulated OCI on Derivatives (Effective Portion) Amount of Gain (Loss) Recognized  in Accumulated OCI on Derivatives (Effective Portion) Entity Address, City or Town Entity Address, City or Town Net gain on debt extinguishment Net gain on debt extinguishment Gain (Loss) on Extinguishment of Debt Convertible Senior Subordinated Debentures at 5.00% February 2021 [Domain] Convertible Senior Subordinated Debentures at 5.00% February 2021 [Member] Convertible Senior Subordinated Debentures at 5.00% February 2021 20 Years 20 Years [Member] 20 Years Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Debt Instrument, Repurchase Amount Debt Instrument, Repurchase Amount Current period gain (loss) on cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent Mobility and Seating [Domain] Mobility and Seating [Domain] Mobility and Seating Balance Sheet Location [Axis] Balance Sheet Location [Axis] Accumulated Other Comprehensive Income (Loss) by Component Comprehensive Income (Loss) Note [Text Block] Accrued Expenses Accrued Liabilities [Member] Other long-term liabilities Increase (Decrease) in Other Deferred Liability Fair Value, Measurement Frequency [Domain] Measurement Frequency [Domain] Cash surrender value of life insurance policies Cash Surrender Value of Life Insurance Weighted-Average Remaining Lease Terms and Discount Rates [Table] Weighted-Average Remaining Lease Terms and Discount Rates [Table Text Block] Weighted-Average Remaining Lease Terms and Discount Rates [Table Text Block] Interest expense Interest Expense Finance Lease, Liability, Payments, Due Next Twelve Months Finance Lease, Liability, to be Paid, Year One License agreements Licensing Agreements [Member] Debt Instrument, Interest Rate, Effective Percentage Debt Instrument, Interest Rate, Effective Percentage Changes in liability for pre-existing warranties during the period, including expirations Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Gain (loss) Before Income Taxes, as a Percent of Net Sales Gain (loss) Before Income Taxes, as a Percent of Net Sales Gain (loss) Before Income Taxes, as a Percent of Net Sales Retained earnings (accumulated deficit) Retained Earnings (Accumulated Deficit) Expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Taxes other than income taxes, primarily value added taxes Accrual for Taxes Other than Income Taxes, Current Additional amount of machinery and equipment Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Additional Long-Lived Asset Amount Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Additional Long-Lived Asset Amount Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Entity Filer Category Entity Filer Category Line of Credit Facility, Fair Value of Amount Outstanding Line of Credit Facility, Fair Value of Amount Outstanding Supplemental executive retirement plan liability Deferred Compensation Cash-based Arrangements, Liability, Classified, Noncurrent Estimate of Fair Value Measurement [Member] Estimate of Fair Value Measurement [Member] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] NOK / SEK Foreign Exchange Forward NOK / SEK [Member] Foreign Exchange Forward NOK / SEK [Member] 0-30 days past due Installment Receivable, 0 to 30 Days Past Due Installment Receivable, 0 to 30 Days Past Due Accretion Expense Accretion Expense Historical Cost Indefinite-lived Intangible Assets (Excluding Goodwill) Capitalized Computer Software, Net Capitalized Computer Software, Net Finance Lease, Liability, Payments, Due Year Two Finance Lease, Liability, to be Paid, Year Two Additional amount after closing (round 2) [Domain] Additional amount after closing (round 2) [Member] Additional amount after closing (round 2) Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Amendment Flag Amendment Flag Proceeds from revolving lines of credit and long-term borrowings Proceeds from Issuance of Long-term Debt Business Day Period Business Day Period Business Day Period Equity Components [Axis] Equity Components [Axis] Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Government Tenders Government Tenders [Member] Government Tenders [Member] Inventories, net Inventories, net Inventory, Net Receivables Billing Status [Domain] Receivables Billing Status [Domain] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Product and Service [Axis] Product and Service [Axis] Goodwill, Impairment Test, Discounted Cash Flow, Discount Rate Goodwill, Impairment Test, Discounted Cash Flow, Discount Rate Goodwill, Impairment Test, Discounted Cash Flow, Discount Rate Short-term Lease, Cost Short-term Lease, Cost AUD / THB Foreign Exchange Forward AUD / THB [Member] Foreign Exchange Forward AUD / THB Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Statement [Line Items] Statement [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Income Tax Provision, as a Percent of Net Sales Income Tax Provision, as a Percent of Net Sales Income Tax Provision, as a Percent of Net Sales Debt Instrument, Springing Maturity Date, days prior to maturity of Convertible Notes due 2024 Debt Instrument, Springing Maturity Date, days prior to maturity of Convertible Notes due 2024 Debt Instrument, Springing Maturity Date, days prior to maturity of Convertible Notes due 2024 Year 2 and on Year 2 and on [Member] Year 2 and on Product Liability Contingency [Table] Product Liability Contingency [Table] Installment Receivables, Long-Term Financing Receivable, before Allowance for Credit Loss, Noncurrent Convertible Senior Notes at 4.25% March 2026 Convertible Senior Notes at 4.25% March 2026 [Member] Convertible Senior Notes at 4.25% March 2026 Debt Disclosure [Abstract] Debt Disclosure [Abstract] Derivative, percentage of forcasted transactions with currency rate exposure Derivative, Percentage of Forcasted Transactions With Currency Rate Exposure Derivative, Percentage of Forcasted Transactions With Currency Rate Exposure Tax Period [Axis] Tax Period [Axis] 2018 Plan [Member] 2018 Plan [Member] 2018 Plan Property, Plant and Equipment by Type [Axis] Long-Lived Tangible Asset [Axis] Disposal Group, Including Discontinued Operation, Revenue Disposal Group, Including Discontinued Operation, Revenue Other Expense Other Expense [Member] Fair Value of Convertible Note Derivative Schedule of Convertible Note Derivatives [Table Text Block] Schedule of Convertible Note Derivatives Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Percentage of eligible Canadian inventory Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Percent Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Percent Debt Instrument, Convertible, Threshold Trading Days Debt Instrument, Convertible, Threshold Trading Days Vesting [Axis] Vesting [Axis] Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities Derivative, Amount of Hedged Item Derivative, Amount of Hedged Item Amount Available to Invacare Limited and Invacare Poirier SAS Amount Available to Invacare Limited and Invacare Poirier SAS [Member] Invacare Limited and Invacare Poirier SAS USD / CAD Foreign Exchange Forward CAD / USD [Member] Foreign Exchange Forward CAD / USD [Member] Total Assets Assets Assets Plan Name [Domain] Plan Name [Domain] Geographical [Domain] Geographical [Domain] Cost of Products Sold, as a Percent of Net Sales Cost of Products Sold, as a Percent of Net Sales Cost of Products Sold, as a Percent of Net Sales Financing Receivable Portfolio Segment Financing Receivable Portfolio Segment [Domain] Schedule of Installment Receivables Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Derivative Contract [Domain] Derivative Contract [Domain] Charges related to restructuring activities, as a Percent of Net Sales Charges related to restructuring activities, as a Percent of Net Sales Charges related to restructuring activities, as a Percent of Net Sales Direct write-offs charged against the allowance Financing Receivable, Allowance for Credit Loss, Writeoff Rate applicable period [Domain] Rate applicable period [Domain] Rate applicable period [Domain] Secured Revolving Credit and Security Agreement (ABL Credit Agreement) Secured Revolving Credit and Security Agreement (ABL Credit Agreement) [Member] Secured Revolving Credit and Security Agreement (ABL Credit Agreement) Schedule of Unrecognized Compensation Cost, Nonvested Awards Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block] Accrued Expenses Accounts Payable and Accrued Liabilities [Member] All Currencies [Domain] All Currencies [Domain] Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Operating Activities Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Furniture and fixtures Furniture and Fixtures [Member] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Net Loss per Share—Basic Earnings Per Share, Basic [Abstract] Disposal Group, Including Discontinued Operation, Other Assets Disposal Group, Including Discontinued Operation, Other Assets Lease Contractual Term [Domain] Lease Contractual Term [Domain] Loss per Share—Assuming Dilution Net earnings (loss) per per common share—assuming dilution (in dollars per share) Earnings Per Share, Diluted Weighted Average Shares Outstanding—Basic Average common shares outstanding Weighted Average Number of Shares Outstanding, Basic Segments [Domain] Segments [Domain] Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Sales [Member] Sales [Member] Debt Instrument, Hedge Options Debt Instrument, Hedge Options Debt Instrument, Hedge Options Debt Instrument, Amount Outstanding Debt Instrument, Amount Outstanding Debt Instrument, Amount Outstanding Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Intangibles, net Intangible Assets, Net (Excluding Goodwill) Comprehensive Loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive Income (Loss), Net of Tax, Attributable to Parent Severance Employee Severance [Member] Restructuring Reserve, Current Restructuring Reserve, Current Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Product Liability Contingency Product Liability Contingency [Line Items] Adoption of ASU 2020-06 Adoption of ASU 2020-06 Adoption of ASU 2020-06 Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] [Line Items] for Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table] Liability Components of Convertible 2026 Note Liability Components of Convertible 2026 Note [Table Text Block] Liability Components of Convertible 2026 Note Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments Schedule of Financing Receivables Financing Receivables [Table Text Block] Financing Receivables [Table Text Block] Schedule of Accounts Receivable Schedule of Accounts Receivable [Table Text Block] [Table Text Block] for Schedule of Accounts Receivable [Table] Service Services [Member] Services [Member] Retained Recourse Obligation For Events Of Default Under Contracts Concentration Risk, Retained Recourse Obligation For Default of Customer Lease Obligations Under Contract Concentration Risk, Retained Recourse Obligation For Default of Customer Lease Obligations Under Contract Subsegments [Domain] Subsegments [Domain] Accounts payable Accounts Payable, Current Disposal Group, Including Discontinued Operation, Earnings Before Taxes Disposal Group, Including Discontinued Operation, Earnings Before Taxes Disposal Group, Including Discontinued Operation, Earnings Before Taxes Depreciation and amortization Depreciation, Depletion and Amortization Collateral [Axis] Collateral Held [Axis] Additional amount after closing (round 4) [Domain] Additional amount after closing (round 4) [Member] Additional amount after closing (round 4) Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Net Sales, as a Percent of Net Sales Net Sales, as a Percent of Net Sales Net Sales, as a Percent of Net Sales AOCI Attributable to Parent [Member] AOCI Attributable to Parent [Member] Future amortization expense, remainder of fiscal year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Inventories, net Increase (Decrease) in Inventories Common Stock, Shares, Issued Common Stock, Shares, Outstanding Investments Long-term Investments Financial Instruments [Domain] Financial Instruments [Domain] Other Other Sundry Liabilities, Noncurrent Debt Instrument, Hedge Options available for exercise Debt Instrument, Hedge Options available for exercise Debt Instrument, Hedge Options available for exercise Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Credit Loss Status [Domain] Credit Loss Status [Domain] Class B Common Shares [Member] Class B Common Shares [Member] Common Class B [Member] Warranty Balance as of January 1, 2022 Balance as of September 30, 2022 Product Warranty Accrual, Current Entity Central Index Key Entity Central Index Key Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table] Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table] Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Schedule of Financing Receivables Past Due [Table] Financing Receivable, Past Due [Table] Restructuring and Related Activities, Expected Payout Period Restructuring and Related Activities, Expected Payout Period Restructuring and Related Activities, Expected Payout Period Exercise price range, upper limit (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Contract Type Sales Split Contract Type Sales Split Contract Type Sales Split Risk Level, Medium Risk Level, Medium [Member] Deferred income taxes Deferred Tax Assets, Tax Deferred Expense Concentration Of Credit Risk Concentration Risk Disclosure [Text Block] Prepaid and other current assets Other Prepaid Expense, Current Property And Equipment Property, Plant and Equipment Disclosure [Text Block] Other Long-Term Obligations Other Long-Term Obligations Other Liabilities, Noncurrent Freight Accrued Freight Expense, Current Freight Accrual, Current [Line Items] Schedule of Long-term Debt Instruments Schedule of Long-term Debt Instruments [Table Text Block] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Debt Instrument [Line Items] Debt Instrument [Line Items] Trading Symbol Trading Symbol Capital Lease Obligations Capital Lease Obligations Derivative assets Derivative Asset Series II Convertible Senior Notes at 5.00% November 2024 [Domain] Series II Convertible Senior Notes at 5.00% November 2024 b [Member] Series II Convertible Senior Notes at 5.00% November 2024 b Other current assets Increase (Decrease) in Other Operating Assets NZD / THB Foreign Exchange Forward NZD / THB [Member] Foreign Exchange Forward NZD / THB Derivative, Price Risk Option Strike Price Class of Warrant or Right, Exercise Price of Warrants or Rights Line of Credit Facility, Current Borrowing Capacity Line of Credit Facility, Current Borrowing Capacity 31-60 days past due Installment Receivable, 31 to 60 Days Past Due Installment Receivable, 31 to 60 Days Past Due Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset Long-Term Debt Long-term Debt, Excluding Current Maturities Defined Benefit Plans: Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent [Abstract] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Allocated Share-based Compensation Expense Share-based Payment Arrangement, Expense Revenue Recognition, Multiple-deliverable Arrangements [Line Items] Revenue Recognition, Multiple-deliverable Arrangements [Line Items] EUR / USD Foreign Exchange Forward EUR / USD [Member] Foreign Exchange Forward EUR / USD [Member] Financing Receivable, Gross Financing Receivable, Gross Financing Receivable, Gross Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Entities [Table] Entities [Table] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Payables and Accruals [Abstract] Payables and Accruals [Abstract] CARES Act Loan [Member] CARES Act Loan [Member] CARES Act Loan Cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Common Stock, Par or Stated Value Per Share Common Stock, Par or Stated Value Per Share Convertible due 2022 - Bond Hedge, Fair Value at Issuance Convertible due 2022 - Bond Hedge, Fair Value at Issuance Convertible due 2022 - Bond Hedge, Fair Value at Issuance Capitalized Software [Member] Capitalized Software [Member] Capitalized Software [Member] Current Assets Assets, Current [Abstract] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Debt Instrument, Maturity Date Range, Start Debt Instrument, Maturity Date Range, Start Historical Cost Finite-Lived Intangible Assets, Gross Risk Factor [Axis] Risk Factor [Axis] Risk Factor Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Deferred revenue Deferred Revenue, Current Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure EUR / THB Foreign Exchange Forward EUR / THB [Member] Foreign Exchange Forward EUR / THB Financing Lease, Cost Financing Lease, Cost Financing Lease, Cost Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Exercise Price Range [Domain] Other Comprehensive Loss Other Comprehensive Income (Loss), Net of Tax Fair Value, Measurements, Recurring Fair Value, Recurring [Member] Award requisite service period Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period Additional increase in borrowing capacity available Line of Credit Facility, Additional Borrowing Capacity Line of Credit Facility, Additional Borrowing Capacity Interest Interest Payable, Current Prepaid inventory and freight Prepaid Inventory Prepaid Inventory Measurement Basis [Axis] Measurement Basis [Axis] Future amortization expense, 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Five Other Current Assets Other Current Assets [Text Block] Revolving Credit and Security Agreement (New Credit Agreement) Revolving Credit and Security Agreement (Prior Credit Agreement) [Member] Revolving Credit and Security Agreement (Prior Credit Agreement) [Member] Convertible Senior Secured Notes at 5.68% July 2026 Convertible Senior Secured Notes at 5.68% July 2026 [Member] Convertible Senior Secured Notes at 5.68% July 2026 Credit amount requiring additional analysis Financing Receivable Credit Limit Financing Receivable Credit Limit Net Cash Used by Investing Activities Net Cash Provided by (Used in) Investing Activities Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Convertible Senior Notes, Additional Accrued interest in the Event of Failure to File Requirements under SEC Act of 1934 Convertible Senior Notes, Additional Accrued interest in the Event of Failure to File Requirements under SEC Act of 1934 Convertible Senior Notes, Additional Accrued interest in the Event of Failure to File Requirements under SEC Act of 1934 Allowance for doubtful accounts, long-term Financing Receivable, Allowance for Credit Loss, Noncurrent Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Credit Loss Status [Axis] Credit Loss Status [Axis] Class of Stock [Domain] Class of Stock [Domain] Euro Member Countries, Euro Euro Member Countries, Euro Borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Remaining borrowing capacity Line of Credit Facility, Covenant Feature, Increase Limit Line of Credit Facility, Covenant Feature, Increase Limit USD / DKK Foreign Exchange Forward DKK / USD [Member] Foreign Exchange Forward DKK / USD [Member] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Other current assets Other current assets Other Assets, Current Customer lists Customer Lists [Member] Debt Instrument, Loss on Exchange Debt Instrument, Loss on Exchange Debt Instrument, Loss on Exchange Divested Businesses [Abstract] Divested Businesses [Abstract] Divested Businesses [Abstract] Derivative liabilities Derivative Liability, Fair Value, Gross Liability Allowance for doubtful accounts Balance as of beginning of period Balance as of end of period Financing Receivable, Allowance for Credit Loss Options Outstanding - Number Outstanding at end of period (in shares) Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Sale Leaseback Transaction, Deferred Gain, Gross Sale Leaseback Transaction, Deferred Gain, Gross Risk Level, Low Risk Level, Low [Member] Cost of Sales [Member] Cost of Sales [Member] Rate applicable period [Axis] Rate applicable period [Axis] Rate applicable period DKK / SEK Foreign Exchange Forward DKK / SEK [Member] Foreign Exchange Forward DKK / SEK [Member] Common Shares Common Stock, Value, Outstanding Developed technology Developed Technology Rights [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Debt Instrument, Unamortized Discount Unamortized discount Debt Instrument, Unamortized Discount Round 1 funding (Initial closing) [Domain] Round 1 funding (Initial closing) [Member] Round 1 funding (Initial closing) Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Finite-Lived Intangible Assets [Table] Long-term Debt Long-term Debt [Text Block] EX-101.PRE 11 ivc-20220930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 12 ivc-20220930_g1.jpg begin 644 ivc-20220930_g1.jpg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ivc-20220930_g2.jpg begin 644 ivc-20220930_g2.jpg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end GRAPHIC 14 ivc-20220930_g3.jpg begin 644 ivc-20220930_g3.jpg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
  •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end GRAPHIC 15 ivc-20220930_g4.jpg begin 644 ivc-20220930_g4.jpg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end GRAPHIC 16 ivc-20220930_g5.jpg begin 644 ivc-20220930_g5.jpg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end GRAPHIC 17 ivc-20220930_g6.jpg begin 644 ivc-20220930_g6.jpg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end GRAPHIC 18 ivc-20220930_g7.jpg begin 644 ivc-20220930_g7.jpg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htm IDEA: XBRL DOCUMENT v3.22.2.2
    DEI Document - shares
    		 9 Months Ended
    Sep. 30, 2022
    Nov. 04, 2022
    Entity Information [Line Items]    
    Document Type 10-Q  
    Document Quarterly Report true  
    Document Period End Date Sep. 30, 2022  
    Document Transition Report false  
    Entity File Number 001-15103  
    Entity Registrant Name INVACARE CORPORATION  
    Entity Incorporation, State or Country Code OH  
    Entity Tax Identification Number 95-2680965  
    Entity Address, Address Line One One Invacare Way,  
    Entity Address, City or Town Elyria,  
    Entity Address, State or Province OH  
    Entity Address, Postal Zip Code 44035  
    City Area Code 440  
    Local Phone Number 329-6000  
    Title of 12(b) Security Common Shares, without par value  
    Trading Symbol IVC  
    Security Exchange Name NYSE  
    Entity Current Reporting Status Yes  
    Entity Interactive Data Current Yes  
    Entity Filer Category Accelerated Filer  
    Entity Small Business true  
    Entity Emerging Growth Company false  
    Entity Shell Company false  
    Entity Central Index Key 0000742112  
    Current Fiscal Year End Date --12-31  
    Document Fiscal Year Focus 2022  
    Document Fiscal Period Focus Q3  
    Amendment Flag false  
    Common Shares [Member]    
    Entity Information [Line Items]    
    Entity Common Stock, Shares Outstanding   37,754,335
    Class B Common Shares [Member]    
    Entity Information [Line Items]    
    Entity Common Stock, Shares Outstanding   3,667

    XML 20 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Condensed Consolidated Statement of Comprehensive Income (Loss) - USD ($)
    shares in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Statement of Comprehensive Income [Abstract]        
    Net Sales $ 170,408,000 $ 224,200,000 $ 560,413,000 $ 646,266,000
    Cost of products sold 139,029,000 163,890,000 433,323,000 470,500,000
    Gross Profit 31,379,000 60,310,000 127,090,000 175,766,000
    Selling, general and administrative expenses 55,365,000 56,135,000 174,552,000 178,721,000
    Charges related to restructuring activities 8,440,000 377,000 16,383,000 2,476,000
    Impairment of Intangible Assets (Excluding Goodwill) 1,012,000 0 1,012,000 0
    Goodwill, Impairment Loss 0 28,564,000 0 28,564,000
    Operating Loss (33,438,000) (24,766,000) (64,857,000) (33,995,000)
    Net gain on convertible debt derivatives (950,000) 0 (950,000) 0
    Net gain on debt extinguishment (6,398,000) (10,131,000) (6,398,000) (9,422,000)
    Interest expense 7,354,000 6,284,000 19,836,000 18,099,000
    Interest Income, Other 10,000 0 11,000 1,000
    Loss Before Income Taxes (33,434,000) (20,919,000) (77,334,000) (42,671,000)
    Income tax provision 920,000 1,840,000 3,160,000 4,830,000
    Net Loss $ (34,354,000) $ (22,759,000) $ (80,494,000) $ (47,501,000)
    Net Loss per Share—Basic        
    Net Loss per Share—Basic $ (0.92) $ (0.65) $ (2.23) $ (1.36)
    Weighted Average Shares Outstanding—Basic 37,537 35,013 36,073 34,826
    Loss per Share—Assuming Dilution        
    Loss per Share—Assuming Dilution [1] $ (0.92) $ (0.65) $ (2.23) $ (1.36)
    Weighted Average Shares Outstanding—Assuming Dilution 37,680 35,488 36,241 35,371
    Other comprehensive income (loss):        
    Foreign currency translation adjustments $ (34,051,000) $ (19,202,000) $ (66,938,000) $ (6,487,000)
    Defined Benefit Plans:        
    Amortization of prior service costs and unrecognized losses 45,000 (27,000) 4,608,000 (422,000)
    Deferred tax adjustment resulting from defined benefit plan activity (9,000) 20,000 (94,000) (43,000)
    Valuation reserve associated with defined benefit plan activity 9,000 (20,000) 94,000 43,000
    Current period gain (loss) on cash flow hedges (1,394,000) 1,423,000 298,000 649,000
    Deferred tax benefit (provision) related to gain on cash flow hedges 178,000 (170,000) (62,000) (73,000)
    Other Comprehensive Loss (35,222,000) (17,976,000) (62,094,000) (6,333,000)
    Comprehensive Loss $ (69,576,000) $ (40,735,000) $ (142,588,000) $ (53,834,000)
    [1] Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.
    XML 21 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Condensed Consolidated Balance Sheets - USD ($)
    $ in Thousands
    Sep. 30, 2022
    Jun. 30, 2022
    Dec. 31, 2021
    Sep. 30, 2021
    Jun. 30, 2021
    Dec. 31, 2020
    Current Assets            
    Cash and cash equivalents $ 45,439   $ 83,745      
    Trade receivables, net 80,105   117,115      
    Installment receivables, net 255   218      
    Inventories, net 120,687   144,274      
    Other current assets 48,338   40,036      
    Total Current Assets 294,824   385,388      
    Other Assets 5,330   5,362      
    Intangibles, net 23,390   26,356      
    Property and Equipment, net 53,244   60,921      
    Finance Lease, Right-of-Use Asset 56,083   63,029      
    Operating Lease, Right-of-Use Asset 9,980   12,600      
    Goodwill 314,755   355,875      
    Total Assets 757,606   909,531      
    Current Liabilities            
    Accounts payable 95,973   130,036      
    Accrued expenses 116,330   102,971      
    Current taxes payable 2,136   3,914      
    Current portion of long-term debt 2,150   3,107      
    Current portion of finance lease obligations 3,031   3,009      
    Current portion of operating lease obligations 3,062   4,217      
    Total Current Liabilities 222,682   247,254      
    Long-Term Debt 333,129   305,022      
    Finance Lease Long-Term Obligations 57,511   63,736      
    Operating Leases Long-Term Obligations 6,865   8,234      
    Other Long-Term Obligations 56,374   66,796      
    Shareholders’ Equity            
    Preferred Shares (Authorized 300 shares; none outstanding) 0   0      
    Additional paid-in-capital 281,130   276,665      
    Retained earnings (accumulated deficit) (57,849)   22,645      
    Accumulated other comprehensive income (loss) (45,106) $ (9,884) 16,988 $ 39,103 $ 57,079 $ 45,436
    Treasury Shares (4,535 and 4,397 shares at September 30, 2022 and December 31, 2021, respectively) (107,939)   (107,788)      
    Total Shareholders’ Equity 81,045 $ 147,604 218,489 $ 239,714 $ 280,890 $ 333,846
    Total Liabilities and Shareholders’ Equity 757,606   909,531      
    Common Shares [Member]            
    Shareholders’ Equity            
    Common Shares 10,807   9,977      
    Class B Common Shares [Member]            
    Shareholders’ Equity            
    Common Shares $ 2   $ 2      
    XML 22 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
    shares in Thousands, $ in Thousands
    Sep. 30, 2022
    Dec. 31, 2021
    Preferred Stock, Shares Authorized 300 300
    Preferred Stock, Shares Outstanding 0 0
    Treasury Stock, Shares 4,535 4,397
    Cash and cash equivalents $ 45,439 $ 83,745
    Operating Leases Long-Term Obligations 6,865 8,234
    Trade receivables, net 80,105 117,115
    Installment receivables, net 255 218
    Inventories, net 120,687 144,274
    Other current assets 48,338 40,036
    Assets, Current 294,824 385,388
    Other Assets 5,330 5,362
    Intangibles, net 23,390 26,356
    Property and Equipment, net 53,244 60,921
    Finance Lease, Right-of-Use Asset 56,083 63,029
    Operating Lease, Right-of-Use Asset 9,980 12,600
    Goodwill 314,755 355,875
    Assets 757,606 909,531
    Preferred Shares (Authorized 300 shares; none outstanding) 0 0
    Liabilities and Equity 757,606 909,531
    Accounts payable 95,973 130,036
    Accrued expenses 116,330 102,971
    Current taxes payable 2,136 3,914
    Current portion of long-term debt 2,150 3,107
    Current portion of finance lease obligations 3,031 3,009
    Current portion of operating lease obligations 3,062 4,217
    Liabilities, Current 222,682 247,254
    Long-Term Debt 333,129 305,022
    Finance Lease Long-Term Obligations 57,511 63,736
    Other Long-Term Obligations 56,374 66,796
    Treasury Stock, Value 107,939 107,788
    Accumulated other comprehensive income (loss) (45,106) 16,988
    Retained earnings (accumulated deficit) (57,849) 22,645
    Additional paid-in-capital 281,130 276,665
    Total Shareholders’ Equity $ 81,045 $ 218,489
    Common Shares [Member]    
    Common Stock, Shares Authorized 150,000 150,000
    Common Stock, Shares, Issued 42,328 39,416
    Common Shares $ 10,807 $ 9,977
    Class B Common Shares [Member]    
    Common Stock, Shares Authorized 12,000 12,000
    Common Stock, Shares, Issued 4 4
    Common Shares $ 2 $ 2
    XML 23 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Condensed Consolidated Statement Of Cash Flows - USD ($)
    		 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Purchases of capped calls $ 0 $ (18,787,000)
    Convertible Debt Discount Amortization and Accretion 2,864,000 2,637,000
    Goodwill, Impairment Loss 0 28,564,000
    Inventory Write-down 8,651,000 0
    Cash and cash equivalents 45,439,000 73,656,000
    Effect of exchange rate changes on cash (4,863,000) (133,000)
    Impairment of Intangible Assets (Excluding Goodwill) 1,012,000 0
    Provision (benefit) for deferred income taxes 33,000 (148,000)
    Provision for Doubtful Accounts 715,000 327,000
    Net gain on convertible debt derivatives 950,000 0
    Operating Activities    
    Net loss (80,494,000) (47,501,000)
    Adjustments to reconcile net loss to net cash used by operating activities:    
    Depreciation and amortization 11,796,000 12,511,000
    Amortization of operating lease right of use assets 3,749,000 4,757,000
    Provision for losses on trade and installment receivables 715,000 327,000
    Provision (benefit) for deferred income taxes 33,000 (148,000)
    Provision (benefit) for other deferred liabilities (738,000) 165,000
    Provision for equity compensation 1,839,000 5,369,000
    Loss (gain) on disposals of property and equipment 216,000 (232,000)
    Net gain on debt extinguishment (6,398,000) (9,422,000)
    Amortization of debt fees 1,676,000 1,622,000
    Changes in operating assets and liabilities:    
    Trade receivables 29,087,000 (8,030,000)
    Installment sales contracts, net 296,000 222,000
    Inventories, net 5,969,000 (37,199,000)
    Other current assets (7,784,000) 8,215,000
    Accounts payable (26,160,000) 24,769,000
    Accrued expenses 11,714,000 (24,182,000)
    Other long-term liabilities (3,967,000) 731,000
    Net Cash Provided by (Used in) Operating Activities (46,874,000) (36,825,000)
    Investing Activities    
    Purchases of property and equipment (3,302,000) (14,397,000)
    Proceeds from sale of property and equipment 5,000 23,000
    Change in other long-term assets (77,000) (93,000)
    Other 539,000 0
    Net Cash Used by Investing Activities (3,913,000) (14,467,000)
    Financing Activities    
    Proceeds from revolving lines of credit and long-term borrowings 84,693,000 154,830,000
    Repurchases of convertible debt, payments on revolving lines of credit and finance leases (59,152,000) (109,139,000)
    Payment of financing costs (8,046,000) (5,369,000)
    Purchases of capped calls 0 (18,787,000)
    Purchases of treasury shares (151,000) (1,752,000)
    Net Cash Provided by Financing Activities 17,344,000 19,783,000
    Effect of exchange rate changes on cash (4,863,000) (133,000)
    Cash, Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (38,306,000) (31,642,000)
    Cash and cash equivalents at beginning of year 83,745,000 105,298,000
    Cash and cash equivalents at end of period $ 45,439,000 $ 73,656,000
    XML 24 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Condensed Consolidated Statement of Shareholders' Equity Statement - USD ($)
    Total
    Common Stock [Member]
    Common Stock [Member]
    Class B Common Shares [Member]
    Additional Paid-in Capital [Member]
    Retained Earnings [Member]
    AOCI Attributable to Parent [Member]
    Treasury Stock [Member]
    Total Shareholders’ Equity at Dec. 31, 2020 $ 333,846,000 $ 9,816,000 $ 2,000 $ 326,088,000 $ 58,538,000 $ 45,436,000 $ (106,034,000)
    Purchases of capped calls (18,787,000)            
    Total Shareholders’ Equity at Jun. 30, 2021 280,890,000 9,977,000 2,000 278,152,000 43,466,000 57,079,000 (107,786,000)
    Total Shareholders’ Equity at Dec. 31, 2020 333,846,000 9,816,000 2,000 326,088,000 58,538,000 45,436,000 (106,034,000)
    Allocated Share-based Compensation Expense 131,000 52,000   747,000     (668,000)
    Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 3,486,000 109,000   4,461,000     (1,084,000)
    Net Loss (47,501,000)       (47,501,000)    
    Foreign currency translation adjustments (6,487,000)            
    Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (6,487,000)            
    Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 576,000         576,000  
    Amortization of prior service costs and unrecognized losses (422,000)            
    Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax (422,000)            
    Comprehensive Income (Loss), Net of Tax, Attributable to Parent (53,834,000)            
    Adoption of ASU 2020-06 (25,128,000)     (34,798,000) 9,670,000    
    Purchases of capped calls (18,787,000)     (18,787,000)      
    Total Shareholders’ Equity at Sep. 30, 2021 239,714,000 9,977,000 2,000 277,711,000 20,707,000 39,103,000 (107,786,000)
    Total Shareholders’ Equity at Jun. 30, 2021 280,890,000 9,977,000 2,000 278,152,000 43,466,000 57,079,000 (107,786,000)
    Allocated Share-based Compensation Expense (1,250,000) 0   (1,250,000)     0
    Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 809,000 0   809,000     0
    Net Loss (22,759,000)       (22,759,000)    
    Foreign currency translation adjustments (19,202,000)            
    Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (19,202,000)            
    Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 1,253,000         1,253,000  
    Amortization of prior service costs and unrecognized losses (27,000)            
    Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax (27,000)            
    Comprehensive Income (Loss), Net of Tax, Attributable to Parent (40,735,000)            
    Total Shareholders’ Equity at Sep. 30, 2021 239,714,000 9,977,000 2,000 277,711,000 20,707,000 39,103,000 (107,786,000)
    Total Shareholders’ Equity at Dec. 31, 2021 218,489,000 9,977,000 2,000 276,665,000 22,645,000 16,988,000 (107,788,000)
    Allocated Share-based Compensation Expense (814,000) 0   (814,000)     0
    Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 2,502,000 155,000   2,498,000     (151,000)
    Net Loss (80,494,000)       (80,494,000)    
    Foreign currency translation adjustments (66,938,000)            
    Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (66,938,000)            
    Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 236,000         236,000  
    Amortization of prior service costs and unrecognized losses 4,608,000            
    Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax 4,608,000            
    Comprehensive Income (Loss), Net of Tax, Attributable to Parent (142,588,000)            
    Stock Issued During Period, Value, New Issues 3,456,000 675,000   2,781,000      
    Purchases of capped calls 0            
    Total Shareholders’ Equity at Sep. 30, 2022 81,045,000 10,807,000 2,000 281,130,000 (57,849,000) (45,106,000) (107,939,000)
    Total Shareholders’ Equity at Jun. 30, 2022 147,604,000 10,132,000 2,000 278,788,000 (23,495,000) (9,884,000) (107,939,000)
    Allocated Share-based Compensation Expense (495,000) 0   (495,000)     0
    Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 56,000 0   56,000     0
    Net Loss (34,354,000)       (34,354,000)    
    Foreign currency translation adjustments (34,051,000)            
    Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (34,051,000)            
    Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax (1,216,000)         (1,216,000)  
    Amortization of prior service costs and unrecognized losses 45,000            
    Comprehensive Income (Loss), Net of Tax, Attributable to Parent (69,576,000)            
    Stock Issued During Period, Value, New Issues 3,456,000 675,000   2,781,000      
    Total Shareholders’ Equity at Sep. 30, 2022 $ 81,045,000 $ 10,807,000 $ 2,000 $ 281,130,000 $ (57,849,000) $ (45,106,000) $ (107,939,000)
    XML 25 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Accounting Policies
    		 9 Months Ended
    Sep. 30, 2022
    Accounting Policies [Abstract]  
    Accounting Policies Accounting Policies
    Principles of Consolidation: The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2022 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2022 and 2021, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year.

    Use of Estimates: The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.

    Recent Accounting Pronouncements (Already Adopted): 
    In March 2020, the FASB issued ASU 2020-04 "Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting," which is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burden related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates if certain criteria are met. The guidance may be adopted in any period prior to the guidance expiration on December 31, 2022.
    The company adopted ASU 2020-04 effective January 1, 2022 and the adoption did not have a material impact on the company's financial statements. Interest arrangements previously referring to LIBOR prior to adoption, now refer to a secured overnight finance rate (SOFR).
    XML 26 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Receivables
    		 9 Months Ended
    Sep. 30, 2022
    Receivables [Abstract]  
    Receivables
    Receivables

    Receivables consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Accounts receivable, gross$99,780 $142,806 
    Customer rebate reserve(8,722)(12,267)
    Cash discount reserves(7,174)(9,179)
    Allowance for doubtful accounts(3,214)(3,642)
    Other, principally returns and allowances reserves(565)(603)
    Accounts receivable, net$80,105 $117,115 

    Reserves for customer rebates and cash discounts are recorded as a reduction in revenue and netted against gross accounts receivable. Customer rebates in excess of a given customer's accounts receivable balance are classified in Accrued Expenses. Customer rebates and cash discounts are estimated based on the most likely amount principle as well as historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such, the company estimates the expected returns based on an analysis of historical experience and adjusts revenue accordingly.

    During the third quarter of 2021, the company entered into an agreement with a bank to sell certain trade receivables with governmental entity customers in the Nordic region without recourse. Under ASC 860, the sale of the receivables qualify as a true sale and not a secured borrowing. No gain or loss was recorded on the sale of the receivables. Bank charges, which are recorded as interest expense attributable to the program, were immaterial for the nine months ended September 30, 2022.

    Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities predominantly located throughout the United States, Australia, Canada, New Zealand and Europe. A significant portion of products sold to providers, both foreign and domestic, are ultimately funded through government reimbursement programs such as Medicare and Medicaid in the U.S. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability.

    The company's approach is to separate its receivables into good-standing and collection receivables. Good-standing
    receivables are assigned to risk pools of high, medium and low. The risk pools are driven by the specifics associated with the geography of origination. Expected loss percentages are calculated and assigned to each risk pool, driven primarily by historical experience. The historical loss percentages are calculated for each risk pool and then judgmentally revised to consider current risk factors as well as consideration of the impact of forecasted events, as applicable. The expected loss percentages are then applied to receivables balances each period to determine the allowance for doubtful accounts.

    In North America, excluding Canada, good-standing receivables are assigned to the low risk pool and assigned an expected loss percentage of 1.0% as these receivables are deemed to share the same risk profile and collections efforts are the same. Installment receivables in North America are characterized as collection receivables and thus reserves are based on specific analysis of each customer. In Canada, good-standing receivables are deemed low risk and assigned a loss percentage of 0.1%.

    In Europe, expected losses are determined by each location in each region. Most locations have a majority of their receivables assigned to the low risk pool, which has an average expected loss percentage of 0.3%. About half of the locations have a portion of their receivables assigned as medium risk with an average expected loss percentage of 0.7%. Only a few locations have any receivables characterized as high risk and the average credit loss percentage for those locations is 2.8%. Collection risk is generally low as payment terms in certain key markets, such as Germany, are immediate and in many locations the ultimate customer is the government.

    In the Asia Pacific region, receivables are characterized as low risk, which have an average expected loss percentage of 1.0%. Historical losses are low in this region where the use of credit insurance is often customary.


    The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):
     Nine Months Ended
    September 30, 2022
    Balance as of beginning of period$3,642 
    Current period provision715 
    Recoveries (direct write-offs), net(1,143)
    Balance as of end of period$3,214 

    The company did not make any material changes to the assignment of receivables to the different risk pools or to the expected loss reserves in the quarter. The company is monitoring the impacts of the COVID-19 pandemic and the possibility for an impact on collections, but to date this has not materially impacted 2022.

    For collections receivables, the estimated allowance for uncollectible amounts is based primarily on management’s evaluation of the financial condition of each customer. In addition, as a result of the company's financing arrangement with DLL, a third-party financing company which the company has worked with since 2000, management monitors the collection status of these contracts in accordance with the company’s limited recourse obligations and provides amounts necessary for estimated losses in the allowance for doubtful accounts and establishes reserves for specific customers as needed.

    The company writes off uncollectible trade accounts receivable after such receivables are moved to collection status and legal remedies are exhausted. Refer to Concentration of Credit Risk in the notes to the condensed consolidated financial statements for a description of the financing arrangement. Long-term installment receivables are included in “Other Assets” on the condensed consolidated balance sheets.

    The company has recorded a contingent liability in the amount of $393,000 related to the contingent aspect of the company's guarantee associated with its arrangement with DLL. The contingent liability is recorded applying the same expected loss model used for the trade and installment receivables recorded on the company's books. Specifically, historical loss history is used to determine the expected loss percentage, which is then adjusted judgmentally to consider other factors, as needed.

    The company’s U.S. customers electing to finance their purchases can do so using DLL. Repurchased DLL receivables recorded on the books of the company represent a single portfolio segment of receivables to the independent provider channel and long-term care customers. The portfolio segment
    of these receivables are distinguished by geography and credit quality. These receivables were repurchased from DLL because the customers were in default. Default with DLL is defined as a customer being delinquent by three payments.

    The estimated allowance for uncollectible amounts and evaluation for both classes of installment receivables is based on the company’s quarterly review of the financial condition of each individual customer with the allowance for doubtful accounts adjusted accordingly. Installments are individually and not collectively reviewed. The company assesses the bad debt reserve levels based upon the status of the customer’s adherence to a legally negotiated payment schedule and the company’s ability to enforce judgments, liens, etc.

    For purposes of granting or extending credit, the company utilizes a scoring model to generate a composite score that considers each customer’s consumer credit score and/or D&B credit rating, payment history, security collateral and time in business. Additional analysis is performed for most customers desiring credit greater than $250,000, which generally includes a detailed review of the customer’s financial statements as well as consideration of other factors such as exposure to changing reimbursement laws.

    Interest income is recognized on installment receivables based on the terms of the installment agreements. Installment accounts are monitored and if a customer defaults on payments and is moved to collection, interest income is no longer recognized. Subsequent payments received once an account is put on non-accrual status are generally first applied to the principal balance and then to the interest. Accruing of interest on collection accounts would only be restarted if the account became current again.

    All installment accounts are accounted for using the same methodology regardless of the duration of the installment agreements. When an account is placed in collection status, the company goes through a legal process for pursuing collection of outstanding amounts, the length of which typically approximates eighteen months. Any write-offs are made after the legal process has been completed.
    Installment receivables consist of the following (in thousands):
     September 30, 2022December 31, 2021
     CurrentLong-TermTotalCurrentLong-TermTotal
    Installment receivables$255 $274 $529 $218 $734 $952 
    Allowance for doubtful accounts— — — — — — 
    Installment receivables, net$255 $274 $529 $218 $734 $952 
    No sales of installment receivables were recorded by the company in 2022.

    The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):
     Nine Months Ended September 30, 2022Year Ended December 31, 2021
    Balance as of beginning of period$— $487 
    Current period provision (benefit)— (75)
    Direct write-offs charged against the allowance— (412)
    Balance as of end of period$— $— 
     
    Installment receivables by class as of September 30, 2022 consist of the following (in thousands):
     Total
    Installment
    Receivables    		Unpaid
    Principal
    Balance    		Related
    Allowance for
    Doubtful
    Accounts    		Interest
    Income
    Recognized
    Asia Pacific
    Non-Impaired installment receivables with no related allowance recorded529 529 — — 
    Total
    Non-Impaired installment receivables with no related allowance recorded529 529 — — 
    Impaired installment receivables with a related allowance recorded— — — — 
    Total installment receivables$529 $529 $— $— 
    Installment receivables by class as of December 31, 2021 consist of the following (in thousands):
     Total
    Installment
    Receivables    		Unpaid
    Principal
    Balance    		Related
    Allowance for
    Doubtful
    Accounts    		Interest
    Income
    Recognized
    Asia Pacific
    Non-impaired installment receivables with no related allowance recorded952 952 — — 
    Total installment receivables$952 $952 $— $— 

    The aging of the company’s installment receivables was as follows (in thousands):
    September 30, 2022December 31, 2021
    TotalAsia PacificTotalAsia Pacific
    Current$529 $529 $952 $952 
    0-30 days past due— — — — 
    31-60 days past due— — — — 
    61-90 days past due— — — — 
    90+ days past due— — — — 
    $529 $529 $952 $952 
    XML 27 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Inventories
    		 9 Months Ended
    Sep. 30, 2022
    Inventory Disclosure [Abstract]  
    Inventories
    Inventories, Net

    Inventories consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Raw materials$60,082 $69,371 
    Finished goods49,270 62,124 
    Work in process11,335 12,779 
    Inventories, net$120,687 $144,274 
    XML 28 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Other Current Assets
    		 9 Months Ended
    Sep. 30, 2022
    Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
    Other Current Assets
    Other Current Assets


    Other current assets consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Tax receivables principally value added taxes$29,152 $21,943 
    Prepaid insurance3,045 4,462 
    Prepaid inventory and freight2,938 2,394 
    Derivatives (foreign currency forward exchange contracts)2,626 386 
    Recoverable income taxes2,440 2,301 
    Service contracts682 304 
    Receivable due from information technology provider612 612 
    Deferred financing fees323 379 
    Prepaid and other current assets6,520 7,255 
    Other Current Assets$48,338 $40,036 
    XML 29 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Other Long-Term Assets
    		 9 Months Ended
    Sep. 30, 2022
    Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
    Other Long-Term Assets
    Other Long-Term Assets


    Other long-term assets consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Cash surrender value of life insurance policies$2,551 $2,481 
    Deferred income taxes1,615 1,540 
    Deferred financing fees726 409 
    Installment receivables274 734 
    Investments85 86 
    Other79 112 
    Other Long-Term Assets$5,330 $5,362 
    XML 30 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Property And Equipment
    		 9 Months Ended
    Sep. 30, 2022
    Property, Plant and Equipment [Abstract]  
    Property And Equipment
    Property and Equipment
    Property and equipment consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Machinery and equipment$267,218 $278,347 
    Capitalized software30,904 30,448 
    Land, buildings and improvements24,432 27,299 
    Furniture and fixtures7,970 8,943 
    Leasehold improvements4,730 6,782 
    Property and Equipment, gross335,254 351,819 
    Accumulated depreciation(282,010)(290,898)
    Property and Equipment, net$53,244 $60,921 

    Machinery and equipment includes demonstration units placed in provider locations which are depreciated to their estimated recoverable values over their estimated useful lives.

    In the fourth quarter of 2019, the company initiated the first stage of an Enterprise Resource Planning ("ERP") software implementation. Related to the ERP project, the company capitalized certain costs in accordance with ASC 350 as shown in capitalized software above. The net book value of capitalized software was $26,833,000 and $28,715,000 at September 30, 2022 and December 31, 2021, respectively. Depreciation expense related to capitalized software started in 2021 and was $832,000 and $2,342,000 for the three and nine months ended September 30, 2022, respectively, compared to $419,000 and $1,084,000 for the three and nine months ended September 30, 2021, respectively.




    Unpaid purchases of property and equipment at September 30, 2022 and December 31, 2021 were $0 and $1,090,000, respectively and are excluded from purchases of property and equipment on the condensed consolidated statements of cash flows for the periods ending and are included in subsequent periods when paid.
    XML 31 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Goodwill
    		 9 Months Ended
    Sep. 30, 2022
    Goodwill and Intangible Assets Disclosure [Abstract]  
    Goodwill
    Goodwill
    The change in goodwill from December 31, 2021 to September 30, 2022 was due to foreign currency translation.
    In accordance with Intangibles—Goodwill and Other, ASC 350, goodwill is tested annually for impairment or whenever events or changes in circumstances indicate the carrying value of a reporting unit could be above its fair value. A reporting unit is defined as an operating segment or one level below. The company has determined that its reporting units are North America, Europe and Asia Pacific.
    During the three months ended September 30, 2022, a continued decline in the share price of the company's Common Shares sustained the company's market capitalization below the carrying value of shareholders' equity. Further, inputs used in estimating the weighted average cost of capital ("WACC") had moved unfavorably to increase the WACC used in a discounted cash flows model. The combination of these and other developments were identified as a triggering event and the company proceeded with a quantitative goodwill impairment assessment of its Europe reporting unit (the only reporting unit with goodwill).
    A quantitative goodwill impairment assessment was performed as of September 30, 2022, utilizing a discounted cash flows methodology. Key assumptions used in the discounted cash flow analysis included, but were not limited to, a WACC of approximately 14.51%, terminal growth rates and financial projections of performance and cash flows. Components of the WACC include quoted rates for 20-year debt of potential acquirer companies with similar credit risk and the cost of equity based on the 20-year treasury rate for the risk free rate, a market risk premium, an industry average beta and a small cap stock adjustment. The assumptions are based on a market participant's point of view and thus these inputs are deemed Level III inputs in regard to the fair value hierarchy. The WACC used in the 2021 annual assessment was 11.19%. The WACC used has a significant impact in the outcome of the discounted cash flow methodology utilized in the company's impairment assessment as a higher WACC would decrease fair value estimates.
    The company also utilized an Enterprise Value ("EV") to Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA") method to compute the fair value of reporting units which considers potential acquirers and their EV to EBITDA multiples adjusted by an estimated premium. The EV method is used to corroborate fair values but more weight is placed on the discounted cash flow method results.
    The company concluded based on the results of the interim quantitative goodwill impairment assessment
    performed as of September 30, 2022 that goodwill was not impaired.
    The valuation of goodwill can differ materially if financial projections or market inputs used to determine the WACC change significantly. For instance, higher interest rates or greater stock price volatility would increase the WACC and thus increase the chance of impairment. Assumptions used in the quantitative assessment require significant judgements and estimates which are inherently uncertain. If actual results are materially lower than estimates, it could result in a material impact on the consolidated financial statements in future periods. In addition, business changes impacting the company's assessment of reporting units could also have a material impact on impairment assessment results. For instance, higher interest rates or greater stock price volatility would increase the WACC and thus increase the chance of impairment. In consideration of this potential, the company assessed the results if the discount rate used were 100 basis points higher for the third quarter quantitative assessment and determined that there still would not be impairment of goodwill for the Europe reporting unit.
    The company completed an interim test of the North America reporting unit in the third quarter of 2021 which resulted in impairment of $28,564,000.

    Refer to Goodwill in the company's Annual Report on Form 10-K for the period ending December 31, 2021 for further disclosure regarding the company's annual impairment assessment methodology.
    XML 32 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Intangibles
    		 9 Months Ended
    Sep. 30, 2022
    Goodwill and Intangible Assets Disclosure [Abstract]  
    Other Intangibles
    Intangibles

    The company's intangibles consist of the following (in thousands):
     
     September 30, 2022December 31, 2021
     Historical
    Cost    		Accumulated
    Amortization    		Historical
    Cost    		Accumulated
    Amortization
    Customer lists$47,041 $47,041 $52,447 $52,447 
    Trademarks20,447 — 24,137 — 
    Developed technology6,973 6,648 7,652 7,149 
    Patents5,471 5,471 5,543 5,543 
    License agreements3,967 1,356 2,905 1,196 
    Other1,148 1,141 1,147 1,140 
    Intangibles$85,047 $61,657 $93,831 $67,475 
    All of the company’s intangible assets have been assigned definite lives and continue to be amortized over their useful lives, except for trademarks shown above, which have indefinite lives.

    The changes in intangible balances reflected on the balance sheet from December 31, 2021 to September 30, 2022 were primarily the result of foreign currency translation on historical cost and accumulated amortization as well as new license agreements.
    The company evaluates the carrying value of definite-lived assets annually in the fourth quarter and whenever events or circumstances indicate possible impairment.
    Definite-lived assets are determined to be impaired if the future undiscounted cash flows expected to be generated by the asset are less than the carrying value. Actual impairment amounts for definite-lived assets are then calculated using a discounted cash flow calculation.
    Any impairment for indefinite-lived intangible assets is calculated as the difference between the future discounted cash flows expected to be generated by the asset and the carrying value of the asset.
    Amortization expense related to intangible assets was $358,000 in the first nine months of 2022 and is expected to be $510,000 in 2022, $612,000 in 2023, $547,000 in 2024, $439,000 in 2025, $437,000 in 2026 and $311,000 in 2027. Amortized intangible assets are being amortized on a straight-line basis over remaining lives of 2 to 7 years with a weighted average remaining life of approximately 5.8 years.
    During the third quarter of 2022, the company recognized an intangible impairment charge in the North America segment of $1,012,000 related to a trademark with an indefinite life the company determined it would no longer use.
    XML 33 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Accrued Expenses
    		 9 Months Ended
    Sep. 30, 2022
    Payables and Accruals [Abstract]  
    Accrued Expenses
    Accrued Expenses

    Accrued expenses consist of accruals for the following (in thousands):
    September 30, 2022December 31, 2021
    Taxes other than income taxes, primarily value added taxes$32,221 $23,217 
    Salaries and wages17,177 24,012 
    Professional11,759 8,697 
    Warranty8,576 11,198 
    Freight5,918 5,460 
    Interest5,197 3,297 
    Derivative liabilities (foreign currency forward exchange contracts)4,890 1,938 
    Rebates4,782 6,569 
    IT service contracts4,000 4,013 
    Insurance3,837 625 
    Severance3,450 400 
    Product line exit obligations3,264 — 
    Product liability, current portion2,620 2,362 
    Deferred revenue1,903 4,156 
    Supplemental executive retirement program liability391 391 
    Other items, principally trade accruals6,345 6,636 
    Accrued Expenses$116,330 $102,971 
    Generally, the company's products are covered by warranties against defects in material and workmanship for various periods depending on the product from the date of sales to the customer. Certain components carry a lifetime warranty. A provision for estimated warranty cost is recorded at the time of sale based upon actual experience. In addition, the company has sold extended warranties that, while immaterial, require the company to defer the revenue associated with those warranties until earned. The company has established procedures to appropriately defer such revenue. The company continuously assesses the adequacy of its product warranty accrual and makes adjustments as needed. Historical analysis is primarily used to determine the company's warranty reserves. Claims history is reviewed and provisions are adjusted as needed. However, the company does consider other events, such as a product field action and recalls, which could require additional warranty reserve provision.







    Accrued rebates relate to several volume incentive programs the company offers its customers. The company accounts for these rebates as a reduction of revenue when the products are sold. Rebates are netted against gross accounts receivables. If rebates are in excess of such receivables, they are then classified as accrued expenses. The reduction in accrued rebates from December 31, 2021 to September 30, 2022 primarily relates to payments principally made in the first quarter each year, earned from the previous year.
















    The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):
    Balance as of January 1, 2022$11,198 
    Warranties provided during the period1,842 
    Settlements made during the period(4,596)
    Changes in liability for pre-existing warranties during the period, including expirations132 
    Balance as of September 30, 2022$8,576 
    Warranty reserves are subject to adjustment in future periods as new developments change the company's estimate of the total cost. Lower balance at September 30, 2022 is primarily attributable to favorable claim development and lower sales.
    XML 34 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Long-Term Debt
    		 9 Months Ended
    Sep. 30, 2022
    Debt Disclosure [Abstract]  
    Long-term Debt
    Long-Term Debt

    Debt consists of the following (in thousands):
    September 30, 2022December 31, 2021
    Convertible senior notes at 4.50%, due in June 2022— 2,642 
    Convertible senior notes Series I at 5.00%, due in November 202472,341 72,140 
    Convertible senior notes Series II at 5.00%, due in November 202475,764 78,251 
    Convertible senior notes at 4.25%, due in March 202680,898 119,036 
    Secured convertible senior notes at 5.68%, due in July 202627,463 — 
    Term loan, due in July 202659,724 — 
    Other obligations19,089 36,060 
    335,279 308,129 
    Less current maturities of long-term debt(2,150)(3,107)
    Long-Term Debt$333,129 $305,022 
    On September 30, 2015, the company entered into an Amended and Restated Revolving Credit and Security Agreement, which was subsequently amended (the “Prior Credit Agreement”) and which was to mature on January 16, 2024. The Prior Credit Agreement was entered into by and among the company, certain of the company’s direct and indirect U.S. and Canadian subsidiaries and certain of the company’s European subsidiaries, certain other of the company’s direct and indirect U.S., Canadian and European subsidiaries, and PNC Bank, National Association (“PNC”), JPMorgan Chase Bank, N.A., J.P. Morgan Europe Limited, KeyBank National Association, and Citizens Bank, National Association. PNC was the administrative agent (the “Prior Credit Agreement Administrative Agent”) and J.P. Morgan Europe Limited is the European agent (the “European Agent”) under the Prior Credit Agreement. As discussed further below, the Prior Credit Agreement was amended and restated ("the ABL Credit Agreement") on July 26, 2022.

    The company had outstanding letters of credit of $3,576,000 and $3,450,000 as of September 30, 2022 and December 31, 2021, respectively. Outstanding letters of credit and other reserves impacting borrowing capacity were $4,902,000 and $2,585,000 as of September 30, 2022 and December 31, 2021, respectively.

    The company had outstanding borrowings of $16,900,000 under its ABL Credit Agreement as of September 30, 2022. The company had outstanding borrowings of $22,150,000 under its North America Credit Facility under the Prior Credit Agreement as of December 31, 2021. The company had outstanding borrowings of $7,366,000 (€6,500,000) under its
    French Credit Facility and $5,986,000 (£4,500,000) under its UK Credit Facility under its Prior Credit Agreement as of December 31, 2021, together referred to as the European Credit Facility. No borrowings were outstanding under the European Credit Facility as of September 30, 2022 as it was terminated July 26, 2022.

    North America Borrowers Credit Facility

    For the company's North America Borrowers, the Prior Credit Agreement provided for an asset-based-lending senior secured revolving credit facility which was secured by substantially all the company’s U.S. and Canadian assets, other than real estate. The Prior Credit Agreement provided the company and the other Borrowers with a credit facility in an aggregate principal amount of $60,000,000, subject to availability based on a borrowing base formula, under a senior secured revolving credit, letter of credit and swing line loan facility (the “North America Credit Facility”). Up to $20,000,000 of the North America Credit Facility was available for issuance of letters of credit. The aggregate principal amount of the North America Credit Facility could have been increased by up to $25,000,000 to the extent requested by the company and agreed to by any lender or new financial institution approved by the Prior Credit Agreement Administrative Agent.

    The aggregate borrowing availability under the North America Credit Facility was determined based on a borrowing base formula. The aggregate usage under the North America Credit Facility could not exceed an amount equal to the sum of (a) 85% of eligible U.S. accounts receivable plus (b) the lesser
    of (i) 70% of eligible U.S. inventory and eligible foreign in-transit inventory and (ii) 85% of the net orderly liquidation value of eligible U.S. inventory and eligible foreign in-transit inventory (not to exceed $4,000,000), plus (c) the lesser of (i) 80% of the net orderly liquidation value of U.S. eligible machinery and equipment and (ii) $0 as of September 30, 2022 (subject to reduction as provided in the Prior Credit Agreement), plus (d) 85% of eligible Canadian accounts receivable, plus (e) the lesser of (i) 70% of eligible Canadian inventory and (ii) 85% of the net orderly liquidation value of eligible Canadian inventory, less (f) swing loans outstanding under the North America Credit Facility, less (g) letters of credit issued and undrawn under the North America Credit Facility, less (h) a $3,000,000 minimum availability reserve, less (i) other reserves required by the Prior Credit Agreement Administrative Agent, and in each case subject to the definitions and limitations in the Prior Credit Agreement.

    Interest accrued on outstanding indebtedness under the Prior Credit Agreement at the SOFR rate, plus a margin ranging from 2.25% to 2.75%, or at the alternate base rate, plus a margin ranging from 1.25% to 1.75%, as selected by the company. Borrowings under the North America Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization.

    The Prior Credit Agreement contained customary representations, warranties and covenants. Exceptions to the operating covenants in the Prior Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale and leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Prior Credit Agreement, as amended. The Prior Credit Agreement also contained a covenant requiring the company to maintain minimum availability under the North America Credit Facility of not less than (i) 12.5% of the maximum amount that may be drawn under the North America Credit Facility for five (5) consecutive business days, or (ii) 11.25% of the maximum amount that may be drawn under the North America Credit Facility on any business day. The company also is subject to dominion triggers under the North America Credit Facility requiring the company to maintain borrowing capacity of not less than $7,500,000 on any business day or any five consecutive days in order to avoid triggering full control by an agent for the lenders of the company's cash receipts for application to the company’s obligations under the agreement.

    The Prior Credit Agreement contained customary default provisions, with certain grace periods and exceptions, which provide for events of default that include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical
    reimbursement program, and an interruption of any material manufacturing facilities for more than 10 consecutive days. The proceeds of the North America Credit Facility were used to finance the working capital and other business needs of the company. There was $16,900,000 of outstanding borrowings under the North America Credit Facility on September 30, 2022.

    European Credit Facility

    The Prior Credit Agreement also provided for a revolving credit, letter of credit and swing line loan facility which gives the company and the European Borrowers the ability to borrow up to an aggregate principal amount of $30,000,000, with a $5,000,000 sublimit for letters of credit and a $2,000,000 sublimit for swing line loans (the “European Credit Facility”). Up to $15,000,000 of the European Credit Facility was available to each of Invacare Limited (the “UK Borrower”) and Invacare Poirier SAS (the “French Borrower” and, together with the UK Borrower, the “European Borrowers”). The European Credit Facility was terminated on July 26, 2022.

    The aggregate borrowing availability for each European Borrower under the European Credit Facility is determined based on a borrowing base formula. The aggregate borrowings of each of the European Borrowers under the European Credit Facility may not exceed an amount equal to (a) 85% of the European Borrower’s eligible accounts receivable, less (b) the European Borrower’s borrowings and swing line loans outstanding under the European Credit Facility, less (c) the European Borrower’s letters of credit issued and undrawn under the European Credit Facility, less (d) a $3,000,000 minimum availability reserve, less (e) other reserves required by the European Agent, and in each case subject to the definitions and limitations in the Prior Credit Agreement.

    Interest was accrued on outstanding indebtedness under the European Credit Facility at the SOFR rate, plus a margin ranging from 2.50% to 3.00%, or for swing line loans, at the overnight SOFR rate, plus a margin ranging from 2.50% to 3.00%, as selected by the company. The margin was adjusted quarterly based on utilization. Borrowings under the European Credit Facility were subject to commitment fees of 0.25% or 0.375% per year, depending on utilization.

    The European Credit Facility was secured by substantially all the personal property assets of the UK Borrower and its in-country subsidiaries, and all the receivables of the French Borrower and its in-country subsidiaries. The UK and French facilities (which comprised the European Credit Facility) were cross collateralized, and the US personal property assets previously pledged under the North America Credit Facility also served as collateral for the European Credit Facility.

    The European Credit Facility was subject to customary representations, warranties and covenants generally consistent with those applicable to the North America Credit Facility. Exceptions to the operating covenants in the Prior Credit Agreement provided the company with flexibility to, among other things, enter into or undertake certain sale/leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Prior Credit Agreement. The Prior Credit Agreement also contained a covenant requiring the European Borrowers to maintain undrawn availability under the European Credit Facility of not less than (i) 12.5% of the maximum amount that may be drawn under the European Credit Facility for five (5) consecutive business days, or (ii) 11.25% of the maximum amount that may be drawn under the European Credit Facility on any business day. The European Borrowers also were subject to cash dominion triggers under the European Credit Facility requiring the European Borrower to maintain borrowing capacity of not less than $3,750,000 on any business day or $3,750,000 for five consecutive business days in order to avoid triggering full control by an agent for the lenders of the European Borrower’s cash receipts for application to its obligations under the European Credit Facility.

    The European Credit Facility was subject to customary default provisions, with certain grace periods and exceptions, consistent with those applicable to the North America Credit Facility, which provide that events of default include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, cross-default, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption in the operations of any material manufacturing facility for more than 10 consecutive days. The proceeds of the European Credit Facility were used to finance the working capital and other business needs of the company. The company had outstanding borrowings of $7,366,000 (€6,500,000) under its French Credit Facility and $5,986,000 (£4,500,000) under its UK Credit Facility as of December 31, 2021.

    In January 2021, the Prior Credit Agreement was amended to provide for, among other things, the addition of the company's Netherlands subsidiary as a guarantor under the European Credit Facility, amendments to the restrictive covenants in the Prior Credit Agreement to (1) increase the maximum amount of permitted miscellaneous indebtedness to $30,000,000 from $10,000,000 and (2) permit up to $9,000,000 of financing based on certain European public and government receivables, and terms that, upon the occurrence of certain events related to a transition from the use of LIBOR, permit the agent for the lenders to amend the Prior Credit
    Agreement to replace the LIBOR rate and/or the Euro rate with a benchmark replacement rate.

    In March 2021, the Prior Credit Agreement was further amended to permit the issuance of the 2026 Notes and the capped call transactions entered into by the company in connection with the issuance of the 2026 Notes, as further discussed in the sections below.

    On December 29, 2021, the Prior Credit Agreement was further amended with the primary provisions to replace the references to the LIBOR rate or Euro rate to a term secured overnight finance rate ("SOFR").
    ABL Credit Agreement
    On July 26, 2022, the company entered into a Second Amended and Restated Revolving Credit and Security Agreement (the “ABL Credit Agreement”), amending and restating the company’s existing Revolving Credit and Security Agreement, as amended (the “Prior Credit Agreement”). The ABL Credit Agreement was entered into by and among the company, certain of the company’s direct and indirect domestic and Canadian subsidiaries (together with the company, the “Borrowers”), certain other of the company’s direct and indirect domestic and Canadian subsidiaries (the “Guarantors”), and PNC Bank, National Association (“PNC”) and JPMorgan Chase Bank, N.A. (the “ABL Lenders”). PNC is the administrative agent (the “Administrative Agent”) under the ABL Credit Agreement.
    The ABL Credit Agreement retained the existing asset-based lending senior secured revolving credit facility provided for the company and the domestic and Canadian Borrowers under the Prior Credit Agreement but extended the maturity date to January 16, 2026, reduced the maximum aggregate principal amount the company and the domestic and Canadian Borrowers may borrow to $35,000,000, limits the borrowing base thereunder to eligible domestic and Canadian accounts receivable and includes a minimum availability reserve of $3,000,000. Borrowings under the ABL Credit Agreement also are subject to a springing maturity date of 191 days prior to the maturity dates of certain convertible notes due 2024 and 2026, and 100 days prior to the maturity date of the Secured Term Loan under the Highbridge Loan Agreement, if such notes or such term loan remain outstanding as of such respective dates. The ABL Credit Agreement also permits the loans made under the Highbridge Loan Agreement and terminated the European Credit Facility under the Prior Credit Agreement. In connection with the ABL Credit Agreement and the Highbridge Loan Agreement, the European Credit Facility under the Prior Credit Agreement was repaid in full and the liens securing the European Credit Facility under the Prior Credit Agreement were terminated and released.
    The aggregate borrowing availability under the ABL Credit Agreement is determined based on a borrowing base formula. As of September 30, 2022, the company had gross
    borrowing base of $33,133,000 and net borrowing availability of $17,336,000 under the ABL Credit Agreement, considering the minimum availability reserve, then-outstanding letters of credit, other reserves and the $4,375,000 dominion trigger amount.
    Interest accrues on outstanding indebtedness under the ABL Credit Agreement at an adjusted Term SOFR rate, plus a margin of 3.25%, or for swing line loans and prime rate revolving loans, at the overnight Prime rate, plus a margin of 2.25%.
    The ABL Credit Agreement contains customary terms and covenants and negative covenants, such as limitations on indebtedness, liens, fundamental changes, asset sales, investments and other matters customarily restricted in such agreements. Most of these restrictions are subject to certain minimum thresholds and exceptions. The ABL Credit Agreement also contains customary events of default, after which the revolving loan may be due and payable immediately, including, without limitation, payment defaults, material inaccuracy of representations and warranties, covenant defaults, bankruptcy and insolvency proceedings, cross-defaults to certain other agreements, judgments against the company and its subsidiaries, change in control and lien priority.
    Proceeds from the Secured Term Loan under the Highbridge Loan Agreement were used to repay in full outstanding borrowings under the Prior Credit Agreement. Refer to the Term Loan due 2026 section below.
    In connection with entering into the company's Prior Credit Agreement and the ABL Credit Agreement, the company incurred fees which were capitalized and are being amortized as interest expense. As of September 30, 2022, debt fees yet to be amortized totaled $1,043,000.
    The company was in compliance with the ABL Credit Agreement covenants at September 30, 2022.

    Convertible senior notes due 2022

    In the second quarter of 2017, the company issued $120,000,000 aggregate principal amount of 4.50% Convertible Senior Notes due 2022 (the “2022 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2022 Notes bore interest at a rate of 4.50% per year payable semi-annually in arrears on June 1 and December 1 of each year, beginning December 1, 2017. The 2022 Notes matured on June 1, 2022. At maturity, $2,650,000 principal amount of the 2022 Notes were outstanding, which the company repaid in cash.

    In connection with the offering of the 2022 Notes, the company entered into privately negotiated convertible note hedge transactions with one financial institution (the “option counterparty”). The company evaluated the note hedges under
    the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the note hedges should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and were adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $24,780,000. All note hedge options relating to the 2022 Notes expired on June 1, 2022.

    The company entered into separate, privately negotiated warrant transactions with the option counterparty at a higher strike price relating to the same number of the company’s Common Shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding Common Shares and the company’s earnings per share to the extent that the price of the company’s Common Shares exceeds the strike price of those warrants. The initial strike price of the warrants is $21.4375 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including Derivatives and Hedging, ASC 815, and determined that the warrants meet the definition of a derivative, are indexed to the company's own shares and should be classified in shareholders' equity. The amount paid for the warrants and capitalized in shareholders' equity was $14,100,000.

    Warrants relating to the 2022 Notes outstanding on September 30, 2022 were 6,918,006. If exercised, one common share is issued upon exercise of each warrant, but may be adjusted under certain circumstances if the relevant share price exceeds the warrant strike price for the relevant measurement period at the time of exercise. Common Shares are reserved for issuance upon exercise of the remaining warrants relating to the 2022 Notes at two Common Shares per warrant. The warrants began to expire on September 1, 2022 and then partially expire on each trading day over the 220 trading day period following September 1, 2022.

    The net proceeds from the offering of the 2022 Notes were approximately $115,289,000, after deducting fees and offering expenses of $4,711,000, which were paid in 2017. These debt issuance costs were capitalized and were amortized as interest expense through June 2022. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. A portion of the net proceeds from the offering were used to pay the cost of the convertible note hedge transactions (after such cost is partially offset by the proceeds to the company from the warrant transactions), which net cost was $10,680,000.

    During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of the company's previously outstanding convertible notes due 2021 (the "2021 Notes") and certain holders of its
    2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 Notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new Series II 2024 Notes and $5,593,000 in cash.

    During the first quarter of 2021, the company repurchased $78,850,000 in principal amount of 2022 Notes, resulting in a loss on debt extinguishment of $709,000.

    The liability components of the 2022 Notes consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Principal amount of liability component$— $2,650 
    Debt fees— (8)
    Net carrying amount of liability component$— $2,642 

    The effective interest rate on the liability component was 10.9% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption of ASU 2020-06 includes coupon interest and amortization of debt fees. Interest expense of $0 and $50,000 was accrued for the three and nine months ended September 30, 2022 compared to $30,000 and $829,000 for the three and nine months ended September 30, 2021, based on the stated coupon rate of 4.5%.

    Convertible senior notes Series I due 2024

    During the fourth quarter of 2019, the company entered into separate privately negotiated agreements with certain holders of its 2021 Notes to exchange $72,909,000 in aggregate principal amount of 2021 Notes for aggregate consideration of $72,909,000 in aggregate principal amount of new 5.00% Convertible Senior Notes due 2024 (the “Series I 2024 Notes”) of the company and $6,928,000 in cash.

    The notes bear interest at a rate of 5.00% per year payable semi-annually in arrears on May 15 and November 15 of each year, beginning May 15, 2020. The notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series I 2024 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series I 2024 Notes may be settled in cash, the company’s Common Shares or a combination of cash and the company’s Common Shares, at the company’s election.

    Prior to the maturity of the Series I 2024 Notes, the company may, at its election, redeem for cash all or part of the Series I 2024 Notes if the last reported sale price of the company’s Common Shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the Series I 2024 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series I 2024 Notes, which means the company is not required to redeem or retire the Series I 2024 Notes periodically.

    Holders of the Series I 2024 Notes may convert their Series I 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending December 31, 2019 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the Series I 2024 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series I 2024 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the Series I 2024 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series I 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the Series I 2024 Notes will have the right to require the company to repurchase all or some of their Series I 2024 Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 Common Shares per $1,000 principal amount of Series I 2024 Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series I 2024 Notes, holders may convert their Series I 2024 Notes, at the option of the holder, regardless of the foregoing circumstances.

    Debt issuance costs of $1,394,000 were capitalized and are being amortized as interest expense through November 15, 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

    The liability components of the Series I 2024 Notes consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Principal amount of liability component$72,909 $72,909 
    Debt fees(568)(769)
    Net carrying amount of liability component$72,341 $72,140 

    The effective interest rate on the liability component was 8.8% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption of ASU 2020-06 includes coupon interest and amortization of debt fees. Interest expense of $911,000 and $2,734,000 was accrued for the three and nine months ended September 30, 2022 compared to $911,000 and $2,733,000 for the three and nine months ended September 30, 2021 based on the stated coupon rate of 5.0%. The effective interest rate of the Series I 2024 Notes as of September 30, 2022 was 5.4%. The Series I 2024 Notes were not convertible as of September 30, 2022 nor was the applicable conversion threshold met.

    Convertible senior notes Series II due 2024

    During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 Notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new 5.00% Series II Convertible Senior Notes due 2024 (the “Series II 2024 Notes”) of the company and $5,593,000 in cash.

    The Series II 2024 Notes bear interest at a rate of 5.00% per year, payable semi-annually in arrears on May 15 and November 15 of each year, beginning November 15, 2020. The Series II 2024 Notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series II 2024 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series II 2024 Notes may be settled in cash, the company’s Common Shares or a combination of cash and the company’s Common Shares, at the company’s election.

    Prior to the maturity of the Series II 2024 Notes, the company may, at its election, redeem for cash all or part of the Series II 2024 Notes, if the last reported sale price of the company’s Common Shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the accreted principal amount of the Series II 2024 Notes to be redeemed, plus any accrued and unpaid interest, if any, on the original principal amount of the Series II 2024 Notes redeemed to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series II 2024 Notes, which means the company is not required to redeem or retire the Series II 2024 Notes periodically.

    Holders of the Series II 2024 Notes may convert their Series II 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the Series II 2024 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series II 2024 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the Series II 2024 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series II 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the Series II 2024 Notes will have the right to require the company to repurchase all or some of their Series II 2024 Notes at 100% of the accreted principal amount, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 Common Shares per $1,000 principal amount of Series II 2024 Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series II 2024 Notes, holders may convert their Series II 2024 Notes,
    at the option of the holder, regardless of the foregoing circumstances.

    The principal amount of the Series II 2024 Notes also will accrete at a rate of approximately 4.7% per year commencing June 4, 2020, compounding on a semi-annual basis. The accreted portion of the principal is payable in cash upon maturity but does not bear interest and is not convertible into the company’s Common Shares. The total amount accreted as of September 30, 2022 was $7,558,000, of which $383,000 and $2,211,000 was for the three and nine months ended September 30, 2022, respectively, compared to $890,000 and $2,637,000 for the three and nine months ended September 30, 2021, respectively. Remaining accretion until maturity (at current principal) was $9,064,000 at September 30, 2022.

    Debt issuance costs of $1,505,000 were capitalized and are being amortized as interest expense through November 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

    In the third quarter of 2022, $5,000,000 aggregate principal amount of Series II 2024 Notes were retired as part of the Secured 2026 Notes and Secured Term Loan transactions discussed below.

    The liability components of the Series II 2024 Notes consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Principal amount of liability component - including accretion$76,433 $79,222 
    Debt fees(669)(971)
    Net carrying amount of liability component$75,764 $78,251 

    The effective interest rate on the liability component was 9.0% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption of ASU 2020-06 includes coupon interest, accretion and amortization of debt fees. Interest expense for accretion of $886,000 and $2,714,000 was recognized for the three and nine months ended September 30, 2022 compared to $890,000 and $2,637,000 for the three and nine months ended September 30, 2021. Interest expense of $879,000 and $2,726,000 were recognized for the three and nine months ended September 30, 2022 compared to $923,000 and $2,770,000 for the three and nine months ended September 30, 2021, based on the stated coupon rate of 5.0%. The effective interest rate of the Series II 2024 Notes as of September 30, 2022 including coupon interest, amortization of debt fees and accretion to maturity was 10.4%. The Series II 2024 Notes
    were not convertible as of September 30, 2022 nor was the applicable conversion threshold met.

    Convertible senior notes due 2026

    In the first quarter of 2021, the company issued $125,000,000 aggregate principal amount of 4.25% Convertible Senior Notes due 2026 (the “2026 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act.

    The notes bear interest at a rate of 4.25% per year payable semi-annually in arrears on March 15 and September 15 of each year, beginning September 15, 2021. The notes will mature on March 15, 2026, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to September 15, 2025, the 2026 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The 2026 Notes may be settled in cash, the company’s Common Shares or a combination of cash and the company’s Common Shares, at the company’s election.

    The company may not redeem the 2026 Notes prior to March 20, 2024. The company may, at its election, redeem for cash all or part of the 2026 Notes, on or after March 20, 2024, if the last reported sale price of the company’s Common Shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the 2026 Notes, which means the company is not required to redeem or retire the 2026 Notes periodically.

    Holders of the 2026 Notes may convert their 2026 Notes at their option at any time prior to the close of business on the business day immediately preceding September 15, 2025 in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2021 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the 2026 Notes on each applicable trading day; (2) during the five business day period
    after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2026 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2026 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls any or all of the 2026 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date. Holders of the 2026 Notes will have the right to require the company to repurchase all or some of their 2026 Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 94.6096 Common Shares per $1,000 principal amount of 2026 notes (equivalent to an initial conversion price of approximately $10.57 per common share). On or after September 15, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2026 Notes, holders may convert their 2026 Notes, at the option of the holder, regardless of the foregoing circumstances.

    Debt issuance costs of $5,697,000 were capitalized and are being amortized as interest expense through March 2026. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.

    The liability components of the 2026 Notes consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Principal amount of liability component$83,525 $125,000 
    Debt fees(2,627)(5,964)
    Net carrying amount of liability component$80,898 $119,036 

    Interest expense of $1,015,000 and $3,671,000 was accrued for the three and nine months ended September 30, 2022 compared to $1,328,000 and $2,892,000 for the three and nine months ended September 30, 2021 based on the stated coupon rate of 4.25%. The effective interest rate of the 2026 Notes as of September 30, 2022 was 5.4%. The 2026 Notes were not convertible as of September 30, 2022 nor was the applicable conversion threshold met.

    In the third quarter of 2022, $41,475,000 aggregate principal amount of 2026 Notes were exchanged and retired as part of the Secured 2026 Notes and Secured Term Loan transactions discussed below.

    As part of the transactions for the closing of the Term Loan, exchange of 2026 Notes for Secured 2026 Notes and retirement of $5,000,000 of Series II 2024 Notes in the third quarter of 2022, 2,700,000 Common Shares were issued. These transactions resulted in a net gain on extinguishment of debt of $6,398,000.

    In March 2021, in connection with the pricing of the 2026 Notes, the company entered into capped call transactions (the “Capped Call Transactions”) with certain option counterparties. The company used $18,787,000 of the net proceeds of the private offering of the 2026 Notes to pay the cost of the Capped Call Transactions with the offset recorded to additional paid-in-capital.

    The Capped Call Transactions are expected generally to reduce the potential dilution upon conversion of the 2026 Notes and/or offset any cash payments the company is required to make in excess of the principal amount of converted notes, as the case may be, in the event that the market price per share of the company’s Common Shares, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which is initially $10.57, corresponding to the initial conversion price of the 2026 Notes, subject to anti-dilution adjustments. If, however, the market price per company common share, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions, which is initially $16.58 (subject to adjustments), there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the Capped Call Transactions. The Capped Call Transactions expire March 15, 2026, subject to earlier exercise. There were 125,000 capped call options related to the 2026 Notes outstanding on September 30, 2022.

    The company will not be required to make any cash payments to the option counterparties upon the exercise of the options that are a part of the Capped Call Transactions, but the company will be entitled to receive from the option counterparties a number of company Common Shares, an amount of cash or a combination thereof generally based on the amount by which the market price per company common share, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions during the relevant valuation period under the Capped Call Transactions. However, if the market price per Company common share, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions during such valuation period, the number of company Common Shares and/or the amount of cash the company expects to receive upon exercise of the Capped Call Transactions will be capped based on the amount
    by which the cap price exceeds the strike price of the Capped Call Transactions.

    For any conversions of the 2026 Notes prior to September 15, 2025, a corresponding portion of the relevant Capped Call Transactions may be terminated at the company’s option. Upon any such termination, the company expects to receive from the option counterparties a number of company Common Shares, or, if the company so elects, subject to certain conditions, an amount of cash, in each case, with a value equal to the fair value of such portion of the relevant Capped Call Transactions being terminated, as calculated in accordance with the terms of the relevant Capped Call Transaction.

    The Capped Call Transactions are separate transactions, in each case, entered into by the company with the option counterparties, and are not part of the terms of the 2026 Notes and will not affect any holder’s rights under the 2026 Notes. Holders of the 2026 Notes will not have any rights with respect to the Capped Call Transactions.
    Secured convertible senior notes due 2026

    In the third quarter of 2022, the company issued and aggregate $31,106,000 (split equally between two separate tranches ("Tranche I Notes" and "Tranche II Notes" or "Indentures") in aggregate principal amount of 5.68% Secured Convertible Senior Notes due 2026 (the “Secured 2026 Notes”) in a private offering. This was in exchange for $41,475,000 aggregate principal amount of 2026 Notes which were retired. In October 2022, additional principal amount of Secured 2026 Notes were issued aggregating to $20,739,000 and $20,736,000 in aggregate principal amount of Tranche I Notes and Tranche II Notes, respectively, in exchange for $13,825,000 of 2026 Notes. Refer to October 2022 Financings below.
    The Secured 2026 Notes are initially guaranteed by certain subsidiaries of the company in the United States, United Kingdom, Canada, France, the Netherlands and Luxembourg pursuant to separate guarantees (each, a “Guarantee”), and are secured on a pari passu basis by the same collateral that secures the Highbridge Loan Agreement (discussed below). In addition, the company's subsidiaries that provide guarantees of the Highbridge Loan Agreement in connection with the post-closing draws provided Guarantees of the Secured 2026 Notes.
    Interest on the Secured 2026 Notes will be payable semi-annually in cash in arrears on January 1 and July 1 of each year, beginning on January 1, 2023, at a rate of 5.68% per year. The Secured 2026 Notes will mature on July 1, 2026, unless earlier converted, redeemed or repurchased in accordance with their terms. Holders of the Secured 2026 Notes have the right, at their option, at any time prior to the close of business on the second scheduled trading day immediately preceding July 1, 2026 (the maturity date), to
    convert any Secured 2026 Notes or portion thereof that is $1,000 or an integral multiple thereof, subject to certain conditions, into cash, Common Shares or a combination of cash and Common Shares at the company’s election (subject to, and in accordance with, the settlement provisions set forth the Indentures). The initial conversion rate for the (i) Tranche I Notes is 333.3333 Common Shares (subject to adjustment as provided for in the Tranche I Indenture) per $1,000 principal amount of the Tranche I Notes, which is equal to an initial conversion price of $3.00 per share, and (ii) Tranche II Notes is 222.222 Common Shares (subject to adjustment as provided for in the Tranche II Indenture) per $1,000 principal amount of the Tranche II Notes, which is equal to an initial conversion price of $4.50 per share. In addition, following certain corporate events as described in the Indentures that occur prior to the maturity date of the Secured 2026 Notes or if the company delivers a notice of redemption, the company will pay a make-whole premium by increasing the conversion rate for a holder who elects to convert its Secured 2026 Notes in connection with such a corporate event or notice of redemption, as the case may be, in certain circumstances, subject to adjustment as provided for and in accordance with the Indentures. These features are bifurcated driving convertible derivative liability.
    The company may not elect to redeem the Secured 2026 Notes prior to January 26, 2023. The company may redeem for cash all or any portion of the Secured 2026 Notes, at its option, on or after January 26, 2023 if the last reported sale price of the Common Shares exceeds 150% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the Secured 2026 Notes to be redeemed, plus any accrued and unpaid interest on such Secured 2026 Notes to, but excluding, the redemption date (subject to certain conditions set forth the Indentures). No sinking fund is provided for the Secured 2026 Notes.
    If the company undergoes a Fundamental Change (as defined in the Indentures), prior to the maturity date of the Secured 2026 Notes, holders of the Secured 2026 Notes will, subject to specified conditions, have the right, at their option, to require the company to repurchase for cash all or a portion of their Secured 2026 Notes at a repurchase price equal to 100% of the principal amount of the Secured 2026 Notes to be repurchased, plus any accrued and unpaid interest to, but not including, the Fundamental Change repurchase date.
    The Indentures provide for customary events of default. In the case of an event of default with respect to the Secured 2026 Notes arising from specified events of bankruptcy or insolvency, all outstanding Secured 2026 Notes will become due and payable immediately without further action or notice. If any other event of default with respect to the Secured 2026
    Notes under the Indentures occur or is continuing, the Trustee or holders of at least 25% in aggregate principal amount of the then outstanding Secured 2026 Notes may declare the principal amount of the Secured 2026 Notes to be immediately due and payable.
    In certain circumstances if, at any time during the six-month period beginning on, and including, the date that is six months after the date of original issuance for any sub-tranche of the Secured 2026 Notes, the company fails to timely file certain documents or reports required under the Securities Exchange Act of 1934, as amended, or the Secured 2026 Notes are not otherwise freely tradable under Rule 144 by holders of the Secured 2026 Notes other than the company’s affiliates or holders that were affiliates at any time during the three months preceding, additional interest will accrue at a rate of up to 0.50% on the Secured 2026 Notes during the period in which its failure to file has occurred and is continuing or such Secured 2026 Notes are not otherwise freely tradable under Rule 144 by holders other than the company’s affiliates or holders that were affiliates at any time during the three months preceding until such failure is cured.
    In addition, if, and for so long as, the restrictive legend on any sub-tranche of the Secured 2026 Notes has not been removed, any sub-tranche of the Secured 2026 Notes are assigned a restricted CUSIP number or any sub-tranche of the Secured 2026 Notes are not otherwise freely tradable under Rule 144 by holders other than the company’s affiliates or holders that were affiliates at any time during the three months preceding (without restrictions pursuant to U.S. securities laws or the terms of the Indentures or the Secured 2026 Notes) as of the 380th day after the date of original issuance of such sub-tranche of the Secured 2026 Notes, the company will pay additional interest at a rate of 0.50% on the Secured 2026 Notes during the period in which the Secured 2026 Notes remain so restricted.
    The company may not issue Common Shares upon conversions of the Secured 2026 Notes, net of the 2,700,000 Common Shares issued in the Exchange, in excess of 19.99% of the company’s Common Shares outstanding on July 25, 2022; until the requisite approval under the applicable New York Stock Exchange rules by the company’s shareholders is obtained. The company intends to seek this approval at its 2023 Annual Meeting of Shareholders.

    Debt issuance costs of $2,389,000 were capitalized and are being amortized as interest expense through July 2026. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.






    The liability components of the Secured 2026 Notes consist of the following (in thousands):
    September 30, 2022
    Principal amount of liability component$31,106 
    Unamortized discount(1,365)
    Debt fees(2,278)
    Net carrying amount of liability component$27,463 

    Interest expense of $324,000 was accrued for the three and nine months ended September 30, 2022 based on the stated coupon rate of 5.68%. The effective interest rate of the 2026 Notes as of September 30, 2022 was 8.7%. The 2026 Notes were not convertible as of September 30, 2022 nor was the applicable conversion threshold met.
    Secured Term Loan due 2026
    On July 26, 2022, the company entered into a Credit Agreement (the “Highbridge Loan Agreement” or "Secured Term Loan") with a certain fund managed by Highbridge Capital Management, LLC (“Highbridge”), as the lender (together with the other lenders from time to time party thereto, the “Lenders”), Cantor Fitzgerald Securities as administrative agent and GLAS Trust Corporation Limited, as collateral agent.
    Pursuant to the Highbridge Loan Agreement, the company may borrow up to an aggregate of $104,500,000 principal amount of Secured Term Loan, including $66,500,000 with $2,000,000 original issuance discount in initial secured term loans drawn at closing, $8,500,000 in additional Secured Term Loans principal to be made in a single draw subject to satisfaction of certain conditions, another $10,000,000 in additional Secured Term Loan principal to be made in a single draw subject to satisfaction of certain further conditions and $19,500,000 in additional Secured Term Loan to be made in a single draw subject to satisfaction of certain further conditions. The company expects to use the proceeds of the Secured Term loan for working capital and general corporate purposes and to pay fees and expenses in connection with the transactions described herein.
    The Secured Term Loan is scheduled to mature on July 26, 2026 and accrues interest at an initial annual rate of SOFR plus 7.00% or a base rate plus 6.00% and after the second anniversary of closing at an annual rate of SOFR plus 8.75% or a base rate plus 7.75%. The Secured Term Loan is also subject to a springing maturity date of 91 days prior to the maturity date of certain convertible notes due November 2024 if more than $20,000,000 of such notes remain outstanding as of such date. The obligations under the Highbridge Loan Agreement are secured, initially, by substantially all assets of the company and certain subsidiaries of the company (subject
    to certain exceptions), subject to intercreditor agreements in connection with the ABL Credit Agreement and the 5.68% Indentures, and are guaranteed by certain subsidiaries of the company in the United States, United Kingdom, Canada, France, the Netherlands and Luxembourg at the closing. Additional collateral owned by subsidiaries of the company in various jurisdictions will be added to the security for the Secured Term Loan and additional subsidiaries of the company in various jurisdictions will guarantee the obligations in connection with the post-closing draws.
    The company will have the right to prepay the Secured Term Loan at any time, subject to a prepayment premium, which in case of a prepayment before the second anniversary of the closing date is equal to the greater of (i) 1.00% of the aggregate principal amount of the Secured Term Loan so prepaid and (ii) the excess, if any of (A) the present value as of the date of repayment of all interest that would have accrued on the Secured Term Loan being prepaid from such date through the second anniversary of the closing plus the present value as of such date of the principal amount of the Secured Term Loan being prepaid assuming a prepayment date of the second anniversary of the closing over (B) the principal amount of such Secured Term Loan being prepaid and, after the second anniversary of the closing is equal to 1.00% of the aggregate principal amount of the Secured Term Loan so prepaid, as well as, in each case, an additional redemption fee equal to 3.00% of the aggregate principal amount of the Secured Term Loan so prepaid.
    The Highbridge Loan Agreement contains customary terms and covenants, including without limitation a financial covenant to maintain a minimum liquidity of $20,000,000 and negative covenants, such as limitations on indebtedness, liens, fundamental changes, asset sales, investments and other matters customarily restricted in such agreements. Most of these restrictions are subject to certain minimum thresholds and exceptions. The Highbridge Loan Agreement also contains customary events of default, after which the Secured Term Loan may be due and payable immediately, including, without limitation, payment defaults, material inaccuracy of representations and warranties, covenant defaults, bankruptcy and insolvency proceedings, cross-defaults to certain other agreements, judgments against the company and its subsidiaries, change in control and lien priority.
    Debt issuance costs of $5,107,000 were capitalized and are being amortized as interest expense through July 2026. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability.
    The liability components of the Secured Term Loan consist of the following (in thousands):
    September 30, 2022
    Principal amount of liability component$66,500 
    Unamortized original issuance discount(1,907)
    Debt fees(4,869)
    Net carrying amount of liability component$59,724 

    Interest expense of $1,217,000 was accrued for the three and nine months ended September 30, 2022 based on the stated coupon rate of 5.68%. The effective interest rate of the 2026 Notes as of September 30, 2022 was 12.7%.

    The weighted average interest rate on all borrowings, excluding finance leases, was 5.0% for the nine months ended September 30, 2022 and 4.5% for the year ended December 31, 2021.
    Other

    In the second quarter of 2022, the company borrowed $2,000,000 against the cash surrender value of its life insurance policies which the company intends to repay in the next twelve months.

    October 2022 Financings
    Highbridge Loan Agreement and Indentures
    On October 3, 2022, the company consummated additional draws of an aggregate of $18,500,000 under the Highbridge Loan Agreement. Additional borrowing under the Term Loan of $19,500,000 remains available, subject to the satisfaction of certain conditions.
    Further, the company issued $5,186,000 in aggregate principal amount of additional 5.68% Tranche I Notes and $5,183,000 in aggregate principal amount of additional 5.68% Tranche II Notes of the Secured 2026 Notes in exchange for $13,825,000 of 2026 Notes which were retired. Following these transactions, $69,700,000 aggregate principal amount of 2026 Notes remain outstanding.
    XML 35 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Other Long-Term Obligations
    		 9 Months Ended
    Sep. 30, 2022
    Other Liabilities Disclosure [Abstract]  
    Other Long-Term Obligations
    Other Long-Term Obligations

    Other long-term obligations consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Deferred income taxes$19,385 $21,664 
    Product liability12,010 11,342 
    Deferred compensation5,090 6,174 
    Deferred gain on sale leaseback4,920 5,174 
    Supplemental executive retirement plan liability4,697 5,106 
    Death benefit obligation plan3,499 4,568 
    Uncertain tax obligation including interest2,980 3,171 
    Pension 2,783 7,814 
    Secured Convertible 2026 debt conversion liability473 — 
    Other537 1,783 
    Other Long-Term Obligations$56,374 $66,796 

    The Secured Convertible 2026 debt conversion liability amounts included in the above table represent the fair values of the conversion liabilities.

    On April 23, 2015, the company entered into a real estate sale leaseback transaction which resulted in the company recording an initial deferred gain of $7,414,000, the majority of which is included in Other Long-Term Obligations and will be recognized over the 20-year life of the leases. The gains realized were $82,000 and $245,000 for the three and nine months ended September 30, 2022 respectively, compared to $80,000 and $237,000 for the three and nine months ended September 30, 2021 respectively.
    XML 36 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Leases and Commitments (Notes)
    		 9 Months Ended
    Sep. 30, 2022
    Leases [Abstract]  
    Lessee, Finance Leases
    Leases and Commitments

    The company reviews new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, the company has recognized those amounts as part of the right-of-use assets and lease liabilities. The company combines lease and certain non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, the company uses an incremental borrowing rate (IBR) based on information available at commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. The company calculates its IBR based on the secured rates of the company's recent debt issuances, the credit rating of the company, changes in currencies, lease repayment timing as well as other publicly available data.

    The company leases a portion of its facilities, transportation equipment, data processing equipment and certain other equipment. These leases have terms from 1 to 20 years and provide for renewal options. Generally, the company is required to pay taxes and normal expenses associated with operating the facilities and equipment. As of September 30, 2022, the company is committed under non-cancelable leases, which have initial or remaining terms in excess of one year and expire on various dates through 2040.

    On April 23, 2015, the company sold and leased back, under four separate lease agreements, four properties located in Ohio and one property in Florida for net proceeds of $23,000,000, which were used to reduce debt under the U.S. and Canadian Credit Facility. The initial total annual rent for the properties was $2,275,000 and can increase annually over the 20-year term of the leases based on the applicable geographical consumer price index (CPI). Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases.

    In connection with the transaction, the requirements for sale lease-back accounting were met. Accordingly, the company recorded the sale of the properties, removed the related property and equipment from the company's balance sheet, recognized an initial deferred gain of $7,414,000 and an immediate loss of $257,000 related to one property and recorded new lease liabilities. Specifically, the company
    recorded four finance leases totaling $32,339,000 and one operating lease related to leased land, which was not a material component of the transaction. The gains on the sales of the properties were required to be deferred and recognized over the life of the leases as the property sold is being leased back. The deferred gain is classified under Other Long-Term Obligations on the condensed consolidated balance sheets.
    Lease expenses for the three and nine months ended September 30, 2022 and September 30, 2021, respectively, were as follows (in thousands):
    For the Three Months Ended September 30,For the Nine Months Ended September 30,
    2022202120222021
    Operating leases$1,391 $1,811 $4,421 $5,592 
    Variable and short-term leases616 764 1,961 2,825 
    Total operating leases$2,007 $2,575 $6,382 $8,417 
    Finance lease interest cost$1,062 $1,146 $3,224 $3,487 
    Finance lease depreciation1,055 1,265 3,210 3,807 
    Total finance leases$2,117 $2,411 $6,434 $7,294 






















    Future minimum operating and finance lease commitments, as of September 30, 2022, are as follows (in thousands):
    Finance 
    Leases    		Operating Leases
    2022$1,637 $1,100 
    20236,501 3,192 
    20246,443 2,452 
    20256,353 1,973 
    20266,248 1,209 
    Thereafter65,253 1,615 
    Total future minimum lease payments92,435 11,541 
    Amounts representing interest(31,893)(1,614)
    Present value of minimum lease payments60,542 9,927 
    Less: current maturities of lease obligations(3,031)(3,062)
    Long-term lease obligations$57,511 $6,865 
    Supplemental cash flow amounts for the three and nine months ended September 30, 2022 and September 30, 2021 were as follows (in thousands):
    For the Three Months Ended September 30,For the Nine Months Ended September 30,
    Cash Activity: Cash paid in measurement of amounts for lease liabilities2022202120222021
    Operating leases$1,967 $2,584 $6,266 $8,501 
    Finance leases1,810 2,100 5,478 6,311 
    Total$3,777 $4,684 $11,744 $14,812 
    Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligations2022202120222021
    Operating leases$1,264 $989 $2,429 $5,418 
    Finance leases54 189 969 6,345 
    Total$1,318 $1,178 $3,398 $11,763 











    Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2022 and December 31, 2021, respectively:
    September 30, 2022December 31, 2021
    Weighted-average remaining lease term - finance leases14.9 years15.8 years
    Weighted-average remaining lease term - operating leases4.8 years5.0 years
    Weighted-average discount rate - finance leases6.37%6.43%
    Weighted-average discount rate - operating leases8.07%7.10%
    Lessee, Operating Leases
    Leases and Commitments

    The company reviews new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, the company has recognized those amounts as part of the right-of-use assets and lease liabilities. The company combines lease and certain non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, the company uses an incremental borrowing rate (IBR) based on information available at commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. The company calculates its IBR based on the secured rates of the company's recent debt issuances, the credit rating of the company, changes in currencies, lease repayment timing as well as other publicly available data.

    The company leases a portion of its facilities, transportation equipment, data processing equipment and certain other equipment. These leases have terms from 1 to 20 years and provide for renewal options. Generally, the company is required to pay taxes and normal expenses associated with operating the facilities and equipment. As of September 30, 2022, the company is committed under non-cancelable leases, which have initial or remaining terms in excess of one year and expire on various dates through 2040.

    On April 23, 2015, the company sold and leased back, under four separate lease agreements, four properties located in Ohio and one property in Florida for net proceeds of $23,000,000, which were used to reduce debt under the U.S. and Canadian Credit Facility. The initial total annual rent for the properties was $2,275,000 and can increase annually over the 20-year term of the leases based on the applicable geographical consumer price index (CPI). Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases.

    In connection with the transaction, the requirements for sale lease-back accounting were met. Accordingly, the company recorded the sale of the properties, removed the related property and equipment from the company's balance sheet, recognized an initial deferred gain of $7,414,000 and an immediate loss of $257,000 related to one property and recorded new lease liabilities. Specifically, the company
    recorded four finance leases totaling $32,339,000 and one operating lease related to leased land, which was not a material component of the transaction. The gains on the sales of the properties were required to be deferred and recognized over the life of the leases as the property sold is being leased back. The deferred gain is classified under Other Long-Term Obligations on the condensed consolidated balance sheets.
    Lease expenses for the three and nine months ended September 30, 2022 and September 30, 2021, respectively, were as follows (in thousands):
    For the Three Months Ended September 30,For the Nine Months Ended September 30,
    2022202120222021
    Operating leases$1,391 $1,811 $4,421 $5,592 
    Variable and short-term leases616 764 1,961 2,825 
    Total operating leases$2,007 $2,575 $6,382 $8,417 
    Finance lease interest cost$1,062 $1,146 $3,224 $3,487 
    Finance lease depreciation1,055 1,265 3,210 3,807 
    Total finance leases$2,117 $2,411 $6,434 $7,294 






















    Future minimum operating and finance lease commitments, as of September 30, 2022, are as follows (in thousands):
    Finance 
    Leases    		Operating Leases
    2022$1,637 $1,100 
    20236,501 3,192 
    20246,443 2,452 
    20256,353 1,973 
    20266,248 1,209 
    Thereafter65,253 1,615 
    Total future minimum lease payments92,435 11,541 
    Amounts representing interest(31,893)(1,614)
    Present value of minimum lease payments60,542 9,927 
    Less: current maturities of lease obligations(3,031)(3,062)
    Long-term lease obligations$57,511 $6,865 
    Supplemental cash flow amounts for the three and nine months ended September 30, 2022 and September 30, 2021 were as follows (in thousands):
    For the Three Months Ended September 30,For the Nine Months Ended September 30,
    Cash Activity: Cash paid in measurement of amounts for lease liabilities2022202120222021
    Operating leases$1,967 $2,584 $6,266 $8,501 
    Finance leases1,810 2,100 5,478 6,311 
    Total$3,777 $4,684 $11,744 $14,812 
    Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligations2022202120222021
    Operating leases$1,264 $989 $2,429 $5,418 
    Finance leases54 189 969 6,345 
    Total$1,318 $1,178 $3,398 $11,763 











    Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2022 and December 31, 2021, respectively:
    September 30, 2022December 31, 2021
    Weighted-average remaining lease term - finance leases14.9 years15.8 years
    Weighted-average remaining lease term - operating leases4.8 years5.0 years
    Weighted-average discount rate - finance leases6.37%6.43%
    Weighted-average discount rate - operating leases8.07%7.10%
    XML 37 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Revenue Revenue
    		 9 Months Ended
    Sep. 30, 2022
    Revenue [Abstract]  
    Revenue Recognition, Deferred Revenue [Policy Text Block]
    Revenue

    The company has two revenue streams: products and services. Services include repair, refurbishment, preventive maintenance and rental of products. Services for the North America segment include maintenance and repair of products. Services for the Europe segment include repair, refurbishment and preventive maintenance services. Services in All Other, are in the Asia Pacific region, and include rental and repair of products.

    The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2022 and September 30, 2021 (in thousands):
    Three Months Ended September 30, 2022
    ProductServiceTotal
    Europe$94,723 $2,764 $97,487 
    North America65,068 246 65,314 
    All Other6,380 1,227 7,607 
    Total$166,171 $4,237 $170,408 
    % Split98%2%100%
    Nine Months Ended September 30, 2022
    ProductServiceTotal
    Europe$319,467 $8,867 $328,334 
    North America208,776 575 209,351 
    All Other19,067 3,661 22,728 
    Total$547,310 $13,103 $560,413 
    % Split98%2%100%
    Three Months Ended September 30, 2021
    ProductServiceTotal
    Europe$123,671 $3,355 $127,026 
    North America87,936 118 88,054 
    All Other7,788 1,332 9,120 
    Total$219,395 $4,805 $224,200 
    % Split98%2%100%
    Nine Months Ended September 30, 2021
    ProductServiceTotal
    Europe$351,680 $9,417 $361,097 
    North America259,623 652 260,275 
    All Other21,010 3,884 24,894 
    Total$632,313 $13,953 $646,266 
    % Split98%2%100%
    The company's revenues are principally related to the sale of products, approximately 98%, with the remaining 2% related to services including repair, refurbishment, preventive maintenance and rental of products. While the company has a significant amount of contract types, the sales split by contract type is estimated as follows: general terms and conditions (30%), large national customers (23%), governments, principally pursuant to tender contracts (22%) and other customers including buying groups and independent customers (25%).

    All product revenues and substantially all service revenues are recognized at a point in time. The remaining service revenue, recognized over time, are reflected in the Europe segment and include multiple performance obligations. For such contracts, the company allocates revenue to each performance obligation based on its relative standalone selling price. The company generally determines the standalone selling price based on the expected cost-plus margin methodology.    

    Revenue is recognized when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the company’s products and services. The amount of consideration received and revenue recognized by the company can vary as a result of variable consideration terms included in the contracts related to customer rebates, cash discounts and return policies. Revenue is measured as the amount of consideration probable of not having a significant reversal of cumulative revenue recognized when related uncertainties are resolved. Customer rebates and cash discounts are estimated based on the most likely amount principle and these estimates are based on historical experience and anticipated performance. In addition, customers have the right to return products within the company’s normal terms policy, and as such the company estimates the expected returns based on an analysis of historical experience. The company adjusts its estimate of revenue at the earlier of when the most likely amount of consideration it expects to receive changes or when the consideration becomes fixed. The company generally does not expect that there will be significant changes to its estimates of variable consideration (refer to “Receivables” and "Accrued
    Expenses" in the notes to the condensed consolidated financial statements include elsewhere in this report for more detail). Depending on the terms of the contract, the company may defer the recognition of a portion of the revenue at the end of a reporting period to align with transfer of control of the company’s products to the customer. In addition, to the extent performance obligations are satisfied over time, the company defers revenue recognition until the performance obligations are satisfied. As of September 30, 2022 and December 31, 2021, the company had deferred revenue of $1,903,000 and $4,156,000, respectively, related to outstanding performance obligations with substantially all expected to be recognized as revenue within a year.
    XML 38 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Equity Compensation
    		 9 Months Ended
    Sep. 30, 2022
    Share-based Payment Arrangement [Abstract]  
    Shareholders' Equity Transactions
    Equity Compensation

    The company’s Common Shares have a $0.25 stated value. The Common Shares and the Class B Common Shares generally have identical rights, terms and conditions and vote together as a single class on most issues, except that the Class B Common Shares have ten votes per share and, in general, can only be transferred to family members or for estate planning purposes. Holders of Class B Common Shares are entitled to convert their shares into Common Shares at any time on a share-for-share basis. When Class B Common Shares are transferred out of a familial relationship, they automatically convert to Common Shares.

    As of September 30, 2022, 3,667 Class B Common Shares remained outstanding. Prior conversions of Class B Common Shares have virtually eliminated the company’s dual class voting structure. As of September 30, 2022, the holders of the Common Shares represented approximately 99.9% of the company’s total outstanding voting power.

    Equity Compensation Plan

    On May 17, 2018, the shareholders of the company approved the Invacare Corporation 2018 Equity Compensation Plan (the “2018 Plan”), which was adopted on March 27, 2018 by the company's Board of Directors (the “Board”). The company’s Board adopted the 2018 Plan in order to authorize additional Common Shares for grant as equity compensation, and to reflect changes to Section 162(m) of the Internal Revenue Code (the “Code”) resulting from the U.S. Tax Cuts and Jobs Act of 2017.
    Following shareholder approval of the 2018 Plan, all of the Common Shares then-remaining available for issuance under the Invacare Corporation 2013 Equity Compensation Plan (the “2013 Plan”) and all of the Common Shares that were forfeited or remained unpurchased or undistributed upon termination or expiration of awards under the 2013 Plan and under the Invacare Corporation 2003 Performance Plan (the “2003 Plan”), become available for issuance under the 2018 Plan. Awards granted previously under the 2013 Plan and 2003 Plan will remain in effect under their original terms.
    The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of stock options or stock appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a stock option or a SAR will count against the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003
    Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share.
    The Compensation and Management Development Committee of the Board (the “Compensation Committee”), in its discretion, may grant an award under the 2018 Plan to any director or employee of the company or an affiliate. As of September 30, 2022, 5,507,144 Common Shares were available for future issuance under the 2018 Plan in connection with the following types of awards with respect to the company's Common Shares: incentive stock options, nonqualified stock options, SARs, restricted stock, restricted stock units, unrestricted stock and performance shares. The Compensation Committee also may grant performance units that are payable in cash. The Compensation Committee has the authority to determine which participants will receive awards, the amount of the awards and the other terms and conditions of the awards.
    The 2018 Plan provides that shares granted come from the company's authorized but unissued Common Shares or treasury shares. In addition, the company's stock-based compensation plans allow employee participants to exchange shares for minimum withholding taxes, which results in the company acquiring treasury shares.
    The amounts of equity-based compensation expense recognized as part of SG&A expenses in All Other in business segment reporting were as follows (in thousands):
    For the Nine Months Ended September 30,
    20222021
    Restricted stock and restricted stock units$2,653 $4,570 
    Performance shares and performance share units(814)799 
    Total stock-based compensation expense$1,839 $5,369 

    As of September 30, 2022, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan, which is related to non-vested awards, was as follows (in thousands):
    September 30, 2022
    Restricted stock and restricted stock units$2,826 
    Performance shares and performance share units168 
    Total unrecognized stock-based compensation expense$2,994 
    Total unrecognized compensation cost will be adjusted for future changes in actual and estimated forfeitures and for updated vesting assumptions for the performance share awards (refer to "Performance Shares and Performance Share Units" below). No tax benefits for stock compensation were realized during the three and nine months ended September 30, 2022 and 2021, respectively, due to a valuation allowance against deferred tax assets. In accordance with ASC 718, any tax benefits resulting from tax deductions in excess of the compensation expense recognized is classified as a component of financing cash flows.

    Stock Options

    Generally, non-qualified stock option awards have a term of ten years and were granted with an exercise price per share equal to the fair market value of the company’s Common Shares on the date of grant.

    The following table summarizes information about stock option activity for the nine months ended September 30, 2022:
    Weighted Average
    Exercise Price
    Options outstanding at January 1, 2022750,159 $12.69 
    Expired(107,987)13.48
    Options outstanding at September 30, 2022642,172 $12.55 
    Options exercise price range at September 30, 2022$12.15 to$14.49 
    Options exercisable at September 30, 2022642,172 
    Shares available for grant under the 2018 Plan at September 30, 2022*5,507,144 
    ________
     *    Shares available for grant under the 2018 Plan as of September 30, 2022 are reduced by awards and increased by forfeitures or expirations. At September 30, 2022, an aggregate of 910,624 Common Shares underlie awards which were forfeited or expired unexercised under the 2003 and 2013 Plans and thus are available for future issuance under the 2018 Plan upon transfer.

    The following table summarizes information about stock options outstanding at September 30, 2022:
     Options OutstandingOptions Exercisable
    Exercise PricesNumber
    Outstanding at
    September 30, 2022    		Weighted Average
    Remaining
    Contractual Life (Years)    		Weighted Average
    Exercise Price    		Number Exercisable at
    September 30, 2022    		Weighted Average
    Exercise Price
    $12.15 – $14.49
    		642,172 0.8$12.55 642,172 $12.55 
    The 2018 Plan provides for a one-year minimum vesting period for stock options and, generally, options must be exercised within ten years from the date granted. No stock options were issued in 2022 or 2021.

    Restricted Stock and Restricted Stock Units

    The following table summarizes information about restricted stock and restricted stock units (primarily for non-U.S. recipients):
    Weighted Average Fair Value
    Stock / Units unvested at January 1, 20221,160,847 $8.17 
    Granted1,321,249 1.37 
    Vested(553,071)8.43 
    Forfeited(741,679)4.30 
    Stock / Units unvested at
    September 30, 2022    		1,187,346 $2.90 

    The restricted awards generally vest ratably over the three years after the award date. Unearned restricted awards compensation, determined as the market value of the shares at the date of grant, is being amortized on a straight-line basis over the vesting period as adjusted for forfeiture estimates.

    Performance Shares and Performance Share Units

    The following table summarizes information about performance shares and performance share units (primarily for non-U.S. recipients):
     Weighted Average Fair Value
    Shares / Units unvested at January 1, 2022972,288 $7.76 
    Granted460,187 1.48 
    Forfeited(942,201)5.79 
    Shares / Units unvested at
    September 30, 2022    		490,274 $5.67 

    During the nine months ended September 30, 2022, performance shares and performance share units (for non-U.S. recipients) were granted. Performance awards have a three year performance period with payouts based on achievement of certain performance goals. The awards are classified as equity awards as they will be settled in Common Shares upon vesting. The number of shares earned will be determined at the end of the three year performance period based on achievement of performance criteria for January 1, 2020 through December 31, 2022, January 1, 2021 through
    December 31, 2023 and January 1, 2022 through December 31, 2024, respectively established by the Compensation Committee at the time of grant. Recipients will be entitled to receive a number of Common Shares equal to the number of performance shares that vest based upon the levels of achievement which may range between 0% and 150% of the target number of shares with the target being 100% of the initial grant.

    The fair value of the performance awards is based on the stock price on the date of grant discounted for the estimated value of dividends foregone as the awards are not eligible for dividends except to the extent vested. The grant fair value is further updated each reporting period while variable accounting applies. The company assesses the probability that the performance targets will be met with expense recognized whenever it is probable that at least the minimum performance criteria will be achieved. Depending upon the company's assessment of the probability of achievement of the goals, the company may not recognize any expense associated with performance awards in a given period, may reverse prior expense recorded or record additional expense to recognize the cumulative estimated achievement level of proportionate term of the award. Performance award compensation expense is generally expected to be recognized over three years. The company continues to recognize expense (benefit) related to the awards granted in 2020, 2021 and 2022 based on estimates that the performance goals for those awards will be or will not be met.
    XML 39 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Accumulated Other Comprehensive Income (Loss) by Component
    		 9 Months Ended
    Sep. 30, 2022
    Equity [Abstract]  
    Accumulated Other Comprehensive Income (Loss) by Component
    Accumulated Other Comprehensive Income (Loss) by Component

    Changes in accumulated other comprehensive income (loss) ("OCI") (in thousands):
    Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
    June 30, 2022$(13,347)$1,548 $462 $1,453 $(9,884)
    OCI before reclassifications(31,883)(2,168)155 59 (33,837)
    Amount reclassified from accumulated OCI— — (110)(1,275)(1,385)
    Net current-period OCI(31,883)(2,168)45 (1,216)(35,222)
    September 30, 2022$(45,230)$(620)$507 $237 $(45,106)
    Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
    December 31, 2021$18,961 $2,127 $(4,101)$1 $16,988 
    OCI before reclassifications(64,191)(2,747)4,772 2,197 (59,969)
    Amount reclassified from accumulated OCI— — (164)(1,961)(2,125)
    Net current-period OCI(64,191)(2,747)4,608 236 (62,094)
    September 30, 2022$(45,230)$(620)$507 $237 $(45,106)
    Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
    June 30, 2021$60,381 $2,146 $(4,069)$(1,379)$57,079 
    OCI before reclassifications(19,155)(47)(209)944 (18,467)
    Amount reclassified from accumulated OCI— — 182 309 491 
    Net current-period OCI(19,155)(47)(27)1,253 (17,976)
    September 30, 2021$41,226 $2,099 $(4,096)$(126)$39,103 
    Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
    December 31, 2020$50,329 $(517)$(3,674)$(702)$45,436 
    OCI before reclassifications(9,103)2,616 (440)(643)(7,570)
    Amount reclassified from accumulated OCI— — 18 1,219 1,237 
    Net current-period OCI(9,103)2,616 (422)576 (6,333)
    September 30, 2021$41,226 $2,099 $(4,096)$(126)$39,103 
    Reclassifications out of accumulated OCI were as follows (in thousands):
    Amount reclassified from OCIAmount reclassified from OCIAffected line item in the Statement of Comprehensive (Income) Loss
    For the Three Months Ended September 30,For the Nine Months Ended September 30,
    2022202120222021
    Defined Benefit Plans 
    Service and interest costs$(110)$182 $(164)$18 Selling, general and administrative expenses
    Tax— — — — Income taxes
    Total after tax$(110)$182 $(164)$18 
    Derivatives
    Foreign currency forward contracts hedging sales$(68)$476 $(125)$657 Net sales
    Foreign currency forward contracts hedging purchases(1,263)(92)(1,997)746 Cost of products sold
    Total loss (income) before tax(1,331)384 (2,122)1,403 
    Tax56 (75)161 (184)Income taxes
    Total after tax$(1,275)$309 $(1,961)$1,219 
    XML 40 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Charges Related To Restructuring Activities
    		 9 Months Ended
    Sep. 30, 2022
    Restructuring and Related Activities [Abstract]  
    Charges Related To Restructuring Activities
    Charges Related to Restructuring Activities

    The company's restructuring charges were originally necessitated primarily by continued declines in Medicare and Medicaid reimbursement by the U.S. government, as well as similar healthcare reimbursement pressures abroad, which negatively affected the company's customers (e.g. home health care providers) and continued pricing pressures faced by the company due to the outsourcing by competitors to lower cost locations. Restructuring decisions were also the result of reduced profitability in each of the segments. Restructuring actions have continued into 2022.

    For the nine months ended September 30, 2022, severance and other charges totaled $16,383,000 which were related to North America of $5,534,000, Europe of $9,766,000 and All Other of $1,083,000. Payments for the nine months ended September 30, 2022 were $10,789,000 and the cash payments were funded with the company's cash on hand. The 2022 charges are expected to be paid out within 12 months.

    For the nine months ended September 30, 2021, charges totaled $2,476,000 which were related to North America of $975,000 and Europe of $1,501,000. In North America costs were incurred related to severance. The European charges were for severance costs $895,000 and contract terminations $606,000, primarily related to the closure of a German manufacturing facility. Payments for the nine months ended September 30, 2021 were $7,367,000 and the cash payments were funded with company's cash on hand.
    There have been no material changes in accrued balances related to the charges, either as a result of revisions to the plans or changes in estimates. In addition, the savings anticipated as a result of the company's restructuring plans have been or are expected to be achieved, primarily resulting in reduced salary and benefit costs principally impacting selling, general and administrative expenses, and to a lesser extent, costs of products sold. To date, the company's liquidity has been sufficient to absorb these charges and payments.
    A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2022 is as follows (in thousands):
    SeveranceOtherTotal
    December 31, 2021 Balances
    North America$482 $— $482 
    Total482 — 482 
    Charges
    North America 1,124 538 1,662 
    Europe2,119 — 2,119 
    All Other9 — 9 
    Total 3,252 538 3,790 
    Payments
    North America (422)(538)(960)
    Europe (367)— (367)
    All Other(9)— (9)
    Total (798)(538)(1,336)
    March 31, 2022 Balances
    North America1,184 — 1,184 
    Europe1,752 — 1,752 
    Total$2,936 $— $2,936 
    Charges
    North America$542 998 $1,540 
    Europe1,288 1,325 2,613 
    Total1,830 2,323 4,153 
    Payments
    North America(768)(442)(1,210)
    Europe(1,254)(624)(1,878)
    Total(2,022)(1,066)(3,088)
    June 30, 2022 Balances
    North America958 556 1,514 
    Europe1,786 701 2,487 
    Total$2,744 $1,257 $4,001 
    Charges
    North America116 2,216 2,332 
    Europe1,033 4,001 5,034 
    All Other1,074 — 1,074 
    Total2,223 6,217 8,440 
    Payments
    North America(438)(1,807)(2,245)
    Europe(1,067)(3,041)(4,108)
    All Other(12)— (12)
    Total(1,517)(4,848)(6,365)
    September 30, 2022 Balances
    North America636 965 1,601 
    Europe1,752 1,661 3,413 
    All Other1,062 — 1,062 
    Total$3,450 $2,626 $6,076 
    XML 41 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Income Taxes
    		 9 Months Ended
    Sep. 30, 2022
    Income Tax Disclosure [Abstract]  
    Income Taxes
    Income Taxes

    The company had an effective tax rate of 2.8% and 4.1% on losses before tax for the three and nine months ended September 30, 2022, respectively, compared to a statutory benefit of 21.0% on the pre-tax loss for each period. The company had an effective tax rate of 8.8% and 11.3% on losses before tax for the three and nine months ended September 30, 2021, respectively, compared to a statutory benefit of 21.0% on the pre-tax loss for each period. The company's effective tax rate for the three and nine months ended September 30, 2022 and September 30, 2021 were unfavorable as compared to the U.S. federal statutory rate, principally due to the negative impact of the company not being able to record tax benefits related to the significant losses in countries which had tax valuation allowances. The effective tax rate was increased for the three and nine months ended September 30, 2022 and September 30, 2021 by certain taxes outside the United States, excluding countries with tax valuation allowances, that were at an effective rate higher than the U.S. statutory rate.
    XML 42 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Net Earnings (Loss) Per Common Share
    		 9 Months Ended
    Sep. 30, 2022
    Earnings Per Share [Abstract]  
    Net Earnings (Loss) Per Common Share
    Net Loss Per Common Share

    The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.
    (In thousands except per share data)For the Three Months Ended September 30,For the Nine Months Ended September 30,
    2022202120222021
    Basic
    Weighted average common shares outstanding37,537 35,013 36,073 34,826 
    Net loss$(34,354)$(22,759)$(80,494)$(47,501)
    Net loss per common share$(0.92)$(0.65)$(2.23)$(1.36)
    Diluted
    Weighted average common shares outstanding37,537 35,013 36,073 34,826 
    Share options and awards143 475 168 545 
    Weighted average common shares assuming dilution37,680 35,488 36,241 35,371 
    Net loss$(34,354)$(22,759)$(80,494)$(47,501)
    Net loss per common share *$(0.92)$(0.65)$(2.23)$(1.36)
    ________
    * Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.
    For the three and nine months ended September 30, 2022, shares associated with equity compensation awards of 1,659,909 and 1,120,192, respectively, and for the three and nine months ended September 30, 2021, shares associated with equity compensation awards of 1,432,833 and 1,163,526, respectively, were excluded from the weighted average common shares assuming dilution as incremental shares were antidilutive.

    At September 30, 2022, the majority of the antidilutive incremental shares were awards granted at an exercise price above $12.14, which was higher than the average fair market value price of $1.05 and $1.50 for the three and nine months ended September 30, 2022. At September 30, 2021, the majority of the antidilutive incremental shares were awards granted at an exercise price above $14.49, which was higher than the average fair market value price of $7.30 and $8.30 for the three and nine months ended September 30, 2021.

    For the three and nine months ended September 30, 2022 and September 30, 2021, respectively, no shares were included in the common shares assuming dilution related to the company's issued warrants as the average market price of the company shares for these periods did not exceed the strike price of the warrants.
    Further, upon adoption of ASU 2020-06, effective in 2021 for the company, use of the if-converted earnings per share method is required. However, no shares were included in the weighted average common shares assuming dilution for the three and nine months ended September 30, 2022 and September 30, 2021 related to the company's convertible senior notes as conversion prices were above the company's average stock price for the periods and other requirements for the notes to be convertible to shares were not met.
    XML 43 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Concentration Of Credit Risk
    		 9 Months Ended
    Sep. 30, 2022
    Risks and Uncertainties [Abstract]  
    Concentration Of Credit Risk
    Concentration of Credit Risk

    The company manufactures and distributes durable medical equipment to the home health care, retail and extended care markets. The company performs credit evaluations of its customers’ financial condition. The company utilizes De Lage Landen, Inc. (“DLL”), a third-party financing company, to provide lease financing to Invacare's U.S. customers. The DLL agreement provides for direct leasing between DLL and the Invacare customer. The company retains a recourse obligation of $2,071,000 at September 30, 2022 to DLL for events of default under the contracts, which total $8,588,000 at September 30, 2022. Guarantees, ASC 460, requires the company to record a guarantee liability as it relates to the limited recourse obligation. As such, the company has recorded an immaterial liability for this guarantee obligation within other long-term obligations. The company's recourse is reevaluated by DLL biannually, considers activity between the biannual dates and excludes any receivables purchased by the company from DLL. The company monitors the collections status of these contracts and has provided amounts for estimated losses in its allowances for doubtful accounts in accordance with Receivables, ASC 310-10-05-4. Credit losses are provided for in the financial statements.






























    Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities located throughout the United States, Australia, Canada, New Zealand and Europe or also direct from governmental entities in certain countries. A significant portion of products sold to dealers, both foreign and domestic, is ultimately funded through government reimbursement programs such as Medicare and Medicaid. Changes in these programs can have a significant shift in reimbursement to customers from managed care entities. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability. In addition, reimbursement guidelines in the home health care industry have a substantial impact on the nature and type of equipment an end user can obtain as well as the timing of reimbursement and, thus, affect the product mix, pricing and payment patterns of the company’s customers.
    XML 44 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Derivatives
    		 9 Months Ended
    Sep. 30, 2022
    Derivative Instruments and Hedging Activities Disclosure [Abstract]  
    Derivatives
    Derivatives

    ASC 815 requires companies to recognize all derivative instruments in the condensed consolidated balance sheets as either assets or liabilities at fair value. The accounting for changes in fair value of a derivative is dependent upon whether or not the derivative has been designated and qualifies for hedge accounting treatment and the type of hedging relationship. For derivatives designated and qualifying as hedging instruments, the company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

    Cash Flow Hedging Strategy

    The company uses derivative instruments in an attempt to manage its exposure to transactional foreign currency exchange risk. Foreign forward exchange contracts are used to manage the price risk associated with forecasted sales denominated in foreign currencies and the price risk associated with forecasted purchases of inventory over the next twelve months.

    The company recognizes its derivative instruments as assets or liabilities in the condensed consolidated balance sheets measured at fair value. All of the company’s derivative instruments are designated and qualify as cash flow hedges. Accordingly, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The remaining gain or loss on the derivative instrument in excess of the cumulative change in the fair value of the hedged item, if any, is recognized in current earnings during the period of change.



















    To protect against increases/decreases in forecasted foreign currency cash flows resulting from inventory purchases/sales over the next year, the company utilizes foreign currency forward contracts to hedge portions of its forecasted purchases/sales denominated in foreign currencies. The gains and losses are included in cost of products sold and selling, general and administrative expenses on the condensed consolidated statements of comprehensive income (loss). If it is later determined that a hedged forecasted transaction is unlikely to occur, any prospective gains or losses on the forward contracts would be recognized in earnings. The company does not expect any material amount of hedge ineffectiveness related to forward contract cash flow hedges during the next twelve months.

    The company has historically not recognized any material amount of ineffectiveness related to forward contract cash flow hedges because the company generally limits its hedges to between 50% and 90% of total forecasted transactions for a given entity’s exposure to currency rate changes and the transactions hedged are recurring in nature. Furthermore, most of the hedged transactions are related to intercompany sales and purchases for which settlement occurs on a specific day each month. Forward contracts with a total notional amount in USD of $67,853,000 and $90,800,000 matured during the nine months ended September 30, 2022 and September 30, 2021, respectively, compared to $29,189,000 and $32,685,000 during the three month ended September 30, 2022 and September 30, 2021, respectively.






    Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):
     September 30, 2022December 31, 2021
     Notional
    Amount    		Unrealized
    Net Gain
    (Loss)    		Notional
    Amount    		Unrealized
    Net Gain
    (Loss)
    USD / EUR3,492 441 — — 
    USD / CAD4,523 (343)— — 
    EUR / GBP5,961 179 — — 
    EUR / NOK689 (5)— — 
    NOK / SEK1,089 (43)— — 
    USD / MXN1,089 70 23 1 
    $16,843 $299 $23 $1 

    Derivatives Not Qualifying or Designated for Hedge Accounting Treatment

    The company utilizes foreign currency forward contracts that are not designated as hedges in accordance with ASC 815. These contracts are entered into to eliminate the risk associated with the settlement of short-term intercompany trading receivables and payables between Invacare Corporation and its foreign subsidiaries. The currency forward contracts are entered into at the same time as the intercompany
    receivables or payables are created so that upon settlement, the gain/loss on the settlement is offset by the gain/loss on the foreign currency forward contract. No material net gain or loss was realized by the company in 2022 or 2021 related to these contracts and the associated short-term intercompany trading receivables and payables.

    Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2022 and 2021, respectively, and outstanding were as follows (in thousands USD):
     September 30, 2022December 31, 2021
     Notional
    Amount    		Gain
    (Loss)    		Notional
    Amount    		Gain
    (Loss)
    USD / AUD$1,194 $104 $3,792 $(57)
    USD / CAD19,765 (272)14,556 (24)
    USD / EUR73,507 (1,852)70,454 (1,104)
    USD / DKK5,099 (137)10,850 (257)
    USD / GBP— — 4,028 32 
    USD / NOK4,790 (467)2,352 (81)
    USD / SEK1,880 (72)2,344 (131)
    EUR / GBP1,200 36 — — 
    EUR / NOK1,099 (8)— — 
    AUD / NZD17,082 (163)7,366 (17)
    USD / THB4,310 278 4,500 86 
    EUR / SEK2,353 (10)— — 
    $132,279 $(2,563)$120,242 $(1,553)
    The fair values of the company’s derivative instruments were as follows (in thousands):
     September 30, 2022December 31, 2021
     AssetsLiabilitiesAssetsLiabilities
    Derivatives designated as hedging instruments under ASC 815
    Foreign currency forward exchange contracts$690 $391 $1 $— 
    Derivatives not designated as hedging instruments under ASC 815
    Foreign currency forward exchange contracts1,936 4,499 385 1,938 
    Total derivatives$2,626 $4,890 $386 $1,938 

    The fair values of the company’s foreign currency forward exchange contract assets and liabilities are included in Other Current Assets and Accrued Expenses, respectively in the condensed consolidated balance sheets.

    The effect of derivative instruments on Accumulated Other Comprehensive Income (Loss) (OCI) and the condensed consolidated Statements of comprehensive income (loss) was as follows (in thousands):
    Derivatives (foreign currency forward exchange contracts) in ASC 815 cash flow hedge
    relationships    		Amount of Gain
    (Loss) Recognized in Accumulated OCI on Derivatives
    (Effective Portion)    		Amount of Gain (Loss)
    Reclassified from
    Accumulated OCI into
    Income (Effective
    Portion)    		Amount of Gain (Loss)
    Recognized in Income on
    Derivatives (Ineffective Portion and Amount Excluded from
    Effectiveness Testing)
    Three months ended September 30, 2022
    Foreign currency forward exchange contracts$59 $1,275 $1,002 
    Nine months ended September 30, 2022
    Foreign currency forward exchange contracts$2,197 $1,961 $1,117 
    Three months ended September 30, 2021
    Foreign currency forward exchange contracts$944 $(309)$51 
    Nine months ended September 30, 2021
    Foreign currency forward exchange contracts$(643)$(1,219)$(37)
    Derivatives (foreign currency forward exchange contracts) not designated as hedging
    instruments under ASC 815    		  Amount of Gain (Loss)
    Recognized in Income on Derivatives
    Three months ended September 30, 2022
    Foreign currency forward exchange contracts$2,072 
    Nine months ended September 30, 2022
    Foreign currency forward exchange contracts$(2,563)
    Three months ended September 30, 2021
    Foreign currency forward exchange contracts$(592)
    Nine months ended September 30, 2021
    Foreign currency forward exchange contracts$(1,315)
    The gains or losses recognized as the result of the settlement of cash flow hedge foreign currency forward contracts are recognized in net sales for hedges of inventory sales and in cost of products sold for hedges of inventory purchases. For the three and nine months ended September 30, 2022, net sales were increased by $68,000 and $125,000, while cost of products sold was decreased by $1,263,000 and $1,997,000 for net pre-tax realized gains of $1,331,000 and
    $2,122,000, respectively. For the three and nine months ended September 30, 2021, net sales were decreased by $476,000 and $657,000 while cost of products sold was decreased by $92,000 and increased by $746,000 for net realized pre-tax losses of $384,000 and $1,403,000, respectively.

    A gain of $2,072,000 and $2,563,000 was recognized in selling, general and administrative (SG&A) expenses for the
    three and nine months ended September 30, 2022 compared to a loss of $592,000 and a loss of $1,315,000 for the three and nine months ended September 30, 2021 related to forward contracts not designated as hedging instruments. The forward contracts were entered into to offset gains/losses that were also recorded in SG&A expenses on intercompany trade receivables or payables. The gains/losses on the non-designated hedging instruments were substantially offset by gains/losses on intercompany trade payables.

    The company's derivative agreements provide the counterparties with a right of set off in the event of a default. The right of set off would enable the counterparty to offset any net payment due by the counterparty to the company under the applicable agreement by any amount due by the company to the counterparty under any other agreement. For example, the terms of the agreement would permit a counterparty to a derivative contract that is also a lender under the company's
    Prior Credit Agreement and ABL Credit Agreement to reduce any derivative settlement amounts owed to the company under the derivative contract by any amounts owed to the counterparty by the company under the Prior Credit Agreement and ABL Credit Agreement. In addition, the agreements contain cross-default provisions that could trigger a default by the company under the agreement in the event of a default by the company under another agreement with the same counterparty.

    During the third quarter of 2022, the company entered into privately negotiated Secured Convertible 2026 Notes of $31,106,000 in aggregate principal amount. Convertible debt conversion liabilities of $1,423,000 were recorded based on initial fair values and these fair values are updated quarterly with the offset to the income statement. Refer to "Long-Term Debt" in the notes to the condensed consolidated financial statements for more detail.
    The fair values of the outstanding convertible note derivatives as of September 30, 2022 and their effect on the Statement of Comprehensive Income (Loss) were as follows (in thousands):
     Gain
     Fair ValueThree and Nine Months Ended
    September 30, 2022September 30, 2022
    Secured Convertible 2026 Notes conversion long-term liability$473 $950 
    The secured convertible 2026 notes conversion liability amounts are included in Other Long-Term Obligations in the company's condensed consolidated balance sheets.
    XML 45 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Fair Values
    		 9 Months Ended
    Sep. 30, 2022
    Fair Value Disclosures [Abstract]  
    Fair Value of Financial Instruments
    Fair Values

    Pursuant to ASC 820, the inputs used to derive the fair value of assets and liabilities are analyzed and assigned a level I, II or III priority, with level I being the highest and level III being the lowest in the hierarchy. Level I inputs are quoted prices in active markets for identical assets or liabilities.


    Level II inputs are quoted prices for similar assets or liabilities in active markets: quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets. Level III inputs are based on valuations derived from valuation techniques in which one or more significant inputs are unobservable.
    The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):
     Basis for Fair Value Measurements at Reporting Date
    Quoted Prices in Active
    Markets for Identical
    Assets / (Liabilities)    		Significant Other
    Observable
    Inputs    		Significant Other
    Unobservable
    Inputs
    Level ILevel IILevel III
    September 30, 2022
    Forward exchange contracts—net—$(2,264)—
    Secured convertible 2026 debt conversion liability—(473)—
    December 31, 2021
    Forward exchange contracts—net—$(1,552)—

    The carrying values and fair values of the company’s financial instruments are as follows (in thousands):
     September 30, 2022December 31, 2021
     Carrying ValueFair ValueCarrying ValueFair Value
    Cash and cash equivalents$45,439 $45,439 $83,745 $83,745 
    Forward contracts in Other current assets2,626 2,626 386 386 
    Forward contracts in Accrued expenses(4,890)(4,890)(1,938)(1,938)
    Total debt (including current maturities of long-term debt) *(335,279)(272,485)(308,129)(259,472)
    2022 Notes— — (2,642)(2,632)
    Series I 2024 Notes(72,341)(62,887)(72,140)(64,897)
    Series II 2024 Notes(75,764)(63,963)(78,251)(74,165)
    2026 Notes(80,898)(36,832)(119,036)(81,718)
    2026 Secured Notes(27,463)(25,369)— — 
    2026 Term Loan(59,724)(64,345)— — 
    Other(19,089)(19,089)(36,060)(36,060)
    Secured convertible 2026 debt conversion liability in Other Long-Term Obligations(473)(473)— — 
    ________
    * The company's total debt is shown net of discount and fees associated with the convertible senior notes and term loan due in 2022, 2024 and 2026 on the company's condensed consolidated balance sheets. Accordingly, the fair values due in 2022, 2024 and 2026 are included in the long-term debt presented in this table are also shown net of fees. Total debt amounts exclude operating and finance lease obligations.
    The company, in estimating its fair value disclosures for financial instruments, used the following methods and assumptions:

    Cash, cash equivalents: The carrying value reported in the balance sheet for cash, cash equivalents equals its fair value. The fair values are deemed to be categorized as Level 1.

    Forward Contracts: The company operates internationally, and as a result, is exposed to foreign currency fluctuations. Specifically, the exposure includes intercompany loans and third-party sales or payments. In an attempt to reduce this exposure, foreign currency forward contracts are utilized and accounted for as hedging instruments. The forward contracts are used to hedge the following currencies: AUD, CAD, DKK, EUR, GBP, MXN, NOK, NZD, SEK, THB, and USD. The company does not use derivative financial instruments for speculative purposes. Fair values for the company’s foreign exchange forward contracts are based on quoted market prices for contracts with similar maturities. The fair values are deemed to be categorized as Level 2. The company's forward contracts are included in Other Current Assets or Accrued Expenses in the condensed consolidated balance sheets.

    Total debt: Fair value for the company’s convertible debt other than the 2026 Secured Notes and Term Loan is based on quoted market-based estimates as of the end of the period, while the revolving credit facility fair value is based on an estimate of the market for similar borrowing arrangements. The fair values are deemed to be categorized as Level 2 in the fair value hierarchy. The 2026 Secured Notes and Term Loan fair values are based on valuation models in which significant inputs are observable in active markets. The fair values are deemed to be categorized as Level 2. Other total debt is primarily attributable to credit facilities borrowings where the carrying value reported in the balance approximates its fair value.

    Convertible debt derivative: The fair value for the convertible debt conversion liability is based on valuation models in which significant inputs are observable in active markets. The fair values are deemed to be categorized as Level 2.
    XML 46 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Business Segments
    		 9 Months Ended
    Sep. 30, 2022
    Segment Reporting [Abstract]  
    Business Segments
    Business Segments
    The company operates in two primary business segments: North America and Europe with each selling the company's primary product categories, which include: lifestyle, mobility and seating and respiratory therapy products. Sales in Asia Pacific are reported in All Other and include products similar to those sold in North America and Europe. The accounting policies of each segment are the same as those described in the summary of significant accounting policies for the company's condensed consolidated financial statements. Intersegment sales and transfers are based on the costs to manufacture plus a reasonable profit element.

    Segment performance is measured and resources are allocated based on a number of factors, with the primary income or loss measure being segment operating income (loss). Segment operating income (loss) represents net sales less cost of products sold less selling general and administrative expenses. Segment operating income (loss)
    excludes unallocated corporate general and administrative expenses not allocated to the segments and intersegment sales and profit eliminations, which are included in All Other. In addition, segment operating income (loss) further excludes charges related to restructuring activities, asset impairment and gain on sale of business (as applicable).

    This performance measure, segment operating income (loss), is used by the Chief Operating Decision Maker (CODM) for purposes of making decisions about allocating resources to a segment and assessing its performance. In addition, this metric is reviewed by the company's Board of Directors regarding segment performance and is a key metric in the performance management assessment of the company's employees.


    The information by segment is as follows (in thousands):
     For the Three Months Ended September 30,For the Nine Months Ended September 30,
    2022202120222021
    Revenues from external customers
    Europe$97,487 $127,026 $328,334 $361,097 
    North America65,314 88,054 209,351 260,275 
    All Other (Asia Pacific)7,607 9,120 22,728 24,894 
    Consolidated$170,408 $224,200 $560,413 $646,266 
    Intersegment revenues
    Europe$2,763 $6,221 $11,327 $17,758 
    North America5,738 15,044 24,274 45,903 
    Consolidated$8,501 $21,265 $35,601 $63,661 
    Restructuring charges before income taxes
    Europe$5,034 $255 $9,766 $1,501 
    North America2,332 122 5,534 975 
    All Other1,074 — 1,083 — 
    Consolidated$8,440 $377 $16,383 $2,476 
    Operating income (loss)
    Europe$(2,588)$9,554 $4,126 $18,378 
    North America(15,007)(1,523)(29,607)(2,308)
    All Other(6,391)(3,856)(21,981)(19,025)
    Charges related to restructuring activities(8,440)(377)(16,383)(2,476)
    Impairment of an intangible asset(1,012)— (1,012)— 
    Impairment of goodwill— (28,564)— (28,564)
    Consolidated operating loss(33,438)(24,766)(64,857)(33,995)
    Net gain on convertible debt derivatives950 — 950 — 
    Net gain on debt extinguishment6,398 10,131 6,398 9,422 
    Net interest expense(7,344)(6,284)(19,825)(18,098)
    Loss before income taxes$(33,434)$(20,919)$(77,334)$(42,671)
    Net sales by product, are as follows (in thousands):
    For the Three Months Ended September 30,For the Nine Months Ended September 30,
    2022202120222021
    Europe
    Lifestyle$46,881 $61,683 $162,942 $181,628 
    Mobility and Seating43,778 56,535 139,010 152,660 
    Respiratory Therapy2,262 4,225 11,847 13,613 
    Other(1)4,566 4,583 14,535 13,196 
    $97,487 $127,026 $328,334 $361,097 
    North America
    Lifestyle$34,379 $38,666 $102,516 $114,951 
    Mobility and Seating23,453 28,414 74,876 82,243 
    Respiratory Therapy7,236 20,856 31,384 62,429 
    Other(1)246 118 575 652 
    $65,314 $88,054 $209,351 $260,275 
    All Other (Asia Pacific)
    Mobility and Seating$3,311 $3,171 $8,989 $9,239 
    Lifestyle2,556 3,230 8,239 8,736 
    Respiratory Therapy407 1,215 1,538 2,547 
    Other(1)1,333 1,504 3,962 4,372 
    $7,607 $9,120 $22,728 $24,894 
    Total Consolidated$170,408 $224,200 $560,413 $646,266 
       ________________________
    (1)Includes various services, including repair services, equipment rentals and external contracting.
    XML 47 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Contingencies
    		 9 Months Ended
    Sep. 30, 2022
    Commitments and Contingencies Disclosure [Abstract]  
    Contingencies
    Contingencies
    General

    In the ordinary course of its business, the company is a defendant in a number of lawsuits, primarily product liability actions in which various plaintiffs seek damages for injuries allegedly caused by defective products. All the product liability lawsuits that the company faces in the United States have been referred to the company's captive insurance company and/or excess insurance carriers while all non-U.S. lawsuits have been referred to the company's commercial insurance carriers. All such lawsuits are generally contested vigorously. The coverage territory of the company's insurance is worldwide with the exception of those countries with respect to which, at the time the product is sold for use or at the time a claim is made, the U.S. government has suspended or prohibited diplomatic or trade relations. The amount recorded for identified contingent liabilities is based on estimates. Amounts recorded are reviewed periodically and adjusted to reflect additional technical and legal information that becomes available. Actual costs to be incurred in future periods may vary from the estimates, given the inherent uncertainties in evaluating certain exposures.

    As a medical device manufacturer, the company is subject to extensive government regulation, including numerous laws directed at preventing fraud and abuse and laws regulating reimbursement under various government programs. The marketing, invoicing, documenting, developing, testing, manufacturing, labeling, promoting, distributing and other practices of health care suppliers and medical device manufacturers are all subject to government scrutiny. Most of the company's facilities are subject to inspection at any time by the FDA or similar medical device regulatory agencies in other jurisdictions. Violations of law or regulations can result in administrative, civil and criminal penalties and sanctions, which could have a material adverse effect on the company's business.

    Medical Device Regulatory Matters

    The FDA in the United States and comparable medical device regulatory authorities in other jurisdictions regulate virtually all aspects of the marketing, invoicing, documenting, development, testing, manufacturing, labeling, promotion, distribution and other practices regarding medical devices. The company and its products are subject to the laws and regulations of the FDA and other regulatory bodies in the various jurisdictions where the company's products are manufactured or sold. The company's failure to comply with the regulatory requirements of the FDA and other applicable medical device regulatory requirements can subject the company to administrative or judicially imposed sanctions or
    enforcement actions. These sanctions include injunctions, consent decrees, warning letters, civil penalties, criminal penalties, product seizure or detention, product recalls and total or partial suspension of production.
    In December 2012, the company became subject to a consent decree of injunction filed by the FDA with respect to the company's Corporate facility and its Taylor Street manufacturing facility in Elyria, Ohio. The consent decree initially limited the company's (i) manufacture and distribution of power and manual wheelchairs, wheelchair components and wheelchair sub-assemblies at or from its Taylor Street manufacturing facility ("Taylor Street products") , except in verified cases of medical necessity, (ii) design activities related to wheelchairs and power beds that take place at the impacted Elyria facilities and (iii) replacement, service and repair of products already in use from the Taylor Street manufacturing facility. Under the terms of the consent decree, in order to resume full operations, the company had to successfully complete independent, third-party expert certification audits at the impacted Elyria facilities, comprising three distinct certification reports separately submitted to, and subject to acceptance by, the FDA; submit its own report to the FDA; and successfully complete a reinspection by the FDA of the company's Corporate and Taylor Street facilities.
    On July 24, 2017, following its June 2017 reinspection of the Corporate and Taylor Street facilities, the FDA notified the company that it was in substantial compliance with the FDA Act, FDA regulations and the terms of the consent decree and, that the company was permitted to resume full operations at those facilities including the resumption of unrestricted sales of products made in those facilities.
    The consent decree will continue in effect for at least five years from July 24, 2017, during which time the company's Corporate and Taylor Street facilities must complete two semi-annual audits in the first year and then four annual audits in the next four years performed by an independent company-retained audit firm. The expert audit firm will determine whether the facilities remain in continuous compliance with the Federal Food, Drug and Cosmetic Act ("FDA Act"), FDA regulations and the terms of the consent decree and issue post audit reports contemporaneously to the FDA, and the FDA has the authority to inspect these facilities and any other FDA registered facility, at any time.
    The FDA has continued to actively inspect the company's facilities, other than through the processes established under the consent decree. The company expects that the FDA will, from time to time, inspect substantially all the company's domestic and foreign FDA-registered facilities.
    In 2021, FDA conducted an inspection of the company’s Corporate and Taylor Street facilities from May 25 through June 24, 2021. At the close of the inspection, six FDA Form 483 observations were issued, and the company timely responded to FDA, has diligently taken actions to address FDA’s inspectional observations, and has provided FDA monthly updates on the corrective actions taken to address these observations. On November 18, 2021, the company received a warning letter from the FDA concerning certain of the inspectional observations in the June 2021 FDA Form 483 related to the complaint handling process, the corrective and preventive action (“CAPA”) process, and medical device reporting (“MDR”) associated with oxygen concentrators (the “Warning Letter”). On November 16, 2021, the company received a consent decree non-compliance letter from the FDA concerning the same complaint and CAPA handling matters as in the Warning Letter observations but associated with the Taylor Street products (this letter, together with the Warning Letter, the “FDA Letters”). The company timely responded to the FDA Letters, has diligently taken actions to address FDA’s concerns, and has provided FDA with periodic updates on the corrective actions taken to address the matters in the FDA Letters. The company remains committed to resolving the FDA’s concerns; however, it is not possible to predict the outcome or timing of a resolution at this time. There can be no assurance that the FDA will be satisfied with the company’s responses to the FDA Letters, nor any assurance as to the timeframe that may be required for the company to adequately address the FDA’s concerns or whether the matters in the FDA Letters will result in an extension in the duration of the consent decree. As of the date of filing of the company’s Quarterly Report on Form 10-Q, there has been no impact on the Company’s ability to produce and market its products as a result of the FDA Letters.

    Under the consent decree, the FDA has the authority to order the company to take a wide variety of actions if the FDA finds that the company is not in compliance with the consent decree, FDA Act or FDA regulations, including requiring the company to cease all operations relating to Taylor Street products. The FDA also can order the company to undertake a partial cessation of operations or a recall, issue a safety alert, public health advisory, or press release, or to take any other corrective action the FDA deems necessary with respect to Taylor Street products.

    The FDA also has authority under the consent decree to assess liquidated damages of $15,000 per violation per day for any violations of the consent decree, FDA regulations or the FDA Act. The FDA also may assess liquidated damages for shipments of adulterated or misbranded devices in the amount of twice the sale price of any such adulterated or misbranded device. The liquidated damages, if assessed, are limited to a total of $7,000,000 for each calendar year. The authority to
    assess liquidated damages is in addition to any other remedies otherwise available to the FDA, including civil money penalties.
    The results of regulatory claims, proceedings, investigations, or litigation are difficult to predict. An unfavorable resolution or outcome of the FDA Letters, any other FDA warning letters or inspectional observations, or other FDA enforcement related to company facilities, could materially and adversely affect the company's business, financial condition, and results of operations.
    The limitations previously imposed by the FDA consent decree negatively affected net sales in the North America segment and, to a certain extent, the Asia Pacific region beginning in 2012. The limitations led to delays in new product introductions. Further, uncertainty regarding how long the limitations would be in effect limited the company's ability to renegotiate and bid on certain customer contracts and otherwise led to a decline in customer orders.
    Although the company has been permitted to resume full operations at the Corporate and Taylor Street facilities, the negative effect of the consent decree on customer orders and net sales in the North America segment and Asia Pacific region has been considerable, and it is uncertain as to whether, or how quickly, the company will be able to rebuild net sales to more typical historical levels, irrespective of market conditions. Accordingly, when compared to the company's historic results, the previous limitations in the consent decree had, and likely may continue to have, a material adverse effect on the company's business, financial condition and results of operations.
    Warranty Matters
    The company's warranty reserves are subject to adjustment in future periods based on historical analysis of warranty claims and as new developments occur that may change the company's estimates related to specific product recalls. Refer to Current Liabilities in the notes to the condensed consolidated financial statements for the total provision amounts and a reconciliation of the changes in the warranty accrual.
    Any of the above contingencies could have an adverse impact on the company's financial condition or results of operations.
    For additional information regarding the consent decree, other regulatory matters, and risks and trends that may impact the company’s financial condition or results of operations, please see the following sections of the company's Annual Report on Form 10-K for the year ended December 31, 2021: Item 1. Business - Government Regulation and Item 1A. Risk Factors; Item 3. Legal Proceedings; and Item 7. Management's
    Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources.
    XML 48 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Accounting Policies (Policies)
    		 9 Months Ended
    Sep. 30, 2022
    Accounting Policies [Abstract]  
    Principles of Consolidation Principles of Consolidation: The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2022 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2022 and 2021, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year.
    Use of Estimates Use of Estimates: The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.
    Recent Accounting Pronouncements Recent Accounting Pronouncements (Already Adopted):
    New Accounting Pronouncements, Not yet Adopted In March 2020, the FASB issued ASU 2020-04 "Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting," which is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burden related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates if certain criteria are met. The guidance may be adopted in any period prior to the guidance expiration on December 31, 2022. The company adopted ASU 2020-04 effective January 1, 2022 and the adoption did not have a material impact on the company's financial statements. Interest arrangements previously referring to LIBOR prior to adoption, now refer to a secured overnight finance rate (SOFR).
    XML 49 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Receivables (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Receivables [Abstract]  
    Schedule of Accounts Receivable
    Receivables consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Accounts receivable, gross$99,780 $142,806 
    Customer rebate reserve(8,722)(12,267)
    Cash discount reserves(7,174)(9,179)
    Allowance for doubtful accounts(3,214)(3,642)
    Other, principally returns and allowances reserves(565)(603)
    Accounts receivable, net$80,105 $117,115 
    Schedule for Allowance for Credit Losses
    The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):
     Nine Months Ended
    September 30, 2022
    Balance as of beginning of period$3,642 
    Current period provision715 
    Recoveries (direct write-offs), net(1,143)
    Balance as of end of period$3,214 
    Schedule of Installment Receivables
    Installment receivables consist of the following (in thousands):
     September 30, 2022December 31, 2021
     CurrentLong-TermTotalCurrentLong-TermTotal
    Installment receivables$255 $274 $529 $218 $734 $952 
    Allowance for doubtful accounts— — — — — — 
    Installment receivables, net$255 $274 $529 $218 $734 $952 
    Schedule of Installment Receivables Allowance for Doubtful Accounts
    The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):
     Nine Months Ended September 30, 2022Year Ended December 31, 2021
    Balance as of beginning of period$— $487 
    Current period provision (benefit)— (75)
    Direct write-offs charged against the allowance— (412)
    Balance as of end of period$— $— 
    Schedule of Installment Receivables by Class
    Installment receivables by class as of September 30, 2022 consist of the following (in thousands):
     Total
    Installment
    Receivables    		Unpaid
    Principal
    Balance    		Related
    Allowance for
    Doubtful
    Accounts    		Interest
    Income
    Recognized
    Asia Pacific
    Non-Impaired installment receivables with no related allowance recorded529 529 — — 
    Total
    Non-Impaired installment receivables with no related allowance recorded529 529 — — 
    Impaired installment receivables with a related allowance recorded— — — — 
    Total installment receivables$529 $529 $— $— 
    Installment receivables by class as of December 31, 2021 consist of the following (in thousands):
     Total
    Installment
    Receivables    		Unpaid
    Principal
    Balance    		Related
    Allowance for
    Doubtful
    Accounts    		Interest
    Income
    Recognized
    Asia Pacific
    Non-impaired installment receivables with no related allowance recorded952 952 — — 
    Total installment receivables$952 $952 $— $— 
    Schedule of Financing Receivables
    Installment receivables by class as of September 30, 2022 consist of the following (in thousands):
     Total
    Installment
    Receivables    		Unpaid
    Principal
    Balance    		Related
    Allowance for
    Doubtful
    Accounts    		Interest
    Income
    Recognized
    Asia Pacific
    Non-Impaired installment receivables with no related allowance recorded529 529 — — 
    Total
    Non-Impaired installment receivables with no related allowance recorded529 529 — — 
    Impaired installment receivables with a related allowance recorded— — — — 
    Total installment receivables$529 $529 $— $— 
    Installment receivables by class as of December 31, 2021 consist of the following (in thousands):
     Total
    Installment
    Receivables    		Unpaid
    Principal
    Balance    		Related
    Allowance for
    Doubtful
    Accounts    		Interest
    Income
    Recognized
    Asia Pacific
    Non-impaired installment receivables with no related allowance recorded952 952 — — 
    Total installment receivables$952 $952 $— $— 
    Schedule of Aging of Installment Receivables
    The aging of the company’s installment receivables was as follows (in thousands):
    September 30, 2022December 31, 2021
    TotalAsia PacificTotalAsia Pacific
    Current$529 $529 $952 $952 
    0-30 days past due— — — — 
    31-60 days past due— — — — 
    61-90 days past due— — — — 
    90+ days past due— — — — 
    $529 $529 $952 $952 
    XML 50 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Inventories (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Inventory Disclosure [Abstract]  
    Schedule of Inventory
    Inventories consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Raw materials$60,082 $69,371 
    Finished goods49,270 62,124 
    Work in process11,335 12,779 
    Inventories, net$120,687 $144,274 
    XML 51 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Other Current Assets (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
    Schedule of Other Current Assets
    Other current assets consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Tax receivables principally value added taxes$29,152 $21,943 
    Prepaid insurance3,045 4,462 
    Prepaid inventory and freight2,938 2,394 
    Derivatives (foreign currency forward exchange contracts)2,626 386 
    Recoverable income taxes2,440 2,301 
    Service contracts682 304 
    Receivable due from information technology provider612 612 
    Deferred financing fees323 379 
    Prepaid and other current assets6,520 7,255 
    Other Current Assets$48,338 $40,036 
    XML 52 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Other Long-Term Assets (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
    Schedule of Other Assets, Noncurrent
    Other long-term assets consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Cash surrender value of life insurance policies$2,551 $2,481 
    Deferred income taxes1,615 1,540 
    Deferred financing fees726 409 
    Installment receivables274 734 
    Investments85 86 
    Other79 112 
    Other Long-Term Assets$5,330 $5,362 
    XML 53 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Property And Equipment (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Property, Plant and Equipment [Abstract]  
    Property, Plant and Equipment
    Property and equipment consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Machinery and equipment$267,218 $278,347 
    Capitalized software30,904 30,448 
    Land, buildings and improvements24,432 27,299 
    Furniture and fixtures7,970 8,943 
    Leasehold improvements4,730 6,782 
    Property and Equipment, gross335,254 351,819 
    Accumulated depreciation(282,010)(290,898)
    Property and Equipment, net$53,244 $60,921 
    XML 54 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Intangibles (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Goodwill and Intangible Assets Disclosure [Abstract]  
    Schedule of Indefinite-Lived Intangible Assets
    The company's intangibles consist of the following (in thousands):
     
     September 30, 2022December 31, 2021
     Historical
    Cost    		Accumulated
    Amortization    		Historical
    Cost    		Accumulated
    Amortization
    Customer lists$47,041 $47,041 $52,447 $52,447 
    Trademarks20,447 — 24,137 — 
    Developed technology6,973 6,648 7,652 7,149 
    Patents5,471 5,471 5,543 5,543 
    License agreements3,967 1,356 2,905 1,196 
    Other1,148 1,141 1,147 1,140 
    Intangibles$85,047 $61,657 $93,831 $67,475 
    Schedule of Finite-Lived Intangible Assets
    The company's intangibles consist of the following (in thousands):
     
     September 30, 2022December 31, 2021
     Historical
    Cost    		Accumulated
    Amortization    		Historical
    Cost    		Accumulated
    Amortization
    Customer lists$47,041 $47,041 $52,447 $52,447 
    Trademarks20,447 — 24,137 — 
    Developed technology6,973 6,648 7,652 7,149 
    Patents5,471 5,471 5,543 5,543 
    License agreements3,967 1,356 2,905 1,196 
    Other1,148 1,141 1,147 1,140 
    Intangibles$85,047 $61,657 $93,831 $67,475 
    XML 55 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Accrued Expenses (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Payables and Accruals [Abstract]  
    Schedule of Accrued Expenses
    Accrued expenses consist of accruals for the following (in thousands):
    September 30, 2022December 31, 2021
    Taxes other than income taxes, primarily value added taxes$32,221 $23,217 
    Salaries and wages17,177 24,012 
    Professional11,759 8,697 
    Warranty8,576 11,198 
    Freight5,918 5,460 
    Interest5,197 3,297 
    Derivative liabilities (foreign currency forward exchange contracts)4,890 1,938 
    Rebates4,782 6,569 
    IT service contracts4,000 4,013 
    Insurance3,837 625 
    Severance3,450 400 
    Product line exit obligations3,264 — 
    Product liability, current portion2,620 2,362 
    Deferred revenue1,903 4,156 
    Supplemental executive retirement program liability391 391 
    Other items, principally trade accruals6,345 6,636 
    Accrued Expenses$116,330 $102,971 
    Schedule of Product Warranty Liability
    The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):
    Balance as of January 1, 2022$11,198 
    Warranties provided during the period1,842 
    Settlements made during the period(4,596)
    Changes in liability for pre-existing warranties during the period, including expirations132 
    Balance as of September 30, 2022$8,576 
    XML 56 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Long-Term Debt (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Debt Disclosure [Abstract]  
    Schedule of Long-term Debt Instruments
    Debt consists of the following (in thousands):
    September 30, 2022December 31, 2021
    Convertible senior notes at 4.50%, due in June 2022— 2,642 
    Convertible senior notes Series I at 5.00%, due in November 202472,341 72,140 
    Convertible senior notes Series II at 5.00%, due in November 202475,764 78,251 
    Convertible senior notes at 4.25%, due in March 202680,898 119,036 
    Secured convertible senior notes at 5.68%, due in July 202627,463 — 
    Term loan, due in July 202659,724 — 
    Other obligations19,089 36,060 
    335,279 308,129 
    Less current maturities of long-term debt(2,150)(3,107)
    Long-Term Debt$333,129 $305,022 
    Liability Components of Convertible 2022 Note
    The liability components of the 2022 Notes consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Principal amount of liability component$— $2,650 
    Debt fees— (8)
    Net carrying amount of liability component$— $2,642 
    Liability Components of Convertible 2024 Note
    The liability components of the Series I 2024 Notes consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Principal amount of liability component$72,909 $72,909 
    Debt fees(568)(769)
    Net carrying amount of liability component$72,341 $72,140 
    Liability Components of Convertible Series II 2024 Note
    The liability components of the Series II 2024 Notes consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Principal amount of liability component - including accretion$76,433 $79,222 
    Debt fees(669)(971)
    Net carrying amount of liability component$75,764 $78,251 
    Liability Components of Convertible 2026 Note
    The liability components of the 2026 Notes consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Principal amount of liability component$83,525 $125,000 
    Debt fees(2,627)(5,964)
    Net carrying amount of liability component$80,898 $119,036 
    Liability Components of Secured 2026 Notes
    The liability components of the Secured 2026 Notes consist of the following (in thousands):
    September 30, 2022
    Principal amount of liability component$31,106 
    Unamortized discount(1,365)
    Debt fees(2,278)
    Net carrying amount of liability component$27,463 
    Liability Components of Secured Term Loan
    The liability components of the Secured Term Loan consist of the following (in thousands):
    September 30, 2022
    Principal amount of liability component$66,500 
    Unamortized original issuance discount(1,907)
    Debt fees(4,869)
    Net carrying amount of liability component$59,724 
    XML 57 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Other Long-Term Obligations (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Other Liabilities Disclosure [Abstract]  
    Other Noncurrent Liabilities
    Other long-term obligations consist of the following (in thousands):
    September 30, 2022December 31, 2021
    Deferred income taxes$19,385 $21,664 
    Product liability12,010 11,342 
    Deferred compensation5,090 6,174 
    Deferred gain on sale leaseback4,920 5,174 
    Supplemental executive retirement plan liability4,697 5,106 
    Death benefit obligation plan3,499 4,568 
    Uncertain tax obligation including interest2,980 3,171 
    Pension 2,783 7,814 
    Secured Convertible 2026 debt conversion liability473 — 
    Other537 1,783 
    Other Long-Term Obligations$56,374 $66,796 
    XML 58 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Leases and Commitments (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Leases [Abstract]  
    Lease, Cost [Table]
    Lease expenses for the three and nine months ended September 30, 2022 and September 30, 2021, respectively, were as follows (in thousands):
    For the Three Months Ended September 30,For the Nine Months Ended September 30,
    2022202120222021
    Operating leases$1,391 $1,811 $4,421 $5,592 
    Variable and short-term leases616 764 1,961 2,825 
    Total operating leases$2,007 $2,575 $6,382 $8,417 
    Finance lease interest cost$1,062 $1,146 $3,224 $3,487 
    Finance lease depreciation1,055 1,265 3,210 3,807 
    Total finance leases$2,117 $2,411 $6,434 $7,294 
    Schedule of Cash Flow, Supplemental Disclosures [Table]
    Supplemental cash flow amounts for the three and nine months ended September 30, 2022 and September 30, 2021 were as follows (in thousands):
    For the Three Months Ended September 30,For the Nine Months Ended September 30,
    Cash Activity: Cash paid in measurement of amounts for lease liabilities2022202120222021
    Operating leases$1,967 $2,584 $6,266 $8,501 
    Finance leases1,810 2,100 5,478 6,311 
    Total$3,777 $4,684 $11,744 $14,812 
    Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligations2022202120222021
    Operating leases$1,264 $989 $2,429 $5,418 
    Finance leases54 189 969 6,345 
    Total$1,318 $1,178 $3,398 $11,763 
    Weighted-Average Remaining Lease Terms and Discount Rates [Table]
    Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2022 and December 31, 2021, respectively:
    September 30, 2022December 31, 2021
    Weighted-average remaining lease term - finance leases14.9 years15.8 years
    Weighted-average remaining lease term - operating leases4.8 years5.0 years
    Weighted-average discount rate - finance leases6.37%6.43%
    Weighted-average discount rate - operating leases8.07%7.10%
    Lessee, Operating Lease, Liability, Maturity
    Future minimum operating and finance lease commitments, as of September 30, 2022, are as follows (in thousands):
    Finance 
    Leases    		Operating Leases
    2022$1,637 $1,100 
    20236,501 3,192 
    20246,443 2,452 
    20256,353 1,973 
    20266,248 1,209 
    Thereafter65,253 1,615 
    Total future minimum lease payments92,435 11,541 
    Amounts representing interest(31,893)(1,614)
    Present value of minimum lease payments60,542 9,927 
    Less: current maturities of lease obligations(3,031)(3,062)
    Long-term lease obligations$57,511 $6,865 
    Finance Lease, Liability, Fiscal Year Maturity
    Future minimum operating and finance lease commitments, as of September 30, 2022, are as follows (in thousands):
    Finance 
    Leases    		Operating Leases
    2022$1,637 $1,100 
    20236,501 3,192 
    20246,443 2,452 
    20256,353 1,973 
    20266,248 1,209 
    Thereafter65,253 1,615 
    Total future minimum lease payments92,435 11,541 
    Amounts representing interest(31,893)(1,614)
    Present value of minimum lease payments60,542 9,927 
    Less: current maturities of lease obligations(3,031)(3,062)
    Long-term lease obligations$57,511 $6,865 
    XML 59 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Revenue (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
    Revenue Recognition, Multiple-deliverable Arrangements The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2022 and September 30, 2021 (in thousands):
    Three Months Ended September 30, 2022
    ProductServiceTotal
    Europe$94,723 $2,764 $97,487 
    North America65,068 246 65,314 
    All Other6,380 1,227 7,607 
    Total$166,171 $4,237 $170,408 
    % Split98%2%100%
    Nine Months Ended September 30, 2022
    ProductServiceTotal
    Europe$319,467 $8,867 $328,334 
    North America208,776 575 209,351 
    All Other19,067 3,661 22,728 
    Total$547,310 $13,103 $560,413 
    % Split98%2%100%
    Three Months Ended September 30, 2021
    ProductServiceTotal
    Europe$123,671 $3,355 $127,026 
    North America87,936 118 88,054 
    All Other7,788 1,332 9,120 
    Total$219,395 $4,805 $224,200 
    % Split98%2%100%
    Nine Months Ended September 30, 2021
    ProductServiceTotal
    Europe$351,680 $9,417 $361,097 
    North America259,623 652 260,275 
    All Other21,010 3,884 24,894 
    Total$632,313 $13,953 $646,266 
    % Split98%2%100%
    XML 60 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Equity Compensation (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Share-based Payment Arrangement [Abstract]  
    Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
    The amounts of equity-based compensation expense recognized as part of SG&A expenses in All Other in business segment reporting were as follows (in thousands):
    For the Nine Months Ended September 30,
    20222021
    Restricted stock and restricted stock units$2,653 $4,570 
    Performance shares and performance share units(814)799 
    Total stock-based compensation expense$1,839 $5,369 
    Schedule of Unrecognized Compensation Cost, Nonvested Awards
    As of September 30, 2022, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan, which is related to non-vested awards, was as follows (in thousands):
    September 30, 2022
    Restricted stock and restricted stock units$2,826 
    Performance shares and performance share units168 
    Total unrecognized stock-based compensation expense$2,994 
    Schedule of Share-based Compensation, Stock Options, Activity
    The following table summarizes information about stock option activity for the nine months ended September 30, 2022:
    Weighted Average
    Exercise Price
    Options outstanding at January 1, 2022750,159 $12.69 
    Expired(107,987)13.48
    Options outstanding at September 30, 2022642,172 $12.55 
    Options exercise price range at September 30, 2022$12.15 to$14.49 
    Options exercisable at September 30, 2022642,172 
    Shares available for grant under the 2018 Plan at September 30, 2022*5,507,144 
    ________
     *    Shares available for grant under the 2018 Plan as of September 30, 2022 are reduced by awards and increased by forfeitures or expirations
    Schedule of Share-based Compensation, Stock Options Outstanding
    The following table summarizes information about stock options outstanding at September 30, 2022:
     Options OutstandingOptions Exercisable
    Exercise PricesNumber
    Outstanding at
    September 30, 2022    		Weighted Average
    Remaining
    Contractual Life (Years)    		Weighted Average
    Exercise Price    		Number Exercisable at
    September 30, 2022    		Weighted Average
    Exercise Price
    $12.15 – $14.49
    		642,172 0.8$12.55 642,172 $12.55 
    Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
    The following table summarizes information about restricted stock and restricted stock units (primarily for non-U.S. recipients):
    Weighted Average Fair Value
    Stock / Units unvested at January 1, 20221,160,847 $8.17 
    Granted1,321,249 1.37 
    Vested(553,071)8.43 
    Forfeited(741,679)4.30 
    Stock / Units unvested at
    September 30, 2022    		1,187,346 $2.90 
    Share-based Compensation, Performance Shares Award Unvested Activity
    The following table summarizes information about performance shares and performance share units (primarily for non-U.S. recipients):
     Weighted Average Fair Value
    Shares / Units unvested at January 1, 2022972,288 $7.76 
    Granted460,187 1.48 
    Forfeited(942,201)5.79 
    Shares / Units unvested at
    September 30, 2022    		490,274 $5.67 
    XML 61 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Accumulated Other Comprehensive Income (Loss) by Component (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Equity [Abstract]  
    Schedule of Accumulated Other Comprehensive Income (Loss)
    Changes in accumulated other comprehensive income (loss) ("OCI") (in thousands):
    Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
    June 30, 2022$(13,347)$1,548 $462 $1,453 $(9,884)
    OCI before reclassifications(31,883)(2,168)155 59 (33,837)
    Amount reclassified from accumulated OCI— — (110)(1,275)(1,385)
    Net current-period OCI(31,883)(2,168)45 (1,216)(35,222)
    September 30, 2022$(45,230)$(620)$507 $237 $(45,106)
    Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
    December 31, 2021$18,961 $2,127 $(4,101)$1 $16,988 
    OCI before reclassifications(64,191)(2,747)4,772 2,197 (59,969)
    Amount reclassified from accumulated OCI— — (164)(1,961)(2,125)
    Net current-period OCI(64,191)(2,747)4,608 236 (62,094)
    September 30, 2022$(45,230)$(620)$507 $237 $(45,106)
    Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
    June 30, 2021$60,381 $2,146 $(4,069)$(1,379)$57,079 
    OCI before reclassifications(19,155)(47)(209)944 (18,467)
    Amount reclassified from accumulated OCI— — 182 309 491 
    Net current-period OCI(19,155)(47)(27)1,253 (17,976)
    September 30, 2021$41,226 $2,099 $(4,096)$(126)$39,103 
    Foreign CurrencyLong-Term NotesDefined Benefit PlansDerivativesTotal
    December 31, 2020$50,329 $(517)$(3,674)$(702)$45,436 
    OCI before reclassifications(9,103)2,616 (440)(643)(7,570)
    Amount reclassified from accumulated OCI— — 18 1,219 1,237 
    Net current-period OCI(9,103)2,616 (422)576 (6,333)
    September 30, 2021$41,226 $2,099 $(4,096)$(126)$39,103 
    Schedule of Amounts Recognized in Other Comprehensive Income (Loss)
    Reclassifications out of accumulated OCI were as follows (in thousands):
    Amount reclassified from OCIAmount reclassified from OCIAffected line item in the Statement of Comprehensive (Income) Loss
    For the Three Months Ended September 30,For the Nine Months Ended September 30,
    2022202120222021
    Defined Benefit Plans 
    Service and interest costs$(110)$182 $(164)$18 Selling, general and administrative expenses
    Tax— — — — Income taxes
    Total after tax$(110)$182 $(164)$18 
    Derivatives
    Foreign currency forward contracts hedging sales$(68)$476 $(125)$657 Net sales
    Foreign currency forward contracts hedging purchases(1,263)(92)(1,997)746 Cost of products sold
    Total loss (income) before tax(1,331)384 (2,122)1,403 
    Tax56 (75)161 (184)Income taxes
    Total after tax$(1,275)$309 $(1,961)$1,219 
    XML 62 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Charges Related To Restructuring Activities (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Restructuring and Related Activities [Abstract]  
    Schedule of Restructuring and Related Costs
    A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2022 is as follows (in thousands):
    SeveranceOtherTotal
    December 31, 2021 Balances
    North America$482 $— $482 
    Total482 — 482 
    Charges
    North America 1,124 538 1,662 
    Europe2,119 — 2,119 
    All Other9 — 9 
    Total 3,252 538 3,790 
    Payments
    North America (422)(538)(960)
    Europe (367)— (367)
    All Other(9)— (9)
    Total (798)(538)(1,336)
    March 31, 2022 Balances
    North America1,184 — 1,184 
    Europe1,752 — 1,752 
    Total$2,936 $— $2,936 
    Charges
    North America$542 998 $1,540 
    Europe1,288 1,325 2,613 
    Total1,830 2,323 4,153 
    Payments
    North America(768)(442)(1,210)
    Europe(1,254)(624)(1,878)
    Total(2,022)(1,066)(3,088)
    June 30, 2022 Balances
    North America958 556 1,514 
    Europe1,786 701 2,487 
    Total$2,744 $1,257 $4,001 
    Charges
    North America116 2,216 2,332 
    Europe1,033 4,001 5,034 
    All Other1,074 — 1,074 
    Total2,223 6,217 8,440 
    Payments
    North America(438)(1,807)(2,245)
    Europe(1,067)(3,041)(4,108)
    All Other(12)— (12)
    Total(1,517)(4,848)(6,365)
    September 30, 2022 Balances
    North America636 965 1,601 
    Europe1,752 1,661 3,413 
    All Other1,062 — 1,062 
    Total$3,450 $2,626 $6,076 
    XML 63 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Net Earnings (Loss) Per Common Share (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Earnings Per Share [Abstract]  
    Schedule of Earnings Per Share, Basic and Diluted
    The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.
    (In thousands except per share data)For the Three Months Ended September 30,For the Nine Months Ended September 30,
    2022202120222021
    Basic
    Weighted average common shares outstanding37,537 35,013 36,073 34,826 
    Net loss$(34,354)$(22,759)$(80,494)$(47,501)
    Net loss per common share$(0.92)$(0.65)$(2.23)$(1.36)
    Diluted
    Weighted average common shares outstanding37,537 35,013 36,073 34,826 
    Share options and awards143 475 168 545 
    Weighted average common shares assuming dilution37,680 35,488 36,241 35,371 
    Net loss$(34,354)$(22,759)$(80,494)$(47,501)
    Net loss per common share *$(0.92)$(0.65)$(2.23)$(1.36)
    ________
    * Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.
    XML 64 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Derivatives (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Derivative Instruments and Hedging Activities Disclosure [Abstract]  
    Schedule of Notional Amounts of Outstanding Derivative Positions
    Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):
     September 30, 2022December 31, 2021
     Notional
    Amount    		Unrealized
    Net Gain
    (Loss)    		Notional
    Amount    		Unrealized
    Net Gain
    (Loss)
    USD / EUR3,492 441 — — 
    USD / CAD4,523 (343)— — 
    EUR / GBP5,961 179 — — 
    EUR / NOK689 (5)— — 
    NOK / SEK1,089 (43)— — 
    USD / MXN1,089 70 23 1 
    $16,843 $299 $23 $1 
    Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location
    Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2022 and 2021, respectively, and outstanding were as follows (in thousands USD):
     September 30, 2022December 31, 2021
     Notional
    Amount    		Gain
    (Loss)    		Notional
    Amount    		Gain
    (Loss)
    USD / AUD$1,194 $104 $3,792 $(57)
    USD / CAD19,765 (272)14,556 (24)
    USD / EUR73,507 (1,852)70,454 (1,104)
    USD / DKK5,099 (137)10,850 (257)
    USD / GBP— — 4,028 32 
    USD / NOK4,790 (467)2,352 (81)
    USD / SEK1,880 (72)2,344 (131)
    EUR / GBP1,200 36 — — 
    EUR / NOK1,099 (8)— — 
    AUD / NZD17,082 (163)7,366 (17)
    USD / THB4,310 278 4,500 86 
    EUR / SEK2,353 (10)— — 
    $132,279 $(2,563)$120,242 $(1,553)
    Schedule of Derivatives Instruments Statements of Financial Position, Fair Value
    The fair values of the company’s derivative instruments were as follows (in thousands):
     September 30, 2022December 31, 2021
     AssetsLiabilitiesAssetsLiabilities
    Derivatives designated as hedging instruments under ASC 815
    Foreign currency forward exchange contracts$690 $391 $1 $— 
    Derivatives not designated as hedging instruments under ASC 815
    Foreign currency forward exchange contracts1,936 4,499 385 1,938 
    Total derivatives$2,626 $4,890 $386 $1,938 
    Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)
    The effect of derivative instruments on Accumulated Other Comprehensive Income (Loss) (OCI) and the condensed consolidated Statements of comprehensive income (loss) was as follows (in thousands):
    Derivatives (foreign currency forward exchange contracts) in ASC 815 cash flow hedge
    relationships    		Amount of Gain
    (Loss) Recognized in Accumulated OCI on Derivatives
    (Effective Portion)    		Amount of Gain (Loss)
    Reclassified from
    Accumulated OCI into
    Income (Effective
    Portion)    		Amount of Gain (Loss)
    Recognized in Income on
    Derivatives (Ineffective Portion and Amount Excluded from
    Effectiveness Testing)
    Three months ended September 30, 2022
    Foreign currency forward exchange contracts$59 $1,275 $1,002 
    Nine months ended September 30, 2022
    Foreign currency forward exchange contracts$2,197 $1,961 $1,117 
    Three months ended September 30, 2021
    Foreign currency forward exchange contracts$944 $(309)$51 
    Nine months ended September 30, 2021
    Foreign currency forward exchange contracts$(643)$(1,219)$(37)
    Derivatives (foreign currency forward exchange contracts) not designated as hedging
    instruments under ASC 815    		  Amount of Gain (Loss)
    Recognized in Income on Derivatives
    Three months ended September 30, 2022
    Foreign currency forward exchange contracts$2,072 
    Nine months ended September 30, 2022
    Foreign currency forward exchange contracts$(2,563)
    Three months ended September 30, 2021
    Foreign currency forward exchange contracts$(592)
    Nine months ended September 30, 2021
    Foreign currency forward exchange contracts$(1,315)
    Fair Value of Convertible Note Derivative The fair values of the outstanding convertible note derivatives as of September 30, 2022 and their effect on the Statement of Comprehensive Income (Loss) were as follows (in thousands):
     Gain
     Fair ValueThree and Nine Months Ended
    September 30, 2022September 30, 2022
    Secured Convertible 2026 Notes conversion long-term liability$473 $950 
    The secured convertible 2026 notes conversion liability amounts are included in Other Long-Term Obligations in the company's condensed consolidated balance sheets.
    XML 65 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Fair Values (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Fair Value Disclosures [Abstract]  
    Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
    The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):
     Basis for Fair Value Measurements at Reporting Date
    Quoted Prices in Active
    Markets for Identical
    Assets / (Liabilities)    		Significant Other
    Observable
    Inputs    		Significant Other
    Unobservable
    Inputs
    Level ILevel IILevel III
    September 30, 2022
    Forward exchange contracts—net—$(2,264)—
    Secured convertible 2026 debt conversion liability—(473)—
    December 31, 2021
    Forward exchange contracts—net—$(1,552)—
    Fair Value, by Balance Sheet Grouping
    The carrying values and fair values of the company’s financial instruments are as follows (in thousands):
     September 30, 2022December 31, 2021
     Carrying ValueFair ValueCarrying ValueFair Value
    Cash and cash equivalents$45,439 $45,439 $83,745 $83,745 
    Forward contracts in Other current assets2,626 2,626 386 386 
    Forward contracts in Accrued expenses(4,890)(4,890)(1,938)(1,938)
    Total debt (including current maturities of long-term debt) *(335,279)(272,485)(308,129)(259,472)
    2022 Notes— — (2,642)(2,632)
    Series I 2024 Notes(72,341)(62,887)(72,140)(64,897)
    Series II 2024 Notes(75,764)(63,963)(78,251)(74,165)
    2026 Notes(80,898)(36,832)(119,036)(81,718)
    2026 Secured Notes(27,463)(25,369)— — 
    2026 Term Loan(59,724)(64,345)— — 
    Other(19,089)(19,089)(36,060)(36,060)
    Secured convertible 2026 debt conversion liability in Other Long-Term Obligations(473)(473)— — 
    ________
    * The company's total debt is shown net of discount and fees associated with the convertible senior notes and term loan due in 2022, 2024 and 2026 on the company's condensed consolidated balance sheets. Accordingly, the fair values due in 2022, 2024 and 2026 are included in the long-term debt presented in this table are also shown net of fees. Total debt amounts exclude operating and finance lease obligations.
    XML 66 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Business Segments (Tables)
    		 9 Months Ended
    Sep. 30, 2022
    Segment Reporting [Abstract]  
    Schedule of Segment Reporting Information, by Segment
    The information by segment is as follows (in thousands):
     For the Three Months Ended September 30,For the Nine Months Ended September 30,
    2022202120222021
    Revenues from external customers
    Europe$97,487 $127,026 $328,334 $361,097 
    North America65,314 88,054 209,351 260,275 
    All Other (Asia Pacific)7,607 9,120 22,728 24,894 
    Consolidated$170,408 $224,200 $560,413 $646,266 
    Intersegment revenues
    Europe$2,763 $6,221 $11,327 $17,758 
    North America5,738 15,044 24,274 45,903 
    Consolidated$8,501 $21,265 $35,601 $63,661 
    Restructuring charges before income taxes
    Europe$5,034 $255 $9,766 $1,501 
    North America2,332 122 5,534 975 
    All Other1,074 — 1,083 — 
    Consolidated$8,440 $377 $16,383 $2,476 
    Operating income (loss)
    Europe$(2,588)$9,554 $4,126 $18,378 
    North America(15,007)(1,523)(29,607)(2,308)
    All Other(6,391)(3,856)(21,981)(19,025)
    Charges related to restructuring activities(8,440)(377)(16,383)(2,476)
    Impairment of an intangible asset(1,012)— (1,012)— 
    Impairment of goodwill— (28,564)— (28,564)
    Consolidated operating loss(33,438)(24,766)(64,857)(33,995)
    Net gain on convertible debt derivatives950 — 950 — 
    Net gain on debt extinguishment6,398 10,131 6,398 9,422 
    Net interest expense(7,344)(6,284)(19,825)(18,098)
    Loss before income taxes$(33,434)$(20,919)$(77,334)$(42,671)
    Revenue from External Customer [Line Items]  
    Revenue from External Customers by Products and Services [Table Text Block]
    Net sales by product, are as follows (in thousands):
    For the Three Months Ended September 30,For the Nine Months Ended September 30,
    2022202120222021
    Europe
    Lifestyle$46,881 $61,683 $162,942 $181,628 
    Mobility and Seating43,778 56,535 139,010 152,660 
    Respiratory Therapy2,262 4,225 11,847 13,613 
    Other(1)4,566 4,583 14,535 13,196 
    $97,487 $127,026 $328,334 $361,097 
    North America
    Lifestyle$34,379 $38,666 $102,516 $114,951 
    Mobility and Seating23,453 28,414 74,876 82,243 
    Respiratory Therapy7,236 20,856 31,384 62,429 
    Other(1)246 118 575 652 
    $65,314 $88,054 $209,351 $260,275 
    All Other (Asia Pacific)
    Mobility and Seating$3,311 $3,171 $8,989 $9,239 
    Lifestyle2,556 3,230 8,239 8,736 
    Respiratory Therapy407 1,215 1,538 2,547 
    Other(1)1,333 1,504 3,962 4,372 
    $7,607 $9,120 $22,728 $24,894 
    Total Consolidated$170,408 $224,200 $560,413 $646,266 
       ________________________
    (1)Includes various services, including repair services, equipment rentals and external contracting.
    XML 67 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Receivables (Narrative) (Details)
    		 9 Months Ended
    Sep. 30, 2022
    USD ($)
    payment
    Accounts, Notes, Loans and Financing Receivable [Line Items]  
    Contingent Liability, Guarantee $ 393,000
    Number of missed payments before delinquent | payment 3
    Credit amount requiring additional analysis $ 250,000
    Average period of adjudication 18 months
    Risk Level, Low  
    Accounts, Notes, Loans and Financing Receivable [Line Items]  
    Receivables, Expected Loss Percentage, North America excluding Canada 1.00%
    Receivables, Expected Loss Percentage, Canada 0.10%
    Receivables, Expected Loss Percentage, Europe 0.30%
    Receivables, Expected Loss Percentage, AsiaPac 1.00%
    Risk Level, Medium  
    Accounts, Notes, Loans and Financing Receivable [Line Items]  
    Receivables, Expected Loss Percentage, Canada 0.70%
    Risk Level, High  
    Accounts, Notes, Loans and Financing Receivable [Line Items]  
    Receivables, Expected Loss Percentage, Canada 2.80%
    XML 68 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Receivables (Schedule of Accounts Receivable) (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2022
    Dec. 31, 2021
    Schedule of Accounts Receivable [Abstract]    
    Accounts receivable, gross $ 99,780 $ 142,806
    Customer rebate reserve (8,722) (12,267)
    Cash discount reserves (7,174) (9,179)
    Allowance for doubtful accounts (3,214) (3,642)
    Other, principally returns and allowances reserves (565) (603)
    Accounts Receivable, Net $ 80,105 $ 117,115
    XML 69 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Receivables Schedule for Allowance for Credit Losses (Details) - USD ($)
    $ in Thousands
    		 9 Months Ended
    Sep. 30, 2022
    Dec. 31, 2021
    Financing Receivable, Allowance for Credit Losses [Line Items]    
    Allowance for Credit Losses $ 3,214 $ 3,642
    Allowance for Loan and Lease Losses, Adjustments, Other 715  
    Financing Receivable, Allowance for Credit Losses, Write-downs $ 1,143  
    XML 70 R52.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Receivables (Installment Recevables) (Details) - USD ($)
    Sep. 30, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Receivables [Abstract]      
    Non-Impaired Financing Receivable, Related Allowance $ 0    
    Installment Receivables, Current 255,000 $ 218,000  
    Installment Receivables, Long-Term 274,000 734,000  
    Total Installment Receivables 529,000 952,000  
    Total Unearned Interest (1,903,000) (4,156,000)  
    Allowance for doubtful accounts, current 0 0  
    Allowance for doubtful accounts, long-term 0 0  
    Allowance for doubtful accounts 0 0 $ (487,000)
    Installment receivables, net 255,000 218,000  
    Installment receivables, net, long-term 274,000 734,000  
    Installment receivables, net $ 529,000 $ 952,000  
    XML 71 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Receivables (Rollforward of Allowance for Doubtful Accounts) (Details) - USD ($)
    $ in Thousands
    		 9 Months Ended 12 Months Ended
    Sep. 30, 2022
    Dec. 31, 2021
    Allowance for Doubtful Accounts [Roll Forward]    
    Balance as of beginning of period $ 0 $ 487
    Current period provision (benefit) 0 (75)
    Direct write-offs charged against the allowance 0 (412)
    Balance as of end of period $ 0 $ 0
    XML 72 R54.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Receivables (Installment Receivables by Class) (Details) - USD ($)
    $ in Thousands
    		 9 Months Ended 12 Months Ended
    Sep. 30, 2022
    Dec. 31, 2021
    Total Installment Receivables    
    Non-Impaired installment receivables with no related allowance recorded $ 529  
    Impaired installment receivables with a related allowance recorded 0  
    Total installment receivables 529 $ 952
    Unpaid Principal Balance    
    Impaired installment receivables with a related allowance recorded 0  
    Non-Impaired installment receivables with no related allowance recorded 529  
    Total installment receivables 529 952
    Non-Impaired Financing Receivable, Related Allowance 0  
    Related Allowance for Doubtful Accounts    
    Impaired Financing Receivable, Related Allowance 0 0
    Interest Income Recognized    
    Non-Impaired installment receivables with no related allowance recorded 0  
    Impaired Financing Receivable, with Related Allowance, Interest Income, Accrual Method 0  
    Total installment receivables 0 0
    All Other    
    Total Installment Receivables    
    Non-Impaired installment receivables with no related allowance recorded 529 952
    Unpaid Principal Balance    
    Non-Impaired installment receivables with no related allowance recorded 529 952
    Non-Impaired Financing Receivable, Related Allowance 0 0
    Interest Income Recognized    
    Non-Impaired installment receivables with no related allowance recorded $ 0 $ 0
    XML 73 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Receivables (Aging of Installment Receivables) (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2022
    Dec. 31, 2021
    Financing Receivable, Recorded Investment, Past Due [Line Items]    
    0-30 days past due $ 0 $ 0
    31-60 days past due 0 0
    61-90 days past due 0 0
    90+ days past due 0 0
    Installment Receivable, Not Past Due 529 952
    Financing Receivable, Gross 529 952
    All Other    
    Financing Receivable, Recorded Investment, Past Due [Line Items]    
    0-30 days past due 0 0
    31-60 days past due 0 0
    61-90 days past due 0 0
    90+ days past due 0 0
    Installment Receivable, Not Past Due 529 952
    Financing Receivable, Gross $ 529 $ 952
    XML 74 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Inventories (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2022
    Dec. 31, 2021
    Inventory Disclosure [Abstract]    
    Finished goods $ 49,270 $ 62,124
    Raw materials 60,082 69,371
    Work in process 11,335 12,779
    Inventories, net $ 120,687 $ 144,274
    XML 75 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Other Current Assets Components of Other Current Assets (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2022
    Dec. 31, 2021
    Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
    Tax receivables principally value added taxes $ 29,152 $ 21,943
    Prepaid inventory and freight 2,938 2,394
    Receivable due from information technology provider 612 612
    Prepaid insurance 3,045 4,462
    Derivatives (foreign currency forward exchange contracts) 2,626 386
    Recoverable income taxes 2,440 2,301
    Service contracts 682 304
    Deferred financing fees 323 379
    Prepaid and other current assets 6,520 7,255
    Other current assets $ 48,338 $ 40,036
    XML 76 R58.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Other Long-Term Assets Components of Other Long-Term Assets (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2022
    Dec. 31, 2021
    Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
    Cash surrender value of life insurance policies $ 2,551 $ 2,481
    Deferred income taxes 1,615 1,540
    Installment receivables 274 734
    Deferred financing fees 726 409
    Investments 85 86
    Other 79 112
    Other Long-Term Assets $ 5,330 $ 5,362
    XML 77 R59.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Property And Equipment (Details) - USD ($)
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Dec. 31, 2021
    Property, Plant and Equipment [Line Items]          
    Property and equipment, gross $ 335,254,000   $ 335,254,000   $ 351,819,000
    Less allowance for depreciation (282,010,000)   (282,010,000)   (290,898,000)
    Property and equipment, net 53,244,000   53,244,000   60,921,000
    Capitalized Computer Software, Net 26,833,000   26,833,000   28,715,000
    Computer Software Depreciation Expense 832,000 $ 419,000 2,342,000 $ 1,084,000  
    Unpaid Purchases of Property and Equipment 0   0   1,090,000
    Machinery and equipment          
    Property, Plant and Equipment [Line Items]          
    Property and equipment, gross 267,218,000   267,218,000   278,347,000
    Land, buildings and improvements          
    Property, Plant and Equipment [Line Items]          
    Property and equipment, gross 24,432,000   24,432,000   27,299,000
    Furniture and fixtures          
    Property, Plant and Equipment [Line Items]          
    Property and equipment, gross 7,970,000   7,970,000   8,943,000
    Leasehold improvements          
    Property, Plant and Equipment [Line Items]          
    Property and equipment, gross 4,730,000   4,730,000   6,782,000
    Capitalized Software [Member]          
    Property, Plant and Equipment [Line Items]          
    Property and equipment, gross $ 30,904,000   $ 30,904,000   $ 30,448,000
    XML 78 R60.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Goodwill Goodwill Details (Details) - USD ($)
    		 3 Months Ended 9 Months Ended 12 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Dec. 31, 2021
    Goodwill [Line Items]          
    Goodwill, Impairment Test, Discounted Cash Flow, Discount Rate     14.51%   11.19%
    Impairment of Intangible Assets (Excluding Goodwill) $ 1,012,000 $ 0 $ 1,012,000 $ 0  
    XML 79 R61.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Intangibles (Narrative) (Details) - USD ($)
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Finite-Lived Intangible Assets [Line Items]        
    Amortization expense     $ 358,000  
    Impairment of Intangible Assets (Excluding Goodwill) $ 1,012,000 $ 0 $ 1,012,000 $ 0
    Minimum        
    Finite-Lived Intangible Assets [Line Items]        
    Finite-Lived intangible assets, useful life     2 years  
    Maximum        
    Finite-Lived Intangible Assets [Line Items]        
    Finite-Lived intangible assets, useful life     7 years  
    Weighted Average        
    Finite-Lived Intangible Assets [Line Items]        
    Finite-Lived intangible assets, useful life     5 years 9 months 18 days  
    XML 80 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Intangibles (Intangible Table) (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2022
    Dec. 31, 2021
    Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
    Historical Cost $ 85,047 $ 93,831
    Accumulated Amortization 61,657 67,475
    Customer lists    
    Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
    Historical Cost 47,041 52,447
    Accumulated Amortization 47,041 52,447
    Developed technology    
    Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
    Historical Cost 6,973 7,652
    Accumulated Amortization 6,648 7,149
    Patents    
    Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
    Historical Cost 5,471 5,543
    Accumulated Amortization 5,471 5,543
    License agreements    
    Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
    Historical Cost 3,967 2,905
    Accumulated Amortization 1,356 1,196
    Other    
    Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
    Historical Cost 1,148 1,147
    Accumulated Amortization 1,141 1,140
    Trademarks    
    Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]    
    Historical Cost $ 20,447 $ 24,137
    XML 81 R63.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details)
    Sep. 30, 2022
    USD ($)
    Goodwill and Intangible Assets Disclosure [Abstract]  
    Future amortization expense, remainder of fiscal year $ 510,000
    Future amortization expense, 2022 612,000
    Future amortization expense, 2023 547,000
    Future amortization expense, 2024 439,000
    Future amortization expense, 2025 437,000
    Future amortization expense, 2026 $ 311,000
    XML 82 R64.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Accrued Expenses Components of Accrued Expenses (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2022
    Dec. 31, 2021
    Payables and Accruals [Abstract]    
    Taxes other than income taxes, primarily value added taxes $ 32,221 $ 23,217
    Salaries and wages 17,177 24,012
    Warranty 8,576 11,198
    Professional 11,759 8,697
    Freight 5,918 5,460
    Interest 5,197 3,297
    IT service contracts 4,000 4,013
    Deferred revenue 1,903 4,156
    Severance 3,450 400
    Restructuring Reserve, Current 3,264 0
    Rebates 4,782 6,569
    Product liability, current portion 2,620 2,362
    Derivative liabilities (foreign currency forward exchange contracts) 4,890 1,938
    Insurance 3,837 625
    Supplemental executive retirement program liability 391 391
    Other items, principally trade accruals 6,345 6,636
    Accrued expenses $ 116,330 $ 102,971
    XML 83 R65.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Accrued Expenses Warranty Schedule (Details)
    $ in Thousands
    		 9 Months Ended
    Sep. 30, 2022
    USD ($)
    Product Liability Contingency  
    Balance as of January 1, 2022 $ 11,198
    Warranties provided during the period 1,842
    Settlements made during the period (4,596)
    Changes in liability for pre-existing warranties during the period, including expirations 132
    Balance as of September 30, 2022 $ 8,576
    XML 84 R66.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Long-Term Debt (Details) - USD ($)
    		 3 Months Ended 6 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Mar. 31, 2021
    Jun. 30, 2020
    Dec. 31, 2019
    Jun. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Jul. 26, 2022
    Dec. 31, 2021
    Mar. 11, 2021
    Dec. 31, 2020
    Dec. 31, 2017
    Jun. 30, 2017
    Debt Instrument [Line Items]                            
    Long-term debt $ 335,279,000           $ 335,279,000     $ 308,129,000        
    Long-term Debt and Capital Lease Obligations, Current (2,150,000)           (2,150,000)     (3,107,000)        
    Long-term debt net of current maturities 333,129,000           333,129,000     305,022,000        
    Accretion Expense $ 886,000 $ 890,000         $ 2,714,000 $ 2,637,000            
    Accretion Rate 4.70%           4.70%              
    Net gain on debt extinguishment $ 6,398,000 10,131,000         $ 6,398,000 9,422,000            
    Purchases of capped calls           $ 18,787,000 $ 0 18,787,000            
    Cap Price of Capped Call Transaction $ 16.58           $ 16.58              
    Lifetime to date - Accretion Expense             $ 7,558,000              
    Remaining Accretion $ 9,064,000           9,064,000              
    Accretion Expense, net of extinguishment fees 383,000           2,211,000              
    Convertible Subordinated Debt | Convertible Senior Notes at 5.00% February 2021                            
    Debt Instrument [Line Items]                            
    Debt Instrument Exchange Amount       $ 35,375,000 $ 72,909,000                  
    Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024                            
    Debt Instrument [Line Items]                            
    Debt Instrument, Face Amount 72,909,000           72,909,000     72,909,000        
    Debt Instrument, Fee Amount (568,000)           (568,000)     (769,000)        
    Debt Instrument, Net Carrying Amount $ 72,341,000           $ 72,341,000     72,140,000        
    Interest rate (as a percent) 5.00%           5.00%              
    Debt Instrument Repurchase Amount, Cash Paid         6,928,000                  
    Debt Instrument, Increase, Accrued Interest $ 911,000 911,000         $ 2,734,000 2,733,000            
    Percent of the Applicable Conversion Price 130.00%           130.00%              
    Last Reported Sales Price Period, Common Stock             20 days              
    Debt Instrument, Convertible, Threshold Consecutive Trading Days             30              
    Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%           100.00%              
    Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000           $ 1,000              
    Business Day Period             5 years              
    Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%           98.00%              
    Convertible Preferred Stock, Shares Issued upon Conversion 67.6819           67.6819              
    Debt Instrument, Convertible, Conversion Price $ 14.78           $ 14.78              
    Debt Instrument, Fee Amount         $ 1,394,000                  
    Debt Instrument, Interest Rate, Effective Percentage 540.00%           540.00%              
    Debt Instrument, Interest Rate on Liability Component, Effective Percentage 8.80%           8.80%              
    Convertible Subordinated Debt | Series II Convertible Senior Notes at 5.00% November 2024                            
    Debt Instrument [Line Items]                            
    Debt Instrument, Face Amount $ 76,433,000           $ 76,433,000     79,222,000        
    Debt Instrument, Fee Amount (669,000)           (669,000)     (971,000)        
    Debt Instrument, Net Carrying Amount $ 75,764,000           $ 75,764,000     78,251,000        
    Interest rate (as a percent) 5.00%           5.00%              
    Debt Instrument Repurchase Amount, Cash Paid                       $ 5,593,000    
    Debt Instrument Exchange Amount $ 5,000,000     73,875,000                    
    Debt Instrument, Increase, Accrued Interest $ 879,000 923,000         $ 2,726,000 2,770,000            
    Percent of the Applicable Conversion Price 130.00%           130.00%              
    Last Reported Sales Price Period, Common Stock             20 days              
    Debt Instrument, Convertible, Threshold Consecutive Trading Days             30              
    Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%           100.00%              
    Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000           $ 1,000              
    Debt Instrument, Convertible, Threshold Trading Days             10              
    Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%           98.00%              
    Convertible Preferred Stock, Shares Issued upon Conversion 67.6819           67.6819              
    Debt Instrument, Convertible, Conversion Price $ 14.78           $ 14.78              
    Debt Instrument, Loss on Exchange     $ 709,000                      
    Debt Instrument, Fee Amount                       $ 1,505,000    
    Debt Instrument, Interest Rate, Effective Percentage 10.40%           10.40%              
    Debt Instrument, Interest Rate on Liability Component, Effective Percentage 9.00%           9.00%              
    Convertible Subordinated Debt | Convertible Senior Notes at 4.25% March 2026                            
    Debt Instrument [Line Items]                            
    Debt Instrument, Face Amount $ 83,525,000           $ 83,525,000     125,000,000        
    Debt Instrument, Fee Amount (2,627,000)           (2,627,000)     (5,964,000)        
    Debt Instrument, Net Carrying Amount $ 80,898,000           $ 80,898,000     119,036,000        
    Interest rate (as a percent) 4.25%           4.25%              
    Debt Instrument, Increase, Accrued Interest $ 1,015,000 1,328,000         $ 3,671,000 2,892,000            
    Percent of the Applicable Conversion Price 130.00%           130.00%              
    Last Reported Sales Price Period, Common Stock             20 days              
    Debt Instrument, Convertible, Threshold Consecutive Trading Days             30              
    Convertible Senior Notes, Percentage of Principal Required for Repurchase 100.00%           100.00%              
    Convertible Debt, Conversion Rate of Commmon Shares, Principal $ 1,000           $ 1,000              
    Business Day Period             5 days              
    Debt Instrument, Convertible, Threshold Trading Days             10              
    Percent of the Product of the Last Reported Sale Price, Common Shares 98.00%           98.00%              
    Convertible Preferred Stock, Shares Issued upon Conversion 94.6096           94.6096              
    Debt Instrument, Convertible, Conversion Price $ 10.57           $ 10.57              
    Debt Instrument, Fee Amount                     $ 5,697,000      
    Capped Call Options, Outstanding 125,000           125,000              
    Debt Instrument, Interest Rate, Effective Percentage 5.40%           5.40%              
    Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022                            
    Debt Instrument [Line Items]                            
    Debt Instrument, Repurchase Amount     $ 78,850,000                      
    Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022 [Domain]                            
    Debt Instrument [Line Items]                            
    Debt Instrument, Face Amount $ 0           $ 0     2,650,000       $ 120,000,000
    Long-term debt 0           0     2,642,000        
    Debt Instrument, Fee Amount 0           0     (8,000)        
    Debt Instrument, Net Carrying Amount $ 0           $ 0     2,642,000        
    Interest rate (as a percent) 4.50%           4.50%              
    Debt Instrument Repurchase Amount, Cash Paid $ 2,650,000           $ 2,650,000              
    Debt Instrument Exchange Amount       $ 38,500,000                    
    Debt Instrument, Increase, Accrued Interest $ 0 $ 30,000         $ 50,000 $ 829,000            
    Debt Instrument, Fee Amount                         $ 4,711,000  
    Class of Warrant or Right, Outstanding 6,918,006           6,918,006              
    Debt Instrument, Interest Rate on Liability Component, Effective Percentage 10.90%           10.90%              
    Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024 [Domain]                            
    Debt Instrument [Line Items]                            
    Long-term debt $ 72,341,000           $ 72,341,000     72,140,000        
    Debt Instrument, Convertible, Threshold Trading Days             10              
    Convertible Subordinated Debt | Series II Convertible Senior Notes at 5.00% November 2024 [Domain]                            
    Debt Instrument [Line Items]                            
    Long-term debt 75,764,000           $ 75,764,000     78,251,000        
    Business Day Period             5 years              
    Convertible Subordinated Debt | Convertible Senior Notes at 4.25% March 2026 [Domain]                            
    Debt Instrument [Line Items]                            
    Debt Instrument, Face Amount                     $ 125,000,000      
    Long-term debt $ 80,898,000           $ 80,898,000     119,036,000        
    Interest rate (as a percent) 4.25%           4.25%              
    Convertible Subordinated Debt | Convertible Senior Secured Notes at 5.68% July 2026 - July 26, 2022 Issuance [Domain]                            
    Debt Instrument [Line Items]                            
    Long-term debt $ 27,463,000           $ 27,463,000     0        
    Debt Instrument, Increase, Accrued Interest $ 324,000                          
    Debt Instrument, Fee Amount                 $ 2,389,000          
    Debt Instrument, Interest Rate on Liability Component, Effective Percentage 8.70%           8.70%              
    Other Notes and Capital Lease Obligations                            
    Debt Instrument [Line Items]                            
    Long-term debt $ 19,089,000           $ 19,089,000     36,060,000        
    Secured Term Loan - issuance July 26th, 2022 [Domain] | Secured Term Loans due July 2026 [Domain]                            
    Debt Instrument [Line Items]                            
    Long-term debt                   0        
    Secured Debt | Secured Term Loans due July 2026 [Domain]                            
    Debt Instrument [Line Items]                            
    Debt Instrument, Face Amount 66,500,000           66,500,000   $ 104,500,000          
    Long-term debt 59,724,000           59,724,000              
    Debt Instrument, Unamortized Discount (1,907,000)           (1,907,000)              
    Debt Instrument, Fee Amount (4,869,000)           $ (4,869,000)              
    Interest rate (as a percent)                 5.68%          
    Debt Instrument, Increase, Accrued Interest $ 1,217,000                          
    Debt Instrument, Fee Amount                 $ 5,107,000          
    Debt Instrument, Interest Rate on Liability Component, Effective Percentage 12.70%           12.70%              
    Senior secured revolving credit facility, due in October 2015 | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                            
    Debt Instrument [Line Items]                            
    Line of Credit Facility, Fair Value of Amount Outstanding $ 16,900,000           $ 16,900,000     22,150,000        
    Line of Credit Facility, Covenant Feature, Dominion Trigger 7,500,000           7,500,000   $ 4,375,000          
    Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France)                   7,366,000        
    Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK)                   5,986,000        
    Line Of Credit Facility Gross Borrowing Base $ 33,133,000           $ 33,133,000              
    Minimum required undrawn balance (as a percent) 11.25%           11.25%              
    Senior secured revolving credit facility, due in October 2015 | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement) | Maximum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate                            
    Debt Instrument [Line Items]                            
    Basis spread on variable rate             2.75%              
    Senior secured revolving credit facility, due in October 2015 | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement) | Euro Member Countries, Euro                            
    Debt Instrument [Line Items]                            
    Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France)                   6,500,000        
    Senior secured revolving credit facility, due in October 2015 | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement) | United Kingdom, Pounds                            
    Debt Instrument [Line Items]                            
    Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK)                   $ 4,500,000        
    Senior secured revolving credit facility, due in October 2015 | Line of Credit | Revolving Credit and Security Agreement (North America Credit Agreement)                            
    Debt Instrument [Line Items]                            
    Minimum required undrawn balance (as a percent) 12.50%           12.50%              
    Senior secured revolving credit facility, due in October 2015 | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                            
    Debt Instrument [Line Items]                            
    Line of Credit Facility, Covenant Feature, Dominion Trigger $ 3,750,000           $ 3,750,000              
    Minimum required undrawn balance (as a percent) 12.50%           12.50%              
    Remaining borrowing capacity $ 30,000,000           $ 30,000,000              
    Line of Credit Facility, Covenant Feature, Prior Limit 10,000,000           10,000,000              
    Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables 9,000,000           9,000,000              
    Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days $ 3,750,000           $ 3,750,000              
    Senior secured revolving credit facility, due in October 2015 | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement) | Maximum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate                            
    Debt Instrument [Line Items]                            
    Basis spread on variable rate             3.00%              
    XML 85 R67.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Long-Term Debt Components of Convertible Debt (Details) - USD ($)
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Dec. 31, 2021
    Debt Instrument [Line Items]          
    Long-term debt $ 335,279,000   $ 335,279,000   $ 308,129,000
    Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024          
    Debt Instrument [Line Items]          
    Debt Instrument, Increase, Accrued Interest 911,000 $ 911,000 2,734,000 $ 2,733,000  
    Debt Instrument, Face Amount $ 72,909,000   $ 72,909,000   72,909,000
    Interest rate (as a percent) 5.00%   5.00%    
    Debt fees $ (568,000)   $ (568,000)   (769,000)
    Debt Instrument, Net Carrying Amount 72,341,000   72,341,000   72,140,000
    Convertible Subordinated Debt | Convertible Senior Notes at 4.25% March 2026          
    Debt Instrument [Line Items]          
    Debt Instrument, Increase, Accrued Interest 1,015,000 $ 1,328,000 3,671,000 $ 2,892,000  
    Debt Instrument, Face Amount $ 83,525,000   $ 83,525,000   125,000,000
    Interest rate (as a percent) 4.25%   4.25%    
    Debt fees $ (2,627,000)   $ (2,627,000)   (5,964,000)
    Debt Instrument, Net Carrying Amount 80,898,000   80,898,000   119,036,000
    Convertible Subordinated Debt | Convertible Senior Secured Notes at 5.68% July 2026          
    Debt Instrument [Line Items]          
    Debt Instrument, Face Amount 31,106,000   31,106,000    
    Unamortized discount (1,365,000)   (1,365,000)    
    Debt fees (2,278,000)   (2,278,000)    
    Convertible Subordinated Debt | Convertible Senior Secured Notes at 5.68% July 2026 - July 26, 2022 Issuance [Domain]          
    Debt Instrument [Line Items]          
    Debt Instrument, Increase, Accrued Interest 324,000        
    Long-term debt $ 27,463,000   $ 27,463,000   $ 0
    XML 86 R68.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Long-Term Debt Narrative (Details)
    		 3 Months Ended 6 Months Ended 9 Months Ended
    Dec. 31, 2022
    USD ($)
    Sep. 30, 2022
    USD ($)
    d
    $ / shares
    shares
    Sep. 30, 2021
    USD ($)
    Mar. 31, 2021
    USD ($)
    Jun. 30, 2020
    USD ($)
    Dec. 31, 2019
    USD ($)
    Jun. 30, 2017
    USD ($)
    $ / shares
    Jun. 30, 2021
    USD ($)
    Sep. 30, 2022
    USD ($)
    $ / shares
    shares
    Sep. 30, 2021
    USD ($)
    Oct. 03, 2022
    USD ($)
    Jul. 26, 2022
    USD ($)
    $ / shares
    shares
    Dec. 31, 2021
    USD ($)
    Mar. 11, 2021
    USD ($)
    Dec. 31, 2020
    USD ($)
    Dec. 31, 2017
    USD ($)
    Debt Instrument [Line Items]                                
    Payments for Repurchase of Common Stock                 $ 151,000 $ 1,752,000            
    Amortization of debt fees                 1,676,000 1,622,000            
    Net gain on debt extinguishment   $ (6,398,000) $ (10,131,000)           (6,398,000) (9,422,000)            
    Cash surrender value of life insurance policies   2,551,000             2,551,000       $ 2,481,000      
    Borrowing against Cash Surrender Value of Life Insurance   $ 2,000,000             2,000,000              
    Purchases of capped calls               $ 18,787,000 $ 0 18,787,000            
    Cap Price of Capped Call Transaction | $ / shares   $ 16.58             $ 16.58              
    Accretion Expense   $ 886,000 890,000           $ 2,714,000 2,637,000            
    Accretion Rate   4.70%             4.70%              
    Lifetime to date - Accretion Expense                 $ 7,558,000              
    Remaining Accretion   $ 9,064,000             9,064,000              
    Long-term debt   335,279,000             335,279,000       308,129,000      
    Secured Term Loans due July 2026 [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net                       $ 2,000,000        
    Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Fee Amount           $ 1,394,000                    
    Debt Instrument, Face Amount   $ 72,909,000             $ 72,909,000       72,909,000      
    Interest rate (as a percent)   5.00%             5.00%              
    Debt Instrument Repurchase Amount, Cash Paid           6,928,000                    
    Last Reported Sales Price Period, Common Stock                 20 days              
    Debt Instrument, Convertible, Threshold Consecutive Trading Days                 30              
    Percent of the Applicable Conversion Price   130.00%             130.00%              
    Business Day Period                 5 years              
    Percent of the Product of the Last Reported Sale Price, Common Shares   98.00%             98.00%              
    Convertible Senior Notes, Percentage of Principal Required for Repurchase   100.00%             100.00%              
    Convertible Preferred Stock, Shares Issued upon Conversion | shares   67.6819             67.6819              
    Convertible Debt, Conversion Rate of Commmon Shares, Principal   $ 1,000             $ 1,000              
    Debt Instrument, Convertible, Conversion Price | $ / shares   $ 14.78             $ 14.78              
    Debt Instrument, Net Carrying Amount   $ 72,341,000             $ 72,341,000       72,140,000      
    Debt Instrument, Fee Amount   $ (568,000)             $ (568,000)       (769,000)      
    Debt Instrument, Interest Rate, Effective Percentage   540.00%             540.00%              
    Debt Instrument, Increase, Accrued Interest   $ 911,000 911,000           $ 2,734,000 2,733,000            
    Debt Instrument, Interest Rate on Liability Component, Effective Percentage   8.80%             8.80%              
    Convertible Subordinated Debt | Convertible Senior Notes at 5.00% February 2021                                
    Debt Instrument [Line Items]                                
    Debt Instrument Exchange Amount         $ 35,375,000 $ 72,909,000                    
    Convertible Subordinated Debt | Series II Convertible Senior Notes at 5.00% November 2024                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Fee Amount                             $ 1,505,000  
    Debt Instrument, Face Amount   $ 76,433,000             $ 76,433,000       79,222,000      
    Interest rate (as a percent)   5.00%             5.00%              
    Debt Instrument Exchange Amount   $ 5,000,000     73,875,000                      
    Debt Instrument Repurchase Amount, Cash Paid                             $ 5,593,000  
    Last Reported Sales Price Period, Common Stock                 20 days              
    Debt Instrument, Convertible, Threshold Consecutive Trading Days                 30              
    Percent of the Applicable Conversion Price   130.00%             130.00%              
    Debt Instrument, Convertible, Threshold Trading Days                 10              
    Percent of the Product of the Last Reported Sale Price, Common Shares   98.00%             98.00%              
    Convertible Senior Notes, Percentage of Principal Required for Repurchase   100.00%             100.00%              
    Convertible Preferred Stock, Shares Issued upon Conversion | shares   67.6819             67.6819              
    Convertible Debt, Conversion Rate of Commmon Shares, Principal   $ 1,000             $ 1,000              
    Debt Instrument, Convertible, Conversion Price | $ / shares   $ 14.78             $ 14.78              
    Debt Instrument, Net Carrying Amount   $ 75,764,000             $ 75,764,000       78,251,000      
    Debt Instrument, Fee Amount   $ (669,000)             $ (669,000)       (971,000)      
    Debt Instrument, Interest Rate, Effective Percentage   10.40%             10.40%              
    Debt Instrument, Increase, Accrued Interest   $ 879,000 923,000           $ 2,726,000 2,770,000            
    Debt Instrument, Loss on Exchange       $ 709,000                        
    Debt Instrument, Interest Rate on Liability Component, Effective Percentage   9.00%             9.00%              
    Convertible Subordinated Debt | Convertible Senior Notes at 4.25% March 2026                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Fee Amount                           $ 5,697,000    
    Debt Instrument, Face Amount   $ 83,525,000             $ 83,525,000       125,000,000      
    Interest rate (as a percent)   4.25%             4.25%              
    Last Reported Sales Price Period, Common Stock                 20 days              
    Debt Instrument, Convertible, Threshold Consecutive Trading Days                 30              
    Percent of the Applicable Conversion Price   130.00%             130.00%              
    Business Day Period                 5 days              
    Debt Instrument, Convertible, Threshold Trading Days                 10              
    Percent of the Product of the Last Reported Sale Price, Common Shares   98.00%             98.00%              
    Convertible Senior Notes, Percentage of Principal Required for Repurchase   100.00%             100.00%              
    Convertible Preferred Stock, Shares Issued upon Conversion | shares   94.6096             94.6096              
    Convertible Debt, Conversion Rate of Commmon Shares, Principal   $ 1,000             $ 1,000              
    Debt Instrument, Convertible, Conversion Price | $ / shares   $ 10.57             $ 10.57              
    Debt Instrument, Net Carrying Amount   $ 80,898,000             $ 80,898,000       119,036,000      
    Debt Instrument, Fee Amount   $ (2,627,000)             $ (2,627,000)       (5,964,000)      
    Debt Instrument, Interest Rate, Effective Percentage   5.40%             5.40%              
    Debt Instrument, Increase, Accrued Interest   $ 1,015,000 1,328,000           $ 3,671,000 2,892,000            
    Capped Call Options, Outstanding   125,000             125,000              
    Convertible Subordinated Debt | Convertible Senior Notes at 4.25% March 2026 | Round 1 funding (Initial closing) [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument Exchange Amount   $ 41,475,000                            
    Convertible Subordinated Debt | Convertible Senior Notes at 4.25% March 2026 | Subsequent Event                                
    Debt Instrument [Line Items]                                
    Debt Instrument Exchange Amount $ 69,700,000                              
    Convertible Subordinated Debt | Convertible Senior Notes at 4.25% March 2026 | Subsequent Event | Additional amount after closing (round 2) [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument Exchange Amount $ 13,825,000                              
    Convertible Subordinated Debt | Convertible Senior Secured Notes at 5.68% July 2026                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Face Amount   $ 31,106,000             $ 31,106,000              
    Debt Instrument, Convertible, Threshold Consecutive Trading Days | d   30                            
    Debt Instrument, Fee Amount   $ (2,278,000)             (2,278,000)              
    Debt Instrument, Unamortized Discount   $ (1,365,000)             $ (1,365,000)              
    Convertible Subordinated Debt | Convertible Senior Notes at 4.25% March 2026 [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Face Amount                           $ 125,000,000    
    Interest rate (as a percent)   4.25%             4.25%              
    Long-term debt   $ 80,898,000             $ 80,898,000       119,036,000      
    Convertible Subordinated Debt | Series II Convertible Senior Notes at 5.00% November 2024 [Domain]                                
    Debt Instrument [Line Items]                                
    Business Day Period                 5 years              
    Long-term debt   75,764,000             $ 75,764,000       78,251,000      
    Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022 [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Fee Amount                               $ 4,711,000
    Debt Instrument, Face Amount   $ 0         $ 120,000,000   $ 0       2,650,000      
    Interest rate (as a percent)   4.50%             4.50%              
    Debt Instrument Exchange Amount         $ 38,500,000                      
    Debt Instrument Repurchase Amount, Cash Paid   $ 2,650,000             $ 2,650,000              
    Convertible due 2022 - Bond Hedge, Fair Value at Issuance             $ 24,780,000                  
    Derivative, Price Risk Option Strike Price | $ / shares             $ 21.4375                  
    Issuance of warrants             $ 14,100,000                  
    Debt Instrument, Net Proceeds             115,289,000                  
    Debt Instrument, Net Carrying Amount   0             0       2,642,000      
    Debt Instrument, Fee Amount   0             0       (8,000)      
    Derivative, Amount of Hedged Item             $ (10,680,000)                  
    Debt Instrument, Increase, Accrued Interest   $ 0 $ 30,000           $ 50,000 $ 829,000            
    Debt Instrument, Interest Rate on Liability Component, Effective Percentage   10.90%             10.90%              
    Class of Warrant or Right, Outstanding | shares   6,918,006             6,918,006              
    Long-term debt   $ 0             $ 0       2,642,000      
    Convertible Subordinated Debt | Convertible Senior Notes at 5.00% November 2024 [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Convertible, Threshold Trading Days                 10              
    Long-term debt   72,341,000             $ 72,341,000       72,140,000      
    Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Repurchase Amount       $ 78,850,000                        
    Convertible Subordinated Debt | Convertible Senior Subordinated Debentures at 5.00% February 2021 [Domain]                                
    Debt Instrument [Line Items]                                
    Unamortized Financing Costs                 $ 1,043,000              
    Convertible Subordinated Debt | Convertible Senior Secured Notes at 5.68% July 2026 - Tranche I Notes [Domain]                                
    Debt Instrument [Line Items]                                
    Interest rate (as a percent)                       5.68%        
    Convertible Subordinated Debt | Convertible Senior Secured Notes at 5.68% July 2026 - Tranche I Notes [Domain] | Subsequent Event | Additional amount after closing (round 3) [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Face Amount                     $ 5,186,000          
    Convertible Subordinated Debt | Convertible Senior Secured Notes at 5.68% July 2026 - Tranche II Notes [Domain] | Subsequent Event | Additional amount after closing (round 3) [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Face Amount                     5,183,000          
    Convertible Subordinated Debt | Convertible Senior Secured Notes at 5.68% July 2026 - July 26, 2022 Issuance [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Fee Amount                       $ 2,389,000        
    Debt Instrument, Increase, Accrued Interest   $ 324,000                            
    Debt Instrument, Interest Rate on Liability Component, Effective Percentage   8.70%             8.70%              
    Long-term debt   $ 27,463,000             $ 27,463,000       0      
    Secured Debt | Convertible Senior Secured Notes at 5.68% July 2026                                
    Debt Instrument [Line Items]                                
    Interest rate (as a percent)                       5.68%        
    Last Reported Sales Price Period, Common Stock   20 days                            
    Percent of the Applicable Conversion Price                       150.00%        
    Convertible Senior Notes, Percentage of Principal Required for Repurchase                       100.00%        
    Convertible Debt, Conversion Rate of Commmon Shares, Principal                       $ 1,000        
    Debt Instrument, Common Shares Exchanged | shares   2,700,000                            
    Convertible Senior Notes, Holders Aggregate Principal Minimum requirement percentage, in the event of default                       25.00%        
    Convertible Senior Notes, Additional Accrued interest in the Event of Failure to File Requirements under SEC Act of 1934                       0.50%        
    Convertible Senior Notes, Additional Accrued interest in the Event of restrictive legends not being removed as of the 380th day after date of original issuance                       0.50%        
    Debt Instrument, Percent limit on issuing common shares upon Conversion of the New 2026 Notes                       19.99%        
    Secured Debt | Convertible Senior Secured Notes at 5.68% July 2026 | First year of loan period                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Prepayment Premium, Percentage of aggregate principal amount   100.00%                            
    Secured Debt | Convertible Senior Secured Notes at 5.68% July 2026 | Year 2 and on                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Prepayment Premium, Percentage of aggregate principal amount   1.00%                            
    Secured Debt | Convertible Senior Secured Notes at 5.68% July 2026 | Year 2 and on | Subsequent Event                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Additional Prepayment Premium, Percentage of aggregate principal amount 3.00%                              
    Secured Debt | Secured Term Loans due July 2026 [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Fee Amount                       $ 5,107,000        
    Debt Instrument, Face Amount   $ 66,500,000             66,500,000     $ 104,500,000        
    Interest rate (as a percent)                       5.68%        
    Debt Instrument, Fee Amount   (4,869,000)             (4,869,000)              
    Debt Instrument, Unamortized Discount   (1,907,000)             $ (1,907,000)              
    Debt Instrument, Increase, Accrued Interest   $ 1,217,000                            
    Debt instrument, Springing Maturity Date   91 days                            
    Debt Instrument, Debt Default, Amount                       $ 20,000,000        
    Debt Instrument, Interest Rate on Liability Component, Effective Percentage   12.70%             12.70%              
    Long-term debt   $ 59,724,000             $ 59,724,000              
    Secured Debt | Secured Term Loans due July 2026 [Domain] | Initial amount at closing [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Face Amount                       66,500,000        
    Secured Debt | Secured Term Loans due July 2026 [Domain] | Additional amount after closing (round 2) [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Face Amount                       8,500,000        
    Secured Debt | Secured Term Loans due July 2026 [Domain] | Additional amount after closing (round 3) [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Face Amount                       10,000,000        
    Secured Debt | Secured Term Loans due July 2026 [Domain] | Additional amount after closing (round 4) [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Face Amount                       19,500,000        
    Secured Debt | Secured Term Loans due July 2026 [Domain] | Subsequent Event | Additional amount after closing (round 3) [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Face Amount                     18,500,000          
    Secured Debt | Secured Term Loans due July 2026 [Domain] | Subsequent Event | Additional amount after closing (round 4) [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Face Amount                     $ 19,500,000          
    Secured Debt | Convertible Senior Secured Notes at 5.68% July 2026 - Tranche I Notes [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Face Amount                       $ 20,739,000        
    Interest rate (as a percent)                       5.68%        
    Convertible Preferred Stock, Shares Issued upon Conversion | shares                       333.3333        
    Convertible Debt, Conversion Rate of Commmon Shares, Principal                       $ 1,000        
    Debt Instrument, Convertible, Conversion Price | $ / shares                       $ 3.00        
    Secured Debt | Convertible Senior Secured Notes at 5.68% July 2026 - Tranche I Notes [Domain] | Subsequent Event                                
    Debt Instrument [Line Items]                                
    Interest rate (as a percent)                     5.68%          
    Secured Debt | Convertible Senior Secured Notes at 5.68% July 2026 - Tranche II Notes [Domain]                                
    Debt Instrument [Line Items]                                
    Debt Instrument, Face Amount                       $ 20,736,000        
    Convertible Preferred Stock, Shares Issued upon Conversion | shares                       222.222        
    Convertible Debt, Conversion Rate of Commmon Shares, Principal                       $ 1,000        
    Debt Instrument, Convertible, Conversion Price | $ / shares                       $ 4.50        
    Secured Debt | Convertible Senior Secured Notes at 5.68% July 2026 - Tranche II Notes [Domain] | Subsequent Event                                
    Debt Instrument [Line Items]                                
    Interest rate (as a percent)                     568.00%          
    Secured Term Loan - issuance July 26th, 2022 [Domain] | Secured Term Loans due July 2026 [Domain]                                
    Debt Instrument [Line Items]                                
    Long-term debt                         $ 0      
    Revolving Credit Facility | Line of Credit                                
    Debt Instrument [Line Items]                                
    Weighted average interest rate (as a percent)   5.00%             5.00%       4.50%      
    Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Line of Credit Facility, Fair Value of Amount Outstanding   $ 16,900,000             $ 16,900,000       $ 22,150,000      
    Borrowing capacity   60,000,000             60,000,000              
    Additional increase in borrowing capacity available   25,000,000             $ 25,000,000              
    Percentage of domestic accounts receivable                 85.00%              
    Percentage of eligible domestic inventory and in-transit inventory                 70.00%              
    Percentage of net orderly liquidation value of domestic inventory                 85.00%              
    Maximum value of net orderly liquidation value domestic inventory and in-transit inventory   4,000,000             $ 4,000,000              
    Net orderly liquidation value of domestic eligible machinery and equipment                 80.00%              
    Additional amount of machinery and equipment   0             $ 0              
    Percentage of eligible Canadian accounts receivable                 85.00%              
    Percentage of eligible Canadian inventory                 70.00%              
    Percentage of net orderly liquidation value of eligible Canadian inventory                 85.00%              
    Minimum availability reserve   3,000,000             $ 3,000,000              
    Line of Credit Facility, Current Borrowing Capacity   17,336,000             17,336,000              
    Line of Credit Facility, Covenant Feature, Dominion Trigger   $ 7,500,000             $ 7,500,000     $ 4,375,000        
    Minimum required undrawn balance (as a percent)   11.25%             11.25%              
    Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance                 5 days              
    Interruption of material manufacturing facilities, period                 10 days              
    Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France)                         7,366,000      
    Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK)                         5,986,000      
    Line Of Credit Facility Gross Borrowing Base   $ 33,133,000             $ 33,133,000              
    Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement) | Euro Member Countries, Euro                                
    Debt Instrument [Line Items]                                
    Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France)                         6,500,000      
    Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement) | United Kingdom, Pounds                                
    Debt Instrument [Line Items]                                
    Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK)                         4,500,000      
    Revolving Credit Facility | Line of Credit | Secured Revolving Credit and Security Agreement (ABL Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Borrowing capacity                       35,000,000        
    Minimum availability reserve                       $ 3,000,000        
    Debt Instrument, Springing Maturity Date, days prior to maturity of Convertible Notes due 2024   191 days                            
    Debt Instrument, Springing Maturity, days prior to maturity of secured term loans due 2026   100 days                            
    Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Borrowing capacity   $ 30,000,000             $ 30,000,000              
    Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent                 85.00%              
    Minimum availability reserve   3,000,000             $ 3,000,000              
    Line of Credit Facility, Covenant Feature, Dominion Trigger   3,750,000             3,750,000              
    Remaining borrowing capacity   $ 30,000,000             $ 30,000,000              
    Minimum required undrawn balance (as a percent)   12.50%             12.50%              
    Consecutive business days for minimum undrawn balance                 5 days              
    Interruption of material manufacturing facilities, period                 10 days              
    Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days   $ 3,750,000             $ 3,750,000              
    Line of Credit Facility, Covenant Feature, Prior Limit   10,000,000             10,000,000              
    Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables   $ 9,000,000             $ 9,000,000              
    Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (North America Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Minimum required undrawn balance (as a percent)   12.50%             12.50%              
    Letter of Credit                                
    Debt Instrument [Line Items]                                
    Line of Credit Facility, Fair Value of Amount Outstanding   $ 4,902,000             $ 4,902,000       2,585,000      
    Letters of Credit Outstanding, Amount   3,576,000             3,576,000       $ 3,450,000      
    Letter of Credit | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Borrowing capacity   20,000,000             20,000,000              
    Letter of Credit | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Borrowing capacity   5,000,000             5,000,000              
    Swing Line Loans | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Borrowing capacity   2,000,000             2,000,000              
    Amount Available to Invacare Limited and Invacare Poirier SAS | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Borrowing capacity   $ 15,000,000             $ 15,000,000              
    Base Rate | Secured Debt | Secured Term Loans due July 2026 [Domain] | First year of loan period                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate   6.00%                            
    Base Rate | Secured Debt | Secured Term Loans due July 2026 [Domain] | Year 2 and on                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate   7.75%                            
    Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Secured Debt | Secured Term Loans due July 2026 [Domain] | First year of loan period                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate   7.00%                            
    Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Secured Debt | Secured Term Loans due July 2026 [Domain] | Year 2 and on                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate   8.75%                            
    Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Revolving Credit Facility | Line of Credit | Secured Revolving Credit and Security Agreement (ABL Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate   3.25%                            
    Prime Rate | Revolving Credit Facility | Line of Credit | Secured Revolving Credit and Security Agreement (ABL Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate   2.25%                            
    Minimum | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Commitment fee percentage                 0.25%              
    Minimum | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Commitment fee percentage                 0.25%              
    Minimum | Base Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate                 1.25%              
    Minimum | Base Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate                 2.50%              
    Minimum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate                 2.25%              
    Minimum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate                 2.50%              
    Maximum | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Commitment fee percentage                 0.375%              
    Maximum | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Commitment fee percentage                 0.375%              
    Maximum | Base Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate                 1.75%              
    Maximum | Base Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate                 3.00%              
    Maximum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (New Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate                 2.75%              
    Maximum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Revolving Credit Facility | Line of Credit | Revolving Credit and Security Agreement (Europe Credit Agreement)                                
    Debt Instrument [Line Items]                                
    Basis spread on variable rate                 3.00%              
    XML 87 R69.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Long-Term Debt Sale Leaseback Transactions (Details)
    Apr. 23, 2015
    USD ($)
    Sale Leaseback Transactions [Abstract]  
    Sale Leaseback Transaction, Deferred Gain, Gross $ 7,414,000
    XML 88 R70.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Other Long-Term Obligations (Details) - USD ($)
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Dec. 31, 2021
    Apr. 23, 2015
    Other Liabilities Disclosure [Abstract]            
    Deferred income taxes $ 19,385,000   $ 19,385,000   $ 21,664,000  
    Product liability 12,010,000   12,010,000   11,342,000  
    Pension 2,783,000   2,783,000   7,814,000  
    Deferred compensation 5,090,000   5,090,000   6,174,000  
    Deferred gain on sale leaseback, Net 4,920,000   4,920,000   5,174,000  
    Supplemental executive retirement plan liability 4,697,000   4,697,000   5,106,000  
    Death benefit obligation plan 3,499,000   3,499,000   4,568,000  
    Uncertain tax obligation including interest 2,980,000   2,980,000   3,171,000  
    Other 537,000   537,000   1,783,000  
    Other Long-Term Obligations 56,374,000   56,374,000   66,796,000  
    Sale Leaseback Transaction, Deferred Gain, Gross           $ 7,414,000
    Sale and Leaseback Transaction, Gain (Loss), Net 82,000 $ 80,000 245,000 $ 237,000    
    Convertible Debt Derivative $ 473,000   $ 473,000   $ 0  
    XML 89 R71.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Leases and Commitments (Details) - USD ($)
    		 3 Months Ended 9 Months Ended
    Apr. 23, 2015
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2015
    Sep. 30, 2022
    Sep. 30, 2021
    Lessee, Lease, Description [Line Items]            
    Sale Leaseback Transaction, Lease Term         20 years  
    Sale and Leaseback Transaction, Gain (Loss), Net   $ 82,000 $ 80,000   $ 245,000 $ 237,000
    Sale Leaseback Transaction, Annual Payments         $ 2,275,000  
    Sale Leaseback Transaction, Net Proceeds, Investing Activities       $ 23,000,000    
    Sale Leaseback Transaction, Lease Terms         Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases.  
    Sale Leaseback Transaction, Deferred Gain, Gross $ 7,414,000          
    Sale Leaseback Transaction, Immediate Loss Recognized 257,000          
    Capital Lease Obligations $ 32,339,000          
    Minimum            
    Lessee, Lease, Description [Line Items]            
    General Lease Term         1 year  
    Maximum            
    Lessee, Lease, Description [Line Items]            
    General Lease Term         20 years  
    XML 90 R72.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Leases and Commitments Lease Expenses (Details) - USD ($)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Leases [Abstract]        
    Operating Lease, Expense $ 1,391 $ 1,811 $ 4,421 $ 5,592
    Short-term Lease, Cost 616 764 1,961 2,825
    Operating Lease, Cost 2,007 2,575 6,382 8,417
    Finance Lease, Interest Expense 1,062 1,146 3,224 3,487
    Finance Lease, Right-of-Use Asset, Amortization 1,055 1,265 3,210 3,807
    Financing Lease, Cost $ 2,117 $ 2,411 $ 6,434 $ 7,294
    XML 91 R73.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2022
    Dec. 31, 2021
    Leases [Abstract]    
    Finance Lease, Liability, Payments, Due Next Twelve Months $ 1,637  
    2022 1,100  
    Finance Lease, Liability, Payments, Due Year Two 6,501  
    2023 3,192  
    Finance Lease, Liability, Payments, Due Year Three 6,443  
    Finance Lease, Liability, Payments, Due Year Four 6,353  
    Finance Lease, Liability, Payments, Due Year Five 6,248  
    2026 1,209  
    Finance Lease, Liability, Payments, Due after Year Five 65,253  
    Thereafter 1,615  
    Finance Lease, Liability, Payments, Due 92,435  
    Total future minimum lease payments 11,541  
    Financing Leases, Future Minimum Payments, Interest Included in Payments (31,893)  
    Operating Leases, Future Minimum Payments, Interest Included in Payments (1,614)  
    Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments 60,542  
    Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments 9,927  
    Finance Lease, Liability, Current (3,031) $ (3,009)
    Operating Lease, Liability, Current (3,062) (4,217)
    Financing Lease Liability, non-current 57,511  
    Operating Leases Long-Term Obligations 6,865 $ 8,234
    2024 2,452  
    2025 $ 1,973  
    XML 92 R74.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Leases and Commitments Supplemental Cash Flow Information (Details) - USD ($)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Leases [Abstract]        
    Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities $ 1,967 $ 2,584 $ 6,266 $ 8,501
    Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities 1,810 2,100 5,478 6,311
    Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 1,264 989 2,429 5,418
    Right-of-Use Asset Obtained in Exchange for Finance Lease Liability 54 189 969 6,345
    Right-of-Use Asset Obtained in Exchange for Total Lease Liability 1,318 1,178 3,398 11,763
    Total Cash Paid in Measurement of Amounts for Lease Liabilities $ 3,777 $ 4,684 $ 11,744 $ 14,812
    XML 93 R75.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details)
    Sep. 30, 2022
    Dec. 31, 2021
    Leases [Abstract]    
    Finance Lease, Weighted Average Remaining Lease Term 14 years 10 months 24 days 15 years 9 months 18 days
    Operating Lease, Weighted Average Remaining Lease Term 4 years 9 months 18 days 5 years
    Finance Lease, Weighted Average Discount Rate, Percent 6.37% 6.43%
    Operating Lease, Weighted Average Discount Rate, Percent 8.07% 7.10%
    XML 94 R76.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Revenue (Details) - USD ($)
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Dec. 31, 2021
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Net Sales $ 170,408,000 $ 224,200,000 $ 560,413,000 $ 646,266,000  
    Net Revenue 100.00% 100.00% 100.00% 100.00%  
    Deferred Revenue $ 1,903,000   $ 1,903,000   $ 4,156,000
    Product          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Net Sales $ 166,171,000 $ 219,395,000 $ 547,310,000 $ 632,313,000  
    Net Revenue 98.00% 98.00% 98.00% 98.00%  
    Service          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Net Sales $ 4,237,000 $ 4,805,000 $ 13,103,000 $ 13,953,000  
    Net Revenue 2.00% 2.00% 2.00% 2.00%  
    Europe (EMEA)          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Net Sales $ 97,487,000 $ 127,026,000 $ 328,334,000 $ 361,097,000  
    Europe (EMEA) | Product          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Net Sales 94,723,000 123,671,000 319,467,000 351,680,000  
    Europe (EMEA) | Service          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Net Sales 2,764,000 3,355,000 8,867,000 9,417,000  
    North America (NA)          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Net Sales 65,314,000 88,054,000 209,351,000 260,275,000  
    North America (NA) | Product          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Net Sales 65,068,000 87,936,000 208,776,000 259,623,000  
    North America (NA) | Service          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Net Sales 246,000 118,000 575,000 652,000  
    All Other          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Net Sales 7,607,000 9,120,000 22,728,000 24,894,000  
    All Other | Product          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Net Sales 6,380,000 7,788,000 19,067,000 21,010,000  
    All Other | Service          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Net Sales $ 1,227,000 $ 1,332,000 $ 3,661,000 $ 3,884,000  
    General Terms and Conditions          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Contract Type Sales Split     30.00%    
    Large National Customers          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Contract Type Sales Split     23.00%    
    Government Tenders          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Contract Type Sales Split     22.00%    
    Other Customers          
    Revenue Recognition, Multiple-deliverable Arrangements [Line Items]          
    Contract Type Sales Split     25.00%    
    XML 95 R77.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Equity Compensation (Narrative) (Details)
    $ / shares in Units, $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    USD ($)
    $ / shares
    shares
    Sep. 30, 2021
    USD ($)
    Sep. 30, 2022
    USD ($)
    votes
    $ / shares
    shares
    Sep. 30, 2021
    USD ($)
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Common Stock, Par or Stated Value Per Share | $ / shares $ 0.25   $ 0.25  
    Share-based Compensation Arrangement by Share-based Payment Award, Description     The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of stock options or stock appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a stock option or a SAR will count against the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003 Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share.  
    Allocated Share-based Compensation Expense | $ $ (495) $ (1,250) $ (814) $ 131
    Selling, General and Administrative Expenses        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Allocated Share-based Compensation Expense | $     $ 1,839 5,369
    Performance Shares        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Award requisite service period     3 years  
    Performance achievement level, lower range     0.00%  
    Performance achievement level, upper range     150.00%  
    Performance achievement level, target range     100.00%  
    Performance Shares | Selling, General and Administrative Expenses        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Allocated Share-based Compensation Expense | $     $ (814) $ 799
    Stock Options        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Expiration period     10 years  
    Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares [1] 5,507,144   5,507,144  
    2013 Plan [Member]        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 Plan | shares 910,624   910,624  
    Weighted Average | Performance Shares        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Period for recognition of unrecognized compensation costs     3 years  
    Class B Common Shares [Member]        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Common Stock, Number of Votes | votes     10  
    Common Stock, Shares, Issued | shares 3,667   3,667  
    Common Stock [Member]        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Common Stock, Holders Percentage of Total Outstanding     99.90%  
    [1]  *    Shares available for grant under the 2018 Plan as of September 30, 2022 are reduced by awards and increased by forfeitures or expirations. At September 30, 2022, an aggregate of 910,624 Common Shares underlie awards which were forfeited or expired unexercised under the 2003 and 2013 Plans and thus are available for future issuance under the 2018 Plan upon transfer.
    XML 96 R78.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Equity Compensation Share-based Compensation Expense (Details) - USD ($)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
    Allocated Share-based Compensation Expense $ (495) $ (1,250) $ (814) $ 131
    Selling, General and Administrative Expenses        
    Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
    Allocated Share-based Compensation Expense     1,839 5,369
    Restricted Stock and Restricted Stock Units (RSUs) | Selling, General and Administrative Expenses        
    Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
    Allocated Share-based Compensation Expense     2,653 4,570
    Performance Shares | Selling, General and Administrative Expenses        
    Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
    Allocated Share-based Compensation Expense     $ (814) $ 799
    XML 97 R79.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Equity Compensation Unrecognized Compensation Expense (Details)
    $ in Thousands
    Sep. 30, 2022
    USD ($)
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
    Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 2,994
    Performance Shares  
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
    Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized 168
    Restricted Stock and Restricted Stock Units (RSUs)  
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
    Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 2,826
    XML 98 R80.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Equity Compensation (Options Activity) (Details)
    		 9 Months Ended
    Sep. 30, 2022
    $ / shares
    shares
    Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
    Options outstanding at beginning of period (in shares) | shares 750,159
    Canceled (in shares) | shares (107,987)
    Options outstanding at end of period (in shares) | shares 642,172
    Weighted Average Exercise Price  
    Options outstanding at beginning of period - Weighted Average Exercise Price (in dollars per share) $ 12.69
    Canceled - Weighted Average Exercise Price (in dollars per share) 13.48
    Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share) $ 12.55
    Options exercisable at end of period (in shares) | shares 642,172
    Stock Options  
    Weighted Average Exercise Price  
    Options available for grant at end of period (in shares) | shares 5,507,144 [1]
    $12.15 – $14.49  
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
    Exercise price range, lower limit (in dollars per share) $ 12.15
    $12.15 – $14.49 | Stock Options  
    Weighted Average Exercise Price  
    Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share) 12.55
    Range of Exercise Price Max [Member]  
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
    Exercise price range, upper limit (in dollars per share) $ 14.49
    [1]  *    Shares available for grant under the 2018 Plan as of September 30, 2022 are reduced by awards and increased by forfeitures or expirations. At September 30, 2022, an aggregate of 910,624 Common Shares underlie awards which were forfeited or expired unexercised under the 2003 and 2013 Plans and thus are available for future issuance under the 2018 Plan upon transfer.
    XML 99 R81.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Equity Compensation (Stock Options Outstanding by Exercise Price) (Details) - $ / shares
    		 9 Months Ended
    Sep. 30, 2022
    Dec. 31, 2021
    Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
    Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 12.55 $ 12.69
    $12.15 – $14.49    
    Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
    Exercise price range, lower limit (in dollars per share) 12.15  
    $12.15 – $14.49 | Minimum    
    Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
    Exercise price range, upper limit (in dollars per share) 12.15  
    $12.15 – $14.49 | Maximum    
    Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
    Exercise price range, upper limit (in dollars per share) $ 14.49  
    Stock Options | $12.15 – $14.49    
    Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]    
    Options Outstanding - Number Outstanding at end of period (in shares) 642,172  
    Options Outstanding - Weighted Average Remaining Contractual Life 9 months 18 days  
    Options Outstanding - Weighted Average Exercise Price (in dollars per share) $ 12.55  
    Options Exercisable - Number Exercisable At end of period (in shares) 642,172  
    Options Exercisable - Weighted Average Exercise Price (in dollars per share) $ 12.55  
    XML 100 R82.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Equity Compensation Restricted Stock Activity (Details) - Restricted Stock and Restricted Stock Units (RSUs)
    		 9 Months Ended
    Sep. 30, 2022
    $ / shares
    shares
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance | shares 1,160,847
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 1,321,249
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares (741,679)
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance | shares 1,187,346
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 8.17
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares 1.37
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares 4.30
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 2.90
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares 553,071
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares $ 8.43
    XML 101 R83.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Equity Compensation Performance Share Activity (Details) - Performance Shares - $ / shares
    		 9 Months Ended
    Sep. 30, 2022
    Dec. 31, 2021
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 490,274 972,288
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 5.67 $ 7.76
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 460,187  
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 1.48  
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (942,201)  
    Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value $ 5.79  
    XML 102 R84.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details) - USD ($)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
    Beginning Balance $ (9,884) $ 57,079 $ 16,988 $ 45,436
    OCI before reclassifications (33,837) (18,467) (59,969) (7,570)
    Amount reclassified from accumulated OCI (1,385) 491 (2,125) 1,237
    Other Comprehensive Loss (35,222) (17,976) (62,094) (6,333)
    Ending Balance (45,106) 39,103 (45,106) 39,103
    Accumulated Translation Adjustment [Member]        
    Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
    Beginning Balance (13,347) 60,381 18,961 50,329
    OCI before reclassifications (31,883) (19,155) (64,191) (9,103)
    Amount reclassified from accumulated OCI 0 0 0 0
    Other Comprehensive Loss (31,883) (19,155) (64,191) (9,103)
    Ending Balance (45,230) 41,226 (45,230) 41,226
    Accumulated Long-Term Notes Adjustment [Member]        
    Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
    Beginning Balance 1,548 2,146 2,127 (517)
    OCI before reclassifications (2,168) (47) (2,747) 2,616
    Amount reclassified from accumulated OCI 0 0 0 0
    Other Comprehensive Loss (2,168) (47) (2,747) 2,616
    Ending Balance (620) 2,099 (620) 2,099
    Accumulated Defined Benefit Plans Adjustment [Member]        
    Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
    Beginning Balance 462 (4,069) (4,101) (3,674)
    OCI before reclassifications 155 (209) 4,772 (440)
    Amount reclassified from accumulated OCI (110) 182 (164) 18
    Other Comprehensive Loss 45 (27) 4,608 (422)
    Ending Balance 507 (4,096) 507 (4,096)
    Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]        
    Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]        
    Beginning Balance 1,453 (1,379) 1 (702)
    OCI before reclassifications 59 944 2,197 (643)
    Amount reclassified from accumulated OCI (1,275) 309 (1,961) 1,219
    Other Comprehensive Loss (1,216) 1,253 236 576
    Ending Balance $ 237 $ (126) $ 237 $ (126)
    XML 103 R85.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details) - USD ($)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
    Cost of Products Sold $ 139,029 $ 163,890 $ 433,323 $ 470,500
    Amortization of prior service costs and unrecognized gains 55,365 56,135 174,552 178,721
    Income tax provision (920) (1,840) (3,160) (4,830)
    Net Sales (170,408) (224,200) (560,413) (646,266)
    Accumulated Defined Benefit Plans Adjustment [Member] | Reclassification out of Accumulated Other Comprehensive Income        
    Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
    Amortization of prior service costs and unrecognized gains 110 182 164 (18)
    Income tax provision 0 0 0 0
    Net loss from Continuing Operations (110) 182 (164) 18
    Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income        
    Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
    Income (Loss) from Continuing Operations before Income Taxes (1,331) 384 (2,122) 1,403
    Income tax provision 56 (75) 161 (184)
    Net loss from Continuing Operations (1,275) 309 (1,961) 1,219
    Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income | Foreign currency forward contracts        
    Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
    Cost of Products Sold 1,263 (92) 1,997 (746)
    Net Sales $ (68) $ (476) $ (125) $ (657)
    XML 104 R86.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Charges Related To Restructuring Activities (Details) - USD ($)
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Jun. 30, 2022
    Mar. 31, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Restructuring Reserve [Roll Forward]            
    Beginning Balance $ 4,001,000 $ 2,936,000 $ 482,000   $ 482,000  
    Charges 8,440,000 4,153,000 3,790,000 $ 377,000 16,383,000 $ 2,476,000
    Payments (6,365,000) (3,088,000) (1,336,000)   (10,789,000) (7,367,000)
    Ending Balance 6,076,000 4,001,000 2,936,000   6,076,000  
    Severance            
    Restructuring Reserve [Roll Forward]            
    Beginning Balance 2,744,000 2,936,000 482,000   482,000  
    Charges 2,223,000 1,830,000 3,252,000      
    Payments (1,517,000) (2,022,000) (798,000)      
    Ending Balance 3,450,000 2,744,000 2,936,000   3,450,000  
    Other Restructuring            
    Restructuring Reserve [Roll Forward]            
    Beginning Balance 1,257,000 0 0   0  
    Charges 6,217,000 2,323,000 538,000      
    Payments (4,848,000) (1,066,000) (538,000)      
    Ending Balance 2,626,000 1,257,000 0   2,626,000  
    North America (NA)            
    Restructuring Reserve [Roll Forward]            
    Beginning Balance 1,514,000 1,184,000 482,000   482,000  
    Charges 2,332,000 1,540,000 1,662,000 122,000 5,534,000 975,000
    Restructuring Reserve, Accrual Adjustment 2,332,000       5,534,000  
    Payments (2,245,000) (1,210,000) (960,000)      
    Ending Balance 1,601,000 1,514,000 1,184,000   1,601,000  
    North America (NA) | Severance            
    Restructuring Reserve [Roll Forward]            
    Beginning Balance 958,000 1,184,000 482,000   482,000  
    Charges 116,000 542,000 1,124,000     975,000
    Payments (438,000) (768,000) (422,000)      
    Ending Balance 636,000 958,000 1,184,000   636,000  
    North America (NA) | Other Restructuring            
    Restructuring Reserve [Roll Forward]            
    Beginning Balance 556,000 0 0   0  
    Charges 2,216,000 998,000 538,000      
    Payments 1,807,000 442,000 538,000      
    Ending Balance 965,000 556,000 0   965,000  
    Europe (EMEA)            
    Restructuring Reserve [Roll Forward]            
    Beginning Balance 2,487,000 1,752,000        
    Charges 5,034,000 2,613,000 2,119,000 255,000 9,766,000 1,501,000
    Payments (4,108,000) (1,878,000) (367,000)      
    Ending Balance 3,413,000 2,487,000 1,752,000   3,413,000  
    Europe (EMEA) | Severance            
    Restructuring Reserve [Roll Forward]            
    Beginning Balance 1,786,000 1,752,000        
    Charges 1,033,000 1,288,000 2,119,000     895,000
    Payments (1,067,000) (1,254,000) (367,000)      
    Ending Balance 1,752,000 1,786,000 1,752,000   1,752,000  
    Europe (EMEA) | Contract Termination            
    Restructuring Reserve [Roll Forward]            
    Charges           606,000
    Europe (EMEA) | Other Restructuring            
    Restructuring Reserve [Roll Forward]            
    Beginning Balance 701,000 0        
    Charges 4,001,000 1,325,000 0      
    Payments 3,041,000 624,000 0      
    Ending Balance 1,661,000 $ 701,000 0   1,661,000  
    All Other            
    Restructuring Reserve [Roll Forward]            
    Charges 1,074,000   9,000 $ 0 1,083,000 $ 0
    Payments (12,000)   (9,000)      
    Ending Balance 1,062,000       1,062,000  
    All Other | Severance            
    Restructuring Reserve [Roll Forward]            
    Charges 1,074,000   9,000      
    Payments (12,000)   (9,000)      
    Ending Balance 1,062,000       1,062,000  
    All Other | Other Restructuring            
    Restructuring Reserve [Roll Forward]            
    Charges 0   0      
    Payments 0   $ 0      
    Ending Balance $ 0       $ 0  
    XML 105 R87.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Charges Related To Restructuring Activities Narrative (Details) - USD ($)
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Jun. 30, 2022
    Mar. 31, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Restructuring Cost and Reserve [Line Items]            
    Charges $ 8,440,000 $ 4,153,000 $ 3,790,000 $ 377,000 $ 16,383,000 $ 2,476,000
    Restructuring and Related Activities, Expected Payout Period 12 months       12 months  
    Payments $ (6,365,000) (3,088,000) (1,336,000)   $ (10,789,000) (7,367,000)
    Severance            
    Restructuring Cost and Reserve [Line Items]            
    Charges 2,223,000 1,830,000 3,252,000      
    Payments (1,517,000) (2,022,000) (798,000)      
    North America (NA)            
    Restructuring Cost and Reserve [Line Items]            
    Charges 2,332,000 1,540,000 1,662,000 122,000 5,534,000 975,000
    Restructuring Reserve, Accrual Adjustment 2,332,000       5,534,000  
    Payments (2,245,000) (1,210,000) (960,000)      
    North America (NA) | Severance            
    Restructuring Cost and Reserve [Line Items]            
    Charges 116,000 542,000 1,124,000     975,000
    Payments (438,000) (768,000) (422,000)      
    Europe (EMEA)            
    Restructuring Cost and Reserve [Line Items]            
    Charges 5,034,000 2,613,000 2,119,000 255,000 9,766,000 1,501,000
    Payments (4,108,000) (1,878,000) (367,000)      
    Europe (EMEA) | Severance            
    Restructuring Cost and Reserve [Line Items]            
    Charges 1,033,000 1,288,000 2,119,000     895,000
    Payments (1,067,000) $ (1,254,000) (367,000)      
    Europe (EMEA) | Contract Termination            
    Restructuring Cost and Reserve [Line Items]            
    Charges           606,000
    All Other            
    Restructuring Cost and Reserve [Line Items]            
    Charges 1,074,000   9,000 $ 0 $ 1,083,000 $ 0
    Payments (12,000)   (9,000)      
    All Other | Severance            
    Restructuring Cost and Reserve [Line Items]            
    Charges 1,074,000   9,000      
    Payments $ (12,000)   $ (9,000)      
    XML 106 R88.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Income Taxes (Narrative) (Details)
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Valuation Allowance [Line Items]        
    Effective income tax rate, continuing operations (2.80%) (8.80%) (4.10%) (11.30%)
    U.S. statutory income tax rate     21.00%  
    Effective income tax rate, continuing operations (2.80%) (8.80%) (4.10%) (11.30%)
    U.S. statutory income tax rate     21.00%  
    XML 107 R89.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details) - USD ($)
    $ / shares in Units, shares in Thousands, $ in Thousands
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Net Loss per Share—Basic        
    Average common shares outstanding 37,537 35,013 36,073 34,826
    Net Loss $ (34,354) $ (22,759) $ (80,494) $ (47,501)
    Net earnings (loss) per common share $ (0.92) $ (0.65) $ (2.23) $ (1.36)
    Loss per Share—Assuming Dilution        
    Average common shares outstanding 37,537 35,013 36,073 34,826
    Stock options and awards 143 475 168 545
    Average common shares assuming dilution 37,680 35,488 36,241 35,371
    Net Loss $ (34,354) $ (22,759) $ (80,494) $ (47,501)
    Net earnings (loss) per per common share—assuming dilution (in dollars per share) [1] $ (0.92) $ (0.65) $ (2.23) $ (1.36)
    [1] Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.
    XML 108 R90.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Net Earnings (Loss) Per Common Share Textuals (Details) - Stock Options - $ / shares
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
    Antidilutive securities excluded from computation of earnings per share, amount 1,659,909 1,432,833 1,120,192 1,163,526
    Antidilutive share granted, average exercise price $ 12.14 $ 14.49 $ 12.14 $ 14.49
    Fair value stock price $ 1.05 $ 7.30 $ 1.50 $ 8.30
    XML 109 R91.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Concentration Of Credit Risk (Details)
    Sep. 30, 2022
    USD ($)
    Risks and Uncertainties [Abstract]  
    Retained Recourse Obligation For Events Of Default Under Contracts $ 2,071,000
    Events of Default Under Contract by Third Party $ 8,588,000
    XML 110 R92.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Derivatives Notional Amounts - Designated as Hedges (Details) - USD ($)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Mar. 31, 2022
    Sep. 30, 2022
    Dec. 31, 2021
    Not Designated as Hedging Instrument [Member]      
    Derivative [Line Items]      
    Notional Amount   $ 132,279 $ 120,242
    Gain (Loss) $ (1,553) (2,563)  
    Designated as Hedging Instrument [Member]      
    Derivative [Line Items]      
    Notional Amount   16,843 23
    Unrealized Gain (Loss) 1 299  
    USD / CAD | Designated as Hedging Instrument [Member]      
    Derivative [Line Items]      
    Notional Amount   4,523 0
    Unrealized Gain (Loss) 0 (343)  
    USD / EUR | Designated as Hedging Instrument [Member]      
    Derivative [Line Items]      
    Notional Amount   3,492 0
    Unrealized Gain (Loss) 0 441  
    USD / MXN | Designated as Hedging Instrument [Member]      
    Derivative [Line Items]      
    Notional Amount   1,089 23
    Unrealized Gain (Loss) 1 70  
    EUR / GBP | Not Designated as Hedging Instrument [Member]      
    Derivative [Line Items]      
    Notional Amount   1,200 0
    Gain (Loss) 0 36  
    EUR / GBP | Designated as Hedging Instrument [Member]      
    Derivative [Line Items]      
    Notional Amount   5,961 0
    Unrealized Gain (Loss) 0 179  
    EUR / SEK | Not Designated as Hedging Instrument [Member]      
    Derivative [Line Items]      
    Notional Amount   2,353 0
    Gain (Loss) 0 (10)  
    EUR / NOK | Not Designated as Hedging Instrument [Member]      
    Derivative [Line Items]      
    Notional Amount   1,099 0
    Gain (Loss) 0 (8)  
    EUR / NOK | Designated as Hedging Instrument [Member]      
    Derivative [Line Items]      
    Notional Amount   689 0
    Unrealized Gain (Loss) 0 (5)  
    AUD / NZD | Not Designated as Hedging Instrument [Member]      
    Derivative [Line Items]      
    Notional Amount   17,082 7,366
    Gain (Loss) (17) (163)  
    NOK / SEK | Designated as Hedging Instrument [Member]      
    Derivative [Line Items]      
    Notional Amount   1,089 0
    Unrealized Gain (Loss) 0 (43)  
    USD / THB | Not Designated as Hedging Instrument [Member]      
    Derivative [Line Items]      
    Notional Amount   4,310 $ 4,500
    Gain (Loss) $ 86 $ 278  
    XML 111 R93.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Derivatives Notional Amounts - Not Designated as Hedges (Details) - Not Designated as Hedging Instrument [Member] - USD ($)
    $ in Thousands
    		 3 Months Ended 9 Months Ended
    Mar. 31, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Dec. 31, 2021
    Derivative [Line Items]          
    Notional Amount     $ 132,279   $ 120,242
    Gain (Loss) $ (1,553)   (2,563)    
    Forward exchange contracts—net          
    Derivative [Line Items]          
    Gain (Loss)   $ (592)   $ (1,315)  
    USD / AUD          
    Derivative [Line Items]          
    Notional Amount     1,194   3,792
    Gain (Loss) (57)   104    
    USD / CAD          
    Derivative [Line Items]          
    Notional Amount     19,765   14,556
    Gain (Loss) (24)   (272)    
    USD / DKK          
    Derivative [Line Items]          
    Notional Amount     5,099   10,850
    Gain (Loss) (257)   (137)    
    USD / GBP          
    Derivative [Line Items]          
    Notional Amount     0   4,028
    Gain (Loss) 32   0    
    USD / NOK          
    Derivative [Line Items]          
    Notional Amount     4,790   2,352
    Gain (Loss) (81)   (467)    
    USD / SEK          
    Derivative [Line Items]          
    Notional Amount     1,880   2,344
    Gain (Loss) (131)   (72)    
    AUD / NZD          
    Derivative [Line Items]          
    Notional Amount     17,082   7,366
    Gain (Loss) (17)   (163)    
    USD / THB          
    Derivative [Line Items]          
    Notional Amount     4,310   4,500
    Gain (Loss) 86   278    
    EUR / GBP          
    Derivative [Line Items]          
    Notional Amount     1,200   0
    Gain (Loss) 0   36    
    EUR / NOK          
    Derivative [Line Items]          
    Notional Amount     1,099   0
    Gain (Loss) 0   (8)    
    EUR / USD          
    Derivative [Line Items]          
    Notional Amount     73,507   $ 70,454
    Gain (Loss) $ (1,104)   $ (1,852)    
    XML 112 R94.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Derivatives Balance Sheet Location (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2022
    Dec. 31, 2021
    Other Current Assets    
    Derivatives, Fair Value [Line Items]    
    Derivative assets $ 2,626 $ 386
    Other Current Assets | Foreign currency forward contracts | Designated as Hedging Instrument [Member]    
    Derivatives, Fair Value [Line Items]    
    Derivative assets 690 1
    Other Current Assets | Foreign currency forward contracts | Not Designated as Hedging Instrument [Member]    
    Derivatives, Fair Value [Line Items]    
    Derivative assets 1,936 385
    Accrued Expenses    
    Derivatives, Fair Value [Line Items]    
    Derivative liabilities 4,890 1,938
    Accrued Expenses | Foreign currency forward contracts | Designated as Hedging Instrument [Member]    
    Derivatives, Fair Value [Line Items]    
    Derivative liabilities 391 0
    Accrued Expenses | Foreign currency forward contracts | Not Designated as Hedging Instrument [Member]    
    Derivatives, Fair Value [Line Items]    
    Derivative liabilities $ 4,499 $ 1,938
    XML 113 R95.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Derivatives Gain (Loss) in Statement of Finacial Position (Details) - USD ($)
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Mar. 31, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Cash Flow Hedging [Member]          
    Derivative Instruments, Gain (Loss) [Line Items]          
    Gain (Loss) $ (1,331,000)   $ 384,000 $ (2,122,000) $ 1,403,000
    Foreign currency forward contracts | Cash Flow Hedging [Member]          
    Derivative Instruments, Gain (Loss) [Line Items]          
    Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] 59,000   944,000 2,197,000 (643,000)
    Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) 1,275,000   (309,000) 1,961,000 (1,219,000)
    Amount of Gain (Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) $ 1,002,000   51,000 1,117,000 (37,000)
    Not Designated as Hedging Instrument [Member]          
    Derivative Instruments, Gain (Loss) [Line Items]          
    Gain (Loss)   $ (1,553,000)   $ (2,563,000)  
    Not Designated as Hedging Instrument [Member] | Foreign currency forward contracts          
    Derivative Instruments, Gain (Loss) [Line Items]          
    Gain (Loss)     $ (592,000)   $ (1,315,000)
    XML 114 R96.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Derivatives Narrative (Details) - USD ($)
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Sep. 30, 2021
    Jun. 30, 2017
    Sep. 30, 2022
    Sep. 30, 2021
    Dec. 31, 2021
    Derivative [Line Items]            
    Convertible Debt Derivative $ 473,000     $ 473,000   $ 0
    Debt Instrument, Convertible, Beneficial Conversion Feature 1,423,000          
    Foreign currency forward contracts            
    Derivative [Line Items]            
    Notional amount of derivatives, matured during period 29,189,000 $ 32,685,000   67,853,000 $ 90,800,000  
    Selling, General and Administrative Expenses | Foreign currency forward contracts            
    Derivative [Line Items]            
    Gain (Loss) 2,072,000     $ (2,563,000)    
    Minimum            
    Derivative [Line Items]            
    Derivative, percentage of forcasted transactions with currency rate exposure       50.00%    
    Maximum            
    Derivative [Line Items]            
    Derivative, percentage of forcasted transactions with currency rate exposure       90.00%    
    Cash Flow Hedging [Member]            
    Derivative [Line Items]            
    Gain (Loss) 1,331,000 (384,000)   $ 2,122,000 (1,403,000)  
    Cash Flow Hedging [Member] | Sales [Member]            
    Derivative [Line Items]            
    Gain (Loss) 68,000 476,000   125,000 657,000  
    Cash Flow Hedging [Member] | Cost of Sales [Member]            
    Derivative [Line Items]            
    Gain (Loss) 1,263,000 $ (92,000)   1,997,000 $ 746,000  
    Convertible Subordinated Debt | Convertible Senior Notes at 4.50% February 2022 [Domain]            
    Derivative [Line Items]            
    Proceeds from Issuance of Warrants     $ 14,100,000      
    Debt Instrument, Face Amount $ 0   $ 120,000,000 $ 0   $ 2,650,000
    Interest rate (as a percent) 4.50%     4.50%    
    Convertible Subordinated Debt | Convertible Senior Secured Notes at 5.68% July 2026            
    Derivative [Line Items]            
    Debt Instrument, Face Amount $ 31,106,000     $ 31,106,000    
    XML 115 R97.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2022
    Dec. 31, 2021
    Carrying Value    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Debt Instrument, Fair Value Disclosure $ (335,279) $ (308,129)
    Convertible Subordinated Debt | Carrying Value    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Debt Instrument, Fair Value Disclosure (473) 0
    Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 [Member] | Convertible Subordinated Debt    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Debt Instrument, Fair Value Disclosure 0  
    Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 [Member] | Convertible Subordinated Debt    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Debt Instrument, Fair Value Disclosure 0  
    Forward exchange contracts—net | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Derivative assets (liabilities), at fair value, net 0 0
    Forward exchange contracts—net | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Derivative assets (liabilities), at fair value, net (2,264) (1,552)
    Forward exchange contracts—net | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Derivative assets (liabilities), at fair value, net 0 $ 0
    Convertible Debt Derivative | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Derivative assets (liabilities), at fair value, net $ (473)  
    XML 116 R98.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details) - USD ($)
    $ in Thousands
    Sep. 30, 2022
    Dec. 31, 2021
    Sep. 30, 2021
    Dec. 31, 2020
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Cash and cash equivalents $ 45,439 $ 83,745 $ 73,656 $ 105,298
    Cash and cash equivalents 45,439 83,745    
    Estimate of Fair Value Measurement [Member]        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Cash and cash equivalents 45,439 83,745    
    Debt Instrument, Fair Value Disclosure (272,485) (259,472)    
    Carrying Value        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Cash and cash equivalents   83,745    
    Debt Instrument, Fair Value Disclosure (335,279) (308,129)    
    Convertible Senior Notes at 4.50% February 2022 | Estimate of Fair Value Measurement [Member]        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure 0 (2,632)    
    Convertible Senior Notes at 4.50% February 2022 | Carrying Value        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure 0 (2,642)    
    Convertible Senior Notes at 5.00% November 2024 | Estimate of Fair Value Measurement [Member]        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (62,887) (64,897)    
    Convertible Senior Notes at 5.00% November 2024 | Carrying Value        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (72,341) (72,140)    
    Series II Convertible Senior Notes at 5.00% November 2024 | Estimate of Fair Value Measurement [Member]        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (63,963) (74,165)    
    Series II Convertible Senior Notes at 5.00% November 2024 | Carrying Value        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (75,764) (78,251)    
    Other Notes and Capital Lease Obligations | Estimate of Fair Value Measurement [Member]        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (19,089) (36,060)    
    Other Notes and Capital Lease Obligations | Carrying Value        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (19,089) (36,060)    
    Convertible Senior Notes at 4.25% March 2026 | Estimate of Fair Value Measurement [Member]        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (36,832) (81,718)    
    Convertible Senior Notes at 4.25% March 2026 | Carrying Value        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (80,898) (119,036)    
    Convertible Senior Secured Notes at 5.68% July 2026 - July 26, 2022 Issuance [Domain] | Estimate of Fair Value Measurement [Member]        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (25,369) 0    
    Convertible Senior Secured Notes at 5.68% July 2026 - July 26, 2022 Issuance [Domain] | Carrying Value        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (27,463) 0    
    Secured Term Loans due July 2026 [Domain] | Estimate of Fair Value Measurement [Member]        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (64,345) 0    
    Secured Term Loans due July 2026 [Domain] | Carrying Value        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (59,724) 0    
    Convertible Subordinated Debt | Estimate of Fair Value Measurement [Member]        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (473) 0    
    Convertible Subordinated Debt | Carrying Value        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Debt Instrument, Fair Value Disclosure (473) 0    
    Foreign currency forward contracts | Other Current Assets | Estimate of Fair Value Measurement [Member]        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Derivative assets 2,626 386    
    Foreign currency forward contracts | Other Current Assets | Carrying Value        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Derivative assets 2,626 386    
    Foreign currency forward contracts | Accrued Expenses | Estimate of Fair Value Measurement [Member]        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Derivative liabilities (4,890) (1,938)    
    Foreign currency forward contracts | Accrued Expenses | Carrying Value        
    Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
    Derivative liabilities $ (4,890) $ (1,938)    
    XML 117 R99.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Business Segments (Information by Segment) (Details) - USD ($)
    		 3 Months Ended 9 Months Ended
    Sep. 30, 2022
    Jun. 30, 2022
    Mar. 31, 2022
    Sep. 30, 2021
    Sep. 30, 2022
    Sep. 30, 2021
    Dec. 31, 2021
    Segment Reporting Information [Line Items]              
    Net Sales $ 170,408,000     $ 224,200,000 $ 560,413,000 $ 646,266,000  
    Restructuring Reserve 6,076,000 $ 4,001,000 $ 2,936,000   6,076,000   $ 482,000
    Charges (8,440,000) (4,153,000) (3,790,000) (377,000) (16,383,000) (2,476,000)  
    Goodwill, Impairment Loss 0     (28,564,000) 0 (28,564,000)  
    Operating Loss (33,438,000)     (24,766,000) (64,857,000) (33,995,000)  
    Interest Revenue (Expense), Net (7,344,000)     (6,284,000) (19,825,000) (18,098,000)  
    Earnings (loss) before income taxes (33,434,000)     (20,919,000) (77,334,000) (42,671,000)  
    Net gain on debt extinguishment 6,398,000     10,131,000 6,398,000 9,422,000  
    Net gain on convertible debt derivatives 950,000     0 950,000 0  
    Impairment of Intangible Assets (Excluding Goodwill) (1,012,000)     0 (1,012,000) 0  
    Europe (EMEA)              
    Segment Reporting Information [Line Items]              
    Net Sales 97,487,000     127,026,000 328,334,000 361,097,000  
    Restructuring Reserve 3,413,000 2,487,000 1,752,000   3,413,000    
    Charges (5,034,000) (2,613,000) (2,119,000) (255,000) (9,766,000) (1,501,000)  
    Operating Loss (2,588,000)     9,554,000 4,126,000 18,378,000  
    North America (NA)              
    Segment Reporting Information [Line Items]              
    Net Sales 65,314,000     88,054,000 209,351,000 260,275,000  
    Restructuring Reserve 1,601,000 1,514,000 1,184,000   1,601,000   482,000
    Restructuring Reserve, Accrual Adjustment 2,332,000       5,534,000    
    Charges (2,332,000) (1,540,000) (1,662,000) (122,000) (5,534,000) (975,000)  
    Operating Loss (15,007,000)     (1,523,000) (29,607,000) (2,308,000)  
    All Other              
    Segment Reporting Information [Line Items]              
    Net Sales 7,607,000     9,120,000 22,728,000 24,894,000  
    Restructuring Reserve 1,062,000       1,062,000    
    Charges (1,074,000)   (9,000) 0 (1,083,000) 0  
    Operating Loss (6,391,000)     (3,856,000) (21,981,000) (19,025,000)  
    Operating Segments [Member] | Europe (EMEA)              
    Segment Reporting Information [Line Items]              
    Net Sales 97,487,000     127,026,000 328,334,000 361,097,000  
    Operating Segments [Member] | North America (NA)              
    Segment Reporting Information [Line Items]              
    Net Sales 65,314,000     88,054,000 209,351,000 260,275,000  
    Operating Segments [Member] | All Other              
    Segment Reporting Information [Line Items]              
    Net Sales 7,607,000     9,120,000 22,728,000 24,894,000  
    Intersegment revenues              
    Segment Reporting Information [Line Items]              
    Net Sales 8,501,000     21,265,000 35,601,000 63,661,000  
    Intersegment revenues | Europe (EMEA)              
    Segment Reporting Information [Line Items]              
    Net Sales 2,763,000     6,221,000 11,327,000 17,758,000  
    Intersegment revenues | North America (NA)              
    Segment Reporting Information [Line Items]              
    Net Sales 5,738,000     15,044,000 24,274,000 45,903,000  
    Severance              
    Segment Reporting Information [Line Items]              
    Restructuring Reserve 3,450,000 2,744,000 2,936,000   3,450,000   482,000
    Charges (2,223,000) (1,830,000) (3,252,000)        
    Severance | Europe (EMEA)              
    Segment Reporting Information [Line Items]              
    Restructuring Reserve 1,752,000 1,786,000 1,752,000   1,752,000    
    Charges (1,033,000) (1,288,000) (2,119,000)     (895,000)  
    Severance | North America (NA)              
    Segment Reporting Information [Line Items]              
    Restructuring Reserve 636,000 958,000 1,184,000   636,000   $ 482,000
    Charges (116,000) $ (542,000) (1,124,000)     (975,000)  
    Severance | All Other              
    Segment Reporting Information [Line Items]              
    Restructuring Reserve 1,062,000       1,062,000    
    Charges (1,074,000)   $ (9,000)        
    Contract Termination | Europe (EMEA)              
    Segment Reporting Information [Line Items]              
    Charges           (606,000)  
    Lifestyle Products [Domain] | Operating Segments [Member] | Europe (EMEA)              
    Segment Reporting Information [Line Items]              
    Net Sales 46,881,000     61,683,000 162,942,000 181,628,000  
    Lifestyle Products [Domain] | Operating Segments [Member] | North America (NA)              
    Segment Reporting Information [Line Items]              
    Net Sales 34,379,000     38,666,000 102,516,000 114,951,000  
    Lifestyle Products [Domain] | Operating Segments [Member] | All Other              
    Segment Reporting Information [Line Items]              
    Net Sales 2,556,000     3,230,000 8,239,000 8,736,000  
    Mobility and Seating [Domain] | Operating Segments [Member] | Europe (EMEA)              
    Segment Reporting Information [Line Items]              
    Net Sales 43,778,000     56,535,000 139,010,000 152,660,000  
    Mobility and Seating [Domain] | Operating Segments [Member] | North America (NA)              
    Segment Reporting Information [Line Items]              
    Net Sales 23,453,000     28,414,000 74,876,000 82,243,000  
    Mobility and Seating [Domain] | Operating Segments [Member] | All Other              
    Segment Reporting Information [Line Items]              
    Net Sales 3,311,000     3,171,000 8,989,000 9,239,000  
    Respiratory Therapy [Domain] | Operating Segments [Member] | Europe (EMEA)              
    Segment Reporting Information [Line Items]              
    Net Sales 2,262,000     4,225,000 11,847,000 13,613,000  
    Respiratory Therapy [Domain] | Operating Segments [Member] | North America (NA)              
    Segment Reporting Information [Line Items]              
    Net Sales 7,236,000     20,856,000 31,384,000 62,429,000  
    Respiratory Therapy [Domain] | Operating Segments [Member] | All Other              
    Segment Reporting Information [Line Items]              
    Net Sales 407,000     1,215,000 1,538,000 2,547,000  
    Other [Domain] | Operating Segments [Member] | Europe (EMEA)              
    Segment Reporting Information [Line Items]              
    Net Sales 4,566,000     4,583,000 14,535,000 13,196,000  
    Other [Domain] | Operating Segments [Member] | North America (NA)              
    Segment Reporting Information [Line Items]              
    Net Sales 246,000     118,000 575,000 652,000  
    Other [Domain] | Operating Segments [Member] | All Other              
    Segment Reporting Information [Line Items]              
    Net Sales $ 1,333,000     $ 1,504,000 $ 3,962,000 $ 4,372,000  
    XML 118 R100.htm IDEA: XBRL DOCUMENT v3.22.2.2
    Contingencies Contingencies (Details)
    Sep. 30, 2022
    USD ($)
    Commitments and Contingencies Disclosure [Abstract]  
    Liquidated Damages amount per violation per day $ 15,000
    Liquidated Damages - Yearly Limit $ 7,000,000
    XML 119 ivc-20220930_htm.xml IDEA: XBRL DOCUMENT 0000742112 2022-01-01 2022-09-30 0000742112 us-gaap:CommonStockMember 2022-11-04 0000742112 us-gaap:CommonClassBMember 2022-11-04 0000742112 2022-07-01 2022-09-30 0000742112 2021-07-01 2021-09-30 0000742112 2021-01-01 2021-09-30 0000742112 2022-09-30 0000742112 2021-12-31 0000742112 us-gaap:CommonStockMember 2021-12-31 0000742112 us-gaap:CommonStockMember 2022-09-30 0000742112 us-gaap:CommonClassBMember 2022-09-30 0000742112 us-gaap:CommonClassBMember 2021-12-31 0000742112 2020-12-31 0000742112 2021-09-30 0000742112 us-gaap:CommonStockMember 2022-06-30 0000742112 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000742112 us-gaap:RetainedEarningsMember 2022-06-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000742112 us-gaap:TreasuryStockMember 2022-06-30 0000742112 2022-06-30 0000742112 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000742112 us-gaap:TreasuryStockMember 2022-07-01 2022-09-30 0000742112 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0000742112 us-gaap:CommonStockMember 2022-09-30 0000742112 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000742112 us-gaap:RetainedEarningsMember 2022-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000742112 us-gaap:TreasuryStockMember 2022-09-30 0000742112 us-gaap:CommonStockMember 2021-06-30 0000742112 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000742112 us-gaap:RetainedEarningsMember 2021-06-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000742112 us-gaap:TreasuryStockMember 2021-06-30 0000742112 2021-06-30 0000742112 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000742112 us-gaap:TreasuryStockMember 2021-07-01 2021-09-30 0000742112 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0000742112 us-gaap:CommonStockMember 2021-09-30 0000742112 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000742112 us-gaap:RetainedEarningsMember 2021-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0000742112 us-gaap:TreasuryStockMember 2021-09-30 0000742112 us-gaap:CommonStockMember 2021-12-31 0000742112 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0000742112 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000742112 us-gaap:RetainedEarningsMember 2021-12-31 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000742112 us-gaap:TreasuryStockMember 2021-12-31 0000742112 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0000742112 us-gaap:TreasuryStockMember 2022-01-01 2022-09-30 0000742112 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0000742112 us-gaap:CommonStockMember 2020-12-31 0000742112 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0000742112 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000742112 us-gaap:RetainedEarningsMember 2020-12-31 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000742112 us-gaap:TreasuryStockMember 2020-12-31 0000742112 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000742112 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0000742112 us-gaap:TreasuryStockMember 2021-01-01 2021-09-30 0000742112 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0000742112 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0000742112 us-gaap:RiskLevelLowMember 2022-01-01 2022-09-30 0000742112 us-gaap:RiskLevelMediumMember 2022-01-01 2022-09-30 0000742112 us-gaap:RiskLevelHighMember 2022-01-01 2022-09-30 0000742112 2021-01-01 2021-12-31 0000742112 ivc:AllOtherMember 2022-09-30 0000742112 ivc:AllOtherMember 2022-01-01 2022-09-30 0000742112 ivc:AllOtherMember 2021-12-31 0000742112 ivc:AllOtherMember 2021-01-01 2021-12-31 0000742112 us-gaap:MachineryAndEquipmentMember 2022-09-30 0000742112 us-gaap:MachineryAndEquipmentMember 2021-12-31 0000742112 ivc:CapitalizedSoftwareMember 2022-09-30 0000742112 ivc:CapitalizedSoftwareMember 2021-12-31 0000742112 us-gaap:LandBuildingsAndImprovementsMember 2022-09-30 0000742112 us-gaap:LandBuildingsAndImprovementsMember 2021-12-31 0000742112 us-gaap:FurnitureAndFixturesMember 2022-09-30 0000742112 us-gaap:FurnitureAndFixturesMember 2021-12-31 0000742112 us-gaap:LeaseholdImprovementsMember 2022-09-30 0000742112 us-gaap:LeaseholdImprovementsMember 2021-12-31 0000742112 us-gaap:CustomerListsMember 2022-09-30 0000742112 us-gaap:CustomerListsMember 2021-12-31 0000742112 us-gaap:TrademarksMember 2022-09-30 0000742112 us-gaap:TrademarksMember 2021-12-31 0000742112 us-gaap:DevelopedTechnologyRightsMember 2022-09-30 0000742112 us-gaap:DevelopedTechnologyRightsMember 2021-12-31 0000742112 us-gaap:PatentsMember 2022-09-30 0000742112 us-gaap:PatentsMember 2021-12-31 0000742112 us-gaap:LicensingAgreementsMember 2022-09-30 0000742112 us-gaap:LicensingAgreementsMember 2021-12-31 0000742112 us-gaap:OtherIntangibleAssetsMember 2022-09-30 0000742112 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0000742112 srt:MinimumMember 2022-01-01 2022-09-30 0000742112 srt:MaximumMember 2022-01-01 2022-09-30 0000742112 srt:WeightedAverageMember 2022-01-01 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt450February20221Member us-gaap:ConvertibleSubordinatedDebtMember 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt450February20221Member us-gaap:ConvertibleSubordinatedDebtMember 2021-12-31 0000742112 ivc:ConvertibleSeniorNotesAt500November2024AMember us-gaap:ConvertibleSubordinatedDebtMember 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt500November2024AMember us-gaap:ConvertibleSubordinatedDebtMember 2021-12-31 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024BMember us-gaap:ConvertibleSubordinatedDebtMember 2022-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024BMember us-gaap:ConvertibleSubordinatedDebtMember 2021-12-31 0000742112 ivc:ConvertibleSeniorNotesAt425March2026CMember us-gaap:ConvertibleSubordinatedDebtMember 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026CMember us-gaap:ConvertibleSubordinatedDebtMember 2021-12-31 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember us-gaap:ConvertibleSubordinatedDebtMember 2022-09-30 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember us-gaap:ConvertibleSubordinatedDebtMember 2021-12-31 0000742112 ivc:SecuredTermLoansDueJuly2026Member us-gaap:SecuredDebtMember 2022-09-30 0000742112 ivc:SecuredTermLoansDueJuly2026Member ivc:SecuredTermLoanIssuanceJuly26th2022Member 2021-12-31 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember 2022-09-30 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember 2021-12-31 0000742112 us-gaap:LetterOfCreditMember 2022-09-30 0000742112 us-gaap:LetterOfCreditMember 2021-12-31 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember us-gaap:LineOfCreditMember 2022-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember us-gaap:LineOfCreditMember 2021-12-31 0000742112 currency:EUR us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember us-gaap:LineOfCreditMember 2021-12-31 0000742112 currency:GBP us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember us-gaap:LineOfCreditMember 2021-12-31 0000742112 us-gaap:LetterOfCreditMember ivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember us-gaap:LineOfCreditMember 2022-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember us-gaap:LineOfCreditMember 2022-01-01 2022-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-01-01 2022-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-01-01 2022-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2022-01-01 2022-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2022-01-01 2022-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember us-gaap:LineOfCreditMember 2022-01-01 2022-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember us-gaap:LineOfCreditMember 2022-01-01 2022-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementNorthAmericaCreditAgreementMember us-gaap:LineOfCreditMember 2022-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember us-gaap:LineOfCreditMember 2022-09-30 0000742112 us-gaap:LetterOfCreditMember ivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember us-gaap:LineOfCreditMember 2022-09-30 0000742112 ivc:SwingLineLoansMember ivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember us-gaap:LineOfCreditMember 2022-09-30 0000742112 ivc:AmountAvailableToInvacareLimitedAndInvacarePoirierSASMember ivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember us-gaap:LineOfCreditMember 2022-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember us-gaap:LineOfCreditMember 2022-01-01 2022-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-01-01 2022-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-01-01 2022-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2022-01-01 2022-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2022-01-01 2022-09-30 0000742112 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember us-gaap:LineOfCreditMember 2022-01-01 2022-09-30 0000742112 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember us-gaap:LineOfCreditMember 2022-01-01 2022-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:SecuredRevolvingCreditAndSecurityAgreementABLCreditAgreementMember us-gaap:LineOfCreditMember 2022-07-26 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:SecuredRevolvingCreditAndSecurityAgreementABLCreditAgreementMember us-gaap:LineOfCreditMember 2022-07-01 2022-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember us-gaap:LineOfCreditMember 2022-07-26 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:SecuredRevolvingCreditAndSecurityAgreementABLCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-07-01 2022-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember ivc:SecuredRevolvingCreditAndSecurityAgreementABLCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:PrimeRateMember 2022-07-01 2022-09-30 0000742112 ivc:ConvertibleSeniorSubordinatedDebenturesAt500February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2022-01-01 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt450February20221Member us-gaap:ConvertibleSubordinatedDebtMember 2017-06-30 0000742112 ivc:ConvertibleSeniorNotesAt450February20221Member us-gaap:ConvertibleSubordinatedDebtMember 2017-04-01 2017-06-30 0000742112 ivc:ConvertibleSeniorNotesAt450February20221Member us-gaap:ConvertibleSubordinatedDebtMember 2017-12-31 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2020-04-01 2020-06-30 0000742112 ivc:ConvertibleSeniorNotesAt450February20221Member us-gaap:ConvertibleSubordinatedDebtMember 2020-04-01 2020-06-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-04-01 2020-06-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2020-12-31 0000742112 ivc:ConvertibleSeniorNotesAt450February2022Member us-gaap:ConvertibleSubordinatedDebtMember 2021-03-31 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-03-31 0000742112 ivc:ConvertibleSeniorNotesAt450February20221Member us-gaap:ConvertibleSubordinatedDebtMember 2022-07-01 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt450February20221Member us-gaap:ConvertibleSubordinatedDebtMember 2022-01-01 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt450February20221Member us-gaap:ConvertibleSubordinatedDebtMember 2021-07-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesAt450February20221Member us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesat5.00February2021Member us-gaap:ConvertibleSubordinatedDebtMember 2019-10-01 2019-12-31 0000742112 ivc:ConvertibleSeniorNotesAt500November2024BMember us-gaap:ConvertibleSubordinatedDebtMember 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt500November2024BMember us-gaap:ConvertibleSubordinatedDebtMember 2019-12-31 0000742112 ivc:ConvertibleSeniorNotesAt500November2024BMember us-gaap:ConvertibleSubordinatedDebtMember 2022-01-01 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt500November2024AMember us-gaap:ConvertibleSubordinatedDebtMember 2022-01-01 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt500November2024BMember us-gaap:ConvertibleSubordinatedDebtMember 2021-12-31 0000742112 ivc:ConvertibleSeniorNotesAt500November2024BMember us-gaap:ConvertibleSubordinatedDebtMember 2022-07-01 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt500November2024BMember us-gaap:ConvertibleSubordinatedDebtMember 2021-07-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesAt500November2024BMember us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2022-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2022-01-01 2022-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024BMember us-gaap:ConvertibleSubordinatedDebtMember 2022-01-01 2022-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2022-07-01 2022-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2021-12-31 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2021-07-01 2021-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026CMember us-gaap:ConvertibleSubordinatedDebtMember 2021-03-11 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:ConvertibleSubordinatedDebtMember 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:ConvertibleSubordinatedDebtMember 2022-01-01 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:ConvertibleSubordinatedDebtMember 2021-03-11 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:ConvertibleSubordinatedDebtMember 2021-12-31 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:ConvertibleSubordinatedDebtMember 2022-07-01 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:ConvertibleSubordinatedDebtMember 2021-07-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:ConvertibleSubordinatedDebtMember 2021-01-01 2021-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member ivc:Round1FundingInitialClosingMember us-gaap:ConvertibleSubordinatedDebtMember 2022-07-01 2022-09-30 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026Member us-gaap:SecuredDebtMember 2022-07-01 2022-09-30 0000742112 2021-01-01 2021-06-30 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026Member us-gaap:ConvertibleSubordinatedDebtMember 2022-09-30 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheINotesMember us-gaap:SecuredDebtMember 2022-07-26 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheIINotesMember us-gaap:SecuredDebtMember 2022-07-26 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member ivc:AdditionalAmountAfterClosingRound2Member us-gaap:ConvertibleSubordinatedDebtMember us-gaap:SubsequentEventMember 2022-10-01 2022-12-31 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026Member us-gaap:SecuredDebtMember 2022-07-26 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026Member us-gaap:ConvertibleSubordinatedDebtMember 2022-07-01 2022-09-30 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember us-gaap:ConvertibleSubordinatedDebtMember 2022-07-26 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember us-gaap:ConvertibleSubordinatedDebtMember 2022-07-01 2022-09-30 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheINotesMember us-gaap:ConvertibleSubordinatedDebtMember 2022-07-26 0000742112 ivc:SecuredTermLoansDueJuly2026Member us-gaap:SecuredDebtMember 2022-07-26 0000742112 ivc:SecuredTermLoansDueJuly2026Member ivc:InitialAmountAtClosingMember us-gaap:SecuredDebtMember 2022-07-26 0000742112 ivc:SecuredTermLoansDueJuly2026Member 2022-07-26 0000742112 ivc:SecuredTermLoansDueJuly2026Member ivc:AdditionalAmountAfterClosingRound2Member us-gaap:SecuredDebtMember 2022-07-26 0000742112 ivc:SecuredTermLoansDueJuly2026Member ivc:AdditionalAmountAfterClosingRound3Member us-gaap:SecuredDebtMember 2022-07-26 0000742112 ivc:SecuredTermLoansDueJuly2026Member ivc:AdditionalAmountAfterClosingRound4Member us-gaap:SecuredDebtMember 2022-07-26 0000742112 ivc:SecuredTermLoansDueJuly2026Member us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember ivc:FirstYearOfLoanPeriodMember 2022-07-01 2022-09-30 0000742112 ivc:SecuredTermLoansDueJuly2026Member us-gaap:SecuredDebtMember us-gaap:BaseRateMember ivc:FirstYearOfLoanPeriodMember 2022-07-01 2022-09-30 0000742112 ivc:SecuredTermLoansDueJuly2026Member us-gaap:SecuredDebtMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember ivc:Year2AndOnMember 2022-07-01 2022-09-30 0000742112 ivc:SecuredTermLoansDueJuly2026Member us-gaap:SecuredDebtMember us-gaap:BaseRateMember ivc:Year2AndOnMember 2022-07-01 2022-09-30 0000742112 ivc:SecuredTermLoansDueJuly2026Member us-gaap:SecuredDebtMember 2022-07-01 2022-09-30 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026Member us-gaap:SecuredDebtMember ivc:FirstYearOfLoanPeriodMember 2022-07-01 2022-09-30 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026Member us-gaap:SecuredDebtMember ivc:Year2AndOnMember 2022-07-01 2022-09-30 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026Member us-gaap:SecuredDebtMember us-gaap:SubsequentEventMember ivc:Year2AndOnMember 2022-10-01 2022-12-31 0000742112 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-09-30 0000742112 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2021-12-31 0000742112 ivc:SecuredTermLoansDueJuly2026Member ivc:AdditionalAmountAfterClosingRound3Member us-gaap:SecuredDebtMember us-gaap:SubsequentEventMember 2022-10-03 0000742112 ivc:SecuredTermLoansDueJuly2026Member ivc:AdditionalAmountAfterClosingRound4Member us-gaap:SecuredDebtMember us-gaap:SubsequentEventMember 2022-10-03 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheINotesMember ivc:AdditionalAmountAfterClosingRound3Member us-gaap:ConvertibleSubordinatedDebtMember us-gaap:SubsequentEventMember 2022-10-03 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheINotesMember us-gaap:SecuredDebtMember us-gaap:SubsequentEventMember 2022-10-03 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheIINotesMember ivc:AdditionalAmountAfterClosingRound3Member us-gaap:ConvertibleSubordinatedDebtMember us-gaap:SubsequentEventMember 2022-10-03 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026TrancheIINotesMember us-gaap:SecuredDebtMember us-gaap:SubsequentEventMember 2022-10-03 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:ConvertibleSubordinatedDebtMember us-gaap:SubsequentEventMember 2022-10-01 2022-12-31 0000742112 2015-04-23 0000742112 2015-07-01 2015-09-30 0000742112 2015-04-22 2015-04-23 0000742112 us-gaap:ProductMember ivc:EuropeEMEAMember 2022-07-01 2022-09-30 0000742112 ivc:ServicesMember ivc:EuropeEMEAMember 2022-07-01 2022-09-30 0000742112 ivc:EuropeEMEAMember 2022-07-01 2022-09-30 0000742112 us-gaap:ProductMember ivc:NorthAmericaNAMember 2022-07-01 2022-09-30 0000742112 ivc:ServicesMember ivc:NorthAmericaNAMember 2022-07-01 2022-09-30 0000742112 ivc:NorthAmericaNAMember 2022-07-01 2022-09-30 0000742112 us-gaap:ProductMember ivc:AllOtherMember 2022-07-01 2022-09-30 0000742112 ivc:ServicesMember ivc:AllOtherMember 2022-07-01 2022-09-30 0000742112 ivc:AllOtherMember 2022-07-01 2022-09-30 0000742112 us-gaap:ProductMember 2022-07-01 2022-09-30 0000742112 ivc:ServicesMember 2022-07-01 2022-09-30 0000742112 us-gaap:ProductMember ivc:EuropeEMEAMember 2022-01-01 2022-09-30 0000742112 ivc:ServicesMember ivc:EuropeEMEAMember 2022-01-01 2022-09-30 0000742112 ivc:EuropeEMEAMember 2022-01-01 2022-09-30 0000742112 us-gaap:ProductMember ivc:NorthAmericaNAMember 2022-01-01 2022-09-30 0000742112 ivc:ServicesMember ivc:NorthAmericaNAMember 2022-01-01 2022-09-30 0000742112 ivc:NorthAmericaNAMember 2022-01-01 2022-09-30 0000742112 us-gaap:ProductMember ivc:AllOtherMember 2022-01-01 2022-09-30 0000742112 ivc:ServicesMember ivc:AllOtherMember 2022-01-01 2022-09-30 0000742112 us-gaap:ProductMember 2022-01-01 2022-09-30 0000742112 ivc:ServicesMember 2022-01-01 2022-09-30 0000742112 us-gaap:ProductMember ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 ivc:ServicesMember ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:ProductMember ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 ivc:ServicesMember ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:ProductMember ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 ivc:ServicesMember ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:ProductMember 2021-07-01 2021-09-30 0000742112 ivc:ServicesMember 2021-07-01 2021-09-30 0000742112 us-gaap:ProductMember ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 ivc:ServicesMember ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:ProductMember ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 ivc:ServicesMember ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:ProductMember ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 ivc:ServicesMember ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 us-gaap:ProductMember 2021-01-01 2021-09-30 0000742112 ivc:ServicesMember 2021-01-01 2021-09-30 0000742112 ivc:GeneralTermsandConditionsMember 2022-01-01 2022-09-30 0000742112 ivc:LargeNationalCustomersMember 2022-01-01 2022-09-30 0000742112 ivc:GovernmentTendersMember 2022-01-01 2022-09-30 0000742112 ivc:OtherCustomersMember 2022-01-01 2022-09-30 0000742112 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0000742112 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2022-09-30 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-09-30 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-09-30 0000742112 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-09-30 0000742112 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-09-30 0000742112 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-09-30 0000742112 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-09-30 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember 2022-09-30 0000742112 us-gaap:PerformanceSharesMember 2022-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0000742112 ivc:RangeOfExercisePriceRangeMinMember 2022-01-01 2022-09-30 0000742112 ivc:RangeOfExercisePriceMaxMember 2022-01-01 2022-09-30 0000742112 ivc:A2013PlanMember 2022-09-30 0000742112 srt:MinimumMember ivc:RangeOfExercisePriceRangeMinMember 2022-01-01 2022-09-30 0000742112 srt:MaximumMember ivc:RangeOfExercisePriceRangeMinMember 2022-01-01 2022-09-30 0000742112 us-gaap:EmployeeStockOptionMember ivc:RangeOfExercisePriceRangeMinMember 2022-09-30 0000742112 us-gaap:EmployeeStockOptionMember ivc:RangeOfExercisePriceRangeMinMember 2022-01-01 2022-09-30 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember 2021-12-31 0000742112 ivc:RestrictedStockandRestrictedStockUnitsRSUsMember 2022-01-01 2022-09-30 0000742112 us-gaap:PerformanceSharesMember 2021-12-31 0000742112 us-gaap:PerformanceSharesMember 2022-01-01 2022-09-30 0000742112 srt:WeightedAverageMember us-gaap:PerformanceSharesMember 2022-01-01 2022-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2022-06-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-06-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-06-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-01 2022-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2022-07-01 2022-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-07-01 2022-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-07-01 2022-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2022-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2022-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2021-12-31 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-12-31 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2022-01-01 2022-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-01-01 2022-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2021-06-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2021-06-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-06-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-06-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2021-07-01 2021-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2021-07-01 2021-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-07-01 2021-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-07-01 2021-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2021-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2021-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-09-30 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2020-12-31 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0000742112 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-09-30 0000742112 ivc:AccumulatedLongTermNotesAdjustmentMember 2021-01-01 2021-09-30 0000742112 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-09-30 0000742112 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-07-01 2022-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-07-01 2021-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-07-01 2022-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-07-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-01-01 2022-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-07-01 2022-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-07-01 2021-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-01-01 2022-09-30 0000742112 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:ContractTerminationMember ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2021-12-31 0000742112 us-gaap:OtherRestructuringMember ivc:NorthAmericaNAMember 2021-12-31 0000742112 ivc:NorthAmericaNAMember 2021-12-31 0000742112 us-gaap:EmployeeSeveranceMember 2021-12-31 0000742112 us-gaap:OtherRestructuringMember 2021-12-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2022-01-01 2022-03-31 0000742112 us-gaap:OtherRestructuringMember ivc:NorthAmericaNAMember 2022-01-01 2022-03-31 0000742112 ivc:NorthAmericaNAMember 2022-01-01 2022-03-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2022-01-01 2022-03-31 0000742112 us-gaap:OtherRestructuringMember ivc:EuropeEMEAMember 2022-01-01 2022-03-31 0000742112 ivc:EuropeEMEAMember 2022-01-01 2022-03-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:AllOtherMember 2022-01-01 2022-03-31 0000742112 us-gaap:OtherRestructuringMember ivc:AllOtherMember 2022-01-01 2022-03-31 0000742112 ivc:AllOtherMember 2022-01-01 2022-03-31 0000742112 us-gaap:EmployeeSeveranceMember 2022-01-01 2022-03-31 0000742112 us-gaap:OtherRestructuringMember 2022-01-01 2022-03-31 0000742112 2022-01-01 2022-03-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2022-03-31 0000742112 us-gaap:OtherRestructuringMember ivc:NorthAmericaNAMember 2022-03-31 0000742112 ivc:NorthAmericaNAMember 2022-03-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2022-03-31 0000742112 us-gaap:OtherRestructuringMember ivc:EuropeEMEAMember 2022-03-31 0000742112 ivc:EuropeEMEAMember 2022-03-31 0000742112 us-gaap:EmployeeSeveranceMember 2022-03-31 0000742112 us-gaap:OtherRestructuringMember 2022-03-31 0000742112 2022-03-31 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2022-04-01 2022-06-30 0000742112 us-gaap:OtherRestructuringMember ivc:NorthAmericaNAMember 2022-04-01 2022-06-30 0000742112 ivc:NorthAmericaNAMember 2022-04-01 2022-06-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2022-04-01 2022-06-30 0000742112 us-gaap:OtherRestructuringMember ivc:EuropeEMEAMember 2022-04-01 2022-06-30 0000742112 ivc:EuropeEMEAMember 2022-04-01 2022-06-30 0000742112 us-gaap:EmployeeSeveranceMember 2022-04-01 2022-06-30 0000742112 us-gaap:OtherRestructuringMember 2022-04-01 2022-06-30 0000742112 2022-04-01 2022-06-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2022-06-30 0000742112 us-gaap:OtherRestructuringMember ivc:NorthAmericaNAMember 2022-06-30 0000742112 ivc:NorthAmericaNAMember 2022-06-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2022-06-30 0000742112 us-gaap:OtherRestructuringMember ivc:EuropeEMEAMember 2022-06-30 0000742112 ivc:EuropeEMEAMember 2022-06-30 0000742112 us-gaap:EmployeeSeveranceMember 2022-06-30 0000742112 us-gaap:OtherRestructuringMember 2022-06-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2022-07-01 2022-09-30 0000742112 us-gaap:OtherRestructuringMember ivc:NorthAmericaNAMember 2022-07-01 2022-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2022-07-01 2022-09-30 0000742112 us-gaap:OtherRestructuringMember ivc:EuropeEMEAMember 2022-07-01 2022-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:AllOtherMember 2022-07-01 2022-09-30 0000742112 us-gaap:OtherRestructuringMember ivc:AllOtherMember 2022-07-01 2022-09-30 0000742112 us-gaap:EmployeeSeveranceMember 2022-07-01 2022-09-30 0000742112 us-gaap:OtherRestructuringMember 2022-07-01 2022-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:NorthAmericaNAMember 2022-09-30 0000742112 us-gaap:OtherRestructuringMember ivc:NorthAmericaNAMember 2022-09-30 0000742112 ivc:NorthAmericaNAMember 2022-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:EuropeEMEAMember 2022-09-30 0000742112 us-gaap:OtherRestructuringMember ivc:EuropeEMEAMember 2022-09-30 0000742112 ivc:EuropeEMEAMember 2022-09-30 0000742112 us-gaap:EmployeeSeveranceMember ivc:AllOtherMember 2022-09-30 0000742112 us-gaap:OtherRestructuringMember ivc:AllOtherMember 2022-09-30 0000742112 us-gaap:EmployeeSeveranceMember 2022-09-30 0000742112 us-gaap:OtherRestructuringMember 2022-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2022-07-01 2022-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2021-07-01 2021-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2022-09-30 0000742112 us-gaap:EmployeeStockOptionMember 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember 2022-01-01 2022-09-30 0000742112 us-gaap:ForeignExchangeForwardMember 2021-01-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember 2022-07-01 2022-09-30 0000742112 us-gaap:ForeignExchangeForwardMember 2021-07-01 2021-09-30 0000742112 ivc:ForeignExchangeForwardUSDEURMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardUSDEURMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardUSDEURMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardUSDEURMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardUSDCADMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardUSDCADMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardUSDCADMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardUSDCADMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardNOKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardNOKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardNOKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardNOKSEKMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardUSDMXPMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardUSDMXPMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardUSDMXPMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardUSDMXPMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0000742112 us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0000742112 us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-09-30 0000742112 us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000742112 us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardAUDUSDMember us-gaap:NondesignatedMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardAUDUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardAUDUSDMember us-gaap:NondesignatedMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardAUDUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardCADUSDMember us-gaap:NondesignatedMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardCADUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardCADUSDMember us-gaap:NondesignatedMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardCADUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardEURUSDMember us-gaap:NondesignatedMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardEURUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardEURUSDMember us-gaap:NondesignatedMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardEURUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardDKKUSDMember us-gaap:NondesignatedMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardDKKUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardDKKUSDMember us-gaap:NondesignatedMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardDKKUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardGBPUSDMember us-gaap:NondesignatedMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardGBPUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardGBPUSDMember us-gaap:NondesignatedMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardGBPUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardNOKUSDMember us-gaap:NondesignatedMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardNOKUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardNOKUSDMember us-gaap:NondesignatedMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardNOKUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardSEKUSDMember us-gaap:NondesignatedMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardSEKUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardSEKUSDMember us-gaap:NondesignatedMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardSEKUSDMember us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:NondesignatedMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:NondesignatedMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardEURGBPMember us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:NondesignatedMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:NondesignatedMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardEURNOKMember us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:NondesignatedMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:NondesignatedMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardAUDNZDMember us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardUSDTHBMember us-gaap:NondesignatedMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardUSDTHBMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardUSDTHBMember us-gaap:NondesignatedMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardUSDTHBMember us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0000742112 ivc:ForeignExchangeForwardEURSEKMember us-gaap:NondesignatedMember 2022-09-30 0000742112 ivc:ForeignExchangeForwardEURSEKMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000742112 ivc:ForeignExchangeForwardEURSEKMember us-gaap:NondesignatedMember 2021-12-31 0000742112 ivc:ForeignExchangeForwardEURSEKMember us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0000742112 us-gaap:NondesignatedMember 2022-09-30 0000742112 us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0000742112 us-gaap:NondesignatedMember 2021-12-31 0000742112 us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0000742112 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000742112 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2022-09-30 0000742112 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2022-09-30 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-12-31 0000742112 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-12-31 0000742112 us-gaap:OtherCurrentAssetsMember 2022-09-30 0000742112 us-gaap:AccruedLiabilitiesMember 2022-09-30 0000742112 us-gaap:OtherCurrentAssetsMember 2021-12-31 0000742112 us-gaap:AccruedLiabilitiesMember 2021-12-31 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2022-07-01 2022-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2022-01-01 2022-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2021-07-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2021-01-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-01 2022-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-07-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2022-07-01 2022-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2022-01-01 2022-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0000742112 us-gaap:CashFlowHedgingMember 2022-07-01 2022-09-30 0000742112 us-gaap:CashFlowHedgingMember 2022-01-01 2022-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2021-07-01 2021-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2021-01-01 2021-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0000742112 us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0000742112 us-gaap:CashFlowHedgingMember 2021-07-01 2021-09-30 0000742112 us-gaap:CashFlowHedgingMember 2021-01-01 2021-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0000742112 us-gaap:ConvertibleSubordinatedDebtMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0000742112 ivc:ConvertibleDebtDerivativeMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0000742112 us-gaap:ConvertibleSubordinatedDebtMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000742112 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000742112 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0000742112 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0000742112 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0000742112 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0000742112 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0000742112 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0000742112 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0000742112 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0000742112 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt450February2022Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt450February2022Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt450February2022Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0000742112 ivc:ConvertibleSeniorNotesAt450February2022Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0000742112 ivc:ConvertibleSeniorNotesAt500November2024BMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt500November2024BMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt500November2024BMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0000742112 ivc:ConvertibleSeniorNotesAt500November2024BMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0000742112 ivc:SeriesIIConvertibleSeniorNotesAt500November2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0000742112 ivc:ConvertibleSeniorNotesAt425March2026Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0000742112 ivc:ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0000742112 ivc:SecuredTermLoansDueJuly2026Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0000742112 ivc:SecuredTermLoansDueJuly2026Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0000742112 ivc:SecuredTermLoansDueJuly2026Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0000742112 ivc:SecuredTermLoansDueJuly2026Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0000742112 ivc:OtherNotesandCapitalLeaseObligationsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0000742112 us-gaap:ConvertibleSubordinatedDebtMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0000742112 us-gaap:ConvertibleSubordinatedDebtMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0000742112 us-gaap:ConvertibleSubordinatedDebtMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0000742112 us-gaap:ConvertibleSubordinatedDebtMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0000742112 us-gaap:IntersegmentEliminationMember ivc:EuropeEMEAMember 2022-07-01 2022-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:EuropeEMEAMember 2022-01-01 2022-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:NorthAmericaNAMember 2022-07-01 2022-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:NorthAmericaNAMember 2022-01-01 2022-09-30 0000742112 us-gaap:IntersegmentEliminationMember ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:IntersegmentEliminationMember 2022-07-01 2022-09-30 0000742112 us-gaap:IntersegmentEliminationMember 2021-07-01 2021-09-30 0000742112 us-gaap:IntersegmentEliminationMember 2022-01-01 2022-09-30 0000742112 us-gaap:IntersegmentEliminationMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:EuropeEMEAMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:EuropeEMEAMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:EuropeEMEAMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:EuropeEMEAMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:EuropeEMEAMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:EuropeEMEAMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:EuropeEMEAMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:EuropeEMEAMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:EuropeEMEAMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:EuropeEMEAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:EuropeEMEAMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:EuropeEMEAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:NorthAmericaNAMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:NorthAmericaNAMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:NorthAmericaNAMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:NorthAmericaNAMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:NorthAmericaNAMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:NorthAmericaNAMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:NorthAmericaNAMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:NorthAmericaNAMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:NorthAmericaNAMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:NorthAmericaNAMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:NorthAmericaNAMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:NorthAmericaNAMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:AllOtherMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:AllOtherMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:MobilityandSeatingDomain ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:AllOtherMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:AllOtherMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:LifestyleProductsDomain ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:AllOtherMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:AllOtherMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:RespiratoryTherapyDomain ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:AllOtherMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:AllOtherMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:OtherDomain ivc:AllOtherMember 2021-01-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:AllOtherMember 2022-07-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:AllOtherMember 2021-07-01 2021-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:AllOtherMember 2022-01-01 2022-09-30 0000742112 us-gaap:OperatingSegmentsMember ivc:AllOtherMember 2021-01-01 2021-09-30 shares iso4217:USD iso4217:USD shares pure ivc:payment utr:D ivc:votes 0000742112 --12-31 2022 Q3 false P5Y P5Y P5D 10-Q true 2022-09-30 false 001-15103 INVACARE CORPORATION OH 95-2680965 One Invacare Way, Elyria, OH 44035 440 329-6000 Common Shares, without par value IVC NYSE Yes Yes Accelerated Filer true false false 37754335 3667 170408000 224200000 560413000 646266000 139029000 163890000 433323000 470500000 31379000 60310000 127090000 175766000 55365000 56135000 174552000 178721000 8440000 377000 16383000 2476000 1012000 0 1012000 0 0 28564000 0 28564000 -33438000 -24766000 -64857000 -33995000 950000 0 950000 0 6398000 10131000 6398000 9422000 7354000 6284000 19836000 18099000 10000 0 11000 1000 -33434000 -20919000 -77334000 -42671000 920000 1840000 3160000 4830000 -34354000 -22759000 -80494000 -47501000 -0.92 -0.65 -2.23 -1.36 37537000 35013000 36073000 34826000 -0.92 -0.65 -2.23 -1.36 37680000 35488000 36241000 35371000 -34354000 -22759000 -80494000 -47501000 -34051000 -19202000 -66938000 -6487000 45000 -27000 4608000 -422000 9000 -20000 94000 43000 9000 -20000 94000 43000 -1394000 1423000 298000 649000 -178000 170000 62000 73000 -35222000 -17976000 -62094000 -6333000 -69576000 -40735000 -142588000 -53834000 45439000 83745000 80105000 117115000 255000 218000 120687000 144274000 48338000 40036000 294824000 385388000 5330000 5362000 23390000 26356000 53244000 60921000 56083000 63029000 9980000 12600000 314755000 355875000 757606000 909531000 95973000 130036000 116330000 102971000 2136000 3914000 2150000 3107000 3031000 3009000 3062000 4217000 222682000 247254000 333129000 305022000 57511000 63736000 6865000 8234000 56374000 66796000 300000 300000 0 0 0 0 150000000 150000000 42328000 39416000 10807000 9977000 12000000 12000000 4000 4000 2000 2000 281130000 276665000 -57849000 22645000 -45106000 16988000 4535000 4397000 107939000 107788000 81045000 218489000 757606000 909531000 -80494000 -47501000 11796000 12511000 3749000 4757000 715000 327000 33000 -148000 738000 -165000 1839000 5369000 -216000 232000 6398000 9422000 1012000 0 0 28564000 8651000 0 2864000 2637000 1676000 1622000 950000 0 -29087000 8030000 -296000 -222000 -5969000 37199000 7784000 -8215000 -26160000 24769000 11714000 -24182000 -3967000 731000 -46874000 -36825000 3302000 14397000 5000 23000 77000 93000 539000 0 -3913000 -14467000 84693000 154830000 59152000 109139000 8046000 5369000 0 -18787000 151000 1752000 17344000 19783000 -4863000 -133000 -38306000 -31642000 83745000 105298000 45439000 73656000 10132000 2000 278788000 -23495000 -9884000 -107939000 147604000 0 -495000 0 -495000 0 56000 0 56000 -34354000 -34354000 -34051000 -34051000 -1216000 -1216000 45000 45000 -69576000 675000 2781000 3456000 10807000 2000 281130000 -57849000 -45106000 -107939000 81045000 9977000 2000 278152000 43466000 57079000 -107786000 280890000 0 -1250000 0 -1250000 0 809000 0 809000 -22759000 -22759000 -19202000 -19202000 1253000 1253000 -27000 -27000 -40735000 9977000 2000 277711000 20707000 39103000 -107786000 239714000 9977000 2000 276665000 22645000 16988000 -107788000 218489000 0 -814000 0 -814000 155000 2498000 -151000 2502000 -80494000 -80494000 -66938000 -66938000 236000 236000 4608000 4608000 -142588000 675000 2781000 3456000 10807000 2000 281130000 -57849000 -45106000 -107939000 81045000 9816000 2000 326088000 58538000 45436000 -106034000 333846000 52000 747000 -668000 131000 109000 4461000 -1084000 3486000 -47501000 -47501000 -6487000 -6487000 576000 576000 -422000 -422000 -53834000 -34798000 9670000 -25128000 -18787000 -18787000 9977000 2000 277711000 20707000 39103000 -107786000 239714000 Accounting Policies<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2022 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2022 and 2021, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements (Already Adopted):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 "Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting," which is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burden related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates if certain criteria are met. The guidance may be adopted in any period prior to the guidance expiration on December 31, 2022. </span></div>The company adopted ASU 2020-04 effective January 1, 2022 and the adoption did not have a material impact on the company's financial statements. Interest arrangements previously referring to LIBOR prior to adoption, now refer to a secured overnight finance rate (SOFR). <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The condensed consolidated financial statements include the accounts of the company and its wholly owned subsidiaries and include all adjustments, which were of a normal recurring nature, necessary to present fairly the financial position of the company as of September 30, 2022 and the results of its operations and changes in its cash flow for the nine months ended September 30, 2022 and 2021, respectively. Certain foreign subsidiaries, represented by the European segment, are consolidated using an August 31 quarter end to meet filing deadlines. No material subsequent events have occurred related to the European segment, which would require disclosure or adjustment to the company's financial statements. All significant intercompany transactions are eliminated. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year.</span> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States, which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates.</span> Recent Accounting Pronouncements (Already Adopted): In March 2020, the FASB issued ASU 2020-04 "Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting," which is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burden related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates if certain criteria are met. The guidance may be adopted in any period prior to the guidance expiration on December 31, 2022. The company adopted ASU 2020-04 effective January 1, 2022 and the adoption did not have a material impact on the company's financial statements. Interest arrangements previously referring to LIBOR prior to adoption, now refer to a secured overnight finance rate (SOFR). <div style="display:inline-block;vertical-align:top;width:46.666%"><div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Receivables</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.007%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, gross</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">99,780 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">142,806 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer rebate reserve</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8,722)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12,267)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash discount reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9,179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3,214)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3,642)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other, principally returns and allowances reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(603)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">80,105 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">117,115 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserves for customer rebates and cash discounts are recorded as a reduction in revenue and netted against gross accounts receivable. Customer rebates in excess of a given customer's accounts receivable balance are classified in Accrued Expenses. Customer rebates and cash discounts are estimated based on the most likely amount principle as well as historical experience and anticipated performance. In addition, customers have the right to return product within the company’s normal terms policy, and as such, the company estimates the expected returns based on an analysis of historical experience and adjusts revenue accordingly. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the company entered into an agreement with a bank to sell certain trade receivables with governmental entity customers in the Nordic region without recourse. Under ASC 860, the sale of the receivables qualify as a true sale and not a secured borrowing. No gain or loss was recorded on the sale of the receivables. Bank charges, which are recorded as interest expense attributable to the program, were immaterial for the nine months ended September 30, 2022. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities predominantly located throughout the United States, Australia, Canada, New Zealand and Europe. A significant portion of products sold to providers, both foreign and domestic, are ultimately funded through government reimbursement programs such as Medicare and Medicaid in the U.S. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's approach is to separate its receivables into good-standing and collection receivables. Good-standing </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receivables are assigned to risk pools of high, medium and low. The risk pools are driven by the specifics associated with the geography of origination. Expected loss percentages are calculated and assigned to each risk pool, driven primarily by historical experience. The historical loss percentages are calculated for each risk pool and then judgmentally revised to consider current risk factors as well as consideration of the impact of forecasted events, as applicable. The expected loss percentages are then applied to receivables balances each period to determine the allowance for doubtful accounts.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In North America, excluding Canada, good-standing receivables are assigned to the low risk pool and assigned an expected loss percentage of 1.0% as these receivables are deemed to share the same risk profile and collections efforts are the same. Installment receivables in North America are characterized as collection receivables and thus reserves are based on specific analysis of each customer. In Canada, good-standing receivables are deemed low risk and assigned a loss percentage of 0.1%.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Europe, expected losses are determined by each location in each region. Most locations have a majority of their receivables assigned to the low risk pool, which has an average expected loss percentage of 0.3%. About half of the locations have a portion of their receivables assigned as medium risk with an average expected loss percentage of 0.7%. Only a few locations have any receivables characterized as high risk and the average credit loss percentage for those locations is 2.8%. Collection risk is generally low as payment terms in certain key markets, such as Germany, are immediate and in many locations the ultimate customer is the government. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Asia Pacific region, receivables are characterized as low risk, which have an average expected loss percentage of 1.0%. Historical losses are low in this region where the use of credit insurance is often customary.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.054%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.746%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,642 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current period provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">715 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Recoveries (direct write-offs), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of end of period</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,214 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company did not make any material changes to the assignment of receivables to the different risk pools or to the expected loss reserves in the quarter. The company is monitoring the impacts of the COVID-19 pandemic and the possibility for an impact on collections, but to date this has not materially impacted 2022. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For collections receivables, the estimated allowance for uncollectible amounts is based primarily on management’s evaluation of the financial condition of each customer. In addition, as a result of the company's financing arrangement with DLL, a third-party financing company which the company has worked with since 2000, management monitors the collection status of these contracts in accordance with the company’s limited recourse obligations and provides amounts necessary for estimated losses in the allowance for doubtful accounts and establishes reserves for specific customers as needed. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company writes off uncollectible trade accounts receivable after such receivables are moved to collection status and legal remedies are exhausted. Refer to Concentration of Credit Risk in the notes to the condensed consolidated financial statements for a description of the financing arrangement. Long-term installment receivables are included in “Other Assets” on the condensed consolidated balance sheets.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has recorded a contingent liability in the amount of $393,000 related to the contingent aspect of the company's guarantee associated with its arrangement with DLL. The contingent liability is recorded applying the same expected loss model used for the trade and installment receivables recorded on the company's books. Specifically, historical loss history is used to determine the expected loss percentage, which is then adjusted judgmentally to consider other factors, as needed.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company’s U.S. customers electing to finance their purchases can do so using DLL. Repurchased DLL receivables recorded on the books of the company represent a single portfolio segment of receivables to the independent provider channel and long-term care customers. The portfolio segment </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of these receivables are distinguished by geography and credit quality. These receivables were repurchased from DLL because the customers were in default. Default with DLL is defined as a customer being delinquent by three payments. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated allowance for uncollectible amounts and evaluation for both classes of installment receivables is based on the company’s quarterly review of the financial condition of each individual customer with the allowance for doubtful accounts adjusted accordingly. Installments are individually and not collectively reviewed. The company assesses the bad debt reserve levels based upon the status of the customer’s adherence to a legally negotiated payment schedule and the company’s ability to enforce judgments, liens, etc.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of granting or extending credit, the company utilizes a scoring model to generate a composite score that considers each customer’s consumer credit score and/or D&amp;B credit rating, payment history, security collateral and time in business. Additional analysis is performed for most customers desiring credit greater than $250,000, which generally includes a detailed review of the customer’s financial statements as well as consideration of other factors such as exposure to changing reimbursement laws.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income is recognized on installment receivables based on the terms of the installment agreements. Installment accounts are monitored and if a customer defaults on payments and is moved to collection, interest income is no longer recognized. Subsequent payments received once an account is put on non-accrual status are generally first applied to the principal balance and then to the interest. Accruing of interest on collection accounts would only be restarted if the account became current again.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All installment accounts are accounted for using the same methodology regardless of the duration of the installment agreements. When an account is placed in collection status, the company goes through a legal process for pursuing collection of outstanding amounts, the length of which typically approximates eighteen months. Any write-offs are made after the legal process has been completed. </span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables consist of the following (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:28.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Long-Term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Long-Term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Installment receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">274 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">734 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Installment receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">274 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">734 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No sales of installment receivables were recorded by the company in 2022. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current period provision (benefit)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Direct write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of end of period</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of September 30, 2022 consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of December 31, 2021 consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aging of the company’s installment receivables was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0-30 days past due</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31-60 days past due</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61-90 days past due</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90+ days past due</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.007%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, gross</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">99,780 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">142,806 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Customer rebate reserve</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8,722)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12,267)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash discount reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9,179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3,214)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3,642)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other, principally returns and allowances reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(603)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">80,105 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">117,115 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 99780000 142806000 8722000 12267000 7174000 9179000 3214000 3642000 565000 603000 80105000 117115000 0.010 0.001 0.003 0.007 0.028 0.010 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the trade receivables allowance for doubtful accounts was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.054%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.746%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,642 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current period provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">715 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Recoveries (direct write-offs), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of end of period</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,214 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 3642000 715000 1143000 3214000 393000 3 250000 P18M <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables consist of the following (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:28.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Long-Term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Long-Term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Installment receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">274 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">734 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Installment receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">274 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">734 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div> 255000 274000 529000 218000 734000 952000 0 0 0 0 0 0 255000 274000 529000 218000 734000 952000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movement in the installment receivables allowance for doubtful accounts was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current period provision (benefit)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Direct write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Balance as of end of period</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 487000 0 -75000 0 412000 0 0 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of September 30, 2022 consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of December 31, 2021 consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of September 30, 2022 consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-Impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impaired installment receivables with a related allowance recorded</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment receivables by class as of December 31, 2021 consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total<br/>Installment<br/>Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Unpaid<br/>Principal<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Related<br/>Allowance for<br/>Doubtful<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Interest<br/>Income<br/>Recognized</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-impaired installment receivables with no related allowance recorded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total installment receivables</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">952 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 529000 529000 0 0 529000 529000 0 0 0 0 0 0 529000 529000 0 0 952000 952000 0 0 952000 952000 0 0 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aging of the company’s installment receivables was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asia Pacific</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0-30 days past due</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31-60 days past due</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61-90 days past due</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90+ days past due</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 529000 529000 952000 952000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 529000 529000 952000 952000 <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories, Net</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,082 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,270 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,124 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,335 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,687 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,274 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,082 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,270 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,124 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,335 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,687 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,274 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 60082000 69371000 49270000 62124000 11335000 12779000 120687000 144274000 <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Assets</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivables principally value added taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,152 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,943 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,045 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,462 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid inventory and freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives (foreign currency forward exchange contracts)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoverable income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,440 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable due from information technology provider</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,520 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,255 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,338 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,036 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivables principally value added taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,152 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,943 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,045 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,462 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid inventory and freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives (foreign currency forward exchange contracts)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoverable income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,440 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,301 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable due from information technology provider</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,520 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,255 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,338 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,036 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 29152000 21943000 3045000 4462000 2938000 2394000 2626000 386000 2440000 2301000 682000 304000 612000 612000 323000 379000 6520000 7255000 48338000 40036000 <div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Long-Term Assets</span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div><span><br/></span></div></div></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,481 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,615 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Installment receivables</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long-Term Assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,330 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,362 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,481 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,615 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Installment receivables</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long-Term Assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,330 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,362 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2551000 2481000 1615000 1540000 726000 409000 274000 734000 85000 86000 79000 112000 5330000 5362000 <div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:9pt"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,347 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,448 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, buildings and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,432 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,299 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,943 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,730 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,782 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,254 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,819 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282,010)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290,898)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,244 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,921 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Machinery and equipment includes demonstration units placed in provider locations which are depreciated to their estimated recoverable values over their estimated useful lives. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2019, the company initiated the first stage of an Enterprise Resource Planning ("ERP") software implementation. Related to the ERP project, the company capitalized certain costs in accordance with ASC 350 as shown in capitalized software above. The net book value of capitalized software was $26,833,000 and $28,715,000 at September 30, 2022 and December 31, 2021, respectively. Depreciation expense related to capitalized software started in 2021 and was $832,000 and $2,342,000 for the three and nine months ended September 30, 2022, respectively, compared to $419,000 and $1,084,000 for the three and nine months ended September 30, 2021, respectively. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid purchases of property and equipment at September 30, 2022 and December 31, 2021 were $0 and $1,090,000, respectively and are excluded from purchases of property and equipment on the condensed consolidated statements of cash flows for the periods ending and are included in subsequent periods when paid.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div></div> <div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,347 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,448 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, buildings and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,432 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,299 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,943 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,730 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,782 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,254 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,819 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282,010)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290,898)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,244 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,921 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 267218000 278347000 30904000 30448000 24432000 27299000 7970000 8943000 4730000 6782000 335254000 351819000 282010000 290898000 53244000 60921000 26833000 28715000 832000 2342000 419000 1084000 0 1090000 <div style="display:inline-block;vertical-align:top;width:46.666%"><div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in goodwill from December 31, 2021 to September 30, 2022 was due to foreign currency translation.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles—Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ASC 350, goodwill is tested annually for impairment or whenever events or changes in circumstances indicate the carrying value of a reporting unit could be above its fair value. A reporting unit is defined as an operating segment or one level below. The company has determined that its reporting units are North America, Europe and Asia Pacific.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2022, a continued decline in the share price of the company's Common Shares sustained the company's market capitalization below the carrying value of shareholders' equity. Further, inputs used in estimating the weighted average cost of capital ("WACC") had moved unfavorably to increase the WACC used in a discounted cash flows model. The combination of these and other developments were identified as a triggering event and the company proceeded with a quantitative goodwill impairment assessment of its Europe reporting unit (the only reporting unit with goodwill). </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A quantitative goodwill impairment assessment was performed as of September 30, 2022, utilizing a discounted cash flows methodology. Key assumptions used in the discounted cash flow analysis included, but were not limited to, a WACC of approximately 14.51%, terminal growth rates and financial projections of performance and cash flows. Components of the WACC include quoted rates for 20-year debt of potential acquirer companies with similar credit risk and the cost of equity based on the 20-year treasury rate for the risk free rate, a market risk premium, an industry average beta and a small cap stock adjustment. The assumptions are based on a market participant's point of view and thus these inputs are deemed Level III inputs in regard to the fair value hierarchy. The WACC used in the 2021 annual assessment was 11.19%. The WACC used has a significant impact in the outcome of the discounted cash flow methodology utilized in the company's impairment assessment as a higher WACC would decrease fair value estimates. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company also utilized an Enterprise Value ("EV") to Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA") method to compute the fair value of reporting units which considers potential acquirers and their EV to EBITDA multiples adjusted by an estimated premium. The EV method is used to corroborate fair values but more weight is placed on the discounted cash flow method results. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company concluded based on the results of the interim quantitative goodwill impairment assessment </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performed as of September 30, 2022 that goodwill was not impaired.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation of goodwill can differ materially if financial projections or market inputs used to determine the WACC change significantly. For instance, higher interest rates or greater stock price volatility would increase the WACC and thus increase the chance of impairment. Assumptions used in the quantitative assessment require significant judgements and estimates which are inherently uncertain. If actual results are materially lower than estimates, it could result in a material impact on the consolidated financial statements in future periods. In addition, business changes impacting the company's assessment of reporting units could also have a material impact on impairment assessment results. For instance, higher interest rates or greater stock price volatility would increase the WACC and thus increase the chance of impairment. In consideration of this potential, the company assessed the results if the discount rate used were 100 basis points higher for the third quarter quantitative assessment and determined that there still would not be impairment of goodwill for the Europe reporting unit. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company completed an interim test of the North America reporting unit in the third quarter of 2021 which resulted in impairment of $28,564,000. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Goodwill in the company's Annual Report on Form 10-K for the period ending December 31, 2021 for further disclosure regarding the company's annual impairment assessment methodology.</span></div></div> 0.1451 0.1119 <div style="margin-top:9pt"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangibles</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's intangibles consist of the following (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer lists</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,041 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,041 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,447 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,447 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,447 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,137 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,973 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,543 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,543 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,967 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,905 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,047 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,657 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,831 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,475 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the company’s intangible assets have been assigned definite lives and continue to be amortized over their useful lives, except for trademarks shown above, which have indefinite lives. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in intangible balances reflected on the balance sheet from December 31, 2021 to September 30, 2022 were primarily the result of foreign currency translation on historical cost and accumulated amortization as well as new license agreements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company evaluates the carrying value of definite-lived assets annually in the fourth quarter and whenever events or circumstances indicate possible impairment. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definite-lived assets are determined to be impaired if the future undiscounted cash flows expected to be generated by the asset are less than the carrying value. Actual impairment amounts for definite-lived assets are then calculated using a discounted cash flow calculation. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any impairment for indefinite-lived intangible assets is calculated as the difference between the future discounted cash flows expected to be generated by the asset and the carrying value of the asset. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets was $358,000 in the first nine months of 2022 and is expected to be $510,000 in 2022, $612,000 in 2023, $547,000 in 2024, $439,000 in 2025, $437,000 in 2026 and $311,000 in 2027. Amortized intangible assets are being amortized on a straight-line basis over remaining lives of 2 to 7 years with a weighted average remaining life of approximately 5.8 years.</span></div>During the third quarter of 2022, the company recognized an intangible impairment charge in the North America segment of $1,012,000 related to a trademark with an indefinite life the company determined it would no longer use. <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's intangibles consist of the following (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer lists</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,041 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,041 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,447 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,447 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,447 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,137 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,973 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,543 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,543 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,967 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,905 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,047 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,657 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,831 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,475 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's intangibles consist of the following (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Historical<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer lists</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,041 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,041 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,447 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,447 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,447 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,137 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,973 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,471 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,543 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,543 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,967 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,905 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,047 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,657 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,831 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,475 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 47041000 47041000 52447000 52447000 20447000 24137000 6973000 6648000 7652000 7149000 5471000 5471000 5543000 5543000 3967000 1356000 2905000 1196000 1148000 1141000 1147000 1140000 85047000 61657000 93831000 67475000 358000 510000 612000 547000 439000 437000 311000 P2Y P7Y P5Y9M18D 1012000 <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Expenses</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of accruals for the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes other than income taxes, primarily value added taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,221 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,217 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,012 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,759 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,576 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,460 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities (foreign currency forward exchange contracts)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,782 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT service contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,837 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product line exit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,264 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product liability, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,620 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,362 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental executive retirement program liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items, principally trade accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,345 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,330 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,971 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the company's products are covered by warranties against defects in material and workmanship for various periods depending on the product from the date of sales to the customer. Certain components carry a lifetime warranty. A provision for estimated warranty cost is recorded at the time of sale based upon actual experience. In addition, the company has sold extended warranties that, while immaterial, require the company to defer the revenue associated with those warranties until earned. The company has established procedures to appropriately defer such revenue. The company continuously assesses the adequacy of its product warranty accrual and makes adjustments as needed. Historical analysis is primarily used to determine the company's warranty reserves. Claims history is reviewed and provisions are adjusted as needed. However, the company does consider other events, such as a product field action and recalls, which could require additional warranty reserve provision.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued rebates relate to several volume incentive programs the company offers its customers. The company accounts for these rebates as a reduction of revenue when the products are sold. Rebates are netted against gross accounts receivables. If rebates are in excess of such receivables, they are then classified as accrued expenses. The reduction in accrued rebates from December 31, 2021 to September 30, 2022 primarily relates to payments principally made in the first quarter each year, earned from the previous year.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties provided during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,842 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,596)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in liability for pre-existing warranties during the period, including expirations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,576 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Warranty reserves are subject to adjustment in future periods as new developments change the company's estimate of the total cost. Lower balance at September 30, 2022 is primarily attributable to favorable claim development and lower sales. <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of accruals for the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes other than income taxes, primarily value added taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,221 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,217 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and wages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,012 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,759 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,576 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Freight</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,460 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,297 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities (foreign currency forward exchange contracts)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,782 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IT service contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,837 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product line exit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,264 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product liability, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,620 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,362 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental executive retirement program liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items, principally trade accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,345 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,330 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,971 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 32221000 23217000 17177000 24012000 11759000 8697000 8576000 11198000 5918000 5460000 5197000 3297000 4890000 1938000 4782000 6569000 4000000 4013000 3837000 625000 3450000 400000 3264000 0 2620000 2362000 1903000 4156000 391000 391000 6345000 6636000 116330000 102971000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the changes in accrued warranty costs for the reporting period (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties provided during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,842 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,596)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in liability for pre-existing warranties during the period, including expirations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,576 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 11198000 1842000 4596000 132000 8576000 <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Term Debt</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 4.50%, due in June 2022</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes Series I at 5.00%, due in November 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,341 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,140 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes Series II at 5.00%, due in November 2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,764 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,251 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 4.25%, due in March 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,898 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,036 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured convertible senior notes at 5.68%, due in July 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,463 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, due in July 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,724 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,089 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,060 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,279 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308,129 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current maturities of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,150)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,107)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,129 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305,022 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2015, the company entered into an Amended and Restated Revolving Credit and Security Agreement, which was subsequently amended (the “Prior Credit Agreement”) and which was to mature on January 16, 2024. The Prior Credit Agreement was entered into by and among the company, certain of the company’s direct and indirect U.S. and Canadian subsidiaries and certain of the company’s European subsidiaries, certain other of the company’s direct and indirect U.S., Canadian and European subsidiaries, and PNC Bank, National Association (“PNC”), JPMorgan Chase Bank, N.A., J.P. Morgan Europe Limited, KeyBank National Association, and Citizens Bank, National Association. PNC was the administrative agent (the “Prior Credit Agreement Administrative Agent”) and J.P. Morgan Europe Limited is the European agent (the “European Agent”) under the Prior Credit Agreement. As discussed further below, the Prior Credit Agreement was amended and restated ("the ABL Credit Agreement") on July 26, 2022. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company had outstanding letters of credit of $3,576,000 and $3,450,000 as of September 30, 2022 and December 31, 2021, respectively. Outstanding letters of credit and other reserves impacting borrowing capacity were $4,902,000 and $2,585,000 as of September 30, 2022 and December 31, 2021, respectively. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company had outstanding borrowings of $16,900,000 under its ABL Credit Agreement as of September 30, 2022. The company had outstanding borrowings of $22,150,000 under its North America Credit Facility under the Prior Credit Agreement as of December 31, 2021. The company had outstanding borrowings of $7,366,000 (€6,500,000) under its </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">French Credit Facility and $5,986,000 (£4,500,000) under its UK Credit Facility under its Prior Credit Agreement as of December 31, 2021, together referred to as the European Credit Facility. No borrowings were outstanding under the European Credit Facility as of September 30, 2022 as it was terminated July 26, 2022.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">North America Borrowers Credit Facility</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the company's North America Borrowers, the Prior Credit Agreement provided for an asset-based-lending senior secured revolving credit facility which was secured by substantially all the company’s U.S. and Canadian assets, other than real estate. The Prior Credit Agreement provided the company and the other Borrowers with a credit facility in an aggregate principal amount of $60,000,000, subject to availability based on a borrowing base formula, under a senior secured revolving credit, letter of credit and swing line loan facility (the “North America Credit Facility”). Up to $20,000,000 of the North America Credit Facility was available for issuance of letters of credit. The aggregate principal amount of the North America Credit Facility could have been increased by up to $25,000,000 to the extent requested by the company and agreed to by any lender or new financial institution approved by the Prior Credit Agreement Administrative Agent. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate borrowing availability under the North America Credit Facility was determined based on a borrowing base formula. The aggregate usage under the North America Credit Facility could not exceed an amount equal to the sum of (a) 85% of eligible U.S. accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (b) the lesser </span></div></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of (i) 70% of eligible U.S. inventory and eligible foreign in-transit inventory and (ii) 85% of the net orderly liquidation value of eligible U.S. inventory and eligible foreign in-transit inventory (not to exceed $4,000,000), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (c) the lesser of (i) 80% of the net orderly liquidation value of U.S. eligible machinery and equipment and (ii) $0 as of September 30, 2022 (subject to reduction as provided in the Prior Credit Agreement), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (d) 85% of eligible Canadian accounts receivable, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (e) the lesser of (i) 70% of eligible Canadian inventory and (ii) 85% of the net orderly liquidation value of eligible Canadian inventory, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (f) swing loans outstanding under the North America Credit Facility, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (g) letters of credit issued and undrawn under the North America Credit Facility, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (h) a $3,000,000 minimum availability reserve, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (i) other reserves required by the Prior Credit Agreement Administrative Agent, and in each case subject to the definitions and limitations in the Prior Credit Agreement. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest accrued on outstanding indebtedness under the Prior Credit Agreement at the SOFR rate, plus a margin ranging from 2.25% to 2.75%, or at the alternate base rate, plus a margin ranging from 1.25% to 1.75%, as selected by the company. Borrowings under the North America Credit Facility are subject to commitment fees of 0.25% or 0.375% per year, depending on utilization. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Prior Credit Agreement contained customary representations, warranties and covenants. Exceptions to the operating covenants in the Prior Credit Agreement provide the company with flexibility to, among other things, enter into or undertake certain sale and leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Prior Credit Agreement, as amended. The Prior Credit Agreement also contained a covenant requiring the company to maintain minimum availability under the North America Credit Facility of not less than (i) 12.5% of the maximum amount that may be drawn under the North America Credit Facility for five (5) consecutive business days, or (ii) 11.25% of the maximum amount that may be drawn under the North America Credit Facility on any business day. The company also is subject to dominion triggers under the North America Credit Facility requiring the company to maintain borrowing capacity of not less than $7,500,000 on any business day or any five consecutive days in order to avoid triggering full control by an agent for the lenders of the company's cash receipts for application to the company’s obligations under the agreement.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Prior Credit Agreement contained customary default provisions, with certain grace periods and exceptions, which provide for events of default that include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reimbursement program, and an interruption of any material manufacturing facilities for more than 10 consecutive days. The proceeds of the North America Credit Facility were used to finance the working capital and other business needs of the company. There was $16,900,000 of outstanding borrowings under the North America Credit Facility on September 30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">European Credit Facility</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Prior Credit Agreement also provided for a revolving credit, letter of credit and swing line loan facility which gives the company and the European Borrowers the ability to borrow up to an aggregate principal amount of $30,000,000, with a $5,000,000 sublimit for letters of credit and a $2,000,000 sublimit for swing line loans (the “European Credit Facility”). Up to $15,000,000 of the European Credit Facility was available to each of Invacare Limited (the “UK Borrower”) and Invacare Poirier SAS (the “French Borrower” and, together with the UK Borrower, the “European Borrowers”). The European Credit Facility was terminated on July 26, 2022. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate borrowing availability for each European Borrower under the European Credit Facility is determined based on a borrowing base formula. The aggregate borrowings of each of the European Borrowers under the European Credit Facility may not exceed an amount equal to (a) 85% of the European Borrower’s eligible accounts receivable, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) the European Borrower’s borrowings and swing line loans outstanding under the European Credit Facility, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) the European Borrower’s letters of credit issued and undrawn under the European Credit Facility, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) a $3,000,000 minimum availability reserve, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">less </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) other reserves required by the European Agent, and in each case subject to the definitions and limitations in the Prior Credit Agreement.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest was accrued on outstanding indebtedness under the European Credit Facility at the SOFR rate, plus a margin ranging from 2.50% to 3.00%, or for swing line loans, at the overnight SOFR rate, plus a margin ranging from 2.50% to 3.00%, as selected by the company. The margin was adjusted quarterly based on utilization. Borrowings under the European Credit Facility were subject to commitment fees of 0.25% or 0.375% per year, depending on utilization. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Credit Facility was secured by substantially all the personal property assets of the UK Borrower and its in-country subsidiaries, and all the receivables of the French Borrower and its in-country subsidiaries. The UK and French facilities (which comprised the European Credit Facility) were cross collateralized, and the US personal property assets previously pledged under the North America Credit Facility also served as collateral for the European Credit Facility. </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Credit Facility was subject to customary representations, warranties and covenants generally consistent with those applicable to the North America Credit Facility. Exceptions to the operating covenants in the Prior Credit Agreement provided the company with flexibility to, among other things, enter into or undertake certain sale/leaseback transactions, dispositions of assets, additional credit facilities, sales of receivables, additional indebtedness and intercompany indebtedness, all subject to limitations set forth in the Prior Credit Agreement. The Prior Credit Agreement also contained a covenant requiring the European Borrowers to maintain undrawn availability under the European Credit Facility of not less than (i) 12.5% of the maximum amount that may be drawn under the European Credit Facility for five (5) consecutive business days, or (ii) 11.25% of the maximum amount that may be drawn under the European Credit Facility on any business day. The European Borrowers also were subject to cash dominion triggers under the European Credit Facility requiring the European Borrower to maintain borrowing capacity of not less than $3,750,000 on any business day or $3,750,000 for five consecutive business days in order to avoid triggering full control by an agent for the lenders of the European Borrower’s cash receipts for application to its obligations under the European Credit Facility. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Credit Facility was subject to customary default provisions, with certain grace periods and exceptions, consistent with those applicable to the North America Credit Facility, which provide that events of default include, among other things, failure to pay amounts due, breach of covenants, representations or warranties, cross-default, bankruptcy, the occurrence of a material adverse effect, exclusion from any medical reimbursement program, and an interruption in the operations of any material manufacturing facility for more than 10 consecutive days. The proceeds of the European Credit Facility were used to finance the working capital and other business needs of the company. The company had outstanding borrowings of $7,366,000 (€6,500,000) under its French Credit Facility and $5,986,000 (£4,500,000) under its UK Credit Facility as of December 31, 2021. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Prior Credit Agreement was amended to provide for, among other things, the addition of the company's Netherlands subsidiary as a guarantor under the European Credit Facility, amendments to the restrictive covenants in the Prior Credit Agreement to (1) increase the maximum amount of permitted miscellaneous indebtedness to $30,000,000 from $10,000,000 and (2) permit up to $9,000,000 of financing based on certain European public and government receivables, and terms that, upon the occurrence of certain events related to a transition from the use of LIBOR, permit the agent for the lenders to amend the Prior Credit </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement to replace the LIBOR rate and/or the Euro rate with a benchmark replacement rate.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Prior Credit Agreement was further amended to permit the issuance of the 2026 Notes and the capped call transactions entered into by the company in connection with the issuance of the 2026 Notes, as further discussed in the sections below.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2021, the Prior Credit Agreement was further amended with the primary provisions to replace the references to the LIBOR rate or Euro rate to a term secured overnight finance rate ("SOFR"). </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">ABL Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 26, 2022, the company entered into a Second Amended and Restated Revolving Credit and Security Agreement (the “ABL Credit Agreement”), amending and restating the company’s existing Revolving Credit and Security Agreement, as amended (the “Prior Credit Agreement”). The ABL Credit Agreement was entered into by and among the company, certain of the company’s direct and indirect domestic and Canadian subsidiaries (together with the company, the “Borrowers”), certain other of the company’s direct and indirect domestic and Canadian subsidiaries (the “Guarantors”), and PNC Bank, National Association (“PNC”) and JPMorgan Chase Bank, N.A. (the “ABL Lenders”). PNC is the administrative agent (the “Administrative Agent”) under the ABL Credit Agreement.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The ABL Credit Agreement retained the existing asset-based lending senior secured revolving credit facility provided for the company and the domestic and Canadian Borrowers under the Prior Credit Agreement but extended the maturity date to January 16, 2026, reduced the maximum aggregate principal amount the company and the domestic and Canadian Borrowers may borrow to $35,000,000, limits the borrowing base thereunder to eligible domestic and Canadian accounts receivable and includes a minimum availability reserve of $3,000,000. Borrowings under the ABL Credit Agreement also are subject to a springing maturity date of 191 days prior to the maturity dates of certain convertible notes due 2024 and 2026, and 100 days prior to the maturity date of the Secured Term Loan under the Highbridge Loan Agreement, if such notes or such term loan remain outstanding as of such respective dates. The ABL Credit Agreement also permits the loans made under the Highbridge Loan Agreement and terminated the European Credit Facility under the Prior Credit Agreement. In connection with the ABL Credit Agreement and the Highbridge Loan Agreement, the European Credit Facility under the Prior Credit Agreement was repaid in full and the liens securing the European Credit Facility under the Prior Credit Agreement were terminated and released.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The aggregate borrowing availability under the ABL Credit Agreement is determined based on a borrowing base formula. As of September 30, 2022, the company had gross </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">borrowing base of $33,133,000 and net borrowing availability of $17,336,000 under the ABL Credit Agreement, considering the minimum availability reserve, then-outstanding letters of credit, other reserves and the $4,375,000 dominion trigger amount. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest accrues on outstanding indebtedness under the ABL Credit Agreement at an adjusted Term SOFR rate, plus a margin of 3.25%, or for swing line loans and prime rate revolving loans, at the overnight Prime rate, plus a margin of 2.25%.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The ABL Credit Agreement contains customary terms and covenants and negative covenants, such as limitations on indebtedness, liens, fundamental changes, asset sales, investments and other matters customarily restricted in such agreements. Most of these restrictions are subject to certain minimum thresholds and exceptions. The ABL Credit Agreement also contains customary events of default, after which the revolving loan may be due and payable immediately, including, without limitation, payment defaults, material inaccuracy of representations and warranties, covenant defaults, bankruptcy and insolvency proceedings, cross-defaults to certain other agreements, judgments against the company and its subsidiaries, change in control and lien priority.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Proceeds from the Secured Term Loan under the Highbridge Loan Agreement were used to repay in full outstanding borrowings under the Prior Credit Agreement. Refer to the Term Loan due 2026 section below. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with entering into the company's Prior Credit Agreement and the ABL Credit Agreement, the company incurred fees which were capitalized and are being amortized as interest expense. As of September 30, 2022, debt fees yet to be amortized totaled $1,043,000. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The company was in compliance with the ABL Credit Agreement covenants at September 30, 2022.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible senior notes due 2022</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2017, the company issued $120,000,000 aggregate principal amount of 4.50% Convertible Senior Notes due 2022 (the “2022 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2022 Notes bore interest at a rate of 4.50% per year payable semi-annually in arrears on June 1 and December 1 of each year, beginning December 1, 2017. The 2022 Notes matured on June 1, 2022. At maturity, $2,650,000 principal amount of the 2022 Notes were outstanding, which the company repaid in cash. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2022 Notes, the company entered into privately negotiated convertible note hedge transactions with one financial institution (the “option counterparty”). The company evaluated the note hedges under </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the applicable accounting literature, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ASC 815, and determined that the note hedges should be accounted for as derivatives. These derivatives were capitalized on the balance sheet as long-term assets and were adjusted to reflect fair value each quarter. The fair value of the convertible note hedge assets at issuance was $24,780,000. All note hedge options relating to the 2022 Notes expired on June 1, 2022.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company entered into separate, privately negotiated warrant transactions with the option counterparty at a higher strike price relating to the same number of the company’s Common Shares, subject to customary anti-dilution adjustments, pursuant to which the company sold warrants to the option counterparties. The warrants could have a dilutive effect on the company’s outstanding Common Shares and the company’s earnings per share to the extent that the price of the company’s Common Shares exceeds the strike price of those warrants. The initial strike price of the warrants is $21.4375 per share and is subject to certain adjustments under the terms of the warrant transactions. The company evaluated the warrants under the applicable accounting literature, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ASC 815, and determined that the warrants meet the definition of a derivative, are indexed to the company's own shares and should be classified in shareholders' equity. The amount paid for the warrants and capitalized in shareholders' equity was $14,100,000. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Warrants relating to the 2022 Notes outstanding on September 30, 2022 were 6,918,006. If exercised, one common share is issued upon exercise of each warrant, but may be adjusted under certain circumstances if the relevant share price exceeds the warrant strike price for the relevant measurement period at the time of exercise. Common Shares are reserved for issuance upon exercise of the remaining warrants relating to the 2022 Notes at two Common Shares per warrant. The warrants began to expire on September 1, 2022 and then partially expire on each trading day over the 220 trading day period following September 1, 2022. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the offering of the 2022 Notes were approximately $115,289,000, after deducting fees and offering expenses of $4,711,000, which were paid in 2017. These debt issuance costs were capitalized and were amortized as interest expense through June 2022. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. A portion of the net proceeds from the offering were used to pay the cost of the convertible note hedge transactions (after such cost is partially offset by the proceeds to the company from the warrant transactions), which net cost was $10,680,000.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of the company's previously outstanding convertible notes due 2021 (the "2021 Notes") and certain holders of its </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 Notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new Series II 2024 Notes and $5,593,000 in cash.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, the company repurchased $78,850,000 in principal amount of 2022 Notes, resulting in a loss on debt extinguishment of $709,000. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2022 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective interest rate on the liability component was 10.9% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption of ASU 2020-06 includes coupon interest and amortization of debt fees. Interest expense of $0 and $50,000 was accrued for the three and nine months ended September 30, 2022 compared to $30,000 and $829,000 for the three and nine months ended September 30, 2021, based on the stated coupon rate of 4.5%. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible senior notes Series I due 2024</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, the company entered into separate privately negotiated agreements with certain holders of its 2021 Notes to exchange $72,909,000 in aggregate principal amount of 2021 Notes for aggregate consideration of $72,909,000 in aggregate principal amount of new 5.00% Convertible Senior Notes due 2024 (the “Series I 2024 Notes”) of the company and $6,928,000 in cash. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes bear interest at a rate of 5.00% per year payable semi-annually in arrears on May 15 and November 15 of each year, beginning May 15, 2020. The notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series I 2024 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series I 2024 Notes may be settled in cash, the company’s Common Shares or a combination of cash and the company’s Common Shares, at the company’s election. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the maturity of the Series I 2024 Notes, the company may, at its election, redeem for cash all or part of the Series I 2024 Notes if the last reported sale price of the company’s Common Shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the Series I 2024 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series I 2024 Notes, which means the company is not required to redeem or retire the Series I 2024 Notes periodically.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series I 2024 Notes may convert their Series I 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending December 31, 2019 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the Series I 2024 Notes on each applicable trading day; (2) during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU0YmE3YTI3M2U1NTQ3ZjBiZThlMWJhY2ZjYjllYTliL3NlYzo1NGJhN2EyNzNlNTU0N2YwYmU4ZTFiYWNmY2I5ZWE5Yl8xMjEvZnJhZzplNDRlODYzZTVlZjc0OGM4YTI0OGFkNDk0MGQ1NTYyNy90ZXh0cmVnaW9uOmU0NGU4NjNlNWVmNzQ4YzhhMjQ4YWQ0OTQwZDU1NjI3XzI1MTEw_48d303c8-c9a6-45e8-b1a3-f12a58f8b834">five</span> business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series I 2024 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the Series I 2024 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series I 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the Series I 2024 Notes will have the right to require the company to repurchase all or some of their Series I 2024 Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 Common Shares per $1,000 principal amount of Series I 2024 Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series I 2024 Notes, holders may convert their Series I 2024 Notes, at the option of the holder, regardless of the foregoing circumstances.</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt issuance costs of $1,394,000 were capitalized and are being amortized as interest expense through November 15, 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Series I 2024 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(568)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(769)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,341 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,140 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective interest rate on the liability component was 8.8% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption of ASU 2020-06 includes coupon interest and amortization of debt fees. Interest expense of $911,000 and $2,734,000 was accrued for the three and nine months ended September 30, 2022 compared to $911,000 and $2,733,000 for the three and nine months ended September 30, 2021 based on the stated coupon rate of 5.0%. The effective interest rate of the Series I 2024 Notes as of September 30, 2022 was 5.4%. The Series I 2024 Notes were not convertible as of September 30, 2022 nor was the applicable conversion threshold met.</span></div><div style="text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible senior notes Series II due 2024</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, the company entered into separate, privately negotiated agreements with certain holders of its 2021 Notes and certain holders of its 2022 Notes to exchange $35,375,000 in aggregate principal amount of 2021 Notes and $38,500,000 in aggregate principal amount of 2022 Notes, for aggregate consideration of $73,875,000 in aggregate principal amount of new 5.00% Series II Convertible Senior Notes due 2024 (the “Series II 2024 Notes”) of the company and $5,593,000 in cash. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series II 2024 Notes bear interest at a rate of 5.00% per year, payable semi-annually in arrears on May 15 and November 15 of each year, beginning November 15, 2020. The Series II 2024 Notes will mature on November 15, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to May 15, 2024, the Series II 2024 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Series II 2024 Notes may be settled in cash, the company’s Common Shares or a combination of cash and the company’s Common Shares, at the company’s election. </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the maturity of the Series II 2024 Notes, the company may, at its election, redeem for cash all or part of the Series II 2024 Notes, if the last reported sale price of the company’s Common Shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the accreted principal amount of the Series II 2024 Notes to be redeemed, plus any accrued and unpaid interest, if any, on the original principal amount of the Series II 2024 Notes redeemed to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the Series II 2024 Notes, which means the company is not required to redeem or retire the Series II 2024 Notes periodically.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series II 2024 Notes may convert their Series II 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2024 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the Series II 2024 Notes on each applicable trading day; (2) during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU0YmE3YTI3M2U1NTQ3ZjBiZThlMWJhY2ZjYjllYTliL3NlYzo1NGJhN2EyNzNlNTU0N2YwYmU4ZTFiYWNmY2I5ZWE5Yl8xMjEvZnJhZzplNDRlODYzZTVlZjc0OGM4YTI0OGFkNDk0MGQ1NTYyNy90ZXh0cmVnaW9uOmU0NGU4NjNlNWVmNzQ4YzhhMjQ4YWQ0OTQwZDU1NjI3XzMwNDA1_0910967e-b6e8-4ad3-b779-538bebeea602">five</span> business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Series II 2024 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the Series II 2024 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls the Series II 2024 Notes for redemption pursuant to the terms of the Indenture. Holders of the Series II 2024 Notes will have the right to require the company to repurchase all or some of their Series II 2024 Notes at 100% of the accreted principal amount, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 67.6819 Common Shares per $1,000 principal amount of Series II 2024 Notes (equivalent to an initial conversion price of approximately $14.78 per common share). On or after May 15, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity of the Series II 2024 Notes, holders may convert their Series II 2024 Notes, </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at the option of the holder, regardless of the foregoing circumstances.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The principal amount of the Series II 2024 Notes also will accrete at a rate of approximately 4.7% per year commencing June 4, 2020, compounding on a semi-annual basis. The accreted portion of the principal is payable in cash upon maturity but does not bear interest and is not convertible into the company’s Common Shares. The total amount accreted as of September 30, 2022 was $7,558,000, of which $383,000 and $2,211,000 was for the three and nine months ended September 30, 2022, respectively, compared to $890,000 and $2,637,000 for the three and nine months ended September 30, 2021, respectively. Remaining accretion until maturity (at current principal) was $9,064,000 at September 30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt issuance costs of $1,505,000 were capitalized and are being amortized as interest expense through November 2024. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, $5,000,000 aggregate principal amount of Series II 2024 Notes were retired as part of the Secured 2026 Notes and Secured Term Loan transactions discussed below. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Series II 2024 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component - including accretion</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,433 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(669)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(971)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,764 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,251 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective interest rate on the liability component was 9.0% upon original issuance including consideration of the discount. Total interest expense subsequent to adoption of ASU 2020-06 includes coupon interest, accretion and amortization of debt fees. Interest expense for accretion of $886,000 and $2,714,000 was recognized for the three and nine months ended September 30, 2022 compared to $890,000 and $2,637,000 for the three and nine months ended September 30, 2021. Interest expense of $879,000 and $2,726,000 were recognized for the three and nine months ended September 30, 2022 compared to $923,000 and $2,770,000 for the three and nine months ended September 30, 2021, based on the stated coupon rate of 5.0%. The effective interest rate of the Series II 2024 Notes as of September 30, 2022 including coupon interest, amortization of debt fees and accretion to maturity was 10.4%. The Series II 2024 Notes </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were not convertible as of September 30, 2022 nor was the applicable conversion threshold met.</span></div><div style="text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Convertible senior notes due 2026</span></div><div style="text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, the company issued $125,000,000 aggregate principal amount of 4.25% Convertible Senior Notes due 2026 (the “2026 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes bear interest at a rate of 4.25% per year payable semi-annually in arrears on March 15 and September 15 of each year, beginning September 15, 2021. The notes will mature on March 15, 2026, unless repurchased, redeemed or converted in accordance with their terms prior to such date. Prior to September 15, 2025, the 2026 Notes will be convertible only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The 2026 Notes may be settled in cash, the company’s Common Shares or a combination of cash and the company’s Common Shares, at the company’s election. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company may not redeem the 2026 Notes prior to March 20, 2024. The company may, at its election, redeem for cash all or part of the 2026 Notes, on or after March 20, 2024, if the last reported sale price of the company’s Common Shares equals or exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (subject to certain limited exceptions). No sinking fund is provided for the 2026 Notes, which means the company is not required to redeem or retire the 2026 Notes periodically.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2026 Notes may convert their 2026 Notes at their option at any time prior to the close of business on the business day immediately preceding September 15, 2025 in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2021 (and only during such calendar quarter), if the last reported sale price of the company’s Common Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than 130% of the conversion price for the 2026 Notes on each applicable trading day; (2) during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU0YmE3YTI3M2U1NTQ3ZjBiZThlMWJhY2ZjYjllYTliL3NlYzo1NGJhN2EyNzNlNTU0N2YwYmU4ZTFiYWNmY2I5ZWE5Yl8xMjEvZnJhZzplNDRlODYzZTVlZjc0OGM4YTI0OGFkNDk0MGQ1NTYyNy90ZXh0cmVnaW9uOmU0NGU4NjNlNWVmNzQ4YzhhMjQ4YWQ0OTQwZDU1NjI3XzM2MDc4_850b7a62-83d1-40d0-a2d1-feff70307f32">five</span> business day period </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of 2026 Notes for each trading day of such measurement period was less than 98% of the product of the last reported sale price of the company’s Common Shares and the applicable conversion rate for the 2026 Notes on each such trading day; (3) upon the occurrence of specified corporate events described in the Indenture; or (4) if the company calls any or all of the 2026 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date. Holders of the 2026 Notes will have the right to require the company to repurchase all or some of their 2026 Notes at 100% of their principal, plus any accrued and unpaid interest, upon the occurrence of certain fundamental changes. The initial conversion rate is 94.6096 Common Shares per $1,000 principal amount of 2026 notes (equivalent to an initial conversion price of approximately $10.57 per common share). On or after September 15, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity of the 2026 Notes, holders may convert their 2026 Notes, at the option of the holder, regardless of the foregoing circumstances.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt issuance costs of $5,697,000 were capitalized and are being amortized as interest expense through March 2026. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2026 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,525 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,627)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,964)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,898 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,036 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense of $1,015,000 and $3,671,000 was accrued for the three and nine months ended September 30, 2022 compared to $1,328,000 and $2,892,000 for the three and nine months ended September 30, 2021 based on the stated coupon rate of 4.25%. The effective interest rate of the 2026 Notes as of September 30, 2022 was 5.4%. The 2026 Notes were not convertible as of September 30, 2022 nor was the applicable conversion threshold met.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, $41,475,000 aggregate principal amount of 2026 Notes were exchanged and retired as part of the Secured 2026 Notes and Secured Term Loan transactions discussed below. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the transactions for the closing of the Term Loan, exchange of 2026 Notes for Secured 2026 Notes and retirement of $5,000,000 of Series II 2024 Notes in the third quarter of 2022, 2,700,000 Common Shares were issued. These transactions resulted in a net gain on extinguishment of debt of $6,398,000. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, in connection with the pricing of the 2026 Notes, the company entered into capped call transactions (the “Capped Call Transactions”) with certain option counterparties. The company used $18,787,000 of the net proceeds of the private offering of the 2026 Notes to pay the cost of the Capped Call Transactions with the offset recorded to additional paid-in-capital.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Capped Call Transactions are expected generally to reduce the potential dilution upon conversion of the 2026 Notes and/or offset any cash payments the company is required to make in excess of the principal amount of converted notes, as the case may be, in the event that the market price per share of the company’s Common Shares, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which is initially $10.57, corresponding to the initial conversion price of the 2026 Notes, subject to anti-dilution adjustments. If, however, the market price per company common share, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions, which is initially $16.58 (subject to adjustments), there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the Capped Call Transactions. The Capped Call Transactions expire March 15, 2026, subject to earlier exercise. There were 125,000 capped call options related to the 2026 Notes outstanding on September 30, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company will not be required to make any cash payments to the option counterparties upon the exercise of the options that are a part of the Capped Call Transactions, but the company will be entitled to receive from the option counterparties a number of company Common Shares, an amount of cash or a combination thereof generally based on the amount by which the market price per company common share, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions during the relevant valuation period under the Capped Call Transactions. However, if the market price per Company common share, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions during such valuation period, the number of company Common Shares and/or the amount of cash the company expects to receive upon exercise of the Capped Call Transactions will be capped based on the amount </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by which the cap price exceeds the strike price of the Capped Call Transactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For any conversions of the 2026 Notes prior to September 15, 2025, a corresponding portion of the relevant Capped Call Transactions may be terminated at the company’s option. Upon any such termination, the company expects to receive from the option counterparties a number of company Common Shares, or, if the company so elects, subject to certain conditions, an amount of cash, in each case, with a value equal to the fair value of such portion of the relevant Capped Call Transactions being terminated, as calculated in accordance with the terms of the relevant Capped Call Transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Capped Call Transactions are separate transactions, in each case, entered into by the company with the option counterparties, and are not part of the terms of the 2026 Notes and will not affect any holder’s rights under the 2026 Notes. Holders of the 2026 Notes will not have any rights with respect to the Capped Call Transactions.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Secured convertible senior notes due 2026</span></div><div style="text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, the company issued and aggregate $31,106,000 (split equally between two separate tranches ("Tranche I Notes" and "Tranche II Notes" or "Indentures") in aggregate principal amount of 5.68% Secured Convertible Senior Notes due 2026 (the “Secured 2026 Notes”) in a private offering. This was in exchange for $41,475,000 aggregate principal amount of 2026 Notes which were retired. In October 2022, additional principal amount of Secured 2026 Notes were issued aggregating to $20,739,000 and $20,736,000 in aggregate principal amount of Tranche I Notes and Tranche II Notes, respectively, in exchange for $13,825,000 of 2026 Notes. Refer to October 2022 Financings below. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Secured 2026 N</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">otes are initially guaranteed by certain subsidiaries of the company in the United States, United Kingdom, Canada, France, the Netherlands and Luxembourg pursuant to separate guarantees (each, a “Guarantee”), and are secured on a pari passu basis by the same collateral that secures the Highbridge Loan Agreement (discussed below). In addition, the company's subsidiaries that provide guarantees of the Highbridge Loan Agreement in connection with the post-closing draws provided Guarantees of the Secured 2026 Notes.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest on the Secured 2026 Notes will be payable semi-annually in cash in arrears on January 1 and July 1 of each year, beginning on January 1, 2023, at a rate of 5.68% per year. The Secured 2026 Notes will mature on July 1, 2026, unless earlier converted, redeemed or repurchased in accordance with their terms. Holders of the Secured 2026 Notes have the right, at their option, at any time prior to the close of business on the second scheduled trading day immediately preceding July 1, 2026 (the maturity date), to </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">convert any Secured 2026 Notes or portion thereof that is $1,000 or an integral multiple thereof, subject to certain conditions, into cash, Common Shares or a combination of cash and Common Shares at the company’s election (subject to, and in accordance with, the settlement provisions set forth the Indentures). The initial conversion rate for the (i) Tranche I Notes is 333.3333 Common Shares (subject to adjustment as provided for in the Tranche I Indenture) per $1,000 principal amount of the Tranche I Notes, which is equal to an initial conversion price of $3.00 per share, and (ii) Tranche II Notes is 222.222 Common Shares (subject to adjustment as provided for in the Tranche II Indenture) per $1,000 principal amount of the Tranche II Notes, which is equal to an initial conversion price of $4.50 per share. In addition, following certain corporate events as described in the Indentures that occur prior to the maturity date of the Secured 2026 Notes or if the company delivers a notice of redemption, the company will pay a make-whole premium by increasing the conversion rate for a holder who elects to convert its Secured 2026 Notes in connection with such a corporate event or notice of redemption, as the case may be, in certain circumstances, subject to adjustment as provided for and in accordance with the Indentures. These features are bifurcated driving convertible derivative liability. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The company may not elect to redeem the Secured 2026 Notes prior to January 26, 2023. The company may redeem for cash all or any portion of the Secured 2026 Notes, at its option, on or after January 26, 2023 if the last reported sale price of the Common Shares exceeds 150% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the Secured 2026 Notes to be redeemed, plus any accrued and unpaid interest on such Secured 2026 Notes to, but excluding, the redemption date (subject to certain conditions set forth the Indentures). No sinking fund is provided for the Secured 2026 Notes.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If the company undergoes a Fundamental Change (as defined in th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">e Indentures), prio</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">r to the maturity date of the Secured 2026 Notes, holders of the Secured 2026 Notes will, subject to specified conditions, have the right, at their option, to require the company to repurchase for cash all or a portion of their Secured 2026 Notes at a repurchase price equal to 100% of the principal amount of the Secured 2026 Notes to be repurchased, plus any accrued and unpaid interest to, but not including, the Fundamental Change repurchase date.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Indentures provide for customary events of default. In the case of an event of default with respect to the Secured 2026 Notes arising from specified events of bankruptcy or insolvency, all outstanding Secured 2026 Notes will become due and payable immediately without further action or notice. If any other event of default with respect to the Secured 2026 </span></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Notes under the Indentures occur or is continuing, the Trustee or holders of at least 25% in aggregate principal amount of the then outstanding Secured 2026 Notes may declare the principal amount of the Secured 2026 Notes to be immediately due and payable.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In certain circumstances if, at any time during the six-month period beginning on, and including, the date that is six months after the date of original issuance for any sub-tranche of the Secured 2026 Notes, the company fails to timely file certain documents or reports required under the Securities Exchange Act of 1934, as amended, or the Secured 2026 Notes are not otherwise freely tradable under Rule 144 by holders of the Secured 2026 Notes other than the company’s affiliates or holders that were affiliates at any time during the three months preceding, additional interest will accrue at a rate of up to 0.50% on the Secured 2026 Notes during the period in which its failure to file has occurred and is continuing or such Secured 2026 Notes are not otherwise freely tradable under Rule 144 by holders other than the company’s affiliates or holders that were affiliates at any time during the three months preceding until such failure is cured.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, if, and for so long as, the restrictive legend on any sub-tranche of the Secured 2026 Notes has not been removed, any sub-tranche of the Secured 2026 Notes are assigned a restricted CUSIP number or any sub-tranche of the Secured 2026 Notes are not otherwise freely tradable under Rule 144 by holders other than the company’s affiliates or holders that were affiliates at any time during the three months preceding (without restrictions pursuant to U.S. securities laws or the terms of the Indentures or the Secured 2026 Notes) as of the 380th day after the date of original issuance of such sub-tranche of the Secured 2026 Notes, the company will pay additional interest at a rate of 0.50% on the Secured 2026 Notes during the period in which the Secured 2026 Notes remain so restricted.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company may not issue Common Shares upon conversions of the Secured 2026 Notes, net of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,700,000</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Common Shares issued in the Exchange, in excess of 19.99% of the company’s Common Shares outstanding on July 25, 2022; until the requisite approval under the applicable New York Stock Exchange rules by the company’s shareholders is obtained. The company intends to seek this approval at its 2023 Annual Meeting of Shareholders.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt issuance costs of $2,389,000 were capitalized and are being amortized as interest expense through July 2026. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Secured 2026 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,106 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,365)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,463 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense of $324,000 was accrued for the three and nine months ended September 30, 2022 based on the stated coupon rate of 5.68%. The effective interest rate of the 2026 Notes as of September 30, 2022 was 8.7%. The 2026 Notes were not convertible as of September 30, 2022 nor was the applicable conversion threshold met.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Secured Term Loan due 2026</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 26, 2022, the company entered into a Credit Agreement (the “Highbridge Loan Agreement” or "Secured Term Loan") with a certain fund managed by Highbridge Capital Management, LLC (“Highbridge”), as the lender (together with the other lenders from time to time party thereto, the “Lenders”), Cantor Fitzgerald Securities as administrative agent and GLAS Trust Corporation Limited, as collateral agent.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Highbridge Loan Agreement, the company may borrow up to an aggregate of $104,500,000 principal amount of Secured Term Loan, including $66,500,000 with $2,000,000 original issuance discount in initial secured term loans drawn at closing, $8,500,000 in additional Secured Term Loans principal to be made in a single draw subject to satisfaction of certain conditions, another $10,000,000 in additional Secured Term Loan principal to be made in a single draw subject to satisfaction of certain further conditions and $19,500,000 in additional Secured Term Loan to be made in a single draw subject to satisfaction of certain further conditions. The company expects to use the proceeds of the Secured Term loan for working capital and general corporate purposes and to pay fees and expenses in connection with the transactions described herein.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Secured Term Loan is scheduled to mature on July 26, 2026 and accrues interest at an initial annual rate of SOFR plus 7.00% or a base rate plus 6.00% and after the second anniversary of closing at an annual rate of SOFR plus 8.75% or a base rate plus 7.75%. The Secured Term Loan is also subject to a springing maturity date of 91 days prior to the maturity date of certain convertible notes due November 2024 if more than $20,000,000 of such notes remain outstanding as of such date. The obligations under the Highbridge Loan Agreement are secured, initially, by substantially all assets of the company and certain subsidiaries of the company (subject </span></div></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to certain exceptions), subject to intercreditor agreements in connection with the ABL Credit Agreement and the 5.68% Indentures, and are guaranteed by certain subsidiaries of the company in the United States, United Kingdom, Canada, France, the Netherlands and Luxembourg at the closing. Additional collateral owned by subsidiaries of the company in various jurisdictions will be added to the security for the Secured Term Loan and additional subsidiaries of the company in various jurisdictions will guarantee the obligations in connection with the post-closing draws.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The company will have the right to prepay the Secured Term Loan at any time, subject to a prepayment premium, which in case of a prepayment before the second anniversary of the closing date is equal to the greater of (i) 1.00% of the aggregate principal amount of the Secured Term Loan so prepaid and (ii) the excess, if any of (A) the present value as of the date of repayment of all interest that would have accrued on the Secured Term Loan being prepaid from such date through the second anniversary of the closing plus the present value as of such date of the principal amount of the Secured Term Loan being prepaid assuming a prepayment date of the second anniversary of the closing over (B) the principal amount of such Secured Term Loan being prepaid and, after the second anniversary of the closing is equal to 1.00% of the aggregate principal amount of the Secured Term Loan so prepaid, as well as, in each case, an additional redemption fee equal to 3.00% of the aggregate principal amount of the Secured Term Loan so prepaid.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Highbridge Loan Agreement contains customary terms and covenants, including without limitation a financial covenant to maintain a minimum liquidity of $20,000,000 and negative covenants, such as limitations on indebtedness, liens, fundamental changes, asset sales, investments and other matters customarily restricted in such agreements. Most of these restrictions are subject to certain minimum thresholds and exceptions. The Highbridge Loan Agreement also contains customary events of default, after which the Secured Term Loan may be due and payable immediately, including, without limitation, payment defaults, material inaccuracy of representations and warranties, covenant defaults, bankruptcy and insolvency proceedings, cross-defaults to certain other agreements, judgments against the company and its subsidiaries, change in control and lien priority.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Debt issuance costs of $5,107,000 were capitalized and are being amortized as interest expense through July 2026. Debt issuance costs are presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Secured Term Loan consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized original issuance discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,907)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,869)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,724 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense of $1,217,000 was accrued for the three and nine months ended September 30, 2022 based on the stated coupon rate of 5.68%. The effective interest rate of the 2026 Notes as of September 30, 2022 was 12.7%.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average interest rate on all borrowings, excluding finance leases, was 5.0% for the nine months ended September 30, 2022 and 4.5% for the year ended December 31, 2021.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022, the company borrowed $2,000,000 against the cash surrender value of its life insurance policies which the company intends to repay in the next twelve months. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">October 2022 Financings</span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Highbridge Loan Agreement and Indentures</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 3, 2022, the company consummated additional draws of an aggregate of $18,500,000 under the Highbridge Loan Agreement. Additional borrowing under the Term Loan of $19,500,000 remains available, subject to the satisfaction of certain conditions.</span></div>Further, the company issued $5,186,000 in aggregate principal amount of additional 5.68% Tranche I Notes and $5,183,000 in aggregate principal amount of additional 5.68% Tranche II Notes of the Secured 2026 Notes in exchange for $13,825,000 of 2026 Notes which were retired. Following these transactions, $69,700,000 aggregate principal amount of 2026 Notes remain outstanding. <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 4.50%, due in June 2022</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,642 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes Series I at 5.00%, due in November 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,341 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,140 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes Series II at 5.00%, due in November 2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,764 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,251 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes at 4.25%, due in March 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,898 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,036 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured convertible senior notes at 5.68%, due in July 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,463 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, due in July 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,724 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,089 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,060 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,279 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308,129 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current maturities of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,150)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,107)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,129 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305,022 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div> 0 2642000 72341000 72140000 75764000 78251000 80898000 119036000 27463000 0 59724000 0 19089000 36060000 335279000 308129000 2150000 3107000 333129000 305022000 3576000 3450000 4902000 2585000 16900000 22150000 7366000 6500000 5986000 4500000 60000000 20000000 25000000 0.85 0.70 0.85 4000000 0.80 0 0.85 0.70 0.85 3000000 0.0225 0.0275 0.0125 0.0175 0.0025 0.00375 0.125 P5D 0.1125 7500000 P10D 16900000 30000000 5000000 2000000 15000000 0.85 3000000 0.0250 0.0300 0.0250 0.0300 0.0025 0.00375 0.125 P5D 0.1125 3750000 3750000 P10D 7366000 6500000 5986000 4500000 30000000 10000000 9000000 35000000 3000000 P191D P100D 33133000 17336000 4375000 0.0325 0.0225 1043000 120000000 0.0450 0.0450 2650000 24780000 21.4375 14100000 6918006 115289000 4711000 -10680000 35375000 38500000 73875000 5593000 78850000 709000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2022 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,650 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 0 2650000 0 -8000 0 2642000 0.109 0 50000 30000 829000 0.045 72909000 72909000 0.0500 6928000 0.0500 1.30 P20D 30 1 P20D 30 1.30 10 0.98 1 67.6819 1000 14.78 1394000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Series I 2024 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,909 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(568)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(769)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,341 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,140 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 72909000 72909000 -568000 -769000 72341000 72140000 0.088 911000 2734000 911000 2733000 0.050 5.4 35375000 38500000 73875000 0.0500 5593000 0.0500 1.30 P20D 30 1 P20D 30 1.30 10 0.98 1 67.6819 1000 14.78 0.047 7558000 383000 2211000 890000 2637000 9064000 1505000 5000000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Series II 2024 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component - including accretion</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,433 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(669)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(971)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,764 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,251 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 76433000 79222000 -669000 -971000 75764000 78251000 0.090 886000 2714000 890000 2637000 879000 2726000 923000 2770000 0.050 0.104 125000000 0.0425 0.0425 1.30 P20D 30 1 1000 P20D 30 1.30 10 0.98 1 94.6096 1000 10.57 5697000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the 2026 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,525 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,627)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,964)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,898 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,036 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 83525000 125000000 -2627000 -5964000 80898000 119036000 1015000 3671000 1328000 2892000 0.0425 0.054 41475000 5000000 2700000 6398000 -18787000 10.57 16.58 125000 31106000 0.0568 41475000 20739000 20736000 13825000 0.0568 1000 333.3333 1000 3.00 222.222 1000 4.50 1.50 P20D 30 1 1 0.25 0.0050 0.0050 2700000 0.1999 2389000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Secured 2026 Notes consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,106 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,365)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,463 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 31106000 1365000 -2278000 27463000 324000 0.0568 0.087 104500000 66500000 2000000 8500000 10000000 19500000 0.0700 0.0600 0.0875 0.0775 P91D 20000000 0.0568 1 0.0100 0.0300 20000000 5107000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability components of the Secured Term Loan consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of liability component</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized original issuance discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,907)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,869)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,724 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 66500000 1907000 -4869000 59724000 1217000 0.0568 0.127 0.050 0.045 2000000 18500000 19500000 5186000 0.0568 5183000 5.68 13825000 69700000 <div><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Long-Term Obligations</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term obligations consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,385 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,664 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,010 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred gain on sale leaseback</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental executive retirement plan liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Death benefit obligation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,499 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax obligation including interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,980 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,814 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured Convertible 2026 debt conversion liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long-Term Obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,374 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,796 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Secured Convertible 2026 debt conversion liability amounts included in the above table represent the fair values of the conversion liabilities. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2015, the company entered into a real estate sale leaseback transaction which resulted in the company recording an initial deferred gain of $7,414,000, the majority of which is included in Other Long-Term Obligations and will be recognized over the 20-year life of the leases. The gains realized were $82,000 and $245,000 for the three and nine months ended September 30, 2022 respectively, compared to $80,000 and $237,000 for the three and nine months ended September 30, 2021 respectively.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term obligations consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,385 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,664 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,010 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred gain on sale leaseback</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental executive retirement plan liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Death benefit obligation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,499 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax obligation including interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,980 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,814 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured Convertible 2026 debt conversion liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,783 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long-Term Obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,374 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,796 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 19385000 21664000 12010000 11342000 5090000 6174000 4920000 5174000 4697000 5106000 3499000 4568000 2980000 3171000 2783000 7814000 473000 0 537000 1783000 56374000 66796000 7414000 82000 245000 80000 237000 <div style="text-align:justify"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases and Commitments</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company reviews new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, the company has recognized those amounts as part of the right-of-use assets and lease liabilities. The company combines lease and certain non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, the company uses an incremental borrowing rate (IBR) based on information available at commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. The company calculates its IBR based on the secured rates of the company's recent debt issuances, the credit rating of the company, changes in currencies, lease repayment timing as well as other publicly available data.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company leases a portion of its facilities, transportation equipment, data processing equipment and certain other equipment. These leases have terms from 1 to 20 years and provide for renewal options. Generally, the company is required to pay taxes and normal expenses associated with operating the facilities and equipment. As of September 30, 2022, the company is committed under non-cancelable leases, which have initial or remaining terms in excess of one year and expire on various dates through 2040. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2015, the company </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sold and leased back, under four separate lease agreements, four properties located in Ohio and one property in Florida for net proceeds of $23,000,000, which were used to reduce debt under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. and Canadian Credit Facility</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial total annual rent for the properties was $2,275,000 and can increase annually over the 20-year term of the leases based on the applicable geographical consumer price index (CPI). Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the transaction, the requirements for sale lease-back accounting were met. Accordingly, the company recorded the sale of the properties, removed the related property and equipment from the company's balance sheet, recognized an initial deferred gain of $7,414,000 and an immediate loss of $257,000 related to one property and recorded new lease liabilities. Specifically, the company </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded four finance leases totaling $32,339,000 and one operating lease related to leased land, which was not a material component of the transaction. The gains on the sales of the properties were required to be deferred and recognized over the life of the leases as the property sold is being leased back. The deferred gain is classified under Other Long-Term Obligations on the condensed consolidated balance sheets. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expenses for the three and nine months ended September 30, 2022 and September 30, 2021, respectively, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.685%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,391 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,811 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,421 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,592 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">616 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">764 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,961 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,825 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,007 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,575 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,382 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,417 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,062 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,055 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,265 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,210 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,807 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,117 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,434 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,294 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating and finance lease commitments, as of September 30, 2022, are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance <br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,501 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,192 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,443 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,353 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,973 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,253 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,615 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,435 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,541 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts representing interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,893)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,614)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,542 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,927 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities of lease obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,031)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,062)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,511 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,865 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow amounts for the three and nine months ended September 30, 2022 and September 30, 2021 were as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.190%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Activity: Cash paid in measurement of amounts for lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,967 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,584 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,266 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,501 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,810 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,100 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,478 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,311 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,777 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,684 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,744 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,264 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">989 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,418 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">969 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,345 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,318 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,178 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,398 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,763 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2022 and December 31, 2021, respectively: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.940%"><tr><td style="width:1.0%"/><td style="width:42.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.488%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.37%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.43%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.07%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.10%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div></div> <div style="text-align:justify"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases and Commitments</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company reviews new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, the company has recognized those amounts as part of the right-of-use assets and lease liabilities. The company combines lease and certain non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, the company uses an incremental borrowing rate (IBR) based on information available at commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. The company calculates its IBR based on the secured rates of the company's recent debt issuances, the credit rating of the company, changes in currencies, lease repayment timing as well as other publicly available data.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company leases a portion of its facilities, transportation equipment, data processing equipment and certain other equipment. These leases have terms from 1 to 20 years and provide for renewal options. Generally, the company is required to pay taxes and normal expenses associated with operating the facilities and equipment. As of September 30, 2022, the company is committed under non-cancelable leases, which have initial or remaining terms in excess of one year and expire on various dates through 2040. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2015, the company </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sold and leased back, under four separate lease agreements, four properties located in Ohio and one property in Florida for net proceeds of $23,000,000, which were used to reduce debt under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. and Canadian Credit Facility</span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial total annual rent for the properties was $2,275,000 and can increase annually over the 20-year term of the leases based on the applicable geographical consumer price index (CPI). Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the transaction, the requirements for sale lease-back accounting were met. Accordingly, the company recorded the sale of the properties, removed the related property and equipment from the company's balance sheet, recognized an initial deferred gain of $7,414,000 and an immediate loss of $257,000 related to one property and recorded new lease liabilities. Specifically, the company </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded four finance leases totaling $32,339,000 and one operating lease related to leased land, which was not a material component of the transaction. The gains on the sales of the properties were required to be deferred and recognized over the life of the leases as the property sold is being leased back. The deferred gain is classified under Other Long-Term Obligations on the condensed consolidated balance sheets. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expenses for the three and nine months ended September 30, 2022 and September 30, 2021, respectively, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.685%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,391 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,811 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,421 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,592 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">616 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">764 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,961 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,825 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,007 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,575 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,382 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,417 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,062 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,055 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,265 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,210 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,807 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,117 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,434 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,294 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating and finance lease commitments, as of September 30, 2022, are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance <br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,501 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,192 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,443 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,353 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,973 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,253 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,615 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,435 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,541 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts representing interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,893)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,614)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,542 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,927 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities of lease obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,031)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,062)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,511 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,865 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow amounts for the three and nine months ended September 30, 2022 and September 30, 2021 were as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.190%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Activity: Cash paid in measurement of amounts for lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,967 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,584 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,266 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,501 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,810 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,100 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,478 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,311 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,777 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,684 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,744 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,264 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">989 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,418 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">969 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,345 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,318 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,178 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,398 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,763 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2022 and December 31, 2021, respectively: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.940%"><tr><td style="width:1.0%"/><td style="width:42.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.488%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.37%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.43%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.07%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.10%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div></div> P1Y P20Y 23000000 2275000 P20Y Each of the four lease agreements contains three 10-year renewals with the rent for each option term based on the greater of the then-current fair market rent for each property or the then- current rate and increasing annually by the applicable CPI. Under the terms of the lease agreements, the company is responsible for all taxes, insurance and utilities. The company is required to adequately maintain each of the properties and any leasehold improvements will be amortized over the lesser of the lives of the improvements or the remaining lease lives, consistent with any other company leases. 7414000 257000 32339000 <div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease expenses for the three and nine months ended September 30, 2022 and September 30, 2021, respectively, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.685%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,391 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,811 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,421 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,592 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">616 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">764 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,961 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,825 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,007 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,575 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,382 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,417 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,062 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,055 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,265 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,210 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,807 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,117 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,434 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,294 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div> 1391000 1811000 4421000 5592000 616000 764000 1961000 2825000 2007000 2575000 6382000 8417000 1062000 1146000 3224000 3487000 1055000 1265000 3210000 3807000 2117000 2411000 6434000 7294000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating and finance lease commitments, as of September 30, 2022, are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance <br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,501 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,192 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,443 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,353 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,973 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,253 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,615 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,435 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,541 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts representing interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,893)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,614)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,542 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,927 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities of lease obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,031)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,062)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,511 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,865 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum operating and finance lease commitments, as of September 30, 2022, are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.721%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance <br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,501 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,192 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,443 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,452 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,353 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,973 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,248 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,253 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,615 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,435 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,541 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts representing interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,893)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,614)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,542 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,927 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities of lease obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,031)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,062)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term lease obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,511 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,865 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1637000 1100000 6501000 3192000 6443000 2452000 6353000 1973000 6248000 1209000 65253000 1615000 92435000 11541000 31893000 1614000 60542000 9927000 3031000 3062000 57511000 6865000 <div style="margin-top:4pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow amounts for the three and nine months ended September 30, 2022 and September 30, 2021 were as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.190%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Activity: Cash paid in measurement of amounts for lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,967 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,584 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,266 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,501 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,810 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,100 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,478 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,311 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,777 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,684 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,744 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Cash Activity: Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,264 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">989 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,418 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">969 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,345 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,318 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,178 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,398 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,763 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div> 1967000 2584000 6266000 8501000 1810000 2100000 5478000 6311000 3777000 4684000 11744000 14812000 1264000 989000 2429000 5418000 54000 189000 969000 6345000 1318000 1178000 3398000 11763000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease terms and discount rates for finance and operating leases are as follows as of September 30, 2022 and December 31, 2021, respectively: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.940%"><tr><td style="width:1.0%"/><td style="width:42.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.488%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.8 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.37%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.43%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.07%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.10%</span></td></tr></table></div> P14Y10M24D P15Y9M18D P4Y9M18D P5Y 0.0637 0.0643 0.0807 0.0710 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has two revenue streams: products and services. Services include repair, refurbishment, preventive maintenance and rental of products. Services for the North America segment include maintenance and repair of products. Services for the Europe segment include repair, refurbishment and preventive maintenance services. Services in All Other, are in the Asia Pacific region, and include rental and repair of products.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2022 and September 30, 2021 (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,723 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,764 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,068 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,314 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,380 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,227 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,171 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,237 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,408 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319,467 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,867 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328,334 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208,776 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">575 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,351 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,067 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,661 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,728 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">547,310 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,103 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">560,413 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,671 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,355 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,026 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,936 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,054 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,332 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,395 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,805 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224,200 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,417 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361,097 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259,623 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260,275 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,010 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">632,313 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,953 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646,266 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="padding-right:4.5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's revenues are principally related to the sale of products, approximately 98%, with the remaining 2% related to services including repair, refurbishment, preventive maintenance and rental of products. While the company has a significant amount of contract types, the sales split by contract type is estimated as follows: general terms and conditions (30%), large national customers (23%), governments, principally pursuant to tender contracts (22%) and other customers including buying groups and independent customers (25%). </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All product revenues and substantially all service revenues are recognized at a point in time. The remaining service revenue, recognized over time, are reflected in the Europe segment and include multiple performance obligations. For such contracts, the company allocates revenue to each performance obligation based on its relative standalone selling price. The company generally determines the standalone selling price based on the expected cost-plus margin methodology.    </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when obligations under the terms of a contract with the customer are satisfied; generally, this occurs with the transfer of control of the company’s products and services. The amount of consideration received and revenue recognized by the company can vary as a result of variable consideration terms included in the contracts related to customer rebates, cash discounts and return policies. Revenue is measured as the amount of consideration probable of not having a significant reversal of cumulative revenue recognized when related uncertainties are resolved. Customer rebates and cash discounts are estimated based on the most likely amount principle and these estimates are based on historical experience and anticipated performance. In addition, customers have the right to return products within the company’s normal terms policy, and as such the company estimates the expected returns based on an analysis of historical experience. The company adjusts its estimate of revenue at the earlier of when the most likely amount of consideration it expects to receive changes or when the consideration becomes fixed. The company generally does not expect that there will be significant changes to its estimates of variable consideration (refer to “Receivables” and "Accrued </span></div></div></div>Expenses" in the notes to the condensed consolidated financial statements include elsewhere in this report for more detail). Depending on the terms of the contract, the company may defer the recognition of a portion of the revenue at the end of a reporting period to align with transfer of control of the company’s products to the customer. In addition, to the extent performance obligations are satisfied over time, the company defers revenue recognition until the performance obligations are satisfied. As of September 30, 2022 and December 31, 2021, the company had deferred revenue of $1,903,000 and $4,156,000, respectively, related to outstanding performance obligations with substantially all expected to be recognized as revenue within a year. The following tables disaggregate the company’s revenues by major source and by reportable segment for the three and nine months ended September 30, 2022 and September 30, 2021 (in thousands):<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,723 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,764 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,068 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,314 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,380 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,227 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166,171 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,237 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,408 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319,467 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,867 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328,334 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208,776 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">575 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,351 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,067 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,661 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,728 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">547,310 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,103 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">560,413 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123,671 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,355 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,026 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,936 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,054 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,788 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,332 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,395 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,805 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224,200 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.404%"><tr><td style="width:1.0%"/><td style="width:36.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,417 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361,097 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259,623 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260,275 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,010 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">632,313 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,953 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646,266 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Split</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table> 94723000 2764000 97487000 65068000 246000 65314000 6380000 1227000 7607000 166171000 4237000 170408000 0.98 0.02 1 319467000 8867000 328334000 208776000 575000 209351000 19067000 3661000 22728000 547310000 13103000 560413000 0.98 0.02 1 123671000 3355000 127026000 87936000 118000 88054000 7788000 1332000 9120000 219395000 4805000 224200000 0.98 0.02 1 351680000 9417000 361097000 259623000 652000 260275000 21010000 3884000 24894000 632313000 13953000 646266000 0.98 0.02 1 0.98 0.02 0.30 0.23 0.22 0.25 1903000 4156000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Equity Compensation</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company’s Common Shares have a $0.25 stated value. The Common Shares and the Class B Common Shares generally have identical rights, terms and conditions and vote together as a single class on most issues, except that the Class B Common Shares have ten votes per share and, in general, can only be transferred to family members or for estate planning purposes. Holders of Class B Common Shares are entitled to convert their shares into Common Shares at any time on a share-for-share basis. When Class B Common Shares are transferred out of a familial relationship, they automatically convert to Common Shares.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, 3,667 Class B Common Shares remained outstanding. Prior conversions of Class B Common Shares have virtually eliminated the company’s dual class voting structure. As of September 30, 2022, the holders of the Common Shares represented approximately 99.9% of the company’s total outstanding voting power.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity Compensation Plan</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2018, the shareholders of the company approved the Invacare Corporation 2018 Equity Compensation Plan (the “2018 Plan”), which was adopted on March 27, 2018 by the company's Board of Directors (the “Board”). The company’s Board adopted the 2018 Plan in order to authorize additional Common Shares for grant as equity compensation, and to reflect changes to Section 162(m) of the Internal Revenue Code (the “Code”) resulting from the U.S. Tax Cuts and Jobs Act of 2017. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following shareholder approval of the 2018 Plan, all of the Common Shares then-remaining available for issuance under the Invacare Corporation 2013 Equity Compensation Plan (the “2013 Plan”) and all of the Common Shares that were forfeited or remained unpurchased or undistributed upon termination or expiration of awards under the 2013 Plan and under the Invacare Corporation 2003 Performance Plan (the “2003 Plan”), become available for issuance under the 2018 Plan. Awards granted previously under the 2013 Plan and 2003 Plan will remain in effect under their original terms.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of stock options or stock appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a stock option or a SAR will count against the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003 </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Management Development Committee of the Board (the “Compensation Committee”), in its discretion, may grant an award under the 2018 Plan to any director or employee of the company or an affiliate. As of September 30, 2022, 5,507,144 Common Shares were available for future issuance under the 2018 Plan in connection with the following types of awards with respect to the company's Common Shares: incentive stock options, nonqualified stock options, SARs, restricted stock, restricted stock units, unrestricted stock and performance shares. The Compensation Committee also may grant performance units that are payable in cash. The Compensation Committee has the authority to determine which participants will receive awards, the amount of the awards and the other terms and conditions of the awards. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Plan provides that shares granted come from the company's authorized but unissued Common Shares or treasury shares. In addition, the company's stock-based compensation plans allow employee participants to exchange shares for minimum withholding taxes, which results in the company acquiring treasury shares. </span></div></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of equity-based compensation expense recognized as part of SG&amp;A expenses in All Other in business segment reporting were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock and restricted stock units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,653 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,570 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(814)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">799 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,839 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,369 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan, which is related to non-vested awards, was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock and restricted stock units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,826 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total unrecognized stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,994 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unrecognized compensation cost will be adjusted for future changes in actual and estimated forfeitures and for updated vesting assumptions for the performance share awards (refer to "Performance Shares and Performance Share Units" below). No tax benefits for stock compensation were realized during the three and nine months ended September 30, 2022 and 2021, respectively, due to a valuation allowance against deferred tax assets. In accordance with ASC 718, any tax benefits resulting from tax deductions in excess of the compensation expense recognized is classified as a component of financing cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, non-qualified stock option awards have a term of ten years and were granted with an exercise price per share equal to the fair market value of the company’s Common Shares on the date of grant. </span></div></div></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about stock option activity for the nine months ended September 30, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,159 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107,987)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.48</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642,172 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercise price range at September 30, 2022</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.15 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">to</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.49 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercisable at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642,172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares available for grant under the 2018 Plan at September 30, 2022*</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,507,144 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> *    Shares available for grant under the 2018 Plan as of September 30, 2022 are reduced by awards and increased by forfeitures or expirations. At September 30, 2022, an aggregate of 910,624 Common Shares underlie awards which were forfeited or expired unexercised under the 2003 and 2013 Plans and thus are available for future issuance under the 2018 Plan upon transfer.</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about stock options outstanding at September 30, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:21.044%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Prices</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>Outstanding at<br/>September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number Exercisable at<br/>September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12.15 – $14.49</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642,172 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642,172 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Plan provides for a one-year minimum vesting period for stock options and, generally, options must be exercised within ten years from the date granted. No stock options were issued in 2022 or 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock and Restricted Stock Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about restricted stock and restricted stock units (primarily for non-U.S. recipients):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock / Units unvested at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,160,847 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,321,249 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.37 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(553,071)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(741,679)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.30 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock / Units unvested at <br/>September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,187,346 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restricted awards generally vest ratably over the three years after the award date. Unearned restricted awards compensation, determined as the market value of the shares at the date of grant, is being amortized on a straight-line basis over the vesting period as adjusted for forfeiture estimates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Shares and Performance Share Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about performance shares and performance share units (primarily for non-U.S. recipients):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.716%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.877%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares / Units unvested at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">972,288 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.76 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,187 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.48 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(942,201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.79 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares / Units unvested at <br/>September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">490,274 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.67 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2022, performance shares and performance share units (for non-U.S. recipients) were granted. Performance awards have a three year performance period with payouts based on achievement of certain performance goals. The awards are classified as equity awards as they will be settled in Common Shares upon vesting. The number of shares earned will be determined at the end of the three year performance period based on achievement of performance criteria for January 1, 2020 through December 31, 2022, January 1, 2021 through </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2023 and January 1, 2022 through December 31, 2024, respectively established by the Compensation Committee at the time of grant. Recipients will be entitled to receive a number of Common Shares equal to the number of performance shares that vest based upon the levels of achievement which may range between 0% and 150% of the target number of shares with the target being 100% of the initial grant. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the performance awards is based on the stock price on the date of grant discounted for the estimated value of dividends foregone as the awards are not eligible for dividends except to the extent vested. The grant fair value is further updated each reporting period while variable accounting applies. The company assesses the probability that the performance targets will be met with expense recognized whenever it is probable that at least the minimum performance criteria will be achieved. Depending upon the company's assessment of the probability of achievement of the goals, the company may not recognize any expense associated with performance awards in a given period, may reverse prior expense recorded or record additional expense to recognize the cumulative estimated achievement level of proportionate term of the award. Performance award compensation expense is generally expected to be recognized over three years. The company continues to recognize expense (benefit) related to the awards granted in 2020, 2021 and 2022 based on estimates that the performance goals for those awards will be or will not be met.</span></div> 0.25 10 3667 0.999 The 2018 Plan uses a fungible share-counting method, under which each Common Share underlying an award of stock options or stock appreciation rights ("SAR") will count against the number of total shares available under the 2018 Plan as one share; and each Common Share underlying any award other than a stock option or a SAR will count against the number of total shares available under the 2018 Plan as two shares. Shares underlying awards made under the 2003 Plan or 2013 Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the awards will become available under the 2018 Plan for use in future awards. Any Common Shares that are added back to the 2018 Plan as the result of forfeiture, termination or expiration of an award granted under the 2018 Plan or the 2013 Plan will be added back in the same manner such shares were originally counted against the total number of shares available under the 2018 Plan or 2013 Plan, as applicable. Each Common Share that is added back to the 2018 Plan due to a forfeiture, termination or expiration of an award granted under the 2003 Plan will be added back as one Common Share. 5507144 <div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of equity-based compensation expense recognized as part of SG&amp;A expenses in All Other in business segment reporting were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock and restricted stock units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,653 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,570 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(814)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">799 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,839 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,369 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2653000 4570000 -814000 799000 1839000 5369000 <div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, unrecognized compensation expense related to equity-based compensation arrangements granted under the company's 2018 Plan, which is related to non-vested awards, was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock and restricted stock units</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,826 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance shares and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total unrecognized stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,994 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2826000 168000 2994000 P10Y <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about stock option activity for the nine months ended September 30, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,159 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107,987)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.48</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options outstanding at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642,172 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercise price range at September 30, 2022</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.15 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">to</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.49 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercisable at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642,172 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares available for grant under the 2018 Plan at September 30, 2022*</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,507,144 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div> *    Shares available for grant under the 2018 Plan as of September 30, 2022 are reduced by awards and increased by forfeitures or expirations 750159 12.69 107987 13.48 642172 12.55 12.15 14.49 642172 5507144 910624 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about stock options outstanding at September 30, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:21.044%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Prices</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number<br/>Outstanding at<br/>September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number Exercisable at<br/>September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12.15 – $14.49</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642,172 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">642,172 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.55 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 12.15 14.49 642172 P0Y9M18D 12.55 642172 12.55 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about restricted stock and restricted stock units (primarily for non-U.S. recipients):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock / Units unvested at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,160,847 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.17 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,321,249 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.37 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(553,071)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(741,679)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.30 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock / Units unvested at <br/>September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,187,346 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1160847 8.17 1321249 1.37 553071 8.43 741679 4.30 1187346 2.90 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about performance shares and performance share units (primarily for non-U.S. recipients):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.716%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.877%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares / Units unvested at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">972,288 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.76 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,187 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.48 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(942,201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.79 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares / Units unvested at <br/>September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">490,274 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.67 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 972288 7.76 460187 1.48 942201 5.79 490274 5.67 P3Y 0 1.50 1 P3Y <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss) by Component</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income (loss) ("OCI") (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,884)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,883)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,168)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,837)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,275)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,883)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,168)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,216)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,222)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,230)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,106)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,961 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,127 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,101)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,191)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,747)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,772 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,969)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,961)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,191)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,747)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,608 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,094)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,230)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,106)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,381 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,069)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,079 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,467)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,155)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,976)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,096)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,103 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,329 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(517)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,674)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(702)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,436 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,103)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(643)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,570)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,103)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,333)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,096)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,103 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated OCI were as follows (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.161%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount reclassified from OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount reclassified from OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Affected line item in the Statement of Comprehensive (Income) Loss</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and interest costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts hedging sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts hedging purchases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,263)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,997)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loss (income) before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,331)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,275)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,961)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in accumulated other comprehensive income (loss) ("OCI") (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,884)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,883)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,168)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,837)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,275)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,883)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,168)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,216)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,222)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,230)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,106)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,961 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,127 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,101)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,191)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,747)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,772 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,969)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,961)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,191)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,747)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,608 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,094)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,230)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,106)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,381 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,069)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,079 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,467)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,155)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,976)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,096)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,103 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.497%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,329 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(517)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,674)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(702)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,436 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI before reclassifications</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,103)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(643)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,570)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount reclassified from accumulated OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,103)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,333)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,096)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,103 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div> -13347000 1548000 462000 1453000 -9884000 -31883000 -2168000 155000 59000 -33837000 0 0 110000 1275000 1385000 -31883000 -2168000 45000 -1216000 -35222000 -45230000 -620000 507000 237000 -45106000 18961000 2127000 -4101000 1000 16988000 -64191000 -2747000 4772000 2197000 -59969000 0 0 164000 1961000 2125000 -64191000 -2747000 4608000 236000 -62094000 -45230000 -620000 507000 237000 -45106000 60381000 2146000 -4069000 -1379000 57079000 -19155000 -47000 -209000 944000 -18467000 0 0 -182000 -309000 -491000 -19155000 -47000 -27000 1253000 -17976000 41226000 2099000 -4096000 -126000 39103000 50329000 -517000 -3674000 -702000 45436000 -9103000 2616000 -440000 -643000 -7570000 0 0 -18000 -1219000 -1237000 -9103000 2616000 -422000 576000 -6333000 41226000 2099000 -4096000 -126000 39103000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications out of accumulated OCI were as follows (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.161%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount reclassified from OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount reclassified from OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Affected line item in the Statement of Comprehensive (Income) Loss</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and interest costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts hedging sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts hedging purchases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,263)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,997)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loss (income) before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,331)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,122)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total after tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,275)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,961)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div> 110000 182000 164000 -18000 0 0 0 0 -110000 182000 -164000 18000 68000 476000 125000 657000 1263000 -92000 1997000 -746000 -1331000 384000 -2122000 1403000 -56000 75000 -161000 184000 -1275000 309000 -1961000 1219000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Charges Related to Restructuring Activities</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's restructuring charges were originally necessitated primarily by continued declines in Medicare and Medicaid reimbursement by the U.S. government, as well as similar healthcare reimbursement pressures abroad, which negatively affected the company's customers (e.g. home health care providers) and continued pricing pressures faced by the company due to the outsourcing by competitors to lower cost locations. Restructuring decisions were also the result of reduced profitability in each of the segments. Restructuring actions have continued into 2022. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2022, severance and other charges totaled $16,383,000 which were related to North America of $5,534,000, Europe of $9,766,000 and All Other of $1,083,000. Payments for the nine months ended September 30, 2022 were $10,789,000 and the cash payments were funded with the company's cash on hand. The 2022 charges are expected to be paid out within 12 months.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2021, charges totaled $2,476,000 which were related to North America of $975,000 and Europe of $1,501,000. In North America costs were incurred related to severance. The European charges were for severance costs $895,000 and contract terminations $606,000, primarily related to the closure of a German manufacturing facility. Payments for the nine months ended September 30, 2021 were $7,367,000 and the cash payments were funded with company's cash on hand. </span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in accrued balances related to the charges, either as a result of revisions to the plans or changes in estimates. In addition, the savings anticipated as a result of the company's restructuring plans have been or are expected to be achieved, primarily resulting in reduced salary and benefit costs principally impacting selling, general and administrative expenses, and to a lesser extent, costs of products sold. To date, the company's liquidity has been sufficient to absorb these charges and payments. </span></div></div></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2022 is as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"/><td style="width:48.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.032%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Severance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021 Balances</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,662 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,119 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,119 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,252 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,790 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(538)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(960)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(798)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(538)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,336)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022 Balances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,936 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,936 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,288 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,830 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,323 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,153 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,210)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(624)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,878)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,022)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,066)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,088)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022 Balances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,514 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,744 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,001 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,216 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,332 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,001 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,034 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,223 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,217 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,807)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,041)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,108)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,517)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,848)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,365)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022 Balances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,601 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,661 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,413 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,450 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,076 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div> 16383000 5534000 9766000 1083000 10789000 P12M 2476000 975000 1501000 895000 606000 7367000 <div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A progression by reporting segment of the accruals recorded as a result of the restructuring for the nine months ended September 30, 2022 is as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"/><td style="width:48.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.032%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Severance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021 Balances</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,662 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,119 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,119 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,252 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,790 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(538)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(960)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(798)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(538)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,336)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022 Balances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,936 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,936 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges </span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,288 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,830 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,323 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,153 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,210)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(624)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,878)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,022)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,066)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,088)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022 Balances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,514 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,744 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,001 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,216 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,332 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,001 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,034 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,223 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,217 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,807)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,067)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,041)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,108)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,517)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,848)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,365)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022 Balances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,601 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,661 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,413 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,450 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,076 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div> 482000 0 482000 482000 0 482000 1124000 538000 1662000 2119000 0 2119000 9000 0 9000 3252000 538000 3790000 422000 -538000 960000 367000 0 367000 9000 0 9000 798000 538000 1336000 1184000 0 1184000 1752000 0 1752000 2936000 0 2936000 542000 998000 1540000 1288000 1325000 2613000 1830000 2323000 4153000 768000 -442000 1210000 1254000 -624000 1878000 2022000 1066000 3088000 958000 556000 1514000 1786000 701000 2487000 2744000 1257000 4001000 116000 2216000 2332000 1033000 4001000 5034000 1074000 0 1074000 2223000 6217000 8440000 438000 -1807000 2245000 1067000 -3041000 4108000 12000 0 12000 1517000 4848000 6365000 636000 965000 1601000 1752000 1661000 3413000 1062000 0 1062000 3450000 2626000 6076000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The company had an effective tax rate of 2.8% and 4.1% on losses before tax for the three and nine months ended September 30, 2022, respectively, compared to a statutory benefit of 21.0% on the pre-tax loss for each period. The company had an effective tax rate of 8.8% and 11.3% on losses before tax for the three and nine months ended September 30, 2021, respectively, compared to a statutory benefit of 21.0% on the pre-tax loss for each period. The company's effective tax rate for the three and nine months ended September 30, 2022 and September 30, 2021 were unfavorable as compared to the U.S. federal statutory rate, principally due to the negative impact of the company not being able to record tax benefits related to the significant losses in countries which had tax valuation allowances. The effective tax rate was increased for the three and nine months ended September 30, 2022 and September 30, 2021 by certain taxes outside the United States, excluding countries with tax valuation allowances, that were at an effective rate higher than the U.S. statutory rate.</span></div><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div> -0.028 -0.041 0.210 -0.088 -0.113 0.210 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Net Loss Per Common Share</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.611%"><tr><td style="width:1.0%"/><td style="width:53.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,073 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,826 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,354)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,073 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,826 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options and awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,488 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,241 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,371 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,354)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share *</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2022, shares associated with equity compensation awards of 1,659,909 and 1,120,192, respectively, and for the three and nine months ended September 30, 2021, shares associated with equity compensation awards of 1,432,833 and 1,163,526, respectively, were excluded from the weighted average common shares assuming dilution as incremental shares were antidilutive. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022, the majority of the antidilutive incremental shares were awards granted at an exercise price above $12.14, which was higher than the average fair market value price of $1.05 and $1.50 for the three and nine months ended September 30, 2022. At September 30, 2021, the majority of the antidilutive incremental shares were awards granted at an exercise price above $14.49, which was higher than the average fair market value price of $7.30 and $8.30 for the three and nine months ended September 30, 2021.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2022 and September 30, 2021, respectively, no shares were included in the common shares assuming dilution related to the company's issued warrants as the average market price of the company shares for these periods did not exceed the strike price of the warrants.</span></div>Further, upon adoption of ASU 2020-06, effective in 2021 for the company, use of the if-converted earnings per share method is required. However, no shares were included in the weighted average common shares assuming dilution for the three and nine months ended September 30, 2022 and September 30, 2021 related to the company's convertible senior notes as conversion prices were above the company's average stock price for the periods and other requirements for the notes to be convertible to shares were not met. <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.611%"><tr><td style="width:1.0%"/><td style="width:53.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,073 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,826 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,354)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,013 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,073 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,826 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options and awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares assuming dilution</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,488 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,241 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,371 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,354)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,759)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share *</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.</span></div> 37537000 35013000 36073000 34826000 -34354000 -22759000 -80494000 -47501000 -0.92 -0.65 -2.23 -1.36 37537000 35013000 36073000 34826000 143000 475000 168000 545000 37680000 35488000 36241000 35371000 -34354000 -22759000 -80494000 -47501000 -0.92 -0.65 -2.23 -1.36 1659909 1120192 1432833 1163526 12.14 1.05 1.50 14.49 7.30 8.30 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company manufactures and distributes durable medical equipment to the home health care, retail and extended care markets. The company performs credit evaluations of its customers’ financial condition. The company utilizes De Lage Landen, Inc. (“DLL”), a third-party financing company, to provide lease financing to Invacare's U.S. customers. The DLL agreement provides for direct leasing between DLL and the Invacare customer. The company retains a recourse obligation of $2,071,000 at September 30, 2022 to DLL for events of default under the contracts, which total $8,588,000 at September 30, 2022. Guarantees, ASC 460, requires the company to record a guarantee liability as it relates to the limited recourse obligation. As such, the company has recorded an immaterial liability for this guarantee obligation within other long-term obligations. The company's recourse is reevaluated by DLL biannually, considers activity between the biannual dates and excludes any receivables purchased by the company from DLL. The company monitors the collections status of these contracts and has provided amounts for estimated losses in its allowances for doubtful accounts in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASC 310-10-05-4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Credit losses are provided for in the financial statements.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all the company’s receivables are due from health care, medical equipment providers and long-term care facilities located throughout the United States, Australia, Canada, New Zealand and Europe or also direct from governmental entities in certain countries. A significant portion of products sold to dealers, both foreign and domestic, is ultimately funded through government reimbursement programs such as Medicare and Medicaid. Changes in these programs can have a significant shift in reimbursement to customers from managed care entities. As a consequence, changes in these programs can have an adverse impact on dealer liquidity and profitability. In addition, reimbursement guidelines in the home health care industry have a substantial impact on the nature and type of equipment an end user can obtain as well as the timing of reimbursement and, thus, affect the product mix, pricing and payment patterns of the company’s customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div></div></div> 2071000 8588000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Derivatives</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 815 requires companies to recognize all derivative instruments in the condensed consolidated balance sheets as either assets or liabilities at fair value. The accounting for changes in fair value of a derivative is dependent upon whether or not the derivative has been designated and qualifies for hedge accounting treatment and the type of hedging relationship. For derivatives designated and qualifying as hedging instruments, the company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Flow Hedging Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company uses derivative instruments in an attempt to manage its exposure to transactional foreign currency exchange risk. Foreign forward exchange contracts are used to manage the price risk associated with forecasted sales denominated in foreign currencies and the price risk associated with forecasted purchases of inventory over the next twelve months.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company recognizes its derivative instruments as assets or liabilities in the condensed consolidated balance sheets measured at fair value. All of the company’s derivative instruments are designated and qualify as cash flow hedges. Accordingly, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The remaining gain or loss on the derivative instrument in excess of the cumulative change in the fair value of the hedged item, if any, is recognized in current earnings during the period of change.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect against increases/decreases in forecasted foreign currency cash flows resulting from inventory purchases/sales over the next year, the company utilizes foreign currency forward contracts to hedge portions of its forecasted purchases/sales denominated in foreign currencies. The gains and losses are included in cost of products sold and selling, general and administrative expenses on the condensed consolidated statements of comprehensive income (loss). If it is later determined that a hedged forecasted transaction is unlikely to occur, any prospective gains or losses on the forward contracts would be recognized in earnings. The company does not expect any material amount of hedge ineffectiveness related to forward contract cash flow hedges during the next twelve months.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has historically not recognized any material amount of ineffectiveness related to forward contract cash flow hedges because the company generally limits its hedges to between 50% and 90% of total forecasted transactions for a given entity’s exposure to currency rate changes and the transactions hedged are recurring in nature. Furthermore, most of the hedged transactions are related to intercompany sales and purchases for which settlement occurs on a specific day each month. Forward contracts with a total notional amount in USD of $67,853,000 and $90,800,000 matured during the nine months ended September 30, 2022 and September 30, 2021, respectively, compared to $29,189,000 and $32,685,000 during the three month ended September 30, 2022 and September 30, 2021, respectively.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Net Gain<br/>(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Net Gain<br/>(Loss)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / EUR</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,492 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / CAD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,523 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,961 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / NOK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOK / SEK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / MXN</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,843 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives Not Qualifying or Designated for Hedge Accounting Treatment</span></div><div><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company utilizes foreign currency forward contracts that are not designated as hedges in accordance with ASC 815. These contracts are entered into to eliminate the risk associated with the settlement of short-term intercompany trading receivables and payables between Invacare Corporation and its foreign subsidiaries. The currency forward contracts are entered into at the same time as the intercompany </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receivables or payables are created so that upon settlement, the gain/loss on the settlement is offset by the gain/loss on the foreign currency forward contract. No material net gain or loss was realized by the company in 2022 or 2021 related to these contracts and the associated short-term intercompany trading receivables and payables.</span></div></div></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2022 and 2021, respectively, and outstanding were as follows (in thousands USD):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:52.307%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain<br/>(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain<br/>(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / AUD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,792 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / CAD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,765 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,556 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">73,507 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,852)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">70,454 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / DKK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,099 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / NOK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,790 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(467)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,352 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / SEK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,880 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,344 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / GBP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / NOK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">AUD / NZD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,082 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,366 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / THB</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,310 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">132,279 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,563)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">120,242 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,553)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the company’s derivative instruments were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Derivatives designated as hedging instruments under ASC 815</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">690 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Derivatives not designated as hedging instruments under ASC 815</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,936 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,499 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">385 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,938 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,626 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,890 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">386 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,938 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the company’s foreign currency forward exchange contract assets and liabilities are included in Other Current Assets and Accrued Expenses, respectively in the condensed consolidated balance sheets. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of derivative instruments on Accumulated Other Comprehensive Income (Loss) (OCI) and the condensed consolidated Statements of comprehensive income (loss) was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:39.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.156%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives (foreign currency forward exchange contracts) in ASC 815 cash flow hedge<br/>relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain<br/>(Loss) Recognized in Accumulated OCI on Derivatives<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Reclassified from<br/>Accumulated OCI into<br/>Income (Effective<br/>Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized in Income on<br/>Derivatives (Ineffective Portion and Amount Excluded from<br/>Effectiveness Testing)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,275 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,002 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,961 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">944 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives (foreign currency forward exchange contracts) not designated as hedging<br/>instruments under ASC 815</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized in Income on Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,072 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,563)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(592)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,315)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains or losses recognized as the result of the settlement of cash flow hedge foreign currency forward contracts are recognized in net sales for hedges of inventory sales and in cost of products sold for hedges of inventory purchases. For the three and nine months ended September 30, 2022, net sales were increased by $68,000 and $125,000, while cost of products sold was decreased by $1,263,000 and $1,997,000 for net pre-tax realized gains of $1,331,000 and </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2,122,000, respectively. For the three and nine months ended September 30, 2021, net sales were decreased by $476,000 and $657,000 while cost of products sold was decreased by $92,000 and increased by $746,000 for net realized pre-tax losses of $384,000 and $1,403,000, respectively.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A gain of $2,072,000 and $2,563,000 was recognized in selling, general and administrative (SG&amp;A) expenses for the </span></div></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended September 30, 2022 compared to a loss of $592,000 and a loss of $1,315,000 for the three and nine months ended September 30, 2021 related to forward contracts not designated as hedging instruments. The forward contracts were entered into to offset gains/losses that were also recorded in SG&amp;A expenses on intercompany trade receivables or payables. The gains/losses on the non-designated hedging instruments were substantially offset by gains/losses on intercompany trade payables.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's derivative agreements provide the counterparties with a right of set off in the event of a default. The right of set off would enable the counterparty to offset any net payment due by the counterparty to the company under the applicable agreement by any amount due by the company to the counterparty under any other agreement. For example, the terms of the agreement would permit a counterparty to a derivative contract that is also a lender under the company's </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior Credit Agreement and ABL Credit Agreement to reduce any derivative settlement amounts owed to the company under the derivative contract by any amounts owed to the counterparty by the company under the Prior Credit Agreement and ABL Credit Agreement. In addition, the agreements contain cross-default provisions that could trigger a default by the company under the agreement in the event of a default by the company under another agreement with the same counterparty. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the company entered into privately negotiated Secured Convertible 2026 Notes of $31,106,000 in aggregate principal amount. Convertible debt conversion liabilities of $1,423,000 were recorded based on initial fair values and these fair values are updated quarterly with the offset to the income statement. Refer to "Long-Term Debt" in the notes to the condensed consolidated financial statements for more detail. </span></div></div></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the outstanding convertible note derivatives as of September 30, 2022 and their effect on the Statement of Comprehensive Income (Loss) were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Three and Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Secured Convertible 2026 Notes conversion long-term liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">473 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>The secured convertible 2026 notes conversion liability amounts are included in Other Long-Term Obligations in the company's condensed consolidated balance sheets. 0.50 0.90 67853000 90800000 29189000 32685000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding foreign currency forward exchange contracts qualifying and designated for hedge accounting treatment were as follows (in thousands USD):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:41.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Net Gain<br/>(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>Net Gain<br/>(Loss)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / EUR</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,492 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / CAD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,523 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,961 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR / NOK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOK / SEK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD / MXN</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,843 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3492000 441000 0 0 4523000 -343000 0 0 5961000 179000 0 0 689000 -5000 0 0 1089000 -43000 0 0 1089000 70000 23000 1000 16843000 299000 23000 1000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward exchange contracts not qualifying or designated for hedge accounting treatment, as well as ineffective hedges, entered into in 2022 and 2021, respectively, and outstanding were as follows (in thousands USD):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:52.307%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain<br/>(Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Notional<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain<br/>(Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / AUD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,194 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,792 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / CAD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,765 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,556 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / EUR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">73,507 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,852)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">70,454 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / DKK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,099 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / GBP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / NOK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,790 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(467)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,352 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / SEK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,880 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,344 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / GBP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / NOK</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">AUD / NZD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,082 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,366 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">USD / THB</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,310 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">278 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EUR / SEK</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">132,279 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,563)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">120,242 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,553)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1194000 104000 3792000 -57000 19765000 -272000 14556000 -24000 73507000 -1852000 70454000 -1104000 5099000 -137000 10850000 -257000 0 0 4028000 32000 4790000 -467000 2352000 -81000 1880000 -72000 2344000 -131000 1200000 36000 0 0 1099000 -8000 0 0 17082000 -163000 7366000 -17000 4310000 278000 4500000 86000 2353000 -10000 0 0 132279000 -2563000 120242000 -1553000 <div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the company’s derivative instruments were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Derivatives designated as hedging instruments under ASC 815</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">690 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Derivatives not designated as hedging instruments under ASC 815</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,936 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,499 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">385 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,938 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,626 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,890 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">386 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,938 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 690000 391000 1000 0 1936000 4499000 385000 1938000 2626000 4890000 386000 1938000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of derivative instruments on Accumulated Other Comprehensive Income (Loss) (OCI) and the condensed consolidated Statements of comprehensive income (loss) was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:39.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.156%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives (foreign currency forward exchange contracts) in ASC 815 cash flow hedge<br/>relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain<br/>(Loss) Recognized in Accumulated OCI on Derivatives<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Reclassified from<br/>Accumulated OCI into<br/>Income (Effective<br/>Portion)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized in Income on<br/>Derivatives (Ineffective Portion and Amount Excluded from<br/>Effectiveness Testing)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,275 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,002 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,961 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">944 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Derivatives (foreign currency forward exchange contracts) not designated as hedging<br/>instruments under ASC 815</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amount of Gain (Loss)<br/>Recognized in Income on Derivatives</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,072 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,563)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Three months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(592)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nine months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,315)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 59000 1275000 1002000 2197000 1961000 1117000 944000 -309000 51000 -643000 -1219000 -37000 -2072000 2563000 -592000 -1315000 -68000 -125000 -1263000 -1997000 -1331000 -2122000 -476000 -657000 92000 -746000 384000 1403000 -2072000 2563000 -592000 -1315000 31106000 1423000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the outstanding convertible note derivatives as of September 30, 2022 and their effect on the Statement of Comprehensive Income (Loss) were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.984%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Gain</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Three and Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Secured Convertible 2026 Notes conversion long-term liability</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">473 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">950 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>The secured convertible 2026 notes conversion liability amounts are included in Other Long-Term Obligations in the company's condensed consolidated balance sheets. 473000 950000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Fair Values</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 820, the inputs used to derive the fair value of assets and liabilities are analyzed and assigned a level I, II or III priority, with level I being the highest and level III being the lowest in the hierarchy. Level I inputs are quoted prices in active markets for identical assets or liabilities. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level II inputs are quoted prices for similar assets or liabilities in active markets: quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets. Level III inputs are based on valuations derived from valuation techniques in which one or more significant inputs are unobservable. </span></div></div></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:46.048%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.923%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basis for Fair Value Measurements at Reporting Date</span></td></tr><tr style="height:32pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets for Identical<br/>Assets / (Liabilities)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable<br/>Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level III</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward exchange contracts—net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured convertible 2026 debt conversion liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(473)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward exchange contracts—net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,552)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values and fair values of the company’s financial instruments are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:58.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,439 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,439 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,745 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,745 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts in Other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts in Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,890)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,890)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,938)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,938)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt (including current maturities of long-term debt) *</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335,279)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272,485)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308,129)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259,472)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,632)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series I 2024 Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,341)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,887)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,140)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,897)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series II 2024 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,963)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,251)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,898)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,832)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,036)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,718)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Secured Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Term Loan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,724)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,345)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,089)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,089)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured convertible 2026 debt conversion liability in Other Long-Term Obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* The company's total debt is shown net of discount and fees associated with the convertible senior notes and term loan due in 2022, 2024 and 2026 on the company's condensed consolidated balance sheets. Accordingly, the fair values due in 2022, 2024 and 2026 are included in the long-term debt presented in this table are also shown net of fees. Total debt amounts exclude operating and finance lease obligations.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company, in estimating its fair value disclosures for financial instruments, used the following methods and assumptions:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash, cash equivalents:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The carrying value reported in the balance sheet for cash, cash equivalents equals its fair value. The fair values are deemed to be categorized as Level 1. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward Contracts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company operates internationally, and as a result, is exposed to foreign currency fluctuations. Specifically, the exposure includes intercompany loans and third-party sales or payments. In an attempt to reduce this exposure, foreign currency forward contracts are utilized and accounted for as hedging instruments. The forward contracts are used to hedge the following currencies: AUD, CAD, DKK, EUR, GBP, MXN, NOK, NZD, SEK, THB, and USD. The company does not use derivative financial instruments for speculative purposes. Fair values for the company’s foreign exchange forward contracts are based on quoted market prices for contracts with similar maturities. The fair values are deemed to be categorized as Level 2. The company's forward contracts are included in Other Current Assets or Accrued Expenses in the condensed consolidated balance sheets. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total debt:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair value for the company’s convertible debt other than the 2026 Secured Notes and Term Loan is based on quoted market-based estimates as of the end of the period, while the revolving credit facility fair value is based on an estimate of the market for similar borrowing arrangements. The fair values are deemed to be categorized as Level 2 in the fair value hierarchy. The 2026 Secured Notes and Term Loan fair values are based on valuation models in which significant inputs are observable in active markets. The fair values are deemed to be categorized as Level 2. Other total debt is primarily attributable to credit facilities borrowings where the carrying value reported in the balance approximates its fair value. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible debt derivative:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value for the convertible debt conversion liability is based on valuation models in which significant inputs are observable in active markets. The fair values are deemed to be categorized as Level 2.</span></div> <div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the company’s assets and liabilities that are measured on a recurring basis (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:46.048%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.923%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basis for Fair Value Measurements at Reporting Date</span></td></tr><tr style="height:32pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quoted Prices in Active<br/>Markets for Identical<br/>Assets / (Liabilities)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Significant Other<br/>Unobservable<br/>Inputs</span></td></tr><tr style="height:14pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level III</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">September 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward exchange contracts—net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured convertible 2026 debt conversion liability</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(473)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forward exchange contracts—net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,552)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 0 -2264000 0 0 -473000 0 0 -1552000 0 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values and fair values of the company’s financial instruments are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:58.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,439 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,439 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,745 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,745 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts in Other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward contracts in Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,890)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,890)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,938)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,938)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt (including current maturities of long-term debt) *</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335,279)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272,485)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308,129)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259,472)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,632)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series I 2024 Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,341)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,887)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,140)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,897)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series II 2024 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,963)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,251)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,898)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,832)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,036)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,718)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Secured Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 Term Loan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,724)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,345)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,089)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,089)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secured convertible 2026 debt conversion liability in Other Long-Term Obligations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* The company's total debt is shown net of discount and fees associated with the convertible senior notes and term loan due in 2022, 2024 and 2026 on the company's condensed consolidated balance sheets. Accordingly, the fair values due in 2022, 2024 and 2026 are included in the long-term debt presented in this table are also shown net of fees. Total debt amounts exclude operating and finance lease obligations.</span></div> 45439000 45439000 83745000 83745000 2626000 2626000 386000 386000 4890000 4890000 1938000 1938000 335279000 272485000 308129000 259472000 0 0 2642000 2632000 72341000 62887000 72140000 64897000 75764000 63963000 78251000 74165000 80898000 36832000 119036000 81718000 27463000 25369000 0 0 59724000 64345000 0 0 19089000 19089000 36060000 36060000 473000 473000 0 0 <div style="margin-bottom:6pt;text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company operates in two primary business segments: North America and Europe with each selling the company's primary product categories, which include: lifestyle, mobility and seating and respiratory therapy products. Sales in Asia Pacific are reported in All Other and include products similar to those sold in North America and Europe. The accounting policies of each segment are the same as those described in the summary of significant accounting policies for the company's condensed consolidated financial statements. Intersegment sales and transfers are based on the costs to manufacture plus a reasonable profit element. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment performance is measured and resources are allocated based on a number of factors, with the primary income or loss measure being segment operating income (loss). Segment operating income (loss) represents net sales less cost of products sold less selling general and administrative expenses. Segment operating income (loss) </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excludes unallocated corporate general and administrative expenses not allocated to the segments and intersegment sales and profit eliminations, which are included in All Other. In addition, segment operating income (loss) further excludes charges related to restructuring activities, asset impairment and gain on sale of business (as applicable).</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This performance measure, segment operating income (loss), is used by the Chief Operating Decision Maker (CODM) for purposes of making decisions about allocating resources to a segment and assessing its performance. In addition, this metric is reviewed by the company's Board of Directors regarding segment performance and is a key metric in the performance management assessment of the company's employees. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information by segment is as follows (in thousands):</span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:52.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">97,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">127,026 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">328,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">361,097 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">65,314 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,054 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">209,351 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">260,275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,728 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">170,408 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">224,200 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">560,413 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">646,266 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,763 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,327 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,758 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,738 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,044 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24,274 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45,903 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,501 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,265 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35,601 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,661 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restructuring charges before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,034 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,766 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,501 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,332 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,534 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">975 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,383 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,476 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,588)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,554 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,126 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18,378 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15,007)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,523)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(29,607)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,308)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,391)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3,856)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(21,981)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(19,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Charges related to restructuring activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8,440)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(377)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(16,383)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,476)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impairment of an intangible asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,012)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,012)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(28,564)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(28,564)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,438)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(24,766)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(64,857)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,995)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net gain on convertible debt derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">950 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">950 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net gain on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,422 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,344)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,284)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(19,825)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18,098)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,434)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(20,919)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(77,334)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(42,671)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales by product, are as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:52.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">46,881 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">61,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">162,942 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">181,628 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">43,778 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56,535 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">139,010 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">152,660 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,847 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,566 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,583 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,535 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13,196 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">97,487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">127,026 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">328,334 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">361,097 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34,379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38,666 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">102,516 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">114,951 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23,453 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28,414 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">74,876 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,243 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,236 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20,856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31,384 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62,429 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">246 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">575 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">652 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">65,314 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,054 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">209,351 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">260,275 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,989 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,556 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,230 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,239 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,736 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">407 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,538 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,333 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,504 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,962 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,372 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,607 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,120 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,728 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">170,408 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">224,200 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">560,413 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">646,266 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes various services, including repair services, equipment rentals and external contracting.</span></div> <div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information by segment is as follows (in thousands):</span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"/></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:52.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">97,487 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">127,026 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">328,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">361,097 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">65,314 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,054 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">209,351 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">260,275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,728 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">170,408 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">224,200 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">560,413 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">646,266 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,763 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,327 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,758 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,738 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,044 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24,274 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45,903 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,501 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,265 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35,601 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,661 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restructuring charges before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,034 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,766 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,501 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,332 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,534 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">975 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,440 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,383 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,476 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,588)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,554 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,126 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18,378 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15,007)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,523)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(29,607)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,308)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,391)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3,856)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(21,981)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(19,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Charges related to restructuring activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8,440)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(377)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(16,383)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,476)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impairment of an intangible asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,012)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,012)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(28,564)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(28,564)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Consolidated operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,438)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(24,766)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(64,857)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,995)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net gain on convertible debt derivatives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">950 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">950 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net gain on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,422 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7,344)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6,284)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(19,825)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18,098)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,434)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(20,919)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(77,334)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(42,671)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 97487000 127026000 328334000 361097000 65314000 88054000 209351000 260275000 7607000 9120000 22728000 24894000 170408000 224200000 560413000 646266000 2763000 6221000 11327000 17758000 5738000 15044000 24274000 45903000 8501000 21265000 35601000 63661000 5034000 255000 9766000 1501000 2332000 122000 5534000 975000 1074000 0 1083000 0 8440000 377000 16383000 2476000 -2588000 9554000 4126000 18378000 -15007000 -1523000 -29607000 -2308000 -6391000 -3856000 -21981000 -19025000 8440000 377000 16383000 2476000 1012000 0 1012000 0 0 28564000 0 28564000 -33438000 -24766000 -64857000 -33995000 950000 0 950000 0 6398000 10131000 6398000 9422000 -7344000 -6284000 -19825000 -18098000 -33434000 -20919000 -77334000 -42671000 <div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales by product, are as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:52.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">46,881 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">61,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">162,942 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">181,628 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">43,778 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56,535 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">139,010 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">152,660 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,847 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,566 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,583 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">14,535 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13,196 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">97,487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">127,026 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">328,334 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">361,097 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34,379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">38,666 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">102,516 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">114,951 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23,453 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28,414 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">74,876 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,243 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,236 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20,856 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31,384 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62,429 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">246 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">118 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">575 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">652 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">65,314 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,054 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">209,351 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">260,275 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">All Other (Asia Pacific)</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mobility and Seating</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,989 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lifestyle</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,556 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,230 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,239 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,736 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Respiratory Therapy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">407 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,215 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,538 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other(1)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,333 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,504 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,962 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,372 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,607 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,120 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">22,728 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24,894 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total Consolidated</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">170,408 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">224,200 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">560,413 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">646,266 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes various services, including repair services, equipment rentals and external contracting.</span></div> 46881000 61683000 162942000 181628000 43778000 56535000 139010000 152660000 2262000 4225000 11847000 13613000 4566000 4583000 14535000 13196000 97487000 127026000 328334000 361097000 34379000 38666000 102516000 114951000 23453000 28414000 74876000 82243000 7236000 20856000 31384000 62429000 246000 118000 575000 652000 65314000 88054000 209351000 260275000 3311000 3171000 8989000 9239000 2556000 3230000 8239000 8736000 407000 1215000 1538000 2547000 1333000 1504000 3962000 4372000 7607000 9120000 22728000 24894000 170408000 224200000 560413000 646266000 <div style="text-align:center"><span style="color:#003399;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">General</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of its business, the company is a defendant in a number of lawsuits, primarily product liability actions in which various plaintiffs seek damages for injuries allegedly caused by defective products. All the product liability lawsuits that the company faces in the United States have been referred to the company's captive insurance company and/or excess insurance carriers while all non-U.S. lawsuits have been referred to the company's commercial insurance carriers. All such lawsuits are generally contested vigorously. The coverage territory of the company's insurance is worldwide with the exception of those countries with respect to which, at the time the product is sold for use or at the time a claim is made, the U.S. government has suspended or prohibited diplomatic or trade relations. The amount recorded for identified contingent liabilities is based on estimates. Amounts recorded are reviewed periodically and adjusted to reflect additional technical and legal information that becomes available. Actual costs to be incurred in future periods may vary from the estimates, given the inherent uncertainties in evaluating certain exposures.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a medical device manufacturer, the company is subject to extensive government regulation, including numerous laws directed at preventing fraud and abuse and laws regulating reimbursement under various government programs. The marketing, invoicing, documenting, developing, testing, manufacturing, labeling, promoting, distributing and other practices of health care suppliers and medical device manufacturers are all subject to government scrutiny. Most of the company's facilities are subject to inspection at any time by the FDA or similar medical device regulatory agencies in other jurisdictions. Violations of law or regulations can result in administrative, civil and criminal penalties and sanctions, which could have a material adverse effect on the company's business.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medical Device Regulatory Matters</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA in the United States and comparable medical device regulatory authorities in other jurisdictions regulate virtually all aspects of the marketing, invoicing, documenting, development, testing, manufacturing, labeling, promotion, distribution and other practices regarding medical devices. The company and its products are subject to the laws and regulations of the FDA and other regulatory bodies in the various jurisdictions where the company's products are manufactured or sold. The company's failure to comply with the regulatory requirements of the FDA and other applicable medical device regulatory requirements can subject the company to administrative or judicially imposed sanctions or </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enforcement actions. These sanctions include injunctions, consent decrees, warning letters, civil penalties, criminal penalties, product seizure or detention, product recalls and total or partial suspension of production.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2012, the company became subject to a consent decree of injunction filed by the FDA with respect to the company's Corporate facility and its Taylor Street manufacturing facility in Elyria, Ohio. The consent decree initially limited the company's (i) manufacture and distribution of power and manual wheelchairs, wheelchair components and wheelchair sub-assemblies at or from its Taylor Street manufacturing facility ("Taylor Street products") , except in verified cases of medical necessity, (ii) design activities related to wheelchairs and power beds that take place at the impacted Elyria facilities and (iii) replacement, service and repair of products already in use from the Taylor Street manufacturing facility. Under the terms of the consent decree, in order to resume full operations, the company had to successfully complete independent, third-party expert certification audits at the impacted Elyria facilities, comprising three distinct certification reports separately submitted to, and subject to acceptance by, the FDA; submit its own report to the FDA; and successfully complete a reinspection by the FDA of the company's Corporate and Taylor Street facilities.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 24, 2017, following its June 2017 reinspection of the Corporate and Taylor Street facilities, the FDA notified the company that it was in substantial compliance with the FDA Act, FDA regulations and the terms of the consent decree and, that the company was permitted to resume full operations at those facilities including the resumption of unrestricted sales of products made in those facilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consent decree will continue in effect for at least five years from July 24, 2017, during which time the company's Corporate and Taylor Street facilities must complete two semi-annual audits in the first year and then four annual audits in the next four years performed by an independent company-retained audit firm. The expert audit firm will determine whether the facilities remain in continuous compliance with the Federal Food, Drug and Cosmetic Act ("FDA Act"), FDA regulations and the terms of the consent decree and issue post audit reports contemporaneously to the FDA, and the FDA has the authority to inspect these facilities and any other FDA registered facility, at any time. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has continued to actively inspect the company's facilities, other than through the processes established under the consent decree. The company expects that the FDA will, from time to time, inspect substantially all the company's domestic and foreign FDA-registered facilities.</span></div></div></div><div style="display:inline-block;vertical-align:top;width:46.666%"><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, FDA conducted an inspection of the company’s Corporate and Taylor Street facilities from May 25 through June 24, 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the close of the inspection, six FDA Form 483 observations were issued, and the company timely responded to FDA, has diligently taken actions to address FDA’s inspectional observations, and has provided FDA monthly updates on the corrective actions taken to address these observations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2021, the company received a warning letter from the FDA concerning certain of the inspectional observations in the June 2021 FDA Form 483 related to the complaint handling process, the corrective and preventive action (“CAPA”) process, and medical device reporting (“MDR”) associated with oxygen concentrators (the “Warning Letter”).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 16, 2021, the company received a consent decree non-compliance letter from the FDA concerning the same complaint and CAPA handling matters as in the Warning Letter observations but associated with the Taylor Street products (this letter, together with the Warning Letter, the “FDA Letters”). The company timely responded to the FDA Letters, has diligently taken actions to address FDA’s concerns, and has provided FDA with periodic updates on the corrective actions taken to address the matters in the FDA Letters. The company remains committed to resolving the FDA’s concerns; however, it is not possible to predict the outcome or timing of a resolution at this time. There can be no assurance that the FDA will be satisfied with the company’s responses to the FDA Letters, nor any assurance as to the timeframe that may be required for the company to adequately address the FDA’s concerns or whether the matters in the FDA Letters will result in an extension in the duration of the consent decree. As of the date of filing of the company’s Quarterly Report on Form 10-Q, there has been no impact on the Company’s ability to produce and market its products as a result of the FDA Letters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the consent decree, the FDA has the authority to order the company to take a wide variety of actions if the FDA finds that the company is not in compliance with the consent decree, FDA Act or FDA regulations, including requiring the company to cease all operations relating to Taylor Street products. The FDA also can order the company to undertake a partial cessation of operations or a recall, issue a safety alert, public health advisory, or press release, or to take any other corrective action the FDA deems necessary with respect to Taylor Street products. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA also has authority under the consent decree to assess liquidated damages of $15,000 per violation per day for any violations of the consent decree, FDA regulations or the FDA Act. The FDA also may assess liquidated damages for shipments of adulterated or misbranded devices in the amount of twice the sale price of any such adulterated or misbranded device. The liquidated damages, if assessed, are limited to a total of $7,000,000 for each calendar year. The authority to </span></div></div><div style="display:inline-block;max-width:6.666%;min-width:5.666%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:46.668%"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assess liquidated damages is in addition to any other remedies otherwise available to the FDA, including civil money penalties.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of regulatory claims, proceedings, investigations, or litigation are difficult to predict. An unfavorable resolution or outcome of the FDA Letters, any other FDA warning letters or inspectional observations, or other FDA enforcement related to company facilities, could materially and adversely affect the company's business, financial condition, and results of operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The limitations previously imposed by the FDA consent decree negatively affected net sales in the North America segment and, to a certain extent, the Asia Pacific region beginning in 2012. The limitations led to delays in new product introductions. Further, uncertainty regarding how long the limitations would be in effect limited the company's ability to renegotiate and bid on certain customer contracts and otherwise led to a decline in customer orders. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the company has been permitted to resume full operations at the Corporate and Taylor Street facilities, the negative effect of the consent decree on customer orders and net sales in the North America segment and Asia Pacific region has been considerable, and it is uncertain as to whether, or how quickly, the company will be able to rebuild net sales to more typical historical levels, irrespective of market conditions. Accordingly, when compared to the company's historic results, the previous limitations in the consent decree had, and likely may continue to have, a material adverse effect on the company's business, financial condition and results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Warranty Matters</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's warranty reserves are subject to adjustment in future periods based on historical analysis of warranty claims and as new developments occur that may change the company's estimates related to specific product recalls. Refer to Current Liabilities in the notes to the condensed consolidated financial statements for the total provision amounts and a reconciliation of the changes in the warranty accrual.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of the above contingencies could have an adverse impact on the company's financial condition or results of operations. </span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding the consent decree, other regulatory matters, and risks and trends that may impact the company’s financial condition or results of operations, please see the following sections of the company's Annual Report on Form 10-K for the year ended December 31, 2021: Item 1. Business - Government Regulation and Item 1A. Risk Factors; Item 3. Legal Proceedings; and Item 7. Management's </span></div></div>Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources. 15000 7000000 Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.  *    Shares available for grant under the 2018 Plan as of September 30, 2022 are reduced by awards and increased by forfeitures or expirations. At September 30, 2022, an aggregate of 910,624 Common Shares underlie awards which were forfeited or expired unexercised under the 2003 and 2013 Plans and thus are available for future issuance under the 2018 Plan upon transfer. EXCEL 120 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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

    O$,/R(;Q"#W)9OHYU\0J]1*_0F_\] M:0_/P*+N9KNNPO?B(2H>HN?N(;JVXS-1ZGF?=SM=E:P/-8?[LS<8#CX>@$WX1]X=_-N>5
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�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�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

    C]>CZI-?,+\73L59W?J5_M_[G;3>::#,07(,B/=F&RV.O: MQ,MT:V!G4XIQ%87KG@AFJR?&U=T4X4)Y?7DO?/Q0>Z&H7$C:.^+G E_GMRZ] M>>J)@\L_%V&25["I3"<*CA/TM:>U9N@S3-0M)S3\.C]%7SQ+\8Z?6%+65FXX M)5J56NU2?P(FX>7.V,.&R/]?5"M%-EXJ8#@RE2?#ZCIT7Z[?^E22N).TDW]E MVJCB4[RGE)J0C_?U(WP6=E:2*_&!7+-5U7^ZZIY_E;LX_:9V:2@TP"]L>W%A M9-;JF;G&AZ%7,'%,[N^_>S ,5B994B_+:RO*3!XT!1KZ)A49^7 M^*0_<"B$R&ZAG1':O(.9D1$;")$HIUU/5":-I%YCS<;"6$>>=>FPBB"6B 55 M];.8D@6$JZ1Y$L["X/BI?]7Q?\V0^BT& MU%!G-H<9 9@%;#/O/6@*RF^U#B+GELEC=S4JLRBX#&-#*@/'$]A^(<++I-W# M^H7E9VS06(3@0&2#WEA8O(JBUYP2UZ\E0C%V#LX6B%K&$2O9@F^6ST&YR69* M@(^6:[*XEH+SD-RF_*B0OHP[ 90Z'\&!3-GR^ABKA/?SM;AO.]S*88,6J%S? MP&[31 CH+;#D*D3SZF9E&=.1A2,$DU+;LS(M[]7I=5KVF2K-?-%=LY8:7K#4 M[]@1WEY0#2R[%L0?O4"N]WR*5J)#-13?YLXFPENT!^$)!, ./K]%W85U(U/: M6]/"-+J$/ .7CCVZ!. 3A1RLQ;^U&MW&/ATV:B_U[\KH[W%%OZTX0(#4]!X_ M5.\0>7433ZLAR_1[PMTFF:XU7Z5CLH-4SK0_) [[1D2&)4R6^VER2CN.C-Q] MH\;IDJ"+[7$SE<3V'$60*Y -MG_O5I4N28(U%.1];-/,O9+OVLEPD2^$S!FV M^/IZ2%ZKJ><_M/>+G_KL;&WO =0^4P9!#V3U8Z% M*/\LKRL(<4EN +Q8#=90%99:@YZG-'ER-+L7[QVT/UADGSENSZ2?S1[DL'34 M39$]_U1*FREJVT=HBDU D+.QW$UP8GVT'NV!HEP16FXV(F[/DW"54*.C]YGO MW_F$.H? WL,NO]7_C .BPJ&JN<+N(0"7M$$71,/9Q6_M8\E,9$CINN+QAN;M M:\#G!Q\]3GD"]\'R57H=@$MB2I&1<]5#3LVTK>1:YL6]I6AGH9F8YZHW M9Y\I^O"V-F:XV>0^>%IX5HRNBIU/_:W-%JAG()EVX!GR+DP(\Q;*M?I -(VQ M7,QLE^FK*OKBN6?V2#CSS W8J:L-=PLX#GS_9Y#SM9 JUUNVGJ<;1#0]L>$% MV #SMDSD7 T]8(8ZU:5).G4O8!DAU\O=0I0__OM:TZM])=^LU?R.RN/Y?JW) M.3-EPMG\!35>KLAY9G1;6N^M_$QE(*: IK;:YUR/\EGWM,J[TG#1^IGHJF^8 MA/C!J_SBHKJNA/T$,DX&T9C/%).A.F\<9SO_+22H;K>D^LH6@UCRM RZ 54;5"_DC+3O2GP;@L=JKV9;8H32=2\ MJA,LLVXEQ%VX.+K#_[F:]UVO+]N\EV5M3J0R8=_0"!3;$$U9!J6 MG$MX]8AI!9H)US#-:"6O2Q0!CYE7&N-!$TT.-OJ,D"2_/Y 4&OG12X0E>JD:?/]RK/#VQL/0MQ[W# MT&+?E'2.U;M$S[*<['=WW6%WT22&(VJ+3F2E8LG)4%L3R'6[,&%"V"XL[5;^ MP&@D4F2]1#=I8$FO[9.>L,^P2\(7ANR$BF] 6/;OAVI-8H,,,^9 :L-M9Z9D MS7(Z G#$@P;4=3H=(/5OR8"'CX!QID_K0$0O,:,]J+WNAY=E0*SOK2/QUD=: M4[_PIV/<^U>NUI\<0+="Y$>*]=)4$#,!!ZX3-N891]%\M _%5%(*<<5T+]"$ MV,L\%=E:2%P*NF(A7WY;->U"D5^KT_"!L6)%'07K/RKT=)#C[S[!*(3OEZ(1 M<*$\H.%WY;#"\?%PIP+ M8640( >@#TYM$KR%;R^7H8-HY2WYBD:??OJ!6,U?]0!3AZ]I#MLD+A:F(O- M1+7MR=#G'.,.YB?&4>1#'."/[,".KSFMNW*;\( MZ4M]P?3"R(J^,\74(]>K'LG;<+:]/41P-[Y,)0BBY/MF,)HT?,I-%OS\J^3A M.R_6\E/"PT/WK?VP/BB0-N9PNE1D&$^T8?,K01)28(ZAQQ['"OU"-@0A1(U/ M,2Q1A0P*(>UY6I'@9$#E]]:"?Z0-&C<=LRTB'CSD'*]"%&.!\!FF5!H5QQ07 MI#=,_]5T6,#N6@>P>@_?87\$I[:>E06>U9^^VA5#C4F3CW=\P^DKGT.QNI*+ MHXNP^448X9AW!#@SCG$&5**H#.W"!-;=1G!-B&2M#;V:B\'2KZ<# M=\)>MX0?"6VTD.7+2#XA!6$!$+D+8XIVB8"JB%Y7; A^KJ@W916G($Z*K?\R*H ESMP>QKCY^WG&GF_N0PZ-QA)GB) MAMG:/'[VD7+PY,M?#P<3,*E0T3LA_._<&F;SUP!%]%PLL9+ZA"Z30K6)!EU- M\3YHS>L6S7=$BA1>-\H<.FLW_"C2LD#IR=4$>0+@A1=@.K&JL.2[):8TWKL$ M_T[G/F>=8+G89,T.R98#P7:!'X/KK;3"0LM.7RW:*/48YAWY*/Q^I2DT/0O4 M8]!;0,0R$CRBW8>?L^R)-7I>0]WB123[T?Z):3_7.WG6M;FHIB@B(I+B0S*. M/?YX.:-X_GI2H$OQ/UR_X .*\N-,/TJQ9:_BP>;M#7UWV=JMIPN6!4)5]C-* MV;D^ZK]=P4V&-K;'!T&>'2.Z>X!UC!.H-(]\2@:[5'QR,,8-.]\D'//VY(\# MG^K>'@V/E$I%4_8=?]ASD#<::PMOUE]<3-H8H"FR>[]8J=SOOM7_<%0P%[7@ M>L'LZ/YXOK>'NHR@E#M"YG=A_EO$+;HQD'4?<5UD7Y 7!U@$O[]9UX&D(%(U M"I%,93&^*[HOYM(V4^X$11(Z#AMNZ$B&&33>C9MABHFP]^YAX:#>JB6)W]R% M)4%+L%00FQ=DE8*1?TR4W=Y/S*X;B#=WS/3V6II>NW"QHJ/!W8Y5CXV*(L?[0'Z,HZA+'OR+Z.P@UW\T]\[CE?&U0]P MUU0OKC_D(T8W(&L4UP!G2N#)V/XL\"2:/04'+HQ*?Y@G MR_3)!TQU(*E(H2C*9YK0GSL#'<0KN3J8M:MCQI=HO1WJ*.\:HL_.)5NM*7EOB[=OW#FJ,O"FSR KT7UR&-R&9+^?* ML+,4"IYU[OKZ$\@D+]KL/GF&N1]/:[P OB%KBX/N+K0')5J3>B2(;(LO>!$] M%]>G\^T'C(C\#LI68HNK"Z&?1%L?.];(D9J00[CX)+:(RB1;6WL@2P0NX(;: M[IO.]SHBUW^D]V@9L%A1GCPCWU'?0-Y7I/FCO>&):"#7)@%4W6)*U7C0\$SI ML6XL8)V&(/HC[L/Y?PKG[\+DT'=X4Y7&M;8^&UTK?'(K./CZU^EC[7?RQ(%W M^^L.#ZMZUY]!D(O@@*-">"\"\""D((#SHX)T'&Y9NZJ")*>-HO382#^^,ZZ9"X92.';[>*$W=8).*#0Z[+S@?$-,[!Q^!&"_-3M#!VE+Q5$,3K3IHWZB='&(!EN7ME(BW#9>9VRZR2_FHIQO\#9L MJSS68X#_>+FZ>D?IXQP[D7'G";Q+.VNN:8R>5L7(]P+[9+],WGS7.2C76IKWI MAB@A;Q^<&S/1WO0GJ5]3IKO0,RE#7[[.9C/'*_@&<4BJ?\O4]LF$5>WG=X?3 MKOVXB(%A>US8$O]Z"IE+"4_6GY,G*_ M.V@L"#:74G_(FT7HNIB?P!9?LY$(3J_;YBPW//"1]Y/C?X7>Y3;R*@B_8_ B MO/)TOB&'^4#OV6?69]-5_;DT[TV:J-U2Y13T5+_0T/ZZJV'R:N+MEBOMA:I. M7CY[."+WN-SK'O4C,77!\&I(Z22^ !CGVG 6H43C';D+6G25DR/*+WU.LK^K MAZ7"U-37Y34O?;B(<&A,I2Y=.ZHG,:B@8&OG"%C6OP@L%9@I-,VN"JJT($S4 M53:J5H<>N>=VJ&R?O-7@GCU[3CDE.)GSI<*X8!S=DDUV'![;:"70;A+P8!8;,U\D-U0] D59>/JI_,J4].?).TXS/]C JW-(4M ;E YT*\N11\:H: X_)$3G]C]:L]?/C@'G*]%/J5\P!),AKCO-J MN9CW9X'HJ!DGOKS/-77+/K,;L@9SNJ-K-7'3)BJ@+"B&GJV7OBE5*RB7IW+X M5:E0R9=:^]-BBT0W)''8&QNZ'["5M]33/7 MFZ_G"F\\WXD#TY9I;#GT2?!^ MA=E3U$ZWW)$VW^L]=1N_,M3D'S\[<%7*6C+AQ/(]]YMV/)XRY\;1AA5G2L%8 MJ^97]12[+T,=\'-L$[Z9M?'5=&;E-S+XA_/(C^WB MHOKBME4%W]XG.";6%/ZE($514WY+X.!G82M"3 MU]2U;?9LF3:Z4VTF9/.$8@]SDC5)\'QV][BVJ2S3<$J[:11B'11VBLF'Y*GH*+KY[')?P3R M_DU#ZN[#[E]'IA]II.Y[X?=+P=SF-(^D_7_9V,<^O M[V)6U"T-6[L+.Z->[ M_/=_^#?-\D)6SA%^,0S9">Y2663L;VX;R&0C]JO3OV?Q_S&DD%:??N)$@PS: MZ?=?S"_-+LU7#.1NEJ]K.(L9)5J+33U<>W]&B)];U-REE#-5M50(*[X+>XNT MW(7A)W=AI86SM?_]'_[ULO_=(83E@JP<0O[YNZEZMBYU"$ PXZ$,XN<(/]7^ M/9/_:1!.(?ASZ(_PYM:>Q!S"/H4,/B&(8^9 M*.$?9R+]HLKFU]JS$IM/>%@+B;\S/N9EIK896"YNIE-;?R)'QZ@JXC77*D0, MB_;#$,-N6[L(UL0(3*R9Z5,]RT![1[N]3!K'#&9;#2EG89]:9O>F<& M/C=I&4:[MUKF(UMN:)M+O20RPED(^S-)9[/*NJ2P/:I_/]: %",$9]UERTZL M&%DD2';)89OUJ6OM%2L/B:X>MJ?>6*.,WSW+7BPN6+;X_6;F [;9N0^;#G^5 MSQ0/^;N/_!#%2\6G_@K/PG"-_X3+@#M>,VC;.&/3XS(2[MB0H/R6T8-W7?=] M]__A8S6SL73.U#;/\1&PT[\+F^M;ED0"YF.@JLQ&$K 6>MD9C :4Z)FY77+N MMKIC=!.M8;OX9;N&C-E'#<2%VN]&O#HM'%'(,B3@N@M+5Y3ZJ\D7QQ28%SZ& MY5#[!N$"/[D_FA,^A&56F#R(6=^WORW.)\O1X,*L2 M])\8]0;PB1TB$I&8O M:%+-Y ?G][XQ3-(OBDVR:_F(=L:6=WQ][UC3^<^XWHL/%R+#,EX9*MTL%2G" MDN]5TJMM9_>>$B$64;7PRQR^R\7!DY36M XS)1-V&\6J4NS;3N.IG!_\,:/* ME_KS[CT]D*MF^X0]990TL OCQ/;T$1KR$Y58SY@152B;08PDK?GSZCV\OLOR MA&9E\\1+XTJ;$!35E4_BJO'2]?M7?__Y,L8415!F!A%SC_I)3:T;2E21%.), M.EL>+0/6A)8SU6>BUW%-MN%!495#<5I%7\A<])N%,Y&J3JZ''R:<[CG#"-N% MO>\GU(NPDG=A8HB?4X%<[5"&2>PYA"36GQ!/V&O*S1XK.9I_%DQAG$&[CGBSK:1=_ M"/M@4C=&&ZSP TA42#W^PDLNK44$3Q/3Q9N[&H]VY)W5#BUOB0U).&2=9Y%I M<=4YS):Y_SA%T\P,;&5(L*=B/]8#8WUX8MF9K %GE]\:H5MA=?2%M[?4U-TV M%U"+AT2HDMB>45.)3VP]ICRKZ._^/4_OCJ(2;6?3GO)6CQ&8Z!E*;>EBF \I MB!]4OCXZ[IAS@P>&R1__GW^DX3]]O.$_KR(N_VF)^5^V K/WF!G03B?PLO> MU\&Q9>1 N# *82G.]Z&&6AQ#LFW9>TN[Z-2SU7G]8B"$GLMZ0@@] MO!,/ 6Y(ZZ:SHC#-J>3%_E/M82%!^[5N!]3!8OY'M[*DEI$*!!_M)*1\ETX@ MMLD?1Y,8,N4%[U$VI3WAMK2 >QWF]#CXI1Q[7:)M2,3^Z5C[N%+KE%+T,6[% M/29YJ;#?>/H^J 1"T8:L[*9P?M3P /O()W0LS? T&%0!ZG>$4.5))UR"IE^= MJ_-]WEV5[>I6H$1ZD&YS1'14N;9TQF89,6M(R:RG[<*<656F^\ =J+*%F>'4 M.T=(%VC/\62;=9='_7D?.34'-CL7._O%+XHW*L>JIMQ('N!^>IIK_FOI7GGR MZL8BX$PV[)4"I8#Y[I9IMJSWS?#:<,_O\PYYWY9L7GS__.3-XNBI=TK#RK6C M2J>D5?17E@3^]73$J*DPDA_EXXD<^#-S#Z.X'E*+-@&]\>O4U3/ YIJNGGB? M3-Z1)Z<]T\4\+QI?V84=35%23<#D/+MKJOQW@XK=O:3(JB$$$^XB9-$J4E8=;,LJ_A52Y>ZR)+WR.N:CWT/U=Z'ZQEAU#P2\O$EPG M)XU#($$V#3BG(H+J;M.? S.;EK3A7B-"ZH'6M'Y%.-#:G^(S'LY]K%:5Y%MX M\HKT[-VPY*?<]9X5CW&Q-&UFPD_L'Q;B#W]=*NPS1H@I#GHS3$%I>!*<'ZU5 MZ)6O,+)S>4];'O7VFQ?E.K;1$1&ZQJV&XF]'?EQ4[\@M"P=!$0&1+C4J($A5:18@-OH+D2(H M+4J1)B B$ 02 0'I @)6HB(B-=*+2.B@B/06A)#0I$D"$AY(.P]K?^?[UNMY MS]IKG[/7=?;UG1_)KSQ/QIRCW/>8,M-P.HP'L*"9T ^/H-CI 63'O(?T8R1[=O=B M3]'&!S6)CQIC+HAKVURYF[JO[$SA,9O+AABZ&B.**0)PDAIB*1WMV6AD@9Y]G 4ZZE-^('CC6)FWWF"&(,7.:?YHWW/-SM.'GO^DG1+IIDRT"Q10R*.+%A*QR]'D:F)U-&SJ0; X,XO8$_M,*^/= M4C5:L%AC(5 BU%OA1O)L<:XC64Q8^*O/EY]M]ZPQ9.L>X)2T A[\UZAPXWU< MAU$G1P4!R%.8"80V3X4!%.T5&$V9KL=XK:;!_M81P#7;G,G.S:D*R)LTWO<\ MP2H[0&C2-8P%N?-)NN$VZ \&#LBY5297-[EAB82.GN^EFQY-OSMYN,_7^=A1 M3)A?"0_U9W%DL>3SWJA.I?AMO7]+'>CK.X7XX+A#T,2O(-[ZOV)!6A19D.9. M%B0ZPJW (01'?L&"N#"BEOUN??2G2F"TT?B %^\F7JYW_'!#Z[ @Y+!@^F/8 M6 >SL4&>!>G#NT%\T*T!F(T$++T;PYC-8YK7.9+SB(ZS^2=B*OY<2VRBNP+Y)^[.L MT/\U.1K ,7F!"GJ$O-?B1(.E4Y<42G2*:55^Y\8#(EZXBS465B:1IYG&;K+^O?PWWI:UXY9";E'F1KGLFU M3K-G#L(J<(TO8=1'P!9-'9 GJK5,&.K[F+9T0U/F/]6GFW U<(\="C\SJ60? MB@60GB:F(;E*&N<,>G*!SD$4^J6;E M>1%$?/U6L#J>RN?4M2\^,] \>8KQ9IGN?PM_-(_X@_]&:$+H^2K2Z/?6A+G&BYT% MKG$64;&(:IW#9"J!R:5"VP=847T9*3 WM8-T*TPS2BK4$6I$_EQ:Y6-ZF;8V MX=03J&/,B?&7^;+<<,.QNU+"JQAR;V0YBC+2@JG +<\2,3\7_?!VLRWQ[W^#GNQ,A ?X?8@Z]&\CV_OYO MW;&P\Q@F7S(+DA9+.\6"C(J">]S V"\QN;*F\)8@<]O9N3V5B%VY;SOOD/ET%. M[%0J'XI#+U']&/NJE*"-+,C:WBPF[B8+TEOH_,^MI'13$D6#G?B'?.X"$WGI M9B^O7V52 B0@G W^=E?@K78Y/U!0W'#. Z/AH#O?2DL;G1_:B]$5V&?X[O]M ML[KR&5\3=*]']G%&5<.>))N!%IOCBTKY]-V#/TMLW"+8B\H-2=QW,YHXU(M. M[#GT,N&%K=7[!03Y*BZF3H.IF$""-T+C?9R3S@(7!HA4+-'^D[&U:].>5]N? MZ,>_-!Z(L;_S_.'W+[4R'3J[61#."V#,%M:!3X7+M#H=9906_](UH9E%AAL: M?"0[U?2/FG?R/%*72Y<1JCRQ"A;-Y\X04.TC*1,O[>0NC&_0:7KA6F7P[C) MN XP*TAUNO@6R#-.IG*;F? I+G9_L['W')!W[?V"%4I(8V]OD1 L3?2 M+NPL4$CNH?*3M=(I+_Y-!\P0,!$%5K<4T.4IC(@P. N24_&%&:.T-0_*/XV;>$@$ Z:T3(CND$"*6H(H(FK8WQ$S&B%HY;$ MV9O/&^\%&"V)[YY/T)%$]V9QD9@YT M^R-#L#DH*!W+<9MB4'1*'G=O'N>-28:)-.P#_)J#$+OT1#PF3U*"$^E^WL05 MB4LC]<9'T[UCJVOK:FK2YLYZQUR)P?>'Q#\<+6MMNM-V?NLB]3&HSB>H290Z MHT%C%3B:1Q?TF]IL+O;KF!0E)TH?!L9(N(?/DG/D8^LURCE.7#6@.I_&!]LF M9<2?..+*&!:Q.MK_F("C>O\P:'??$DK%@VJULD)L#.(<MU?Y>GL4.5)LX)^G\I8TB,CQZID) M&&B[X35TEVBI:GKWF<^]XB\5%OK^4K]S6,[-CM\0]BIA/VPFVP.TX$I04B5[ MC7]Q.FMCF$(/)L*B&SB&&XX"FU<=SUX@_TP/R%^RBVK_637\Z%)_]S'KW4\4 M9;2$!/P;-;&7O>Q\,44+(^)Z6!?AH=SO?+Q#E:TWIC.U=E\3@_.\%=BK<\"# M?7V="LY_)$CMFWC0GFJQ&'($D,7<9YCGH2TR0O$2A\;1Y0/#W0I^5/?%\$_8 M=5-MN [9INYUNXN<2=,V-'33$Z:=8HYAR'X]RV;DA ZFY$Z+MMTA%'UL(DK> M.ZD0N30M/$(WH]L7?"=2,S/#I3VT7H5HL?FL/3T855N&RF/4L" W4L:TB:++ MW5/&&M#10@,*[+[>062>40,E[X'.Z2E:Z"=#ZU[EE;D'J 6KKPTBF[SNH((,/5'M2-+%.F5="MT@<&Z^6$ MF4\+@1*JTDL;XD^IN1K:K0]M L9WR^N[E#@<.DO,S8TWM[>JF7M9D%=T9_(( M7?#B%#65LMJ8UR*M -_'^9%,?Q1R9X&ZJH/UYOERSD_7YQG;,?\Y,>VLK2[; M?NN_J=)VO0<,_!WHSQ<9+\"014(SI-[9_CKQUYYQ#AIU]_?%AMXPI=[E,$,* MYQ]]&[*\'.F9&1(Y#VS"\T97.J8=&'9]@0FK?(O#V\//CWY><1.X9#1]Z)?> MJU^:XYDV+<1R1E>MVDD!!H!?1Z\+SBA=V\')O@W#G@O>O M^<]!KD-.[:J!XM7.#VSP08R+S002DO0\\&(GODDUGV2KOX2T)$PW&DH5U6RPA%4;]D(1CE M^.WE\5MQP](V5Z3V52$_[S/?C8;[0P7)F=XM0[=+V_I]*QR6YBL()SL*W)S?YE559G]0 H++[(@XF@W M/F&Z5J\5R3TBL LA!H@LE+N3/AT0,8K=5'69+9X1@\1,R_+,1\P*TSN>S#ZA MYPDNG[CMG[E4X+FB4!FHT)"6X/G+?7',U_-^-YEPM=G:*FEY6V.8DA;DG[8D M)CMB#<[[;>G[?^_2# H=9$YI(6"B-2HRPH)<*KXUK-V2LB7_C(\1X8/^93+< M_0]W=?^<2=O\EF?_TYO#2%&Z4"CU^R#N^NI]+82@C@SYXA4@E=0CB&SY@XR) MJ!=\.YE;Z%771H]6(:41AS(G81EQCPJOWS_QS;"MD(0&E%L;]&"25DS>448V MD9+R8N08B0MU](=985&MK&!0?LUGYC +TFH[C"#;(J)9D$KWMM51$GHOJOV, M8;2?SKTP]U>FN5"1L1Y9$;E A5V+)W1X9*LSOUD)_WC"B:]*H55_&Y@*9@J! M#OKZ%Z^ CZT=XS7.^;W*98'B&[5G0#KC7E9YA]PS(66IP\=FE7[Z M=!UT_FH^O10X3?B@#)-^Q4BE2\.\5)P&+@,/R!.?21,7S1]_RIV8GOS6HUEX M_>;0FK@ !'$LIY%]UZ>8_TRBLG]@JAKD5?%0R,;\,%-J:4ZA1/1F3NZ$_'-W M-/1"^@64+8> >@O$?&_WO?(P'08&YSVK3=@M5T[F;.4RN$DVS[DM^L>0ZRI5 M+&4[3_ZM6<^ZBK?KKFE/5AZ^PIY?,UXK.W3 MK'GH0%8NB?G=M4(O^"1Q\6H1?.1VH!2/^62_XJ*QC_@C_-MP'P5&G/ZB%T!H MS#X!^)#L,9S 9DOP/?,\C]'L;]0CR;I[E[_LCL.:Q/J8-S9GROY@I)VCOL:["#,]9-WLY,8 MR$@.(#/Y)(']%TR6\"90K0Y<5@CG9$3L'8/)IW@C.X+P(\M6XFSBEZ-+EO'U M;X8*!A"$>. -;GYIWV>_Q?#.%UT'KZ"D=TK,<&_.^M.!<"Q;DCA\QG07! M!%3@,KI573H]WL1O12U&_I=A@#NOF65! "5H?+W?6U3/I 09_H %\?(#+$6D M-8'H&Z^ /!+>6.@.TL\L-#1_;/K9S:LKLS7/)B<_'W76TEU,_:8TM0IB;&P"Q1A;/0 L;O>QE+J MRKR B:G*K]2FV=9'.C^_MG09V?V1]!0;@9[*G3S$2-<[2K<$=OHZH $K\/M. MGYX>LJ>)*0 _T#5EZB=A2/RH%GO&V!JNL'@[)?7M+MT^WZN$P(_0$]DGSD'! MF6L2VX ^P.?1!4:FPGL:)^Q;;1M$X+O&6W*[2!\WZG!PE>S3-]*LDS4#DZ^D M:2@^;+ [*L2S;]NKOH5Z8J3A(#**>IT<2I<"K,.X7GGB SR/(Z6*WT333^L^ M[K_V?:&D5"0E_%.KX(4VL8QG)YN>'(#G_>\32+9?L&4_FCM2FWJ87 R&-<0N M^EXR(K%!<=$.-_:+84]2B[6]\H$\_%3(8](MMRCV2^C'.%U)_0S$TJ?IE# &); MSQ3%*/%RFR>FG-G^>8[+*/U.(J1'ILY0O#[MB'8.:H@%J1!"B]>?)J;F]F MI5X*H$WC6R"4KBXK3;$@XS 2W_*66ALBD2">-$#G!=P"B5N:9C#]/I^JA!0! M+Q&%(K6K3X_8AX98CY/<,O4?HU90,D '19[4TXH5ZPFGI-C6/[)61R3P%Y#43]I? MW'IXO*1%$%S(&-(7OI6]KC7&7&M2 1HG$JQ; J RLW+1(?-TR=.DGMUT#\28 M'[5@4*.0&P8J6!CFK@MU!%Y3E>X^('Q/+9/8XC\GD3M^BL<@K";'X5'D<]-7 M;PA67\'_3<:5=40TJ-F'H1CY>H>1,#A%%[<,VH7I%0HJENCC-.APS4O\2SNI MNX3H*U_YX&VZCLI:IXM^V&LWO:<[+;?[,&?N2PI!:D(#723)F[J M#0O"O]-F1:(2%NHV&(]3V$E *0^9 M1>+!,W.+)AU?XJ/L:JLKX!^N952EOO5PO4.NN!G>XI):&6E[@@6YB=@-2$P% MW]_IKH?:#WA.P?F6[! KHM,KYK D]\N]Q5C#^"/I3E7]"'B-IT5*JK>G;(0S MAZ+)BI8V,;8#I0&*(F'ZMX9Q761O8\JM;=LF%N1!PVD*.Y#5UI=Z=F%2\L/@ M3%5*E[*_YF!'9U7U!7^5MM9SCW*?^$/+L2M/:3?#%,K[] Z@>A '5ONM1]RR MFO#A#;'>Z-#%#H:I8P: M)'#MZ#);G$(VA?/3C4K]DID:_269-L.5$U_+[>V[UY4_>/9^:JOG79>MMIPP MYWY;NEOUB5?*8Y@'"Y)D2EDE?5I-KEC=>PWIIQ]_\"X+P@VXF,_Q0DVKSPL7 M%U2Q961J6JYK]V@4RV*S4N->DZ.FT:V$"+VCTHJ .RFDZ.AUD<7O=+(C".CE'DH"]0*C0.]TF#2@DD?7'43?3$FT37<[?[H>8,C2C)>HF\A",C#%:LQ M&/ZYV5]*<5H>SP;SF.$$IJ.K2[_Z6MHYMC@5)SF*!!&3@A) OD/OIAN2*R?3 M\^T9M-#WE-J ^S]:%'_PO@]DZJ@!UB0V>4K^2 M'1C5#TUB M070U_>;R0CNW_/+G';1+]@ O3K(@6989BTWH@?S/M 5T3UTR"])E.1Q'TK M M#[-BI/DJURNIM?.-+;693N,X>"HV@RQ CS"9UG.X*1$5$341'.XMWLW M?5U[@;)PM&R[,&*;8';J\]W'LE@Q_K';7^K/])2+!Y17I9B8GE\3: M\!9I*[*83H4W\>LI1O\+*XY85>S;EL+SK[KSQW,WNNNK18;-SL2YQ6LEN:9: MG78SR#ST=8]0Y_WIV]_\6E\BVIR@0#!V:7)W;Y;U\/)=^\(DB3_NG*NO,[KV MYL%45.SM0F!D>IXND.((\().8SZ$$D=B2+@.-:DEJ#B&Z-ZJ!;2$^E XK?LK M5[F7\DL 'Q]4MW ])4EKXD@:O+QMGS(/?U1.9]I]-MI9?>3N+-#$UDG09?[^[TR%0FRI8+?I9-,];U8'_WI]-3)8*MV6(4 M7)(>_Y*> ! X/4^NPN:;R55('XGLEG]N;OB8ZV:$[&Z>)?Y'K:ZV^NDN9XQ> MY:!"PIP9$4PY5"N,; D;RVM'?X"O"%/\K@SJ!$^;%OHE20M2JEN55H)ZKI ' M#Q15;W_J_!C$K^,VK(D2[:FMXG_@$KMS64###48];@J#X4?[P261?G\T,"I0 MBF$R9%B,QMB<%F%W_56\5G'Q8D"-I>]/\6-"]N>%3&?;A1,^?7W[>&T$W84N M"UX6+D9](Y"OO802\UJP.T?OGP"I1%PLC,M7!T[A- >**;Z.SHV+9][V7_44 MN;GW3:3NI/69C#Z!N-/Q$X]53YZ#77Z/_08#Y)4GA<&HWP8$3.>M0&E&2TXR MGZHK@)YB0*GQS/X,TL>5,VI[%\3OVBSYR979=4,SWAL-:+96AWTQ-2BXPF_S M$0,<#EX)IB1,;X+!.AY=GK3UZTI;I-Z?5B[:U\MAZEW MCHL'74%.E&:M72Q57O9@_WGFWUE4UPFF3I([(C4Q#VRRCU)L5^1OD*,LR>VX M_?E$M8?XEVUI33F+*.OA+XYJ1I%W,[D3$H*C'ZI)_A1.I=;1/6ER86<9J6@7 M,RAII%U7D,FM3G9O0T/UCB]VH:?5DJ1/X_KEXQ6<#:[ZK/P:U32RW.ML:9*7 M;:5X/]^H7W,[BKDOX2VS"9^RW+=[E2Z4CN@O:A!::%#Z\''HQHC S?)/M8@3 M/J^>7.#..%G6P,G1SK9ES+D^0(*EX*:ZDTP;Q8>SYZ?:LEZ^^R-RO:5!X!,M MC.-UR_A*E;,;YVZ#O;(\D2<5V'_E,+E*7P/!EQ@Q>A(.@/VT3-BE\N$*Z,HJ M8#X[H/_B&1W_N-]+T*D+DFDA5-9UY^V@LS&!HV_2-T- MN!6'*0+"4] 86Q%IF4&!5:. Q@=0+5J[\X_C']R[\SL:%>:@)3(49;B64 M2!@/L*?LP10!A&;\-PPZ1S7_;3,^L&ST@;V]T8H,EY!6J:&XP:-6?I5:E8"JU] MMVYG]+JL[OZC_09CXOK7S$[J"V"(!D?&M[1"#X8AJ*._'#4U"/M_ M4&W\KRW4R<6'=YDJG0TT\KDA%620D&:J-2>7PJZO%)TZL7-X3;I>GW8*J&)! M2/(1%=YB.@;;PD.QL1N%'^8<]X0,&HQ0FZZRW4T5LSDFH6=E(G=9-EG;02V: M!1'4"22[D,RC**'$V#CY/KHQ,G;GO&L5E.J\9(T*7[-<30VHWX@U;$5(I8F'&TONKZ@TIJA^T MA4*2NK\V*P@8RV6HO.9O+3/IKMZE"7_QXTW,3Y$/.]E.?Y@R\(DB,86-?T/) M:E$3=EBP[2.O<+L=_6/>]>&=LL/,I5UG-[ W>Y9G:2Z,U64"**S S=4O'F=F M.M:UTDJW\^6!L9JMX?C-,I!:\T>\(F=,%=X8_YAW%L^"=.^IS(.MZA>NR,F] MGKKY A;;,7*U3O"N_[%KUM$E(VO=L*"WL(^R*_4.;OG]=&O@/ 4ZE1>?2_9K M)>S[OA#<-_/F:VWRW6_:[=-*1Z"KQV2JG92>86\"MC1[QZM(&[6=OD*BT58= M*$ZHLDAPF3/-9%K:[67'9&)$'Q?^''Y?9( +26TYW;L0L$,G$,I&XC'M3,&' M?@WE1I1"C^_N;MTUL_?G-Q\>OVV^*ZFCK.%B[%>%+L&T[L%XVXQC]N/G X/L MK".92!61\@?[%27/QW45&G)GG[=,#TJZ2A@=]',++CZ-FWD^M,#UE3F!^HU8 MB/Z)6'@U6&\W_KXNH-VNITI>O:\C4P"LMVT_*N^_:Z85RK"DY+@?L&^1,)9] M?EG$YWW1;39YR5W>ZYS,?>"\OG?=[W\J7(6ME^/Z[S779'%D0S[.BR0U M'N19XL+DI;IJD)V78R>PUE1%YX7*79ONT M\L;528WU*XUG5P$Y[95@$A90B*4+1A'S5FPI,LU=KY>+OO9R$6KDTZFRJT=36JR2:69LA<*E0[3X-0' M.\UXP[B!57)H(X&C'D;"2=)5^U$23O8]4_FH \@JGST^QR]RQ9S*^K);^GBL MA*.$U,,N]_? ,=JA,"U DS1-T=ML;5"@5">9IS,R=7RF5_PKI2Y(""RN^'!^ M>81O__EP39G?<*["H]]/(?J?#2' MW,'\/)? @KP]/FRX\IHF0==F?$1Q><'*\]I3A)&9(TUX_%[Z^;= P.7XWD6/ M,D-%V;(GSZY<03:U^D:47?0]R.[2"-M%UP3)> B4+26Q_DH1@/Z#O.X95"T> M/?(R__SU*I)PS&D?9V/7P"24;PI(T>0U&VFS.).=*8:E7 MJ^N>P56XO^)J8EWU$,]I12N!OP@[_=3H C)$0@3L!BP>6EKRFH2)EX8";M/P MAYQ69+/$;/7,@58[W1>71YGT[^<$E_OA(=Z:/6-4HDN&B+6 QGN<49@XJ)AP M^DD 48 ,:)4^"U12E$@EN5,+/ T". [S3GTW/A)>U_XNU-#,G$_+_G^4'4S M?'GENW*\5 LDM#[-D,='N4386N!K!X1M,!UQ!-UTY%4Z:3X*I8!N.A?HT>4 M*D#0KS*%KUNA!1M=0?>TDT7^$"[VX>WM")W375K )6#V%Z&.ARE2M)M]K%K% MWZ5[DY)VK1O7#FF<[E<:-_IY VEW5:IO2.[R;$;\!QZV0]-"F+T-(H#VE%]S M"@]=! A\QTAI8?*3&=E);^S2N&+ZAX5BY&39TOB%!),]V(D8868+" (<;RAJ M'=#QE"GX"H&S>36J03E[NATF4,]&@L;V>5_&>[D*:GY+O3WR*#PS9.R!)W?; M[<05<8[KI6\^,GD[&(]1)^G'1>*Q0O2-+*H7 [E Y-7ZJO MC"1'^6;MBQ,O^J;3%7/ETCCUT<<#^18;T$06Q!D> Q5%'?9LT&.\HE\AP1]^ M^"%>,T@_040+3]BCG1=$O=K>O+SEG4< M?_P(R?W9=0NCYK*X_1RN(ZTX;IP'!CAVMT$VA12< IL:3=GG.0E9%R%I]-8C MB.4D;Z6PG^LVWVY(])R\#_,O$U4^Q^'E$GPDXU9$Y?HH@\EYJ-0S4+U@_4N1:.M MEI-+5P?5W ?5G@D?XN?#^[[CGV'_H,;^:J/@;[/[5QL)2ML'__H(SBN^IKI_ MMEYH @@$C1'#%6;%F:0G";Q9-1XL[OD'?!\5_>N\H\OG_8=+#B98Z=X.:W<[.BST'?925"\?%0% E]- M52+'9&"! XLP$91HPW..36FQERW>D]"D'$O]'#"S_ZZ4?01VG,UZ-UMV0Q0@ M1KL8=H214R^KXT).;R-['3_,%>J%#@YP4:.O91_=RO'ELXA*C#34K/WS_OD, M"R()FG0*'W*Z+6\:TU6@<157.]+?2SX!6F_M^)-0V,7P,MAV^MQAQ[Y'#A!O7)W@Z\VMW3?#DEU7[_=6O MCX7V(7[-OFCMHLNC1/^TW,B1/H^%(UPRM[^T*#;.\"\Y'?5,GUZ+ M3TT^HK><,:U0J6 6_" SS7&EX)Y&=FQMAOLU5("Y94O79$(%47;ZE-Y PK!: MY="S(:VBMC<%2W48JFI<2-&6M-^8BNSSKHEJ5)M*XM3TJ25$$HPBFL5P <'P M)!A:[A5B98F)ZP^'#+,LYF>JM3\=Q&]6M\F%CBU[IG27T8L[EM1GYSY5^'DC M7&F8"B';G4N;]&=9D*M4%N1K.0LR60 CJ:EM=U0SW3#,#=N/+,B!+A"G?@BR M((J6+,A,SUG&K4[8_";3%,:\Q'CU!B<*4MG_[P$+D..%H(=U<>O*+,AF00H0 MXP#ZV#G,EF46"';0I9OG61 8;@U,'=;D5W8+ [C??Y_0Q2Q=84&>NK,@GZS1 MK2>GT=L[MXT\QFT=9T'L3_)M,4!C!\>9"O-0P+:Q(+\_X(382/&C=\$8BSG, MPUD2+$BO/-,ZEP7Y'+L]]@C=LTK/1-/C:.?U46HLR)]^?&2-!2D*1<^!HJU> M@5)X:@C,"-A:KAKS#]CPUR@F&CT#SLX,?#3ES_5;=*M>%F1JI6?9VZ"2!8E% MASQ_%Z*-;AYNUY:<9IXW*/G72X3?IT1!__[CO[>(]RS(0[=V%N07%PN2<0R] M=H-9Y0I=I[$@ 35:X$ Z<="8X>%!= MG7]M?S0))M?.Q78@6L6^]T:=Z<,17\*(H!$\4!R /P>3B ?2NGOPK8"6I[?EA5V!8],GD"B[VY4$76WOBLQXLY_#G3^:*?OA2:T& MT>+5Z6-W/M_%6:=2AX0L$$="S__IA(YP!,6^T9,")P;'Z1W$Q06:"2%3SM7W M?RM]/?FI=$99 VYSK\B&M.]Z? M1F!3DYC]'BC)CPW]Z*EB0O7+KYE!EL8^+IZ4[5UKCR_8:/"YB[M.*?#\J)51 MSGG$MC&RS$G>),&;_<;4FPF\J!-TD]AV)^4^V4$?'6/2J+RA>-NBE_81[_+2 M)S*=M)<_L24>$ MF0+N_!.PE@F;'U7%.?H@WW'_%O)4Z&YTV>WCK\I%H99]3I.VV:0U_)V6SXH5 MLJN*5A^CUFT\VQWS.,54L-XY+=UW>(ZZVYQZ^+F_5=].\X:;QL>S[_+VDY\] M=J)^>CJ+WL^">&)V$EALLV,P D"0+#2H=6ZM]TJ2D-EFS.=JF8T=.KSKASGX MLZT?W>X0IL>-;&30K)CMV6Q =A;A(%VXT FIU+&->JD^CJQNZ>A*F[WD?GRB M_7CUB0]L1G[/#XJU6[,@:OB>ID^<[?A;#2H ;X%Q_D5QOT_DE;Y=S)X?N+4Q MW7TSOZ GNE%;Q*,2QPKA8O;*CXO5W.\% $3?\+=%!?J_/ WL]#R*)>@MB>4Z M7>Q6?!=/)5ZI?>QM:!* 4VM].7$LV-)7=2G3YZ.:UIN7LG%&) MYX#A97TMW#4=E>9_JJ#5&32#/LR6%/,,>E2I!>0W6DR M([(>!AJ'WQ*QWA@$!WG1!3[&:?8?I^R9AH/HE56&'*:JPD(?+0NM^/T(.A3, M-IKTT5-QZ+(>NA"LPTD4P)"*+R+(V;B<);*C]PB3?SBO],Q&6KYA9&!&X MK1\>2G-CCA'*5Y?YR3(6C!R8IY_HY[?(.\US$E>976YRW=TKW[NK).R1+KMS M,[[=YH3LN:E8\%7O APXK4ZU?\86X$T30 T-&"S4:2=,/6@])7,H:GXJZAS4 M/VP7P$?.HUX'U(FX,=I4\(,WO?5R1%U57=B%_C=/9PZVIGU=-E4_ MX6PL.X)PB_6AFV602/#(.)P?R M--WD?Q,2S\6V"?&/WQ#_UY)/A9W*!-AO'MG^N\_^6^$T5@K=F5H$_H\B&"?T M-=$2=7J5AZ X&8;<:\P(9<;!GU,!D(9\%63,PB[;9;"K[9"Q]VT^?!7&:I:*;&=\2L@(>O?FD;@$8 M$^%Q(B>!K"FM-VM=XF)J.L?"#XD&3=<^3*?-0#'F;TGU^#G\W#?BBIK*Y#'G M.V7Z1X1=;S1Q2)\O\NI[J81P+[>'+:V>)5^+D9!\%CV80]$O--$K7/-:^.7# M\R9>2:;F'V5S?^E@E/Z_\L8&B5;,UA%_U",69."17E0T;B;=^_-!U.MA-EDD5RAWO3&LR=M1&BUV- (Y*1#5JG9D8X=BR]ZWG-RGS:1*9KIF9$;C+QK;N;T=03^J@-]B"F T&^^SFZK;J) M;[36%1^DOJ0G]FNHD!2RB>U M!*+['>@+RFI;+.BA+ BU%S303:OU?I^SEH,:H3\J=16W[;V?2&JH-QTV-)!J MDHS_]=POSHD#^.3[3+O]XWF7@@=S02^:7N^.)>G2@+VZ,=5<_2ZD9!+]WSEYU^:#N7 MEX+LN7.5,L!LK/<:$6D>QTA@)O@49-R@)14YC8>UD) M@>%0P^PE<_+<(^J2?[ABON)#WZ,Q>O6/7"W/'0[6$KH?:&T[2VCA Q1$'_SM M.C&R>9(,M1%@06@P5*^3G%EPH3,LFZ(7VE?'R8\ GL4BR2)R4I[$M*=.QVV^[V>4=KI4 ML" =<##SD4*[\;769H4) MRV-99P]\^79C_<@QF7#^?_.'OSPNAK[XU_[WF W0_@]4S?Z3Y0)L&=/8+0%- M#&VW _K'.^RT):X,]QM2BF?0")'HEHY[ RS(]]AYG5#*#7#.0 .H +7*&*3_ MVE&NHJGIQX_<[U=O^;K&>+S0L+HT>^W@W4/)YS??_\BYH?&L7%>K@U0=Q52X MUD%<31[F44WE"$*I?'C(_<3PQIF('3RJ,O?& +'DX-9)MDA='[E8ZS[5D+(1 MC3D"QZM?'"DUA.7LK:93)29U?K$8$1U[\F2(3+^J3,V'6A+-N %^$C][[T!G MZ'1-$_U4"=9GWY>A:J8;K@ M= LO"H;I >&43-$AO?W?53.*5]3\B2H7_./X+'UR3_' QO18D+O7;3.!LDMD MB1YHXN?^R3&J>59+EZO?'](!*Y,?6MMN'*NKE'T,>[8=ONIW%M\1Q XU/?X\ MEV/H2KWX9E970;BDGVA?\IM:!C<) Z*= ()7VY"B(V#>P258:."PK4K6AN;> M%6Y[T'&]?!]J@-M&4Z9R6DX.;3VV:--".CXP6\PI.O8.0P+],O!@]-]'4E0; M:"$YL+6S]+L@S[$%P]XO'P;JC.TR@BZNSH+(X#K@M-U(- MB0!AI0::#A,A< MK1^Z?8>S]W8U/04T_G'"MBG,Q^--/-,(YO$[J=)3RF+R@BX6B9A@]HO *M[E MD^TM&VK[*Y]JALLT93&/?GS>P*7W^>,3,///:%$3O'4 @ MOUN=AKE<#%/45S:&C1-.C*Y;51+5,'N@[-*"16U^C;DYI?162UAF29GLZ M.&#SY9/-DO;X_S(5A"?K_P=0HMK^[E*A9#B 7+5#TQ[1YU-0RC &C@6I O6) MJ,-D_[U:]\=X%K^S3PBQ.\T?)9-S/5]JK\QKK#@#BU(#UDGH5@D?M?9[ Y-' MH_,Z?&ZN*? TQ3ZY]E L:"ORY^E3%JL8%RS((:*EOV8?(=$H'6A+E4&IR MNUQAH>>FE"Z?U D$%TGOVO,Y^@D=O5TKZP:6\6C)*[^J[<^:3-IYA7Y7MU=I M=K_?5AZ79+WG@,8Z;[3&41Z$@]@3**?#1=GVAJCQ#!+_S+9MX_TF9 MC9K*_NFU7R6".W5=9$/BR H;S:&;S(*T!]U3H8*(O5>K,I"\:D@Y(K. SXH[ M4J7BPOO5;ZWK@,_:DW%%II$-S]O\%;0;W]8%Q J(SRY^D>A?)*4NV-0S#.0N M/ DMH:,_#1/V/I-1DD).)\YA*8)657UJD_VTRV;'!(Q6?.;AV:(AVG4USXD#K<9N.MIA]_P\R[>M,\F.8PFRLS")^Q\0LW1>;]Z MK$ 18QL.+Q+*<2N\/BS([@/D+.JM[/T#A\O(5^9J7S>YY8\"C=];;PPLOY0Q M0#J-?ET_]_S-U?K:(.S/R08Y[ W#I_>A"/;X<;@I!V.YZ7&._J#(('B14K8 M4+(B=7QRJAY4XZVL M3U?LN2VC-GOXD+J/9-4>#I!?N8#V44DB-[_R3^_OZME(+#U)B MK17/<\0/D=U;L(#&!3>5K^WMF"=KZ)0+YYH(=U M8DC^8'Q,P7B;TL8=."FL #ZA*VQR4$?274[,0/C(1*YH=TY#-SW+Q^Y[%]#G M?8/2P^22 /D4'D<*_)1 /]^/\^!>Y1I;.NY)'C?+]^A?.(9R?G2I<$Y9E*/( M-=&@[. (.[?3%9(W-W0,/76([#;[6(4B2G+*VCU9&VN"%VK:O!6?0;&'6E.I6W%XLR-HMG<86&]@ SW!%P+!):UNWY.6[ MI6R9.KT[^.+B%Q:7+F>(:J=%3]Z(.Z(J[N%=,: C/,6K33W;A_;KP7,WB1 $ MZ"X4^^FD]O3\HY_" R6UMF^="!EQVUWT(:,VV[;QCE&RAH2P<>?&Z]/714O? M8T4M\"?>Y:1/IE&>7VJ&2L"(=;="@479R/28EY+VQ&;4YAR)3)"A9D\_!6CS3]*IH&HI /B"2X M0)CN?P<5W7(B9F6((D&T79XGP<;L6PC[PT3]IU8/=OMHQZ]H\JJ2C#>,BR>< MQ*3]3Z6=3"RPOG29_<5^R%MO(?G=1K2U4"QKT;Q_$93B5[\3#([I[#%'27K8=- >6^O[&W93P*.O-E' MROW#>B;&NTHPNO#+PS OM ?-Q#;C.!A2B*M&H,:5*M%)H^E-]M4FVKEWI*] M9E9N'.A_]J*OZZ6@&'8A7XN+2KLOBS+%5TDX^DE1^@G8F 8,N(@CGF1!'CS_ MQNR$5S/*/Z_YS\__]*%.C <1,NOKXO5>1Y69Q?.V_H6KX7FN!,)R2"41!,.:*C%90NER0[IG"W"+][S[A'Y!?).FZM=QV@M=WB2 M214-I^DW*;@5?@JZ%2&)DNWQ4?U$2K(TNW@E[=MW?<$_YI6O<.[3+7S\IHJJ MX>CG\Z6VV'NC><:/&X&9J]813Y]6T3<'/ZV)L:;7PXR..[(OUUS"(%KZ3X M1%G%3N^+Q:8?^N5JZ&IH=7#H(BU+?..UWMV-\=GQWD4]S3!7()9V(>SJ"%,K MS';DN15%-"[PF%JE_?"YB!F7OBO(2Y=W%20+6[,UECC%*]V[N]#_[O5NCUS7 MS,\J:2I7D[U916ROAHS)3P]C\[XLC>HJ4NL^!9[N/ MM)%H&9>_MCV$2.^!LU>&^@BQ$='D532(]UK *@O"K82AY#"E5LEP9@P!]&2B M6P!3\^?CRYS1+$C+IYU^_KWCTSBZ<@FZ/04(QC7!MB7"@D&;R.@!1NHLSDF# M ]N_N7,6ZZ(?. QR62T+(@XC3K(@(/'YX4,A,$5L8=-."_H0)()^EC"%8? V MG&5!FK_,TSU )A!*!SGOZ^H.-'#-@05)"LW]SY4.*H'JA9:)MOBQAYD#CL1N MP38]-2VF+,4ZTRZNEJ+?FBQS0%3:7G!-R]#"J? O!K+,/$$7&V0>!38;I=5* MAU]5IC1-'@XWF!/+<1[9YWRLU.C'G8#N>[S_1\;V7WOF_V^3CE*]'$$['*8% MY),[+E.@\3I6I(V:J#:[C#1N-2&'"]D.5H__>*]3=29[8Q'WVSA*>JC>@'H^ MG8TNU_F+X^Z)A2EE!T5H65]1W]BBGJ/_K9G1/5E[36\],O%EY M9Q^^,=6@O_:F8@%$-CN//=VJ[S_0BIZHI\F"1&:CFW28DF&A*50$A;"20=XT MH?S*\L=#>9R 3*&:^%E*V>0%\]%WM][S?U1*ZXI8YZ$5Q4XA7N M*#=L76HA8>/%AU.F>*$=)YSF%I2S^_"AP-P%?^72YORY8YTTJS,'OA3IK3,R M69";?@]V%JT;^7AV^C3LUE'W>8<,;L;_81/4U[*OT*'N_;KJ31F&:W_#@FQ M9G"0;)H'>SX9FD+GHI@VBZ-;U6*<-/K#]%]Y#9/"U>Q[*P^6K*@=T96-]WB: MIJ]78(25!L; MUX 9S@8Y#\B;P!ARCBU&P@A(D2-7 0\[#KB#L=[(X[OPGA\ M'O>I.=#2?2SCT*_3V!B<.U8"-(ZFL^BI&;0@NDD7)8DI#3O*>*.S*RSD-7"2 M,%O>&_@K?K;$O3+E9V,ZF!P[5:2^VF=G5+?WL>T@3AI,_I_#R'"^O:@6-'^8 M$F5^JB:. Z$FJY'@ MK5@!NB000@EHP:_&ATE(?03*+_1K7BU1U4#K?#ELGY&(D1MM.0,G-$7C4?ROORL*:RI)P6A 1HV$1V8EM &1 MR-(@#>:RBL @V+3LBS8B( *B+!%C@H"R$P$!A9;0(N 2%EE$9$D$PB(@B L[ M)(1%F@1N; S7SN)<7^9U9KYYG(?S6-\YWZFJO_XZ]9VJY:((C0"7@3VE5Q)B MCN50,X4Y1<;3?4OU7[=Q,$L,/&Q56ZRM&T28?K_"DYCEFM)0))-K8OVVAMJI M.AA9&?;1:-K/]J\P-]-*3/;V@+'^]4L6H0K,N-?#O!PB 7H^*M] U]R @%[V^(1H![77"$ M.(E#OH!N"@R$\>!X[F:695UC4 "4X.$D'C S61I*6DW.TKGD13 M@IFH[$L$UX0=ROVAZI/Q-%Y^ZD^VVWO":5/2Y-\V=_<7<:@K [GN&<]"SW;( M.YWVL6^0@C!BZ?F#'!M>G5@F1. IAGE^_0IC7J;E5O.[!V&.=+$R^KS @4&U M>#FNU31UX[<25MG1$(<#MBWR"O>.6P,V8E/A=0@CL, #8AA"R*1]5@!3I#RC MW9Y(3F_VKL&4) AN]YX[N^S<=S/'> B/*%GLW$/\/EIT1]^\NGD7C& >G.W M(V/7A:B"KBV%YK+JPR_6K.*+#ZF/]5CVI_^:.$Z?!YW)Z!G8,FBETA,*MKZG[JE7 O3:U;=M4#CYL;MV7SCG5LY%-E^OB]9\P?&$,;/>B)OU@C MW?/0T0UF4 \PL45_F9!:>Q:R6PCP8 ]7WS+(?_-FPRG6+-'%WT'6>\HG^BXS MKY61'D7X/0G5!%Q 0[KF'">!XMQJB1?72^ &6=);7@Z==\6ZC3>GYBXO[W>^ MYREWSZJ>_K@@:O2X2@ MM!("'A''RG0!2<[*BZN_J2JVKT6L3+?)N[8-[GJ@+NR5NC*8;PTX_*_3@VNH M:ZI>:;'7:+(1+U/-BLS,QOP# V:.>K,R]C:V*=#=R_.O_1"D3)RA-9&%"DK\ MS>\=SX76STK9Z"2B#OY:(#C+I:29BA3<6]['Z7WIO3GV6DTM1"?FD:B\;_%! M>4&,/U)5<":)_A1AHY[B;YX$G$=-/F4!&56\NJZ1239]3O5CE/GU"D\03AZI MG/60V?O3E;>TX]^L.)@C)2N)^"GCZL"9J+]0PYR9)+)J-!;QJD[W?+,L>/S'46L'_,1+X-T2$ ,/W(O,; MP95ND0F3QKW!Q"+7?',IU;M4VN.8$8_&G3XP.=Q_U+G!I[JQ,#NVFH#/94B%X_]GOE:>5,*.J/(V_U*EY/Z%D:@@]&9[4;? MZ]E=0:"[VF&@Q\QC.*9*:"[KH#AFXL2_+NF &T7A_%,Q[/5G".;XI[0T*Q7F M-\0._&5@!^3851)5^-"VMGXU,3+[DM_^> .F?9(N=F[X&/KQA[Q&U+C M?.I/3TGR>#>F8XIIQ_&W6U/SJW-*3$O"4<0 MH09X]Q,_\>:[-B;?L=QROH_1]J(]=^3D2!65:;P5[YS]1%,6VK"BL0)S3][V MX5']"089N7+F0$($\ MU,TWA0RR%C:R*>JF*NT_,MW2IK0&S/Z(+UY;# @<4+9('ML5KI.W?FY:GF5W M9.80!Y4^OUN,)@2!QRO!\87JY"::''3-ISDBTLOA(_67Y8_K.LIZ6I>W47$/ M.J5%^0 S!V<*G]*%^%Y3%X)YHR1[?#,GFD4FLW.LSH+7^I2B=\^5_'8^;'DL M[JPZU3DZ;M^X_CX'^M4MR3R$>1,JF](8*E3[ ,NU0TX"'"$&HI2WI&_.[CN& MMGL7U7PJ0K.E9ACC'_@/C3M-^XQF_)VTBK>K#:8_DOG<%./DQL?"6\/4]95A M+$73@461$$^6H:%FWB ;R*16\#1&4IN^+K5^B):6QK\IE MZNM+5R5S;R7A3$2=)&8=4#]7P"OP$"6UNP@BH%#6FLU%I86^+*#Y=4!X$?GV ME$.*O7)MA?'2N;O!G)A]9^RYLD'QHA12)&D"X!>.87%(,1V'?1>W(2,T>1N[ MIG<>["S5\CU>J$#-B C>F_M(TT8=R< @Y6PW] /L$J.J!4;$X<2YRACJ&M X M?J-VPW#E:NWZ>KMVJ%:C,\?G_F2%]MU\)ZW%@I(YT+$[* U $=4@"7M0 MU#S4&_K_3[GS.[L M+ADF9@;CY/BW_=MS_MNX MN?[M]W!S?IZ]//S_R]MN%TR4EU."4X*+XS",4Y2#2Y1CMP\&AVS<\Q_S.&#_Q\;! MR<6]9R\/9(8 ](4F$\0.Z9S9*V[ORW,X7$+W M?N9S7L6S==V2#F. TO$K$;%\_%+2^V5DCRBKJ!Y5T],W,#QQTLCLG+F%I97U M^?WYQ<$;_^X(H]YY#.GO% MSMCS^(:+']:]SRMQ-O-Y73>?XG$'0/)*Q!B_E)(>Y0CMGVO_\>Q_SK'8_RW/ M_B_'_F^_B#!!+@YH\;A$80@8B_DB617V_\/!M0H'C_(P)2_3C7=AL6X8S18P MD^$ ?@UZW61V&(WJN:TD$%D5XG!P3Y](CIUHQ+NRS"Q]C>*W 79HX0?P%A13 MDFMYM7<=D>HM!!UN^9THG:#OX?]NK!ISAT;5U/9ZU^2_D"7'^RMO?''NQKE( M3XM>A,%2$VB]C$K*GV%*&K+W/1]K1*3F"K\"43;@%NM^R;<6G$G[;86$:/4C M;U*!5\>:LJPEHN[DV=YF5ZIR4;?FUMD""#(J'=?\X_$NC)M&@V\TT>"4K7[$ MQETS!UI TG)!2-"+\>+F))DC+45+;B\F#Q?B18?$]ZBE]CV(0P3-Y*%7Z?:@ MQW(M,:4+W_1E,V&.Z4\VD7,:UT"1T\Z\F]@:,QZ*N:3[,U M#6<+F.W"]FRSFG9AY">[,,!^:R]V1,I=NN=B"(60HN>ECFR=TM?FN48BMGD7 MFI9$!H>+HJ-LM6+L-;W-,WWMHN-^?B(]Y:)+)3._L?)PH210LZ4?":J%%0+O MEG.9XM29+GC#RR;*^LC9&8^VA$W#MKMOFV,TEM;H. M98R$G:)?@2)-P$[B !?A>0*U=F,5BL,O6L)])@X(8FS\(JP@XET=@A!DGP,%>PXAKM]FICTKZ M8PQ>*3R7^G U.JA!0E@PPN+%Z2JU#ABV8PSY% ]0GZ1<65_BU<: XW&E$\NV/U"O56P>-(\W7< M#58!(DAX?F";7@Q&4> ',':@!RV:'-TGS+E&;'Y >T AQ:M,K+R=/&A0(U33 MAPMKNR\QL".89;$+ZYCMJ@X57>*@>V']=F'=UE H5M(@&_P8YD3V"*(Q8\.I M=BE$-OT^JB;8/2..Z1\2&1CCKS?1E:5N(^AP=%OSJ\/K9(N%G[PJOZB$IUN@ MB4XV@ERQ"Q/RFH69[@TNS;HMO-EQY1["%1&L#9XP[$6\@??C]S$-H8@]PO:0 MQ#O%@SLUMO<]6%8_Q3K>)^LY)'F M7>XB(OI&$Q14ZJ?;$50A WDS\ZE?W_L>>1.'8ZU>IB4(5E?SFOX&U7=A/&;8 M&>1>R)<*]\ >^.P@FV_PUB[L0+N?+[6JT,\13RE\EM_1D1J*6C'G(6I.E00\ M>O]IWC5Q6L3SM7-G(=A/4Z1O[,(>X!!D4D:<[%:L,GBW"DV@+#:5):3]@LM^ M:\E_' MW3KZYV(4W;3MRIQQ2&WF.QH_A][<8 6_' M#D[NPBA*61Z%\.Y=&-'P:%"-FL?[C AV3,&U) DULXX6'KLN>)GD=B!3$L[F M3V.<@E9991<6Z _^H?W0M'3(=9BT**#@!(,JX[==.U1'ZVP>U0TDEY5FITOX MP(;?I_TD].% #<--"-RX%Z&S/P>A[*!!9O'.&,.743P8I[$-+8P*S:6G4S;W M[-OQUS]>ES6XHFH4UKZJ//0\RY$ISZ_T<0,I6$+9A8$FMQ#$\PAQIB(N4;8E M]BJ(4BZOPB?0\_73J"'VYS7UQFY'R2AE%V=?*#_V1^>YHY+I\@CLK@=ME;WO M\13BZBXLT6@7UJM-U&;S3=2>J9C#Z$Y@_(L70)6!K:JY13/L)U' M:CH.K7^Y#=]JRTFQG$^3.@;06H2KK6DA]* MOU^!%&B*IR[VU,63+>'$PP=?PX=LGQIE?WS&;&+8L"?P@%W&; J;5T9XTVSY MA"DGNL0-&(R_J=\&])/N-X5T*+H O[]/;/BT9%^=++G99A\QJ@[7/K;A-L%\Q.N+KA/GXS1$M MF?+HAGK=2T)CCH>D+$2V[@Z7.9;T:3D"+&?@"A:TFK9;*I%D9R MGT,WCR^(Z:T7I$2U)DM?#]7RO1E1G/5\YH2*Y/0,&>#>1"L(5^0R%89EZ']E#OH=IN M]#.<,*; #_SR5H+HW5?Z6[S]&@9&9<6M!N,)\2Z1!UYI];9ZA%3C(W3Q)WC6 M]DB"O31QM@ )6KRS(%0Y>]YV0C/9?L-S=PJAZ;S,8_!)#8 MF&3#$_-K\H M!1[7EM99=SOGENQHKXWBR M! 2._!H)>(=RL7D9-.E>4S%PAJ&ZWJDTWAX<$H6(^TW:!Q;-"MR_[BO-IZ'[ MHE&KQACCG_V 4^ZDTPJ!W(0$/#)2$'49FX< ")'F&")HX=[.0^ *)1[R9)WH,E*WD6!^(.^>T)R\)!K/6SP82V-:&<;NP M#:_Z7=@8'S*3!,3,;**6MQX@ZRQ[=V%SC[O^]OV]2^BO%? MZU2&@.T)$@HTP]M<4C":;,D36&U[ @N;^&JN7+E#)4XO MXLCZ.[7]R#@V%S@/C")!!,VR]];?P01CVU+/X/RON;<*2MJ:BHX?2,16#F:^ M-TXWAUUEC^#V/Z8GL@J-.1BGS2G+I=KI[9)EZ+B;+]NV1QYU-"2OOM<-M3T> M6-""G5IL.2'3?ZN)MK-)62:E(8'S)%#IYI(>ZTD37F M>A?&9;RGS*T;WJ?) M^94N?Z7GHZK&QS<-[4U!ROX"RH!71-DMS'SN]C;]+I0A]PCD!E(+@BD^CP0) M##EL3Y$X#=>7(0 V>Z"DUTSEQWX0&FYVZ)3<(_8'^YIL+UPS_#%RXR=O8<[^ MK,-CCU6[>'XY$*=WBXL% &JYVYF0D?ZLEY@!4&H MUL2I" [F!3"0%D'\:N+7M\0/W/V4A*-XK+LT>[Q,-WS7:C-T3OK&6T$Q%SMF M['-7KM\&RT$&S1NG76,6$T"T!YATP#=B%T4?? M LH=9&TAC-X$QIYLFX3UM6_.VI$F3:\(!S$^=B"&C-,"1XV_V-@GCHSB)B#4^'=<*S" ?N,^+9%5ZD"\4&4()OI&UWOELXN-<.#48K)2D M^5[TV/5S,F^-P[V_0_R)>Q?V4087I,T0S6!GGT$^Q@,A.TP) ET'6@\,M!ZG M3 VO$1K+!T+%+TU[#$),RPPX\\Y-_RY:2%?"JB946M>FT_SGSN9L:>%PL1@, M@83J\BD"<"7-#K'YARA"+NZL_"B6\Y G *2UFY-')>;*FLM]#SQ\6' ]POK MFP9.[LQWL!MRO@?AE55_OD!Y?0::X!FB6?H>(@@AAUU$B)C"UXKV &FDWG6" M,-JKW;KL(@]]\E)@3<>+=J85FN7^+?* MO51S6+"X2%!G#*ORK&_4]Z/$;8TK$Y/=%NS6X8Y8Q^XR_D=7.<^B]EA?7'=V$:)#0G9=@05]T8NZQA<&7\F>MPJYS(]\F#+DX MOA5'/+T0>*7Z7L;GK13\ ;8DD[_A,PI[%&PCG4=*H!LN 3,)RT^DLG9ACIW/ MS$)#92N.Y#W-,?:UEY^-LU#\B:*?A4[6SIY2)*F) *JX# A#1)'#WX 8 MW_KB&EZ\71'XR[A$VUL2[%MN&W/]94R3>EKE!9V]:2T5L#C%>+@*KML+:X+K M-F>BH-*19\JPBJ#.I=X-OPYD]&GO6\(< G;FMJX"/W(UOTS:7W'F-_ -=PF;AJ% T4>;\_^B;,WESB_VUP,/MPW6:X &T%J&8EH"2C MP/FQ2]Y:0-,V1HZ&'-"C^2[3B"HPF. &LGJ,AXW^[MG=8GJ7MRY-&L+,! =Y?XG;^XP3<<#@7((Z?F8%D!&PNN5Z#:@_*'I*?"=S;B_EC7N METVH_6&[N2].ITT+@[B 538D1VB# RCB9;; Y6B&"?,VJY2M!E9UYPNU)&EI MWA3RH&+??#Y/3_5[,,*Y(G,V_M/T>R7.,[60OGU0?OW7I@=;8(:A_UWVB?T0 M-UL0*(T^ULD;1.HW>G0PXZRN^HXBW0VRZB:[%UEW:B2:H8D=6A(%[K*& TYU MA/5>%+OFPGOIO/4=G3M)$D4WQD6+0G) !N1)_#]484^2I/S!=889=C@?E]*. M5$VSZ*@.<7_XN",\[45:=]LT+$87F@E6>['P">;18CTY"-]17Y+KOSG MVA&HA$T#'I!?0@1ASR84MF/,X/9QK-SB$4+2:\RIP%=W'B'I;NS^IKR7%[7- MFV>/Y-T3TGO=U_[S4:5@UO&3_,7/.#+X=F$)4E D-9:!7UC>>M;3E09@IA!E MLO-0PSCRM<>WMM+/$CH7[Y9;WFYN^1F;?"%7]/V&A6M=L7"VZ1&T"]F2*;7* MY@ME:&,@EAF;OF:H( 0^I^%[9XPR>K<.N!+[^5IH>\K>_IE65GO=,MW_VG3X M6):J6II;<@;P?>_+M*R+Q 0S&5%+AHS8]QE=ZSWV=L M39].5_E%A8?6S"M2:I1TB:PBIT/15ZM0Z@(S/U0VA1E[L>\13:@XICZY-H/$ MJ8<2"385#$#Q?1_V;TZQBA1Y:-(VWWY%^9P3[] #A<]VKV0JX0T)3/$6^EG6 MD\[#Z\C]['U,[3:%XS2A?+,X(1 *FN,U5+]N_;[QTY7\!\KA(1+ MK"_[BX9,:O(ZN[E\8<-,8^<"PU&,(+ST\QEVIX?+T(_'W[1+[=T47U0K%+5=2I6^X3]XR)+ M>C4K&<*Y>5R/% )J8=?P<77HP3,3KT<6FU/N5GKU!P5V<;K$\]D?B9+A_[3_ MY>I\RYVK7"LD4+^HY^,HFQ<).%/'N:VURFD:+1HEN>'4BQPLT6J?'@%]HG$NN[4>71V71"CCA:PV"'E4>7O.SHWNWNX*^.&8F M #4].ET^(3N&="\6U-@#M6=;NK8QNJRG6'D\'QCA-KQ>3%R7?CS7?4AC&.@U M_O1(.O#(L&_T,ZF%T]T,1^P J4%XLPGXB8C#-R&Z:U0&C#0[B(NS_14\Z7?D M[AU3:7X;EQ42')[Y]=RW6:5 '@D.$,(J'@>(%N,W3T()5LTJ( 3@'M GO-%5 M[H!W'BI$Z*D&_>NR1P=GP.""Z[A*]E.RFJ).E\SK5;9PAC\.[L N-'UDW67@"N0!?5[XQ1'.Q![>!7HI^']MDZOKT^,X@]ACM4CG5)+@F M^RRO%,.YM;7H1'/EZ[XH!PG.?6KEF[905K2S'N)"1Z722NG M9-R_$=G]J;SD2KLVF[<\.+(2*MURO,RO$2.I?"J*&V.3K'K%:_@3,>J]$RQ* M13'C-LN$MLH43Z ;@B4,T^_X>GP?+D[:?;6W4+[$"/=0WU9JK<%MH(Y;9,#I M=1+ZQ<^)CTE)5LW,Y*8:A@:[%UY?NV%/T;2!=/3&.R 'SOM-MIU]E_T@L-)K MY,K/;.*X0,Q7]-CJ/Q6^=!*VC!-I1_.BQW!\3 50ROGP?G!6X;.G0HTP[[Y M-*VOIU ;C+3(G4BBQ[N8K&J[]X_WASY#"9(M*00@2#JQ7?PY%%)[4^-YR]=S M1/S&A"4 M=&,9[;Z"3:LU0U/%UOJ8,YV:;Y4$ WL M-N[0J.[R.#(^R%Z MY\8EF?LPIAW-N&X7UH?203R%! =?6OZJR2Z,(I#JMTW-(.:[#C(5.BC#[_<: M^U'\C7^I]$H]A5!]AY86&=1[V#!&H)*1E).F; M3T[_MCIJY*GY.%:%A\S'D&$W!K+;?'%,9@GR0CGU -L:1TR(A\?<; M$G\6-*>TZ9:2(*QBQ]3-H3MQ,36:/THGS!NS5!E5AYKQ8;?_7 _9$:!_8-TC M^)% 595>AFT\HEFXJT-]H,VY,"),KS=&C[[CK/N&(U^@*D:Q2+Y+U2>=:].K MB^SR" \>Q#'%Q) ":)=N%ZBYQ[_^-;IG*$8K+N1N!6F4,?\\K.%#Q+BG5$=$ M<_,WV96/]E><+E8].FV:!VI&A=X%(GNBFR^7OAFA%/ DN\Y*1AE\.\,=Q1V9 MS_PGQ"H1Y'RD! %5.QMH 28 KV&LEMI6-$0:=F.SOO^HEFKE\=_'';L2%[D MT;WP4CTFFT?KC5%%H/_EOV80B@3VVL9BN2:P4DP%8&\&!2?T#=A_LX;G]$1) M8V/CV?[D00D?M2]Y3\D1KH\_*+=\X_JYS!928[UF[J&5L_G"2[ C7,A8A"P3 M/O5;_KC7YZ^/-,?G%KQ'8D(COQ1A7F@I",TRZ,/")T8'((J!UDYAJ[ _X.1- M1< 6>C $VL+=T@I&XU%S3%L4A91H5-/4M/+9T[TQXH] ^)M.DUJOY$BOG2.AZF MN11H(F#E^HC'6## '=D\ MNE%5O;CP(O5^EYWN\9E\V!\DO1(P2"/7@OI^?;(K[@--%=>\55E%>O(A?;(M MB>WFT:^\D&O2SM.Z(\>'HC12!:PVSA[E;^5PA.WQ^4<*I0R<"0!$:$47/4ZG M:(X.U'C]D+?4ZKTT/AG(YH35CN.(7/2+K"*H&2(>_,.F@?&* MG6\;&K(/#68?R)RWWI^E=.C\P-SI]ZG2JJ6^[ ^[L#?:&YD,P>]_TU,8RLQ# M&=U&MVH,"RN^&WDWW*9?OOCP\LF6G,!$FR91S.?G] JO6>H]A"A$([=J'[*/ M PE,B4AZ!*O:^$S(,4#I[Y'T.,T_#CY-'?73*NUY7FV*QM)!0\_"(&585S>- MZ]XPD&WIPTEA/^)X,!QE(]7H##<"S?AV6$9Y>4%XI,96B5E8XH,<7>M6QWUE M%['SV,^D!E07BCA$\8<"@"!:4BZE+6OSKYF[;UE,;W+7;2%;U11DCTHK52]'R\"0/JP!K:B.:E.S[P,7 M=TO=7? M:Q&='I+]N;C/!HRNDS;EH7/NL#)V82&V\L$(":P)$W[1KU\!_L8 JT#3?-F* M*U\SNF!A=L@@UR"R7[,J1T7WW,>5\'<'G$;G[M"E6-F[,+\081$B>Q3'OSP> MUNYUESXJM9Z?7A5=>:WMR^!(DK;V5EG^UY6T'Z>SSDK?">4*?\^SW031B$,0 M?EOU,HXRCWS&D=]!%66!S'#)0?*'L?NI^V^NR]MU5X(ZK[]:Q7:KZ6P76W]A MZ#TZN>U[,JVO4LF?_8! SMN%P4U5V),$P';KP2ZLT78@3>8ZQFD9#OM.+&HY M<(OM<-$XDS-,E(?WL>"%RA,"JESWO:-"(6'NVBP^O_M =I?09 M,;0::> O,H8&!<]_; ,'<@GK37^@ 2L$ 0^4IO%(.*L,<+ MBZ=AS!$,1)SV6EG+L)(ZC_4="$,FAXNUKG"]G">S$W[63HT2471#5B'B.IY_ M%]:SAV&#EEKM-X7[O, )>Z)3[![8MJI1S8-K? H/%V9/ZC8F]UN1DU=P <+@ M$8A0:#.DP'B<.)3B7);W?FC+>]@E]"XI35*:"6JO7]$+<(U/PVXEW'WA&%JZ MXK-]6H&!_!3-%&T>M25 >=,,Z7^/5FJZ91,-W]<:ZDG>>,RX8O5!@>$U^#F? MG:*]\7RR.G#BM8)_.E4JW:+E+;J4ORO6Z7.\Q6J\ Z]QK!!F"B"P>2'8YIX' MU6GIVD1I"F)C) 3B.0=Z[VJN,H_D!R;I6VVMY#MK'K<^UK:H_=2MO>O+P_M/ M3_CTB0A#&? @'\N+L0!IT P!8&TQYMC$#U3MKS,OUW?CZI-EJ>G;VD2<+_X .A B@0]TV(??K=D=K0<(*;^&%MZ;VE2E.?M*!(X] M]>R]/[F%M$>VU5L>&&MT*/;W,5,7C!6V,\?@JZ"JWO=/D=X>_EO62&B0GKMI M$NEY,= #L,A>-KDVU&L47_Q0HK7@7$O[12-+KQ*YFO?D\*XNGAXX$)+0;9N( M%,"1XW9ATMB#X.JEMW43S#O58(HS,.G"[VCK)Y4I]+S-[H[Q]+;RG<0S*Z+> M4#7OU=/=A5UA3]AD9D:1?UHR>=QK%[3EV:,DWDY%#!QUS_00D/B@.^/ERV<8 MD^=(V[)Y5I+?S_YB*8=SYH3BZ'5\2=G"2U-O&+A&,'HN[466,#-+Y)#X<43#5?#S,TU"/ RQC'+*6@8(U MB?%(. .]M^+G,P0]KJ*3?A9!DU8G_V90-Z"WR>^;%P/"35,9L.M)?N[9U/Q MU])-NHIT.MPBUWAKY^""N&Y9 CF?+0C.P#>/4%!S10+P1/NUK#6S 0!=XBQ; MY?7AW4CAZ\ZIK^_>1N\;[GM[2^A1GT(N'1)PL5<@FUN^UKY )] [6'F_X++7 M3.7-%#)?>5N;= SK2)%6\D)+TU82PC6_G+PZI#.?6N[O M2*%.6;3EI<_&B.>S@_XEW]K,7WC,NWD,/'=073XM*<%Q#U9S&Z;Z(OG_VZ@M MA!*H$M^RF@"]YN'?D%(AZ.P([(7/Y]Z6..81)"OZ=*#E;]KPT)[V,+)873Q. MY_WJ553J,W[FU QT! '>7+X1^N\V@3FK!A?BY=?3J07B&!=%Y]74,\!=&(U$B=[H!5SZ M(.2##]2*]Y>@77IDC8DY31471W,%0PHK.[PM3IP[LWVJOH+[C>0*$KB 2D) MN#M8>T^W(75!\0QHME] M<'Z,'#7X-58?"8:X@M8A+^:/I,5G"-54OQG1_#(U&2VL:/PIZWQZ8DG(]3/( M!NS!9MI '?E5#?-XU6S0;28]9,5K<;;Y.2KX)*QP+.G0<=63!XP":^55N:XD ML['8$[CN,0+@@)]59_.+5V)'X,TJ/1EQG4< VX>84*UW9VF67> =2O[OC M[8RX=J=7W\2N-8OW?#N?T)+^E7@ZVD?W3_(W^R?WNLA<$T&U>0CRXUV8#.ZZ M-O$RW1K8V91D^*#Q7>/7V.KQ,34WA;G0WE\_"ND<;LL7D0U)^4#\DN?G\MZU M)T<]?F#YUR),PAF7S'2BX#E!/WM:2YH^PT3=1<[(RW:'R)>2KL>KT0:3K[*FHV&L91?=.JR"B"6B -5 M]3.8$GD$']*\,.7?=:Z44.".,RW@/DVE^YAG=RAU>=^K,K?GC".]'Z?%3[M/N!E)JK@CTI\N4UMVRBOLX7XW_OL.M%#9@@<[V M"^HRC8> W@)'KD TK6Z6ES =67C"-5)R6T:ZY?T:O0[+7E/%F:_'UZPEAQ8L M]=MWA+875(-*K@;S12V0Z[R>8Q3I4 [%MGJPB?!F[0%X' &P@\]O47=A7<'=)YAN5=^D;F4&JYQI>T0<\@N/"(N;*/77Y)1R'!Z^ M]TZ-TS7N.*[;W50"UWT402Y#UMO^NUM5O"0!5E&0#W"-,_>+?F@GPH6_$M)G MV&+KZR$Y+:9>3ZJ5\FUB"\CO'F"I2Y[SBVXE,-8**[Y=D;;:!:_GZ:WEPDXJ M'"IP >-*T.[$H?Z__0,OM$AVG4FWK","/FP;]W0&6(^.ONE MX_$DF?//);69(K:]A,;H. 0Y$\?=""?61>G1'BK(%F!D9\-C]CY#J80:'7W M_/CA2JA+".PC[/)[_2]X(!(%98TSNYL 7-(&71'U9Q>_MXTF,I$AQ>L*.O5- MVU>!+P\_>Y[R/'0PL33+JN1^@._#XYA2*[^#7-N]; $!AB=V"@_8"L="8+H+ MVS0!;.G3X @%D^IJ1=QZ M]>A^T0WU/_[_'J4#6RB!_4CP\,[&^C(B%M$PTX<.H]!,^D<'<"G>VI\/F%,1 MDHMN&2?32X[G18F-2GPUE,LZD:VH4?ND]CLD=?5I'CWP_9!\17*W7R;?FE08 MF*?$QY7K$>,S(J]>+9J_U!*/T@Q3M,B"<)'//VC?E!=PO=5KIZ[]@>\_*VK5"8P_V M.OH!F_G\4 MC;%'L?!'T\&.-\*JG*]9^MYN4-$TPN' MRL,%FK>F(^>JZ($SU,E.3=*I^X'+"-D>[F:BG,Z?JXUO]A=]MU;S/RI7R_M[ M3=:%*8UB\^55>;LAYYE1K2D]MW/3E8!;>32UU5Z7.O25=2^K'.?ZB]8O1%;] MPL3%#OGPB8D<=R,<()#QTHB&7*:H--5EXRA#QIWD'=)+46X(]+_%9Y21I.^1 M$JSP(\;U0,?42IKJ>G>VHT@EC"E-2Z/G4;5!_7+*3- MTT?WFO!MO?D>/ZDUXQY&V,&+;S\%F*]UV?'\OLGK(V-U,)VW]B&!3+$%U9 I M.'(VXUS8&EY:_ M5GUY5Q1")H"GA.E[0 (#POQND\9:.28/T/^U@PJ/\U8U^O+I?OGI\86E[UD> M[886^R>ELJP^Q'N59&5^N.*]>A;\:D[V8]I@&F?"JFD).**Z3Z@ M$;&/>2JB)9^X%.QL(5=Z1S7E0H%_B]/0P=%"!5UYZ[\J]%20X]]U@A$(WR]% M(>94EG=AJ;_NP@<XLEV""::7-N0I&4[_\09SF[SJ J&:PFK3;I)@M^_DWB MT-U7:[E)*%3H_K6?UH?X4T8=3A<+#]42;=A\BI"$Y)]CZ+''<(*_D?7!"!'C M4PQ+=#Z#0DAYF5(@,!%8_J,E[XF40<.F8Z9%^,-'G&,5B$(<@)IA2J90\4PQ M 7K]]#]-AP/LKK8#J_=KV^V5\6KK&1G@6?UIG\Y;U%LI+HPFT^8@<)^(,"9,8PSH")%97 7QK_N/HQO1"1J;>A57;PF]792(ZVIV&,^ M:"?L;3-*.;3!0H8W+?&$)(0%0,0NC"G2*0RJ(GK<<"&U& M=V&@B#"5I7;0E?C(]/>"F?+>M>5CS[XJ[N=I9W\D-*G$(:[LPL!#SGB&*]C< M1_K.W@M(554)['_)BRJS&<(?7D1R'\VY?,#WS6E243@RGR",(Y?@1"&5O@4J MD?KQH.IJ?RVH]F4&:E+!ZCB1Q36\D*D\.IK:?MLIY[&OO]YA$WWCDZN)M=-1 MXFDSQT85:Y^8B1T@S.$:,C9>+=O.P]E"SL#.1@OYZ2UT;A^>VUU>;)K27FMH MU])Z)_%@Q.Q<9Y"#KNWB@O5WY!ZHVEI)@(OV' ^;#W*Z=@#YAH4PX-)N)G") MAMW:U#G[6.G:Q.O?CP;BL,E0TCLA N[>'F+S50$%]&P.X1 M CI<>EUTK\E&)VJV2S0?O&87]/E:G9566&C):9^"C6+/(9[AST(?5QI#4S- M/0:]&40L(T%E[=[:.]7D!MC^E,*+7L4#C5M;^A[R%1O/5^PS!.LL)]1 MS,R^HO['#=QD:..ZKR#(LZ-$#T^PAG$"G>*92TEC%XM-#-QRQ\TW"MUZ?_+G MP:F:]T=1$9+)&,I^G4?=AWBB<+;P)OW%Q82-?IH"N^>KE(*X+[P_VY@ +X \V:]J1%$2R M1CZ2J23*ZWS\U5S*9M+=X A"^Q'##5V),(.&>S$S3%%A]KZ]+#Q46]4DL9N[ ML 2H!4L&LWE 5C$8\==$R?WC^.RZ@5A3^TQ/CZ7IU0L7R]KK/:SUUN) MTAUIJ(&,>4CG9D*FC#'/L7)QP1E\&$_0CW$,;=F=>QF-&^CDF_[1KE,>4]?/ M756YN/Z(EQA^Z/C &\L;*:+S;;I^>1DC^'HX4[R6C.O+ $]BV)-PX,*(U*=Y MLG2O7.!D.Y**%(RD?*$)_KW;WTYTSM;%KOF,&E^B]5P(YS)*JU0TZV?_4X%( M&4P E$4I6[B 6E 5WXM3 !^01WLS)+UGT0+D\CC,*=/GJ"I2+YQI$W6JPPA1 M<%G<0,ON;112]R LU?2TB25;J.K?D\7L2:0DCEP*EX4:+D*<$)P60MWJK14. M_KOTB@R7 FO=V=.3W+>,.CJ>:;6LY+3&W[ES_Y#&\+L2BXR@@,5E>".2^7JN M!#=+H=2RSEU??P9-R8,Q>T">81ZHI35< -^1M<5 #U?:PR*M"3T21+;%%KR) M7HOKT[GV_49$/@XZ6 (MEI8DS3]!9H_V^J?B01Q;1) U2VF9)4GK98I M-=J% ZQ3$,0 Q ,XWR^AW%V8+.8N3[+BF-;6%Z.K^<]N7[MV_=OTL;:[.6+ MAP,U1X94?>O.(,@%<,!1'M6# #P)20C@_(@ '8]?UNZNB;[$G@;/4#O,!A! MYF)PBTU9=X6GZ^O*<9LC*_PO?VJ3;-1+W,N'!:SQ&3ARHQ&\#P<>@3,/6%,R M0#5\LJF4%[J @DKYK8EP\'A:(Q42LVSD\/UV8?P.BT1\>-AMV>6@J,8Y>'8R MNY?=AP#LMV9GZ"!MJ3"2P8DQ?=Q'E"H,T6 ?IZT4";6.U1B;;O*)NBKE&KP/ MVRJ-]NSGTRE55V\O?IIE)_P!#ZI(,R7K=F%A6T0XM:47/]_"YA>BW2%K#V2( MH(O0G4(+WY>TLP9[O!7FGRZ/^T_ 6?OR6DZ5^[01R4[-LRM7TV;E7]Y<.1 ME*L_+V)AN&Y7MOA_GD(FER+K,I((Y#*$$/8HZ$'AV52G] _V9<1MX>0;T.67 MW?K$_CCK'LNQ5CZ9(_>6J[HXNT"7!TT(1I 33>&L$F--B! 4@X>*V5/+EY$' M/$!C ;"IF/I3SBS\N*OY"5SA51OQ:ZDUVYREA@<_\TPY_G?H76XC[SS478-7 MJ/+3N88#2O#]AHG9;E5/ 2_U"?=O;SOH)G_@[S)/8AX'4960THE_!3#.M>(M0HG&.[(7M.@J)X>57E\YR?ZA M'I8,4U-?E].\].DBPJ$AF;IT]:B>^("\O*V=(V!9]RJHF'\FWS2S(KC<@C!> M4]Z@6AFJ?-_]<,E^.:N!O7OWGG**66MOOEI80WS2=2.X,;I.\84U!?,6SGS8+.ZX'YWX**.=]Z(.;N MT ,GV.H?:-1>>C2@H7 R>ZZ,]LQ4M-[+;2Y^?T&=]#/K _""3*^I_WH"+N4E MQ@",>@$6K0[\1=R[Z7'Q&B :734?;#<8=4)%R;CR^;S*Y/24A!V'^7\-;@/9 M6_@R]Q1YK0&Y(*>\'#ETK*I&_U-R>%;?XS5K_=P88)XR_9SZ#7L0"?*8X[V; M+^;\72 Z:L:(+>]W2]ZR3^^"9H,YW3UN-7[3)C*P)/@6/5,O=5.R6D V1^7( MFV+!HJ_5]J=%%XGN2.*0+R[T & K9ZEW_.#53-YN9YY8WA,'IRU3V+*8D^"# M,K/GZ)TN6>56O^O=-1N_T]3DGKXXZ"-I+1%W8OF^QTV[/5[2Y\8PAF5GBL%H MJZ8W=4VIEB'^_F%UYOS[DBN*]RAT788JX-?H)GPS8^.;Z.RUB6183U:+^1 BPU_DCR/N6;JHU/\1-Z7'R)Z/]*T@*@$?CS_3/:&V\#<9*8R.[%T2&R,#6W%Z M-[E::"=H\H]C#G&1,XKQ>W-/1-I5A&DYJ-XY K(/"3C+YE/C\ M9DA2XU-W&Y@1K^OK*UQZA(64$G#&F NC&$T MRT9NY>3,W)XN?B10D/MI"/W@P(BZSV8:URD?LNPRPA\__XYNQZK_):#I0<>! M$R]"I'?XP[<[L2'AHM9RWG.Y6S[[L^TH!J(=_F=5GAG'DZ21@0A M[^,X$'4NR[;]H\)H;UNQ=8._M@D^TTVNQ;F.G46.R>HAZ-GX(HMH^R8.Q9,G M8/G?,![440%0H*R@[.&& MXSHPF/4)"8[GYAC*+DPX >I)=KAQ*S8/%,-/$PCP]YV[._T9\;+(GCE3PS6< MR"\/W-[^Y[A0&^JKWZJ/;2\:?MCNG T3B+D"5]\I"KBUN7JB>%]L\L]_C[<" M=HA9/WH>[16(8IS"SD#"JSV2NJ<^B]:(Y ,_C=JU>=Q44[@LH7NI YVC2;=EDXUUGG56'*))AS_VZKV^NM4AT8' MWJ])>?#KB=]NH/T/_A2"W6QTX:$*$Z/)*O%L54O 8IN*+8Q<-K0J?=QSV_K. MYOFEH_L4\^^$^&=YH#T:Z]4&[UW:X/+JV-PL*@C4*JE8[$>A4.+6QMM6HHKF M,@$!QC"8TN,NSGM'7KS->(AH3("Z0L9(E&$W/#''6[V^<32O)NCHD4]/-^2" M7;?L+S8.[SOCNA*P_R37WG?_#37!C4!&"'846B''==2# MML$^W ,2?V/''2LP[?DW4;Y:C$%;:K#,]//$9V*** M!B) F!A(]V$]0X34/C0U&-/?Q$%YTU6 XKSF0C13' G[Z1XQB=<6&,:49%<+\F4,(KUT3[VL93 M7H6^#KWB C.NBXNCS.M*HPLU?@V,+!X3C M>A$)Y_'UJ/ZG3(%2E60$I1'#4]Z2.'$Q$:E?(K!J\/7&NV'SDK1F\1;5\@,N M)%PC3Q*FJV2,W8J8 M^@1$*1I,15EU3;9SI&XX'^[*Z&R)-=A-J<#8!\?0Y+IVEI3J)C2U;YJ<'.@9!*?OW.X';JTE*+(CNXP)P\9E!S1R= MWVBVB70O+Z/E*K,RXERY\?V*-X/Z&PB971@*/KM.OPD.44;OP14@F8H7! W[ ML9H3_IW CT*JQU;=X!UN5%WRPGENCI8;%9_D$T\YDC_S#"$ :;8IP& M'P]TPD%IB,UL [4;,[3Y;N?URT)836UJ%D[==]O<++Y397981:/" M[*&F;'P2?DM8&KS+]*"87.YY]1KY/?35]PFBD*U-ME]KHZ[%A]6SP]52YI^^ M*(GLYSSS':+_QP!XSRZ,R,,6T-3>7 >$G2:VF#H4TOUM4+K/6V],R4T#<[': MMM(\4K+T^.!/;[D3FJ1/F0)JQH#YNYN7,AFC&]\A'.)F92!"$"D($>Q>["A> M[MD&A6H<>V[YU\U8F!J1)4;CK/LADB7V3"7^7^4@XGX#* MF$6P^<(9PM@N!2.PA(P#E5NZY5@AO4M2[$^ HU%NSZ8:^P?#O>UJ_<3AF!\^ M,6$*-A\V)]M3/\TG*>4OXU#XM+9_UQPRV+QU (D>S2K((MHF&4X3+7MK.18& MKP?8URSTC497QIQQ?6^F.?SQG:M,6:*DSWG\#5;S!%M6G?Z758CS.X4B!7L? MF-)B:X-_C[#EO."AS1GBJ[%*4ZC#3_?MPN9&OGO;[\)X1)B':?ZCO;7WD,TY M#RA#'8%6K$)$D#S7 /ODQ/508K#+Z7B*[,\O?J?=F'@M91^.O@#+$[Q!7$BZ M".LESA<_:^D!:#/%5SW'.A71-H,(D;D?FZ8',]%X5U M;3Y<#4\,P[2*&!^K3!U(^$ @E\";SK-G\("SD J;S[K-ZDD:E,>Y,*Y:)7>IS&](Y:4?R) <.S=7M' %@C?OH-RO8@6 M[7N0[(4_1#80$G]M0BKS,+A3C"[ISB]Z<.MQT\NX4,&?I/6S5A_ZG]@;FY?R MA%@!JD/U_ GDC(=P^FE(**9UZH7@)&.__]7>1 #KY@30O];;8%8[2E.95Q-U M\^$C(*SY5:MHE,X>13V.W[8;^HR[[(^D9FP>A&?LT=J*;[='>SU^C;5[ 5M] M1?*/+:SUOKC_,/GX[JN.<_S M.(_O]WNWX.:4?%]_X-._G\WB\#(P&B9G &?1ZV,M*9(4IF,$]P>H@[\#[@ M^W>T6B!WI_@&&Z O_.Z$-3[?Z^)J(3X1J:UQRI^@!S.Z?G''#_C3<>7G.4M^ M+_:X=\+XS021EL-=#\P.(.5IY8VH=Z7J4:7 '<+ 4_O&W%E^@ $9)MWUZO/ ;#<% W8/V#8\+I>C;:3?>E/'>3OICK.3 M!>CV5E;V*[\,/UFSU&)S?_] PR3"R(ADFN$C1Z&W;T'G!4![=D3B6K!CX#8( M&.^/DT4-C^;MI96GXH""<[(7]M6>BU: MJFWY,:E;MZF( ML4_L4%K6^AU\3=)?BRP3$L23C5%I,HQ0$/4.F24\^D1U!J.15I%1[6:EN*T]]X12F@OAR'F==P MWCUA'T_D:]K)DJW#-P#F--]6E,0SIXRO0S]HQ(2@4C?Z:N[ $]$_$I2?U]P9 M7GZ %T;)(*_0QA$&E-&V,N$.(^//[YLR*:8'Y>:OAS%+KSUUM9$Q-/S4$]Q_ M4L+D*-G^=P1X)$^,YAQ?]3L"G/RY8E#WHVYM;>VYCUYIQR0%5.^"2M8NG-PA M\?>U?;\IZ<,S^'6F 2?.71)#0F]NM^6"8)7H7TX5?_=;_M10^KR%-XRF.:'' MB1S!6JI6;([SPN^[ /9^04O[YRPT' M.S'##WGOQ%KE/4XGKO $IB^$N0W 6O#85L%/+NBK#QG# MN<3SJZ)6Z)8P+NC7)GY5!N'%!65FTG9(\&WPW/K_M?_>T\O:S^,).[XVY,@L MH8-%>H.99"BMS$1'_[F7B7\#1\_@;[S.N5GBO "1"Z)+1+"D81S,,RY(.SL> MNNEJ]9_IGS<&266G5IUIP8_>SHE'9DN[^314=E>)?.M_XQ5S5\=FUBTLE4;E MV/R\QP5=<8>QQ:HK_Z.M'VW"$P#("-9CZ%@7I[E)E0OJ)_B@3TO^*V8-&/S= M>/.[^UU_U3L7XA[H=)X?E+&#I^CZU=UU_\U#A7_NG\N?.O]O'D?\<[L\VJ&5 M@A?@[ 1N +U46 =Z^S3[.7I!F()FR[\Z+T":_)^8&P@1TH;95,T!LV."T&MG1WJ\D(9< M4'KD"R[HNQ3/ULZ4W?@WX7\GE">_IT6UV*@>+BC_4H<7 .&8BW%!HPO$+WLX>_"\P _P D_\ M;0^D^;*D/&GHE@M04LG44;I]\E'.01D]R'VBX$+U[!I;O94CF?G%_U?G3E=]%@?#?)DHF<;%_T / MMUXRRBLJJ+E=/&4C]"S9,>^VQ)0WD@NZU:C0=)/'.RTO(WXN2I[: YJ;,[Q?1<5/YW.^\18,' TUR#WU()O%[1M!_=;=+',\A +NCEI9J_IH )Y_$5 Z6JPWJVW\O* MRO+]@S55'QZTD(UU'<,(@;:G(T#GMP\Y=]P18$GB.[@@*:0[&2N!ZD%7P%)9 M4;3>]KP]=,W&@D"&='U0^1N*G =/R]I61?7H=_Y[I,O34M>3<6Q]AL'EG\'BR'D.+OHS!M \LD/COK9%#LY4M07 MG]?CMQQ^RICU&9R93[A$C3V>!&(RF[F@E5W9'/QU+JBOY%J#\^\;NYP0,,8D M.[U!BWD1H=3,4:0MI5*UJCW]W6!)!^*-AV."E1.5P^)=]PINBTQ..&'E!MF5^(/):D!5LR,-6 O,M-.VP MUTGO'(JS"R75QBO];;-"K04BNQD[[G@*R*438>R,IL-(DR$3?KIM&V%'$UXU M3L\6T"P8UO6?]LMPJ*B+29HX6:ENKJB&V5\2;U>:!L@N+VZ^111TIQZ(_ MO8!87O \S33A3$(J[1>/,X]T,'U9IG16^-1V.\VE#=>F4?&%]%]H;S#C$[S MZUEDT-=@90=KN8AMGYTPC_W0M$L8_MH8$VFF!?(T($A9WL62 I)+"?Y-HD!1 M>:]?!:3&[(OP^+S>X]ZK/N'CVX]_VF/R*Z4;A+P++O/[-Z)G:M@'2R\K:.OL MM<7K8G)'/+[E:WZYN4T,.=)"P$X9&LH8ZMVJ0"D#2N> I[1E& OF;3;4?Q MU[U,?R[P=J)2&L+MD(_I$P'EJ#Z!7BC-'DL@,O+919SMLUQ054)7[QBV!2J( M4I@S4@_P5/!CH4T7IW/.V]$\N_EG1^ANX]V[Q%[[&Y1Z2YV9A8:7^[1HIB*[6EQ M\JM>BM"\U M^7J_'A1\,EEXPIT@4BO5^5,9IK]-P<)1^6S*?B-V'1F<4,.C#S;P[\ZMV,J( MA4CF$407Y3E'G#9/^+5E%6^76AG@ED#,FF-$O:%8FS 3%9Q]5H66@EZ/._GQ MC^"](6E-^]E%OX^N[F:%T(@Q2R;'] !-E6$3 \1KU8$PW;JLHZ<&'.ZJ?Y&< MCA#]&+/Z_CA:\HX3 LT2O]VL8 8$,44!_I- '?EC(Z0S(B>LLX*:JLG0=:X9 M#1.N6UY7WF80IIW\Y5GJ?>T=^L]7/(SGDG,:4OXE\@SM7 6-"VKO-\D) M_EATV7_K?HC9B-^AU(*'_-\7O7H#ALOAU / [.]P&O6 2&D*Q>T:W*#=9#, M*I6W6EAFW-@D?NQZ5KG,PD]1=?F 6AJ6*K HS@7M_,49)HIP^- MYDW]5/C8 MX!D:)FG-_CY>VD3KU=/RM2"M\\.A1WYR1FI/>7C5Y A; PY6XQ7B?T@>M"= M[T40A?7LXQ3DA\T$ HP\9NZ55T5%-FA'O+RL47/;I7YG'#E,6==GE^*]%%E MF@I9A%$@:6A1$QDR)AE-L[=/@H3@5[')!/6@K&>^Z<69VTCU)I$)25475);8G3+W>]=OGPM\/\+6C271+X ;I67X!% MA*3BUPS5E_.+ 6ER3]9'JJ#2X%I4U)O"X0:K-U_GQ8P+!>4F>I7VFKDHIMIJ MMQ:>-132IB6P1/E;8/N:Q%GGV&^#FHZSMM&[[CE3X(O:%)@\H#G3[BF?=5AK M+6K47N5K2=V!;,$,B3CWG_L$!"3PI'QH=>UB)$6+H-W$[X>EG<6E8,50PD!D MED2&9B'[ M)1=T8UD*<>#&&I203 D:J7L!>%T<9"1C=A^TV9';\U4,G+F!K2U[*[ M7@QD7D*,MEM1H0L"%'A,DV2?[I>PP?$NH^?'YV1_K'T; MVZN"[Y;8:R4ZY5)I?-FBUB^U]B(P0QOMXH(4?CL9M$#HI'.+VTND,7"";.?> MN2$[W)&"'=O")"[S#53->S],Q>A5E\S=?K?]?21-;.SIXB]C.._/RM MREDS87:>'E'TUT/K6XEHY%9N9MOKV0]M\%VJN,^FZK.8\7%&#S#,%.;TC'!! M,AQ!3F>>$C!Z"^D6%-8(;LMY4A6M:K?R,R?:TGG%Q^SR-45\J*;WCES0S%1WTETEPA8R7-=W /BFF>C_0PJ4CY0"$1>T=:5N5U8F.L_M6? ME\=L;OHR#8,&XL,\OKY-X^/).YH#>N\<= ^>1(9\A[9S)!ZE;[3GV*>LR8<< MA-)7BY_I^ECQ+ZO9J'_F(^GP$SXL TK.BXXD+4#5%V,&1;>8H>%X*2ZH%4S? MQ0H;-?$@R^'VFJNIIJZ56;=[U0].'&'>*")?U^ZJ/SUS,$XC?<>6 D4=;H D;]5IM@3!I?P?_K:R/Y7.'SC0.F74<$W=W MZPB@2$H+[D\_:_MVX7S/++9ZIH-(N$=9OK>.'FMCB/'>,(O2')7RT#H/E%!% MMLV?[6^0XQ??/TJ/?J.4?;'.:2*(6FUST%_()/TE^ D_7:L3*XMT!K-$M3A" MZG1Q$BN;X0FB]R[&1,#)^H'^02GA!G?*"B9>)UDX/S"MJT[L?[Q7_O%=<_YU M*$?8G#;?6F_%DNNAJY-GQ@YR>OHXHOZBWRVJ@D[[JF2X4]^U=C24.W8T5=_F 4S^"K&MC)PLSV,J1K?)I)P6^\^;U'!:"P%)J6>+S).<. ML)R'K5DE!7HO3V98+W)&N:'66=:IZOU'\6Z528S)JF M]'61@C9<[FSF6WY^*=.1+O5Z"Y*PO/Z:+*:7^[RR],;-?2^E.M%"H$U^$K1% M"SAZ_1[-JE56-04:A(LI<*JB#:<8)N12;3^0-?&*8J!3;DWOY:%''YYF82\.0*SITHGX&X'18(>FP2O8"_WE+.ER MW1KQ]_S*N[N]/W7LRYPH_1SRT%IQ"+H72OI%!)3LXY%0E=ZV7L+Q2W0&_O#* M&GH78-7LUD8,R!9X0'HPX=:Q-^+:6X-/=:HI?0($?&5"%VX':@BRC:5%YX+( MT\X/9\V.#'@UQ@XZW/M<7WD[,XL0VCVFJU/2<7#Z+OU==V=@#0Z+)V5A]W#4 M6,?9]Y$BA:R;M/P^$X]2>29<.U'A*:8 M?QI^?!X:,#/FG(4L4'EP#>,!YJ]%'7Q^TM_48R"6W/],9)Q)!4*X(.55 %FQU^4Q"P+O0YEE.?^"6\;:&9S+OI#LDFT?4TZ*M;Y2[Q>3 M;CA]^%O2]T^7M#NM]XO+9FQ8JOZS!U;QDBP%6E<7-,$9 C:)B'YMD("#O[*+ ML*C\('JZ=%R^I73)1>O)R/*C)EWO58E]Q-!@>FW^Z=WZM*+&!MO](:\OGKF\ M@_\N2'Z']_^/R(!3=:Z./-SJ8W^YLG?:$L':8_!M@D-ARL;/TOZ3"MHTYN^+ M)X61^C1-#(_9M!'?0]J@%7[U-_3#>PSNKOU\-*(KW/B]+2N\\Z=7MW)&=SF^ M!5JIM3!)&W2S%T,:LK$F8#+;$KH>L:5Z?V%1U7,7F9+JM=Z+&H7N1QU% M2M*(]Q>:MB,U^AM\*,LRP-1H&T$_$8=(MSLT"H;?#@L)4?D:/KJ[1*2Z<%52 MM,(G,?9'TKV5A,4C7-".8^P&EB\3Z4^DV=D#AX@MRW%N1$R#%GF?R6EZ90=: M5$_>TAZ,\+^^Z]J[U(7VVU5+.#EUB6MGNIFE&J5W(?D2SGS,8RRO$3,3EMA MTT&@H/7(B\#XGTQ;NF:BR*^ZI#:GP67?=TVQ1V)QN6*3[N?>: Y/Q;@'S/#C M_[WLKOJEW\:4XO#BFIW^L<')/RK:!:G*ZV9WP_1"9X?*+CC&-CQ[;QL^]>GI MV6/)CW/3U?H]F2]0W_) @VOK"6ZUS\Y_4&=VYT2D^+(S3QTSJRL7IVJUO#81 MWH:XU[;:K7(_?=>/),>L.,RYJ#>SO8K4\L"E2K@(\.S0YRFSAFN4S.D"]<_J M'R_9GFLH&X^N-HL2Z#AQR5AF_4[0*T:0*]0.OE$8N2AQ ;8]>M]?A_/8=-9? MQZ]&#/XU@G46H M#1*61I^JXH(V#FSV*K!E[K"3_W),:CH"X&FO*S@P M;Q;&MUBAN.]X0->78X5.PS*$>);+2<7CXNFJ'.OGL$+HVC3X!1F^";G !=7B MU[)0A'X+2=9#5-^?TN,>\695'K GPV/T<(E-IB/2Y_H:C LGYNZ,O*!_+*LN M%-6M/.O$=UWH04_<]N%<\;A75B2KYWA/E'\+>%!87L0_Q(C;ED MZ=AV9'LL>+LLB,5BOT23*M&TTQ""+7F&I8A2^7TX;)8@TE'-C[A4&9T9:RTY?4K&0^&$Y#G7!#,A MGMKQ1%X(I$(2"=2 *2.@(XP+$D=+S=4:1A<58:UR1%XKV-UU1[ZR5%RZ@7W# M!07_SN.Q RR8QQ%B=@(,M?X&>Q(X7N'(@%:#/QF\!V$VM7QA6%?8.#(?4G]Q M52NNL=+ BO1U*2CL=&G1?X#J79"N-BZ[-9XE_(FM5,$\07 M&%W@OIZ6H 7Z50!'O3%IQNE#5$)DN=FXAO:9= ^-99W/+=(ZZAD9Z=&TZ3R4ZW6_?O?L MYRV2 MR=3 Y7LK!"LR+&5*=2BT[/A%8[/10H+&ZJDOJQIQX(N[)?1U;MXTFD:R\Y$7 M@1CR1]%7OSBJ>8825P^&N6X#6TSMZ5]05W49J0Y";58?#;R0,Q>^3^?KCS13 M@1<,W/AMK/0[PXF7%X\!E^;LW,Z&WZP]LZP* M=T-DQ*_A09MB','3JL:3TR:[D;RH/(*_CDM6D 52KS^ +=P)(U4.4>U=CZHJ MXN1KQ:+5NQJNDF"R2+/A<7/ZZ/UU>85U(\)<.)R?.B3 KS01XLIPKJT/FHC8 M"INH66TEO\R1$3(Z]LM\_[UESQ82%S2.HY:G%FK%F:##7B%63Y','E&C3>%# M:4_%#);-NTZYQ,S"GC#/B7]%&=H+F]'9BU#63KN+2:LSKUF8P#$ZRI5V;M\' MS73V,(PEI'9QFE5W1.MXYVM<%&>$?0]U/*3DE^T2?^./E9;? MGT9R))H5JFT]V??-U#QF;P$%).R#*O"#+1.OVYK;;7#UJ@&VC/+_/%%BJGV MYG-&=/HSE-6#_DOK/?P>M,YBS42*G=2R?>-=2J#M_/4DE]X"I;M6%+4BY!!9 M[59(>J7[J^@SJD*/')+KHW1Y!FEC_O>'&/@RJ;A-,3TL<\=E]*]7.*H#_CU> M'OWI42G/^:KQ/)2%'EHVDTF,1;=UW1GD@B829DRBZ%>YH$4NB%W%(Q?L(=;: MWY-.IL[0XHC(<$&/B-1B=FP#E =:\'GZ /X:#\OZL9OR'"/T=_4V+FA+G],D MUX[=/!B">L@%#3XTNQ>'GXZVXDQQ00.NS$ +"><5<^;)OX8,$HQV87G\M@/[ M7A-H#/D'#=,BXDRQ2C:QHXH<;T7MI)W+N)-5]G9>>D6B-LDVX9([@G/IT*FR M6%#7"8@4+O%W*I08 +!"[ $#+T940J?9[^G']H17E%5F3P= M+@IS_7VSIC1G&"N-]TID'6#NFU60;*#/TO-B-!\CW7U-'KID#KT0?MU..Y8^ MY7[B#^>75R !!.@2T=@^A@@X)'^7;N=-D/$?+\ M]7_*;IWD@KS WV'GV:6.KG1L"L<,$"<; MW#4Q,&VLJ:4N/\@I<"=$E]]<%,DLO5!B&WFK>W]Z9$BYJ-+U\)/.$8$\HO6[ M4,D?2!@[ID&81,1(X24;Y.A69&C[T5DR)!$/KM[Y87 I>*]VH.MIT-4GVQ_& M?>'_\B" ZE\,(1>] MUT2=!)9$]4'WF!VH33&!""16E<'(>97Z^=="-W]D&2JO3L?KH8]WASL\B[FL M?[--)3=V%FO:[XEE'N)\;M)EEZ,.V9&T=B,^MGE*#X8V:MHY=Y@=I[\JU]!% M@V?[&T*JAX>FM9UT;'>??5NZ8J/K]]96:$N:\?L6QJ.(91)\(=]@L8MIS!G" M[S$S9FD.5!NN+4L%$O?@BHXC4#\F+Y@-P]7BK<<*$T_[AON<.J^^4^69>2@F MZ1?N+=H7!ZA@TLQT 2TR] $+1L]HXPCB 29%CBU.JLDH'9OX&C9>8B,V^>-# MNN3!SY-+TVDC)W:%1]I"-"Q?G=WL;2?N9D63P8EW$EIZ]R(<&! )_SL+]7I+ M\>^>:HIQ3J2 ;XCJN)FK/28M6I1Z#=B N*"[.N[MT=F)T3M*!Z M;,KE\Z^*]E,S!2=.G2[*0 M12+=^/S@05IOEY8P DVQ?+2/\ XHL;.L3XS:=#Z\_0%Q49]ZB2>B>-Z."TJ9 M^&5VB YN3?7TS+K3X.LT4!ONE!FB [Z$Y)OU%+2(UC6LU"F3W-UZK,/"GSG< MHQ[I=$[/^65N R8;N\OG\?4YGX$\*7?.CY5.3FA.INK/":V?4:HI^*MPC.R> M]"EUFFE\+K5,.#VG-U9K]'Q*6D,GME% 'N4@4(9@3^9.Q@UE.3/>F^N>N^1R M_51IBE$L6'$$>\\DFHI)<'L_/[6-CBHJ\-2$#H1^&8W[M*:RZQ/#Q/F=&VJB MOC9ET:N?"_+'W/>4!9(#7HLO;M3$?G$\,WO_X]UM#>CW-LW=Q0L?['4 51,- MIOT&C]32#A"[;0;S%B=>=6 V?6R<9DCF;UP M@9Z\@=V-.AZ !E>[HI:2J1^OZCV"+Q5-P^;ZT'?^P ;\;%)"=:"KH&VIQAPQ M:9H]@Y'TV?-H5.M@ZJF!,QS.K_>?FY9*7"B&SH;%%J/YDI[I4Z$YK].752!W M( S6M1X:RSW#J?3U->5?3E&GJCSTB7YU494\\JNB\A,=@O\S[.@ETR;B@8@7 M.L_OO220,%N4ZFJ88?3A_S18M,(%L20Q'9X& U#?91% M15=;< Z(@R699UZ MUX=TI F^K/U7F5; '<:7MD>(#/+H SUX:DAY9CGB#N5KY!WLTTQQ*Y&%B M_',CX MD:KX\#'SE/.LZB*="M^&0)/B\'?-#J"^.D/V+30=0"2-ML[2?DZI']GS=C51 M125KRYJT0K%6B+A^]4?AT4.67T>;\32'Y;VH;JPXZ@A2]3Y_UZUF)5O?I=8M*WD& M=E1<:.>.:#W/J\Q]\\3=)N;,8PA3SAZ6FMGV/MW%$U5/3/:,])_B[,_[[*^Q M%#KJDFS5-$41S+^6\KE'YLK77:J#O_ZB=/\V3.%^7?N;$OHN=.>O?V8->&@2 MTB*,' 7;<3E0O"G#"QT2[5^SEAJX""5$44TWFC& M$KQ5"SBTD:3E!I="9%#T>CO*T+9/5U7CU\864-U%KA]FOJ3_/'((KTW[LI^F M#6GL\$6W'(7ZH,?XN[8L:^GSC.?L&HXX ';M]UE!\I&(#X1#PD2& 8)E/AHN M<4.Y.L$X?3)--?/DXTBU;AW4.+IB8Z&,-DJN3>*"_')M.4*#9$@:7K1Z\IJH M5S["J'6VO'Q94W55$X[SK=]_ID)CXO#$0+?TUQ=[ WK4,T(G,;E07^Q]R%[\ M#2PAHP7/7]7H,,=LA^UE7?4I3+5DV*V=T2U)P5;VMF%V(*\ LV2M.*PH1]-_BJ\/:8X;=PG@ MZ XOY@0&24VY;FL<>B 3H<:?+GR8FG4A2_C%UO,?&-[4O4*@N*#6>E2%B5'X M&PVQ /U'9F(_\C6O$3$-$A_W@F5:.D\J+4+'"GB3M_#[6#P"F/>B/!NQLV6\ M&*J"[P&$3S[:C#:P^9#G8>_JU\NJ$%$;LU"5^[EZ=W+:6CJ/G86^BO]>TH&O MZ4KE[&,A>&OB'@LZR)'BZ93@@Q7TU.G5,5Q:N$DR7/YEY_NJ8Y_/RUS?P:J" M3SX55G)^S1F&5F0OP"E^#1>89U@\>1C[E:5*1Q(@\3Y+=NY;_OXL]WZ:2Z5-V1G"'3'D-G8CU$=+%G&U<68)+^G>_-2]Q23U11D&DDQJ.!AV[;*S#6[EM74=I:FUWXI,W Y$V6>[T=->UFH7 M363ME9P,]$Z'$#TO&UO!A4 G(^\U'4RS@OFSL[@@.%IX%D)SZHV#U<"ZP"(M MKQ#J+1R# 50/N4=3-6>\S4BD0$-_A/'FBQ&A5;++504Q]KTJ_;C8QD[,<8#- MW,49Q%=FQRTC(^F.K5*J=@,L1]5XEE742R#]RT59S0\53R%V3?H9-HS W/QO M8]H?NM3>')6(0=["VZ),D:< .Z89JI588]^&D4!ZT^#)83B",+4<$TVK)[9. MJ54.%V7;50PM50N&U>VH2I>S_A&/(%\PR#X2$3KV9'I\L\BF,/[950L)A[_$ MIIQM:3-4Z0[H?3<,H[@-"IFKURBJM:XQN%'Q&3V.6;(V?2)Z>5BR!B+^H/62 MDY]=:Z"OU*!G:D"*]KX;^CK)!9Y"-Z/>* ^NVUNB SB[V0D\SVY$0V50M,:T M& 5TJWN>0?J"XVUN5!&8Y76_X:32X\B^6'L-8=%.HTO9+-W:Q6R:\0:T*GNA M%&GWRJ(]3QVPNP7?V<^R\](6/]RE\AXTLZUQ_L_9.TT8MC\N>5 W?[?]1F%= MP!VFRZW/]IRFVSBEG_AAHWVFM]ZN'R-.)O\LFETH[MF%V]KXQ.K5 /28 :BO M6 55#RTR%]01;3)75&,6]R;#!Y5F>&3ZG.3W>RV$?5&C;T:Q+!]V)MX70]BY M$T.9:?50<*9; !<$2!XN M&C%?7U+[@IYZU]_>MOFZR88U>S$33Y,=@!?:H^BCK$397G9L.73-T9G^!C:T MS/.-@?Y"C<>3=L&*40U41=A M7\$I3=)(&!;ZTZ0N"B/B=R R3>]'2^_-F@*N.8 Z"^#KE[^NMNZ5^Y M8"&YM;GZ=\7%815H&L_=\$9)'KH@R1MRMAP:EI;)_%T'*(4+^K1,'^2T>$)X ME*EVG3:ES 5UBR>O)7">QZSM/\H%*E@PK_(Z))GUS9H MDU)]R9+%B0U.3)OO2,6A!FU_0WM@??Y3B8EJT[Z(\+K3?]Q!>OT@WY_[H^V:5QQ8:[R<^U@LH&A^C MOM@0VLS@[.JEA/$\HM@&J2M9"5#WI:V'@7 5Z.)!00AMR$$4 M^1>3.,W(,"[HH"6/CE\IP; EAED!SLM3NR[F&E*?R^?.\K@S'/L4D1K7YJ64 M4.PI%+*QYJ_'B,K+X(*$(:3:-)3] Z+PN8Q0+BC*B?8\]@#6D?^':7>WKD&S MG7K'W0FD O"T:+YPI=YG/#IMXY?8.3F%NFT-A+MG'WZV5J19H#;7'_0"%?8] M?ER0B-E:[V?\^P#R>HOS8^A'+10D%*OC>>'QA1(*EA]H:S% 7Z/[QB_K;J@* M,YX(E7!!]9-R11YDG6>=I'3B&XWS!Q<%/;;/U0Z?FI&!+9,X5TQA) M'I()PA8VJ?CL#I1 (ZUZ?AU/6VL*JH!?BN',,55UH]0DS03'&%G8I,'E=]$1 MNJU<4$/?3UB/'7'Y7E5V862O_LM&62HC;*CZDR<71#9(U<5*GBR(>!1H&+OH M/)S_,!9JPG06*0=NMROL:S2"/UBS+1&.&9'[(*N_1;[[::/T[?DR&T_;JB@@VYRWS/%=]LP="#079$D<;4/P)D7YG-8 9.N60-_-6A;F M-1'IS^?2#@<*WUY.D9&CZ[5NDQ0Y0AY:"4J M ;G47D!?J34GXJY)QX=472UIX :0\YEHW#!<^<1R]>L+\,2-N"][^?;A&M%! MN'BH)"N$-F].7VZV%_FUM9R&D@-JB!V>4C3B ZVF+[YE=A+24I6N)DSWA665 MLLE/2==**WJG/VY[&TB%R?'&X_KO0ID*2B-$$JX9!BA&=,K!%2:PE:?? BN; M1QNTKYY0CNQ]W0%Y=%OLN9B4WT8*.6'[7=1]I"Q02\)@($)KD!38'JVB#_TF M%J^Z(J^,ZO=N[R_9V;U]>6J*T?T1,>6Q?^&6>]_33CV9O[D: %X>9?I@'_ M&/FX_.I_O=V%]D$9\62MDBO/EIRZ.$D!'#WU#?QV+B@A;;V8"ZH#?T-L4'A\ M;IP+8OKQL(KY9O/7;X;#C$I.MAGY.1*1=.9&X:.*2XYSNV8]1N*8EDC+=Q6R M6HFOJNB'EQT9*;&9VM-U2(LOMLM"PT)//2CL M[5I4\4^,#1.^0*1.:55-.K8X]_* /6C?U)CO4'[[O5\-0O<6@1M#A[D:-L%FC%@<6TL)^E\E9R_35Y?%;QLM)&S:NF6X&?].0-+@QH0>R' MJS87@Y4,TX4?)!EAPZ[L*EV$N0V$"DL-59=9JKM(W]/X!NI]L6XV/%N/7H10 MYDMT!\P.^A%\DQ8>7[$J)=S3 3-4+A\SFSG4Y,1^A_3*!["4Z1&4*(U%L,SP M"=Q5.^C=X-]J_4O!"U M'B^'6X/=?*X>]766WA/1WR8X>BO/^;J //7VX=9KLY9Z2@K>U"B]T+S4FIR@ ML-'/!+:6V,U)C;S'ZA>>A003"+,$]M&QM;Y?OZ,F)S<5__FV\=_:V>PZ^S>W M00&X&'HZL6/K-!=T[N36'BF>[:U#F#S$M_%=+).X .L66/PSQ$G&T-V;_>GV MY(A$LWWXQ# ["03F9,/ MXK\J<;JQ02"(J*!&5EP@/+48-G*0<;5?+OH284= M/ )Q'< SW5B*["=5Q>R4,%.(!3TBB:.$0+<. J.PP;A)[/V%=;F.FNA++BX2 M8:E3RILMYC/>L3L0SBQC+8YP=LB>8#R)*CP= 9O2@+[GW(M3?>V@V:60P$_# MZ8_@2;&>,C3GUF5A ,[ \4A%"XH@6U-,54\&BP1*Y8 [KQ$\1HHBQ)7[-9SU M;VE7AXOQ_?1>4-2_%=@X"B5-8??XH?9_;!I D\J(M;E?L\(=;(*\_.E;VU8> MG[JD"_:5]28=WOVK3DFCX"'?^NB" &V#8M\*'SO>2A1!:;/.)G1Z:O0K#P69 MV%"^JUK)=LP%&!P,K*QXHO2)F5N@&GKC:PK_$?[O\\UX4K:"/,T@#GT%$F^D MU09)$4.>I%%^'=6,H]IF/YP(E$J_;*OL+*UPK:3LBQ+FA,NV2D&)-5ST/TX& MR^>_)NUCL#3\M/4(>D&2]_S+''SJ6?9R"Y1,;?3G@I9.K^:9 N^X( ;/_@@2 M%RQ08;+5,R7K"/GI'SD3RRT%>=37ZGWO<:I M&W7?8G%!6EE@&;D65D[@=:PEGF2ZY^M.J'@6Q>G.G@'8;8^G)#?PP@QU\?1Y ME[ /5P<7VU KUW.]KT''+JJJSB=MF$I;5_3I/HN6ML/+)QK]'Y[@91[[4K3S1UNQ@^; C:OVAR^:4)! _JJ',&Z*&'7.90Z,!@1 MI#AN6M;;L6A>\!1\\6J>^7Y1F"=G#%T3L%#\R-2^%G^?V\_YFOF>)KVM!#_,X.SY@YWU\^YE J<=6QW: M7Q^<2@$.:._9]4EQ$U#L$YB @9KX64?83\QV\Y8B"I G'Z[2$D38VV+L^ZI> MOXKUY-/7%6WE2F.QKU]=TFWT1D>S41WXJB+<8ASS&&#/>#K(4H_,)R Z M!P+G190<,#[#1;4$%6NOW-/'7._[Y5V+/1G=O/]:H^5_-@"_8.$'6()W3P"5 MMC7TLO7AFM1#!=OF1O4O".2H.QY,]-0S.7Y_XJ2IM43AYK7O Q\KE%SF7'134_7"]^W&,:"(O>5;O@)-AS6!X0(_ZXK [O$-I)D!]+9A*Q;3!@"/.+'%[*KH= M3! F^<8T'*>+DU[Z$1+B3<)(O6"+HF??<>4$/J^;CVB;A^<*C.V?E$KH>N-G M5$)_/$W](Z(ZS@WU+?3'%Q64#\JE6T\EL%A&,[$L1Z?C:D'"]&.5'AGUXD!3 M0H2'WA^'<14L$=[*<:/A6^#;_: "'/#OND%H7S;Z;%_5AQNCGD &;8;IZ#9< M'O*TO/BIIA*H6]U8PP5^].RKC?&,M>!\,C0&7^7,DHKX?=D)Y@$4A-KO=Z\9 M+<(B2B&@+4U2"?8#U1B)ED*[-Y?===6S,I4^A-[O4C+[4>ES8O?8:L@)COJ. M(R:6,IU"XKF;&<'';%^.?2QJREXQ>N,S5%+X9OACL/98460D"SN!":[_7Z0-"KH2K_T,=X;>N#3JM2PK&7 M="R57'<'QL3AU.AZ<9@%/&TO0F?ELQ203->RC9UW72T044TP,?IQO;9&A@MR M#HMZ,'/K6'? @*?\16RY7D)>R*=X0X08;:$N@AP):YE ,8DKL7KO6 MP=F5@&L"3+6))TTA?,^NW,+J]WR?D>!;Z65)BSO2(?>Y("\[" 4= _4U=:;X M)IE Z+ZM.;WW0H.D?ER*L@LP/:?\[L-*"ISQA/#3NJSP?M#UI*53.+G#(=./ M>/;@_5NDH-R>XDE3T.061FH+,O+Z25,Z)[DGJG9Q!UV (Y1+P@"JHW$-OC0J M6: 5*X;J@Z/SW0%3.D*^ 9&UW=5@F\=OL!'/]U!E.6"O'%"+#K=0@P.'KT><$U<0UXG?*UMU_GOIY43F*<7='Z M?@I-.#C/<* 5C2[ZO^KPI:LY-:)EQ]TM+TT9KT;?]);:5-7?Y((NFBMVO(LU MW[ZU^ ]S>'6G\U^S!S_F ML MN7)5;_1YK/6T7,6*SK&,R,UP^"";K ]V=5V[LW87>7EV&#F M,TP<0TOI"DCGJZ AB.\7"&< ^/"\$Y1=V"3%0M-K%T^\\C?;/6SB1>WP6X^V M@M%*#9+AP9\OE)45W*[9Y69:\9C_<:KT"T763YF9=XQJWX2$JO1^IN6@/[," MD"R0&)\;QT>;&N''5J;O!]AF0G\PB1TEX;:#?5^ (KK4>"MTUU'T5?S=B*[+ MU1GN'EZ4G?@"I;--*B,'4],/'V6D='M=3U5K#V&.*><@@_QB$7;1/G1ICK > MTX-E"83A6+K8-KS(FCM4[->H[*7B*#(N@9%E@/7)W7W;,L.27S%4(T'^M*BG M*1JSVG;=MZ,V@KD@B?%IMX7'08%^.39*^VU;A[ ?]0?7QU&6'US*@]]O4G#S (@=Y*9Y_ZT_CB*NP2_H5K0%"]PV ME)__%@;'<$&2ZV!,-K'J&Y8J-VG0&=&DBH7)3N7>[+?;L599U7/PV F(,:0M M[?%R/%X!Z4LK(,^D4!#LT_E]0/EU,^'CM%;K;(LKZV MJE-6YP7R4C5Q"FL3/D(-&'F;87>X"/^Q!/YS,F=1PD?ML^Z!7::.05L+3=.X M5=^!J6W &RH\$24*(T@S"ALKAY'\M($M)QHF-F@MRL/8;M3$*A3YH]K=W?#E M@WPU3;B*<$.;V)G+NGVC_J\0ZLVR\(6(EQPBMDHZ]FB3"M!%J>V22U5UL+NS M-6<8M/;]VFKY9V'7J^JW37!WIQ_M]]-7RWBTJMJ.2\F9:8>+()R;N:"Q\!S/ M.!);:>'.NO8L@1EO#/;5KZ9Z/\A%OC0NDL*46D&S& \((XG+AHSB; ^%^$VJL_/BY M5>T3P:IC1_HOXYZY=*PP+I3F QQ)XWZC +3;2A1E!M+0RTZ5'Y!Y/Z,+3I>>Z+T5TN."4K&2ZS^'6!84C[.VBY?6'RI& M[EMS\A25 +TMB',"W53/QGGQV8M;\9_-.WAY6.):(;-;)6+USG.71(>\@[<* MRZ0FLWVBI2=X3C'L2=S_[OA=N3,U.ZW!D=9%VD@T4P14R5-%E$F85?],_6## MB4+3^@G8V;=G7\HEYF-PRC(2#W=Y],0IRCM);D;0VCA".\A00&69)5Y@S7YG M!N7T$JND$QT]:.78UP'HO0V^=.^T)_HT]29O$WV7>!RE<4!=L[+3- M$$H?H=K.N$-,6(:SH+'Z[ACJ+"*:^S[=VG 2>>,<_A36U_$WH_$@E$C_WWOIPW^9?//? M#>FLQ9+[73P+_Y%=J('VMW,DU11%WRX*U G8LKJGQ;*+,(A?8VYD]$22!SV^ M:M]3_7:5O[N75=D,BK:CX\EVQ$YLPB@,'-2D@:AM>1.U,C''$<3'#Y[7EO3Q M&X@\\+@MMWDYV?ON:P+UX9VYP_QI[#S.#J09^PEG%\*9$0TX^80()#0<>&G^ MRM\V\N;U7&KBR565AZO*Y;>69I:-M9<]4B7^>[K_':?[3P&3_V0<[M]N_WL# M+'_>Q_UO6_UO6_V_P%8]5=ZB6B [JZ//S5RJHSNGCMB^F?*7TI*>>!M_7>,D MB*:#D"\9]WL!%N:"$J)8XEQ0?FT7&G"]S.-,$-HR.A:]I@\LAJ?QEL?[.BY(=N/L8?Y6WDMX&G\[KYM!=")'RAE* MM6(9$TE8MDB3,4_A?IYA!4X>_G?^=< XXR[[89,<0HX2T;J\QR_O"#VREJZ: M5/A^R*XW25,Y9-_=#RO?L8_>&R6MP_ZJ(Z.^= SI6S'=H*L)1(].J]Y1BMI# M%YXS.-8C)_7!4=0NR>IT1EY@G]__F9[]8X_[?[%?EXKW!H\)DVL[[..-$AZP M+E"PTF7M"FI#I0]=$2\I$BN4YR]]S']4#&W@G/YE/\+1E;"67'N2[UT<\L#; M^?.P[C"*W*+%]=K43"??QQ_^4"#MEUV3_2\VI+MT&\U$E/ZH&0C*LTP;V9ZD MG_E%V^D\G_*ZX?Z%:527)1>%9[$F!"2Y('*7- M.@)HD=0Q23!ILX-^'!G:Y/-3MHU1E_&V[M9[4^(CO0]Y-=D^;:MX,9?V>;S%8 O'\$E(+C<)],X)ZEGJ0E=VW?(6;7AV[5&-NOC] M8$.]58$$-)R8 *.YH<>BFJ%\Z.L>-F5=G1@16X/.Z5B27EON]%UIF4-W(1V!N@2)ZD:W'[74@IZ)9&-D=(FN;WM7\S>2^0 M6AQ\A+T0.=;5&&H&X77C :IE2@/P>8L,H.$6DVGCCC148@3#([##")U2^G-P M;;-&8&7F@\WN$/U6N=U6VV6!;!<]H+35V.);"FCL1/[1J0&W\6O8>A4N?CM.,5XJE2^+4(#5':+I6[ M^C>@I#(TS3;:[I*M%G"XN$4_M7"EO8=N8.O2QG#X>?/%BJ'JAW7<;1HF!:E$ MY9FD&Z*K&75D,*SQ($=+I\MI0*N@KN;#']306YUG/WPRB;5 ^G!!.S>!J)-T M5=9>7M>=$Y 6^6/$V8VI/?5)C$[&F$H\69;S2Z?^F!HI[46L"+*2)*(/!93P MK/U.9/B8- .5Y7&<9+]H2_9?]S>#M!W@]-*6'RBYE_;X@*V=\@;TU#YX9,>% M+\8JOH"\JR8;U;(D5CF"/UYP^@*91^:A-;"V:>7V\-B%UX(S*_;@''G6*SA\"]$\[#,X,YOSTLV@_*I-#.)5N]4&TSB5Z1.:3 M:2J*1\-:HEB_JY 7]*&]N2 1WM]ZRRP8K9*,QS1)OTJ_OI-C&37SWS01!74I:37QYB\&8?=>$#S>'VD\W6/0@ M2V!/U^EOL1C9G7.CUD]1:Q'9Q]3;_.99ML?S890.9"J/N1U #6.E\+[+WV?( MV0O%3%/6:?P THJ^W)6#CK5/)M5S0;:U [E.P45I3HJ)/CKF,B'WWKO>-%?$ M_#_E76D\E.WW'[LBDIU0UA#38J<9E*W!E.=!&M,00Y;A5]:*&;NR%B$J4U)* MEF1+-(.Q9"^R3C%C4CUEN*A&=RCU8,U_USQ;MFY^\2SM(E4SM#>E8_4 M@VNCHV[G+X@\ +(%>F5)4)1@%H!R3NS'&*=IDU*&^_2OW*]KN"AZ8$F189"> MKJ/-D:)=B8W]2- (R94GTA(&L+Q*$A2_0)#ILF7 K?<3'::3/$2]%MZ !XJ+ MJ"9S:9)^?IXJ>P/RN)8<.9#APTLCTVB% KP&( HA:'5H!D'!3A.V#Y2@2![% MT>^AE]V@>V9@2NJ7T='^?;=/K_0J2!^&.^(7X(#'!&B H12"^M!^J$22-VA( M#VNI-Z"S&Y]]K[27\KFG 2H]=+L!1"$:<&]C)7:Z MOS,_TU#];H4X]J/JY8\A.==%]YJ@P)1S]F\FL@1&L)2.Z3=>MO6 6OC*GOX[)"T=)[5C^'*DI^S7+GF;I(T MN%W#YR?8ZAD@E+Z>&[R2W, -UE_V0'3V@_+S=_Q9IL\42ZJCYA?J#];5 M5M,8!A4CH"S'FS^FU:I?EM" 'R-J=NDQJ.JJ2<^H2Y+?WX;O[C&0"+*3'E87 MW2M?Z12W: J497*3Z1[(;I+%6Q-SM+K?\XI!G\EUFE] 9UO)3C>%:Q^.'#GL M)2LJCRDB/H?VX:!\27E.?.+4]F-I;B#IF '-H$^6*:N!GZ@\-AME@9HS,B@G M5'\8YXJ?*'RZ;ST?I=IE#X&?;%VG7F7; >0!5W(H08X_11)O8FWTI9IPE>.6 M(X*GL096U'#,6"0SRI'X*MFX5.!)%.'\'36T=?EPOC0+PV0!Z1[3OZ3FZS;& MCFPN*Q'W_DGN,WTWHO!F,EW]X3-C8XB#E^S);MXUO-(B]RR8VRC0'0)V"-1K M65=. MZZE+,N30)5#'@&E(PV1=T?:;_\ ]Q,JJ3S8H34.-?)]K:&B(TCM0J^E2ZJMW M;<)A(>68EK- PW6"Z8YT.=7]0])X2X@64)39LC]C[^,7G.ZU]WE8?WI=X?RW MZ_)IB^"0$&^A2VX!MC-E?81_SVV7:.OY^F T*YH]"V+HA;NI-_3?:PYF/RQ\ M\>T/EI=A$K?7,$Y35PZQ*"7[2#89Q3G#_ M>BD/MJ$0]W3Z+2-43B=<#8K1:^K8%R!>KE,0 H&H^4 @8I!D"8X]?A(.V8)@ MD=E'N?Z\:A@4)/3 U-K+]Q>?86E6E[YM&;MW%?F;='T3.GQ2Z*/";2RN0"3P%D-4 M+9<1FD(.&4$[+[%S>5617)OGB<;N+U$FT?T_G=@:>ZS+[?Z9G8#]?03VYNW( M)CL_)655G1X-[J_3:B+T0ZFV[ Y>(SEP/8>O6MQ3:<6*R@VL 44H =3D[%6+ M@N)O4V<5D8;0J$^=17N4I7.8]\:'5"26".KD"\14>'-HYC*+.+B42]("LN[$ M7&J;\;5A/]4@+ZRIK_4(-WVTJU^PHEBO[HHABA&BH/,Z[&Q6Y@2%F*&E^6L7 MJJ^ME!SV$J!\,&]XW/9[L/+@FK#G^0G- ,=RACD@RY5##&[" 2\R>""4>5C@ MD%3!B7QTEQ##&4P&D)ZOA5V33*I/8".NF[Q="7K9X1 Y>?+EI;/>'YO:"L\+ M[#@'+PG-(=#NDO1Y3_A:&,3]I-.@HJ[F43"&@3MTK?%7>?V70J9K4>&=X=*Y MX7HY6]4,;$F;D+U6<%(X^ 6(8%\$XPBL&,:7_EU2/7R5*6%>)YJE]$CC48M3 M@6+"&WO30:&_L;=O0'27.PCSZ>P/O)MDW#&9+4@?Y@61*4=':J+"O.JNW ?8 M=<6(X+%[E;'^;KLC+2:'17!6!N)=T6RG%E 0NL7.\4K@H1/4='86H%G>.&JW M.\ZJRZ#VC$O,(X=&SYL.,?A]MXYT/6]1/MP]NB/?%#LX.J\I58-_G54 #A+<@I\'L@/?=$Z]0:;"I.CU2JG[-/!U7^.'>,FC+> MIAFR0^R:Q+Q6RQ)7 <56YN6U\BQ[":U0IC>-+!J^T.*(@Y^<-:\N^.:*4)17 MR4*?/RCY4T5T^.;=]',U-()&HO%R=(;9^C4M&3OTXX@_,DT7RLYZMC[$N,1% M7!:1KKN)4#74EGMWZT;$4-GV.G=TLJ(Z&5JR M5(S_(JHMJ+T9>N0PXNI5;(XDP__ F4W&U4[+42T Y]O#"Z*MKQYGO(8[O8\. M 2-JN4DL]'K/@?4H-0^2O+(<=<$U M1XT,$P(@JKJ5D$>U^/W E^PN5-6'Q.C^*XJE-37HQR.=NQRG];.PX_&OK(PH M^_[C$@[A"GQE>LB&5N8/;B2OHPZOZ?^UTH]7LQ%6ISWI;J]Q\,-'*><\ERV( MZ1;DNVCB;W%4]%^89QMO_LV4[Z"AX[44$@UHV1EF.,^Y0^WO8QMWG:5.**T8 M48,+#HV4G*^1N.&ZCDZ&X'V^:UH !*[3TJ,P#% \EUR-'\8]O@V;N=/_A?KY M)0=VE'AT2-OC7KS&7'^R@&:).LP)%S10F&G<:GTQK?WZNYI7M[77 MDXU6Y"XA%T.PIVR*NJ6+C#L)\Q'LX*O-^"U(,S%5^C/RT&C2?FP7*:83YA-3 M&8.6R.>K<:W!27!@DRV;:>K<]FHV+[*^HB=S8T2Q//B6"E6Z M)@*"#QS4[IIBXP%DG@!H-Q !?[04?^?U[0>DOZLA!0A0O??H!8RTG5-#V(MY MHD9X4?WD4'*$PO +\ZH['2H>*36K;R&6=CG$1V8"UXG:%P.2\)-K$$C 3L@$*S2':TE#[OR&MV(5M$8__D?-@FC. M?O;DXYL]QJ@+IX8.-@RNU58UR\^)8+;O R'X%H0>J^W.XP*&L071^OK*H%]6 M),D+(Y]XCDVE/[Y'?^VXY#5MFN3^UN:?=V?L,Q\KD\-^#'0_2%GZ?/[8QF;L M6\I%*>J'$R]L5D-O:;J&[<_W2UTOMM>J@ -_KX-Z@TP_AB".1Z]^K^%:356SX -+\PF> MP$S+'_,NXH4ROZ*!7I7H^@ =_;#C_7NOY[54?:C-NJS@^Q6^.L^YQ!\CM$JL M,H,X"%!V&7\SXCZITF#VX73<@?K/ +.W<7UU0RQ>?";1_XCK"UR/XV51^>_3 MP#I7T98QC*%@$CX:#).-!VR0;D/R@*^8"7-[NV.-^W2(W=8E\*),:ON1< M)Z1>'NP?&+S3[XS(&W@@/&-SJ:V1JY2^W,Y5NH)PB\3+@A$]UVF$]%=K][-$ M68=RS)07^L2Z/YZO,RVR)GVJ^L\P(9[FOYT %BO9;C:&G]%2U0-\!S#4F.X* M3&\T)+' VCGS*GY\T78&I^>G78D]@>4/M95[,QQC$NP0^X47%3B^"P+[O;L% M:>& ,K-T./,ZT$E1?E6G%MCROLN;]NSKRMO6:[V1INP$;4.FIA-G9MEZV?^& M?B!* .B'MB O)GCJVS607)U( C@-\>$)Y @7B$)NR^XE@^>VF\:8FI,E_,/; M+6Q$;@XW%FY8^=*?&>2P$I$;[(P6>8$\* + M5P$V'["J][$<_R1W0%)A+3(OX-.?&=DL>"@Q!;9C-H#ED@X3 M!^&N[YD(=;0+ ABK[P+6O.K;7!G2'3Y8*[LTERN0U?]:%O\CER_3^1H,#0.B MV<$$]9&J^E%"JTRF#B'L,FK@MLD::0Z/3\KC$4?Y>W]?)6>1?2.*60G=R%3" M;O,:ED$A3 I$HMZC%36W(+[ 2OWH:.VAVG,G#MIKB"?>EZE5?="1:6KRV4_G MYG$7[4-&P\X.HG&*/R6X2H.H=[]D05T"4SFA_ELI^R8"R$:UY2#*TXS'3*IO M.JD8/+-]55M0_5RD&..6&-1+4@8\,R4RN:KTSETZ[JW2)K%,TS$36G:,$JYI M0+C!K[Q 0K=X\0G(H"=0X-??HJ@"(A'W(#'+UB6DI=!_;!S"BW-$1$',9> MURU"ZE9 ?DOP=ZX(=@44# SCF('M; =!@*9B]#^1I;J19:W^NI3.[2]['5GR: E_4L*3.,, MJ0S@="_ ,G$Z445+SE/:K?F%3\^4.)@WV6N&L2S9([Q;,*DDS#N8$!?#J[+; M3X]6 8L](W@2%/Z^V?W-E?R/_@\2NV9.S6,#%#3&FI[+3!46DD.0\V1ZO(#5 MB'T&A//VQ%>57XVMKVP0'\X M4?KC1,.)(E=CYE(.IGF]&UD Q1H,D--@NUGI88\*[BX: M,-]W&(H(2R+P.< MHZGW7HY+/(JM4$I_ &)*46 !W8@J@4JG+%60U5RQI'?1+"\L<+V5F] M)K\N#NV\=B;K8N3:0UG-]3#!$F]PPPFJ^$&U[7YM2^R$'*@R-Q)D2,,T@,8T ML]S,TL]2UJ%YB]]\ ]TX)K' M3"8AZ?51T_6M:'G4"T3NU=MS 5G.HJ$O X?O[G: S/:2F^#>Z,1U"/G7S#=D!):<:AU8 M^6!O@U'$3Q)>;')W"_CH!I#-#@1+6$$4L@!4@%%3%))B\XPYLHE2^TTRG7DV M@]E:N="C?UF_%)TW7*?C5.1;8/F4(\ 5SML908MS5B] -P$J[GW'AR:%@>3E MD@X6[ &]WB8,&O?1_CAG**=D/K1F?L&QUZK"_3@.UZ**/8_E2/F!2. A0_%U M60[,F"OQ#FHN%Z[C:N===6;QXUG]Y:0JVG!*<'%&O'_Q&+R7 ,&+)DJA"OL6 MQ4%#NH:R5Z9?X'LSXJX%JF=JJH^PP.,)B::GOS$38BDSIP3F%"]0!3XQG:'? MP1%*_,*> ]I3?Z%MH,W<0)8$FZ+WO@GF@Y2=L]MWJ]))NMUW7SI.7H4!OU"< MW#Y)?+[);.8H\6>N*#VE3Q^G-3_57?P!:>QF]S/1>6C1):@T M)$C)31 J/Q6CM=+P&EPX&/'8K2K)&K HO._G85T9X2'OGC-I<*OVZ:6;1FE] M1GDW[Q[0>")R_G^XA?[_==W/=7I]1^?,63[K^_/^?+\'_F<^!5AWQ-+&$A!8 M)0"<@_\!_)_ V@,7,1<\ \ W@3X(\ A8)7 K^W7YZI?VVK!7Y]"JU<+KA86 M$A;^TQ 170,/$6'A->)K1,5^;?#_),3%)'[M_+K)_W/I*B%!02$Q$6$1L7]Y MX[\%I->L.K*J7%!@"[!*6D!06H#? B!@&87^))X \/]N JL$5PL)B\!BB,,G M5*R#Q1<4A(46@B6&OPV%OP=62PO);-YU0%C6_KS(EJMRN\.3GZY1.UC2*._0 MRU#7OW M0E1,07&]DK+&5DVM;=L-#(V,]YCL/738PM+*VN;(B9.G3CN><7)V MO^CAZ77)V^=Z0."-H.";MR)O1T7'W(F-2TF]GY:>\>!A9DYN7OZS@N M^:67 " H\!_;;_62AO5:]3GY8TBJKI.S#D+USK%5-0-Z!J,'^I]B?-_IAB$?]+FOU_BOU/O4B A* M[#Q!:0 )\+@Y<5K ?Y=!V,LK--?C6K.%&)HM2*4&)2XBOMW13;G?:X!09\(' M1&4F4[\X-\MVZ V/!U],F! (3GCOTXS%LR MP\SU^4#$ 3[0V$(N$^'*XVENM0RD%1M\@35E5CZ\J%>>(-BB_,H1,7*C$&]" M'[ J?(=$W^HN2*UC7V^^M;6,J8EB<$,NEM386J-8,[O"HRTG_,<:'=9W=G;. MO^8D0:**?$#(G7T=_O3EY4#R7*?^S95]=4'4GK#1W?T-&L'."GOZ9S^44 ^6 MM:Q/\2M8,W?89@^)F=(MJPSP]KY!&.P9J@1#W#7]LX: M(%:U4K7W=+/J:<'/TK\NBC_,'KV1LOY9U7V-U\.RA6UG33Y@35F+O&KB9,AU>#OS=E&50Q\BZMJL[7K=JGUEDL*+TM[-MR+=5",F%#* M#<^-G9!9)7'.\@FB&KFJP8AKRLLS7Q<,CE4UV9VO0$BP"X[9\J2.7SH*>E=> MNW%$OEH@[(M^9,1ND2-ES!#:4K->&"@1V'.7K(3U.T_M$0_&H%(X+H.+)I6' MO%>M=4IRL'DK)N!Y0?Z NB"3#W!5)AE9[3@1.!@\N)N8Q%CP4H]B<)D=4[%9 M1]55LRF3GIVQ,2E&SK*EW7.P\LJ7O??>(LIM]2\8-HJH:Z[H3;I;:<0'9,VUN!8H,9>I^<-7-Y54 M)+:MW!Q0-7Z=<&#Y3&[TJ454&)IASW.A$>F%5SFKL7:\5*PO8[I]+[JYL$=Q MJDJ9]_7QAXRKWO*+"7DZ!:XNUC26B?+/@Z[I"G=&[@9.:.&O65[WDGKFTSY9*B"! ZI-D MI6(S8[E1S=X <9[*T8&J9/4;CJG.J*LBKGEFE0I%*:+"NFN^# /D'*(HTK>' MK:7'E5>CDKFRM;19NA/'B>O+Q,PL,N>;\=+T+*IF4Z$X?=,9GUNB#26567Z1 M+AW[)NH.TD*'4DW;U6,5!L5&G1:31LH@<0W.)38:DIQC;X/#'6![%U2FT8AW M:CZD/N,>9FI&SUS0RQW&5^1_ZG[Y(:45HSY'RK.>4\NS_"[X;:X;P-5-I_H: MD70FVF,,IGV[#YHZ*3?US=&+J-GG\G+,7J:L'Z@4N))X4N9@Y4[<3C@$]H.- ME[ :\(,N#T$[@KV:R650$<66>'N(Y/'L>69VM?R/NA3F;/\:]P2CVT9Z*=+F 265A>C9D5TX4JV1ZIXS?4.+K/9343$;[(O-)M M6#\9L2;_\=;8\$0GB5RCN=MI T4X^)GKZO9Q'$:YVK $4>PQEB_OA3^D8!P9 M\*[N0"B8\\-HR3DQ-]"S8?.;\DJG8D&-^NJY[S+W42:Q\1?OR#>'@))Z!;[:3==QO<$0RG)T>DN[PTR M/O:-\N5,N^V'7V:?L\V_FV9?VR6!NV"S(,76R^ ^);*B^$!I"!)*2 Q3A$3E M8?O9?2)2BI!"BPB27A.RC,#=;"[UFBG4=B=E:E17,6A)\4KKZN+3:XI.K3[S MV))UWXA"WKH3=9U1R*IF,\=@Q#%MPY=:$CEZDS7[JL(-=#2=/G$O9B,Y%A6? MLO.6O+U9E\R;4FRV^:H\^0$Y%]S'W>C$L.,AB6$^<-]Z"L\Z$XCGJ?5/TY&1 MK1F06 )SL5=D!FGB#).8*.[^0:P<4> 5((B4@(K*A(SSA1I):IXK]/VJ;I[^:>N M3D"MD_(V7+?*S1MT]7<-WK+WBE2;S@HN"C>$PE[/PGW))'!EDUA'A_C 95'< M6BGE2ZJR(>ZT?7O)+0>;YO84ZSZI2*!(KHXUTG@<)'SIW7'K+\&$"#[@)<76 MP="%&(HL#*^T B0IMSLQ/V7,,%^BKC)\:2)WRA5+^,#M=MN:^LR>HW%3UK1H MDX=;.9MNYI[RLHVP_E*;]8U($G'FU2!]B6PC9#L?8-CWD#195*9N+<@4GO#\ MU+#ARZ5;/I?631YG/Q-?O[DB4>5B-HFJ4>5TN\GS]$'WX,_XG0"N#VS<1[P< M*@6)"7$V!"-830QRA"[7V'W,5SL^*U1FA>F5/F 19%@BN>5E=,?M*N#*6\=H M.&LN$BFE>T&N]%BSN21S*0'6QH6H\L-\%Q&/JJKN,SN6GF%4E:SYP)Z:(GQ" M*4G(]>RC:"%'H +--AJ!CB?==9GF;# 0X MYW.GMA5.&M64'K;W+THY=WO\N8=DTN"K(5H25[Z9]1$V^6VP4=9\.ZZ'7"%) MH#\D<(\S').R?9%W^,!:["$J???(48M*%RJSTFTD\%RW7L MH [[^D+BRQQ_6(-#2$H6L@+=")*LJ 2Z+^TYT9,/W+DU\4AU-^,GGMJMZA30 M+%%B&RA4T3*HMUT\:\OLNAM!3IL????_=%QJ^(CVMWK9%K2,N0%\JP.7*Y!1 MB/+*2IP"VYT:FDV@(24G!U<":OQ+7OADO((NQ] M8ZCUC1L:!)AR;IN3SC"(L<;O+IQY,F!6>'/+@TZ)"R9TVG)G M-"A]U '/Z\7C=E5&['J)YKHH.*:$SQO6*;OF-HDN2%XW1XX:MH&-C+T*]W!2 M4 ]N]YH7+YV")7BI2Z\A8/;XLW^@/^%BG+0*T;'/YCN0PI/-S0A.!O;6]38^]QPH2 M%X())SV2%M.('%EJ@M8,8G]*UO;-WLRK]-BBPNK;X MW3WH_,W&PTD]0Q=3')+PQ:V'F?;);+DH*OIF%6T M88+^4:AWZ%OBJF>VM>^>@3N/S(^TN@,V2F,VZX_<50A#'IZ.9R#H(@P\+:@5 MHX)=S]"+>SI0,1N3=%XQGE*YG(K*GM/,5+GAGXVY_W*&V*1^=,X:\0#/\(/9 MF=PA5NN?\/$=604GC>M%J%9L92+# DU#D?O9^'SO&_8^S!$WBZL5#]7#Z:.7 M,H?CZNZ5F)\;75^,^H!G>/6$0_K86[TX0ZS/ !_P[;GC?+BY/=W87+/OE?## MZXJQQ5Z5;SRS62'3)C^Q;]^[!)RP2KDV\EQPH1\2)<-5S \S,LTJ8M,Y._'# M5JT-0@@A[/Z 7IJ._]C[^-.M+:]QQ^/1._$M1'>8=B; MJNATSA7<$+X*0W?GZ,'X6,ZJH#T6I-8O?DBC3+\(<-T^.(L2?>GF+![&&DPN M[)IHB?E^VJ[K\9MWA$=(RF-R51!7?IHURU;B^!C'(2EYR@U)4F_!M1M1!S[M MJ)/*33CF38UW2M$.S#2]U*>EP0'F'VR^GQ;?&1SS0!V (K0([8C/)R#Q0([S M5S@2JX@R<'8\Q420DH\O^\Y=ETLIX,J[-\*UX;C>>ENF'LTQR2XCO@@3 MD" S9A.B$OFB_(JSD]TYIG/=P:9-2HKJ=2.E1B_#.00:D=6\N( M?F "M)4MS3&?RIQM#KFD6X79ZY7:AKT==4+2)NNQ[,'K- MUNM-J?LWM,_ Y5A(F2W(<87ZD"I\P!,1M8)_2,!*,@V+DPDFCYWTL)\%;E[8 ML&Y+3>+4I_8](5>NQ\HY$H?FS^<%@V=@&G0%MM(8*$6:'C7ZA('DN(ZO*ZL^ MU=D4GU5(6;(;&'9_4U-];_QF.BEO:Y!9U7W\PB#Q$D@I_U4R37O8,&GDRLZW MXN']Z')M5U0+C39BQ?!+8&_]NFCZ3'M#JM"F\JM;NG8=/P!J>SK>H @L!E[% MF?">-,AR][*K*& X;AOSY$XV@:;1RL7)]Z9^RYS<4:0Z]>T"L5GN4ES^"B;= M<.K3/XCN,VJ]05=]\Y/7)5QWM]LLM[4^@0,RC,W(1K#6O<&(B(Z,?!M$FZ M?*3;N#D5+Q7%/;ZE?^;$)(1<056^.[/]I1)JLS.1CUU"\8? M'"S?MY'TT\E?C^[5TNNDGAQKWI:R[M7.GYP;Q7(7(3BK@NAPY5L-%[+(,'-Y MKA#O"7@9)>.&ZT;*![J$%*TEA8I8WG')"F/EM/E6E#A)'/<1%K[^9D_E0V/S MF1* %\MTJ^<#:PA1%7IRX$6W*<1P#78(?:[__+RN+K9<;^+P0Y7QRWZG>M3# MT3O 1E4BY<7LG_IM21HJ(8EC$!Q)Q7/5&G:]^1@570:RWLQBWXR!1B9U#ZXU MXX;5ACF5Z[\,=^_O@WH1TN:;<'U\0*YN%^=,<+L=PSC:H,- *F;E5$)TRL=A MWQOIZ$L#A">O M638Z[4>>-Y?']9)%H3W.P1\X5,T[8!65H1E7S#4N[BK8NKCW\:N=75)IR+A;2#K(%&P>E!K# MKR-)K9DTRM3_7#1<6JYF/Z][6:/&6.#A,8FV+<<]]=,[P48I)*4*4>%U%Z0\ M1)8OT8F< *Y#-3LAD!%%Q>^OR+ M>;U;WZDZ<N--?=%ILP3S M#7D_HJS<,1%Z6\IUJ>:EUNF!S-HQW$.F'KHFPZ&:#T2%YV1A2H.CV^PLO]F* M?XXB_+17+_/UE&Z?>W9#@MX=(@_(V5O\+P_Y"3Y0&=C>DLK9R28?9%LP,&>8 M0W<#_G!-N3OAW8:(*DQ$K!J?BK1K_#6K.9#.UC"$8^;@MV6[V=V$BW$-?D M165AP=$5I]4_+QU1ZQ"5"RNA$_N<)9\V(@_G) M']Q7:B&Q+LY&W B9X8!AJXLD0I)?V)K-).-6O74^-Y2_15+$0Z^9G'\=/3@U M>JJ/?/Q<,NI:;ZO:P]?W8O/GFM=_/$H&>_*:17V8M+JX 35(*N&&B?*!D M"$TD":<\"4J4;_V85\EP#%^L?6>X\8+MH&D4]&+?HQ07E^WTDRZV-S677;]^ MVW%Z#^]9' #=Y,+-P.J7\%.GL'8\.(=\D>'X??8SAS++E9/]4U78 MQUW#>P"IP64"J6/F4HNXNE"?_,X%[GE>(DL2),8C,APID8 M3BS%BC.Z6C.+4J=6'B^D.+O:E>X*VF*U>O=(MYSD]=W5BFIZKTT1"/A2N,HU M[D92GB%*%=]B1G)A$J-,O&!WK?\4FTY)CZ1^S<](X!I>T2U^[_Q^U:BCW8G+ MDG [98T.N9>U.>/;#FG$DBXW5E37YZ5OK]NM[Q.NC@+0Z_G[)[$5WK- M1#'56*<_!98]LQKK$1G]P?2YH,,'+F2>N1-][:%*DTU)Y[B_F*7E=;<""P!G M"C9*=*\)$@.ZQ5)TVP!206L:$9W0307Q=0= M.UI9PO!XEI-11*4KVD6?+*M\4YVT=-W5H,HXM?."CHQ*N+)9!-*01X/UA[E- M1"S8N)4/>(/L;;/AYLKL7*=?<1H<0\V@._&J"US8\[1O^,(?']F8D_W28EV% M;H;YPZGT33LP\J7L3:/FC%=&. E&="YM347(]+Z#HND_ MM>D':9^PS\=\[Q3==VFM[MLS'G1A;DT.=YY!GGD,W^,VBKU)[RZ1DO!K"B;K M)%J6#3K,&C> , ?226PHJH4(DS'1P45Q-W_!" M)Z]4[^NC;0[7E%24UFM^[V&;P 4SGP/;LO$8M ZKQK;@: ;O;C]![.6Z@\]] M'3.+B^0?%T41/SO9YP69:)#7/)5/_+8Z[.D#7#:,6\EHA@/QLS;K%6R#K]QC MO"R<1' AZP+3J@D?@Y3,#D6-K26.N?#,3+NVDRQ7_!^E9^@;#D3Y?;>_ MR^ M^6[D#0D'U_:(S[AF2)%72Z0\1,A @E^M/'R?3]:(3X]*U5=[Q)EN1*$LLP7K M&\XD?W+[^H51TK.9\,J71HXG,JPV*M(*N'(N:%Y=*BN?B7OXC#WVMA*28<

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�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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 122 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 123 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 660 514 1 true 130 0 false 7 false false R1.htm 0000001 - Document - DEI Document Sheet http://www.invacare.com/role/DEIDocument DEI Document Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Statement of Comprehensive Income (Loss) Sheet http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss Condensed Consolidated Statement of Comprehensive Income (Loss) Statements 2 false false R3.htm 0000003 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.invacare.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 3 false false R4.htm 0000004 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 4 false false R5.htm 0000005 - Statement - Condensed Consolidated Statement Of Cash Flows Sheet http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows Condensed Consolidated Statement Of Cash Flows Statements 5 false false R6.htm 0000006 - Statement - Condensed Consolidated Statement of Shareholders' Equity Statement Sheet http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement Condensed Consolidated Statement of Shareholders' Equity Statement Statements 6 false false R7.htm 0000007 - Disclosure - Accounting Policies Sheet http://www.invacare.com/role/AccountingPolicies Accounting Policies Notes 7 false false R8.htm 0000009 - Disclosure - Receivables Sheet http://www.invacare.com/role/Receivables Receivables Notes 8 false false R9.htm 0000010 - Disclosure - Inventories Sheet http://www.invacare.com/role/Inventories Inventories Notes 9 false false R10.htm 0000011 - Disclosure - Other Current Assets Sheet http://www.invacare.com/role/OtherCurrentAssets Other Current Assets Notes 10 false false R11.htm 0000012 - Disclosure - Other Long-Term Assets Sheet http://www.invacare.com/role/OtherLongTermAssets Other Long-Term Assets Notes 11 false false R12.htm 0000013 - Disclosure - Property And Equipment Sheet http://www.invacare.com/role/PropertyAndEquipment Property And Equipment Notes 12 false false R13.htm 0000014 - Disclosure - Goodwill Sheet http://www.invacare.com/role/Goodwill Goodwill Notes 13 false false R14.htm 0000015 - Disclosure - Intangibles Sheet http://www.invacare.com/role/Intangibles Intangibles Notes 14 false false R15.htm 0000016 - Disclosure - Accrued Expenses Sheet http://www.invacare.com/role/AccruedExpenses Accrued Expenses Notes 15 false false R16.htm 0000017 - Disclosure - Long-Term Debt Sheet http://www.invacare.com/role/LongTermDebt Long-Term Debt Notes 16 false false R17.htm 0000018 - Disclosure - Other Long-Term Obligations Sheet http://www.invacare.com/role/OtherLongTermObligations Other Long-Term Obligations Notes 17 false false R18.htm 0000019 - Disclosure - Leases and Commitments (Notes) Notes http://www.invacare.com/role/LeasesandCommitmentsNotes Leases and Commitments (Notes) Notes 18 false false R19.htm 0000020 - Disclosure - Revenue Revenue Sheet http://www.invacare.com/role/RevenueRevenue Revenue Revenue Notes 19 false false R20.htm 0000021 - Disclosure - Equity Compensation Sheet http://www.invacare.com/role/EquityCompensation Equity Compensation Notes 20 false false R21.htm 0000022 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component Sheet http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponent Accumulated Other Comprehensive Income (Loss) by Component Notes 21 false false R22.htm 0000023 - Disclosure - Charges Related To Restructuring Activities Sheet http://www.invacare.com/role/ChargesRelatedToRestructuringActivities Charges Related To Restructuring Activities Notes 22 false false R23.htm 0000024 - Disclosure - Income Taxes Sheet http://www.invacare.com/role/IncomeTaxes Income Taxes Notes 23 false false R24.htm 0000025 - Disclosure - Net Earnings (Loss) Per Common Share Sheet http://www.invacare.com/role/NetEarningsLossPerCommonShare Net Earnings (Loss) Per Common Share Notes 24 false false R25.htm 0000026 - Disclosure - Concentration Of Credit Risk Sheet http://www.invacare.com/role/ConcentrationOfCreditRisk Concentration Of Credit Risk Notes 25 false false R26.htm 0000027 - Disclosure - Derivatives Sheet http://www.invacare.com/role/Derivatives Derivatives Notes 26 false false R27.htm 0000028 - Disclosure - Fair Values Sheet http://www.invacare.com/role/FairValues Fair Values Notes 27 false false R28.htm 0000029 - Disclosure - Business Segments Sheet http://www.invacare.com/role/BusinessSegments Business Segments Notes 28 false false R29.htm 0000030 - Disclosure - Contingencies Sheet http://www.invacare.com/role/Contingencies Contingencies Notes 29 false false R30.htm 0000031 - Disclosure - Accounting Policies (Policies) Sheet http://www.invacare.com/role/AccountingPoliciesPolicies Accounting Policies (Policies) Policies http://www.invacare.com/role/AccountingPolicies 30 false false R31.htm 0000033 - Disclosure - Receivables (Tables) Sheet http://www.invacare.com/role/ReceivablesTables Receivables (Tables) Tables http://www.invacare.com/role/Receivables 31 false false R32.htm 0000034 - Disclosure - Inventories (Tables) Sheet http://www.invacare.com/role/InventoriesTables Inventories (Tables) Tables http://www.invacare.com/role/Inventories 32 false false R33.htm 0000035 - Disclosure - Other Current Assets (Tables) Sheet http://www.invacare.com/role/OtherCurrentAssetsTables Other Current Assets (Tables) Tables http://www.invacare.com/role/OtherCurrentAssets 33 false false R34.htm 0000036 - Disclosure - Other Long-Term Assets (Tables) Sheet http://www.invacare.com/role/OtherLongTermAssetsTables Other Long-Term Assets (Tables) Tables http://www.invacare.com/role/OtherLongTermAssets 34 false false R35.htm 0000037 - Disclosure - Property And Equipment (Tables) Sheet http://www.invacare.com/role/PropertyAndEquipmentTables Property And Equipment (Tables) Tables http://www.invacare.com/role/PropertyAndEquipment 35 false false R36.htm 0000038 - Disclosure - Intangibles (Tables) Sheet http://www.invacare.com/role/IntangiblesTables Intangibles (Tables) Tables http://www.invacare.com/role/Intangibles 36 false false R37.htm 0000039 - Disclosure - Accrued Expenses (Tables) Sheet http://www.invacare.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://www.invacare.com/role/AccruedExpenses 37 false false R38.htm 0000040 - Disclosure - Long-Term Debt (Tables) Sheet http://www.invacare.com/role/LongTermDebtTables Long-Term Debt (Tables) Tables http://www.invacare.com/role/LongTermDebt 38 false false R39.htm 0000041 - Disclosure - Other Long-Term Obligations (Tables) Sheet http://www.invacare.com/role/OtherLongTermObligationsTables Other Long-Term Obligations (Tables) Tables http://www.invacare.com/role/OtherLongTermObligations 39 false false R40.htm 0000042 - Disclosure - Leases and Commitments (Tables) Sheet http://www.invacare.com/role/LeasesandCommitmentsTables Leases and Commitments (Tables) Tables http://www.invacare.com/role/LeasesandCommitmentsNotes 40 false false R41.htm 0000043 - Disclosure - Revenue (Tables) Sheet http://www.invacare.com/role/RevenueTables Revenue (Tables) Tables http://www.invacare.com/role/RevenueRevenue 41 false false R42.htm 0000044 - Disclosure - Equity Compensation (Tables) Sheet http://www.invacare.com/role/EquityCompensationTables Equity Compensation (Tables) Tables http://www.invacare.com/role/EquityCompensation 42 false false R43.htm 0000045 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Tables) Sheet http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables Accumulated Other Comprehensive Income (Loss) by Component (Tables) Tables http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponent 43 false false R44.htm 0000046 - Disclosure - Charges Related To Restructuring Activities (Tables) Sheet http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables Charges Related To Restructuring Activities (Tables) Tables http://www.invacare.com/role/ChargesRelatedToRestructuringActivities 44 false false R45.htm 0000047 - Disclosure - Net Earnings (Loss) Per Common Share (Tables) Sheet http://www.invacare.com/role/NetEarningsLossPerCommonShareTables Net Earnings (Loss) Per Common Share (Tables) Tables http://www.invacare.com/role/NetEarningsLossPerCommonShare 45 false false R46.htm 0000048 - Disclosure - Derivatives (Tables) Sheet http://www.invacare.com/role/DerivativesTables Derivatives (Tables) Tables http://www.invacare.com/role/Derivatives 46 false false R47.htm 0000049 - Disclosure - Fair Values (Tables) Sheet http://www.invacare.com/role/FairValuesTables Fair Values (Tables) Tables http://www.invacare.com/role/FairValues 47 false false R48.htm 0000050 - Disclosure - Business Segments (Tables) Sheet http://www.invacare.com/role/BusinessSegmentsTables Business Segments (Tables) Tables http://www.invacare.com/role/BusinessSegments 48 false false R49.htm 0000053 - Disclosure - Receivables (Narrative) (Details) Sheet http://www.invacare.com/role/ReceivablesNarrativeDetails Receivables (Narrative) (Details) Details http://www.invacare.com/role/ReceivablesTables 49 false false R50.htm 0000054 - Disclosure - Receivables (Schedule of Accounts Receivable) (Details) Sheet http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails Receivables (Schedule of Accounts Receivable) (Details) Details http://www.invacare.com/role/ReceivablesTables 50 false false R51.htm 0000055 - Disclosure - Receivables Schedule for Allowance for Credit Losses (Details) Sheet http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails Receivables Schedule for Allowance for Credit Losses (Details) Details 51 false false R52.htm 0000056 - Disclosure - Receivables (Installment Recevables) (Details) Sheet http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails Receivables (Installment Recevables) (Details) Details http://www.invacare.com/role/ReceivablesTables 52 false false R53.htm 0000057 - Disclosure - Receivables (Rollforward of Allowance for Doubtful Accounts) (Details) Sheet http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails Receivables (Rollforward of Allowance for Doubtful Accounts) (Details) Details http://www.invacare.com/role/ReceivablesTables 53 false false R54.htm 0000058 - Disclosure - Receivables (Installment Receivables by Class) (Details) Sheet http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails Receivables (Installment Receivables by Class) (Details) Details http://www.invacare.com/role/ReceivablesTables 54 false false R55.htm 0000059 - Disclosure - Receivables (Aging of Installment Receivables) (Details) Sheet http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails Receivables (Aging of Installment Receivables) (Details) Details http://www.invacare.com/role/ReceivablesTables 55 false false R56.htm 0000060 - Disclosure - Inventories (Details) Sheet http://www.invacare.com/role/InventoriesDetails Inventories (Details) Details http://www.invacare.com/role/InventoriesTables 56 false false R57.htm 0000061 - Disclosure - Other Current Assets Components of Other Current Assets (Details) Sheet http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails Other Current Assets Components of Other Current Assets (Details) Details 57 false false R58.htm 0000062 - Disclosure - Other Long-Term Assets Components of Other Long-Term Assets (Details) Sheet http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails Other Long-Term Assets Components of Other Long-Term Assets (Details) Details 58 false false R59.htm 0000064 - Disclosure - Property And Equipment (Details) Sheet http://www.invacare.com/role/PropertyAndEquipmentDetails Property And Equipment (Details) Details http://www.invacare.com/role/PropertyAndEquipmentTables 59 false false R60.htm 0000065 - Disclosure - Goodwill Goodwill Details (Details) Sheet http://www.invacare.com/role/GoodwillGoodwillDetailsDetails Goodwill Goodwill Details (Details) Details 60 false false R61.htm 0000066 - Disclosure - Intangibles (Narrative) (Details) Sheet http://www.invacare.com/role/IntangiblesNarrativeDetails Intangibles (Narrative) (Details) Details http://www.invacare.com/role/IntangiblesTables 61 false false R62.htm 0000067 - Disclosure - Intangibles (Intangible Table) (Details) Sheet http://www.invacare.com/role/IntangiblesIntangibleTableDetails Intangibles (Intangible Table) (Details) Details http://www.invacare.com/role/IntangiblesTables 62 false false R63.htm 0000068 - Disclosure - Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details) Sheet http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details) Details http://www.invacare.com/role/IntangiblesTables 63 false false R64.htm 0000069 - Disclosure - Accrued Expenses Components of Accrued Expenses (Details) Sheet http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails Accrued Expenses Components of Accrued Expenses (Details) Details 64 false false R65.htm 0000070 - Disclosure - Accrued Expenses Warranty Schedule (Details) Sheet http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails Accrued Expenses Warranty Schedule (Details) Details 65 false false R66.htm 0000071 - Disclosure - Long-Term Debt (Details) Sheet http://www.invacare.com/role/LongTermDebtDetails Long-Term Debt (Details) Details http://www.invacare.com/role/LongTermDebtTables 66 false false R67.htm 0000072 - Disclosure - Long-Term Debt Components of Convertible Debt (Details) Sheet http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails Long-Term Debt Components of Convertible Debt (Details) Details 67 false false R68.htm 0000073 - Disclosure - Long-Term Debt Narrative (Details) Sheet http://www.invacare.com/role/LongTermDebtNarrativeDetails Long-Term Debt Narrative (Details) Details 68 false false R69.htm 0000074 - Disclosure - Long-Term Debt Sale Leaseback Transactions (Details) Sheet http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails Long-Term Debt Sale Leaseback Transactions (Details) Details 69 false false R70.htm 0000075 - Disclosure - Other Long-Term Obligations (Details) Sheet http://www.invacare.com/role/OtherLongTermObligationsDetails Other Long-Term Obligations (Details) Details http://www.invacare.com/role/OtherLongTermObligationsTables 70 false false R71.htm 0000076 - Disclosure - Leases and Commitments (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsDetails Leases and Commitments (Details) Details http://www.invacare.com/role/LeasesandCommitmentsTables 71 false false R72.htm 0000077 - Disclosure - Leases and Commitments Lease Expenses (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails Leases and Commitments Lease Expenses (Details) Details 72 false false R73.htm 0000078 - Disclosure - Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details) Details 73 false false R74.htm 0000079 - Disclosure - Leases and Commitments Supplemental Cash Flow Information (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails Leases and Commitments Supplemental Cash Flow Information (Details) Details 74 false false R75.htm 0000080 - Disclosure - Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details) Sheet http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details) Details 75 false false R76.htm 0000081 - Disclosure - Revenue (Details) Sheet http://www.invacare.com/role/RevenueDetails Revenue (Details) Details http://www.invacare.com/role/RevenueTables 76 false false R77.htm 0000082 - Disclosure - Equity Compensation (Narrative) (Details) Sheet http://www.invacare.com/role/EquityCompensationNarrativeDetails Equity Compensation (Narrative) (Details) Details http://www.invacare.com/role/EquityCompensationTables 77 false false R78.htm 0000083 - Disclosure - Equity Compensation Share-based Compensation Expense (Details) Sheet http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails Equity Compensation Share-based Compensation Expense (Details) Details 78 false false R79.htm 0000084 - Disclosure - Equity Compensation Unrecognized Compensation Expense (Details) Sheet http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails Equity Compensation Unrecognized Compensation Expense (Details) Details 79 false false R80.htm 0000085 - Disclosure - Equity Compensation (Options Activity) (Details) Sheet http://www.invacare.com/role/EquityCompensationOptionsActivityDetails Equity Compensation (Options Activity) (Details) Details http://www.invacare.com/role/EquityCompensationTables 80 false false R81.htm 0000086 - Disclosure - Equity Compensation (Stock Options Outstanding by Exercise Price) (Details) Sheet http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails Equity Compensation (Stock Options Outstanding by Exercise Price) (Details) Details http://www.invacare.com/role/EquityCompensationTables 81 false false R82.htm 0000087 - Disclosure - Equity Compensation Restricted Stock Activity (Details) Sheet http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails Equity Compensation Restricted Stock Activity (Details) Details 82 false false R83.htm 0000088 - Disclosure - Equity Compensation Performance Share Activity (Details) Sheet http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails Equity Compensation Performance Share Activity (Details) Details 83 false false R84.htm 0000090 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details) Sheet http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details) Details http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables 84 false false R85.htm 0000091 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details) Sheet http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details) Details http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables 85 false false R86.htm 0000092 - Disclosure - Charges Related To Restructuring Activities (Details) Sheet http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails Charges Related To Restructuring Activities (Details) Details http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables 86 false false R87.htm 0000093 - Disclosure - Charges Related To Restructuring Activities Narrative (Details) Sheet http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails Charges Related To Restructuring Activities Narrative (Details) Details http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables 87 false false R88.htm 0000094 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://www.invacare.com/role/IncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) Details http://www.invacare.com/role/IncomeTaxes 88 false false R89.htm 0000095 - Disclosure - Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details) Sheet http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details) Details http://www.invacare.com/role/NetEarningsLossPerCommonShareTables 89 false false R90.htm 0000096 - Disclosure - Net Earnings (Loss) Per Common Share Textuals (Details) Sheet http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails Net Earnings (Loss) Per Common Share Textuals (Details) Details http://www.invacare.com/role/NetEarningsLossPerCommonShareTables 90 false false R91.htm 0000097 - Disclosure - Concentration Of Credit Risk (Details) Sheet http://www.invacare.com/role/ConcentrationOfCreditRiskDetails Concentration Of Credit Risk (Details) Details http://www.invacare.com/role/ConcentrationOfCreditRisk 91 false false R92.htm 0000098 - Disclosure - Derivatives Notional Amounts - Designated as Hedges (Details) Sheet http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails Derivatives Notional Amounts - Designated as Hedges (Details) Details 92 false false R93.htm 0000099 - Disclosure - Derivatives Notional Amounts - Not Designated as Hedges (Details) Sheet http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails Derivatives Notional Amounts - Not Designated as Hedges (Details) Details 93 false false R94.htm 0000100 - Disclosure - Derivatives Balance Sheet Location (Details) Sheet http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails Derivatives Balance Sheet Location (Details) Details 94 false false R95.htm 0000101 - Disclosure - Derivatives Gain (Loss) in Statement of Finacial Position (Details) Sheet http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails Derivatives Gain (Loss) in Statement of Finacial Position (Details) Details 95 false false R96.htm 0000102 - Disclosure - Derivatives Narrative (Details) Sheet http://www.invacare.com/role/DerivativesNarrativeDetails Derivatives Narrative (Details) Details 96 false false R97.htm 0000104 - Disclosure - Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) Sheet http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) Details http://www.invacare.com/role/FairValuesTables 97 false false R98.htm 0000105 - Disclosure - Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details) Sheet http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details) Details http://www.invacare.com/role/FairValuesTables 98 false false R99.htm 0000106 - Disclosure - Business Segments (Information by Segment) (Details) Sheet http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails Business Segments (Information by Segment) (Details) Details http://www.invacare.com/role/BusinessSegmentsTables 99 false false R100.htm 0000107 - Disclosure - Contingencies Contingencies (Details) Sheet http://www.invacare.com/role/ContingenciesContingenciesDetails Contingencies Contingencies (Details) Details 100 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: ivc:BusinessDayPeriod - ivc-20220930.htm 4 ivc-20220930.htm ivc-20220930.xsd ivc-20220930_cal.xml ivc-20220930_def.xml ivc-20220930_lab.xml ivc-20220930_pre.xml q32022ivcex104.htm q32022ivcex311.htm q32022ivcex312.htm q32022ivcex321.htm q32022ivcex322.htm ivc-20220930_g1.jpg ivc-20220930_g2.jpg ivc-20220930_g3.jpg ivc-20220930_g4.jpg ivc-20220930_g5.jpg ivc-20220930_g6.jpg ivc-20220930_g7.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 126 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ivc-20220930.htm": { "axisCustom": 3, "axisStandard": 30, "contextCount": 660, "dts": { "calculationLink": { "local": [ "ivc-20220930_cal.xml" ] }, "definitionLink": { "local": [ "ivc-20220930_def.xml" ] }, "inline": { "local": [ "ivc-20220930.htm" ] }, "labelLink": { "local": [ "ivc-20220930_lab.xml" ] }, "presentationLink": { "local": [ "ivc-20220930_pre.xml" ] }, "schema": { "local": [ "ivc-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 965, "entityCount": 1, "hidden": { "http://www.invacare.com/20220930": 3, "http://xbrl.sec.gov/dei/2021q4": 5, "total": 8 }, "keyCustom": 147, "keyStandard": 367, "memberCustom": 65, "memberStandard": 61, "nsprefix": "ivc", "nsuri": "http://www.invacare.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - DEI Document", "role": "http://www.invacare.com/role/DEIDocument", "shortName": "DEI Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Other Current Assets", "role": "http://www.invacare.com/role/OtherCurrentAssets", "shortName": "Other Current Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:LiquidatedDamagesAmountPerViolationPerDay", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000107 - Disclosure - Contingencies Contingencies (Details)", "role": "http://www.invacare.com/role/ContingenciesContingenciesDetails", "shortName": "Contingencies Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:LiquidatedDamagesAmountPerViolationPerDay", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Other Long-Term Assets", "role": "http://www.invacare.com/role/OtherLongTermAssets", "shortName": "Other Long-Term Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Property And Equipment", "role": "http://www.invacare.com/role/PropertyAndEquipment", "shortName": "Property And Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Goodwill", "role": "http://www.invacare.com/role/Goodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Intangibles", "role": "http://www.invacare.com/role/Intangibles", "shortName": "Intangibles", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Accrued Expenses", "role": "http://www.invacare.com/role/AccruedExpenses", "shortName": "Accrued Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Long-Term Debt", "role": "http://www.invacare.com/role/LongTermDebt", "shortName": "Long-Term Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Other Long-Term Obligations", "role": "http://www.invacare.com/role/OtherLongTermObligations", "shortName": "Other Long-Term Obligations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Leases and Commitments (Notes)", "role": "http://www.invacare.com/role/LeasesandCommitmentsNotes", "shortName": "Leases and Commitments (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionDeferredRevenue", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Revenue Revenue", "role": "http://www.invacare.com/role/RevenueRevenue", "shortName": "Revenue Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionDeferredRevenue", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - Condensed Consolidated Statement of Comprehensive Income (Loss)", "role": "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "shortName": "Condensed Consolidated Statement of Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Equity Compensation", "role": "http://www.invacare.com/role/EquityCompensation", "shortName": "Equity Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component", "role": "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponent", "shortName": "Accumulated Other Comprehensive Income (Loss) by Component", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Charges Related To Restructuring Activities", "role": "http://www.invacare.com/role/ChargesRelatedToRestructuringActivities", "shortName": "Charges Related To Restructuring Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Income Taxes", "role": "http://www.invacare.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Net Earnings (Loss) Per Common Share", "role": "http://www.invacare.com/role/NetEarningsLossPerCommonShare", "shortName": "Net Earnings (Loss) Per Common Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Concentration Of Credit Risk", "role": "http://www.invacare.com/role/ConcentrationOfCreditRisk", "shortName": "Concentration Of Credit Risk", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Derivatives", "role": "http://www.invacare.com/role/Derivatives", "shortName": "Derivatives", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Fair Values", "role": "http://www.invacare.com/role/FairValues", "shortName": "Fair Values", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Business Segments", "role": "http://www.invacare.com/role/BusinessSegments", "shortName": "Business Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Contingencies", "role": "http://www.invacare.com/role/Contingencies", "shortName": "Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Accounting Policies (Policies)", "role": "http://www.invacare.com/role/AccountingPoliciesPolicies", "shortName": "Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ivc:ScheduleofAccountsReceivableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - Receivables (Tables)", "role": "http://www.invacare.com/role/ReceivablesTables", "shortName": "Receivables (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ivc:ScheduleofAccountsReceivableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - Inventories (Tables)", "role": "http://www.invacare.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - Other Current Assets (Tables)", "role": "http://www.invacare.com/role/OtherCurrentAssetsTables", "shortName": "Other Current Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - Other Long-Term Assets (Tables)", "role": "http://www.invacare.com/role/OtherLongTermAssetsTables", "shortName": "Other Long-Term Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - Property And Equipment (Tables)", "role": "http://www.invacare.com/role/PropertyAndEquipmentTables", "shortName": "Property And Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - Intangibles (Tables)", "role": "http://www.invacare.com/role/IntangiblesTables", "shortName": "Intangibles (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - Accrued Expenses (Tables)", "role": "http://www.invacare.com/role/AccruedExpensesTables", "shortName": "Accrued Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - Long-Term Debt (Tables)", "role": "http://www.invacare.com/role/LongTermDebtTables", "shortName": "Long-Term Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - Other Long-Term Obligations (Tables)", "role": "http://www.invacare.com/role/OtherLongTermObligationsTables", "shortName": "Other Long-Term Obligations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:LesseeFinanceLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - Leases and Commitments (Tables)", "role": "http://www.invacare.com/role/LeasesandCommitmentsTables", "shortName": "Leases and Commitments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:LesseeFinanceLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:RevenueRecognitionDeferredRevenue", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - Revenue (Tables)", "role": "http://www.invacare.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:RevenueRecognitionDeferredRevenue", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - Equity Compensation (Tables)", "role": "http://www.invacare.com/role/EquityCompensationTables", "shortName": "Equity Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Tables)", "role": "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables", "shortName": "Accumulated Other Comprehensive Income (Loss) by Component (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - Charges Related To Restructuring Activities (Tables)", "role": "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables", "shortName": "Charges Related To Restructuring Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - Net Earnings (Loss) Per Common Share (Tables)", "role": "http://www.invacare.com/role/NetEarningsLossPerCommonShareTables", "shortName": "Net Earnings (Loss) Per Common Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000048 - Disclosure - Derivatives (Tables)", "role": "http://www.invacare.com/role/DerivativesTables", "shortName": "Derivatives (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - Fair Values (Tables)", "role": "http://www.invacare.com/role/FairValuesTables", "shortName": "Fair Values (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - Business Segments (Tables)", "role": "http://www.invacare.com/role/BusinessSegmentsTables", "shortName": "Business Segments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ContingentLiabilityGuarantee", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000053 - Disclosure - Receivables (Narrative) (Details)", "role": "http://www.invacare.com/role/ReceivablesNarrativeDetails", "shortName": "Receivables (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ContingentLiabilityGuarantee", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:PurchaseOfCappedCalls", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - Condensed Consolidated Statement Of Cash Flows", "role": "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "shortName": "Condensed Consolidated Statement Of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": "-3", "lang": "en-US", "name": "ivc:ConvertibleDebtDiscountAmortizationAndAccretion", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:ScheduleofAccountsReceivableTableTextBlock", "div", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000054 - Disclosure - Receivables (Schedule of Accounts Receivable) (Details)", "role": "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails", "shortName": "Receivables (Schedule of Accounts Receivable) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:ScheduleofAccountsReceivableTableTextBlock", "div", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:AllowanceforCreditLossesTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:AllowanceforCreditLosses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000055 - Disclosure - Receivables Schedule for Allowance for Credit Losses (Details)", "role": "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails", "shortName": "Receivables Schedule for Allowance for Credit Losses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:AllowanceforCreditLossesTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:AllowanceforCreditLosses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:FinancingReceivablesTableTextBlock", "us-gaap:ImpairedFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:NonImpairedFinancingReceivableRelatedAllowance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000056 - Disclosure - Receivables (Installment Recevables) (Details)", "role": "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails", "shortName": "Receivables (Installment Recevables) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:NotesAndLoansReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i7af2618f51d24b44823ea64b298f9b68_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000057 - Disclosure - Receivables (Rollforward of Allowance for Doubtful Accounts) (Details)", "role": "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails", "shortName": "Receivables (Rollforward of Allowance for Doubtful Accounts) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllowanceForLoanAndLeaseLossesAdjustmentsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:FinancingReceivablesTableTextBlock", "us-gaap:ImpairedFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:FinancingReceivablewithNoRelatedAllowanceRecordedInvestment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000058 - Disclosure - Receivables (Installment Receivables by Class) (Details)", "role": "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "shortName": "Receivables (Installment Receivables by Class) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:FinancingReceivablesTableTextBlock", "us-gaap:ImpairedFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:FinancingReceivablewithNoRelatedAllowanceRecordedInvestment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PastDueFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:InstallmentReceivable0To30DaysPastDue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000059 - Disclosure - Receivables (Aging of Installment Receivables) (Details)", "role": "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "shortName": "Receivables (Aging of Installment Receivables) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PastDueFinancingReceivablesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:InstallmentReceivable0To30DaysPastDue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000060 - Disclosure - Inventories (Details)", "role": "http://www.invacare.com/role/InventoriesDetails", "shortName": "Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ValueAddedTaxReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000061 - Disclosure - Other Current Assets Components of Other Current Assets (Details)", "role": "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails", "shortName": "Other Current Assets Components of Other Current Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ValueAddedTaxReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashSurrenderValueOfLifeInsurance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000062 - Disclosure - Other Long-Term Assets Components of Other Long-Term Assets (Details)", "role": "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails", "shortName": "Other Long-Term Assets Components of Other Long-Term Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000064 - Disclosure - Property And Equipment (Details)", "role": "http://www.invacare.com/role/PropertyAndEquipmentDetails", "shortName": "Property And Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i7af2618f51d24b44823ea64b298f9b68_I20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i57fe288df9a748929b4d26bb56d4db10_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - Condensed Consolidated Statement of Shareholders' Equity Statement", "role": "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "shortName": "Condensed Consolidated Statement of Shareholders' Equity Statement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i8774544bbee446eeb2ca48ff53b37335_D20210101-20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "div", "div", "us-gaap:GoodwillDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": "4", "first": true, "lang": "en-US", "name": "ivc:GoodwillImpairmentTestDiscountedCashFlowDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000065 - Disclosure - Goodwill Goodwill Details (Details)", "role": "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "shortName": "Goodwill Goodwill Details (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "us-gaap:GoodwillDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": "4", "first": true, "lang": "en-US", "name": "ivc:GoodwillImpairmentTestDiscountedCashFlowDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000066 - Disclosure - Intangibles (Narrative) (Details)", "role": "http://www.invacare.com/role/IntangiblesNarrativeDetails", "shortName": "Intangibles (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000067 - Disclosure - Intangibles (Intangible Table) (Details)", "role": "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "shortName": "Intangibles (Intangible Table) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000068 - Disclosure - Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details)", "role": "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails", "shortName": "Intangibles (Finite-Lived Intangible Asset Future Amortization Expense) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000069 - Disclosure - Accrued Expenses Components of Accrued Expenses (Details)", "role": "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails", "shortName": "Accrued Expenses Components of Accrued Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i7af2618f51d24b44823ea64b298f9b68_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrualClassifiedCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000070 - Disclosure - Accrued Expenses Warranty Schedule (Details)", "role": "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails", "shortName": "Accrued Expenses Warranty Schedule (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrualWarrantiesIssued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000071 - Disclosure - Long-Term Debt (Details)", "role": "http://www.invacare.com/role/LongTermDebtDetails", "shortName": "Long-Term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i7af2618f51d24b44823ea64b298f9b68_I20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000072 - Disclosure - Long-Term Debt Components of Convertible Debt (Details)", "role": "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "shortName": "Long-Term Debt Components of Convertible Debt (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsForRepurchaseOfCommonStock", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000073 - Disclosure - Long-Term Debt Narrative (Details)", "role": "http://www.invacare.com/role/LongTermDebtNarrativeDetails", "shortName": "Long-Term Debt Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic59e0ee9345c4b14b9de72533042bd5d_I20220726", "decimals": "0", "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i964e7608e5724bd3a2602d6b8fb5444e_I20150423", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:SaleLeasebackTransactionDeferredGainGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000074 - Disclosure - Long-Term Debt Sale Leaseback Transactions (Details)", "role": "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails", "shortName": "Long-Term Debt Sale Leaseback Transactions (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000007 - Disclosure - Accounting Policies", "role": "http://www.invacare.com/role/AccountingPolicies", "shortName": "Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000075 - Disclosure - Other Long-Term Obligations (Details)", "role": "http://www.invacare.com/role/OtherLongTermObligationsDetails", "shortName": "Other Long-Term Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i7af2618f51d24b44823ea64b298f9b68_I20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:LesseeFinanceLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ivc:SaleLeasebackTransactionLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000076 - Disclosure - Leases and Commitments (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsDetails", "shortName": "Leases and Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:LesseeFinanceLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ivc:SaleLeasebackTransactionLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "div", "div", "us-gaap:LesseeFinanceLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000077 - Disclosure - Leases and Commitments Lease Expenses (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails", "shortName": "Leases and Commitments Lease Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "div", "div", "us-gaap:LesseeFinanceLeasesTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000078 - Disclosure - Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails", "shortName": "Leases and Commitments Future Minimum Operating and Financing Lease Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:OperatingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000079 - Disclosure - Leases and Commitments Supplemental Cash Flow Information (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails", "shortName": "Leases and Commitments Supplemental Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:OperatingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:WeightedAverageRemainingLeaseTermsandDiscountRatesTableTextBlock", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000080 - Disclosure - Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details)", "role": "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails", "shortName": "Leases and Commitments Weighted-Average Remaining Lease Terms and Discount Rates (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ivc:WeightedAverageRemainingLeaseTermsandDiscountRatesTableTextBlock", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000081 - Disclosure - Revenue (Details)", "role": "http://www.invacare.com/role/RevenueDetails", "shortName": "Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "div", "div", "us-gaap:RevenueRecognitionDeferredRevenue", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "2", "lang": "en-US", "name": "ivc:NetRevenue", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000082 - Disclosure - Equity Compensation (Narrative) (Details)", "role": "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "shortName": "Equity Compensation (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000083 - Disclosure - Equity Compensation Share-based Compensation Expense (Details)", "role": "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "shortName": "Equity Compensation Share-based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i09d46193e1594035a3a978a30b84c799_D20220101-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000084 - Disclosure - Equity Compensation Unrecognized Compensation Expense (Details)", "role": "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails", "shortName": "Equity Compensation Unrecognized Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - Receivables", "role": "http://www.invacare.com/role/Receivables", "shortName": "Receivables", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i7af2618f51d24b44823ea64b298f9b68_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000085 - Disclosure - Equity Compensation (Options Activity) (Details)", "role": "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "shortName": "Equity Compensation (Options Activity) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i7af2618f51d24b44823ea64b298f9b68_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000086 - Disclosure - Equity Compensation (Stock Options Outstanding by Exercise Price) (Details)", "role": "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "shortName": "Equity Compensation (Stock Options Outstanding by Exercise Price) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i5bcdb1e2f67c4e8297a5811477e0d0e7_D20220101-20220930", "decimals": "2", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i070d8f34e84e40838608ba6e7aab7811_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000087 - Disclosure - Equity Compensation Restricted Stock Activity (Details)", "role": "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "shortName": "Equity Compensation Restricted Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i070d8f34e84e40838608ba6e7aab7811_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic664090163fa437da735bdd41ac6f3d5_I20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000088 - Disclosure - Equity Compensation Performance Share Activity (Details)", "role": "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "shortName": "Equity Compensation Performance Share Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic664090163fa437da735bdd41ac6f3d5_I20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i237bcc6a8ab347c5ae7a8a3f0957f01f_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000090 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details)", "role": "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "shortName": "Accumulated Other Comprehensive Income (Loss) by Component (Changes in Accumulated Other Comprehensive Income) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000091 - Disclosure - Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details)", "role": "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "shortName": "Accumulated Other Comprehensive Income (Loss) by Component (Reclassified Out of Accumulated Other Comprehensive Income) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "if11664be8ba44dd9b237e7287509632d_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i237bcc6a8ab347c5ae7a8a3f0957f01f_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000092 - Disclosure - Charges Related To Restructuring Activities (Details)", "role": "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "shortName": "Charges Related To Restructuring Activities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ibf972767dfb647ababfde14da4485eee_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000093 - Disclosure - Charges Related To Restructuring Activities Narrative (Details)", "role": "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "shortName": "Charges Related To Restructuring Activities Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R88": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000094 - Disclosure - Income Taxes (Narrative) (Details)", "role": "http://www.invacare.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000095 - Disclosure - Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details)", "role": "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails", "shortName": "Net Earnings (Loss) Per Common Share Computation of Basic and Diluted Net Earnings (Loss) Per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Inventories", "role": "http://www.invacare.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0be99f8341aa4e10b1070638b3686d7e_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i5e3df5a39557406cb55bb0335261b053_D20220701-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000096 - Disclosure - Net Earnings (Loss) Per Common Share Textuals (Details)", "role": "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails", "shortName": "Net Earnings (Loss) Per Common Share Textuals (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i5e3df5a39557406cb55bb0335261b053_D20220701-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ConcentrationRiskRetainedRecourseObligationForDefaultofCustomerLeaseObligationsUnderContract", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000097 - Disclosure - Concentration Of Credit Risk (Details)", "role": "http://www.invacare.com/role/ConcentrationOfCreditRiskDetails", "shortName": "Concentration Of Credit Risk (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "ivc:ConcentrationRiskRetainedRecourseObligationForDefaultofCustomerLeaseObligationsUnderContract", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i38067bf986964d6ba4ed7054755bb43f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:NotionalAmountDerivative", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000098 - Disclosure - Derivatives Notional Amounts - Designated as Hedges (Details)", "role": "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "shortName": "Derivatives Notional Amounts - Designated as Hedges (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic08cb71c1e714c4a8c77ab69fa06abe3_I20220930", "decimals": "-3", "lang": "en-US", "name": "ivc:NotionalAmountDerivative", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i38067bf986964d6ba4ed7054755bb43f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:NotionalAmountDerivative", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000099 - Disclosure - Derivatives Notional Amounts - Not Designated as Hedges (Details)", "role": "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails", "shortName": "Derivatives Notional Amounts - Not Designated as Hedges (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i83e02c007919417ca7829545eb335b89_I20220930", "decimals": "-3", "lang": "en-US", "name": "ivc:NotionalAmountDerivative", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i7753a1bb5b9745269c96d5bf3e9bc02c_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000100 - Disclosure - Derivatives Balance Sheet Location (Details)", "role": "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "shortName": "Derivatives Balance Sheet Location (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i7753a1bb5b9745269c96d5bf3e9bc02c_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i2462bd1b619c4510a2984d17e0e81ddf_D20220701-20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000101 - Disclosure - Derivatives Gain (Loss) in Statement of Finacial Position (Details)", "role": "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "shortName": "Derivatives Gain (Loss) in Statement of Finacial Position (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i61d7ae459c4d4a4b860fb8458da74a4d_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "ivc:AmountOfGainLossRecognizedInAccumulatedOCIOnDerivativesEffectivePortion", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ivc:ScheduleOfConvertibleNoteDerivativesTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "ivc:ConvertibleDebtDerivative", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000102 - Disclosure - Derivatives Narrative (Details)", "role": "http://www.invacare.com/role/DerivativesNarrativeDetails", "shortName": "Derivatives Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "0", "lang": "en-US", "name": "us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i513204f8bb7e4dc6abc9e758654ba413_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000104 - Disclosure - Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details)", "role": "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "shortName": "Fair Values (Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i932dc1202735482ca455080549bb510b_I20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "ic078f5d7181e46ab868dd24a86adcbae_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000105 - Disclosure - Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details)", "role": "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "shortName": "Fair Values (Details of Book Value and Fair Value of Financial Instruments) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i0298ba976606441380adcb42d897ccf5_I20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000106 - Disclosure - Business Segments (Information by Segment) (Details)", "role": "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "shortName": "Business Segments (Information by Segment) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ivc-20220930.htm", "contextRef": "i4eaed59f797c47e1b10ecaf7d8f2d7e3_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:InterestRevenueExpenseNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 130, "tag": { "currency_AllCurrenciesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "All Currencies [Domain]", "terseLabel": "All Currencies [Domain]" } } }, "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2021", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "currency_EUR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Euro Member Countries, Euro", "terseLabel": "Euro Member Countries, Euro" } } }, "localname": "EUR", "nsuri": "http://xbrl.sec.gov/currency/2021", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "currency_GBP": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "United Kingdom, Pounds", "terseLabel": "United Kingdom, Pounds" } } }, "localname": "GBP", "nsuri": "http://xbrl.sec.gov/currency/2021", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r782" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r783" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r780" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r780" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r780" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r809" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r780" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r780" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r780" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r780" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r779" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r781" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.invacare.com/role/DEIDocument" ], "xbrltype": "tradingSymbolItemType" }, "ivc_A126YearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "12.6 Years", "label": "12.6 Years [Member]", "terseLabel": "12.6 Years" } } }, "localname": "A126YearsMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "ivc_A2013PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2013 Plan [Member]", "label": "2013 Plan [Member]", "terseLabel": "2013 Plan [Member]" } } }, "localname": "A2013PlanMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_A2018PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2018 Plan", "label": "2018 Plan [Member]", "terseLabel": "2018 Plan [Member]" } } }, "localname": "A2018PlanMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_A20YearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "20 Years", "label": "20 Years [Member]", "terseLabel": "20 Years" } } }, "localname": "A20YearsMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "ivc_AccretionExpenseNetOfExtinguishmentFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accretion Expense, net of extinguishment fees", "label": "Accretion Expense, net of extinguishment fees", "terseLabel": "Accretion Expense, net of extinguishment fees" } } }, "localname": "AccretionExpenseNetOfExtinguishmentFees", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AccretionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accretion Rate", "label": "Accretion Rate", "terseLabel": "Accretion Rate" } } }, "localname": "AccretionRate", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_AccruedFreightExpenseCurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Freight Accrual, Current [Line Items]", "label": "Accrued Freight Expense, Current", "terseLabel": "Freight" } } }, "localname": "AccruedFreightExpenseCurrent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AccumulatedLongTermNotesAdjustmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accumulated Long-Term Notes Adjustment [Member]", "label": "Accumulated Long-Term Notes Adjustment [Member]", "terseLabel": "Accumulated Long-Term Notes Adjustment [Member]" } } }, "localname": "AccumulatedLongTermNotesAdjustmentMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "ivc_AdditionalAmountAfterClosingRound2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional amount after closing (round 2)", "label": "Additional amount after closing (round 2) [Member]", "terseLabel": "Additional amount after closing (round 2) [Domain]" } } }, "localname": "AdditionalAmountAfterClosingRound2Member", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_AdditionalAmountAfterClosingRound3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional amount after closing (round 3)", "label": "Additional amount after closing (round 3) [Member]", "terseLabel": "Additional amount after closing (round 3) [Domain]" } } }, "localname": "AdditionalAmountAfterClosingRound3Member", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_AdditionalAmountAfterClosingRound4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional amount after closing (round 4)", "label": "Additional amount after closing (round 4) [Member]", "terseLabel": "Additional amount after closing (round 4) [Domain]" } } }, "localname": "AdditionalAmountAfterClosingRound4Member", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_AdoptionOfASU202006": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adoption of ASU 2020-06", "label": "Adoption of ASU 2020-06", "terseLabel": "Adoption of ASU 2020-06" } } }, "localname": "AdoptionOfASU202006", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "ivc_AdoptionOfASU202006ConvertibleDebtDiscountsRemoved": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adoption of ASU 2020-06, Convertible Debt Discounts Removed", "label": "Adoption of ASU 2020-06, Convertible Debt Discounts Removed", "terseLabel": "Adoption of ASU 2020-06, Convertible Debt Discounts Removed" } } }, "localname": "AdoptionOfASU202006ConvertibleDebtDiscountsRemoved", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AdoptionOfCreditLossStandard": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adoption of Credit Loss Standard", "label": "Adoption of Credit Loss Standard", "terseLabel": "Adoption of Credit Loss Standard" } } }, "localname": "AdoptionOfCreditLossStandard", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "ivc_AllOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All Other", "label": "All Other [Member]", "terseLabel": "All Other" } } }, "localname": "AllOtherMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_AllowanceforCreditLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Allowance for Credit Losses", "label": "Allowance for Credit Losses", "terseLabel": "Allowance for Credit Losses" } } }, "localname": "AllowanceforCreditLosses", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AllowanceforCreditLossesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Allowance for Credit Losses", "label": "Allowance for Credit Losses [Table Text Block]", "terseLabel": "Schedule for Allowance for Credit Losses" } } }, "localname": "AllowanceforCreditLossesTableTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "ivc_AllowanceforCreditLossesWritedowns": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Allowance for Credit Losses, Write-downs", "label": "Allowance for Credit Losses, Write-downs", "terseLabel": "Financing Receivable, Allowance for Credit Losses, Write-downs" } } }, "localname": "AllowanceforCreditLossesWritedowns", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AllowanceforLossesAdjustmentsOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Allowance for Losses, Adjustments, Other", "label": "Allowance for Losses, Adjustments, Other", "terseLabel": "Allowance for Loan and Lease Losses, Adjustments, Other" } } }, "localname": "AllowanceforLossesAdjustmentsOther", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AmountAvailableToInvacareLimitedAndInvacarePoirierSASMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Invacare Limited and Invacare Poirier SAS", "label": "Amount Available to Invacare Limited and Invacare Poirier SAS [Member]", "terseLabel": "Amount Available to Invacare Limited and Invacare Poirier SAS" } } }, "localname": "AmountAvailableToInvacareLimitedAndInvacarePoirierSASMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_AmountOfGainLossRecognizedInAccumulatedOCIOnDerivativesEffectivePortion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Gain (Loss)\u00a0Recognized \u00a0in Accumulated OCI on Derivatives (Effective Portion)", "label": "Amount of Gain (Loss)\u00a0Recognized \u00a0in Accumulated OCI on Derivatives (Effective Portion)", "terseLabel": "Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]" } } }, "localname": "AmountOfGainLossRecognizedInAccumulatedOCIOnDerivativesEffectivePortion", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "monetaryItemType" }, "ivc_AssetsandLiabilitiesofDivestedBusinessTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets and Liabilities of Divested Business", "label": "Assets and Liabilities of Divested Business [Table Text Block]", "terseLabel": "Assets and Liabilities of Divested Business [Table Text Block]" } } }, "localname": "AssetsandLiabilitiesofDivestedBusinessTableTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesTables" ], "xbrltype": "textBlockItemType" }, "ivc_AverageFairValueStockPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average Fair Value Stock Price", "label": "Average Fair Value Stock Price", "terseLabel": "Fair value stock price" } } }, "localname": "AverageFairValueStockPrice", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "perShareItemType" }, "ivc_BorrowingAgainstCashSurrenderValueOfLifeInsurance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Borrowing against Cash Surrender Value of Life Insurance", "label": "Borrowing against Cash Surrender Value of Life Insurance", "terseLabel": "Borrowing against Cash Surrender Value of Life Insurance" } } }, "localname": "BorrowingAgainstCashSurrenderValueOfLifeInsurance", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_BusinessDayPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Day Period", "label": "Business Day Period", "terseLabel": "Business Day Period" } } }, "localname": "BusinessDayPeriod", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_CARESActLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CARES Act Loan", "label": "CARES Act Loan [Member]", "terseLabel": "CARES Act Loan [Member]" } } }, "localname": "CARESActLoanMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_CapPriceOfCappedCallTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cap Price of Capped Call Transaction", "label": "Cap Price of Capped Call Transaction", "terseLabel": "Cap Price of Capped Call Transaction" } } }, "localname": "CapPriceOfCappedCallTransaction", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "perShareItemType" }, "ivc_CapitalizedSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capitalized Software [Member]", "label": "Capitalized Software [Member]", "terseLabel": "Capitalized Software [Member]" } } }, "localname": "CapitalizedSoftwareMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ivc_CappedCallOptionsOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capped Call Options, Outstanding", "label": "Capped Call Options, Outstanding", "terseLabel": "Capped Call Options, Outstanding" } } }, "localname": "CappedCallOptionsOutstanding", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "integerItemType" }, "ivc_CashDiscountReserves": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 3.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash Discount Reserves", "label": "Cash Discount Reserves", "negatedTerseLabel": "Cash discount reserves" } } }, "localname": "CashDiscountReserves", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ChargesrelatedtorestructuringactivitiesasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Charges related to restructuring activities, as a Percent of Net Sales", "label": "Charges related to restructuring activities, as a Percent of Net Sales", "terseLabel": "Charges related to restructuring activities, as a Percent of Net Sales" } } }, "localname": "ChargesrelatedtorestructuringactivitiesasaPercentofNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_CommonStockHoldersPercentageofTotalOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, Holders Percentage of Total Outstanding", "label": "Common Stock, Holders Percentage of Total Outstanding", "terseLabel": "Common Stock, Holders Percentage of Total Outstanding" } } }, "localname": "CommonStockHoldersPercentageofTotalOutstanding", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_CommonStockNumberofVotes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, Number of Votes", "label": "Common Stock, Number of Votes", "terseLabel": "Common Stock, Number of Votes" } } }, "localname": "CommonStockNumberofVotes", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "integerItemType" }, "ivc_ComputerSoftwareDepreciationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Computer Software Depreciation Expense", "label": "Computer Software Depreciation Expense", "terseLabel": "Computer Software Depreciation Expense" } } }, "localname": "ComputerSoftwareDepreciationExpense", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConcentrationRiskRecourseforCustomerLeaseObligationUnderDefault": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Concentration Risk, Recourse for Customer Lease Obligation Under Default", "label": "Concentration Risk, Recourse for Customer Lease Obligation Under Default", "terseLabel": "Events of Default Under Contract by Third Party" } } }, "localname": "ConcentrationRiskRecourseforCustomerLeaseObligationUnderDefault", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConcentrationRiskRetainedRecourseObligationForDefaultofCustomerLeaseObligationsUnderContract": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Concentration Risk, Retained Recourse Obligation For Default of Customer Lease Obligations Under Contract", "label": "Concentration Risk, Retained Recourse Obligation For Default of Customer Lease Obligations Under Contract", "terseLabel": "Retained Recourse Obligation For Events Of Default Under Contracts" } } }, "localname": "ConcentrationRiskRetainedRecourseObligationForDefaultofCustomerLeaseObligationsUnderContract", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ConcentrationOfCreditRiskDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ContingentLiabilityGuarantee": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contingent Liability, Guarantee", "label": "Contingent Liability, Guarantee", "terseLabel": "Contingent Liability, Guarantee" } } }, "localname": "ContingentLiabilityGuarantee", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ContractTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract Type [Axis]", "label": "Contract Type [Axis]", "terseLabel": "Contract Type [Axis]" } } }, "localname": "ContractTypeAxis", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "stringItemType" }, "ivc_ContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Contract Type [Axis]", "label": "Contract Type [Domain]", "terseLabel": "Contract Type [Domain]" } } }, "localname": "ContractTypeDomain", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_ContractTypeSalesSplit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract Type Sales Split", "label": "Contract Type Sales Split", "terseLabel": "Contract Type Sales Split" } } }, "localname": "ContractTypeSalesSplit", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "percentItemType" }, "ivc_ConvertibleDebtConversionFeatureFairValueatIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible Debt Conversion Feature, Fair Value at Issuance", "label": "Convertible Debt Conversion Feature, Fair Value at Issuance", "terseLabel": "Convertible Debt Conversion Feature, Fair Value at Issuance" } } }, "localname": "ConvertibleDebtConversionFeatureFairValueatIssuance", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebtConversionFeatureGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible Debt Conversion Feature Gain (Loss)", "label": "Convertible Debt Conversion Feature Gain (Loss)", "negatedTerseLabel": "Convertible Debt Conversion Feature Gain (Loss)", "terseLabel": "Convertible Debt Conversion Feature Gain (Loss)" } } }, "localname": "ConvertibleDebtConversionFeatureGainLoss", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebtConversionRateofCommmonSharesPrincipal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible Debt, Conversion Rate of Commmon Shares, Principal", "label": "Convertible Debt, Conversion Rate of Commmon Shares, Principal", "terseLabel": "Convertible Debt, Conversion Rate of Commmon Shares, Principal" } } }, "localname": "ConvertibleDebtConversionRateofCommmonSharesPrincipal", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebtDerivative": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible Debt Derivative", "label": "Convertible Debt Derivative", "terseLabel": "Convertible Debt Derivative" } } }, "localname": "ConvertibleDebtDerivative", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleDebtDerivativeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Debt Derivative", "label": "Convertible Debt Derivative [Member]", "terseLabel": "Convertible Debt Derivative" } } }, "localname": "ConvertibleDebtDerivativeMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleDebtDiscountAmortizationAndAccretion": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Convertible Debt Discount Amortization and Accretion", "label": "Convertible Debt Discount Amortization and Accretion", "terseLabel": "Convertible Debt Discount Amortization and Accretion" } } }, "localname": "ConvertibleDebtDiscountAmortizationAndAccretion", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ivc_ConvertibleSeniorNotesAdditionalAccruedInterestInTheEventOfFailureToFileRequirementsUnderSECActOf1934": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes, Additional Accrued interest in the Event of Failure to File Requirements under SEC Act of 1934", "label": "Convertible Senior Notes, Additional Accrued interest in the Event of Failure to File Requirements under SEC Act of 1934", "terseLabel": "Convertible Senior Notes, Additional Accrued interest in the Event of Failure to File Requirements under SEC Act of 1934" } } }, "localname": "ConvertibleSeniorNotesAdditionalAccruedInterestInTheEventOfFailureToFileRequirementsUnderSECActOf1934", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ConvertibleSeniorNotesAdditionalAccruedInterestInTheEventOfRestrictiveLegendsNotBeingRemovedAsOfThe380thDayAfterDateOfOriginalIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes, Additional Accrued interest in the Event of restrictive legends not being removed as of the 380th day after date of original issuance", "label": "Convertible Senior Notes, Additional Accrued interest in the Event of restrictive legends not being removed as of the 380th day after date of original issuance", "terseLabel": "Convertible Senior Notes, Additional Accrued interest in the Event of restrictive legends not being removed as of the 380th day after date of original issuance" } } }, "localname": "ConvertibleSeniorNotesAdditionalAccruedInterestInTheEventOfRestrictiveLegendsNotBeingRemovedAsOfThe380thDayAfterDateOfOriginalIssuance", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ConvertibleSeniorNotesAt425March2026CMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes at 4.25% March 2026 c", "label": "Convertible Senior Notes at 4.25% March 2026 c [Member]", "terseLabel": "Convertible Senior Notes at 4.25% March 2026 [Domain]" } } }, "localname": "ConvertibleSeniorNotesAt425March2026CMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesAt425March2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes at 4.25% March 2026", "label": "Convertible Senior Notes at 4.25% March 2026 [Member]", "terseLabel": "Convertible Senior Notes at 4.25% March 2026" } } }, "localname": "ConvertibleSeniorNotesAt425March2026Member", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesAt450February20221Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes at 4.50% February 2022 1", "label": "Convertible Senior Notes at 4.50% February 2022 1 [Member]", "terseLabel": "Convertible Senior Notes at 4.50% February 2022 [Domain]" } } }, "localname": "ConvertibleSeniorNotesAt450February20221Member", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesAt450February2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes at 4.50% February 2022", "label": "Convertible Senior Notes at 4.50% February 2022 [Member]", "terseLabel": "Convertible Senior Notes at 4.50% February 2022" } } }, "localname": "ConvertibleSeniorNotesAt450February2022Member", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesAt500November2024AMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes at 5.00% November 2024 a", "label": "Convertible Senior Notes at 5.00% November 2024 a [Member]", "terseLabel": "Convertible Senior Notes at 5.00% November 2024 [Domain]" } } }, "localname": "ConvertibleSeniorNotesAt500November2024AMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesAt500November2024BMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Subordinated Debentures at 4.125% February 2027", "label": "Convertible Senior Notes at 5.00% November 2024 b [Member]", "terseLabel": "Convertible Senior Notes at 5.00% November 2024" } } }, "localname": "ConvertibleSeniorNotesAt500November2024BMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorNotesHoldersAggregatePrincipalMinimumRequirementPercentageInTheEventOfDefault": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes, Holders Aggregate Principal Minimum requirement percentage, in the event of default", "label": "Convertible Senior Notes, Holders Aggregate Principal Minimum requirement percentage, in the event of default", "terseLabel": "Convertible Senior Notes, Holders Aggregate Principal Minimum requirement percentage, in the event of default" } } }, "localname": "ConvertibleSeniorNotesHoldersAggregatePrincipalMinimumRequirementPercentageInTheEventOfDefault", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ConvertibleSeniorNotesPercentageofPrincipalRequiredforRepurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes, Percentage of Principal Required for Repurchase", "label": "Convertible Senior Notes, Percentage of Principal Required for Repurchase", "terseLabel": "Convertible Senior Notes, Percentage of Principal Required for Repurchase" } } }, "localname": "ConvertibleSeniorNotesPercentageofPrincipalRequiredforRepurchase", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ConvertibleSeniorNotesat5.00February2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes at 5.00% February 2021 [Member]", "label": "Convertible Senior Notes at 5.00% February 2021 [Member]", "terseLabel": "Convertible Senior Notes at 5.00% February 2021" } } }, "localname": "ConvertibleSeniorNotesat5.00February2021Member", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Secured Notes at 5.68% July 2026 - July 26, 2022 Issuance", "label": "Convertible Senior Secured Notes at 5.68% July 2026 - July 26, 2022 Issuance [Member]", "terseLabel": "Convertible Senior Secured Notes at 5.68% July 2026 - July 26, 2022 Issuance [Domain]" } } }, "localname": "ConvertibleSeniorSecuredNotesAt568July2026July262022IssuanceMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorSecuredNotesAt568July2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Secured Notes at 5.68% July 2026", "label": "Convertible Senior Secured Notes at 5.68% July 2026 [Member]", "terseLabel": "Convertible Senior Secured Notes at 5.68% July 2026" } } }, "localname": "ConvertibleSeniorSecuredNotesAt568July2026Member", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorSecuredNotesAt568July2026TrancheIINotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Secured Notes at 5.68% July 2026 - Tranche II Notes", "label": "Convertible Senior Secured Notes at 5.68% July 2026 - Tranche II Notes [Member]", "terseLabel": "Convertible Senior Secured Notes at 5.68% July 2026 - Tranche II Notes [Domain]" } } }, "localname": "ConvertibleSeniorSecuredNotesAt568July2026TrancheIINotesMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorSecuredNotesAt568July2026TrancheINotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Secured Notes at 5.68% July 2026 - Tranche I Notes", "label": "Convertible Senior Secured Notes at 5.68% July 2026 - Tranche I Notes [Member]", "terseLabel": "Convertible Senior Secured Notes at 5.68% July 2026 - Tranche I Notes [Domain]" } } }, "localname": "ConvertibleSeniorSecuredNotesAt568July2026TrancheINotesMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ConvertibleSeniorSubordinatedDebenturesAt500February2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Subordinated Debentures at 5.00% February 2021", "label": "Convertible Senior Subordinated Debentures at 5.00% February 2021 [Member]", "terseLabel": "Convertible Senior Subordinated Debentures at 5.00% February 2021 [Domain]" } } }, "localname": "ConvertibleSeniorSubordinatedDebenturesAt500February2021Member", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_Convertibledue2021BondHedgeFairValueatIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible due 2021 - Bond Hedge, Fair Value at Issuance", "label": "Convertible due 2021 - Bond Hedge, Fair Value at Issuance", "terseLabel": "Convertible due 2021 - Bond Hedge, Fair Value at Issuance" } } }, "localname": "Convertibledue2021BondHedgeFairValueatIssuance", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_Convertibledue2022BondHedgeFairValueatIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible due 2022 - Bond Hedge, Fair Value at Issuance", "label": "Convertible due 2022 - Bond Hedge, Fair Value at Issuance", "terseLabel": "Convertible due 2022 - Bond Hedge, Fair Value at Issuance" } } }, "localname": "Convertibledue2022BondHedgeFairValueatIssuance", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_CostofProductsSoldasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cost of Products Sold, as a Percent of Net Sales", "label": "Cost of Products Sold, as a Percent of Net Sales", "terseLabel": "Cost of Products Sold, as a Percent of Net Sales" } } }, "localname": "CostofProductsSoldasaPercentofNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_CustomerRebateReserve": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Customer Rebate Reserve", "label": "Customer Rebate Reserve", "negatedTerseLabel": "Customer rebate reserve" } } }, "localname": "CustomerRebateReserve", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtDiscountAmortizationPerBasicAndDilutedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Discount Amortization, per Basic and Diluted Share", "label": "Debt Discount Amortization, per Basic and Diluted Share", "terseLabel": "Debt Discount Amortization, per Basic and Diluted Share" } } }, "localname": "DebtDiscountAmortizationPerBasicAndDilutedShare", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesDetails" ], "xbrltype": "perShareItemType" }, "ivc_DebtInstrumentAdditionalPrepaymentPremiumPercentageOfAggregatePrincipalAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Additional Prepayment Premium, Percentage of aggregate principal amount", "label": "Debt Instrument, Additional Prepayment Premium, Percentage of aggregate principal amount", "terseLabel": "Debt Instrument, Additional Prepayment Premium, Percentage of aggregate principal amount" } } }, "localname": "DebtInstrumentAdditionalPrepaymentPremiumPercentageOfAggregatePrincipalAmount", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_DebtInstrumentAmountOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Amount Outstanding", "label": "Debt Instrument, Amount Outstanding", "terseLabel": "Debt Instrument, Amount Outstanding" } } }, "localname": "DebtInstrumentAmountOutstanding", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentCommonSharesExchanged": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Common Shares Exchanged", "label": "Debt Instrument, Common Shares Exchanged", "terseLabel": "Debt Instrument, Common Shares Exchanged" } } }, "localname": "DebtInstrumentCommonSharesExchanged", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ivc_DebtInstrumentExchangeAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument Exchange Amount", "label": "Debt Instrument Exchange Amount", "terseLabel": "Debt Instrument Exchange Amount" } } }, "localname": "DebtInstrumentExchangeAmount", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentFeeAmountNetBalanceShownasaLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Fee Amount, Net Balance Shown as a Liability", "label": "Debt Instrument, Fee Amount, Net Balance Shown as a Liability", "terseLabel": "Debt Instrument, Fee Amount", "verboseLabel": "Debt fees" } } }, "localname": "DebtInstrumentFeeAmountNetBalanceShownasaLiability", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentHedgeOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Hedge Options", "label": "Debt Instrument, Hedge Options", "terseLabel": "Debt Instrument, Hedge Options" } } }, "localname": "DebtInstrumentHedgeOptions", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "integerItemType" }, "ivc_DebtInstrumentHedgeOptionsAvailableForExercise": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Hedge Options available for exercise", "label": "Debt Instrument, Hedge Options available for exercise", "terseLabel": "Debt Instrument, Hedge Options available for exercise" } } }, "localname": "DebtInstrumentHedgeOptionsAvailableForExercise", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "integerItemType" }, "ivc_DebtInstrumentInterestRateOnLiabilityComponentEffectivePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Interest Rate on Liability Component, Effective Percentage", "label": "Debt Instrument, Interest Rate on Liability Component, Effective Percentage", "terseLabel": "Debt Instrument, Interest Rate on Liability Component, Effective Percentage" } } }, "localname": "DebtInstrumentInterestRateOnLiabilityComponentEffectivePercentage", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_DebtInstrumentLossonExchange": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Loss on Exchange", "label": "Debt Instrument, Loss on Exchange", "terseLabel": "Debt Instrument, Loss on Exchange" } } }, "localname": "DebtInstrumentLossonExchange", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentNetCarryingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Net Carrying Amount", "label": "Debt Instrument, Net Carrying Amount", "terseLabel": "Debt Instrument, Net Carrying Amount" } } }, "localname": "DebtInstrumentNetCarryingAmount", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentNetProceeds": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Net Proceeds", "label": "Debt Instrument, Net Proceeds", "terseLabel": "Debt Instrument, Net Proceeds" } } }, "localname": "DebtInstrumentNetProceeds", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentNonCashInterestExpenseRecognizedinthePeriod": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Non-Cash Interest Expense Recognized in the Period", "label": "Debt Instrument, Non-Cash Interest Expense Recognized in the Period", "terseLabel": "Debt Instrument, Non-Cash Interest Expense Recognized in the Period" } } }, "localname": "DebtInstrumentNonCashInterestExpenseRecognizedinthePeriod", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentPercentLimitOnIssuingCommonSharesUponConversionOfTheNew2026Notes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Percent limit on issuing common shares upon Conversion of the New 2026 Notes", "label": "Debt Instrument, Percent limit on issuing common shares upon Conversion of the New 2026 Notes", "terseLabel": "Debt Instrument, Percent limit on issuing common shares upon Conversion of the New 2026 Notes" } } }, "localname": "DebtInstrumentPercentLimitOnIssuingCommonSharesUponConversionOfTheNew2026Notes", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_DebtInstrumentPrepaymentPremiumPercentageOfAggregatePrincipalAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Prepayment Premium, Percentage of aggregate principal amount", "label": "Debt Instrument, Prepayment Premium, Percentage of aggregate principal amount", "terseLabel": "Debt Instrument, Prepayment Premium, Percentage of aggregate principal amount" } } }, "localname": "DebtInstrumentPrepaymentPremiumPercentageOfAggregatePrincipalAmount", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_DebtInstrumentRepurchaseAmountCashPaid": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument Repurchase Amount, Cash Paid", "label": "Debt Instrument Repurchase Amount, Cash Paid", "terseLabel": "Debt Instrument Repurchase Amount, Cash Paid" } } }, "localname": "DebtInstrumentRepurchaseAmountCashPaid", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DebtInstrumentSpringingMaturityDateDaysPriorToMaturityDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument, Springing Maturity, days prior to maturity date", "label": "Debt instrument, Springing Maturity Date, days prior to maturity date", "terseLabel": "Debt instrument, Springing Maturity Date" } } }, "localname": "DebtInstrumentSpringingMaturityDateDaysPriorToMaturityDate", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_DebtInstrumentSpringingMaturityDateDaysPriorToMaturityOfConvertibleNotesDue2024": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Springing Maturity Date, days prior to maturity of Convertible Notes due 2024", "label": "Debt Instrument, Springing Maturity Date, days prior to maturity of Convertible Notes due 2024", "terseLabel": "Debt Instrument, Springing Maturity Date, days prior to maturity of Convertible Notes due 2024" } } }, "localname": "DebtInstrumentSpringingMaturityDateDaysPriorToMaturityOfConvertibleNotesDue2024", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_DebtInstrumentSpringingMaturityDaysPriorToMaturityOfSecuredTermLoansDue2026": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Springing Maturity, days prior to maturity of secured term loans due 2026", "label": "Debt Instrument, Springing Maturity, days prior to maturity of secured term loans due 2026", "terseLabel": "Debt Instrument, Springing Maturity, days prior to maturity of secured term loans due 2026" } } }, "localname": "DebtInstrumentSpringingMaturityDaysPriorToMaturityOfSecuredTermLoansDue2026", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_DebtInstrumentWarrantsIssuedandOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Warrants Issued and Outstanding", "label": "Debt Instrument, Warrants Issued and Outstanding", "terseLabel": "Debt Instrument, Warrants Issued and Outstanding" } } }, "localname": "DebtInstrumentWarrantsIssuedandOutstanding", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "integerItemType" }, "ivc_DebtInstrurmentRepurchaseAmountNetReductionofdebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrurment Repurchase Amount, Net Reduction of debt", "label": "Debt Instrurment Repurchase Amount, Net Reduction of debt", "terseLabel": "Debt Instrurment Repurchase Amount, Net Reduction of debt" } } }, "localname": "DebtInstrurmentRepurchaseAmountNetReductionofdebt", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DeferredGainOnSaleLeasebackNet": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 8.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred gain on sale leaseback, Net", "label": "Deferred gain on sale leaseback, Net", "terseLabel": "Deferred gain on sale leaseback, Net" } } }, "localname": "DeferredGainOnSaleLeasebackNet", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DeferredTaxReversalRelatedToGoodwillImpairment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Reversal, related to Goodwill Impairment", "label": "Deferred Tax Reversal, related to Goodwill Impairment", "terseLabel": "Deferred Tax Reversal, related to Goodwill Impairment" } } }, "localname": "DeferredTaxReversalRelatedToGoodwillImpairment", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DerivativeInstrumentsandHedgingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative Instruments and Hedging Activities [Abstract]", "label": "Derivative Instruments and Hedging Activities [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities [Abstract]" } } }, "localname": "DerivativeInstrumentsandHedgingActivitiesAbstract", "nsuri": "http://www.invacare.com/20220930", "xbrltype": "stringItemType" }, "ivc_DerivativePercentageOfForcastedTransactionsWithCurrencyRateExposure": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative, Percentage of Forcasted Transactions With Currency Rate Exposure", "label": "Derivative, Percentage of Forcasted Transactions With Currency Rate Exposure", "terseLabel": "Derivative, percentage of forcasted transactions with currency rate exposure" } } }, "localname": "DerivativePercentageOfForcastedTransactionsWithCurrencyRateExposure", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationDivestitureAccrualBalance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Divestiture Accrual Balance", "label": "Disposal Group, Including Discontinued Operation, Divestiture Accrual Balance", "terseLabel": "Disposal Group, Including Discontinued Operation, Divestiture Accrual Balance" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationDivestitureAccrualBalance", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationEarningsBeforeTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Earnings Before Taxes", "label": "Disposal Group, Including Discontinued Operation, Earnings Before Taxes", "terseLabel": "Disposal Group, Including Discontinued Operation, Earnings Before Taxes" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationEarningsBeforeTaxes", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationInterCompanyRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Inter-Company Revenue", "label": "Disposal Group, Including Discontinued Operation, Inter-Company Revenue", "terseLabel": "Disposal Group, Including Discontinued Operation, Inter-Company Revenue" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationInterCompanyRevenue", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current", "label": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current", "terseLabel": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, Current" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent", "label": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent", "terseLabel": "Disposal Group, Including Discontinued Operation, Operating Lease, Liability, NonCurrent" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNonCurrent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightofUseAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset", "terseLabel": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Asset" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightofUseAsset", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_DivestedBusinessesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Divested Businesses [Abstract]", "label": "Divested Businesses [Abstract]", "terseLabel": "Divested Businesses [Abstract]" } } }, "localname": "DivestedBusinessesAbstract", "nsuri": "http://www.invacare.com/20220930", "xbrltype": "stringItemType" }, "ivc_EuropeEMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Europe (EMEA)", "label": "Europe (EMEA) [Member]", "terseLabel": "Europe (EMEA)" } } }, "localname": "EuropeEMEAMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_ExchangeOfConvertibleNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Exchange of Convertible Notes", "label": "Exchange of Convertible Notes", "terseLabel": "Exchange of Convertible Notes" } } }, "localname": "ExchangeOfConvertibleNotes", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeaseCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Lease, Cost", "label": "Financing Lease, Cost", "terseLabel": "Financing Lease, Cost" } } }, "localname": "FinancingLeaseCost", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeaseLiabilitynoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Financing Lease Liability, non-current", "label": "Financing Lease Liability, non-current", "terseLabel": "Financing Lease Liability, non-current" } } }, "localname": "FinancingLeaseLiabilitynoncurrent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities", "label": "Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities", "terseLabel": "Financing Leases, Cash Paid in Measurement of Amounts for Lease Liabilities" } } }, "localname": "FinancingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeasesFutureMinimumPaymentsInterestIncludedinPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Leases, Future Minimum Payments, Interest Included in Payments", "label": "Financing Leases, Future Minimum Payments, Interest Included in Payments", "negatedTerseLabel": "Financing Leases, Future Minimum Payments, Interest Included in Payments" } } }, "localname": "FinancingLeasesFutureMinimumPaymentsInterestIncludedinPayments", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingLeasesFutureMinimumPaymentsPresentValueofNetMinimumPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "label": "Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "terseLabel": "Financing Leases, Future Minimum Payments, Present Value of Net Minimum Payments" } } }, "localname": "FinancingLeasesFutureMinimumPaymentsPresentValueofNetMinimumPayments", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableCreditLimit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable Credit Limit", "label": "Financing Receivable Credit Limit", "terseLabel": "Credit amount requiring additional analysis" } } }, "localname": "FinancingReceivableCreditLimit", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableGross": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, Gross", "label": "Financing Receivable, Gross", "totalLabel": "Financing Receivable, Gross" } } }, "localname": "FinancingReceivableGross", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableInterestIncomeAccrualMethod": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, Interest Income, Accrual Method", "label": "Financing Receivable, Interest Income, Accrual Method", "totalLabel": "Total installment receivables" } } }, "localname": "FinancingReceivableInterestIncomeAccrualMethod", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableRecordedInvestment": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, Recorded Investment", "label": "Financing Receivable, Recorded Investment", "totalLabel": "Total installment receivables" } } }, "localname": "FinancingReceivableRecordedInvestment", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivableUnpaidPrincipalBalance": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, Unpaid Principal Balance", "label": "Financing Receivable, Unpaid Principal Balance", "totalLabel": "Total installment receivables" } } }, "localname": "FinancingReceivableUnpaidPrincipalBalance", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivablesNotAccruingInterestPast90DaysDue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing Receivables Not Accruing Interest Past 90 Days Due", "label": "Financing Receivables Not Accruing Interest Past 90 Days Due", "terseLabel": "Financing Receivables Not Past 90 Days Due" } } }, "localname": "FinancingReceivablesNotAccruingInterestPast90DaysDue", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_FinancingReceivablesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing Receivables [Table Text Block]", "label": "Financing Receivables [Table Text Block]", "terseLabel": "Schedule of Financing Receivables" } } }, "localname": "FinancingReceivablesTableTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "ivc_FinancingReceivablewithNoRelatedAllowanceInterestIncomeAccrualMethod": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 1.0, "parentTag": "ivc_FinancingReceivableInterestIncomeAccrualMethod", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, with No Related Allowance, Interest Income, Accrual Method", "label": "Financing Receivable, with No Related Allowance, Interest Income, Accrual Method", "terseLabel": "Non-Impaired installment receivables with no related allowance recorded" } } }, "localname": "FinancingReceivablewithNoRelatedAllowanceInterestIncomeAccrualMethod", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivablewithNoRelatedAllowanceRecordedInvestment": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 1.0, "parentTag": "ivc_FinancingReceivableRecordedInvestment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, with No Related Allowance, Recorded Investment", "label": "Financing Receivable, with No Related Allowance, Recorded Investment", "terseLabel": "Non-Impaired installment receivables with no related allowance recorded" } } }, "localname": "FinancingReceivablewithNoRelatedAllowanceRecordedInvestment", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FinancingReceivablewithNoRelatedAllowanceUnpaidPrincipalBalance": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 1.0, "parentTag": "ivc_FinancingReceivableUnpaidPrincipalBalance", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing Receivable, with No Related Allowance, Unpaid Principal Balance", "label": "Financing Receivable, with No Related Allowance, Unpaid Principal Balance", "terseLabel": "Non-Impaired installment receivables with no related allowance recorded" } } }, "localname": "FinancingReceivablewithNoRelatedAllowanceUnpaidPrincipalBalance", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "ivc_FiniteLivedandIndefiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Line Items] for Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table]", "label": "Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedandIndefiniteLivedIntangibleAssetsLineItems", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "stringItemType" }, "ivc_FirstYearOfLoanPeriodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First year of loan period", "label": "First year of loan period [Member]", "terseLabel": "First year of loan period" } } }, "localname": "FirstYearOfLoanPeriodMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardAUDNZDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward AUD / NZD [Member]", "label": "Foreign Exchange Forward AUD / NZD [Member]", "terseLabel": "AUD / NZD" } } }, "localname": "ForeignExchangeForwardAUDNZDMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardAUDTHBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward AUD / THB", "label": "Foreign Exchange Forward AUD / THB [Member]", "terseLabel": "AUD / THB" } } }, "localname": "ForeignExchangeForwardAUDTHBMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardAUDUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward AUD / USD [Member]", "label": "Foreign Exchange Forward AUD / USD [Member]", "terseLabel": "USD / AUD" } } }, "localname": "ForeignExchangeForwardAUDUSDMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardCADUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward CAD / USD [Member]", "label": "Foreign Exchange Forward CAD / USD [Member]", "terseLabel": "USD / CAD" } } }, "localname": "ForeignExchangeForwardCADUSDMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardContractsByExchangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward Contracts, by Exchange [Axis]", "label": "Foreign Exchange Forward Contracts, by Exchange [Axis]", "terseLabel": "Foreign Exchange Forward Contracts, by Exchange [Axis]" } } }, "localname": "ForeignExchangeForwardContractsByExchangeAxis", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "stringItemType" }, "ivc_ForeignExchangeForwardContractsByExchangeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward Contracts, by Exchange [Domain]", "label": "Foreign Exchange Forward Contracts, by Exchange [Domain]", "terseLabel": "Foreign Exchange Forward Contracts, by Exchange [Domain]" } } }, "localname": "ForeignExchangeForwardContractsByExchangeDomain", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardDKKSEKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward DKK / SEK [Member]", "label": "Foreign Exchange Forward DKK / SEK [Member]", "terseLabel": "DKK / SEK" } } }, "localname": "ForeignExchangeForwardDKKSEKMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardDKKUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward DKK / USD [Member]", "label": "Foreign Exchange Forward DKK / USD [Member]", "terseLabel": "USD / DKK" } } }, "localname": "ForeignExchangeForwardDKKUSDMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURCHFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward EUR / CHF [Member]", "label": "Foreign Exchange Forward EUR / CHF [Member]", "terseLabel": "EUR / CHF" } } }, "localname": "ForeignExchangeForwardEURCHFMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURGBPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward EUR / GBP [Member]", "label": "Foreign Exchange Forward EUR / GBP [Member]", "terseLabel": "EUR / GBP" } } }, "localname": "ForeignExchangeForwardEURGBPMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURNOKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward EUR / NOK [Member]", "label": "Foreign Exchange Forward EUR / NOK [Member]", "terseLabel": "EUR / NOK" } } }, "localname": "ForeignExchangeForwardEURNOKMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURSEKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward EUR / SEK [Member]", "label": "Foreign Exchange Forward EUR / SEK [Member]", "terseLabel": "EUR / SEK" } } }, "localname": "ForeignExchangeForwardEURSEKMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURTHBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward EUR / THB", "label": "Foreign Exchange Forward EUR / THB [Member]", "terseLabel": "EUR / THB" } } }, "localname": "ForeignExchangeForwardEURTHBMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardEURUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward EUR / USD [Member]", "label": "Foreign Exchange Forward EUR / USD [Member]", "terseLabel": "EUR / USD" } } }, "localname": "ForeignExchangeForwardEURUSDMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardGBPTHBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward GBP / THB", "label": "Foreign Exchange Forward GBP / THB [Member]", "terseLabel": "GBP / THB" } } }, "localname": "ForeignExchangeForwardGBPTHBMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardGBPUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward GBP / USD [Member]", "label": "Foreign Exchange Forward GBP / USD [Member]", "terseLabel": "USD / GBP" } } }, "localname": "ForeignExchangeForwardGBPUSDMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardNOKSEKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward NOK / SEK [Member]", "label": "Foreign Exchange Forward NOK / SEK [Member]", "terseLabel": "NOK / SEK" } } }, "localname": "ForeignExchangeForwardNOKSEKMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardNOKUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward NOK / USD [Member]", "label": "Foreign Exchange Forward NOK / USD [Member]", "terseLabel": "USD / NOK" } } }, "localname": "ForeignExchangeForwardNOKUSDMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardNZDTHBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward NZD / THB", "label": "Foreign Exchange Forward NZD / THB [Member]", "terseLabel": "NZD / THB" } } }, "localname": "ForeignExchangeForwardNZDTHBMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardSEKUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward SEK/USD", "label": "Foreign Exchange Forward SEK/USD [Member]", "terseLabel": "USD / SEK" } } }, "localname": "ForeignExchangeForwardSEKUSDMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDCADMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward USD / CAD [Member]", "label": "Foreign Exchange Forward USD / CAD [Member]", "terseLabel": "USD / CAD" } } }, "localname": "ForeignExchangeForwardUSDCADMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDCHFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward USD / CHF", "label": "Foreign Exchange Forward USD / CHF [Member]", "terseLabel": "USD / CHF" } } }, "localname": "ForeignExchangeForwardUSDCHFMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDEURMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward USD / EUR [Member]", "label": "Foreign Exchange Forward USD / EUR [Member]", "terseLabel": "USD / EUR" } } }, "localname": "ForeignExchangeForwardUSDEURMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDGBPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward USD / GBP [Member]", "label": "Foreign Exchange Forward USD / GBP [Member]", "terseLabel": "USD / GBP" } } }, "localname": "ForeignExchangeForwardUSDGBPMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDMXPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward USD / MXP [Member]", "label": "Foreign Exchange Forward USD / MXP [Member]", "terseLabel": "USD / MXN" } } }, "localname": "ForeignExchangeForwardUSDMXPMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDSEKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward USD / SEK [Member]", "label": "Foreign Exchange Forward USD / SEK [Member]", "terseLabel": "USD / SEK" } } }, "localname": "ForeignExchangeForwardUSDSEKMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_ForeignExchangeForwardUSDTHBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Exchange Forward USD / THB", "label": "Foreign Exchange Forward USD / THB [Member]", "terseLabel": "USD / THB" } } }, "localname": "ForeignExchangeForwardUSDTHBMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "ivc_GainlossBeforeIncomeTaxesasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gain (loss) Before Income Taxes, as a Percent of Net Sales", "label": "Gain (loss) Before Income Taxes, as a Percent of Net Sales", "terseLabel": "Gain (loss) Before Income Taxes, as a Percent of Net Sales" } } }, "localname": "GainlossBeforeIncomeTaxesasaPercentofNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_GainonsaleofbusinessasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gain on sale of business, as a Percent of Net Sales", "label": "Gain on sale of business, as a Percent of Net Sales", "terseLabel": "Gain on sale of business, as a Percent of Net Sales" } } }, "localname": "GainonsaleofbusinessasaPercentofNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_GeneralLeaseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General Lease Term", "label": "General Lease Term", "terseLabel": "General Lease Term" } } }, "localname": "GeneralLeaseTerm", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "durationItemType" }, "ivc_GeneralTermsandConditionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General Terms and Conditions [Member]", "label": "General Terms and Conditions [Member]", "terseLabel": "General Terms and Conditions" } } }, "localname": "GeneralTermsandConditionsMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_GoodwillImpairmentTestDiscountedCashFlowDiscountRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Goodwill, Impairment Test, Discounted Cash Flow, Discount Rate", "label": "Goodwill, Impairment Test, Discounted Cash Flow, Discount Rate", "terseLabel": "Goodwill, Impairment Test, Discounted Cash Flow, Discount Rate" } } }, "localname": "GoodwillImpairmentTestDiscountedCashFlowDiscountRate", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails" ], "xbrltype": "percentItemType" }, "ivc_GovernmentTendersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Government Tenders [Member]", "label": "Government Tenders [Member]", "terseLabel": "Government Tenders" } } }, "localname": "GovernmentTendersMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_GrossProfitasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross Profit, as a Percent of Net Sales", "label": "Gross Profit, as a Percent of Net Sales", "terseLabel": "Gross Profit, as a Percent of Net Sales" } } }, "localname": "GrossProfitasaPercentofNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_ITServiceContract": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "IT Service Contract", "label": "IT Service Contract", "terseLabel": "IT service contracts" } } }, "localname": "ITServiceContract", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_IVCCanadaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IVC Canada", "label": "IVC Canada [Member]", "terseLabel": "IVC Canada" } } }, "localname": "IVCCanadaMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "domainItemType" }, "ivc_ImpairedFinancingReceivableRelatedAllowanceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Impaired Financing Receivable, Related Allowance [Abstract]", "label": "Impaired Financing Receivable, Related Allowance [Abstract]", "terseLabel": "Related Allowance for Doubtful Accounts" } } }, "localname": "ImpairedFinancingReceivableRelatedAllowanceAbstract", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "ivc_ImpairmentOfGoodwillAsAPercentOfNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Impairment of goodwill, as a Percent of net Sales", "label": "Impairment of goodwill, as a Percent of net Sales", "terseLabel": "Impairment of goodwill, as a Percent of net Sales" } } }, "localname": "ImpairmentOfGoodwillAsAPercentOfNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_IncomeTaxProvisionasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Tax Provision, as a Percent of Net Sales", "label": "Income Tax Provision, as a Percent of Net Sales", "terseLabel": "Income Tax Provision, as a Percent of Net Sales" } } }, "localname": "IncomeTaxProvisionasaPercentofNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_InitialAmountAtClosingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial amount at closing", "label": "Initial amount at closing [Member]", "terseLabel": "Initial amount at closing [Domain]" } } }, "localname": "InitialAmountAtClosingMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_InstallmentReceivable0To30DaysPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 2.0, "parentTag": "ivc_FinancingReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Installment Receivable, 0 to 30 Days Past Due", "label": "Installment Receivable, 0 to 30 Days Past Due", "terseLabel": "0-30 days past due" } } }, "localname": "InstallmentReceivable0To30DaysPastDue", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InstallmentReceivable31To60DaysPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 3.0, "parentTag": "ivc_FinancingReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Installment Receivable, 31 to 60 Days Past Due", "label": "Installment Receivable, 31 to 60 Days Past Due", "terseLabel": "31-60 days past due" } } }, "localname": "InstallmentReceivable31To60DaysPastDue", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InstallmentReceivableGreaterThan90DaysPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 5.0, "parentTag": "ivc_FinancingReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Installment Receivable, Greater than 90 Days Past Due", "label": "Installment Receivable, Greater than 90 Days Past Due", "terseLabel": "90+ days past due" } } }, "localname": "InstallmentReceivableGreaterThan90DaysPastDue", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InstallmentReceivableNotPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 1.0, "parentTag": "ivc_FinancingReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Installment Receivable, Not Past Due", "label": "Installment Receivable, Not Past Due", "terseLabel": "Installment Receivable, Not Past Due" } } }, "localname": "InstallmentReceivableNotPastDue", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InstallmentSales61To90DaysPastDue": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails": { "order": 4.0, "parentTag": "ivc_FinancingReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Installment Sales, 61 to 90 Days Past Due", "label": "Installment Sales, 61 to 90 Days Past Due", "terseLabel": "61-90 days past due" } } }, "localname": "InstallmentSales61To90DaysPastDue", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InterestExpenseSaleOfReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest Expense, Sale of Receivables", "label": "Interest Expense, Sale of Receivables", "terseLabel": "Interest Expense, Sale of Receivables" } } }, "localname": "InterestExpenseSaleOfReceivables", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_InterestexpenseasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest expense, as a Percent of Net Sales", "label": "Interest expense, as a Percent of Net Sales", "terseLabel": "Interest expense, as a Percent of Net Sales" } } }, "localname": "InterestexpenseasaPercentofNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_InterestincomeasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest income, as a Percent of Net Sales", "label": "Interest income, as a Percent of Net Sales", "terseLabel": "Interest income, as a Percent of Net Sales" } } }, "localname": "InterestincomeasaPercentofNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_LargeNationalCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Large National Customers [Member]", "label": "Large National Customers [Member]", "terseLabel": "Large National Customers" } } }, "localname": "LargeNationalCustomersMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_LastReportedSalesPricePeriodCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Last Reported Sales Price Period, Common Stock", "label": "Last Reported Sales Price Period, Common Stock", "terseLabel": "Last Reported Sales Price Period, Common Stock" } } }, "localname": "LastReportedSalesPricePeriodCommonStock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_LiabilityComponentsOfConvertible2026NoteTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability Components of Convertible 2026 Note", "label": "Liability Components of Convertible 2026 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible 2026 Note" } } }, "localname": "LiabilityComponentsOfConvertible2026NoteTableTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LiabilityComponentsOfConvertibleSeriesII2024NoteTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability Components of Convertible Series II 2024 Note", "label": "Liability Components of Convertible Series II 2024 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible Series II 2024 Note" } } }, "localname": "LiabilityComponentsOfConvertibleSeriesII2024NoteTableTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LiabilityComponentsOfSecured2026NotesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability Components of Secured 2026 Notes", "label": "Liability Components of Secured 2026 Notes [Table Text Block]", "terseLabel": "Liability Components of Secured 2026 Notes" } } }, "localname": "LiabilityComponentsOfSecured2026NotesTableTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LiabilityComponentsOfSecuredTermLoanTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability Components of Secured Term Loan", "label": "Liability Components of Secured Term Loan [Table Text Block]", "terseLabel": "Liability Components of Secured Term Loan" } } }, "localname": "LiabilityComponentsOfSecuredTermLoanTableTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LiabilityComponentsofConvertible2021NoteTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Table Text Block] for Liability Components of Convertible 2021 Note", "label": "Liability Components of Convertible 2021 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible 2021 Note" } } }, "localname": "LiabilityComponentsofConvertible2021NoteTableTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LiabilityComponentsofConvertible2022NoteTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability Components of Convertible 2022 Note [Table Text Block] [Table Text Block]", "label": "Liability Components of Convertible 2022 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible 2022 Note" } } }, "localname": "LiabilityComponentsofConvertible2022NoteTableTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LiabilityComponentsofConvertible2024NoteTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liability Components of Convertible 2024 Note", "label": "Liability Components of Convertible 2024 Note [Table Text Block]", "terseLabel": "Liability Components of Convertible 2024 Note" } } }, "localname": "LiabilityComponentsofConvertible2024NoteTableTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ivc_LifeInsuranceLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 9.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Life Insurance Liability, Noncurrent", "label": "Life Insurance Liability, Noncurrent", "terseLabel": "Death benefit obligation plan" } } }, "localname": "LifeInsuranceLiabilityNoncurrent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LifestyleProductsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lifestyle Products", "label": "Lifestyle Products [Domain]", "terseLabel": "Lifestyle Products [Domain]" } } }, "localname": "LifestyleProductsDomain", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "ivc_LifetimeToDateAccretionExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lifetime to date - Accretion Expense", "label": "Lifetime to date - Accretion Expense", "terseLabel": "Lifetime to date - Accretion Expense" } } }, "localname": "LifetimeToDateAccretionExpense", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineOfCreditFacilityCovenantFeatureDominionTriggerForFiveConsecutiveDays": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days", "label": "Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days", "terseLabel": "Line of Credit Facility, Covenant Feature Dominion Trigger for Five Consecutive Days" } } }, "localname": "LineOfCreditFacilityCovenantFeatureDominionTriggerForFiveConsecutiveDays", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineOfCreditFacilityCovenantFeatureIncreaseLimitBasedOnReceivables": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables", "label": "Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables", "terseLabel": "Line of Credit Facility, Covenant Feature, Increase Limit Based on receivables" } } }, "localname": "LineOfCreditFacilityCovenantFeatureIncreaseLimitBasedOnReceivables", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineOfCreditFacilityCovenantFeaturePriorLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Covenant Feature, Prior Limit", "label": "Line of Credit Facility, Covenant Feature, Prior Limit", "terseLabel": "Line of Credit Facility, Covenant Feature, Prior Limit" } } }, "localname": "LineOfCreditFacilityCovenantFeaturePriorLimit", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineOfCreditFacilityForeignCurrencyFairValueOfAmountOutstandingFrance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France)", "label": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France)", "terseLabel": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (France)" } } }, "localname": "LineOfCreditFacilityForeignCurrencyFairValueOfAmountOutstandingFrance", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineOfCreditFacilityForeignCurrencyFairValueOfAmountOutstandingUK": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK)", "label": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK)", "terseLabel": "Line of Credit Facility, Foreign Currency Fair Value of Amount Outstanding (UK)" } } }, "localname": "LineOfCreditFacilityForeignCurrencyFairValueOfAmountOutstandingUK", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineOfCreditFacilityGrossBorrowingBase": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility Gross Borrowing Base", "label": "Line Of Credit Facility Gross Borrowing Base", "terseLabel": "Line Of Credit Facility Gross Borrowing Base" } } }, "localname": "LineOfCreditFacilityGrossBorrowingBase", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditCovenantComplianceConsecutiveBusinessDaysforUndrawnBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn Balance", "label": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn Balance", "terseLabel": "Consecutive business days for minimum undrawn balance" } } }, "localname": "LineofCreditCovenantComplianceConsecutiveBusinessDaysforUndrawnBalance", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_LineofCreditCovenantComplianceConsecutiveBusinessDaysforUndrawn_Balance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance", "label": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance", "terseLabel": "Line of Credit, Covenant Compliance, Consecutive Business Days for Undrawn_Balance" } } }, "localname": "LineofCreditCovenantComplianceConsecutiveBusinessDaysforUndrawn_Balance", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_LineofCreditCovenantComplianceInterruptionofManufacturingFacilitiesPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Interruption of Manufacturing Facilities Period", "label": "Line of Credit, Covenant Compliance, Interruption of Manufacturing Facilities Period", "terseLabel": "Interruption of material manufacturing facilities, period" } } }, "localname": "LineofCreditCovenantComplianceInterruptionofManufacturingFacilitiesPeriod", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityAdditionalLongLivedAssetAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Additional Long-Lived Asset Amount", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Additional Long-Lived Asset Amount", "terseLabel": "Additional amount of machinery and equipment" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityAdditionalLongLivedAssetAmount", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityAvailabilityReserveMinimum": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Availability Reserve, Minimum", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Availability Reserve, Minimum", "terseLabel": "Minimum availability reserve" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityAvailabilityReserveMinimum", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesDomesticPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Domestic, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Domestic, Percent", "terseLabel": "Percentage of eligible domestic inventory and in-transit inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesDomesticPercent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesForeignLiquidationValuePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Liquidation Value, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Liquidation Value, Percent", "terseLabel": "Percentage of net orderly liquidation value of eligible Canadian inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesForeignLiquidationValuePercent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesForeignPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Foreign, Percent", "terseLabel": "Percentage of eligible Canadian inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesForeignPercent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesLiquidationValueAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Amount", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Amount", "terseLabel": "Maximum value of net orderly liquidation value domestic inventory and in-transit inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesLiquidationValueAmount", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesLiquidationValuePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Inventories, Liquidation Value, Percent", "terseLabel": "Percentage of net orderly liquidation value of domestic inventory" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityInventoriesLiquidationValuePercent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityPropertyPlantandEquipmentLiquidationValuePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Property, Plant and Equipment, Liquidation Value, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Property, Plant and Equipment, Liquidation Value, Percent", "terseLabel": "Net orderly liquidation value of domestic eligible machinery and equipment" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityPropertyPlantandEquipmentLiquidationValuePercent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesDomesticPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Domestic, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Domestic, Percent", "terseLabel": "Percentage of domestic accounts receivable" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesDomesticPercent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesEuropePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent", "terseLabel": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Europe, Percent" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesEuropePercent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesForeignPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Foreign, Percent", "label": "Line of Credit, Covenant Compliance, Maximum Borrowing Capacity, Trade Receivables, Foreign, Percent", "terseLabel": "Percentage of eligible Canadian accounts receivable" } } }, "localname": "LineofCreditCovenantComplianceMaximumBorrowingCapacityTradeReceivablesForeignPercent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditCovenantComplianceRequiredUndrawnBalanceMinimumPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of Credit, Covenant Compliance, Required Undrawn Balance, Minimum, Percent", "label": "Line of Credit, Covenant Compliance, Required Undrawn Balance, Minimum, Percent", "terseLabel": "Minimum required undrawn balance (as a percent)" } } }, "localname": "LineofCreditCovenantComplianceRequiredUndrawnBalanceMinimumPercent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_LineofCreditFacilityAdditionalBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Additional Borrowing Capacity", "label": "Line of Credit Facility, Additional Borrowing Capacity", "terseLabel": "Additional increase in borrowing capacity available" } } }, "localname": "LineofCreditFacilityAdditionalBorrowingCapacity", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditFacilityCovenantFeatureDominionTrigger": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Covenant Feature, Dominion Trigger", "label": "Line of Credit Facility, Covenant Feature, Dominion Trigger", "terseLabel": "Line of Credit Facility, Covenant Feature, Dominion Trigger" } } }, "localname": "LineofCreditFacilityCovenantFeatureDominionTrigger", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LineofCreditFacilityCovenantFeatureIncreaseLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Facility, Covenant Feature, Increase Limit", "label": "Line of Credit Facility, Covenant Feature, Increase Limit", "terseLabel": "Remaining borrowing capacity" } } }, "localname": "LineofCreditFacilityCovenantFeatureIncreaseLimit", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LiquidatedDamagesAmountPerViolationPerDay": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liquidated Damages amount per violation per day", "label": "Liquidated Damages amount per violation per day", "terseLabel": "Liquidated Damages amount per violation per day" } } }, "localname": "LiquidatedDamagesAmountPerViolationPerDay", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LiquidatedDamagesYearlyLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liquidated Damages - Yearly Limit", "label": "Liquidated Damages - Yearly Limit", "terseLabel": "Liquidated Damages - Yearly Limit" } } }, "localname": "LiquidatedDamagesYearlyLimit", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_LossGainOnConvertibleDebtDerivatives": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (loss) on Convertible Debt Derivatives", "label": "Loss (gain) on Convertible Debt Derivatives", "negatedTerseLabel": "Net gain on convertible debt derivatives", "terseLabel": "Net gain on convertible debt derivatives" } } }, "localname": "LossGainOnConvertibleDebtDerivatives", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ivc_MobilityandSeatingDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mobility and Seating", "label": "Mobility and Seating [Domain]", "terseLabel": "Mobility and Seating [Domain]" } } }, "localname": "MobilityandSeatingDomain", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "ivc_NetGainLossasapercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Gain (Loss), as a percent of Net Sales", "label": "Net Gain (Loss), as a percent of Net Sales", "terseLabel": "Net Gain (Loss), as a percent of Net Sales" } } }, "localname": "NetGainLossasapercentofNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_NetLossGainOnDebtExtinguishmentAsAPercentOfNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net loss (gain) on debt extinguishment, as a Percent of Net Sales", "label": "Net loss (gain) on debt extinguishment, as a Percent of Net Sales", "terseLabel": "Net loss (gain) on debt extinguishment, as a Percent of Net Sales [Line Items]" } } }, "localname": "NetLossGainOnDebtExtinguishmentAsAPercentOfNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_NetRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Revenue", "label": "Net Revenue", "terseLabel": "Net Revenue" } } }, "localname": "NetRevenue", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "percentItemType" }, "ivc_NetSalesasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Sales, as a Percent of Net Sales", "label": "Net Sales, as a Percent of Net Sales", "terseLabel": "Net Sales, as a Percent of Net Sales" } } }, "localname": "NetSalesasaPercentofNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_NewAccountingPronouncementsNotYetAdoptedPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Accounting Pronouncements, Not yet Adopted", "label": "New Accounting Pronouncements, Not yet Adopted [Policy Text Block]", "terseLabel": "New Accounting Pronouncements, Not yet Adopted" } } }, "localname": "NewAccountingPronouncementsNotYetAdoptedPolicyTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ivc_NonImpairedFinancingReceivableRelatedAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non-Impaired Financing Receivable, Related Allowance", "label": "Non-Impaired Financing Receivable, Related Allowance", "terseLabel": "Non-Impaired Financing Receivable, Related Allowance" } } }, "localname": "NonImpairedFinancingReceivableRelatedAllowance", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_NorthAmericaNAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "North America (NA)", "label": "North America (NA) [Member]", "terseLabel": "North America (NA)" } } }, "localname": "NorthAmericaNAMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_NotesLoansAndFinancingReceivablesNumberOfMissedPaymentsBeforeDelinquent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes, Loans, and Financing Receivables, Number of Missed Payments before Delinquent", "label": "Notes, Loans, and Financing Receivables, Number of Missed Payments before Delinquent", "terseLabel": "Number of missed payments before delinquent" } } }, "localname": "NotesLoansAndFinancingReceivablesNumberOfMissedPaymentsBeforeDelinquent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "integerItemType" }, "ivc_NotesLoansFinancingReceivableAveragePeriodOfAdjudication": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes, Loans, Financing Receivable, Average Period of Adjudication", "label": "Notes, Loans, Financing Receivable, Average Period of Adjudication", "terseLabel": "Average period of adjudication" } } }, "localname": "NotesLoansFinancingReceivableAveragePeriodOfAdjudication", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_NotionalAmountDerivative": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Notional Amount, Derivative", "label": "Notional Amount, Derivative", "terseLabel": "Notional Amount" } } }, "localname": "NotionalAmountDerivative", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_NotionalAmountOfDerivativesMaturedDuringPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Notional Amount of Derivatives, Matured During Period", "label": "Notional Amount of Derivatives, Matured During Period", "terseLabel": "Notional amount of derivatives, matured during period" } } }, "localname": "NotionalAmountOfDerivativesMaturedDuringPeriod", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_OperatingGainLossasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating Gain (Loss), as a Percent of Net Sales", "label": "Operating Gain (Loss), as a Percent of Net Sales", "terseLabel": "Operating Gain (Loss), as a Percent of Net Sales" } } }, "localname": "OperatingGainLossasaPercentofNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_OperatingLeaseRightofUseAmortization": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease, Right-of-Use, Amortization", "label": "Operating Lease, Right-of-Use, Amortization", "terseLabel": "Amortization of operating lease right of use assets" } } }, "localname": "OperatingLeaseRightofUseAmortization", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ivc_OperatingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities", "label": "Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities", "terseLabel": "Operating Leases, Cash Paid in Measurement of Amounts for Lease Liabilities" } } }, "localname": "OperatingLeasesCashPaidinMeasurementofAmountsforLeaseLiabilities", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ivc_OperatingLeasesFutureMinimumPaymentsInterestIncludedinPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Leases, Future Minimum Payments, Interest Included in Payments", "label": "Operating Leases, Future Minimum Payments, Interest Included in Payments", "negatedTerseLabel": "Operating Leases, Future Minimum Payments, Interest Included in Payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsInterestIncludedinPayments", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_OperatingLeasesFutureMinimumPaymentsPresentValueofNetMinimumPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "label": "Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "terseLabel": "Operating Leases, Future Minimum Payments, Present Value of Net Minimum Payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsPresentValueofNetMinimumPayments", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_OtherComprehensiveIncomeLossDeferredTaxValuationReserve": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income (Loss), Deferred Tax Valuation Reserve", "label": "Other Comprehensive Income (Loss), Deferred Tax Valuation Reserve", "terseLabel": "Valuation reserve associated with defined benefit plan activity" } } }, "localname": "OtherComprehensiveIncomeLossDeferredTaxValuationReserve", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ivc_OtherCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Customers [Member]", "label": "Other Customers [Member]", "terseLabel": "Other Customers" } } }, "localname": "OtherCustomersMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_OtherDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other", "label": "Other [Domain]", "terseLabel": "Other [Domain]" } } }, "localname": "OtherDomain", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "ivc_OtherNotesandCapitalLeaseObligationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Notes and Capital Lease Obligations [Member]", "label": "Other Notes and Capital Lease Obligations [Member]", "terseLabel": "Other Notes and Capital Lease Obligations" } } }, "localname": "OtherNotesandCapitalLeaseObligationsMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ivc_PaymentsToDebtHolders": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments to Debt Holders", "label": "Payments to Debt Holders", "negatedTerseLabel": "Payments to debt holders" } } }, "localname": "PaymentsToDebtHolders", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ivc_PercentoftheApplicableConversionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percent of the Applicable Conversion Price", "label": "Percent of the Applicable Conversion Price", "terseLabel": "Percent of the Applicable Conversion Price" } } }, "localname": "PercentoftheApplicableConversionPrice", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_PercentoftheProductoftheLastReportedSalePriceCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percent of the Product of the Last Reported Sale Price, Common Shares", "label": "Percent of the Product of the Last Reported Sale Price, Common Shares", "terseLabel": "Percent of the Product of the Last Reported Sale Price, Common Shares" } } }, "localname": "PercentoftheProductoftheLastReportedSalePriceCommonShares", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_PrepaidDebtFees": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid Debt Fees", "label": "Prepaid Debt Fees", "terseLabel": "Deferred financing fees" } } }, "localname": "PrepaidDebtFees", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_PrepaidInventory": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 7.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid Inventory", "label": "Prepaid Inventory", "terseLabel": "Prepaid inventory and freight" } } }, "localname": "PrepaidInventory", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_PrepaidServiceContracts": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid Service Contracts", "label": "Prepaid Service Contracts", "terseLabel": "Service contracts" } } }, "localname": "PrepaidServiceContracts", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ProductLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 9.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Product Liability, Current", "label": "Product Liability, Current", "terseLabel": "Product liability, current portion" } } }, "localname": "ProductLiabilityCurrent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ProductLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Product Liability, Noncurrent", "label": "Product Liability, Noncurrent", "terseLabel": "Product liability" } } }, "localname": "ProductLiabilityNoncurrent", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_PurchaseOfCappedCalls": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase of Capped Calls", "label": "Purchase of Capped Calls", "negatedTerseLabel": "Purchases of capped calls", "terseLabel": "Purchases of capped calls" } } }, "localname": "PurchaseOfCappedCalls", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RangeOfExercisePriceMaxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range of Exercise Price Max", "label": "Range of Exercise Price Max [Member]", "terseLabel": "Range of Exercise Price Max [Member]" } } }, "localname": "RangeOfExercisePriceMaxMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "domainItemType" }, "ivc_RangeOfExercisePriceRangeMinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range of Exercise Price Range Min", "label": "Range of Exercise Price Range Min [Member]", "terseLabel": "$12.15 \u2013 $14.49" } } }, "localname": "RangeOfExercisePriceRangeMinMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "domainItemType" }, "ivc_RateApplicablePeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rate applicable period", "label": "Rate applicable period [Axis]", "terseLabel": "Rate applicable period [Axis]" } } }, "localname": "RateApplicablePeriodAxis", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "ivc_RateApplicablePeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rate applicable period [Domain]", "label": "Rate applicable period [Domain]", "terseLabel": "Rate applicable period [Domain]" } } }, "localname": "RateApplicablePeriodDomain", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ReceivableDueFromInformationTechnologyProvider": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Receivable Due From Information Technology Provider", "label": "Receivable Due From Information Technology Provider", "terseLabel": "Receivable due from information technology provider" } } }, "localname": "ReceivableDueFromInformationTechnologyProvider", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_ReceivablesExpectedLossPercentageAsiaPac": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivables, Expected Loss Percentage, AsiaPac", "label": "Receivables, Expected Loss Percentage, AsiaPac", "terseLabel": "Receivables, Expected Loss Percentage, AsiaPac" } } }, "localname": "ReceivablesExpectedLossPercentageAsiaPac", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ReceivablesExpectedLossPercentageCanada": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivables, Expected Loss Percentage, Canada", "label": "Receivables, Expected Loss Percentage, Canada", "terseLabel": "Receivables, Expected Loss Percentage, Canada" } } }, "localname": "ReceivablesExpectedLossPercentageCanada", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ReceivablesExpectedLossPercentageEurope": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivables, Expected Loss Percentage, Europe", "label": "Receivables, Expected Loss Percentage, Europe", "terseLabel": "Receivables, Expected Loss Percentage, Europe" } } }, "localname": "ReceivablesExpectedLossPercentageEurope", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_ReceivablesExpectedLossPercentageNorthAmericaExcludingCanada": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivables, Expected Loss Percentage, North America excluding Canada", "label": "Receivables, Expected Loss Percentage, North America excluding Canada", "terseLabel": "Receivables, Expected Loss Percentage, North America excluding Canada" } } }, "localname": "ReceivablesExpectedLossPercentageNorthAmericaExcludingCanada", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_RemainingAccretion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining Accretion", "label": "Remaining Accretion", "terseLabel": "Remaining Accretion" } } }, "localname": "RemainingAccretion", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RespiratoryTherapyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Respiratory Therapy", "label": "Respiratory Therapy [Domain]", "terseLabel": "Respiratory Therapy [Domain]" } } }, "localname": "RespiratoryTherapyDomain", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "ivc_RestrictedStockandRestrictedStockUnitsRSUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock and Restricted Stock Units (RSUs) [Member]", "label": "Restricted Stock and Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock and Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockandRestrictedStockUnitsRSUsMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "ivc_RestructuringAndRelatedActivitiesExpectedPayoutPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restructuring and Related Activities, Expected Payout Period", "label": "Restructuring and Related Activities, Expected Payout Period", "terseLabel": "Restructuring and Related Activities, Expected Payout Period" } } }, "localname": "RestructuringAndRelatedActivitiesExpectedPayoutPeriod", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ivc_ReturnsandAllowancesReserve": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 5.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Returns and Allowances Reserve", "label": "Returns and Allowances Reserve", "negatedTerseLabel": "Other, principally returns and allowances reserves" } } }, "localname": "ReturnsandAllowancesReserve", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue [Abstract]", "label": "Revenue [Abstract]", "terseLabel": "Revenue [Abstract]" } } }, "localname": "RevenueAbstract", "nsuri": "http://www.invacare.com/20220930", "xbrltype": "stringItemType" }, "ivc_ReversalofAccruedWithholdingTaxesonEarnings": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reversal of Accrued Withholding Taxes on Earnings", "label": "Reversal of Accrued Withholding Taxes on Earnings", "terseLabel": "Reversal of Accrued Withholding Taxes on Earnings" } } }, "localname": "ReversalofAccruedWithholdingTaxesonEarnings", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revolving Credit and Security Agreement (Europe Credit Agreement) [Member] [Domain]", "label": "Revolving Credit and Security Agreement (Europe Credit Agreement) [Member]", "terseLabel": "Revolving Credit and Security Agreement (Europe Credit Agreement)" } } }, "localname": "RevolvingCreditAndSecurityAgreementEuropeCreditAgreementMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_RevolvingCreditAndSecurityAgreementNorthAmericaCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revolving Credit and Security Agreement (North America Credit Agreement)", "label": "Revolving Credit and Security Agreement (North America Credit Agreement) [Member]", "terseLabel": "Revolving Credit and Security Agreement (North America Credit Agreement)" } } }, "localname": "RevolvingCreditAndSecurityAgreementNorthAmericaCreditAgreementMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revolving Credit and Security Agreement (Prior Credit Agreement) [Member]", "label": "Revolving Credit and Security Agreement (Prior Credit Agreement) [Member]", "terseLabel": "Revolving Credit and Security Agreement (New Credit Agreement)" } } }, "localname": "RevolvingCreditAndSecurityAgreementPriorCreditAgreementMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_RightofUseAssetObtainedinExchangeforTotalLeaseLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Right-of-Use Asset Obtained in Exchange for Total Lease Liability", "label": "Right-of-Use Asset Obtained in Exchange for Total Lease Liability", "terseLabel": "Right-of-Use Asset Obtained in Exchange for Total Lease Liability" } } }, "localname": "RightofUseAssetObtainedinExchangeforTotalLeaseLiability", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ivc_RiskFactorAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Risk Factor", "label": "Risk Factor [Axis]", "terseLabel": "Risk Factor [Axis]" } } }, "localname": "RiskFactorAxis", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "ivc_RiskFactorDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Risk Factor", "label": "Risk Factor [Domain]", "terseLabel": "Risk Factor [Domain]" } } }, "localname": "RiskFactorDomain", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_Round1FundingInitialClosingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Round 1 funding (Initial closing)", "label": "Round 1 funding (Initial closing) [Member]", "terseLabel": "Round 1 funding (Initial closing) [Domain]" } } }, "localname": "Round1FundingInitialClosingMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_SaleLeasebackTransactionAnnualPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Annual Payments", "label": "Sale Leaseback Transaction, Annual Payments", "terseLabel": "Sale Leaseback Transaction, Annual Payments" } } }, "localname": "SaleLeasebackTransactionAnnualPayments", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_SaleLeasebackTransactionImmediateLossRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Immediate Loss Recognized", "label": "Sale Leaseback Transaction, Immediate Loss Recognized", "terseLabel": "Sale Leaseback Transaction, Immediate Loss Recognized" } } }, "localname": "SaleLeasebackTransactionImmediateLossRecognized", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "ivc_SaleLeasebackTransactionLeaseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transaction, Lease Term", "label": "Sale Leaseback Transaction, Lease Term", "terseLabel": "Sale Leaseback Transaction, Lease Term" } } }, "localname": "SaleLeasebackTransactionLeaseTerm", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "durationItemType" }, "ivc_SaleLeasebackTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Leaseback Transactions [Abstract]", "label": "Sale Leaseback Transactions [Abstract]", "terseLabel": "Sale Leaseback Transactions [Abstract]" } } }, "localname": "SaleLeasebackTransactionsAbstract", "nsuri": "http://www.invacare.com/20220930", "xbrltype": "stringItemType" }, "ivc_ScheduleOfConvertibleNoteDerivativesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Convertible Note Derivatives", "label": "Schedule of Convertible Note Derivatives [Table Text Block]", "terseLabel": "Fair Value of Convertible Note Derivative" } } }, "localname": "ScheduleOfConvertibleNoteDerivativesTableTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "ivc_ScheduleforAllowanceforCreditLossesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule for Allowance for Credit Losses [Abstract]", "label": "Schedule for Allowance for Credit Losses [Abstract]", "terseLabel": "Schedule for Allowance for Credit Losses [Abstract]" } } }, "localname": "ScheduleforAllowanceforCreditLossesAbstract", "nsuri": "http://www.invacare.com/20220930", "xbrltype": "stringItemType" }, "ivc_ScheduleofAccountsReceivableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Accounts Receivable [Abstract]", "label": "Schedule of Accounts Receivable [Abstract]", "terseLabel": "Schedule of Accounts Receivable [Abstract]" } } }, "localname": "ScheduleofAccountsReceivableAbstract", "nsuri": "http://www.invacare.com/20220930", "xbrltype": "stringItemType" }, "ivc_ScheduleofAccountsReceivableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Table Text Block] for Schedule of Accounts Receivable [Table]", "label": "Schedule of Accounts Receivable [Table Text Block]", "terseLabel": "Schedule of Accounts Receivable" } } }, "localname": "ScheduleofAccountsReceivableTableTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "ivc_ScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleofFiniteLivedandIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "stringItemType" }, "ivc_SecuredRevolvingCreditAndSecurityAgreementABLCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Secured Revolving Credit and Security Agreement (ABL Credit Agreement)", "label": "Secured Revolving Credit and Security Agreement (ABL Credit Agreement) [Member]", "terseLabel": "Secured Revolving Credit and Security Agreement (ABL Credit Agreement)" } } }, "localname": "SecuredRevolvingCreditAndSecurityAgreementABLCreditAgreementMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_SecuredTermLoanIssuanceJuly26th2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Secured Term Loan - issuance July 26th, 2022", "label": "Secured Term Loan - issuance July 26th, 2022 [Member]", "terseLabel": "Secured Term Loan - issuance July 26th, 2022 [Domain]" } } }, "localname": "SecuredTermLoanIssuanceJuly26th2022Member", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_SecuredTermLoansDueJuly2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Secured Term Loans due July 2026", "label": "Secured Term Loans due July 2026 [Member]", "terseLabel": "Secured Term Loans due July 2026 [Domain]" } } }, "localname": "SecuredTermLoansDueJuly2026Member", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_SellinggeneralandadministrativeexpensesasaPercentofNetSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Selling, general and administrative expenses, as a Percent of Net Sales", "label": "Selling, general and administrative expenses, as a Percent of Net Sales", "terseLabel": "Selling, general and administrative expenses, as a Percent of Net Sales" } } }, "localname": "SellinggeneralandadministrativeexpensesasaPercentofNetSales", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "percentItemType" }, "ivc_SeriesIIConvertibleSeniorNotesAt500November2024BMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series II Convertible Senior Notes at 5.00% November 2024 b", "label": "Series II Convertible Senior Notes at 5.00% November 2024 b [Member]", "terseLabel": "Series II Convertible Senior Notes at 5.00% November 2024 [Domain]" } } }, "localname": "SeriesIIConvertibleSeniorNotesAt500November2024BMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_SeriesIIConvertibleSeniorNotesAt500November2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series II Convertible Senior Notes at 5.00% November 2024", "label": "Series II Convertible Senior Notes at 5.00% November 2024 [Member]", "terseLabel": "Series II Convertible Senior Notes at 5.00% November 2024" } } }, "localname": "SeriesIIConvertibleSeniorNotesAt500November2024Member", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_ServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Services [Member]", "label": "Services [Member]", "terseLabel": "Service" } } }, "localname": "ServicesMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "ivc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfShareAwardsUnderlyingFrom2003And2013Plans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 and 2013 Plans", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 and 2013 Plans", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Share Awards Underlying from 2003 Plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfShareAwardsUnderlyingFrom2003And2013Plans", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "ivc_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementLowerRangePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Lower Range, Percentage", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Lower Range, Percentage", "terseLabel": "Performance achievement level, lower range" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementLowerRangePercentage", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Level of Performance Award Achievement, Target", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Percentage", "terseLabel": "Performance achievement level, target range" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementPercentage", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementUpperRangePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Upper Range, Percentage", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Performance Award Target Acheivement, Upper Range, Percentage", "terseLabel": "Performance achievement level, upper range" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsPerformanceAwardTargetAcheivementUpperRangePercentage", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "ivc_SwingLineLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swing Line Loans [Domain]", "label": "Swing Line Loans [Member]", "terseLabel": "Swing Line Loans" } } }, "localname": "SwingLineLoansMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "ivc_TotalCashPaidinMeasurementofAmountsforLeaseLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total Cash Paid in Measurement of Amounts for Lease Liabilities", "label": "Total Cash Paid in Measurement of Amounts for Lease Liabilities", "terseLabel": "Total Cash Paid in Measurement of Amounts for Lease Liabilities" } } }, "localname": "TotalCashPaidinMeasurementofAmountsforLeaseLiabilities", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "ivc_UnamortizedFinancingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unamortized Financing Costs", "label": "Unamortized Financing Costs", "terseLabel": "Unamortized Financing Costs" } } }, "localname": "UnamortizedFinancingCosts", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ivc_UnpaidPurchasesOfPropertyAndEquipment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unpaid Purchases of Property and Equipment", "label": "Unpaid Purchases of Property and Equipment", "terseLabel": "Unpaid Purchases of Property and Equipment" } } }, "localname": "UnpaidPurchasesOfPropertyAndEquipment", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ivc_WeightedAverageRemainingLeaseTermsandDiscountRatesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted-Average Remaining Lease Terms and Discount Rates [Table Text Block]", "label": "Weighted-Average Remaining Lease Terms and Discount Rates [Table Text Block]", "terseLabel": "Weighted-Average Remaining Lease Terms and Discount Rates [Table]" } } }, "localname": "WeightedAverageRemainingLeaseTermsandDiscountRatesTableTextBlock", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "ivc_Year2AndOnMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year 2 and on", "label": "Year 2 and on [Member]", "terseLabel": "Year 2 and on" } } }, "localname": "Year2AndOnMember", "nsuri": "http://www.invacare.com/20220930", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r157", "r214", "r227", "r228", "r229", "r230", "r232", "r234", "r238", "r377", "r378", "r379", "r380", "r381", "r382", "r384", "r385", "r387", "r389", "r390" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r157", "r214", "r227", "r228", "r229", "r230", "r232", "r234", "r238", "r377", "r378", "r379", "r380", "r381", "r382", "r384", "r385", "r387", "r389", "r390" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r89", "r91", "r155", "r156", "r397", "r434" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CurrencyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Currency [Axis]", "terseLabel": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r396", "r433", "r467", "r470", "r671", "r672", "r673", "r674", "r675", "r676", "r696", "r744", "r747", "r776", "r777" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r396", "r433", "r467", "r470", "r671", "r672", "r673", "r674", "r675", "r676", "r696", "r744", "r747", "r776", "r777" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r240", "r448", "r449", "r697", "r743", "r745" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/BusinessSegmentsTables", "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r240", "r448", "r449", "r697", "r743", "r745" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/BusinessSegmentsTables", "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r396", "r433", "r456", "r467", "r470", "r671", "r672", "r673", "r674", "r675", "r676", "r696", "r744", "r747", "r776", "r777" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r396", "r433", "r456", "r467", "r470", "r671", "r672", "r673", "r674", "r675", "r676", "r696", "r744", "r747", "r776", "r777" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r90", "r91", "r155", "r156", "r397", "r434" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r3", "r159", "r160", "r161", "r162", "r163", "r166", "r167", "r168", "r169", "r171", "r172", "r173", "r174", "r175", "r176", "r193", "r275", "r276", "r506", "r522", "r588", "r592", "r593", "r594", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r813", "r814" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]", "terseLabel": "Restatement [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r3", "r159", "r160", "r161", "r162", "r163", "r166", "r167", "r168", "r169", "r171", "r172", "r173", "r174", "r175", "r176", "r193", "r275", "r276", "r506", "r522", "r588", "r592", "r593", "r594", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r813", "r814" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]", "terseLabel": "Restatement [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r170", "r176", "r468" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario, Unspecified [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r241", "r242", "r448", "r450", "r746", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r241", "r242", "r448", "r450", "r746", "r761", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r170", "r176", "r357", "r468", "r664" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r671", "r673", "r676", "r776", "r777" ], "lang": { "en-us": { "role": { "label": "Weighted Average [Member]", "terseLabel": "Weighted Average" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Information by type of receivable.", "label": "Receivable Type [Axis]", "terseLabel": "Receivable Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Information by billing status of receivables.", "label": "Billing Status, Type [Axis]", "terseLabel": "Billing Status, Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByIndustryOfCounterpartyTypeAxis": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Information by industry of counterparty. A counterparty is the other party that participates in a financial transaction.", "label": "Industry of Counterparty, Type [Axis]", "terseLabel": "Industry of Counterparty, Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivablesByIndustryOfCounterpartyTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Information by legal entity of counterparty. A counterparty is the other party that participates in a financial transaction.", "label": "Legal Entity of Counterparty, Type [Axis]", "terseLabel": "Legal Entity of Counterparty, Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.", "label": "Accounts Payable and Accrued Liabilities [Member]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r67", "r662" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGross": { "auth_ref": [ "r246" ], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, before Allowance for Credit Loss", "terseLabel": "Accounts receivable, gross" } } }, "localname": "AccountsReceivableGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r47", "r726", "r762" ], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, after Allowance for Credit Loss", "totalLabel": "Accounts Receivable, Net" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r24", "r47", "r246", "r247" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade receivables, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccretionExpense": { "auth_ref": [ "r340", "r341", "r345" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.", "label": "Accretion Expense", "terseLabel": "Accretion Expense" } } }, "localname": "AccretionExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "auth_ref": [ "r33", "r70", "r509" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrual for Taxes Other than Income Taxes, Current", "terseLabel": "Taxes other than income taxes, primarily value added taxes" } } }, "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedInsuranceCurrent": { "auth_ref": [ "r32", "r33", "r70" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 10.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Insurance, Current", "terseLabel": "Insurance" } } }, "localname": "AccruedInsuranceCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r70" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses", "totalLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesMember": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.", "label": "Accrued Liabilities [Member]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccruedMarketingCostsCurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Marketing Costs, Current", "terseLabel": "Rebates" } } }, "localname": "AccruedMarketingCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r32", "r33", "r70" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 8.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Professional" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedRentCurrent": { "auth_ref": [ "r32", "r33", "r70" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 13.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Rent, Current", "terseLabel": "Accrued Rent, Current" } } }, "localname": "AccruedRentCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r32", "r33", "r70" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Salaries, Current", "terseLabel": "Salaries and wages" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r96", "r101", "r110", "r111", "r112", "r547" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Accumulated Defined Benefit Plans Adjustment [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r65", "r332" ], "calculation": { "http://www.invacare.com/role/PropertyAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Less allowance for depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "auth_ref": [ "r95", "r101", "r546" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.", "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]", "terseLabel": "Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]" } } }, "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r50", "r98", "r100", "r101", "r731", "r755", "r759" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r110", "r111", "r621", "r622", "r623", "r624", "r625", "r627" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r97", "r101", "r110", "r111", "r112", "r159", "r160", "r161", "r547", "r750", "r751", "r814" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r94", "r101", "r110", "r111", "r112", "r547", "r622", "r623", "r624", "r625", "r627" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Accumulated Translation Adjustment [Member]" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r48", "r506", "r662" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in-capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r159", "r160", "r161", "r503", "r504", "r505", "r592" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis": { "auth_ref": [ "r162", "r163", "r164", "r165" ], "lang": { "en-us": { "role": { "documentation": "Information by type of change in accounting principle. Excludes change from amendment to accounting standards.", "label": "Change in Accounting Principle, Type [Axis]", "terseLabel": "Adjustments for Change in Accounting Principle [Axis]" } } }, "localname": "AdjustmentsForChangeInAccountingPrincipleAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsForErrorCorrectionDomain": { "auth_ref": [ "r166", "r167", "r168", "r171", "r172", "r174", "r175" ], "lang": { "en-us": { "role": { "documentation": "Type of error correction.", "label": "Error Correction, Type [Domain]", "terseLabel": "Adjustments for Error Correction [Domain]" } } }, "localname": "AdjustmentsForErrorCorrectionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r162", "r163", "r164", "r165", "r176", "r262", "r263", "r271", "r272", "r273", "r274", "r275", "r276", "r376", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r519", "r520", "r521", "r522", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r659", "r699", "r700", "r701", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r810", "r811", "r812", "r813", "r814" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r472", "r496", "r507" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Allocated Share-based Compensation Expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": { "auth_ref": [ "r250", "r283" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on financing receivable.", "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Schedule of Installment Receivables Allowance for Doubtful Accounts" } } }, "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r257", "r277", "r279", "r282" ], "calculation": { "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails": { "order": 4.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "negatedTerseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleofAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForLoanAndLeaseLossesAdjustmentsNet": { "auth_ref": [ "r255" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other addition (reduction) in allowance reserve for credit loss.", "label": "Allowance for Loan and Lease Losses, Adjustments, Other", "terseLabel": "Current period provision (benefit)" } } }, "localname": "AllowanceForLoanAndLeaseLossesAdjustmentsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForNotesAndLoansReceivableCurrent": { "auth_ref": [ "r54", "r257", "r277" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 1.0, "parentTag": "us-gaap_NotesAndLoansReceivableNetCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on financing receivable, classified as current.", "label": "Financing Receivable, Allowance for Credit Loss, Current", "negatedLabel": "Allowance for doubtful accounts, current" } } }, "localname": "AllowanceForNotesAndLoansReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForNotesAndLoansReceivableNoncurrent": { "auth_ref": [ "r54", "r257", "r277" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 2.0, "parentTag": "us-gaap_FinancingReceivableAllowanceForCreditLosses", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on financing receivable, classified as noncurrent.", "label": "Financing Receivable, Allowance for Credit Loss, Noncurrent", "negatedLabel": "Allowance for doubtful accounts, long-term" } } }, "localname": "AllowanceForNotesAndLoansReceivableNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r127", "r143", "r416", "r630" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of Debt Discount (Premium)" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r122", "r143", "r416", "r632" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of debt fees" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r143", "r317", "r324" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "terseLabel": "Arrangements and Non-arrangement Transactions [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r151", "r222", "r229", "r236", "r270", "r377", "r378", "r379", "r381", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r543", "r549", "r611", "r660", "r662", "r706", "r728" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r28", "r30", "r85", "r151", "r270", "r377", "r378", "r379", "r381", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r543", "r549", "r611", "r660", "r662" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "terseLabel": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r5", "r6", "r15", "r17", "r20", "r335" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Assets", "terseLabel": "Total Assets" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r473", "r498" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]", "terseLabel": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]", "terseLabel": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r473", "r498" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r560", "r565" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalLeaseObligations": { "auth_ref": [ "r41", "r635", "r730" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.", "label": "Capital Lease Obligations", "terseLabel": "Capital Lease Obligations" } } }, "localname": "CapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareNet": { "auth_ref": [ "r778" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.", "label": "Capitalized Computer Software, Net", "terseLabel": "Capitalized Computer Software, Net" } } }, "localname": "CapitalizedComputerSoftwareNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r607", "r608" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Value" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r22", "r62", "r145" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r140", "r145", "r146" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of year", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r140", "r620" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Cash, Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging [Member]" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashSurrenderValueOfLifeInsurance": { "auth_ref": [ "r31", "r66" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.", "label": "Cash Surrender Value of Life Insurance", "terseLabel": "Cash surrender value of life insurance policies" } } }, "localname": "CashSurrenderValueOfLifeInsurance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails", "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInAccountingPrincipleMember": { "auth_ref": [ "r162", "r163", "r164", "r165" ], "lang": { "en-us": { "role": { "documentation": "Change in accounting principle. Excludes change from amendment to accounting standards.", "label": "Change in Accounting Principle, Type [Domain]", "terseLabel": "Adjustments for Change in Accounting Principle [Domain]" } } }, "localname": "ChangeInAccountingPrincipleMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerAxis": { "auth_ref": [ "r290" ], "lang": { "en-us": { "role": { "documentation": "Information by type of borrower determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Type of Borrower [Axis]", "terseLabel": "Class of Financing Receivable, Type of Borrower [Axis]" } } }, "localname": "ClassOfFinancingReceivableTypeOfBorrowerAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfFinancingReceivableTypeOfBorrowerDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of entity or individual who borrows funds.", "label": "Class of Financing Receivable, Type of Borrower [Domain]", "terseLabel": "Class of Financing Receivable, Type of Borrower [Domain]" } } }, "localname": "ClassOfFinancingReceivableTypeOfBorrowerDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r149", "r151", "r180", "r184", "r185", "r187", "r189", "r197", "r198", "r199", "r270", "r377", "r382", "r383", "r384", "r390", "r391", "r431", "r432", "r435", "r436", "r611", "r784" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/DEIDocument", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Derivative, Price Risk Option Strike Price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Class of Warrant or Right, Outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CollateralAxis": { "auth_ref": [ "r293" ], "lang": { "en-us": { "role": { "documentation": "Information by category of collateral or no collateral, from lender's perspective.", "label": "Collateral Held [Axis]", "terseLabel": "Collateral [Axis]" } } }, "localname": "CollateralAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CollateralDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of collateral or no collateral, from lender's perspective.", "label": "Collateral Held [Domain]", "terseLabel": "Collateral [Domain]" } } }, "localname": "CollateralDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Class B Common Shares [Member]", "verboseLabel": "Class B Common Shares [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/DEIDocument", "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r445" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends Declared per Common Share" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r159", "r160", "r592" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]", "verboseLabel": "Common Shares [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/DEIDocument", "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r45", "r439" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValueOutstanding": { "auth_ref": [ "r45" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.", "label": "Common Stock, Value, Outstanding", "terseLabel": "Common Shares" } } }, "localname": "CommonStockValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r106", "r108", "r109", "r119", "r717", "r739" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "terseLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive Loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r118", "r128", "r716", "r738" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) by Component" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponent" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r204", "r205", "r244", "r609", "r610", "r763" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r204", "r205", "r244", "r609", "r610", "r760", "r763" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r204", "r205", "r244", "r609", "r610", "r760", "r763" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r209" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Concentration Of Credit Risk" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ConcentrationOfCreditRisk" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r204", "r205", "r244", "r609", "r610", "r763" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r147", "r545" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractTerminationMember": { "auth_ref": [ "r344", "r345", "r351", "r352" ], "lang": { "en-us": { "role": { "documentation": "Termination of a contract associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Contract Termination [Member]", "terseLabel": "Contract Termination" } } }, "localname": "ContractTerminationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r43", "r44", "r437", "r440", "r441" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Convertible Preferred Stock, Shares Issued upon Conversion", "terseLabel": "Convertible Preferred Stock, Shares Issued upon Conversion" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleSubordinatedDebtMember": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Debt that places a lender in a lien position behind debt having a higher priority of repayment in liquidation of the entity's assets which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible Subordinated Debt [Member]", "terseLabel": "Convertible Subordinated Debt" } } }, "localname": "ConvertibleSubordinatedDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r125", "r151", "r270", "r377", "r378", "r379", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r611" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of products sold", "verboseLabel": "Cost of Products Sold" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossStatusAxis": { "auth_ref": [ "r264", "r297", "r302" ], "lang": { "en-us": { "role": { "documentation": "Information by credit loss status of financial asset.", "label": "Credit Loss Status [Axis]", "terseLabel": "Credit Loss Status [Axis]" } } }, "localname": "CreditLossStatusAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditLossStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit loss status of financial asset.", "label": "Credit Loss Status [Domain]", "terseLabel": "Credit Loss Status [Domain]" } } }, "localname": "CreditLossStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerListsMember": { "auth_ref": [ "r535" ], "lang": { "en-us": { "role": { "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.", "label": "Customer Lists [Member]", "verboseLabel": "Customer lists" } } }, "localname": "CustomerListsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDefaultLongtermDebtAmount": { "auth_ref": [ "r148" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of outstanding long-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured.", "label": "Debt Instrument, Debt Default, Amount", "terseLabel": "Debt Instrument, Debt Default, Amount" } } }, "localname": "DebtDefaultLongtermDebtAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r148", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r410", "r417", "r418", "r420", "r430" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt Disclosure" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r39", "r40", "r41", "r150", "r157", "r393", "r394", "r395", "r396", "r397", "r398", "r400", "r406", "r407", "r408", "r409", "r411", "r412", "r413", "r414", "r415", "r416", "r424", "r425", "r426", "r427", "r633", "r707", "r709", "r725" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature": { "auth_ref": [ "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.", "label": "Debt Instrument, Convertible, Beneficial Conversion Feature", "terseLabel": "Debt Instrument, Convertible, Beneficial Conversion Feature" } } }, "localname": "DebtInstrumentConvertibleBeneficialConversionFeature", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r395", "r422" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt Instrument, Convertible, Conversion Price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Debt Instrument, Convertible, Threshold Consecutive Trading Days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Debt Instrument, Convertible, Threshold Trading Days" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r393", "r424", "r425", "r631", "r633", "r634" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt Instrument, Face Amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r408", "r424", "r425", "r606" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "negatedTerseLabel": "Debt Instrument, Fair Value Disclosure" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFeeAmount": { "auth_ref": [ "r75" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.", "label": "Debt Instrument, Fee Amount", "terseLabel": "Debt Instrument, Fee Amount" } } }, "localname": "DebtInstrumentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r150" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt Instrument, Increase, Accrued Interest", "terseLabel": "Debt Instrument, Increase, Accrued Interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r73", "r423", "r631", "r633" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Debt Instrument, Interest Rate, Effective Percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r73", "r394" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate (as a percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDateRangeStart1": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "Earliest date the outstanding debt instruments are required to be repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date Range, Start", "terseLabel": "Debt Instrument, Maturity Date Range, Start" } } }, "localname": "DebtInstrumentMaturityDateRangeStart1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r76", "r150", "r157", "r393", "r394", "r395", "r396", "r397", "r398", "r400", "r406", "r407", "r408", "r409", "r411", "r412", "r413", "r414", "r415", "r416", "r424", "r425", "r426", "r427", "r633" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r723" ], "lang": { "en-us": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r723" ], "lang": { "en-us": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRepurchaseAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value amount of debt instrument that was repurchased.", "label": "Debt Instrument, Repurchase Amount", "terseLabel": "Debt Instrument, Repurchase Amount" } } }, "localname": "DebtInstrumentRepurchaseAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r76", "r150", "r157", "r393", "r394", "r395", "r396", "r397", "r398", "r400", "r406", "r407", "r408", "r409", "r411", "r412", "r413", "r414", "r415", "r416", "r419", "r424", "r425", "r426", "r427", "r440", "r442", "r443", "r444", "r630", "r631", "r633", "r634", "r724" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r406", "r630", "r634" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Unamortized discount", "negatedTerseLabel": "Debt Instrument, Unamortized Discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r406", "r421", "r424", "r425", "r632" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "terseLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationCashBasedArrangementsLiabilityCurrent": { "auth_ref": [ "r451", "r452" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for deferred compensation arrangements payable within one year (or the normal operating cycle, if longer). Represents currently earned compensation under cash arrangements (such as a profit-sharing plan, rabbi trust, and employee contract--excluding equity-based arrangements) that is not actually paid until a later date.", "label": "Deferred Compensation Cash-based Arrangements, Liability, Current", "terseLabel": "Supplemental executive retirement program liability" } } }, "localname": "DeferredCompensationCashBasedArrangementsLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for deferred compensation arrangements payable after one year (or the normal operating cycle, if longer). Represents currently earned compensation under cash arrangements (such as a profit-sharing plan, rabbi trust, and employee contract--excluding equity-based arrangements) that is not actually paid until a later date.", "label": "Deferred Compensation Cash-based Arrangements, Liability, Classified, Noncurrent", "terseLabel": "Supplemental executive retirement plan liability" } } }, "localname": "DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).", "label": "Deferred Compensation Liability, Classified, Noncurrent", "terseLabel": "Deferred compensation" } } }, "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]", "terseLabel": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DeferredFinanceCostsNoncurrentNet": { "auth_ref": [ "r66", "r632" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Noncurrent, Net", "terseLabel": "Deferred financing fees" } } }, "localname": "DeferredFinanceCostsNoncurrentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r143", "r152", "r518", "r525", "r526", "r527" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Provision (benefit) for deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.", "label": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r55" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "negatedTerseLabel": "Total Unearned Interest", "terseLabel": "Deferred Revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r55" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 12.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpense": { "auth_ref": [ "r516", "r517" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.", "label": "Deferred Tax Assets, Tax Deferred Expense", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": { "auth_ref": [ "r42", "r453", "r454", "r455" ], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.", "label": "Liability, Defined Benefit Pension Plan, Noncurrent", "terseLabel": "Pension" } } }, "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r143", "r217" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAmountOfHedgedItem": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of hedged item in hedging relationship. Excludes hedged asset or liability.", "label": "Derivative, Amount of Hedged Item", "terseLabel": "Derivative, Amount of Hedged Item" } } }, "localname": "DerivativeAmountOfHedgedItem", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r87", "r88", "r91", "r606" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "verboseLabel": "Derivative assets" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsCurrent": { "auth_ref": [ "r87" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset, Current", "terseLabel": "Derivatives (foreign currency forward exchange contracts)" } } }, "localname": "DerivativeAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": { "auth_ref": [ "r552" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.", "label": "Derivative Assets (Liabilities), at Fair Value, Net", "terseLabel": "Derivative assets (liabilities), at fair value, net" } } }, "localname": "DerivativeAssetsLiabilitiesAtFairValueNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r86", "r91", "r92", "r563", "r678" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Fair Value, Gross Asset", "verboseLabel": "Derivative assets" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r86", "r91", "r92", "r563", "r678" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Gross Liability", "terseLabel": "Derivative liabilities" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r562" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "negatedLabel": "Gain (Loss)", "terseLabel": "Gain (Loss)", "verboseLabel": "Gain (Loss)" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r91", "r561", "r564", "r571", "r574" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r583", "r595" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivatives" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/Derivatives" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivatives and hedging activities.", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r558", "r561", "r571" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r558", "r561", "r571", "r574", "r575", "r579", "r582" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r568", "r573" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "terseLabel": "Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet": { "auth_ref": [ "r569", "r581" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.", "label": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net", "terseLabel": "Amount of Gain (Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)" } } }, "localname": "DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r87", "r88", "r91", "r606" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "negatedLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r87" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 16.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative liabilities (foreign currency forward exchange contracts)" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r553", "r555", "r556", "r558", "r559", "r566", "r571", "r577", "r578", "r582", "r583" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument [Member]" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r508" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Shareholders' Equity Transactions" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": { "auth_ref": [ "r5", "r6", "r15", "r335" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net", "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": { "auth_ref": [ "r5", "r6", "r15", "r335" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accounts Payable", "terseLabel": "Disposal Group, Including Discontinued Operation, Accounts Payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxPayable": { "auth_ref": [ "r5", "r6", "r15", "r335" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as income tax obligations attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable", "terseLabel": "Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities": { "auth_ref": [ "r5", "r6", "r15", "r335" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities", "terseLabel": "Disposal Group, Including Discontinued Operation, Accrued Liabilities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": { "auth_ref": [ "r5", "r6", "r15", "r335" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Inventory", "terseLabel": "Disposal Group, Including Discontinued Operation, Inventory" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": { "auth_ref": [ "r5", "r6", "r15", "r335" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Other Assets", "terseLabel": "Disposal Group, Including Discontinued Operation, Other Assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": { "auth_ref": [ "r5", "r6", "r15", "r335" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment", "terseLabel": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "auth_ref": [ "r14", "r20" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Revenue", "terseLabel": "Disposal Group, Including Discontinued Operation, Revenue" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r466", "r469" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Groups, Including Discontinued Operations, Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsCommonStockCash": { "auth_ref": [ "r445" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.", "label": "Dividends, Common Stock, Cash", "negatedTerseLabel": "Dividends, Common Stock, Cash" } } }, "localname": "DividendsCommonStockCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r120", "r166", "r167", "r169", "r170", "r171", "r178", "r180", "r187", "r188", "r189", "r193", "r194", "r593", "r594", "r718", "r740" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net Loss per Share\u2014Basic", "verboseLabel": "Net earnings (loss) per common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Net Loss per Share\u2014Basic" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r120", "r166", "r167", "r169", "r170", "r171", "r180", "r187", "r188", "r189", "r193", "r194", "r593", "r594", "r718", "r740" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net earnings (loss) per per common share\u2014assuming dilution (in dollars per share)", "verboseLabel": "Loss per Share\u2014Assuming Dilution" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Loss per Share\u2014Assuming Dilution" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r190", "r191", "r192", "r195" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Earnings (Loss) Per Common Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r620" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r511" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax rate, continuing operations" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r153", "r511", "r528" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "U.S. statutory income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r497" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r497" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Period for recognition of unrecognized compensation costs" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Severance" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails", "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue from External Customer [Line Items]", "terseLabel": "Revenue from External Customer [Line Items]" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r2", "r110", "r111", "r112", "r159", "r160", "r161", "r163", "r172", "r175", "r196", "r274", "r439", "r445", "r503", "r504", "r505", "r521", "r522", "r592", "r621", "r622", "r623", "r624", "r625", "r627", "r750", "r751", "r752", "r814" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesByIndustryAxis": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Axis]", "terseLabel": "Industry Sector [Axis]" } } }, "localname": "EquitySecuritiesByIndustryAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquitySecuritiesIndustryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Domain]", "terseLabel": "Industry Sector [Domain]" } } }, "localname": "EquitySecuritiesIndustryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": { "auth_ref": [ "r166", "r167", "r168", "r171", "r172", "r174", "r175" ], "lang": { "en-us": { "role": { "documentation": "Information by type of error correction.", "label": "Error Correction, Type [Axis]", "terseLabel": "Adjustments for Error Corrections [Axis]" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r408", "r424", "r425", "r606" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Estimate of Fair Value Measurement [Member]" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r596", "r597", "r598", "r602" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r596", "r607", "r608" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r596", "r607" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "terseLabel": "Fair Value, by Balance Sheet Grouping" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r408", "r424", "r425", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r597", "r668", "r669", "r670" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r408", "r424", "r425", "r596", "r603" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r596", "r597", "r599", "r600", "r604" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValues" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r408", "r457", "r458", "r463", "r465", "r597", "r668" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r408", "r424", "r425", "r457", "r458", "r463", "r465", "r597", "r669" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r408", "r424", "r425", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r597", "r670" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Fair Value, Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r408", "r424", "r425", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r668", "r669", "r670" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r601", "r604" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Measurements, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r560", "r566", "r579" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r643", "r646", "r655" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "terseLabel": "Finance Lease, Interest Expense" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r642" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease, Liability, Current", "negatedTerseLabel": "Finance Lease, Liability, Current", "terseLabel": "Current portion of finance lease obligations" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r654" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.", "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Finance Lease, Liability, Fiscal Year Maturity" } } }, "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r642" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Finance Lease Long-Term Obligations" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Payment, Due", "terseLabel": "Finance Lease, Liability, Payments, Due" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, after Year Five", "terseLabel": "Finance Lease, Liability, Payments, Due after Year Five" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year One", "terseLabel": "Finance Lease, Liability, Payments, Due Next Twelve Months" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Five", "terseLabel": "Finance Lease, Liability, Payments, Due Year Five" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Four", "terseLabel": "Finance Lease, Liability, Payments, Due Year Four" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Three", "terseLabel": "Finance Lease, Liability, Payments, Due Year Three" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Two", "terseLabel": "Finance Lease, Liability, Payments, Due Year Two" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r641" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "terseLabel": "Finance Lease, Right-of-Use Asset" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r643", "r646", "r655" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Finance Lease, Right-of-Use Asset, Amortization" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r652", "r655" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Finance Lease, Weighted Average Discount Rate, Percent" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r651", "r655" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance Lease, Weighted Average Remaining Lease Term", "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r265", "r266", "r267", "r268", "r269", "r278", "r283", "r284", "r285", "r287", "r298", "r299", "r300", "r301", "r419", "r438", "r583", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r784", "r785", "r786", "r787", "r792", "r793", "r794" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLosses": { "auth_ref": [ "r248", "r277", "r279", "r282", "r711", "r798", "r800", "r802" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 1.0, "parentTag": "us-gaap_NotesReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, Allowance for Credit Loss", "negatedTotalLabel": "Allowance for doubtful accounts", "periodEndLabel": "Balance as of end of period", "periodStartLabel": "Balance as of beginning of period" } } }, "localname": "FinancingReceivableAllowanceForCreditLosses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails", "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Financing Receivable, Allowance for Credit Loss [Line Items]", "terseLabel": "Financing Receivable, Allowance for Credit Losses [Line Items]" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Financing Receivable, Allowance for Credit Loss [Roll Forward]", "terseLabel": "Allowance for Doubtful Accounts [Roll Forward]" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesWriteOffs": { "auth_ref": [ "r249", "r281", "r295" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of writeoff of financing receivable, charged against allowance for credit loss.", "label": "Financing Receivable, Allowance for Credit Loss, Writeoff", "negatedTerseLabel": "Direct write-offs charged against the allowance" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesWriteOffs", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesRollforwardofAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancingReceivableImpairedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Financing Receivable, Impaired [Line Items]", "terseLabel": "Financing Receivable, Impaired [Line Items]" } } }, "localname": "FinancingReceivableImpairedLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivablePortfolioSegmentAxis": { "auth_ref": [ "r278", "r283", "r288", "r784", "r785", "r786", "r787", "r792", "r793", "r794", "r796", "r797", "r798", "r799", "r800", "r801", "r802" ], "lang": { "en-us": { "role": { "documentation": "Information by the level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses.", "label": "Financing Receivable Portfolio Segment [Axis]", "terseLabel": "Financing Receivable Portfolio Segment [Axis]" } } }, "localname": "FinancingReceivablePortfolioSegmentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivablePortfolioSegmentDomain": { "auth_ref": [ "r784", "r785", "r786", "r787", "r792", "r793", "r794", "r796", "r797", "r798", "r799", "r800", "r801", "r802" ], "lang": { "en-us": { "role": { "documentation": "Level at which an entity develops and documents a systematic methodology to determine its allowance for credit losses.", "label": "Financing Receivable Portfolio Segment [Domain]", "terseLabel": "Financing Receivable Portfolio Segment" } } }, "localname": "FinancingReceivablePortfolioSegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis": { "auth_ref": [ "r256", "r258", "r259", "r284", "r285", "r287", "r289", "r291", "r295", "r296", "r784", "r785", "r786", "r787", "r792", "r793", "r794", "r796", "r797", "r798", "r799", "r800", "r801", "r802" ], "lang": { "en-us": { "role": { "documentation": "Information by class of financing receivable determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Axis]", "terseLabel": "Class of Financing Receivable, Type [Axis]" } } }, "localname": "FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain": { "auth_ref": [ "r784", "r785", "r786", "r787", "r792", "r793", "r794", "r796", "r797", "r798", "r799", "r800", "r801", "r802" ], "lang": { "en-us": { "role": { "documentation": "Financing receivables determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Domain]", "terseLabel": "Class of Financing Receivable, Type" } } }, "localname": "FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentPastDueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Financing Receivable, Past Due [Line Items]", "terseLabel": "Financing Receivable, Recorded Investment, Past Due [Line Items]" } } }, "localname": "FinancingReceivableRecordedInvestmentPastDueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Finite-Lived intangible assets, useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r323" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r325" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "Future amortization expense, 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "Future amortization expense, remainder of fiscal year" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r325" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "Future amortization expense, 2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r325" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "Future amortization expense, 2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r325" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "Future amortization expense, 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r325" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "Future amortization expense, 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesFiniteLivedIntangibleAssetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r318", "r320", "r323", "r327", "r698", "r702" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r323", "r702" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Historical Cost" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r318", "r322" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Forward exchange contracts\u2014net", "verboseLabel": "Foreign currency forward contracts" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and fixtures" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnRepurchaseOfDebtInstrument": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from the difference between the repurchase price of a debt instrument initially issued by the entity and the net carrying amount of the debt at the time of its repurchase.", "label": "Gain (Loss) on Repurchase of Debt Instrument", "negatedTerseLabel": "Gain (Loss) on Repurchase of Debt Instrument" } } }, "localname": "GainLossOnRepurchaseOfDebtInstrument", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfBusiness": { "auth_ref": [ "r143", "r548" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.", "label": "Gain (Loss) on Disposition of Business", "terseLabel": "Gain on sale of business" } } }, "localname": "GainLossOnSaleOfBusiness", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r143" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Loss (gain) on disposals of property and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r143", "r428", "r429" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTerseLabel": "Net gain on debt extinguishment", "terseLabel": "Net gain on debt extinguishment" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicDistributionAxis": { "auth_ref": [ "r294", "r720", "r721", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r803", "r804", "r805", "r806", "r807", "r808" ], "lang": { "en-us": { "role": { "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution [Axis]", "terseLabel": "Geographic Distribution [Axis]" } } }, "localname": "GeographicDistributionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GeographicDistributionDomain": { "auth_ref": [ "r720", "r721", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r795", "r803", "r804", "r805", "r806", "r807", "r808" ], "lang": { "en-us": { "role": { "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution [Domain]", "terseLabel": "Geographic Distribution [Domain]" } } }, "localname": "GeographicDistributionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r308", "r310", "r662", "r704" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r143", "r309", "r311", "r313" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "negatedTerseLabel": "Goodwill, Impairment Loss", "terseLabel": "Goodwill, Impairment Loss" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r123", "r151", "r222", "r228", "r232", "r235", "r238", "r270", "r377", "r378", "r379", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r611" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r558", "r575" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairedFinancingReceivableInterestIncomeAccrualMethodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impaired Financing Receivable, Interest Income, Accrual Method [Abstract]", "terseLabel": "Interest Income Recognized" } } }, "localname": "ImpairedFinancingReceivableInterestIncomeAccrualMethodAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairedFinancingReceivableRecordedInvestmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impaired Financing Receivable, Recorded Investment [Abstract]", "terseLabel": "Total Installment Receivables" } } }, "localname": "ImpairedFinancingReceivableRecordedInvestmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairedFinancingReceivableRelatedAllowance": { "auth_ref": [ "r252" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit losses related to recorded investment.", "label": "Impaired Financing Receivable, Related Allowance", "terseLabel": "Impaired Financing Receivable, Related Allowance" } } }, "localname": "ImpairedFinancingReceivableRelatedAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedFinancingReceivableUnpaidPrincipalBalanceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impaired Financing Receivable, Unpaid Principal Balance [Abstract]", "terseLabel": "Unpaid Principal Balance" } } }, "localname": "ImpairedFinancingReceivableUnpaidPrincipalBalanceAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod": { "auth_ref": [ "r254" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 2.0, "parentTag": "ivc_FinancingReceivableInterestIncomeAccrualMethod", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income, recognized on accrual basis, on financing receivables, for which there is a related allowance for credit losses and are recognized as impaired.", "label": "Impaired Financing Receivable, with Related Allowance, Interest Income, Accrual Method", "terseLabel": "Impaired Financing Receivable, with Related Allowance, Interest Income, Accrual Method" } } }, "localname": "ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment": { "auth_ref": [ "r251" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 2.0, "parentTag": "ivc_FinancingReceivableRecordedInvestment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in impaired financing receivables for which there is a related allowance for credit losses.", "label": "Impaired Financing Receivable, with Related Allowance, Recorded Investment", "terseLabel": "Impaired installment receivables with a related allowance recorded" } } }, "localname": "ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance": { "auth_ref": [ "r253" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails": { "order": 2.0, "parentTag": "ivc_FinancingReceivableUnpaidPrincipalBalance", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unpaid principal balance of impaired financing receivables for which there is a related allowance for credit losses.", "label": "Impaired Financing Receivable, with Related Allowance, Unpaid Principal Balance", "terseLabel": "Impaired installment receivables with a related allowance recorded" } } }, "localname": "ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedFinancingReceivablesTableTextBlock": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of impaired financing receivables.", "label": "Impaired Financing Receivables [Table Text Block]", "terseLabel": "Schedule of Installment Receivables by Class" } } }, "localname": "ImpairedFinancingReceivablesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r143", "r328" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.", "label": "Impairment of Intangible Assets (Excluding Goodwill)", "negatedTerseLabel": "Impairment of Intangible Assets (Excluding Goodwill)", "terseLabel": "Impairment of Intangible Assets (Excluding Goodwill)" } } }, "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r124", "r144", "r166", "r167", "r169", "r170", "r186", "r189", "r540" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "terseLabel": "Net loss from continuing operations", "totalLabel": "Net loss from Continuing Operations" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r116", "r222", "r228", "r232", "r235", "r238", "r703", "r714", "r721", "r741" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Earnings (loss) before income taxes", "totalLabel": "Loss Before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r222", "r228", "r232", "r235", "r238" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "Income (Loss) from Continuing Operations before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r466", "r469" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r6", "r8", "r9", "r10", "r11", "r12", "r13", "r16", "r18", "r19", "r20", "r337", "r338" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r334", "r346" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r153", "r512", "r513", "r515", "r523", "r529", "r531", "r532", "r533" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r154", "r174", "r175", "r220", "r510", "r524", "r530", "r742" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedTerseLabel": "Income tax provision", "terseLabel": "Income tax provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r80", "r713", "r736" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income Taxes Receivable, Current", "terseLabel": "Recoverable income taxes" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r142" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r142" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Trade receivables" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r142" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInFinanceReceivables": { "auth_ref": [ "r142" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in outstanding loans including accrued interest.", "label": "Increase (Decrease) in Finance Receivables", "negatedLabel": "Installment sales contracts, net" } } }, "localname": "IncreaseDecreaseInFinanceReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r142" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories, net" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherDeferredLiability": { "auth_ref": [ "r142" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred obligations classified as other.", "label": "Increase (Decrease) in Other Deferred Liability", "terseLabel": "Other long-term liabilities" } } }, "localname": "IncreaseDecreaseInOtherDeferredLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r142" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r181", "r182", "r183", "r189" ], "calculation": { "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Stock options and awards" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r319", "r326" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r326" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Historical Cost" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r319", "r326" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IndustryOfCounterpartyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The industry of the party or parties having primary responsibility to meet the obligations of the arrangement with the entity.", "label": "Industry of Counterparty [Domain]", "terseLabel": "Industry of Counterparty [Domain]" } } }, "localname": "IndustryOfCounterpartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Other Intangibles" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/Intangibles" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r316", "r321" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangibles, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r114", "r216", "r629", "r632", "r719" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "terseLabel": "Interest Income, Other" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r33", "r34", "r70" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 11.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRevenueExpenseNet": { "auth_ref": [ "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest revenue (income derived from investments in debt securities and on cash and cash equivalents) net of interest expense (cost of borrowed funds accounted for as interest).", "label": "Interest Revenue (Expense), Net", "terseLabel": "Interest Revenue (Expense), Net" } } }, "localname": "InterestRevenueExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r214", "r227", "r228", "r229", "r230", "r232", "r234", "r238" ], "lang": { "en-us": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Eliminations [Member]", "terseLabel": "Intersegment revenues" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r56", "r304" ], "calculation": { "http://www.invacare.com/role/InventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r23", "r83", "r662" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.invacare.com/role/InventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net", "totalLabel": "Inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r58", "r304" ], "calculation": { "http://www.invacare.com/role/InventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r57", "r304" ], "calculation": { "http://www.invacare.com/role/InventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r303" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Inventory Write-down" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandBuildingsAndImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate held and additions or improvements to real estate held and structures used in the conduct of business.", "label": "Land, Buildings and Improvements [Member]", "terseLabel": "Land, buildings and improvements" } } }, "localname": "LandBuildingsAndImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseContractualTermAxis": { "auth_ref": [ "r645" ], "lang": { "en-us": { "role": { "documentation": "Information by contractual term of lease arrangement.", "label": "Lease Contractual Term [Axis]", "terseLabel": "Lease Contractual Term [Axis]" } } }, "localname": "LeaseContractualTermAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseContractualTermDomain": { "auth_ref": [ "r645" ], "lang": { "en-us": { "role": { "documentation": "Contractual term of lease arrangement.", "label": "Lease Contractual Term [Domain]", "terseLabel": "Lease Contractual Term [Domain]" } } }, "localname": "LeaseContractualTermDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r653" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lease, Cost [Table]" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LegalEntityTypeOfCounterpartyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nature of the other party participating in a financial transaction.", "label": "Legal Entity Type of Counterparty [Domain]", "terseLabel": "Legal Entity Type of Counterparty [Domain]" } } }, "localname": "LegalEntityTypeOfCounterpartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeFinanceLeasesTextBlock": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.", "label": "Lessee, Finance Leases [Text Block]", "terseLabel": "Lessee, Finance Leases" } } }, "localname": "LesseeFinanceLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r645" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r654" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Lessee, Operating Lease, Liability, Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "terseLabel": "Total future minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Lessee, Operating Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of Credit Outstanding, Amount" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r53", "r151", "r270", "r611", "r662", "r710", "r733" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "terseLabel": "Liabilities and Equity", "totalLabel": "Total Liabilities and Shareholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Shareholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r72", "r151", "r270", "r377", "r378", "r379", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r544", "r549", "r550", "r611", "r660", "r661", "r662" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "terseLabel": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r5", "r6", "r15", "r17", "r20", "r335" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r77" ], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability for Uncertainty in Income Taxes, Noncurrent", "terseLabel": "Uncertain tax obligation including interest" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LicensingAgreementsMember": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).", "label": "Licensing Agreements [Member]", "verboseLabel": "License agreements" } } }, "localname": "LicensingAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": { "auth_ref": [ "r68" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Current Borrowing Capacity", "terseLabel": "Line of Credit Facility, Current Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityCurrentBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": { "auth_ref": [ "r606" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of the amount outstanding under the credit facility.", "label": "Line of Credit Facility, Fair Value of Amount Outstanding", "terseLabel": "Line of Credit Facility, Fair Value of Amount Outstanding" } } }, "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r68" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r68" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "terseLabel": "Commitment fee percentage" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]", "terseLabel": "Receivables" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/Receivables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r41" ], "calculation": { "http://www.invacare.com/role/LongTermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-term Debt and Lease Obligation", "verboseLabel": "Long-term debt net of current maturities" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "auth_ref": [ "r70" ], "calculation": { "http://www.invacare.com/role/LongTermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as current.", "label": "Long-term Debt and Lease Obligation, Current", "negatedTerseLabel": "Long-term Debt and Capital Lease Obligations, Current" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/LongTermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.", "label": "Long-term Debt and Lease Obligation, Including Current Maturities", "terseLabel": "Long-term debt", "totalLabel": "Long-term debt" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r69" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "terseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r76" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-Term Debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Long-term Debt [Text Block]", "terseLabel": "Long-term Debt" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r63" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-term Investments", "terseLabel": "Investments" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r76", "r375" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesFairValueofConvertibleDebtHedgesDetails", "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Weighted average interest rate (as a percent)" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r367", "r368" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyDisclosures": { "auth_ref": [ "r364", "r365" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.", "label": "Contingencies Disclosure [Text Block]", "terseLabel": "Contingencies" } } }, "localname": "LossContingencyDisclosures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/Contingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r367", "r368" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r21", "r538" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "terseLabel": "Divested Businesses" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DivestedBusinessesNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r140" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r140" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Used by Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r140", "r141", "r144" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Provided by (Used in) Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used by operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r20", "r104", "r107", "r112", "r117", "r144", "r151", "r162", "r166", "r167", "r169", "r170", "r174", "r175", "r186", "r222", "r228", "r232", "r235", "r238", "r270", "r377", "r378", "r379", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r594", "r611", "r715", "r737" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net Loss", "totalLabel": "Net Loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Not Designated as Hedging Instrument [Member]" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/DerivativesGainLossinStatementofFinacialPositionDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails", "http://www.invacare.com/role/DerivativesNotionalAmountsNotDesignatedasHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NotesAndLoansReceivableGrossCurrent": { "auth_ref": [ "r24", "r25", "r81", "r247", "r277" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 1.0, "parentTag": "us-gaap_NotesReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable, classified as current.", "label": "Financing Receivable, before Allowance for Credit Loss, Current", "terseLabel": "Installment Receivables, Current" } } }, "localname": "NotesAndLoansReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableGrossNoncurrent": { "auth_ref": [ "r246", "r277" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": 2.0, "parentTag": "us-gaap_NotesReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable, classified as noncurrent.", "label": "Financing Receivable, before Allowance for Credit Loss, Noncurrent", "terseLabel": "Installment Receivables, Long-Term" } } }, "localname": "NotesAndLoansReceivableGrossNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableNetCurrent": { "auth_ref": [ "r24", "r25", "r46", "r246", "r247", "r712" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.", "label": "Financing Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Installment receivables, net", "totalLabel": "Installment receivables, net" } } }, "localname": "NotesAndLoansReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableNetNoncurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 }, "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.", "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent", "terseLabel": "Installment receivables", "totalLabel": "Installment receivables, net, long-term" } } }, "localname": "NotesAndLoansReceivableNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails", "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableGross": { "auth_ref": [ "r259", "r277", "r284", "r286", "r295", "r296", "r796", "r798", "r799" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable.", "label": "Financing Receivable, before Allowance for Credit Loss", "totalLabel": "Total Installment Receivables" } } }, "localname": "NotesReceivableGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableNet": { "auth_ref": [ "r47", "r246", "r286" ], "calculation": { "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, after Allowance for Credit Loss", "totalLabel": "Installment receivables, net" } } }, "localname": "NotesReceivableNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentRecevablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r222", "r228", "r232", "r235", "r238" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating Loss", "totalLabel": "Operating Loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r647", "r655" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating Lease, Cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r644" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating Lease, Expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r642" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "negatedTerseLabel": "Operating Lease, Liability, Current", "terseLabel": "Current portion of operating lease obligations" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r642" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating Leases Long-Term Obligations" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/LeasesandCommitmentsFutureMinimumOperatingandFinancingLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r641" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating Lease, Right-of-Use Asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r652", "r655" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r651", "r655" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsWeightedAverageRemainingLeaseTermsandDiscountRatesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r227", "r228", "r229", "r230", "r232", "r238" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments [Member]" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r158", "r177", "r209", "r551" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "terseLabel": "Accounting Policies" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r32", "r33", "r34", "r70" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 15.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other items, principally trade accruals" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r84", "r662" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets", "totalLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Other Assets Disclosure [Text Block]", "terseLabel": "Other Long-Term Assets" } } }, "localname": "OtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r66" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other Assets", "totalLabel": "Other Long-Term Assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent [Abstract]", "terseLabel": "Defined Benefit Plans:" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": { "auth_ref": [ "r99" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax", "negatedTerseLabel": "Deferred tax adjustment resulting from defined benefit plan activity" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r541", "r542", "r546" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r98", "r102", "r103", "r464" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax", "terseLabel": "Amortization of prior service costs and unrecognized losses" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": { "auth_ref": [ "r98", "r102", "r103", "r464" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax", "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r101", "r110", "r111", "r113", "r621", "r623", "r627" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "OCI before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r95", "r98" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": { "auth_ref": [ "r98" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent", "terseLabel": "Current period gain (loss) on cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": { "auth_ref": [ "r99" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 6.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax", "negatedTerseLabel": "Deferred tax benefit (provision) related to gain on cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r93" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r105", "r108", "r110", "r111", "r113", "r118", "r439", "r621", "r626", "r627", "r716", "r738" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Other Comprehensive Loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r560", "r579" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other Current Assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesBalanceSheetLocationDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other current assets.", "label": "Other Current Assets [Text Block]", "terseLabel": "Other Current Assets" } } }, "localname": "OtherCurrentAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherEmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r70" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 14.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Other Employee-related Liabilities, Current", "terseLabel": "Severance" } } }, "localname": "OtherEmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherExpenseMember": { "auth_ref": [ "r573" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other expense.", "label": "Other Expense [Member]", "terseLabel": "Other Expense" } } }, "localname": "OtherExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInvestments": { "auth_ref": [ "r63", "r735" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments classified as other.", "label": "Other Investments", "terseLabel": "Other investments" } } }, "localname": "OtherInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]", "terseLabel": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "Other Liabilities Disclosure [Text Block]", "terseLabel": "Other Long-Term Obligations" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligations" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r77" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other Long-Term Obligations", "totalLabel": "Other Long-Term Obligations" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r144" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedTerseLabel": "Provision (benefit) for other deferred liabilities" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Table Text Block]", "terseLabel": "Other Noncurrent Liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r26", "r29", "r307" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 9.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Other Prepaid Expense, Current", "terseLabel": "Prepaid and other current assets" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherRestructuringMember": { "auth_ref": [ "r344", "r345", "r351", "r352" ], "lang": { "en-us": { "role": { "documentation": "Restructuring and related activities classified as other.", "label": "Other Restructuring [Member]", "terseLabel": "Other Restructuring" } } }, "localname": "OtherRestructuringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherSundryLiabilitiesNoncurrent": { "auth_ref": [ "r42", "r708", "r729" ], "calculation": { "http://www.invacare.com/role/OtherLongTermObligationsDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.", "label": "Other Sundry Liabilities, Noncurrent", "terseLabel": "Other" } } }, "localname": "OtherSundryLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PastDueFinancingReceivablesTableTextBlock": { "auth_ref": [ "r258", "r259", "r284", "r296" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of aging analysis for financing receivable.", "label": "Financing Receivable, Past Due [Table Text Block]", "terseLabel": "Schedule of Aging of Installment Receivables" } } }, "localname": "PastDueFinancingReceivablesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]", "terseLabel": "Patents" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]", "terseLabel": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForProceedsFromLongtermInvestments": { "auth_ref": [], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount paid (received) by the reporting entity through acquisition or sale and maturities of long-term investments which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.", "label": "Payments for (Proceeds from) Long-term Investments", "negatedLabel": "Change in other long-term assets" } } }, "localname": "PaymentsForProceedsFromLongtermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r131", "r133" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "terseLabel": "Other" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r136" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedTerseLabel": "Purchases of treasury shares", "terseLabel": "Payments for Repurchase of Common Stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r139", "r345" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedTerseLabel": "Payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r136" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Payment of dividends", "negatedTerseLabel": "Payments of Ordinary Dividends, Common Stock" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r138" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "negatedTerseLabel": "Payment of financing costs" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r132" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance Shares" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r473", "r498" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r605" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred Stock, Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r44", "r662" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred Shares (Authorized 300\u00a0shares; none outstanding)" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent": { "auth_ref": [ "r38", "r705", "r727" ], "calculation": { "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Noncurrent", "terseLabel": "Other" } } }, "localname": "PrepaidExpenseAndOtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsComponentsofOtherLongTermAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidInsurance": { "auth_ref": [ "r27", "r29", "r306", "r307" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 8.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Insurance", "terseLabel": "Prepaid insurance" } } }, "localname": "PrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]", "terseLabel": "Prime Rate" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": { "auth_ref": [ "r129" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.", "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested", "terseLabel": "Proceeds from sale of business" } } }, "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/DivestedBusinessesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r135" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Proceeds from revolving lines of credit and long-term borrowings" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r134" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Issuance of warrants", "verboseLabel": "Proceeds from Issuance of Warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/LongTermDebtComponentsofConvertibleDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r130" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from sale of property and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductLiabilityContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Liability Contingency [Line Items]", "terseLabel": "Product Liability Contingency" } } }, "localname": "ProductLiabilityContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductLiabilityContingencyTable": { "auth_ref": [ "r356", "r358", "r359", "r360", "r361", "r362", "r363" ], "lang": { "en-us": { "role": { "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.", "label": "Product Liability Contingency [Table]", "terseLabel": "Product Liability Contingency [Table]" } } }, "localname": "ProductLiabilityContingencyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r449" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Product" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r70", "r366", "r370" ], "calculation": { "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Product Warranty Accrual, Current", "periodEndLabel": "Balance as of September 30, 2022", "periodStartLabel": "Balance as of January 1, 2022", "terseLabel": "Warranty" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails", "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r371" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Settlements made during the period" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease": { "auth_ref": [ "r373" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the standard and extended product warranty accrual from changes in estimates attributable to preexisting product warranties.", "label": "Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties", "terseLabel": "Changes in liability for pre-existing warranties during the period, including expirations" } } }, "localname": "ProductWarrantyAccrualPreexistingIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r372" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Warranties provided during the period" } } }, "localname": "ProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r65", "r333" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment by Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r339", "r764", "r765", "r766" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property And Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r64", "r331" ], "calculation": { "http://www.invacare.com/role/PropertyAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r36", "r37", "r333", "r662", "r722", "r734" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.invacare.com/role/PropertyAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and Equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r36", "r333" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r36", "r331" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r121", "r280" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Provision for Doubtful Accounts", "verboseLabel": "Provision for losses on trade and installment receivables" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivableTypeDomain": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.", "label": "Receivable [Domain]", "terseLabel": "Receivable [Domain]" } } }, "localname": "ReceivableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]", "terseLabel": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesBillingStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amounts due from customers (or dealers) within the next year (or operating cycle, if longer) for goods or services that have been delivered or used, but not yet paid.", "label": "Receivables Billing Status [Domain]", "terseLabel": "Receivables Billing Status [Domain]" } } }, "localname": "ReceivablesBillingStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r101", "r110", "r111", "r113", "r621", "r625", "r627" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTerseLabel": "Amount reclassified from accumulated OCI" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "Item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r137" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedLabel": "Repurchases of convertible debt, payments on revolving lines of credit and finance leases" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r343", "r345", "r348", "r354", "r355" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Charges Related To Restructuring Activities" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r143", "r342", "r349", "r351" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "negatedTerseLabel": "Charges", "terseLabel": "Charges", "verboseLabel": "Charges related to restructuring activities" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r344", "r345", "r351", "r352" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Cost and Reserve [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r345", "r350" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Restructuring Reserve" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveAccrualAdjustment1": { "auth_ref": [ "r345", "r352" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.", "label": "Restructuring Reserve, Accrual Adjustment", "terseLabel": "Restructuring Reserve, Accrual Adjustment" } } }, "localname": "RestructuringReserveAccrualAdjustment1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r40", "r345", "r352" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "terseLabel": "Restructuring Reserve, Current" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesComponentsofAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r49", "r445", "r506", "r662", "r732", "r754", "r759" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings (accumulated deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r2", "r159", "r160", "r161", "r163", "r172", "r175", "r274", "r503", "r504", "r505", "r521", "r522", "r592", "r750", "r752" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionDeferredRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing unearned income or deferred revenue related to transactions involving the sale of a product or performance of services.", "label": "Revenue Recognition, Deferred Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition, Deferred Revenue [Policy Text Block]" } } }, "localname": "RevenueRecognitionDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/RevenueRevenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionMultipleDeliverableArrangementsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue Recognition, Multiple-deliverable Arrangements [Line Items]", "terseLabel": "Revenue Recognition, Multiple-deliverable Arrangements [Line Items]" } } }, "localname": "RevenueRecognitionMultipleDeliverableArrangementsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning the recognition of revenue arrangements under which the entity does or will perform multiple revenue-generating activities, categorized by type of arrangement, including certain revenue arrangements that include software elements. This item does not include multiple-deliverable arrangements for industries that prepare disclosures under specific requirements (for instance, construction-type and production-type contracts) otherwise provided for in the taxonomy.", "label": "Revenue Recognition, Multiple-deliverable Arrangements [Table]", "terseLabel": "Revenue Recognition, Multiple-deliverable Arrangements [Table]" } } }, "localname": "RevenueRecognitionMultipleDeliverableArrangementsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the recognition of revenue arrangements under which the entity does or will perform multiple revenue-generating activities, categorized by type of arrangement. This item includes certain revenue arrangements that include software elements. This item does not include multiple-deliverable arrangements for industries that prepare disclosures under specific requirements (for instance, construction-type and production-type contracts) otherwise provided for in the taxonomy.", "label": "Revenue Recognition, Multiple-deliverable Arrangements [Table Text Block]", "terseLabel": "Revenue Recognition, Multiple-deliverable Arrangements" } } }, "localname": "RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r115", "r151", "r213", "r214", "r227", "r233", "r234", "r240", "r241", "r244", "r270", "r377", "r378", "r379", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r611", "r721" ], "calculation": { "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 }, "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "negatedTerseLabel": "Net Sales", "terseLabel": "Net Sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility", "verboseLabel": "Senior secured revolving credit facility, due in October 2015" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": { "auth_ref": [ "r650", "r655" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability", "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability" } } }, "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r650", "r655" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RiskLevelHighMember": { "auth_ref": [ "r369", "r576" ], "lang": { "en-us": { "role": { "documentation": "An entity's internal risk assessment as having high risk.", "label": "Risk Level, High [Member]", "terseLabel": "Risk Level, High" } } }, "localname": "RiskLevelHighMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RiskLevelLowMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity's internal risk assessment as having low risk.", "label": "Risk Level, Low [Member]", "terseLabel": "Risk Level, Low" } } }, "localname": "RiskLevelLowMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RiskLevelMediumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity's internal risk assessment as having medium risk.", "label": "Risk Level, Medium [Member]", "terseLabel": "Risk Level, Medium" } } }, "localname": "RiskLevelMediumMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]", "terseLabel": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SaleAndLeasebackTransactionGainLossNet": { "auth_ref": [ "r649", "r655", "r658" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.", "label": "Sale and Leaseback Transaction, Gain (Loss), Net", "terseLabel": "Sale and Leaseback Transaction, Gain (Loss), Net" } } }, "localname": "SaleAndLeasebackTransactionGainLossNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleLeasebackTransactionDeferredGainGross": { "auth_ref": [ "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the gain recorded in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller to be recognized in future periods.", "label": "Sale Leaseback Transaction, Deferred Gain, Gross", "terseLabel": "Sale Leaseback Transaction, Deferred Gain, Gross" } } }, "localname": "SaleLeasebackTransactionDeferredGainGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails", "http://www.invacare.com/role/LongTermDebtSaleLeasebackTransactionsDetails", "http://www.invacare.com/role/OtherLongTermObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleLeasebackTransactionLeaseTerms": { "auth_ref": [ "r637", "r657" ], "lang": { "en-us": { "role": { "documentation": "A description of the terms of the lease(s) related to the assets being leased-back in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.", "label": "Sale Leaseback Transaction, Lease Terms", "terseLabel": "Sale Leaseback Transaction, Lease Terms" } } }, "localname": "SaleLeasebackTransactionLeaseTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionNetProceedsInvestingActivities": { "auth_ref": [ "r638", "r639", "r640" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow after closing and debt issuance costs received by a seller-lessee in a sale-leaseback recognized in investing activities.", "label": "Sale Leaseback Transaction, Net Proceeds, Investing Activities", "terseLabel": "Sale Leaseback Transaction, Net Proceeds, Investing Activities" } } }, "localname": "SaleLeasebackTransactionNetProceedsInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesMember": { "auth_ref": [ "r573" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.", "label": "Sales [Member]", "terseLabel": "Sales [Member]" } } }, "localname": "SalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Schedule of Installment Receivables" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Expenses" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r101", "r626", "r627" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.", "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Schedule of Cash Flow, Supplemental Disclosures [Table]" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]", "terseLabel": "Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r76", "r157", "r424", "r426", "r440", "r442", "r443", "r444", "r630", "r631", "r634", "r724" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Instruments" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r567" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.", "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r566" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Derivatives Instruments Statements of Financial Position, Fair Value" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r472", "r495", "r507" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table]", "terseLabel": "Revenue from External Customers by Products and Services [Table]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "terseLabel": "Revenue from External Customers by Products and Services [Table Text Block]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r596", "r597" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable": { "auth_ref": [ "r283", "r802" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about allowance for credit loss on financing receivable.", "label": "Financing Receivable, Allowance for Credit Loss [Table]", "terseLabel": "Schedule of Financing Receivable, Allowance for Credit Losses [Table]" } } }, "localname": "ScheduleOfFinancingReceivableAllowanceForCreditLossesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesScheduleforAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFinancingReceivablesPastDueTable": { "auth_ref": [ "r284", "r296" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about aging analysis for financing receivable.", "label": "Financing Receivable, Past Due [Table]", "terseLabel": "Schedule of Financing Receivables Past Due [Table]" } } }, "localname": "ScheduleOfFinancingReceivablesPastDueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r318", "r322", "r698" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r318", "r322" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r312", "r314" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfImpairedFinancingReceivableTable": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Schedule of the recorded investment, unpaid principal balance, associated allowance, average recorded investment, accounting policies, and interest income recognized on the accrual and cash basis for impaired financing receivables by class of financing receivable.", "label": "Schedule of Impaired Financing Receivable [Table]", "terseLabel": "Schedule of Impaired Financing Receivable [Table]" } } }, "localname": "ScheduleOfImpairedFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r326", "r329" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r35", "r59", "r60", "r61" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r554" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of noncurrent assets.", "label": "Schedule of Other Assets, Noncurrent [Table Text Block]", "terseLabel": "Schedule of Other Assets, Noncurrent" } } }, "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherLongTermAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other current assets.", "label": "Schedule of Other Current Assets [Table Text Block]", "terseLabel": "Schedule of Other Current Assets" } } }, "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r570", "r572" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.", "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]", "terseLabel": "Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location" } } }, "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of Product Warranty Liability" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r65", "r333" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Schedule of Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/PropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r344", "r345", "r346", "r347", "r351", "r352", "r353" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r345", "r352" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring and Related Costs" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r222", "r225", "r231", "r312" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r222", "r225", "r231", "r312" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Reporting Information, by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r473", "r498" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]", "terseLabel": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Stock Options Outstanding" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r479", "r490", "r491" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Stock Options, Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": { "auth_ref": [ "r497" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]", "terseLabel": "Schedule of Unrecognized Compensation Cost, Nonvested Awards" } } }, "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Secured Debt" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.", "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate" } } }, "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r210", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r227", "r228", "r229", "r230", "r232", "r233", "r234", "r235", "r236", "r238", "r244", "r347", "r353", "r743" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails", "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r210", "r211", "r212", "r222", "r226", "r232", "r236", "r237", "r238", "r239", "r240", "r243", "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Business Segments" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r126" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative expenses", "verboseLabel": "Amortization of prior service costs and unrecognized gains" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, General and Administrative Expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNarrativeDetails", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r142" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Provision for equity compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period", "terseLabel": "Award requisite service period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": { "auth_ref": [ "r471", "r474" ], "lang": { "en-us": { "role": { "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Description", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r488" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r484" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance", "periodStartLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r484" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance", "periodStartLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "The net total number of shares (or other type of equity) under an equity-based award plan, other than a stock option plan, that were granted, vested and forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)", "terseLabel": "Net award activity (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r487" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r487" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Options available for grant at end of period (in shares)", "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Options exercisable at end of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Antidilutive share granted, average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/NetEarningsLossPerCommonShareTextualsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Canceled (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r481", "r498" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options outstanding at end of period (in shares)", "periodStartLabel": "Options outstanding at beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Options outstanding at end of period - Weighted Average Exercise Price (in dollars per share)", "periodStartLabel": "Options outstanding at beginning of period - Weighted Average Exercise Price (in dollars per share)", "terseLabel": "Options Outstanding - Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r471", "r477" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationRestrictedStockActivityDetails", "http://www.invacare.com/role/EquityCompensationSharebasedCompensationExpenseDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Canceled - Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.", "label": "Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block]", "terseLabel": "Share-based Compensation, Performance Shares Award Unvested Activity" } } }, "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]", "terseLabel": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]", "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]", "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit", "terseLabel": "Exercise price range, lower limit (in dollars per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r489" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Options Exercisable - Number Exercisable At end of period (in shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "terseLabel": "Options Outstanding - Number Outstanding at end of period (in shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit", "terseLabel": "Exercise price range, upper limit (in dollars per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails", "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r476" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options Exercisable - Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Options Outstanding - Weighted Average Remaining Contractual Life" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationStockOptionsOutstandingbyExercisePriceDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r648", "r655" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term Lease, Cost", "terseLabel": "Short-term Lease, Cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LeasesandCommitmentsLeaseExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r7", "r210", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r227", "r228", "r229", "r230", "r232", "r233", "r234", "r235", "r236", "r238", "r244", "r312", "r336", "r347", "r353", "r743" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccruedExpensesWarrantyScheduleDetails", "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails", "http://www.invacare.com/role/GoodwillGoodwillDetailsDetails", "http://www.invacare.com/role/IntangiblesNarrativeDetails", "http://www.invacare.com/role/ReceivablesAgingofInstallmentReceivablesDetails", "http://www.invacare.com/role/ReceivablesInstallmentReceivablesbyClassDetails", "http://www.invacare.com/role/ReceivablesNarrativeDetails", "http://www.invacare.com/role/RevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r43", "r44", "r45", "r149", "r151", "r180", "r184", "r185", "r187", "r189", "r197", "r198", "r199", "r270", "r377", "r382", "r383", "r384", "r390", "r391", "r431", "r432", "r435", "r436", "r439", "r611", "r784" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement", "http://www.invacare.com/role/DEIDocument", "http://www.invacare.com/role/EquityCompensationNarrativeDetails", "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r2", "r79", "r110", "r111", "r112", "r159", "r160", "r161", "r163", "r172", "r175", "r196", "r274", "r439", "r445", "r503", "r504", "r505", "r521", "r522", "r592", "r621", "r622", "r623", "r624", "r625", "r627", "r750", "r751", "r752", "r814" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentChangesinAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/AccumulatedOtherComprehensiveIncomeLossbyComponentReclassifiedOutofAccumulatedOtherComprehensiveIncomeDetails", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r159", "r160", "r161", "r196", "r697" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementOfCashFlows", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r44", "r45", "r439", "r445" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Stock Issued During Period, Value, New Issues" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r439", "r445" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r79", "r439", "r445" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "negatedTerseLabel": "Stock Issued During Period, Value, Stock Options Exercised" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r45", "r51", "r52", "r151", "r260", "r270", "r611", "r662" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Total Shareholders\u2019 Equity", "periodStartLabel": "Total Shareholders\u2019 Equity", "terseLabel": "Total Shareholders\u2019 Equity", "totalLabel": "Total Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by business subsegments.", "label": "Subsegments [Axis]", "terseLabel": "Subsegments [Axis]" } } }, "localname": "SubsegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Subsegments [Domain]", "terseLabel": "Subsegments [Domain]" } } }, "localname": "SubsegmentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/ReceivablesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r628", "r663" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r628", "r663" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r628", "r663" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]", "terseLabel": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]", "terseLabel": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r69" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Current taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "terseLabel": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IntangiblesIntangibleTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r265", "r266", "r267", "r268", "r269", "r419", "r438", "r583", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r784", "r785", "r786", "r787", "r792", "r793", "r794" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/FairValuesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.invacare.com/role/FairValuesDetailsofBookValueandFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r78", "r446" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r78", "r446" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Treasury Stock, Shares" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r78", "r446", "r447" ], "calculation": { "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury Shares (4,535 and 4,397 shares at September 30, 2022 and December 31, 2021, respectively)", "terseLabel": "Treasury Stock, Value" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedBalanceSheets", "http://www.invacare.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r162", "r163", "r164", "r165", "r176", "r262", "r263", "r271", "r272", "r273", "r274", "r275", "r276", "r376", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r519", "r520", "r521", "r522", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r659", "r699", "r700", "r701", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r810", "r811", "r812", "r813", "r814" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofShareholdersEquityStatement" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r539" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "terseLabel": "Type of Arrangement and Non-arrangement Transactions [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/RevenueDetails", "http://www.invacare.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r344", "r345", "r351", "r352" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/BusinessSegmentsInformationbySegmentDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesDetails", "http://www.invacare.com/role/ChargesRelatedToRestructuringActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnDerivatives": { "auth_ref": [ "r143" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.", "label": "Unrealized Gain (Loss) on Derivatives", "terseLabel": "Unrealized Gain (Loss)" } } }, "localname": "UnrealizedGainLossOnDerivatives", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/DerivativesNotionalAmountsDesignatedasHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r200", "r201", "r202", "r203", "r206", "r207", "r208" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Valuation Allowance [Line Items]", "terseLabel": "Valuation Allowance [Line Items]" } } }, "localname": "ValuationAllowanceLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowanceTable": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "A listing of an entity's valuation allowances to reduce deferred tax assets to amounts which it is more likely than not will not be realized, including a description of the deferred tax assets for which the valuation allowance has been recorded and the amount of the valuation allowance.", "label": "Valuation Allowance [Table]", "terseLabel": "Valuation Allowance [Table]" } } }, "localname": "ValuationAllowanceTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValueAddedTaxReceivableCurrent": { "auth_ref": [ "r84" ], "calculation": { "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.", "label": "Value Added Tax Receivable, Current", "terseLabel": "Tax receivables principally value added taxes" } } }, "localname": "ValueAddedTaxReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/OtherCurrentAssetsComponentsofOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/LongTermDebtDetails", "http://www.invacare.com/role/LongTermDebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "terseLabel": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "terseLabel": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/EquityCompensationPerformanceShareActivityDetails", "http://www.invacare.com/role/EquityCompensationUnrecognizedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r179", "r189" ], "calculation": { "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted Average Shares\u00a0Outstanding\u2014Assuming Dilution", "totalLabel": "Average common shares assuming dilution" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r178", "r189" ], "calculation": { "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted Average Shares\u00a0Outstanding\u2014Basic", "verboseLabel": "Average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.invacare.com/role/CondensedConsolidatedStatementofComprehensiveIncomeLoss", "http://www.invacare.com/role/NetEarningsLossPerCommonShareComputationofBasicandDilutedNetEarningsLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r128": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r158": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r177": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r195": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r209": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r21": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=2122178" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r245": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953550-111524" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5066-111524" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5111-111524" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r261": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196772" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r264": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196854" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921830-210448" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921833-210448" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "79", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "80", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82922355-210448" }, "r297": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/subtopic&trid=82887181" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r302": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/subtopic&trid=82887182" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r305": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r315": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/subtopic&trid=2144439" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r330": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r339": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(e))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r355": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r364": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/subtopic&trid=2127163" }, "r365": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "450", "URI": "http://asc.fasb.org/subtopic&trid=2127197" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123377177&loc=d3e11281-110244" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12524-110249" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(4))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S65", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4875-112606" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=123585891&loc=d3e19793-108362" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r508": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r533": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r538": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613673-111683" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r551": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1),(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r595": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123386454&loc=d3e45280-112737" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123417499&loc=d3e49567-112750" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123416376&loc=d3e50796-112755" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "50", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123386837&loc=d3e51831-112757" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "51", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123386837&loc=d3e51840-112757" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123386837&loc=d3e51843-112757" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r656": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123417830&loc=SL77919786-209982" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123417830&loc=SL77919786-209982" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(f,g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5(c))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123366838&loc=d3e3073-115593" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r779": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r780": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r781": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r782": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r783": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r784": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r785": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r786": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r787": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r788": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(4)" }, "r789": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(5)" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r790": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)(i)" }, "r791": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)(ii)" }, "r792": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r793": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r794": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r795": { "Name": "Regulation S-K (SK)", "Number": "229", "Publisher": "SEC", "Section": "1402", "Subsection": "Instruction 5" }, "r796": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1404" }, "r797": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1404" }, "r798": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(1)" }, "r799": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(2)" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r800": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(3)" }, "r801": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(4)" }, "r802": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1405" }, "r803": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(1)" }, "r804": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(2)" }, "r805": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(3)" }, "r806": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(4)" }, "r807": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(5)" }, "r808": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1406" }, "r809": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a),(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580" } }, "version": "2.1" } ZIP 127 0000742112-22-000085-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000742112-22-000085-xbrl.zip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